Citrus Sinensis ID: 011988
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 473 | 2.2.26 [Sep-21-2011] | |||||||
| P42158 | 450 | Casein kinase I isoform d | no | no | 0.945 | 0.993 | 0.707 | 0.0 | |
| Q5BP74 | 415 | Casein kinase I isoform d | N/A | no | 0.627 | 0.715 | 0.768 | 1e-144 | |
| P48730 | 415 | Casein kinase I isoform d | yes | no | 0.627 | 0.715 | 0.771 | 1e-143 | |
| P35508 | 415 | Casein kinase I isoform d | yes | no | 0.627 | 0.715 | 0.771 | 1e-143 | |
| Q06486 | 415 | Casein kinase I isoform d | yes | no | 0.627 | 0.715 | 0.771 | 1e-143 | |
| Q9DC28 | 415 | Casein kinase I isoform d | yes | no | 0.627 | 0.715 | 0.771 | 1e-143 | |
| Q5ZLL1 | 416 | Casein kinase I isoform e | no | no | 0.621 | 0.706 | 0.776 | 1e-143 | |
| Q9JMK2 | 416 | Casein kinase I isoform e | no | no | 0.621 | 0.706 | 0.772 | 1e-143 | |
| Q6P647 | 415 | Casein kinase I isoform d | no | no | 0.621 | 0.708 | 0.772 | 1e-143 | |
| Q7T2E3 | 403 | Casein kinase I isoform d | yes | no | 0.621 | 0.729 | 0.776 | 1e-143 |
| >sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 676 bits (1744), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/475 (70%), Positives = 387/475 (81%), Gaps = 28/475 (5%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRVGNKFRLGRKIGSGSFGEIYLGTNI TNEE+AIKL NVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTG+PN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEF H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAK+YRD+ THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGTKKQKYE+ISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 300 ST-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 358
+ P+RA+ P G S+ +PP +N+DR +G EEGR + SRRR SG L NS N+S
Sbjct: 301 TAPPSRALNPAVGTSAALPPGISNIDRYTGEEEGR----PHMESSRRRVSGALDNSGNIS 356
Query: 359 KQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDAS 417
Q + + ++D+M+ S +L +S+GSSRRV + GS+ R RT D S
Sbjct: 357 NQPTSSS-----ARDSMIPSSSLFAQSAGSSRRVTAVSGSRDNFPGSEELLQRSRTGDVS 411
Query: 418 PGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVH 472
G + S G+ +G+ST +++ES ++GI++L ++ H
Sbjct: 412 RGVIPRNSPGE--------------AGKSTR--RHYESVVKGIDNLQVSDEHHPH 450
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5BP74|KC1D_XENLA Casein kinase I isoform delta OS=Xenopus laevis GN=csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 510 bits (1313), Expect = e-144, Method: Compositional matrix adjust.
Identities = 229/298 (76%), Positives = 271/298 (90%), Gaps = 1/298 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-VKTKHPQLQYEAKLYKILQ 59
ME RVGN++RLGRKIGSGSFG+IYLGT+I +EEVAIKL VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAASEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GG GIP ++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 297
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Isoform 1 can phosphorylate a large number of proteins. Isoform 2 has no kinase activity. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P48730|KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2 | Back alignment and function description |
|---|
Score = 509 bits (1312), Expect = e-143, Method: Compositional matrix adjust.
Identities = 230/298 (77%), Positives = 270/298 (90%), Gaps = 1/298 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-VKTKHPQLQYEAKLYKILQ 59
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKL VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 297
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P35508|KC1D_BOVIN Casein kinase I isoform delta OS=Bos taurus GN=CSNK1D PE=2 SV=2 | Back alignment and function description |
|---|
Score = 509 bits (1312), Expect = e-143, Method: Compositional matrix adjust.
Identities = 230/298 (77%), Positives = 270/298 (90%), Gaps = 1/298 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-VKTKHPQLQYEAKLYKILQ 59
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKL VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 297
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q06486|KC1D_RAT Casein kinase I isoform delta OS=Rattus norvegicus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 509 bits (1312), Expect = e-143, Method: Compositional matrix adjust.
Identities = 230/298 (77%), Positives = 270/298 (90%), Gaps = 1/298 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-VKTKHPQLQYEAKLYKILQ 59
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKL VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 297
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q9DC28|KC1D_MOUSE Casein kinase I isoform delta OS=Mus musculus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 509 bits (1312), Expect = e-143, Method: Compositional matrix adjust.
Identities = 230/298 (77%), Positives = 270/298 (90%), Gaps = 1/298 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-VKTKHPQLQYEAKLYKILQ 59
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKL VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 297
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus GN=CSNK1E PE=2 SV=2 | Back alignment and function description |
|---|
Score = 509 bits (1311), Expect = e-143, Method: Compositional matrix adjust.
Identities = 229/295 (77%), Positives = 269/295 (91%), Gaps = 1/295 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-VKTKHPQLQYEAKLYKILQ 59
ME RVGNK+RLGRKIGSGSFG+IYLG NI T EEVAIKL VKTKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIATGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GG GIP+++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 294
C+GYP+EF++Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2 | Back alignment and function description |
|---|
Score = 508 bits (1308), Expect = e-143, Method: Compositional matrix adjust.
Identities = 228/295 (77%), Positives = 269/295 (91%), Gaps = 1/295 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-VKTKHPQLQYEAKLYKILQ 59
ME RVGNK+RLGRKIGSGSFG+IYLG NI + EEVAIKL VKTKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GG GIP+++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 294
C+GYP+EF++Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P647|KC1D_XENTR Casein kinase I isoform delta OS=Xenopus tropicalis GN=csnk1d PE=2 SV=1 | Back alignment and function description |
|---|
Score = 508 bits (1308), Expect = e-143, Method: Compositional matrix adjust.
Identities = 228/295 (77%), Positives = 269/295 (91%), Gaps = 1/295 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-VKTKHPQLQYEAKLYKILQ 59
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKL VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAAEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GG GIP ++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 294
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T2E3|KC1DA_DANRE Casein kinase I isoform delta-A OS=Danio rerio GN=csnk1da PE=2 SV=1 | Back alignment and function description |
|---|
Score = 508 bits (1308), Expect = e-143, Method: Compositional matrix adjust.
Identities = 229/295 (77%), Positives = 270/295 (91%), Gaps = 1/295 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-VKTKHPQLQYEAKLYKILQ 59
ME RVGN++RLGRKIGSGSFG+IYLGT+I T EEVAIKL VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDITTGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GG GIP ++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 294
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 473 | ||||||
| 255560729 | 472 | casein kinase, putative [Ricinus communi | 0.993 | 0.995 | 0.856 | 0.0 | |
| 359482807 | 471 | PREDICTED: casein kinase I isoform delta | 0.989 | 0.993 | 0.842 | 0.0 | |
| 357454569 | 475 | Casein kinase I isoform delta-like prote | 0.995 | 0.991 | 0.817 | 0.0 | |
| 359484471 | 474 | PREDICTED: casein kinase I isoform delta | 0.991 | 0.989 | 0.841 | 0.0 | |
| 363807148 | 471 | uncharacterized protein LOC100795570 [Gl | 0.993 | 0.997 | 0.812 | 0.0 | |
| 356550412 | 472 | PREDICTED: casein kinase I isoform delta | 0.993 | 0.995 | 0.804 | 0.0 | |
| 121501708 | 473 | casein kinase [Beta vulgaris] | 0.993 | 0.993 | 0.812 | 0.0 | |
| 392311590 | 483 | Chain A, Crystal Structure Of Casein Kin | 0.991 | 0.971 | 0.800 | 0.0 | |
| 125527438 | 472 | hypothetical protein OsI_03457 [Oryza sa | 0.989 | 0.991 | 0.805 | 0.0 | |
| 224128674 | 470 | predicted protein [Populus trichocarpa] | 0.987 | 0.993 | 0.827 | 0.0 |
| >gi|255560729|ref|XP_002521378.1| casein kinase, putative [Ricinus communis] gi|223539456|gb|EEF41046.1| casein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2180), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/475 (85%), Positives = 439/475 (92%), Gaps = 5/475 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL NVKTKHPQL YE+KLYKILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 300 ST-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 358
+ P RA+GPGAGPSSGMPP+ AN+DRQ G EEGR T W S DP+RRRNSGP+ +S N S
Sbjct: 301 ANPPTRALGPGAGPSSGMPPSGANIDRQPGGEEGRPT-WPSMDPTRRRNSGPITSSVNFS 359
Query: 359 KQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASP 418
KQK P+AND SKDA +SS N LRSSG+SRR A+ +SR+AA+ G+++DP+ RTTDASP
Sbjct: 360 KQKGPVANDLPLSKDAKLSSTNFLRSSGTSRRPAISSSRDAALTGNESDPTWSRTTDASP 419
Query: 419 GAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 473
KIS GQRSSP+VS+E +H +SGR+T+NIK FESTLRGIESLHFNN+ERV +
Sbjct: 420 AV--KISGGQRSSPIVSAEQKHLSSGRNTTNIKTFESTLRGIESLHFNNDERVQY 472
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482807|ref|XP_002277513.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|297743045|emb|CBI35912.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2122), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/476 (84%), Positives = 439/476 (92%), Gaps = 8/476 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL NVKTKHPQL YE+KLYKILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTGIPN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAK+YRD++THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 300 S-TPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 358
S P+RA+GPGAGPS G+PPA AN+DRQSG E+GR +GWSSADPSRRR + P N +L
Sbjct: 301 SGPPSRALGPGAGPSHGIPPAVANMDRQSGGEDGRPSGWSSADPSRRRTTVPALNLGSL- 359
Query: 359 KQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASP 418
KQKSP+AND +KD++ ++ +R+SGSSRR AV +SR+A +VG ++DPSR R DASP
Sbjct: 360 KQKSPVANDSTMAKDSLSAN---VRASGSSRRGAVSSSRDAVIVGGESDPSRSR-ADASP 415
Query: 419 GAFQKISSGQRSSPVVSSENRHTTSGRST-SNIKNFESTLRGIESLHFNNNERVHH 473
GA +KISSGQR SPV SSE++ +SGR+T SNIKNFESTL+GIESLHFNN ERV +
Sbjct: 416 GALRKISSGQRGSPVHSSEHKRISSGRNTSSNIKNFESTLKGIESLHFNNEERVQY 471
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357454569|ref|XP_003597565.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355486613|gb|AES67816.1| Casein kinase I isoform delta-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 809 bits (2089), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/477 (81%), Positives = 434/477 (90%), Gaps = 6/477 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPR+GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL N+KTKHPQL YE+KLYK+LQ
Sbjct: 1 MEPRIGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENIKTKHPQLLYESKLYKVLQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTGIPN+RWFGVEG+YNVLV+DLLGPSLEDLF+FCSRKLSLKTVLMLADQMINRVE++H
Sbjct: 61 GGTGIPNVRWFGVEGEYNVLVMDLLGPSLEDLFSFCSRKLSLKTVLMLADQMINRVEYIH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE+L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIESL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 300 STP-ARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 358
+TP ARAIG GAGPSSG+PPA + +R SG E+GRH GWSS+DP+RRRNSGP+ N NLS
Sbjct: 301 ATPSARAIGSGAGPSSGLPPAVVSAERPSGGEDGRHAGWSSSDPARRRNSGPIANDGNLS 360
Query: 359 KQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRV-AVPNSREAAVVGSDTDPSRPRTTDAS 417
+QK+P+ +D SK+ M+SS N R SGS+RRV AV NSR+ AVV S+ +PS P D S
Sbjct: 361 RQKAPVPSDSNGSKEVMLSSSNFFRPSGSTRRVGAVSNSRD-AVVSSEIEPSLPLARDGS 419
Query: 418 PGAFQKISSGQRSSPVVSSENRHTT-SGRSTSNIKNFESTLRGIESLHFNNNERVHH 473
PGA K S QR+SP+ SSE++ TT SGR+TSN+KNFEST+RGIESL+F N+E+V +
Sbjct: 420 PGALLKTSGAQRNSPITSSEHKATTSSGRNTSNMKNFESTIRGIESLNF-NDEKVQY 475
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484471|ref|XP_002281345.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|147859066|emb|CAN80417.1| hypothetical protein VITISV_024542 [Vitis vinifera] gi|297738643|emb|CBI27888.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 796 bits (2055), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/478 (84%), Positives = 442/478 (92%), Gaps = 9/478 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL NVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTGIPN+RWFGVEG+YNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGEYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFVH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDTATHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTATHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE+KVSTSIE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISERKVSTSIEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 300 ST-PARAIGPGAGPSSGM-PPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 357
+T P+R +GPGAG SSG+ PPA AN DRQSG EEGR G SS DPSRRR S G+ L
Sbjct: 301 ATPPSRVLGPGAGTSSGLPPPAVANADRQSG-EEGRPAGLSSMDPSRRRIS---GDGGGL 356
Query: 358 SKQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDA 416
SKQKSP+A+D A SKDAM+SS + L RSSGSSRR AV +SR+AA++GS++DPSR TT+A
Sbjct: 357 SKQKSPVASDLAVSKDAMLSSSHFLGRSSGSSRRAAVSSSRDAAIMGSESDPSRAHTTEA 416
Query: 417 SPG-AFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 473
SPG A ++ISSGQRSSPV SS+ + T+SGR+ +NIKN+EST+RGIE+L+F+N+ERVH+
Sbjct: 417 SPGAAVRRISSGQRSSPVGSSDPKRTSSGRNITNIKNYESTIRGIENLNFDNDERVHY 474
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363807148|ref|NP_001242599.1| uncharacterized protein LOC100795570 [Glycine max] gi|255641648|gb|ACU21096.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 787 bits (2033), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/474 (81%), Positives = 429/474 (90%), Gaps = 4/474 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRV NKFRLGRKIGSGS EIYLGTN QTNEEVAIKL NVKTKHPQL YE+KLYKILQ
Sbjct: 1 MEPRVANKFRLGRKIGSGSSCEIYLGTNTQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTGIPN+RWFG+EGDYNVLV+DLLGPSLEDLFNFC+RKLSLKTVLMLADQMINRVEF+H
Sbjct: 61 GGTGIPNVRWFGIEGDYNVLVMDLLGPSLEDLFNFCTRKLSLKTVLMLADQMINRVEFIH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
SMNTHLGIEQSRRDDLESLG+VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE+L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGFVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIESL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 300 STPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 359
+TP R I P AG SSG+PPA N DRQ+G RHTGWSS+DP+RRRNSGP+ N S+
Sbjct: 301 ATPVRVIVPTAGQSSGLPPAVVNADRQTGGVNSRHTGWSSSDPARRRNSGPIANDGMSSR 360
Query: 360 QKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASPG 419
QK+P+ +D SKD M+SS + RSSGS+RR AV +SR+AA VG++T+PS P T DASPG
Sbjct: 361 QKAPVPSDSTGSKDVMLSS-SNFRSSGSTRRGAVSSSRDAA-VGNETEPSHPLTMDASPG 418
Query: 420 AFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 473
A +KIS+ QRSSP++S E+ T+SGR+TSN+KN+ESTLRGIE+L+F N+ER+ +
Sbjct: 419 ALRKISNAQRSSPIMSFEHNRTSSGRNTSNMKNYESTLRGIETLNF-NDERLQY 471
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550412|ref|XP_003543581.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 786 bits (2031), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/475 (80%), Positives = 427/475 (89%), Gaps = 5/475 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRV NKFRLGRKIGSGSFGEIYLGTN QTNEEVA+KL NVKTKHPQL YE+KLYKILQ
Sbjct: 1 MEPRVANKFRLGRKIGSGSFGEIYLGTNTQTNEEVAVKLENVKTKHPQLLYESKLYKILQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFC+RKLSLKTVLMLADQMINRVEF+H
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCTRKLSLKTVLMLADQMINRVEFIH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK++RDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKHRDTSTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
SMNTHLGIEQSRRDDLESLG+VLMYFLRGSLPWQGLKAGTKKQKYE+ISEKKVSTSIE+L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGFVLMYFLRGSLPWQGLKAGTKKQKYERISEKKVSTSIESL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CR YP+EFASYFHYCRSL+FDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRSYPSEFASYFHYCRSLQFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 300 ST-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 358
+T PARAIGP AGPSSG+PPA N DRQ+G E RHTGWSS+DP+RRRNSGP+ N LS
Sbjct: 301 ATPPARAIGPAAGPSSGLPPAVVNADRQTGGENSRHTGWSSSDPARRRNSGPIANDGMLS 360
Query: 359 KQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASP 418
+QK+P +D SKD M+SS N S S+RR V +SR+ A VG++T+PS P T DAS
Sbjct: 361 RQKAPFPSDSTRSKDVMLSSSNFRSSG-STRRGVVSSSRD-ATVGNETEPSHPLTVDASQ 418
Query: 419 GAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 473
GA +KIS QRSSP++ E+ T+SGR+TSN+KN+EST+RGIE+L+F N+ER+ +
Sbjct: 419 GALRKISGAQRSSPIMPFEHNRTSSGRNTSNMKNYESTIRGIETLNF-NDERLQY 472
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|121501708|gb|ABM55249.1| casein kinase [Beta vulgaris] | Back alignment and taxonomy information |
|---|
Score = 786 bits (2031), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/475 (81%), Positives = 421/475 (88%), Gaps = 5/475 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRVGNK+RLGRKIGSGSFGEIYLGTNIQTNEEVAIKL NVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKYRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRK SLKTVLMLADQMINR+EFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKFSLKTVLMLADQMINRIEFVH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAK+YRDT THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDTTTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR++RDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIYRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 300 STPARAIGPGAGPSSGMP-PAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 358
+ P G GAG S+G+P P AN +R+ G EEGR G S+ D RRR SG L NS +L
Sbjct: 301 AAPPARTGAGAGTSAGVPTPPVANPERKLGEEEGRAGGLSTGDGLRRRMSGSLLNSGSLL 360
Query: 359 KQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDAS 417
KQKSP+ANDP SKD +SS NL RSSG +R A+P+SREA G+++DPSR RT +AS
Sbjct: 361 KQKSPLANDPTVSKDPTLSSTNLTGRSSGFLKRAAIPSSREAVTGGNESDPSRSRTAEAS 420
Query: 418 PGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVH 472
P Q+ SSGQRSSPV SS+ + +SGR TS IKN+ESTL+GIESLHF ++ERVH
Sbjct: 421 PSTMQRFSSGQRSSPVGSSDAKQQSSGRITS-IKNYESTLKGIESLHF-DDERVH 473
|
Source: Beta vulgaris Species: Beta vulgaris Genus: Beta Family: Amaranthaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|392311590|pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant | Back alignment and taxonomy information |
|---|
Score = 782 bits (2019), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/476 (80%), Positives = 426/476 (89%), Gaps = 7/476 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL NVKTKHPQL YE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV+TSIEAL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CRGYPTEFASYFHYCRSLRFDDKPDY+YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 300 -STPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 358
S P RA+G GAGPS PPA N DRQSG +EGR +GWSS D RRR P+ + L+
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQN-DRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLA 357
Query: 359 KQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDAS 417
KQK+P+ ND +FSK+ ++S+ N L RSSGSSRR AV +SR+ + + ++PSR R TDAS
Sbjct: 358 KQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDT-SEPSRTRATDAS 416
Query: 418 PGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 473
PGAF++ S Q+SSPV S+E +H++S R +SN+KN+ES L+GIE L+F+ +ERV +
Sbjct: 417 PGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|125527438|gb|EAY75552.1| hypothetical protein OsI_03457 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 782 bits (2019), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/477 (80%), Positives = 428/477 (89%), Gaps = 9/477 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL NVKTKHPQL YE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV+TSIEAL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CRGYPTEFASYFHYCRSLRFDDKPDY+YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 300 -STPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 358
S P RA+G GAGPS PPA N DRQSG +EGR +GWSS D RRR P+ + L+
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQN-DRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLA 357
Query: 359 KQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDT-DPSRPRTTDA 416
KQK+P+ ND +FSK+ ++S+ N L RSSGSSRR AV +SR+ V+ +DT +PSR R TDA
Sbjct: 358 KQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRD--VMPTDTSEPSRTRATDA 415
Query: 417 SPGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 473
SPGAF++ S Q+SSPV S+E +H++S R +SN+KN+ES L+GIE L+F+ +ERV +
Sbjct: 416 SPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128674|ref|XP_002329062.1| predicted protein [Populus trichocarpa] gi|222839733|gb|EEE78056.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 782 bits (2019), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/476 (82%), Positives = 422/476 (88%), Gaps = 9/476 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRVGNKFRLGRKIGSGSFGEIYLG NIQTNEEVAIKL NVKT+HPQL YE+KLYK+LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGANIQTNEEVAIKLENVKTRHPQLLYESKLYKMLQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTGIPN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 300 STP-ARAIGPGAGPSSGMPPAAA-NVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 357
+ P RA GPGAGPSSG+PP A N DRQSG EEG S D +RRRNSGP+ NS NL
Sbjct: 301 ANPTTRAHGPGAGPSSGIPPPGANNADRQSGGEEGGPGW-PSIDHARRRNSGPIVNSGNL 359
Query: 358 SKQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDAS 417
SKQKSP+ ND + SKDA +SS N LRS SSR V +SR AA G+D+DPSRPRTTDAS
Sbjct: 360 SKQKSPVTNDLSLSKDATLSSSNFLRSIVSSRNPVVSSSRGAA-FGNDSDPSRPRTTDAS 418
Query: 418 PGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 473
F + +GQRSS +SSE +H++SGR+T NIK ESTL+GIESLH N R+HH
Sbjct: 419 ---FAVLQNGQRSSAALSSEQKHSSSGRNT-NIKTLESTLKGIESLHVNIEGRLHH 470
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 473 | ||||||
| TAIR|locus:2030170 | 465 | CKL2 "casein kinase 1-like pro | 0.976 | 0.993 | 0.700 | 2.9e-174 | |
| TAIR|locus:2120765 | 450 | CK1 "casein kinase 1" [Arabido | 0.875 | 0.92 | 0.708 | 2.3e-157 | |
| TAIR|locus:504954933 | 435 | ckl12 "casein kinase I-like 12 | 0.784 | 0.852 | 0.755 | 4.3e-156 | |
| TAIR|locus:2050409 | 433 | ckl5 "casein kinase I-like 5" | 0.630 | 0.688 | 0.819 | 1e-141 | |
| TAIR|locus:2024147 | 471 | ADK1 "dual specificity kinase | 0.959 | 0.963 | 0.563 | 6.9e-134 | |
| TAIR|locus:2167634 | 476 | ckl7 "casein kinase I-like 7" | 0.879 | 0.873 | 0.600 | 6.9e-134 | |
| TAIR|locus:2090875 | 442 | ckl10 "casein kinase I-like 10 | 0.627 | 0.671 | 0.768 | 9.3e-130 | |
| UNIPROTKB|Q6K9N1 | 463 | OJ1234_B11.27 "Os02g0622100 pr | 0.966 | 0.987 | 0.549 | 1.5e-129 | |
| UNIPROTKB|Q70YQ4 | 463 | Q70YQ4 "Putative casein kinase | 0.966 | 0.987 | 0.547 | 1.4e-128 | |
| TAIR|locus:2121338 | 479 | CKL6 "casein kinase I-like 6" | 0.627 | 0.620 | 0.755 | 1.4e-126 |
| TAIR|locus:2030170 CKL2 "casein kinase 1-like protein 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1693 (601.0 bits), Expect = 2.9e-174, P = 2.9e-174
Identities = 328/468 (70%), Positives = 373/468 (79%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRVGNKFRLGRKIG GSFGEIYLGTNIQTNEEVAIKL NVKTKHPQL YE+KLYK+LQ
Sbjct: 1 MEPRVGNKFRLGRKIGGGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKVLQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTG+PN++W+GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR+EFVH
Sbjct: 61 GGTGVPNVKWYGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRIEFVH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
KSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAK+YRD+ HQHIPYRENKNLTGTARYA
Sbjct: 121 QKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDS-NHQHIPYRENKNLTGTARYA 179
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 239
SMNTHLGIEQSRRDDLESLG+VLMYFL+GSLPWQGLKAG VSTSIEAL
Sbjct: 180 SMNTHLGIEQSRRDDLESLGFVLMYFLKGSLPWQGLKAGNKKQKYEKISEKKVSTSIEAL 239
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 240 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 299
Query: 300 STXXXXXXXXXXXXXXXXX-XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 358
ST + +R SG +E R +GWSS P RRNSG + NS +L+
Sbjct: 300 STPPPRHHGPVVGPSSALPPAITSAERPSGGDEARPSGWSSGIP--RRNSGQIFNSGSLA 357
Query: 359 KQKSPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTDASP 418
KQK+P+++DPA SKD ++ AV +SREAAV+G+D++PS P+ +A
Sbjct: 358 KQKAPVSSDPAISKDVVLSSSSFLRATGSSRRAAVSSSREAAVLGTDSEPSNPQIVEAGS 417
Query: 419 GAFQKIXXXXXXXXXXXXENRHTTSGRSTSNI-KNFESTLRGIESLHF 465
G+ KI N+ ++ R+T+++ KN+E+ L+GIESLHF
Sbjct: 418 GSNSKIPVSRNSPIVSSEINKLSSPSRATTSVMKNYEANLKGIESLHF 465
|
|
| TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1507 (535.5 bits), Expect = 2.3e-157, Sum P(2) = 2.3e-157
Identities = 302/426 (70%), Positives = 328/426 (76%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRVGNKFRLGRKIGSGSFGEIYLGTNI TNEE+AIKL NVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTG+PN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEF H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAK+YRD+ THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 239
SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGT VSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 300 STXXXXXXXXXXXXXXXXX-XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 358
+ N+DR +G EEGR + SRRR SG L NS N+S
Sbjct: 301 TAPPSRALNPAVGTSAALPPGISNIDRYTGEEEGR----PHMESSRRRVSGALDNSGNIS 356
Query: 359 KQK-SPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTDAS 417
Q S A D ++ AV SR+ GS+ R RT D S
Sbjct: 357 NQPTSSSARDSMIPSSSLFAQSAGSSRRVT----AVSGSRDN-FPGSEELLQRSRTGDVS 411
Query: 418 PGAFQK 423
G +
Sbjct: 412 RGVIPR 417
|
|
| TAIR|locus:504954933 ckl12 "casein kinase I-like 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1475 (524.3 bits), Expect = 4.3e-156, Sum P(2) = 4.3e-156
Identities = 285/377 (75%), Positives = 311/377 (82%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRVGNK+RLGRKIGSGSFGEIYLGT+IQTNEEVAIKL NVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKYRLGRKIGSGSFGEIYLGTHIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTG+PN++WFGVEGDYN LV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVE+ H
Sbjct: 61 GGTGVPNIKWFGVEGDYNTLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEYFH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKSFLHRD+KPDNFLMGLGRRANQV+IIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVHIIDFGLAKKYRDNTTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 239
SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGT VSTSIE+L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIESL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CRGYP+EFASYFHYCRSLRFDDKPDY YLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYGYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 300 STXXXXXXXXXXXXXXXXX--XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 357
+ ++DR G EEG G D SRRR SG L NS NL
Sbjct: 301 TAPPSRGLVSPAVGTSAGLPPGLTSIDRYGGEEEG---GRPPMDSSRRRMSGALENSGNL 357
Query: 358 SKQKSPMANDPAFSKDA 374
S + M + F++ A
Sbjct: 358 SSRGPMMPSSSLFAQSA 374
|
|
| TAIR|locus:2050409 ckl5 "casein kinase I-like 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1349 (479.9 bits), Expect = 1.0e-141, Sum P(2) = 1.0e-141
Identities = 245/299 (81%), Positives = 277/299 (92%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRVGNKFRLGRKIGSGSFGEIYLGT++QTNEEVAIKL +VKT HPQL YE+++Y++LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTDVQTNEEVAIKLESVKTAHPQLSYESRIYRVLQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTGIPN++W+GVEGDYNVLV+DLLGPSLEDLF++C R+ SLKTVLMLADQMINR+EF+H
Sbjct: 61 GGTGIPNMKWYGVEGDYNVLVMDLLGPSLEDLFSYCKRQFSLKTVLMLADQMINRLEFIH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKS+LHRDIKPDNFLMGLGRRANQVYIID+GLAK+YRD++TH+HIPYRENK+L GT RYA
Sbjct: 121 SKSYLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYRDSSTHRHIPYRENKSLIGTPRYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 239
S+NTHLGIEQSRRDD+ESLGY+LMYFL+GSLPWQGLKAG VSTSIE L
Sbjct: 181 SLNTHLGIEQSRRDDIESLGYILMYFLKGSLPWQGLKAGNKKQKYDKISEKKVSTSIETL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 298
CRG+PTEFASYFHYCRSLRFDDKPDYAYLKRLFR+LFIREGFQFD+VFDWT+ KYQQSQ
Sbjct: 241 CRGHPTEFASYFHYCRSLRFDDKPDYAYLKRLFRNLFIREGFQFDFVFDWTVYKYQQSQ 299
|
|
| TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1312 (466.9 bits), Expect = 6.9e-134, P = 6.9e-134
Identities = 262/465 (56%), Positives = 312/465 (67%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
M+ +G KF+LGRKIGSGSFGE+YLG N+QT EEVA+KL +VKTKHPQL YE+KLY +LQ
Sbjct: 1 MDLVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTG+PNL+W+GVEGDYNV+VIDLLGPSLEDLFN+C+RKLSLKTVLMLADQ+INRVEF+H
Sbjct: 61 GGTGVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEFMH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
++ FLHRDIKPDNFLMGLGR+ANQVYIIDFGL K+YRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHRHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 239
S+NTHLG+EQSRRDDLE+LGYVLMYFL+GSLPWQGLKAGT V+T IE L
Sbjct: 181 SVNTHLGVEQSRRDDLEALGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVATPIEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
C+ P+EF SYF YCRSLRFDDKPDY+YLKRLFRDLFIREG+QFDYVFDWT+LKY Q
Sbjct: 241 CKNQPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300
Query: 300 STXXXXXXXXXXXXXXXXXXXXNVDRQS--GAEEGRHTGWSSADP--SRRR--NSGPLGN 353
S+ ++++Q +E R +S A SRR S
Sbjct: 301 SSGSSSRTRNHTTANPGLTAGASLEKQERIAGKETRENRFSGAVEAFSRRHPATSTTRDR 360
Query: 354 SANLSKQKSPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRT 413
SA+ + P++ P + A+P+S + G +D
Sbjct: 361 SASRNSVDGPLSKHPPGDSERPRSSSRYGSSSRR----AIPSSSRPSSAGGPSDSRSSSR 416
Query: 414 TDASPGAFQKIXXXXXXXXXXXXENRHTTSGRSTSNIKNFESTLR 458
S G + N TS S + E LR
Sbjct: 417 LVTSTGGVGTVSNRASTSQRIQAGNESRTSSFSRAARNTREDPLR 461
|
|
| TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1312 (466.9 bits), Expect = 6.9e-134, P = 6.9e-134
Identities = 257/428 (60%), Positives = 307/428 (71%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
M+ +G KF+LG+KIGSGSFGE+YLG N+QT EEVA+KL NVKTKHPQL YE+KLY +LQ
Sbjct: 1 MDLVIGGKFKLGKKIGSGSFGELYLGVNVQTGEEVAVKLENVKTKHPQLHYESKLYMLLQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GG+GIPN++WFGVEGDY+V+VIDLLGPSLEDLFN+C+RKL+LKTVLMLADQ++NRVEF+H
Sbjct: 61 GGSGIPNIKWFGVEGDYSVMVIDLLGPSLEDLFNYCNRKLTLKTVLMLADQLLNRVEFMH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
++ FLHRDIKPDNFLMGLGR+ANQVYIIDFGL K+YRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 239
S+NTHLG+EQSRRDDLESLGYVLMYFL+GSLPWQGLKAGT VST IE L
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
C+ P+EF SYFHYCRSLRFDDKPDY+YLKRLFRDLFIREG+QFDYVFDWT+LKY Q
Sbjct: 241 CKNQPSEFVSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIG- 299
Query: 300 STXXXXXXXXXXXXXXXXXXXXNVDRQS---GAEEGRHTGWSSADPSRRRNSGPLGNSAN 356
S+ ++RQ G E R+ + + RR+ P S+
Sbjct: 300 SSSGSSSRTRHHTTAKPGFNADPIERQERILGKETTRYKIPGAVEAFSRRH--PTTTSSP 357
Query: 357 LSKQKSPMANDPAFSKDA-----MMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRP 411
+ +S ++D FSK VA +SR ++ G +
Sbjct: 358 RDRSRSRNSDDGPFSKQTHGDSERANSSSRYRASSSRKAVAASSSRPSSAGGPSESRTSS 417
Query: 412 RTTDASPG 419
R +S G
Sbjct: 418 RLVSSSGG 425
|
|
| TAIR|locus:2090875 ckl10 "casein kinase I-like 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1273 (453.2 bits), Expect = 9.3e-130, P = 9.3e-130
Identities = 229/298 (76%), Positives = 264/298 (88%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-VKTKHPQLQYEAKLYKILQ 59
M+ +G KF+LGRKIGSGSFGE+Y+G N+QT EEVA+KL VKTKHPQL YE+K+Y +LQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYIGINVQTGEEVALKLEPVKTKHPQLHYESKVYMLLQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTG+P+++WFGVEG+YN + IDLLGPSLEDLFN+C+R SLKTVLMLADQ+INRVE++H
Sbjct: 61 GGTGVPHIKWFGVEGNYNCMAIDLLGPSLEDLFNYCTRSFSLKTVLMLADQLINRVEYMH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
S+ FLHRDIKPDNFLMGLGR+ANQVYIID+GLAK+YRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYF+RGSLPWQGLKAGT + T +E L
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFIRGSLPWQGLKAGTKKQKYEKISEKKMLTPVEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 297
C+ YP+EF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+QFDYVFDWTILKY QS
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQS 298
|
|
| UNIPROTKB|Q6K9N1 OJ1234_B11.27 "Os02g0622100 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1271 (452.5 bits), Expect = 1.5e-129, P = 1.5e-129
Identities = 261/475 (54%), Positives = 322/475 (67%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
ME +G KF+LGRKIGSGSFGE+YLG NIQ++EEVAIKL +VK++HPQL YE+KLY +LQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTGIP+L+WFGVEG+YNV+VIDLLGPSLEDLFN+C+RK SLKTVLMLADQMINRVE++H
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
++ FLHRDIKPDNFLMGLGR+A+QVY+ID+GLAK+YRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKASQVYVIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 239
S+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT + T +E L
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
C+ YPTEF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+Q DY+FDWT K Q S+
Sbjct: 241 CKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT--K-QGSES 297
Query: 300 STXXXXXXXXXXXXXXXXXXXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 359
+ RQ + R +G + DP RR G+ +K
Sbjct: 298 NRLRSSGRTSGLVGPSAERTERAAARQDVPD--RFSG--TVDPFARRTGSGSGHYGEHTK 353
Query: 360 QK----SPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTD 415
+ S +A A D + + +SR ++ G DP+R
Sbjct: 354 HRNILDSLLAPKTAVDLDKRRPTSSSRNGSTSRKAL-LSSSRPSS--GDPIDPNRSNLIP 410
Query: 416 ASPGAFQKIXXXXXXXXXXXXENRHTTSGRSTSNIKNFESTLRGIESLHFNNNER 470
S G+ + E R + + ++ N+ + + TLR E L + + R
Sbjct: 411 TSSGS-SRPSTMQRLHQSTGLETRSSLT-KTARNVHD-DPTLRTFERLSISADRR 462
|
|
| UNIPROTKB|Q70YQ4 Q70YQ4 "Putative casein kinase I" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1262 (449.3 bits), Expect = 1.4e-128, P = 1.4e-128
Identities = 260/475 (54%), Positives = 321/475 (67%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
ME +G KF+LGRKIGSGSFGE+YLG NIQ++EEVAIKL +VK++HPQL YE+KLY +LQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTGIP+L+WFGVEG+YNV+VIDLLGPSLEDLFN+C+RK SLKTVLMLADQMINRVE++H
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
++ FLHRDIKPDNFLMGLGR+A+QVY+ID+ LAK+YRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKASQVYVIDYVLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 239
S+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT + T +E L
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
C+ YPTEF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+Q DY+FDWT K Q S+
Sbjct: 241 CKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT--K-QGSES 297
Query: 300 STXXXXXXXXXXXXXXXXXXXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 359
+ RQ + R +G + DP RR G+ +K
Sbjct: 298 NRLRSSGRTSGLVGPSAERTERAAARQDVPD--RFSG--TVDPFARRTGSGSGHYGEHTK 353
Query: 360 QK----SPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTD 415
+ S +A A D + + +SR ++ G DP+R
Sbjct: 354 HRNILDSLLAPKTAVDLDKRRPTSSSRNGSTSRKAL-LSSSRPSS--GDPIDPNRSNLIP 410
Query: 416 ASPGAFQKIXXXXXXXXXXXXENRHTTSGRSTSNIKNFESTLRGIESLHFNNNER 470
S G+ + E R + + ++ N+ + + TLR E L + + R
Sbjct: 411 TSSGS-SRPSTMQRLHQSTGLETRSSLT-KTARNVHD-DPTLRTFERLSISADRR 462
|
|
| TAIR|locus:2121338 CKL6 "casein kinase I-like 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1243 (442.6 bits), Expect = 1.4e-126, P = 1.4e-126
Identities = 225/298 (75%), Positives = 260/298 (87%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-VKTKHPQLQYEAKLYKILQ 59
M+ +G KF+LGRKIG GSFGE++L ++QT EE A+KL KTKHPQL YE+K+Y +LQ
Sbjct: 5 MDNVIGGKFKLGRKIGGGSFGELFLAVSLQTGEEAAVKLEPAKTKHPQLHYESKIYMLLQ 64
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GG+GIP+L+WFGV+GDYN +VIDLLGPSLEDLFN+C+R+L+LK VLMLADQ+I+RVE++H
Sbjct: 65 GGSGIPSLKWFGVQGDYNAMVIDLLGPSLEDLFNYCNRRLTLKAVLMLADQLISRVEYMH 124
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
S+ FLHRDIKPDNFLMGLGR+ANQVYIIDFGLAK+YRD TH+HIPYRENKNLTGTARYA
Sbjct: 125 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDLQTHRHIPYRENKNLTGTARYA 184
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 239
S+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT VST IE L
Sbjct: 185 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 244
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 297
C+ YP EF SYF YCRSLRF+DKPDY+YLKRLFRDLFIREG+QFDYVFDWT LK+ QS
Sbjct: 245 CKSYPPEFVSYFQYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTALKHPQS 302
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P42158 | KC1D_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7073 | 0.9450 | 0.9933 | no | no |
| Q556Y4 | KC1_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.7040 | 0.6194 | 0.6877 | yes | no |
| P48730 | KC1D_HUMAN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7718 | 0.6279 | 0.7156 | yes | no |
| Q6QNM1 | KC1_TOXGO | 2, ., 7, ., 1, 1, ., 1 | 0.7231 | 0.6469 | 0.9444 | N/A | no |
| P35508 | KC1D_BOVIN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7718 | 0.6279 | 0.7156 | yes | no |
| Q7T2E3 | KC1DA_DANRE | 2, ., 7, ., 1, 1, ., 1 | 0.7762 | 0.6215 | 0.7295 | yes | no |
| Q9DC28 | KC1D_MOUSE | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7718 | 0.6279 | 0.7156 | yes | no |
| Q5RC72 | KC1D_PONAB | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7651 | 0.6279 | 0.7156 | yes | no |
| P29295 | HRR25_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.6633 | 0.6321 | 0.6052 | yes | no |
| P40235 | HHP1_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.7636 | 0.6152 | 0.7972 | yes | no |
| Q06486 | KC1D_RAT | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7718 | 0.6279 | 0.7156 | yes | no |
| O76324 | DCO_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.7186 | 0.6215 | 0.6681 | yes | no |
| Q8IHZ9 | KC1_PLAF7 | 2, ., 7, ., 1, 1, ., 1 | 0.6860 | 0.6173 | 0.9040 | yes | no |
| Q20471 | KIN20_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.7355 | 0.6194 | 0.5895 | yes | no |
| Q6QNL9 | KC1_EIMTE | 2, ., 7, ., 1, 1, ., 1 | 0.7041 | 0.6553 | 0.9253 | N/A | no |
| Q5BP74 | KC1D_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7684 | 0.6279 | 0.7156 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 473 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-33 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-20 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-19 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 9e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-13 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-13 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-13 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-12 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-11 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-11 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-11 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-10 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-09 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-09 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-06 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 9e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-05 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-05 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 1e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-04 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-04 | |
| COG2112 | 201 | COG2112, COG2112, Predicted Ser/Thr protein kinase | 2e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-04 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-04 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.001 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.001 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.001 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 0.001 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.002 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 0.002 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.002 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.002 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.003 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.003 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.003 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.003 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.004 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 69/260 (26%), Positives = 109/260 (41%), Gaps = 24/260 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQY----EAKLYKILQGGTG 63
+ L RK+GSGSFG +Y + T + VA+K L +++ + E ++ + L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 64 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSK 121
+ + F + D+ LV++ DLF++ SR LS +A Q++ +E++HS
Sbjct: 61 VRLIDAF-EDKDHLYLVMEYCEGG--DLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 181
+HRD+KP+N L+ V I DFGLAK+ GT Y +
Sbjct: 118 GIIHRDLKPENILLD---ENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWYMAP 167
Query: 182 NTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240
L G + D+ SLG +L L G P+ G + Q +I +
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS 227
Query: 241 RGYPTEFASYFHYCRSLRFD 260
G E C L D
Sbjct: 228 SGSE-EAKDLIKKC--LNKD 244
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 17/198 (8%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKL----NVKTKHPQLQYEAKLYKILQGGTGIPNLRWF 70
+G G FG +YL + +T ++VAIK+ + + +L E ++ K L I L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGV 59
Query: 71 GVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 129
+ ++ LV++ G SL+DL KLS +L + Q++ +E++HS +HRD+K
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 130 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-E 188
P+N L L +V + DFGL+K K + GT Y + LG
Sbjct: 120 PENIL--LDSDNGKVKLADFGLSKLLTS-------DKSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 189 QSRRDDLESLGYVLMYFL 206
S + D+ SLG V++Y L
Sbjct: 171 YSEKSDIWSLG-VILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 6e-33
Identities = 76/241 (31%), Positives = 117/241 (48%), Gaps = 18/241 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------NVKTKHPQLQYEAKLYKILQGG 61
+R+ RK+G GSFGE+YL + + VA+K+ + + + E ++ L
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 62 TGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFV 118
I L F + LV++ + G SLEDL R LS L + Q+++ +E++
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 178
HSK +HRDIKP+N L L R V +IDFGLAK D + IP + ++ GT Y
Sbjct: 118 HSKGIIHRDIKPENIL--LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGY 174
Query: 179 ASMNTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235
+ LG+ S D+ SLG L L G P++G K + + KI + + S
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 236 I 236
+
Sbjct: 235 L 235
|
Length = 384 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 66/235 (28%), Positives = 107/235 (45%), Gaps = 30/235 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----NVKTKHPQLQYEAKLYKILQGGTGI 64
+ + K+G GSFG++YL + +T + VAIK+ +K ++ E K+ K L+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH---- 56
Query: 65 PN----LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
PN F + D LV++ G L DL +LS Q+++ +E++H
Sbjct: 57 PNIVRLYDVF-EDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSALEYLH 114
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SK +HRD+KP+N L+ V + DFGLA++ GT Y
Sbjct: 115 SKGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKL--------TTFVGTPEYM 163
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 233
+ LG + D+ SLG V++Y L G P+ G + ++KI + K
Sbjct: 164 APEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFPG--DDQLLELFKKIGKPKPP 215
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 25/221 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLNVKTKHPQLQYEAKLYKILQGGT 62
+++ G KIG G+FG++Y N+ T E E+ I+ N ++ E K+ ++L+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-- 58
Query: 63 GIPNL-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 118
PNL +++GVE + I + G +LE+L R L + + Q++ + ++
Sbjct: 59 --PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYL 115
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN-KNLTGTAR 177
HS +HRDIKP N + + + DFG A + ++ T E ++L GT
Sbjct: 116 HSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTT----TMGEEVQSLAGTPA 168
Query: 178 YASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQGL 215
Y + G + R D+ SLG V++ G PW L
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 68/284 (23%), Positives = 116/284 (40%), Gaps = 41/284 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKLYKILQG 60
+ F+ G+ IG GSF + L +TN+E AIK L + K ++ E ++ L G
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 61 GTGIPNLRWFGVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 117
GI L ++ + + N+ V++ G L+ + + S L K A +++ +E+
Sbjct: 61 HPGIIKL-YYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEY 117
Query: 118 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-------------RYRDTATHQHI 164
+HSK +HRD+KP+N L+ + + I DFG AK + +
Sbjct: 118 LHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 224
R + GTA Y S + DL +LG ++ L G P++G + +
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG---SNEYLTF 231
Query: 225 EKISE----------KKVSTSIEALCRGYPTEFASYFHYCRSLR 258
+KI + IE L P + L+
Sbjct: 232 QKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHP----QLQYEAKLYKILQGGT 62
++ G +G GSFG +YL + T E +A+K + + L+ E ++ LQ
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-- 58
Query: 63 GIPNL-RWFGVEGDYNVLVIDLL-----GPSLEDLF-NFCSRKLSLKTVLMLADQMINRV 115
PN+ R++G E D +++ G SL L F KL + Q++ +
Sbjct: 59 --PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGL 114
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 175
++HS +HRDIK N L+ + DFG AKR D T + ++ GT
Sbjct: 115 AYLHSNGIVHRDIKGANILVDSDGVVK---LADFGCAKRLGDIETGE-----GTGSVRGT 166
Query: 176 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 212
+ + G E R D+ SLG ++ G PW
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 51/180 (28%), Positives = 92/180 (51%), Gaps = 22/180 (12%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQLQYEAKLYKILQGGTGI 64
F + KIG G FGE+Y + +T +EVAIK L K K ++ E ++ K +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH---- 56
Query: 65 PN-LRWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
PN ++++G ++ D +V++ G SL+DL ++ L+ + + +++ +E++HS
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 180
+HRDIK N L+ +V +IDFGL+ + DT + + GT + +
Sbjct: 117 NGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDT--------KARNTMVGTPYWMA 165
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 9e-19
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 76 YNVLVIDLLGPSLEDLFN--FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 133
Y ++++ L + +++F C K +K ++ M+ +E++H H DIKP+N
Sbjct: 101 YRFILLEKLVENTKEIFKRIKCKNKKLIKNIMK---DMLTTLEYIHEHGISHGDIKPENI 157
Query: 134 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY-RENKNL-TGTARYASMNTHLGIEQSR 191
++ R YIID+G+A + +HI Y +E K+L GT YA ++ H G +R
Sbjct: 158 MVDGNNRG---YIIDYGIASHF--IIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTR 212
Query: 192 RDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKKVSTSIEALCRGYPT 245
R DLESLGY ++ + LPW+G K +++ E K+
Sbjct: 213 RGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIK-------NAN 265
Query: 246 EFASYFHYCRS-LRFDDKPDYAYLKRLF 272
+F F C + L +++KPDY L ++F
Sbjct: 266 KFIYDFIECVTKLSYEEKPDYDALIKIF 293
|
Length = 294 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 50/225 (22%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHP----------------QLQY 50
++++ +IG G+ G ++ + +T E VA+K + ++ Q Y
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 51 EAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 110
KL + G+G VLV++ + L ++ R L V
Sbjct: 61 VVKLLDVFPHGSGF-------------VLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRM 107
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA----THQHIP- 165
++ V ++H+ +HRD+KP N L+ + I DFGLA+ + + +HQ
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATR 164
Query: 166 -YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS 209
YR + L G +Y G+ DL ++G + L GS
Sbjct: 165 WYRAPELLYGARKYDP-----GV------DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 36/164 (21%), Positives = 60/164 (36%), Gaps = 37/164 (22%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIP--- 65
+ K+G G++G +Y + +T E VA+K ++ GIP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKK---------------IRLDNEEEGIPSTA 45
Query: 66 ----------------NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD 109
L LV + L+ + LS + +
Sbjct: 46 LREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMY 105
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
Q++ + + HS LHRD+KP N L+ R + + DFGLA+
Sbjct: 106 QLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 35/176 (19%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------HPQLQYEAKLYK 56
++ G+K+G G++ +Y + +T VAIK K K + E KL +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIK---KIKLGERKEAKDGINFTALREIKLLQ 57
Query: 57 ILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD------Q 110
L+ I L FG + + N LV + + LE + VL AD
Sbjct: 58 ELKHPNIIGLLDVFGHKSNIN-LVFEFMETDLEKVIK------DKSIVLTPADIKSYMLM 110
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRY---RDTATHQ 162
+ +E++HS LHRD+KP+N L+ ++ + + DFGLA+ + THQ
Sbjct: 111 TLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLARSFGSPNRKMTHQ 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 63/229 (27%), Positives = 103/229 (44%), Gaps = 36/229 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHP--QLQYEAKLYKIL 58
+R G+ +G G+FG +YL ++ T E+A+K + +TK L+ E +L K L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 59 QGGTGIPNLRWFGVEGDYNVLVI---DLLGPSLED-------LFNFCSRKLSLKTVLMLA 108
Q + +++G D L I + G S++D L +RK +
Sbjct: 62 QHERIV---QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR------- 111
Query: 109 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 168
Q++ VE++HS +HRDIK N L A V + DFG +KR + +
Sbjct: 112 -QILEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKRLQTICSSG----TG 163
Query: 169 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 217
K++TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 63/242 (26%), Positives = 97/242 (40%), Gaps = 33/242 (13%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKLYKILQGGTGIPN 66
+ I G+FG +YL T + AIK + K + ++ E + I +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 67 LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 125
L + DY LV++ L G L L +++ VE +H + +H
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 126 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 185
RDIKP+N L+ + + + DFGL++ ENK GT Y + T L
Sbjct: 121 RDIKPENLLID---QTGHLKLTDFGLSRN-----------GLENKKFVGTPDYLAPETIL 166
Query: 186 GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI--------SEKKVSTSIE 237
G+ + D SLG V+ FL G P+ A T ++ I E K S E
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRRINWPEEVKEFCSPE 223
Query: 238 AL 239
A+
Sbjct: 224 AV 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLNVKTKHPQ----LQYEAKLYKILQGG 61
LG+K+G G+FGE+Y G EVA+K + Q EA++ + L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60
Query: 62 TGIPN-LRWFGV-EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEF 117
PN ++ GV + + ++ L KLSL +L A Q+ +E+
Sbjct: 61 ---PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 118 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT----ATHQHIPYR 167
+ SK+F+HRD+ N L+G V I DFGL++ D +P R
Sbjct: 118 LESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 41/166 (24%), Positives = 72/166 (43%), Gaps = 40/166 (24%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LNVK--------TKHPQL 48
+++ +++G G+FG +YL N +T E VAIK +N++ +HP +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 49 QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF-NFCSRKLSLKTVLML 107
KL ++ E D V + + +L L + + S + +
Sbjct: 61 ---VKLKEVF-------------RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSI 104
Query: 108 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
Q++ + +H F HRD+KP+N L+ V I DFGLA+
Sbjct: 105 IYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 7e-13
Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 34/232 (14%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTG--IPNLRW 69
+G GSFG++ L T + A+K+ K K ++++ IL I L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59
Query: 70 FGVEGDYNV-LVIDLL--GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFL 124
+ + + + LV++ G +LF+ S+ + S + A +++ +E++HS +
Sbjct: 60 YAFQTEEKLYLVLEYAPGG----ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 125 HRDIKPDNFLMGLGRRANQVYIIDFGLAKR--YRDTATHQHIPYRENKNLTGTARYASMN 182
+RD+KP+N L L + + + DFGLAK + T+ GT Y +
Sbjct: 116 YRDLKPENIL--LDADGH-IKLTDFGLAKELSSEGSRTNT---------FCGTPEYLAPE 163
Query: 183 THLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 233
LG + D SLG VL+Y L G P+ A +K+ YEKI + +
Sbjct: 164 VLLGKGYGKAVDWWSLG-VLLYEMLTGKPPFY---AEDRKEIYEKILKDPLR 211
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 48/159 (30%), Positives = 68/159 (42%), Gaps = 14/159 (8%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY------EAKLYKILQGGTGIPN 66
KIG G++G +Y + T E VAIK +K + E KL K L I
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIK-KIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 67 LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 126
L F +GD LV + + L L R L + Q++ + F HS LHR
Sbjct: 64 LDVFRHKGDL-YLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122
Query: 127 DIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQ 162
D+KP+N L+ + + DFGLA+ + TH
Sbjct: 123 DLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHY 158
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 8e-13
Identities = 53/161 (32%), Positives = 81/161 (50%), Gaps = 27/161 (16%)
Query: 9 FRLGRKIGSGSFGEIYLGT----NIQTNEEVAIK-LNVKTKHPQLQ---YEAKLYKILQG 60
LG+K+G G+FGE+Y GT T +VA+K L + + EA + K L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 61 GTGIPNL-RWFGV--EGDYNVLVIDL--LGPSLEDLFNF---CSRKLSLKTVLMLADQMI 112
PN+ R GV +G+ +V + G DL +F KL+LK +L +A Q+
Sbjct: 61 ----PNIVRLLGVCTQGEPLYIVTEYMPGG----DLLDFLRKHGEKLTLKDLLQMALQIA 112
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+E++ SK+F+HRD+ N L+ V I DFGL++
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVT---ENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 2e-12
Identities = 53/188 (28%), Positives = 80/188 (42%), Gaps = 50/188 (26%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLNVKTKHPQ----LQYEAKLYKILQGG 61
LG+K+G G+FGE+Y GT EVA+K + Q EA++ + L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60
Query: 62 TGIPN-LRWFGV-EGDYNVLVI-------DLL---------GPSLEDLFNFCSRKLSLKT 103
PN ++ GV + ++++ DLL SL DL +F
Sbjct: 61 ---PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA-------- 109
Query: 104 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TA 159
L +A M E++ SK+F+HRD+ N L+G V I DFGL++ D
Sbjct: 110 -LQIARGM----EYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYKV 161
Query: 160 THQHIPYR 167
+P R
Sbjct: 162 KGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 31/154 (20%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQY-EAKLYKILQGGTGIPN-LRWF 70
KIG G+ GE+Y T+ T +EVAIK + ++ ++ +L E + K + PN + ++
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH----PNIVDYY 81
Query: 71 G--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV--------EFVH 119
+ GD +V++ + G SL D+ +++ + I V E++H
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMN--------EPQIAYVCREVLQGLEYLH 133
Query: 120 SKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLA 152
S++ +HRDIK DN L+ G V + DFG A
Sbjct: 134 SQNVIHRDIKSDNILLSKDGS----VKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 55/270 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKLYKILQGGTGIPN 66
R IG G GE+YL + + VA+K + EAK+ L +P
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP- 66
Query: 67 LRWFGVEGD-----YNVLVIDLLGPSLEDLFNFCSRKLSL----------KTVLMLADQM 111
+ + D Y + I+ G +L+ L +K SL L + ++
Sbjct: 67 --VYSICSDGDPVYYTMPYIE--GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---RYRDTATHQHIPYRE 168
+E+VHSK LHRD+KPDN L+GL +V I+D+G A + + R
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 169 N--KNLT------GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 220
++T GT Y + LG+ S D+ +LG +L L S P+ +
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY-------R 232
Query: 221 KQKYEKISEKKVSTSIEALCRGYPTEFASY 250
++K KIS + V S P E A Y
Sbjct: 233 RKKGRKISYRDVILS--------PIEVAPY 254
|
Length = 932 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 46/162 (28%), Positives = 71/162 (43%), Gaps = 23/162 (14%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGT 62
++LG IG G+FG +Y G N++T + VAIK K + E L K L+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-- 58
Query: 63 GIPNL-RWFGVEGDYNVLVIDL---LGPSLEDL---FNFCSRKLSLKTVLMLADQMINRV 115
PN+ ++ G + L I L SL + F L V Q++ +
Sbjct: 59 --PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVY----QVLQGL 112
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
++H + +HRDIK N L + V + DFG+A + D
Sbjct: 113 AYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLND 151
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 71/245 (28%), Positives = 105/245 (42%), Gaps = 54/245 (22%)
Query: 13 RKIGSGSFGEIYLGT---NIQTNEEVAIKLNVKTKHPQLQY-----EAKLYKILQGGTGI 64
+K+G G+FGE+Y G EVA+K +K + + EA++ K L G
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKL----GH 55
Query: 65 PN-LRWFGV--EGDYNVLVI------DLLG---PSLEDLFNFCSRKLSLKTVLMLADQMI 112
PN +R GV E + LV+ DLL S + LSLK +L A Q+
Sbjct: 56 PNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-----YRDTATHQHIPYR 167
+E++ SK F+HRD+ N L+G V I DFGL++ Y T +P R
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 168 ----ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKK 221
E S+ + +S D+ S G VL++ F G+ P+ GL
Sbjct: 173 WMAPE-----------SLKDGIFTSKS---DVWSFG-VLLWEIFTLGATPYPGLSNEEVL 217
Query: 222 QKYEK 226
+ K
Sbjct: 218 EYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 3e-11
Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 23/165 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKLYKILQGG 61
K+ + ++IG GSFG++YL + +K ++ K + E K+ K L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-EDALNEVKILKKLNH- 58
Query: 62 TGIPNL-RWFG--VEGDYNVLVIDLL-GPSLEDLF---NFCSRKLSLKTVLMLADQMINR 114
PN+ +++ E +V++ G L + + +L Q+
Sbjct: 59 ---PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 115 VEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDT 158
++++HS+ LHRDIKP N FL V + DFG++K T
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSST 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 62/215 (28%), Positives = 91/215 (42%), Gaps = 24/215 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYK---ILQGGTG-- 63
F L R IG G+FG++ + T + A+K K K + + ILQ
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 64 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVHSK 121
+ NL + + + LV+DLL DL S+K+ V +++ +E++HSK
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGG--DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT-GTARYAS 180
+HRDIKPDN L+ V+I DF +A + T GT Y +
Sbjct: 120 GIIHRDIKPDNILLD---EQGHVHITDFNIAT---------KVTPDTLTTSTSGTPGYMA 167
Query: 181 MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 214
S D SLG V Y LRG P++G
Sbjct: 168 PEVLCRQGYSVAVDWWSLG-VTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 22/159 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------NVKTKH--PQLQYEAKLYKILQ 59
++R G +GSGSFG +Y G N+ + A+K + QL+ E L LQ
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 60 GGTGIPNL-RWFGVEGDYNVLVIDL---LGPSLEDLF-NFCSRKLSLKTVLMLADQMINR 114
PN+ ++ G E + + L I L G SL L + S + + + Q++
Sbjct: 61 H----PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV--IRLYTRQILLG 114
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+E++H ++ +HRDIK N L+ V + DFG+AK
Sbjct: 115 LEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 50/194 (25%), Positives = 76/194 (39%), Gaps = 38/194 (19%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LNVKTKHP-QLQYEAKLYKILQGGTG 63
+ + K+G G+FGE+Y I+T VA+K N K P E K+ K L+
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 64 IPNLRWFGVEGD---------YNVL---VIDLLG----PSLEDLFNFCSRKLSLKTVLML 107
+P + D Y V DL G PS++ K +
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCYML----- 122
Query: 108 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167
Q++ + ++H LHRDIK N L+ + I DFGLA+ Y P
Sbjct: 123 --QLLEGINYLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGP-----PPNP 172
Query: 168 ENKNLTGTARYASM 181
+ GT +Y ++
Sbjct: 173 KGGGGGGTRKYTNL 186
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 38/155 (24%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQGGTGIPN- 66
F + K+G GS+G +Y + +T + VAIK + V+ ++ E + K P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS----PYI 60
Query: 67 LRWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 123
++++G D +++ S+ D+ ++ L+ + + + Q + +E++HS
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKK 120
Query: 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
+HRDIK N L+ Q + DFG++ + DT
Sbjct: 121 IHRDIKAGNILLN---EEGQAKLADFGVSGQLTDT 152
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 68/281 (24%), Positives = 123/281 (43%), Gaps = 53/281 (18%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---NVKTKHPQLQYEAKLYKILQGGTGIP 65
F L RK+GSG FGE++ G + VAIK+ + K Q E + K L+ I
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI- 65
Query: 66 NLRWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
F V G+ ++ +L+ G L L + + L + +++ +A Q+ + ++ +
Sbjct: 66 --SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQHIPYRENKNLTGTARY 178
+ +HRD+ N L+G + DFGLA+ ++ ++ + IPY+ TA
Sbjct: 124 NSIHRDLAARNILVGEDLVCK---VADFGLARLIKEDVYLSSDKKIPYK------WTAPE 174
Query: 179 ASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236
A+ + S + D+ S G +L+Y F G +P+ G+ + Y++I+
Sbjct: 175 AASHGTF----STKSDVWSFG-ILLYEMFTYGQVPYPGM---NNHEVYDQIT-------- 218
Query: 237 EALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLK 269
GY P E C + +D+P + L+
Sbjct: 219 ----AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 36/169 (21%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGI------ 64
G +G G++G++ + T + VAIK K K ++ + + L G GI
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIK---KVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 65 ----------PN---LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL----KTVLML 107
N L VEGD+ LV+D++ L+ + + RK+ L ++L
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD---RKIRLTESQVKCILL 126
Query: 108 ADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRY 155
Q++N + +H F+HRD+ P N F+ G I DFGLA+RY
Sbjct: 127 --QILNGLNVLHKWYFMHRDLSPANIFINSKG----ICKIADFGLARRY 169
|
Length = 335 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 74/291 (25%), Positives = 123/291 (42%), Gaps = 70/291 (24%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKH---PQLQY-EAKLYKILQGGTGIPN- 66
+IG G++G++Y N +T E VA+K + ++ + P E KL + L+ PN
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR----HPNI 60
Query: 67 LRWFGV---EGDYNVLVI------DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 117
+R + +G ++ ++ DL G L + K + + Q++ +++
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 118 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP----------YR 167
+HS LHRDIK N L+ + + DFGLA+ Y T ++ YR
Sbjct: 116 LHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPY----TKRNSADYTNRVITLWYR 168
Query: 168 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 227
+ L G RY + D+ S+G +L G +QG T+ ++ EKI
Sbjct: 169 PPELLLGATRYGP-----EV------DMWSVGCILAELFLGKPIFQG---STELEQLEKI 214
Query: 228 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRF--DDKPDYAYLKRLFRDLF 276
E LC G PT+ + L + + KP Y KR R+ F
Sbjct: 215 FE---------LC-GSPTD--ENWPGVSKLPWFENLKPKKPY-KRRLREFF 252
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 46/169 (27%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP------------------QLQYEA---- 52
IG G++G +Y ++ T VA+K K + P QL+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALK---KVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 53 -KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLE-DLFNFCSR----KLSLKTVLM 106
+L + G L + L+ ++ DL + S+ L +T+
Sbjct: 64 VRLLDVCHGPR------------TDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD 111
Query: 107 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155
L Q++ V+F+HS +HRD+KP N L+ QV I DFGLA+ Y
Sbjct: 112 LMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 60/257 (23%), Positives = 100/257 (38%), Gaps = 39/257 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQY--EAKLYKILQGG 61
+ F + + IG G+FGE++L + T + A+K+ K+ K Q+ + +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 62 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVH 119
I L + + ++ LV++ + DL N RK +T +++ ++ VH
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGG--DLMNLLIRKDVFPEETARFYIAELVLALDSVH 118
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT-----------------HQ 162
F+HRDIKPDN L+ + + DFGL K+
Sbjct: 119 KLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 163 HIPYRENKN-----LTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLK 216
+ + GT Y + G D SLG V++Y L G P
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG-VILYEMLYGFPP---FY 231
Query: 217 AGTKKQKYEKISEKKVS 233
+ T ++ Y KI K S
Sbjct: 232 SDTLQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 32/237 (13%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTG-IPNLR-- 68
G IGSGSFG +YLG N + E +A+K V+ + + +L I L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVK-QVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 69 -------WFGVEGDYNVLVIDLL---GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEF 117
+ G D + L I L G S+ L N + + + +L V Q++ + +
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL--VRNFVRQILKGLNY 121
Query: 118 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR----DTATHQHIPYRENKNLT 173
+H++ +HRDIK N L+ + I DFG++K+ T T+ P +L
Sbjct: 122 LHNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP-----SLQ 173
Query: 174 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 230
G+ + + +R+ D+ SLG +++ L G P+ T+ Q KI E
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC---TQLQAIFKIGEN 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 20/203 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVK--TKHPQL--QYEAKLYKILQGGT 62
K+ R +G G+FG ++L + V IK V+ TK +L Q E ++ K+L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 63 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSK 121
I F + +++ G +L + C+ L T+L Q++ + VH+K
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT--GTARYA 179
LHRD+K N L+ + V I DFG++K I ++K T GT Y
Sbjct: 121 LILHRDLKTQNILL--DKHKMVVKIGDFGISK----------ILSSKSKAYTVVGTPCYI 168
Query: 180 SMNTHLGIEQSRRDDLESLGYVL 202
S G +++ D+ +LG VL
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 52/164 (31%), Positives = 87/164 (53%), Gaps = 21/164 (12%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIK-LNVKTKHPQ--LQYEAKLYKIL 58
PR +L RK+G+G FGE+++GT N T +VA+K L T P+ LQ EA++ K L
Sbjct: 4 PR--ESLKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPEAFLQ-EAQIMKKL 58
Query: 59 QGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMIN 113
+ L + + V E + +V + + G L+ L + +KL L ++ +A Q+
Sbjct: 59 RH----DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
+ ++ S++++HRD+ N L+G I DFGLA+ D
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARLIED 155
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKL----NVKTKHP--------------QLQYEAKLYK 56
I G++G ++L T + AIK+ ++ K+ Q Y KLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 57 ILQGGTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 112
QG NL + +E GD L ++ +G ED+ +++
Sbjct: 61 SFQGKK---NL-YLVMEYLPGGDLASL-LENVGSLDEDVARIYIA------------EIV 103
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRENKN 171
+E++HS +HRD+KPDN L+ + + DFGL+K + + +E+K
Sbjct: 104 LALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 172 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231
+ GT Y + LG S+ D SLG +L FL G P+ G T ++ ++ I K
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEEIFQNILNGK 217
Query: 232 V 232
+
Sbjct: 218 I 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 38/153 (24%), Positives = 60/153 (39%), Gaps = 32/153 (20%)
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAK---RYRDTATHQHIP 165
++ E++H++ ++RD+KP+N L+ G V ++DFG AK + T T
Sbjct: 101 CVVLAFEYLHNRGIIYRDLKPENLLLDSNGY----VKLVDFGFAKKLKSGQKTWT----- 151
Query: 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA------- 217
GT Y + L D SLG +L+Y L G P+
Sbjct: 152 ------FCGTPEYVAPEIILNKGYDFSVDYWSLG-ILLYELLTGRPPFGEDDEDPMEIYN 204
Query: 218 ----GTKKQKYEKISEKKVSTSIEALCRGYPTE 246
G K ++ +K I+ L R P E
Sbjct: 205 DILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 6e-09
Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKIL----QGGT 62
K+ KIG G+ G +Y ++ T +EVAIK +N++ Q + E + +IL
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHP 76
Query: 63 GIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
I N L + V + V++ L G SL D+ + + + + + +EF+HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 134
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGL 151
+HRDIK DN L+G+ V + DFG
Sbjct: 135 QVIHRDIKSDNILLGMD---GSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 26/277 (9%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ-LQYEAKLYKILQG 60
PR RL K+G G FGE+++GT T + VAIK L T P+ EA++ K L+
Sbjct: 4 PR--ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRH 60
Query: 61 GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
+P E Y V G L+ L + L L ++ +A Q+ + + ++
Sbjct: 61 DKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 121 KSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
+++HRD++ N L+G N V I DFGLA+ D Y + ++
Sbjct: 121 MNYIHRDLRAANILVG----DNLVCKIADFGLARLIEDNE------YTARQGAKFPIKWT 170
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238
+ L + + D+ S G +L + +G +P+ G+ ++ E +V
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---VNREVLE-----QVERGYRM 222
Query: 239 LC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274
C +G P C D++P + Y++ D
Sbjct: 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 9e-09
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQLQYEAKLYKILQGGTGIP 65
+ +G GS G +Y + T + A+K ++ + + Q +L K L+ P
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF-RKQLLREL-KTLRS-CESP 59
Query: 66 NL-RWFGV---EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
+ + +G EG+ + +V++ + G SL DL K+ + +A Q++ ++++H+
Sbjct: 60 YVVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHT 117
Query: 121 KS-FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
K +HRDIKP N L+ +V I DFG++K +T + GT Y
Sbjct: 118 KRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLENTLD-------QCNTFVGTVTYM 167
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 219
S G S D+ SLG L+ G P+ +
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 68/282 (24%), Positives = 116/282 (41%), Gaps = 31/282 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LNVKTKHPQLQYEAKLYKILQGG 61
F++ +KIG G F E+Y T + + VA+K ++ K + ++ E L K L
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLKQLNHP 62
Query: 62 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFV 118
I L F + + N+++ L + + ++ L +TV Q+ + VE +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 119 HSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 177
HS+ +HRDIKP N F+ G V + D GL + + T H +L GT
Sbjct: 123 HSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPY 171
Query: 178 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYEKISEKKVSTS 235
Y S + + D+ SLG +L P+ G K + QK E+ + T
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT- 230
Query: 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277
Y + C D +PD Y+ ++ + + +
Sbjct: 231 -----EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMHV 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 53/184 (28%), Positives = 86/184 (46%), Gaps = 26/184 (14%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQ--------YEAKLYKILQGGTGIP 65
KIG G++G +Y + TNE +A+K K + Q E L K +Q G I
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALK---KIRLEQEDEGVPSTAIREISLLKEMQHGN-IV 64
Query: 66 NLRWFGVEGDYNV-LVIDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK 121
L+ V + + LV + L L+ + ++ L + Q++ + + HS
Sbjct: 65 RLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY--QILRGIAYCHSH 121
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIP--YRENKNLTGTA 176
LHRD+KP N L + RR N + + DFGLA+ + T TH+ + YR + L G+
Sbjct: 122 RVLHRDLKPQNLL--IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR 179
Query: 177 RYAS 180
Y++
Sbjct: 180 HYST 183
|
Length = 294 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 24/200 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQY----EAKLYKILQGGTGIPNL 67
R +G G+FGE L + + V K +N+ + + E + +LQ PN+
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH----PNI 61
Query: 68 -RWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKS 122
++ D N L+I++ G +L D +L + VL Q+++ V ++H
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 182
LHRDIK N + +A + + DFG++K + + + GT Y S
Sbjct: 122 ILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSMA-------ETVVGTPYYMSPE 171
Query: 183 THLGIEQSRRDDLESLGYVL 202
G++ + + D+ +LG VL
Sbjct: 172 LCQGVKYNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 47/172 (27%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQGGTGIPN 66
++ L + IGSG++G + + +T +VAIK ++ AK +IL+ I
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLID---AK--RILRE---IKL 52
Query: 67 LRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD---------------- 109
LR E N++ ++D+L P + FN + + T LM D
Sbjct: 53 LRHLRHE---NIIGLLDILRPPSPEDFN----DVYIVTELMETDLHKVIKSPQPLTDDHI 105
Query: 110 -----QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK 153
Q++ ++++HS + +HRD+KP N L N + I DFGLA+
Sbjct: 106 QYFLYQILRGLKYLHSANVIHRDLKPSNIL------VNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 42/230 (18%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKL-----NVKTKHPQLQY--------EAKLYKIL 58
G IG G++G +YL N+ T E +A+K + +H Q E + K L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 59 QGGTGIPNL-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSR---KLSLKTVLMLADQM 111
N+ ++ G E L I L G S+ C R + + V +Q+
Sbjct: 66 DH----LNIVQYLGFETTEEYLSIFLEYVPGGSIGS----CLRTYGRFEEQLVRFFTEQV 117
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 171
+ + ++HSK LHRD+K DN L+ I DFG++K+ D + +N +
Sbjct: 118 LEGLAYLHSKGILHRDLKADNLLVDA---DGICKISDFGISKKSDDIYDND-----QNMS 169
Query: 172 LTGT----ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 217
+ G+ A + G S + D+ SLG V++ G PW +A
Sbjct: 170 MQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 20/155 (12%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGI--- 64
+ L ++IGSG++G++Y +I T E VAIK+ +K + ++I+Q +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKV-IKLE------PGDDFEIIQQEISMLKE 56
Query: 65 ---PNL-RWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 117
PN+ +FG + L I + G SL+D++ LS + + + + + +
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAY 116
Query: 118 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152
+H +HRDIK N L+ V + DFG++
Sbjct: 117 LHETGKIHRDIKGANILL---TEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY---EAKLYKILQGGTGI 64
K+ KIG G+ G ++ ++ T +EVAIK K P+ + E + K L+ +
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 65 PNLRWFGVEGDYNVLVIDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKSF 123
L F V + V++ L G SL D+ C + + V + + +EF+H+
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLHANQV 136
Query: 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYASMN 182
+HRDIK DN L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 137 IHRDIKSDNVLLGM---DGSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMAPE 185
Query: 183 THLGIEQSRRDDLESLGYVLMYFLRGSLPW 212
+ D+ SLG + + + G P+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 8/158 (5%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQLQYEAKLYKILQGGTGIPNLRWF 70
+IG GSFG +Y TN TNE VA+K + K + + Q K K LQ + +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 71 G--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 128
G ++ LV++ S DL + L + + + + ++HS + +HRDI
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147
Query: 129 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166
K N L+ QV + DFG A + + PY
Sbjct: 148 KAGNILL---TEPGQVKLADFGSASKSSPANSFVGTPY 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 39/162 (24%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK--------------------LNVKTKHPQLQYEAK 53
KIG G++G ++ N +T+E VA+K L + KH + +
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI---VR 63
Query: 54 LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 113
LY +L + LV + L+ F+ C+ + + V Q++
Sbjct: 64 LYDVLHSDKKL-------------TLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLK 110
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155
+ F HS + LHRD+KP N L+ + ++ + DFGLA+ +
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--NVKTKHPQLQYEAKLYKILQGGTG 63
F L IG G++G++Y + +T + VAIK+ ++ + +++ E Y IL+ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE---YNILRKYSN 61
Query: 64 IPNL-RWFGV--------EGDYNVLVIDLL-GPSLEDLFN---FCSRKLSLKTVLMLADQ 110
PN+ ++G D LV++L G S+ DL ++L + + + +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152
+ + ++H +HRDIK N L L + A +V ++DFG++
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNIL--LTKNA-EVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 23/170 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY----EAKLYKILQGGTGI 64
+++ KIG G+F E+ + +T + AIK K Q E + + L I
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 65 PNLRWFGVEGDYN------VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 118
L +E ++ LV +L+ +L +L R L K V Q++ ++ +
Sbjct: 61 LRL----IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 168
H HRDIKP+N L+ + + + + DFG + + PY E
Sbjct: 117 HRNGIFHRDIKPENILI----KDDILKLADFGSCR-----GIYSKPPYTE 157
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 38/151 (25%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 13 RKIGSGSFGEIYLGT----NIQTNEEVAIK-LNVKTKHPQ---LQYEAKLYKILQGGTGI 64
+++G G FG++ L T E+VA+K LN + + E ++ + L +
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 65 PNLRWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 122
G ++ +I P SL D +++LK +L+ + Q+ ++++ S+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
++HRD+ N L+ + V I DFGLAK
Sbjct: 130 YIHRDLAARNILV---ESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 50/200 (25%), Positives = 76/200 (38%), Gaps = 59/200 (29%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLNVKT-----------------KHPQL----- 48
KIG G++G +Y N T E VA I+L+ +T HP +
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 49 --QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVL 105
E KLY LV + L L+ + + L +
Sbjct: 67 VIHTENKLY-----------------------LVFEFLHQDLKKFMDASPLSGIPLPLIK 103
Query: 106 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQ 162
Q++ + F HS LHRD+KP N L+ + + DFGLA+ + T TH+
Sbjct: 104 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHE 160
Query: 163 HIP--YRENKNLTGTARYAS 180
+ YR + L G Y++
Sbjct: 161 VVTLWYRAPEILLGCKYYST 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 24/222 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------NVKTKHPQLQYEAKLYKILQG 60
+RLG+ +G G+FGE+YL + T E+A+K + L+ E +L K L+
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 61 GTGIPNLRWFGV-----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
+ +++G E ++ V + G S++D L+ Q++ V
Sbjct: 64 DRIV---QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK-AYGALTENVTRRYTRQILQGV 119
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 175
++HS +HRDIK N L A V + DFG +KR + + K++TGT
Sbjct: 120 SYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRIQTI----CMSGTGIKSVTGT 172
Query: 176 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 217
+ S G R+ D+ S+ ++ L PW +A
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 74/287 (25%), Positives = 120/287 (41%), Gaps = 42/287 (14%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ--LQYEAKLYKILQ 59
PR RL K+G G FGE+++GT T VAIK L T P+ LQ EA++ K L+
Sbjct: 4 PR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLR 59
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
+ E Y V G L+ L + L L ++ +A Q+ + + +V
Sbjct: 60 HEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 178
+++HRD++ N L+G N V + DFGLA+ D Y + ++
Sbjct: 120 RMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKW 169
Query: 179 ASMNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237
+ L + + D+ S G +L +G +P+ G+ ++V +E
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE 217
Query: 238 ALCRGY----PTEFASYFH----YCRSLRFDDKPDYAYLKRLFRDLF 276
RGY P E H C +++P + YL+ D F
Sbjct: 218 ---RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 19/156 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIK-LNVKTKHPQ--LQYEAKLYKILQGGT 62
+L RK+G+G FGE++ G N T VA+K L T P+ L EA++ K L+
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTMDPKDFLA-EAQIMKKLRH-- 60
Query: 63 GIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 117
P L + + V + +V +L+ G LE L R L L ++ +A Q+ + + +
Sbjct: 61 --PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 118 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+ +++++HRD+ N L+G N + DFGLA+
Sbjct: 119 LEAQNYIHRDLAARNVLVG---ENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 41/167 (24%), Positives = 74/167 (44%), Gaps = 27/167 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LNVKTKHP-----------QLQYE 51
+K+ KIG G+FGE++ + +T + VA+K N K P L++E
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 52 --AKLYKILQG-GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA 108
L +I + T + G + LV + L L + + K +L + +
Sbjct: 72 NVVNLIEICRTKATPYNRYK-----GSF-YLVFEFCEHDLAGLLSNKNVKFTLSEIKKVM 125
Query: 109 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155
++N + ++H LHRD+K N L+ + + + DFGLA+ +
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 9e-08
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 49/236 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGI-----PNL 67
KIG G+FG++Y G ++ N EVA+K T P L+ K LQ + PN+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLK-----RKFLQEAEILKQYDHPNI 54
Query: 68 -RWFGVEGD-YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKS 122
+ GV + ++ L P L F +K L++K +L ++ +E++ SK+
Sbjct: 55 VKLIGVCVQKQPIYIVMELVPG-GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-----YRDTATHQHIPYR----ENKNLT 173
+HRD+ N L+G N + I DFG+++ Y + + IP + E N
Sbjct: 114 CIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN-- 168
Query: 174 GTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKI 227
RY S + D+ S G +L++ F G P+ G+ + +Q E+I
Sbjct: 169 -YGRYTSES-----------DVWSYG-ILLWETFSLGDTPYPGM---SNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ-------LQYEAKLYKILQG 60
+RLG+ +G G+FG +YL + T E+A+K + + P+ L+ E +L K L
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 61 GTGIPNLRWFGV-----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
+ +++G E ++ + + G S++D L+ Q++ V
Sbjct: 64 ERIV---QYYGCLRDPMERTLSIFMEHMPGGSIKDQLK-SYGALTENVTRKYTRQILEGV 119
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 175
++HS +HRDIK N L V + DFG +KR + + K++TGT
Sbjct: 120 SYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKRLQTIC----LSGTGMKSVTGT 172
Query: 176 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 217
+ S G R+ D+ S+G ++ L PW +A
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 17/159 (10%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQY-EAKLYKILQGGTGIPNL 67
+GSG++G + + + ++VA+K + H + Y E +L K ++ I L
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 68 RWF----GVEGDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
F +E ++N LV +L+G L ++ +KLS + V L Q++ ++++HS
Sbjct: 81 DVFTPATSIE-NFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSA 137
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160
+HRD+KP N + ++ I+DFGLA++ D T
Sbjct: 138 GIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 13/150 (8%)
Query: 13 RKIGSGSFGEI----YLGTNIQTNEEVAIKLNVKTKHPQLQY----EAKLYKILQGGTGI 64
R +G G FG++ Y N T E VA+K + Q E + K L +
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 65 PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 123
+G + +I P L L ++ + KL+L +L+ A Q+ + ++HS+ +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVP-LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHY 128
Query: 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+HRD+ N L+ V I DFGLAK
Sbjct: 129 IHRDLAARNVLL---DNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG- 71
+IG GSFGE+Y G + +T E VAIK ++++ +++ + +L R++G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 72 -VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 129
++G ++++ L G S DL L + + +++ ++++HS+ +HRDIK
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 130 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ 189
N L+ V + DFG+A + DT ++ GT + + I+Q
Sbjct: 129 AANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAPEV---IKQ 175
Query: 190 SRRD---DLESLGYVLMYFLRGSLPWQGL 215
S D D+ SLG + +G P L
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 70/263 (26%), Positives = 112/263 (42%), Gaps = 51/263 (19%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LN----VKTKHPQLQYEAKLYKILQGGTG 63
F + +G+GSFG + L + + + A+K L+ VK K Q+++ +ILQ
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLK--QVEHVLNEKRILQS-IR 59
Query: 64 IPNL--RWFGVEGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
P L + + D N+ LV++ + G L + A Q++ +E++H
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH 118
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-TATHQHIPYRENKNLTGTARY 178
S ++RD+KP+N L+ + I DFG AKR + T T L GT Y
Sbjct: 119 SLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGRTYT-----------LCGTPEY 164
Query: 179 AS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235
+ + G ++ D +LG +L+Y L G P+ Q YEKI E KV
Sbjct: 165 LAPEIILSKGYGKAV--DWWALG-ILIYEMLAGYPPF---FDDNPIQIYEKILEGKV--- 215
Query: 236 IEALCRGYPTEFASYFHY-CRSL 257
F S+F + L
Sbjct: 216 ----------RFPSFFSPDAKDL 228
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 49/172 (28%), Positives = 73/172 (42%), Gaps = 36/172 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLNVKTKHPQ--------LQYEAK 53
PR N G+ +G+G+FG++ T + + +K+ VK P L E K
Sbjct: 33 PR--NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 54 LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSL--------EDLFNFCSRK----LSL 101
+ L I NL G GP L DL NF RK L+L
Sbjct: 91 IMSHLGNHENIVNLLGACTIG----------GPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 102 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+ +L + Q+ + F+ SK+ +HRD+ N L+ G+ I DFGLA+
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK---ICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ-LQYEAKLYKILQG 60
PR +L +K+G+G FGE+++G + +VAIK L + P+ EA L K LQ
Sbjct: 4 PR--ETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 61 GTGIPNL-RWFGVEGDYNVLVID--LLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVE 116
P L R + V + +I + SL D KL++ ++ +A Q+ +
Sbjct: 61 ----PRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 117 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
F+ K+++HRD++ N L+ I DFGLA+ D
Sbjct: 117 FIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDN 155
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 40/162 (24%), Positives = 67/162 (41%), Gaps = 37/162 (22%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG-- 71
+I G++G +Y + +T E VA+K +L+ E + + G I +LR
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALK--------KLKMEKE-----KEGFPITSLREINIL 58
Query: 72 --------------VEGDYNV----LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 113
V G N+ +V++ + L+ L + V L Q+++
Sbjct: 59 LKLQHPNIVTVKEVVVGS-NLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS 117
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155
V +H LHRD+K N L+ + I DFGLA+ Y
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREY 156
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 31/156 (19%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH-PQLQ----YEAKLYKILQGGTGIPNLR 68
KIG GS+G ++ N +T + VAIK V+++ P ++ E ++ K L+ PNL
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH----PNL- 62
Query: 69 WFGVEGDYNVLVIDLLGPSLEDLFNFCS-----------RKLSLKTVLMLADQMINRVEF 117
N++ + L +F +C R + + + Q + V F
Sbjct: 63 -------VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115
Query: 118 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
H + +HRD+KP+N L+ + Q+ + DFG A+
Sbjct: 116 CHKHNCIHRDVKPENILI---TKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPN- 66
K+ KIG G+ G +Y ++ T +EVAI+ + P+ + +++ PN
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNI 79
Query: 67 ---LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 123
L + V + V++ L G SL D+ + + + + + +EF+HS
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYASMN 182
+HRDIK DN L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 138 IHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMAPE 186
Query: 183 THLGIEQSRRDDLESLGYVLMYFLRGSLPW 212
+ D+ SLG + + + G P+
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQLQYEAKLYKILQGGTGIPNLRW 69
R+IG GSFG +Y +++TNE VAIK + K + + Q K K LQ ++ +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 70 FG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 127
G + LV++ S DL + L + + + + ++HS + +HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 128 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166
IK N L+ QV + DFG A + PY
Sbjct: 151 IKAGNILL---TEPGQVKLADFGSASIASPANSFVGTPY 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 28/149 (18%), Positives = 61/149 (40%), Gaps = 19/149 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-KHPQLQYEAKLYKILQG-GTGIPNLRWF 70
+ + G +YL +E+ +K+N K + E + ++L G +P +
Sbjct: 4 KLLKGGLTNRVYLLGT--KDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 71 GVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHR 126
G ++ L+++ + G +L+ ++S + +A+Q+ + +H H
Sbjct: 62 GESDGWSYLLMEWIEGETLD--------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113
Query: 127 DIKPDNFLMGLGRRANQVYIIDFGLAKRY 155
D+ P N L+ + IID+ A
Sbjct: 114 DLHPGNILV---DDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 32/155 (20%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKH---PQLQYEAKLYKILQGGTGIPNL-RW 69
IG G++G +Y G ++ T VA+K +N+ T +Q E L L+ PN+ ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ-PPNITKY 67
Query: 70 FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR------------VEF 117
+G L GP L + + S++T LM A + + +++
Sbjct: 68 YGSY---------LKGPRLWIIMEYAEGG-SVRT-LMKAGPIAEKYISVIIREVLVALKY 116
Query: 118 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152
+H +HRDIK N L+ V + DFG+A
Sbjct: 117 IHKVGVIHRDIKAANILV---TNTGNVKLCDFGVA 148
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 4e-07
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPN- 66
K+ KIG G+ G +Y +I T +EVAIK + P+ + +++ PN
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN-PNI 78
Query: 67 ---LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 123
L + V + V++ L G SL D+ + + + + + ++F+HS
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYASMN 182
+HRDIK DN L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 137 IHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMAPE 185
Query: 183 THLGIEQSRRDDLESLGYVLMYFLRGSLPW 212
+ D+ SLG + + + G P+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 41/162 (25%), Positives = 76/162 (46%), Gaps = 17/162 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQGGTGIP 65
F L IG GSFGE+Y + +TN+ VAIK ++++ +++ + + L P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFL-SQCRSP 59
Query: 66 NL-RWFG-VEGDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
+ +++G + +I G S DL KL + + +++ +E++H +
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYLHEE 117
Query: 122 SFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTAT 160
+HRDIK N L+ G V + DFG++ + T +
Sbjct: 118 GKIHRDIKAANILLSEEG------DVKLADFGVSGQLTSTMS 153
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 15/155 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------NVKTKHPQLQYEAKLYKIL 58
NK+ + +G G++G + N T E VAIK +VK E K+ + L
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT---ALREVKVLRQL 57
Query: 59 QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 118
+ + F +G LV + + +L +L L V Q++ + +
Sbjct: 58 RHENIVNLKEAFRRKGRL-YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
HS + +HRDIKP+N L+ + + + DFG A+
Sbjct: 117 HSHNIIHRDIKPENILV---SESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 47/194 (24%), Positives = 79/194 (40%), Gaps = 47/194 (24%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK--------------------LNVKTKHPQLQYEAK 53
KIG G++G +Y + T E VA+K L + HP + +
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI---VR 62
Query: 54 LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMI 112
L ++ + Y LV + L L+ + L + Q++
Sbjct: 63 LLDVVHSENKL-----------Y--LVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY----RDTATHQHIP--Y 166
+ + HS LHRD+KP N L+ R + + DFGLA+ + R T TH+ + Y
Sbjct: 110 QGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVR-TYTHEVVTLWY 165
Query: 167 RENKNLTGTARYAS 180
R + L G+ +Y++
Sbjct: 166 RAPEILLGSRQYST 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 42/165 (25%), Positives = 78/165 (47%), Gaps = 34/165 (20%)
Query: 15 IGSGSFGEIY------LGTNIQTNEEVAIKLNVKTKHPQLQYEAK-----------LYKI 57
+GSG+FG +Y G N+ +E+ + +P + + I
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVH------NPAFGKDKRERDKSIGDIVSEVTI 61
Query: 58 LQGGTGIPNL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQ 110
++ PN+ R++ +E D +V+DL+ G L + FN K + + + + Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 111 MINRVEFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154
M+ + ++H K +HRD+ P+N ++G ++V I DFGLAK+
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 37/199 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY------EAKLYKILQG 60
+KF + +IG G++G++Y + T E VA+K V+ + + + E K+ + L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALK-KVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 61 GTGIPNLRWFGVEGDYNV----------LVI-----DLLGPSLEDLFNFCSRKLSLKTVL 105
I NL+ + + LV DL+G L +F S +
Sbjct: 66 -RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF-----SEDHIK 119
Query: 106 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY----RDTATH 161
Q++ + + H K+FLHRDIK N L+ Q+ + DFGLA+ Y T+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEESRPYTN 176
Query: 162 QHIP--YRENKNLTGTARY 178
+ I YR + L G RY
Sbjct: 177 KVITLWYRPPELLLGEERY 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 26/172 (15%)
Query: 14 KIGSGSFGEIYLGTNIQTNEE---VAIKLNVKTKHPQ------LQYEAKLYKILQGGTGI 64
K+G GSFG + G + + VA+K +K+ L+ A ++ +
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKC-LKSDKLSDIMDDFLKEAAIMHSLDH----- 55
Query: 65 PNL-RWFGVEGDYNV-LVIDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
NL R +GV + + +V +L LG L+ L + T+ A Q+ N + ++ S
Sbjct: 56 ENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 172
K F+HRD+ N L+ ++V I DFGL + H Y ++L
Sbjct: 116 KRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH----YVMEEHL 160
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 38/283 (13%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ-LQYEAKLYKILQG 60
PR +L +K+G+G FGE+++GT N +VA+K L T P+ EA++ K L+
Sbjct: 4 PR--ESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRH 60
Query: 61 GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
+ E Y V G L+ L + R L L ++ +A Q+ + ++
Sbjct: 61 DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 180
+++HRD++ N L+G G I DFGLA+ D Y + ++ +
Sbjct: 121 MNYIHRDLRSANILVGDGLVCK---IADFGLARLIEDNE------YTARQGAKFPIKWTA 171
Query: 181 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
L + + D+ S G +L + +G +P+ G+ + ++V +E
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM------------NNREVLEQVE-- 217
Query: 240 CRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274
RGY P C +++P + YL+ D
Sbjct: 218 -RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 27/161 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQL-----QYEAKLYKILQGG 61
K+ +G GS+G + + +T + VAIK ++++ ++ E ++ K L+
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRH- 59
Query: 62 TGIPNL--------RWFGVEGDYNVLVIDLLGPS-LEDLFNFCSRKLSLKTVLMLADQMI 112
+ NL R + LV + + + L+DL + + L V Q++
Sbjct: 60 ENLVNLIEVFRRKKRLY--------LVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQIL 110
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+EF HS + +HRDIKP+N L+ ++ V + DFG A+
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 23/219 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LNVKTKHPQLQYEAKLYKILQGG 61
FR+ +KIG G F E+Y T + VA+K ++ K + ++ E L K L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNHP 62
Query: 62 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFV 118
I F + + N+++ L + F R + KTV Q+ + +E +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 119 HSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 177
HS+ +HRDIKP N F+ G V + D GL + + T H +L GT
Sbjct: 123 HSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPY 171
Query: 178 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 216
Y S + + D+ SLG +L P+ G K
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 24/222 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ-------LQYEAKLYKILQG 60
+R G+ +G G+FG +YL ++ T E+A K + + P+ L+ E +L K LQ
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 61 GTGIPNLRWFGVEGDYNVLVIDLL-----GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
+ +++G D + + G S++D L+ Q++ +
Sbjct: 64 ERIV---QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK-AYGALTESVTRKYTRQILEGM 119
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 175
++HS +HRDIK N L A V + DFG +KR + + +++TGT
Sbjct: 120 SYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQTIC----MSGTGIRSVTGT 172
Query: 176 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 217
+ S G R+ D+ SLG ++ L PW +A
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LNVKTKHPQLQYEAKLYKILQ 59
F++ +KIG G F +Y + VA+K ++ K + L+ E L K L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLD 60
Query: 60 GGTGIPN-LRWFGVEGDYNVLVIDLLGPSLEDL------FNFCSRKLSLKTVLMLADQMI 112
PN +++ + N L I L DL F R + +T+ Q+
Sbjct: 61 H----PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHIPYRENKN 171
+ +E +HSK +HRDIKP N + A V + D GL + + T H +
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAAH-------S 165
Query: 172 LTGTARYASMNTHLGIEQSRRDDLESLGYVL 202
L GT Y S + + D+ SLG +L
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 31/164 (18%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLR 68
++LG IG+GSFG +Y I T+E+VAIK ++ QY+ + I++ NL
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMK------NLN 117
Query: 69 WFGV-------------EGDYNV---LVIDLLGPSLEDLFNFCSRK---LSLKTVLMLAD 109
+ + + N+ +V++ + ++ +R L L V + +
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
Q+ + ++HSK HRD+KP N L + + + + DFG AK
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLL--IDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL----NVKTKHPQLQYEAKL-------YKILQGGT 62
KIG GSFGE++ G + +T + VAIK+ + + +Q E + Y G+
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 63 GIPNLR-WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
+ + + W +E +DLL P D + + T+L +++ ++++HS+
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILR---EILKGLDYLHSE 120
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 181
+HRDIK N L+ +V + DFG+A + DT ++ GT + +
Sbjct: 121 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAP 170
Query: 182 NTHLGIEQSRRD---DLESLGYVLMYFLRGSLP 211
I+QS D D+ SLG + +G P
Sbjct: 171 EV---IKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 27/232 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVK--TKHPQLQYEAKLYKILQGGTG-- 63
+ +G+G+FG ++L + + A+K + + + Q Q+ ++L+ +
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 64 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSK 121
I L W + ++ P E LF++ S + S T L A +++ +E++HSK
Sbjct: 63 IIRLFW-TEHDQRFLYMLMEYVPGGE-LFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-TATHQHIPYRENKNLTGTARYAS 180
++RD+KP+N L+ + + + DFG AK+ RD T T L GT Y +
Sbjct: 121 EIVYRDLKPENILLD---KEGHIKLTDFGFAKKLRDRTWT-----------LCGTPEYLA 166
Query: 181 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232
++ D +LG ++ L G P+ YEKI K+
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD---DNPFGIYEKILAGKL 215
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 50/206 (24%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG- 71
+IG GSFGE++ G + +T + VAIK ++++ +++ + +L +++G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 72 -VEGDYNVLVIDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 128
++G ++++ LG +L+ L + + T+L +++ ++++HS+ +HRDI
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHSEKKIHRDI 127
Query: 129 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 188
K N L+ V + DFG+A + DT + GT + + I+
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEV---IQ 174
Query: 189 QSRRD---DLESLGYVLMYFLRGSLP 211
QS D D+ SLG + +G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 53/168 (31%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKL------NVKTKHPQLQYEAKLYKILQGGTGIPNLR 68
IG G++G + N +TNE+VAIK N L+ E KL LR
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKL------------LR 59
Query: 69 WFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLAD------------------ 109
E NV+ I D++ P + FN + + LM D
Sbjct: 60 HLDHE---NVIAIKDIMPPPHREAFN----DVYIVYELMDTDLHQIIRSSQTLSDDHCQY 112
Query: 110 ---QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 153
Q++ ++++HS + LHRD+KP N L+ AN + I DFGLA+
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 42/191 (21%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLNVKTKH-PQLQY-EAKLYKILQGGTGIPNLR 68
KIG G++G +Y G N +T + VA I+L + + P E L K LQ PN+
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH----PNI- 61
Query: 69 WFGVEGDYNVLVIDLL--GPSLEDLFNFCS-------------RKLSLKTVLMLADQMIN 113
V + D+L L +F F S + + + V Q++
Sbjct: 62 ---------VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIP--YRE 168
+ F HS+ LHRD+KP N L+ + + DFGLA+ + TH+ + YR
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRA 169
Query: 169 NKNLTGTARYA 179
+ L G+ RY+
Sbjct: 170 PEVLLGSPRYS 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 62/217 (28%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEA-KLYKILQGGTGIPN 66
++ + +KIG GSFG+IYL +E IK TK P + EA K IL PN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 67 L-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN-------RVEFV 118
+ +F + L I + DL +R+ + VL DQ+++ ++ +
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHI 117
Query: 119 HSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 177
H + LHRDIK N FL G A + DFG+A++ D+ GT
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAK---LGDFGIARQLNDSMELA-------YTCVGTPY 167
Query: 178 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
Y S + + D+ SLG VL P++G
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 18/156 (11%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQY----EAKLYKILQGGTGIPNL- 67
+IG G++G +Y + + VA+K + V+T L E L K L+ PN+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH-PNIV 65
Query: 68 RWFGV----EGDYNVLVIDLLGPSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVH 119
R V D V + +DL + + L +T+ L Q + ++F+H
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155
+ +HRD+KP+N L+ G QV + DFGLA+ Y
Sbjct: 126 ANCIVHRDLKPENILVTSG---GQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 40/159 (25%), Positives = 68/159 (42%), Gaps = 8/159 (5%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQLQYEAKLYKILQGGTGIPNLRW 69
R+IG GSFG +Y +++ +E VAIK + K + + Q K + LQ +++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 70 FG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 127
G + LV++ S DL + L + + + + ++HS + +HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 128 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166
+K N L+ V + DFG A PY
Sbjct: 141 VKAGNILL---SEPGLVKLGDFGSASIMAPANXFVGTPY 176
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 37/146 (25%), Positives = 69/146 (47%), Gaps = 9/146 (6%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ----LQYEAKLYKILQGGTGIPNLRWF 70
+G G++G +Y ++ T +AIK + + + L E L+ L+ + L
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIK-EIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 71 GVEGDYNVLVIDLLGPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 128
G + + + + G SL L + K + +T++ Q++ ++++H +HRDI
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDI 134
Query: 129 KPDNFLMGLGRRANQVYIIDFGLAKR 154
K DN L + + V I DFG +KR
Sbjct: 135 KGDNVL--VNTYSGVVKISDFGTSKR 158
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 3e-06
Identities = 21/67 (31%), Positives = 35/67 (52%), Gaps = 4/67 (5%)
Query: 90 DLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 147
DLF+ KLS V + Q++ + +H + +H DIK +N L R +++Y+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL--YDRAKDRIYLC 152
Query: 148 DFGLAKR 154
D+GL K
Sbjct: 153 DYGLCKI 159
|
Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNL- 67
F L ++IGSG++G++Y N+ T E AIK+ +K + + + I+ N+
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKV-IKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 68 RWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 124
+FG + L I + G SL+D+++ + LS + ++ + + + ++HSK +
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 125 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
HRDIK N L+ V + DFG++ + T
Sbjct: 129 HRDIKGANILL---TDNGHVKLADFGVSAQITAT 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 44/150 (29%), Positives = 69/150 (46%), Gaps = 16/150 (10%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL--NVKTKHPQLQYEAKLYKILQGGTGIPNL- 67
LG IG G FG++ LG ++VA+K + T EA + L+ PNL
Sbjct: 10 LGATIGKGEFGDVMLGD--YRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH----PNLV 63
Query: 68 RWFGV--EGDYNVLVIDLLGP-SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 123
+ GV +G+ +V + + SL D R ++L L A + +E++ K+F
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+HRD+ N L+ + DFGLAK
Sbjct: 124 VHRDLAARNVLVS---EDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 23/155 (14%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVK-------TKHPQLQY-EAKLYKILQGGTGI 64
+GSG++G++ + +T +VAIK K H + Y E +L K + I
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIK---KLSRPFQSAIHAKRTYRELRLLKHMDHENVI 77
Query: 65 PNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
L F +E +V LV L+G L ++ +KLS + L Q++ ++++H
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIH 135
Query: 120 SKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 153
S +HRD+KP N + + ++ I+DFGLA+
Sbjct: 136 SAGIIHRDLKPSN----IAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 46/281 (16%)
Query: 13 RKIGSGSFGEIYLGTNIQTNE---EVAIKLNVKTKHPQLQ----YEAKLYKILQGGTGIP 65
+++G G+FG + G + + EVA+K + + EA + L P
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH----P 56
Query: 66 NL-RWFGV-EGDYNVLVIDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
+ R GV +G+ +LV++L LGP L+ L R++ + + LA Q+ + ++ SK
Sbjct: 57 CIVRLIGVCKGEPLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK 114
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK------RYRDTATHQHIPYRENKNLTGT 175
F+HRD+ N L L R +Q I DFG+++ Y T P +
Sbjct: 115 HFVHRDLAARNVL--LVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLK-------- 163
Query: 176 ARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVS 233
YA + G S + D+ S G V ++ F G+ P+ +K + + E
Sbjct: 164 -WYAPECINYGK-FSSKSDVWSYG-VTLWEAFSYGAKPYGEMKG----AEVIAMLESGER 216
Query: 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274
C P E S C R +D+P ++ L+ FR
Sbjct: 217 LPRPEEC---PQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 54/233 (23%), Positives = 86/233 (36%), Gaps = 58/233 (24%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK---------------------TKH 45
F++ ++G G +G+++L T E VA+K K TK
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 46 PQLQYEAKLYKILQGGTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSL 101
L KL Q + +E GD+ L+ +L LS
Sbjct: 61 EWL---VKLLYAFQD----DEYLYLAMEYVPGGDFRTLLNNL-------------GVLSE 100
Query: 102 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161
+M V+ +H ++HRD+KP+NFL+ + + + DFGL+K A
Sbjct: 101 DHARFYMAEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSKGIVTYA-- 155
Query: 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
++ G+ Y + G D SLG +L FL G P+ G
Sbjct: 156 --------NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 15/177 (8%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ-----LQYEAKLYKILQGGTGIPNLR 68
K+G G++ ++ G + T VA+K ++ +H + E L K L+ I L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALK-EIRLEHEEGAPCTAIREVSLLKDLKHAN-IVTLH 70
Query: 69 WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 128
LV + L L+ + C +S+ V + Q++ + + H + LHRD+
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDL 130
Query: 129 KPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 180
KP N L+ ++ + DFGLA+ + T T+ + + YR L G++ Y++
Sbjct: 131 KPQNLLIN---ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 43/157 (27%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY--EAKLYKILQGGTGIPNL-RWF 70
K+G G +GE+Y G + + VA+K + ++ EA + K ++ PNL +
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLVQLL 68
Query: 71 GV---EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHR 126
GV E + ++ + +L D C+R+ ++ +L +A Q+ + +E++ K+F+HR
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128
Query: 127 DIKPDNFLMGLGRRANQVYIIDFGLAKRYR-DTATHQ 162
D+ N L+G + V + DFGL++ DT T
Sbjct: 129 DLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 162
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP-QLQYEAK-------LYKILQGGTGIPN 66
+GSG++G + + +T E+VAIK K P Q + AK L K +Q I
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIK---KLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 67 LRWFGVEGDYNVLV-IDLLGPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 124
L F + L+ P ++ DL LS V L QM+ ++++HS +
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGII 139
Query: 125 HRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
HRD+KP N + ++ I+DFGLA+
Sbjct: 140 HRDLKPGNLAVN---EDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 72/288 (25%), Positives = 126/288 (43%), Gaps = 58/288 (20%)
Query: 14 KIGSGSFGEIYLG--TNIQTNEEVAIKL-----NVKTKHPQLQYEAKLYKILQGGTGIPN 66
++GSG+FG + G ++ + VA+K+ N +L EA + + L P
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN----PY 57
Query: 67 L-RWFGV-EGDYNVLVIDL--LGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS 120
+ R G+ E + +LV++L LGP L F ++ ++ K + L Q+ ++++
Sbjct: 58 IVRMIGICEAESWMLVMELAELGP----LNKFLQKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVY--IIDFGLAK------RYRDTATHQHIPYRENKNL 172
+F+HRD+ N L+ Q Y I DFGL+K Y TH P +
Sbjct: 114 TNFVHRDLAARNVLL-----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----- 163
Query: 173 TGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKIS 228
YA MN + + S + D+ S G VLM+ F G P++G+K Q E
Sbjct: 164 ----WYAPECMNYY---KFSSKSDVWSFG-VLMWEAFSYGQKPYKGMKGNEVTQMIES-- 213
Query: 229 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276
+++ + P E C + D++P +A ++ R+ +
Sbjct: 214 GERMECP-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 52/202 (25%), Positives = 82/202 (40%), Gaps = 57/202 (28%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIP----NLR 68
R IG G+FG ++ T+ + + VA+K K+ + Q L+
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALK--------------KMPNVFQNLVSCKRVFRELK 51
Query: 69 WFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD------------------ 109
NVL +D+L P D F ++ + T LM +D
Sbjct: 52 MLCFFKHDNVLSALDILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSSDHVKV 107
Query: 110 ---QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHIP 165
Q++ ++++HS LHRDIKP N L+ +N + I DFGLA R + +H+
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFGLA-RVEEPDESKHMT 162
Query: 166 -------YRENKNLTGTARYAS 180
YR + L G+ Y S
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTS 184
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 110 QMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRD 157
Q++N V ++HS LHRD+KP N +MG G V I D GLA+ +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 42/160 (26%), Positives = 79/160 (49%), Gaps = 15/160 (9%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQL-----QYEAKLYKILQ 59
V +++R +++GSG++G + + +T +VAIK + +L E +L K ++
Sbjct: 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 60 GGTGIPNLRWFGVE---GDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 114
I L F + ++ LV+ +G L L KLS + L QM+
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKG 130
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154
++++H+ +HRD+KP N + ++ I+DFGLA++
Sbjct: 131 LKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 47/213 (22%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGI------P 65
G+++G+G+F Y +++T +A+K V + ++ + L+ + P
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVK-QVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 66 NL-RWFGV---EGDYNVLVIDLLGPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHS 120
++ R G + +N+ V + G S+ L + + K ++ ++ +Q++ + ++H
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV--IINYTEQLLRGLSYLHE 121
Query: 121 KSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
+HRD+K N L+ G+R + I DFG A R T L GT +
Sbjct: 122 NQIIHRDVKGANLLIDSTGQR---LRIADFGAAARLAAKGTGAG---EFQGQLLGTIAFM 175
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 212
+ G + R D+ S+G V++ PW
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 57/191 (29%), Positives = 80/191 (41%), Gaps = 48/191 (25%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKL-------------NVKTKHPQL-----QYEAKL 54
+ IG G+FGE+ L + TN A+K +VK + L ++ KL
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 55 YKILQGGTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 110
Y Q NL +F ++ GD L+I L G EDL F +L+
Sbjct: 67 YYSFQDKD---NL-YFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCA-------- 113
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 170
+E VH F+HRDIKPDN L+ R + + DFGL +R TH Y++
Sbjct: 114 ----IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR--WTHDSKYYQKG- 163
Query: 171 NLTGTARYASM 181
R SM
Sbjct: 164 ---DHHRQDSM 171
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 44/178 (24%), Positives = 83/178 (46%), Gaps = 17/178 (9%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ-----LQYEAKLYKILQGGTGIPNLR 68
K+G G++ ++ G + T VA+K ++ +H + E L K L+ I L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALK-EIRLEHEEGAPCTAIREVSLLKNLKHAN-IVTLH 69
Query: 69 WFGVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 127
+ + + LV + L L+ + C +S+ V + Q++ + + H + LHRD
Sbjct: 70 DI-IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128
Query: 128 IKPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 180
+KP N L+ ++ + DFGLA+ + T T+ + + YR L G+ Y++
Sbjct: 129 LKPQNLLIN---EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 38/161 (23%), Positives = 78/161 (48%), Gaps = 18/161 (11%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LNVKTKHPQLQYEAKLYKIL 58
VG++++ IGSG++G + + ++ ++VAIK +V T + E K+ +
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61
Query: 59 QGGTGIPNLRWF---GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
+ I G + +V+DL+ L + + L+ + + Q++ +
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII-HSDQPLTEEHIRYFLYQLLRGL 120
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLAK 153
+++HS + +HRD+KP N L+ N+ + I DFG+A+
Sbjct: 121 KYIHSANVIHRDLKPSNLLV------NEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 64/243 (26%), Positives = 99/243 (40%), Gaps = 49/243 (20%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIP 65
F +G +G+GSFG + + + T E AIK K K Q+Q+ A+ IL
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILM------ 73
Query: 66 NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKL---SLKTVLMLADQMINRV------- 115
E + +V + E+ F + L T L A + N V
Sbjct: 74 -------ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE 126
Query: 116 -----EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-TATHQHIPYREN 169
E++HSK ++RD+KP+N L L + + V + DFG AK+ D T T
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKKVPDRTFT--------- 174
Query: 170 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 229
L GT Y + + D ++G +L F+ G P+ T + YEKI
Sbjct: 175 --LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKILA 229
Query: 230 KKV 232
++
Sbjct: 230 GRL 232
|
Length = 329 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 36/158 (22%), Positives = 54/158 (34%), Gaps = 8/158 (5%)
Query: 295 QQSQVSTPARAIGPGAGPSSGMP-PAAANVDRQSGAEEGRHTGWSSADPSRRRNSGP--- 350
S S+ + + G G GP + P P A + + E S+ P +S
Sbjct: 234 ASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRE 293
Query: 351 LGNSANLSKQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSR 410
S + S S A + + SS R S SS + S A V PSR
Sbjct: 294 RSPSPSPSSPGSGPAPSSPRASSSSSSS----RESSSSSTSSSSESSRGAAVSPGPSPSR 349
Query: 411 PRTTDASPGAFQKISSGQRSSPVVSSENRHTTSGRSTS 448
+ P S +R P + + ++GR T
Sbjct: 350 SPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTR 387
|
Length = 1352 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 65/271 (23%), Positives = 115/271 (42%), Gaps = 42/271 (15%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ-----LQYEAKLYKILQGGTGIPNL-R 68
+G G+FGE++ GT ++ VA+K K PQ EA++ K PN+ +
Sbjct: 3 LGKGNFGEVFKGT-LKDKTPVAVK-TCKEDLPQELKIKFLSEARILKQYDH----PNIVK 56
Query: 69 WFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLH 125
GV + I + D +F +K L K ++ A + ++ SK+ +H
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 126 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYR-ENKNLTGTARYAS 180
RD+ N L+G N + I DFG++++ D ++ + IP + RY+S
Sbjct: 117 RDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 181 MNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
D+ S G +L F G P+ G+ T +Q E++ EK S
Sbjct: 174 -----------ESDVWSYGILLWETFSLGVCPYPGM---TNQQAREQV-EKGYRMSCPQK 218
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270
C P + C + +++P ++ L++
Sbjct: 219 C---PDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 43/177 (24%), Positives = 81/177 (45%), Gaps = 15/177 (8%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ-----LQYEAKLYKILQGGTGIPNLR 68
K+G G++ +Y G + T+ VA+K ++ +H + E L K L+ +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALK-EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 69 WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 128
E LV + L L+ + C +++ V + Q++ + + H + LHRD+
Sbjct: 72 IIHTEKSLT-LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDL 130
Query: 129 KPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 180
KP N L+ ++ + DFGLA+ + T T+ + + YR L G+ Y++
Sbjct: 131 KPQNLLIN---ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 10/152 (6%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLNVKTKHPQLQYEAKLYKILQGGTGI 64
+ +GSG+FG +Y G I E VAIK+ + P+ E +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 65 PNL-RWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
P++ R G+ V +I L P L D + + +L Q+ + ++ K
Sbjct: 69 PHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+HRD+ N L+ + V I DFGLAK
Sbjct: 129 RLVHRDLAARNVLV---KTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 41/175 (23%), Positives = 69/175 (39%), Gaps = 44/175 (25%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------------------LNVKTKHPQLQ 49
+L R IG G++G +Y + + E VA+K L + +HP +
Sbjct: 11 KLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI- 68
Query: 50 YEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD 109
+L +++ G D LV++ L L + S V L
Sbjct: 69 --VELKEVVVGK-----------HLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTATH 161
Q++ ++++H +HRD+K N L+ G + I DFGLA+ Y A
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGC------LKIADFGLARTYGLPAKP 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 49/221 (22%), Positives = 92/221 (41%), Gaps = 34/221 (15%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKLYKILQGGT 62
F++ +K+G GS+G +Y + N+ A+K ++ K + + E ++ +
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNH-- 58
Query: 63 GIPNLRWFGVEG--DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL------MLADQMINR 114
PN+ + E D N L I + DL S++ + ++ + Q++
Sbjct: 59 --PNIISYK-EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAKRYRDTATHQHIPYRENKNLT 173
++ +H + LHRD+K N L AN + I D G++K + K
Sbjct: 116 LQALHEQKILHRDLKSANIL----LVANDLVKIGDLGISKVLKKNMA---------KTQI 162
Query: 174 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
GT Y + G S + D+ SLG +L + P++
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 16/156 (10%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNL--- 67
LGR IG G FG++Y G + E I + VKT + K LQ +
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEK-IAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHP 67
Query: 68 ---RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSK 121
+ GV + V ++ L P L +L ++ L L ++++ + Q+ + ++ SK
Sbjct: 68 HIVKLIGVITENPVWIVMELAP-LGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK 126
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
F+HRDI N L+ + V + DFGL+ RY +
Sbjct: 127 RFVHRDIAARNVLVS---SPDCVKLGDFGLS-RYLE 158
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 45/146 (30%), Positives = 67/146 (45%), Gaps = 10/146 (6%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-KHPQLQ----YEAKLYKILQGGTGIPNL 67
+ +G G+FG + + T + VAIK +K P L E KL K L+ I
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 68 RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 127
F + V +LLG L L SR L + + Q++ +++VHS +HRD
Sbjct: 76 DIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRD 133
Query: 128 IKPDNFLMGLGRRANQVYIIDFGLAK 153
+KP N L+ + I DFGLA+
Sbjct: 134 LKPSNILIN---ENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 69/288 (23%), Positives = 113/288 (39%), Gaps = 62/288 (21%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------------LNVKTKHPQLQ 49
++ L ++IGSG FG ++LG +VAIK + +K HP+L
Sbjct: 4 SELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKL- 61
Query: 50 YEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLA 108
+LY + + I LV + + L D K S +T+L +
Sbjct: 62 --VQLYGVCTERSPI-------------CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106
Query: 109 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYR 167
+ + ++ S + +HRD+ N L+G NQV + DFG+ + D Y
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQ------YT 156
Query: 168 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 227
+ +++S + S + D+ S G VLM W+ G K YE
Sbjct: 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFG-VLM--------WEVFSEG--KTPYENR 205
Query: 228 SEKKVSTSIEALCRGYPTEFAS-----YFHYCRSLRFDDKPDYAYLKR 270
S +V +I A R Y AS +C R +D+P ++ L
Sbjct: 206 SNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 67/250 (26%), Positives = 106/250 (42%), Gaps = 47/250 (18%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK---TKHPQLQYEAKLYKILQGGTGI 64
K LG IG G FG + G T ++VA+K N+K T L+ A + K+
Sbjct: 7 KLTLGEIIGEGEFGAVLQGE--YTGQKVAVK-NIKCDVTAQAFLEETAVMTKLHH----- 58
Query: 65 PNL-RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVE 116
NL R GV G Y +V++L+ S +L NF + +S+ +L + + +E
Sbjct: 59 KNLVRLLGVILHNGLY--IVMELM--SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 117 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 176
++ SK +HRD+ N L+ + DFGLA+ + +P + TA
Sbjct: 115 YLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKLPVK------WTA 165
Query: 177 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236
A + S + D+ S G +L W+ G + Y K+S K+V +
Sbjct: 166 PEALKHKKF----SSKSDVWSYGVLL---------WEVFSYG--RAPYPKMSLKEVKECV 210
Query: 237 EALCRGYPTE 246
E R P E
Sbjct: 211 EKGYRMEPPE 220
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 60/231 (25%), Positives = 106/231 (45%), Gaps = 42/231 (18%)
Query: 11 LGRKIGSGSFGEIYLGT--NIQ-TNEEVAIKLNVKT-KHPQL------QYEAKLYKILQG 60
L R++G G+FG+++L N+ T +++ + VK K P L Q EA+L LQ
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVA--VKALKDPTLAARKDFQREAELLTNLQH 66
Query: 61 GTGIPNLRWFGV--EGDYNVLVIDLL------------GPSLEDLFNFCSRK----LSLK 102
+ +++GV +GD ++V + + GP L + R+ L L
Sbjct: 67 EHIV---KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 103 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162
+L +A Q+ + + ++ S+ F+HRD+ N L+G V I DFG++ RD +
Sbjct: 124 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS---RDVYSTD 177
Query: 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPW 212
+ YR + R+ + + + + D+ S G +L F G PW
Sbjct: 178 Y--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLNVKTKHPQLQYEAKLYKILQGGTGIP 65
+ L +++GSG++G++Y N+ T E A IKL +Q E + K + +
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 66 NLRWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 122
+FG L I + G SL+D+++ + LS + + + + + ++HSK
Sbjct: 71 ---YFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160
+HRDIK N L+ V + DFG+A + TAT
Sbjct: 127 KMHRDIKGANILL---TDNGDVKLADFGVAAKI--TAT 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 32/157 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLR---- 68
R+IG GSFG +Y +++TNE VAIK K + Q K I++ + LR
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIK---KMSYSGKQSNEKWQDIIKEVRFLQQLRHPNT 77
Query: 69 -------------WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
W LV++ S D+ + L + + + +
Sbjct: 78 IEYKGCYLREHTAW---------LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGL 128
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152
++HS +HRDIK N L+ V + DFG A
Sbjct: 129 AYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 22/166 (13%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE-----VAIKLNVKTKHPQLQYEAKLYKILQGGTGI 64
L R +G G+FGE+Y G + + VA+K ++ Q + + + ++
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 65 PNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFC---------SRKLSLKTVLMLADQMINR 114
N+ R GV + I L + DL +F L++K +L A +
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 115 VEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKR-YR 156
+++ F+HRDI N L+ G GR A I DFG+A+ YR
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAK---IADFGMARDIYR 171
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 45/164 (27%), Positives = 68/164 (41%), Gaps = 34/164 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKL-------------NVKTKHPQL-----QYEAKL 54
+ +G G+FGE+ L + T A+K +VK + L ++ +L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 55 YKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 114
Y Q + + + GD L+I + G EDL F ++
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARF------------YIAELTCA 113
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
VE VH F+HRDIKPDN L+ R + + DFGL +R T
Sbjct: 114 VESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWT 154
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 24/181 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQGGTGI- 64
+ + L IG G+ +Y + NE+VAIK ++++ + +L K +Q +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD---ELRKEVQAMSQCN 57
Query: 65 -PNL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRK-----LSLKTVLMLADQMINR 114
PN+ +++ V GD LV+ L G SL D+ + + TVL +++
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL---KEVLKG 114
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 174
+E++HS +HRDIK N L+G V I DFG++ D + K G
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTR---KVRKTFVG 168
Query: 175 T 175
T
Sbjct: 169 T 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 19/203 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------NVKTKHPQLQYEAKLYKILQG 60
NKF + +G G++G + + +T E VAIK N + K L+ E K+ + L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 61 GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
+ F G LV + + ++ +L + + V Q+I + + H
Sbjct: 60 ENIVELKEAFRRRGKL-YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
+HRDIKP+N L+ N V + DFG A+ + + + Y T Y
Sbjct: 119 NDIVHRDIKPENLLIS----HNDVLKLCDFGFARNLSEGSNANYTEY------VATRWYR 168
Query: 180 SMNTHLGIEQSRRDDLESLGYVL 202
S LG + D+ S+G +L
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 43/172 (25%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEE--VAIK--LNVKTKHPQLQYEAKLYKILQGGTGI 64
+ L +++G G++G + N +T+EE VAIK NV +K + + K+L+ G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 65 PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------------- 109
N+ + D ++ +F +L L LM AD
Sbjct: 62 KNITC----------LYD-----MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAH 106
Query: 110 ------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155
Q++ ++++HS + LHRD+KP N L+ ++ I DFGLA+ +
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 39/168 (23%), Positives = 80/168 (47%), Gaps = 16/168 (9%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGT 62
P + + + IG G++G+++ N + + A+K+ + EA+ Y IL+ +
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAE-YNILKALS 72
Query: 63 GIPNL-RWFG-------VEGDYNVLVIDLL-GPSLEDLFN-FCSR--KLSLKTVLMLADQ 110
PN+ +++G GD LV++L G S+ DL F R ++ + + +
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
+ ++ +H +HRD+K +N L+ V ++DFG++ + T
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTST 177
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 56/236 (23%)
Query: 108 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167
A +++ ++F+HSK ++RD+K DN ++ R + I DFG+ K +++ +
Sbjct: 102 AAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCK--------ENV-FG 149
Query: 168 ENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 225
+N+ T GT Y + G++ + D S G +L L G P+ G + + +E
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG---DDEDELFE 206
Query: 226 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF-RDLFIREGF--- 281
I +V T HY R + + K L++LF RD R G
Sbjct: 207 SI---RVDTP----------------HYPRWITKESKD---ILEKLFERDPTRRLGVVGN 244
Query: 282 ----QFDYVFDWTILKYQQSQVSTPARAIGPGAGPSSGMPPAAANVDRQSGAEEGR 333
F +WT L+ R + P P P +N DR+ +E+ R
Sbjct: 245 IRGHPFFKTINWTALE---------KRELDPPFKPKVKSPSDYSNFDREFLSEKPR 291
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 15/156 (9%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVK----TKHPQLQY-EAKLYKILQGGTGIPNLRW 69
+GSG++G + + +T VA+K + H + Y E +L K ++ I L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 70 FGVEGDYN-----VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 124
F LV L+G L ++ +KL+ V L Q++ ++++HS +
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADII 142
Query: 125 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160
HRD+KP N + ++ I+DFGLA+ D T
Sbjct: 143 HRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 175
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 32/211 (15%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LNVKTKHPQLQYEAKLYKILQGGTG 63
++ L +++G GSFG +YL + + E +K + V +P +A L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 64 IPNLRWFG---VEGDYNVLVIDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVE 116
P + F +E D ++ + G L+ + LS V Q++ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 117 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIPYRENKNLT 173
++H + LHRD+K N + + N + I DFG+++ D AT T
Sbjct: 121 YMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLAT----------TFT 166
Query: 174 GTARYASMN--THLGIEQSRRDDLESLGYVL 202
GT Y S H G + + D+ SLG +L
Sbjct: 167 GTPYYMSPEALKHQGYDS--KSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 40/268 (14%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQ----YEAKLYKILQGGTGIPNL-R 68
+IG G+FGE++ G N VA+K +T P L+ EA++ K PN+ R
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSH----PNIVR 57
Query: 69 WFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 125
GV + +V++L+ G +L +K ++ + + +E++ SK +H
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 126 RDIKPDNFLMGLGRRANQVYIIDFGLAKR-----YRDTATHQHIPYR-ENKNLTGTARYA 179
RD+ N L+ N + I DFG+++ Y T + IP + RY+
Sbjct: 118 RDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 180 SMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238
S D+ S G +L F G++P+ L + +Q E I E+ V
Sbjct: 175 S-----------ESDVWSFGILLWEAFSLGAVPYANL---SNQQTREAI-EQGVRLPCPE 219
Query: 239 LCRGYPTEFASYFHYCRSLRFDDKPDYA 266
LC P C +P ++
Sbjct: 220 LC---PDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 38/138 (27%), Positives = 67/138 (48%), Gaps = 18/138 (13%)
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI--PYR 167
QM+ ++ +HS +HRD+KP N ++ + + I+DFGLA+ TA + PY
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR----TACTNFMMTPY- 182
Query: 168 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 227
T Y + LG+ D+ S+G ++ ++GS+ +QG ++ K+
Sbjct: 183 -----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD---HIDQWNKV 234
Query: 228 SEKKVSTSIEALCRGYPT 245
E+ + S E + R PT
Sbjct: 235 IEQLGTPSAEFMNRLQPT 252
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 68/288 (23%), Positives = 114/288 (39%), Gaps = 56/288 (19%)
Query: 9 FRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLNVKTKHP------QLQYEAKLYKILQGG 61
+L +K+G+G FGE+++ T N T K+ VKT P EA + K LQ
Sbjct: 8 LKLEKKLGAGQFGEVWMATYNKHT------KVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61
Query: 62 TGIPNLRWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 118
+ + V + +I G L+ L + K L ++ + Q+ + F+
Sbjct: 62 KLV---KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTA 176
++++HRD++ N L+ + I DFGLA+ D RE + TA
Sbjct: 119 EQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIED----NEYTAREGAKFPIKWTA 171
Query: 177 RYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 235
A I + D+ S G +LM + G +P+ G+
Sbjct: 172 PEAINFGSFTI----KSDVWSFGILLMEIVTYGRIPYPGMSN---------------PEV 212
Query: 236 IEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275
I AL RGY P E + C R +++P + Y++ + D
Sbjct: 213 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 58/227 (25%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK----------------------LNVKTKHPQLQYEA 52
+G GSFG++ L TNE AIK L + +HP L +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH-- 60
Query: 53 KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQ 110
L+ Q ++ V++ L G L +F+ S + A +
Sbjct: 61 -LFCTFQ-------------TKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAE 104
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 170
+I ++F+H K ++RD+K DN L+ + + I DFG+ K +++ E K
Sbjct: 105 IICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCK--------ENM-NGEGK 152
Query: 171 NLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 214
T GT Y + G + + D S G VL+Y L G P+ G
Sbjct: 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 39/182 (21%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQL-QYEAKLYKILQGGTG 63
VG +++ IG G++G + T+ T +VAIK +H Q + KIL
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKIL----- 57
Query: 64 IPNLRWFGVEGDYNVLVI-DLLGPSLEDLFN----------------FCSRKLSLKTVLM 106
R F E N++ I D++ P + FN ++ LS +
Sbjct: 58 ----RRFKHE---NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQY 110
Query: 107 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHIP 165
Q++ ++++HS + LHRD+KP N L+ N + I DFGLA+ A +H
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICDFGLAR----IADPEHDH 162
Query: 166 YR 167
Sbjct: 163 TG 164
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 48/202 (23%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQLQYEAKLYKILQGGTGIPNLRWF 70
KIG GS G + + + +VA+K L + + L E + + Q + + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 71 GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 130
V + VL+ L G +L D+ + +L+ + + + + ++ + ++HS+ +HRDIK
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 131 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS 190
D+ L+ L R V + DFG + + +P R K+L GT + +
Sbjct: 146 DSILLTLDGR---VKLSDFGFCAQ-----ISKDVPKR--KSLVGTPYWMAPEVISRTPYG 195
Query: 191 RRDDLESLGYVLMYFLRGSLPW 212
D+ SLG +++ + G P+
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 70/280 (25%), Positives = 118/280 (42%), Gaps = 52/280 (18%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY--EAKLYKILQGGTGIPNL- 67
+++GSG FG ++LG + +VAIK+ + + + EAK+ L PNL
Sbjct: 8 FLKELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSH----PNLV 62
Query: 68 RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKSFL 124
+ +GV + I + L N+ KL + +L + + +E++ S F+
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 125 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT---ARYASM 181
HRD+ N L+G N V + DFGLA+ D + + GT ++A
Sbjct: 123 HRDLAARNCLVG---EDNVVKVSDFGLARYVLDD---------QYTSSQGTKFPVKWAPP 170
Query: 182 NTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S + D+ S G VLM+ F G +P YE+ S +V +E++
Sbjct: 171 EVFDYSRFSSKSDVWSFG-VLMWEVFSEGKMP------------YERFSNSEV---VESV 214
Query: 240 CRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRL 271
GY PTE + + C + +D+P + L
Sbjct: 215 SAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 30/113 (26%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 115 VEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAK------------RYRDTATH 161
+E++H+ +HRD+KPDN L+ +G + + DFGL+K + + T
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
+ + +K + GT Y + L + D ++G +L FL G +P+ G
Sbjct: 170 EFL----DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 41/168 (24%), Positives = 68/168 (40%), Gaps = 48/168 (28%)
Query: 15 IGSGSFGEIYLGTN-----------IQTNEE-------VAIKLNVKTKHPQLQ--YEAKL 54
+G G+FG++Y + IQ E V I + + KHP + YEA
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 55 YKILQGGTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 110
Y+ L W +E G + ++++L E + R Q
Sbjct: 73 YE--------NKL-WILIEFCDGGALDSIMLELERGLTEPQIRYVCR------------Q 111
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
M+ + F+HS +HRD+K N L+ L V + DFG++ + + T
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKST 156
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 43/149 (28%), Positives = 66/149 (44%), Gaps = 16/149 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLNVKTKHPQLQY-EAKLYKILQGGTGIPN-LR 68
K+G G++ +Y G N T E VA I L+ + P E L K L+ N +R
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH----ENIVR 62
Query: 69 WFGVEGDYN--VLVIDLLGPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 124
V N +LV + + L+ + L TV Q++ + F H L
Sbjct: 63 LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122
Query: 125 HRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
HRD+KP N L+ + ++ + DFGLA+
Sbjct: 123 HRDLKPQNLLIN---KRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 57/288 (19%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP------QLQYEAKLYKILQGGTG 63
+L +K+G+G FGE+++G + K+ VKT P EA L K LQ
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNST-----KVAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 63
Query: 64 IPNLRWFGV----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
+ R + V E Y + G L+ L + K+ L ++ + Q+ + ++
Sbjct: 64 V---RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTAR 177
K+++HRD++ N L+ + I DFGLA+ D RE + TA
Sbjct: 121 RKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIED----NEYTAREGAKFPIKWTAP 173
Query: 178 YASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235
A I + D+ S G +L+Y G +P+ G+ S
Sbjct: 174 EAINFGSFTI----KSDVWSFG-ILLYEIVTYGKIPYPGMSN---------------SDV 213
Query: 236 IEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275
+ AL RGY P E C + +++P + YL+ + D
Sbjct: 214 MSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 107 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166
+A Q+++ + ++H + +HRDIKP N L+ + V I DFG+++ T P
Sbjct: 173 VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMD----PC 225
Query: 167 RENKNLTGTARYAS---MNTHLGIEQSRRD----DLESLGYVLMYFLRGSLP 211
+ GT Y S +NT L D D+ SLG ++ F G P
Sbjct: 226 NSS---VGTIAYMSPERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 45/225 (20%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIK---------LNVKTKHPQLQYEAKLYKILQG-- 60
G +G G++G +Y G + +A+K L + ++ +LQ E L K L+
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 61 -----GT----GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQM 111
GT ++ V G +++ GP E +F ++ Q+
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK------------QI 111
Query: 112 INRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIPYR 167
++ V ++H+ +HRDIK +N LM G + +IDFG A+R TH ++
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRLAWVGLHGTHSNML-- 165
Query: 168 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 212
K++ GT + + R+ D+ S+G + G P
Sbjct: 166 --KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 24/222 (10%)
Query: 2 EPRVGNK-----FRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLNVKTK---HPQLQYEA 52
EP+ NK F R +G+GSFG + L T + VAIK K+K Q+ +
Sbjct: 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF 79
Query: 53 KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL--MLADQ 110
KIL + +G D + L + L + F F R + A Q
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ 139
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 170
++ E++ S + ++RD+KP+N L+ + + + DFG AK DT T+
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAK-VVDTRTY--------- 186
Query: 171 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 212
L GT Y + L + + D +LG + L G P+
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 41/169 (24%), Positives = 75/169 (44%), Gaps = 29/169 (17%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQY---------EAK-LYKILQGGT 62
I G+ EIYLG + + IK + + HP+L EA+ + + + G
Sbjct: 4 IKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61
Query: 63 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
+P + + E ++V++ + G L+DL N S + + +++ ++ HS
Sbjct: 62 NVPAVYFVDPENF--IIVMEYIEGEPLKDLIN--SNGMEELELSREIGRLVGKL---HSA 114
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA---KRYRDTATHQHIPYR 167
+H D+ N ++ ++Y+IDFGLA K D A H+ R
Sbjct: 115 GIIHGDLTTSNMIL----SGGKIYLIDFGLAEFSKDLEDRAVDLHVLLR 159
|
Length = 211 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 37/228 (16%)
Query: 14 KIGSGSFGEIYLG--TNIQTNEE---VAIK-LNVKTKHPQL--QYEAKLYKILQGGTGIP 65
++G G+FG+++L N+ ++ VA+K L ++ + Q EA+L +LQ +
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV- 70
Query: 66 NLRWFGV--EGDYNVLVIDLL------------GPS---LEDLFNFCSRKLSLKTVLMLA 108
R++GV EG ++V + + GP L + +L+L +L +A
Sbjct: 71 --RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 109 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 168
Q+ + + ++ S F+HRD+ N L+G G V I DFG++ RD + + YR
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---RDIYSTDY--YRV 180
Query: 169 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGL 215
R+ + L + + D+ S G VL F G PW L
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 47/164 (28%), Positives = 70/164 (42%), Gaps = 34/164 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-------LN------VKTKHPQL-----QYEAKL 54
+ +G G+FGE+ L + T+ A+K LN VK + L ++ KL
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 55 YKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 114
Y Q + + + GD L+I + E L F +L+L
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLA------------ 113
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
+E VH F+HRDIKPDN L+ L + + DFGL +R T
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLD---GHIKLTDFGLCTGFRWT 154
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 34/146 (23%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTG-----IPNLR 68
++G G+FG++Y N +T A K+ ++TK + + E + +I T + L
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKV-IETKSEE-ELEDYMVEIEILATCNHPYIVKLLG 76
Query: 69 WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 128
F +G +++ G +++ + R L+ + ++ QM+ ++++HS +HRD+
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 129 KPDNFLMGLGRRANQVYIIDFGLAKR 154
K N L+ L + + DFG++ +
Sbjct: 137 KAGNVLLTLD---GDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 39/155 (25%), Positives = 65/155 (41%), Gaps = 11/155 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYK----ILQGGT 62
F + +G G FGE+ + T + A+K+ +K Q ++ IL
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKV-MKKSVLLAQETVSFFEEERDILSISN 59
Query: 63 G--IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
IP L++ + D LV++ G L L N + +++ + VH
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154
++HRDIKP+N L+ R + + DFG A R
Sbjct: 120 QMGYVHRDIKPENVLID---RTGHIKLADFGSAAR 151
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 50/191 (26%), Positives = 84/191 (43%), Gaps = 31/191 (16%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--------HPQLQYEAKLYKILQGGTGIP 65
KIG G++G++Y + T + VA+K KT+ P E L ++L I
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIYI- 63
Query: 66 NLRWFGVE------GDYNV-LVIDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINR 114
+R VE G ++ LV + L L+ + R L KT+ Q++
Sbjct: 64 -VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIP--YREN 169
V H +HRD+KP N L + ++ + I D GL + + + TH+ + YR
Sbjct: 123 VAHCHKHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 170 KNLTGTARYAS 180
+ L G+ Y++
Sbjct: 181 EVLLGSTHYST 191
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 43/206 (20%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYE-AKLYKILQGGTGIPNL-RWF 70
++G+G+ G + + T + +A+K + +Q + + IL P + ++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNS-PYIVGFY 65
Query: 71 G---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHR 126
G GD ++ + + G SL+ + ++ + + +A ++ + ++H K +HR
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR 125
Query: 127 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG 186
D+KP N L+ Q+ + DFG++ + ++ K GT+ Y + G
Sbjct: 126 DVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPERIQG 173
Query: 187 IEQSRRDDLESLGYVLMYFLRGSLPW 212
+ S + D+ SLG L+ G P+
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 41/170 (24%), Positives = 78/170 (45%), Gaps = 30/170 (17%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNV-----KTKHP--------QLQYE 51
+G+++ R +G GS G ++ + ++ VA+K V KH +L ++
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHD 62
Query: 52 --AKLYKILQGGTGIPNLRWFGVEGDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLML 107
K+Y++L G +G G + N + I + + L ++ LS + +
Sbjct: 63 NIVKVYEVL-GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLF 119
Query: 108 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ----VYIIDFGLAK 153
Q++ ++++HS + LHRD+KP N + N + I DFGLA+
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFI------NTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 44/192 (22%), Positives = 71/192 (36%), Gaps = 39/192 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLN-VKTKHPQLQYEAKLYKILQGGTGIPNLRWFG 71
+++ G+ +YLG EVA+K+ + L+ EAK+ +IL G P + ++G
Sbjct: 28 KELAKGTTSVVYLGE--WRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG 85
Query: 72 VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTV---LMLADQMINRVEFVHSKSFLHRDI 128
+ + + + G L L RK L+ + L I E + +
Sbjct: 86 ED---FIRMEYIDGRPLGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNV---L 139
Query: 129 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 188
D VYIIDF D+AT + P +N+T L E
Sbjct: 140 VND----------RDVYIIDF-------DSATFKKKP----RNVTQALSL------LFRE 172
Query: 189 QSRRDDLESLGY 200
R + GY
Sbjct: 173 GLRIEKTILRGY 184
|
Length = 201 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 64/288 (22%)
Query: 14 KIGSGSFGEIYLGTNIQTNEE--VAIKL----NVKTKHPQLQYEAKLYKILQGGTGIPNL 67
++GSG+FG + G ++ VAIK+ N K+ ++ EA++ L P +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN----PYI 57
Query: 68 -RWFGV-EGDYNVLVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 120
R GV E + +LV+++ GP L F S K +++ V+ L Q+ ++++
Sbjct: 58 VRMIGVCEAEALMLVMEMASGGP----LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVY--IIDFGLAK------RYRDTATHQHIPYRENKNL 172
K+F+HRD+ N L+ NQ Y I DFGL+K Y + P +
Sbjct: 114 KNFVHRDLAARNVLL-----VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK----- 163
Query: 173 TGTARYAS--MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 230
YA +N + S R D+ S G + W+ G K Y+K+
Sbjct: 164 ----WYAPECINFR---KFSSRSDVWSYGITM---------WEAFSYGQK--PYKKMKGP 205
Query: 231 KVSTSIEALCR-----GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273
+V + IE R P E + C +++D+P++A ++ R
Sbjct: 206 EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 57/224 (25%), Positives = 88/224 (39%), Gaps = 48/224 (21%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LNVKTKHPQLQY 50
+ +G GSFG+++L TN+ AIK L++ +HP L +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 51 EAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 110
LY Q + +F +E Y L G L C K L A +
Sbjct: 61 ---LYCTFQTKENL----FFVME--Y------LNGGDLMFHIQSC-HKFDLPRATFYAAE 104
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 170
+I ++F+HSK ++RD+K DN L+ + I DFG+ K + +
Sbjct: 105 IICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCK-------ENMLGDAKTC 154
Query: 171 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
GT Y + LG + + D S G +L L G P+ G
Sbjct: 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 16/156 (10%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPN-LRWFGV- 72
IG G++G++Y TN + A+K+ + EA+ Y ILQ PN ++++G+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAE-YNILQSLPNHPNVVKFYGMF 88
Query: 73 -EGDYNV-----LVIDLL-GPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSKS 122
+ D V LV++L G S+ +L C ++L + + + ++ +H+
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR 148
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
+HRD+K +N L+ V ++DFG++ + T
Sbjct: 149 IIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTST 181
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 17/157 (10%)
Query: 13 RKIGSGSFGEIYL------GTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQGGTGIP 65
R +G G FG++ L G N T E+VA+K L ++ + K +IL+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 66 NLRWFGV---EGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
+++ G+ +G + L+++ L SL++ K++LK L A Q+ ++++ S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
+ ++HRD+ N L+ +QV I DFGL K
Sbjct: 128 RQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIET 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 45/164 (27%), Positives = 65/164 (39%), Gaps = 34/164 (20%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQ-------------- 49
F + IG G+FGE+ L T + A+K +K+ K QL
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 50 -YEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA 108
+ LY Q + + F GD ++I S ED+ F + L
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFS-EDVTRFYMAECVLA------ 113
Query: 109 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152
+E VH F+HRDIKPDN L+ R + + DFGL+
Sbjct: 114 ------IEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 14/39 (35%), Positives = 22/39 (56%), Gaps = 3/39 (7%)
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
++ +H ++HRDIKPDN L+ + + DFGL
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 25/235 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYK-----ILQGGTG 63
F + + IG G+FGE+ + ++ A+K+ K + + + E ++ ++ G
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDNQ 61
Query: 64 IPNLRWFGVEGDYNV-LVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
+ + + N+ LV+D +G L L + +L +M+ ++ VH
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 181
++HRDIKPDN LM + + + DFG + + T Q + GT Y S
Sbjct: 122 HYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGTVQ------SSVAVGTPDYISP 172
Query: 182 NTHLGIEQSR-----RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231
+E + D SLG + L G P+ A + + Y KI K
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 40/148 (27%), Positives = 65/148 (43%), Gaps = 10/148 (6%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEE----VAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNL- 67
+ +GSG+FG +Y G I E VAIK+ + P+ E + G G P +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 68 RWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 125
R G+ V ++ L P L D ++ + +L Q+ + ++ +H
Sbjct: 73 RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVH 132
Query: 126 RDIKPDNFLMGLGRRANQVYIIDFGLAK 153
RD+ N L+ + N V I DFGLA+
Sbjct: 133 RDLAARNVLV---KSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 10/146 (6%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVK----TKHPQLQYEAKLYKILQGGTGIPNL-RW 69
+GSG+FG +Y G + E V I + +K T P+ E ++ P+L R
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 70 FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML--ADQMINRVEFVHSKSFLHRD 127
GV + ++ L P L K ++ + L+L Q+ + ++ + +HRD
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRD 134
Query: 128 IKPDNFLMGLGRRANQVYIIDFGLAK 153
+ N L+ + N V I DFGLA+
Sbjct: 135 LAARNVLV---KSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 33/117 (28%), Positives = 46/117 (39%), Gaps = 19/117 (16%)
Query: 120 SKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTA--THQHIPYRENKNLTGTA 176
+ LHRD+KP N FL N V + DFGLAK + ++ GT
Sbjct: 128 GNTVLHRDLKPANIFLDA----NNNVKLGDFGLAKILGHDSSFAKTYV---------GTP 174
Query: 177 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233
Y S + + D+ SLG ++ S P+ A + Q KI E K
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKIKEGKFR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 48/161 (29%), Positives = 71/161 (44%), Gaps = 38/161 (23%)
Query: 15 IGSGSFGEI----Y--LGTNIQTNEEVAIKLNVKTKHPQL---QYEAKLYKILQG----- 60
+G G+FG + Y L N T E VA+K + L + E ++ K LQ
Sbjct: 12 LGKGNFGSVELCRYDPLQDN--TGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 61 ------GTGIPNLRWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMI 112
G NLR LV++ L P SL D +L + +L+ A Q+
Sbjct: 70 YKGVCYSAGRRNLR----------LVMEYL-PYGSLRDYLQKHRERLDHRKLLLYASQIC 118
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+E++ SK ++HRD+ N L+ N+V I DFGL K
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 102 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161
K + +A+ ++ + ++HS+ +HRDIKP N L+ R QV + DFG++ ++
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA- 160
Query: 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 211
TGT+ Y + G S D+ SLG L+ + P
Sbjct: 161 --------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 18/46 (39%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155
Q++ ++F+HS +HRD+KP N L+ Q+ + DFGLA+ Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166
Q++ V VHSK +HRDIK N L+ GL V + DFG +K Y T +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGL------VKLGDFGFSKMYAATVSDD---- 200
Query: 167 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 206
+ GT Y + S++ D+ SLG VL+Y L
Sbjct: 201 -VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG-VLLYEL 238
|
Length = 496 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 22/159 (13%)
Query: 15 IGSGSFGEIYLGT--NIQTNEEVAIKLNVKT--KHPQLQYEAKLYK--ILQGGTGIPN-L 67
+GSG+FGE+Y GT +I I++ VKT K Q + + K L PN +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 68 RWFGV--EGDYNVLVIDLLGPSLEDLFNFC--SRK-------LSLKTVLMLADQMINRVE 116
+ GV + ++++L+ DL ++ +R L+LK +L + +
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGG--DLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 117 FVHSKSFLHRDIKPDNFLMGL--GRRANQVYIIDFGLAK 153
++ F+HRD+ N L+ V I DFGLA+
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 59/247 (23%), Positives = 96/247 (38%), Gaps = 65/247 (26%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT--NIQTNE---EVAIKLNVK--TKHPQLQY--EAKLYKI 57
K L R++G GSFG +Y G + E VAIK + + ++++ EA + K
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 58 LQGGTGIPNL-RWFGV--EGDYNVLVIDLLG-----------------------PSLEDL 91
++ R GV G ++V++L+ P+L+
Sbjct: 66 FN----CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 92 FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 151
+ +AD M ++ +K F+HRD+ N ++ V I DFG+
Sbjct: 122 IQMAAE---------IADGM----AYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGM 165
Query: 152 AKRYRDTATHQHIPYR-ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL--MYFLRG 208
RD + YR K L A + G+ + + D+ S G VL M L
Sbjct: 166 T---RDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTT-KSDVWSFGVVLWEMATL-A 218
Query: 209 SLPWQGL 215
P+QGL
Sbjct: 219 EQPYQGL 225
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 49/206 (23%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQLQYEAKLYKILQGGTGIPNL-RW 69
KIG GS G + + T+ T +VA+K L + + L E + + Q PN+
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH----PNIVEM 81
Query: 70 FG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 126
+ + GD +V++ L G +L D+ +++ + + + ++ + F+H++ +HR
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLAVLKALSFLHAQGVIHR 139
Query: 127 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG 186
DIK D+ L+ +V + DFG + + +P R K+L GT + +
Sbjct: 140 DIKSDSILL---TSDGRVKLSDFGFCAQ-----VSKEVPRR--KSLVGTPYWMAPEVISR 189
Query: 187 IEQSRRDDLESLGYVLMYFLRGSLPW 212
+ D+ SLG +++ + G P+
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 30/171 (17%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------NVKTKHPQLQYEAKLYKILQGG 61
++++ IG GS+G + + T E+VAIK +V L+ E KL ++L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHP 59
Query: 62 TGI--------PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 113
+ P+ R F D V V +L+ L + + L+ + Q++
Sbjct: 60 DIVEIKHIMLPPSRREFK---DIYV-VFELMESDLHQVIK-ANDDLTPEHHQFFLYQLLR 114
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK-RYRDTAT 160
++++H+ + HRD+KP N L AN ++ I DFGLA+ + DT T
Sbjct: 115 ALKYIHTANVFHRDLKPKNIL------ANADCKLKICDFGLARVAFNDTPT 159
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 28/108 (25%), Positives = 51/108 (47%), Gaps = 11/108 (10%)
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 169
Q++ + ++H + LHRD+KP N L+ ++ + DFGLA+ + +P
Sbjct: 111 QLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARA-------KSVPSHTY 160
Query: 170 KNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLK 216
N T Y + LG E S D+ +G + + ++G + G+K
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 34/123 (27%), Positives = 51/123 (41%), Gaps = 13/123 (10%)
Query: 99 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
S + A ++I +E +H++ ++RD+KP N L+ V I D GLA +
Sbjct: 94 FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK 150
Query: 159 ATHQHIPYRENKNLTGTARY-ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 217
H + GT Y A G+ D SLG +L LRG P++ K
Sbjct: 151 KPHASV---------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201
Query: 218 GTK 220
K
Sbjct: 202 KDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 54/219 (24%), Positives = 86/219 (39%), Gaps = 28/219 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK---TKHPQLQYEAKLYKILQGG--TG 63
F + + IG G+FGE+ + T A+K+ K K + + +L G
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 64 IPNLRWFGVEGDYNVLVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 122
I L + + +Y LV+D +G L L + +L +M+ + +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 182
++HRDIKPDN L+ + + + DFG + T Q + GT Y S
Sbjct: 123 YVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGTVQ------SSVAVGTPDYISPE 173
Query: 183 THLGIEQSRRD---------DLESLGYVLMYFLRGSLPW 212
I Q+ D D SLG + L G P+
Sbjct: 174 ----ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 106 MLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164
+L Q++ ++ VHS+ +HRD+K N FLM G + + DFG +K+Y D+ +
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSDS-----V 223
Query: 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
+ GT Y + S++ D+ SLG +L L P++G
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 48/187 (25%), Positives = 83/187 (44%), Gaps = 15/187 (8%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWF- 70
IG G+FGE+ L T A+K+ K + Q+ + IL + ++ F
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 71 GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFVHSKSFLHRD 127
+ N+ +I P D+ +K +L +T +A+ ++ ++ +H F+HRD
Sbjct: 69 SFQDKLNLYLIMEFLPG-GDMMTLLMKKDTLTEEETQFYIAETVL-AIDSIHQLGFIHRD 126
Query: 128 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE-NKNLTGTARYASMNTHLG 186
IKPDN L+ V + DFGL + H+ YR N +L + +MN+
Sbjct: 127 IKPDNLLLD---SKGHVKLSDFGLCTGLKK--AHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 187 IEQSRRD 193
E +R+
Sbjct: 182 AETWKRN 188
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 44/202 (21%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQLQYEAKLYKILQGGTGIPNLRWF 70
KIG GS G + + T T ++VA+K L + + L E + + + +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 71 GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 130
V + V++ L G +L D+ +++ + + + ++ + ++H++ +HRDIK
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 131 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS 190
D+ L+ R + + DFG + + +P R K+L GT + + +
Sbjct: 147 DSILLTSDGR---IKLSDFGFCAQ-----VSKEVPKR--KSLVGTPYWMAPEVISRLPYG 196
Query: 191 RRDDLESLGYVLMYFLRGSLPW 212
D+ SLG +++ + G P+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.001
Identities = 39/169 (23%), Positives = 75/169 (44%), Gaps = 31/169 (18%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---------------LNVKTKHPQLQYEAK 53
F L +G+G++G++Y G +++T + AIK +N+ K+ + A
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 54 LYK--ILQGGTGIPNLRWFGVEGDYNVLVIDLLGP-SLEDLF-NFCSRKLSLKTVLMLAD 109
Y I + G+ + W LV++ G S+ DL N L + + +
Sbjct: 68 YYGAFIKKNPPGMDDQLW---------LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
+++ + +H +HRDIK N L+ +V ++DFG++ + T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRT 164
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 25/167 (14%)
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 169
Q+I+ +E +H + ++RD+KP+N L+ V I D GLA +D + +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS-------KT 154
Query: 170 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 229
K GT + + G E D +LG L + P+ + + EK+
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF--------RARGEKVEN 206
Query: 230 KKVSTSIEALCRGYPTEF-ASYFHYCRSLRFDDKPDYAYLKRL-FRD 274
K++ I YP +F + +C +L P+ KRL FRD
Sbjct: 207 KELKQRILNDSVTYPDKFSPASKSFCEAL-LAKDPE----KRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 39/231 (16%)
Query: 11 LGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLNVKT-------KHPQLQYEAKLYKILQGGT 62
L R++G G+FG+++L E+ I + VKT EA+L LQ
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 63 GIPNLRWFGV--EGDYNVLVIDLLGPSLEDLFNFCS---------------RKLSLKTVL 105
+ +++GV EGD ++V + + DL F +L+ +L
Sbjct: 69 IV---KFYGVCVEGDPLIMVFEYMKHG--DLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 106 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165
+A Q+ + ++ S+ F+HRD+ N L+G V I DFG++ RD + +
Sbjct: 124 HIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---RDVYSTDY-- 175
Query: 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGL 215
YR + R+ + + + + D+ SLG VL F G PW L
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 63/270 (23%), Positives = 96/270 (35%), Gaps = 25/270 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKLYKILQGGT 62
F + KIG GSFG ++ A+K +N + + + EA++ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSSY 60
Query: 63 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSK 121
I F +G N+++ L L R L V Q++ + +HSK
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 181
LHRDIK N + + V I D G+AK D + GT Y S
Sbjct: 121 KILHRDIKSLNLFLDAY---DNVKIGDLGVAKLLSDNTNFA-------NTIVGTPYYLSP 170
Query: 182 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241
+ + D+ +LG VL G P+ G K + VS +
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS-------Q 223
Query: 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRL 271
Y + A C + + +PD L R
Sbjct: 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 16/44 (36%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
Q++ ++++HS + +HRD+KP N L+ +V + DFGLA+
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 39/165 (23%), Positives = 74/165 (44%), Gaps = 38/165 (23%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH------PQLQYE----------- 51
F + + I G+FG++YLG ++ A+K+ K Q+Q E
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 52 -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 110
LY LQ + + + + GD SL ++ + ++++K + +
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVK---------SLLHIYGYFDEEMAVKYI----SE 112
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI--IDFGLAK 153
+ ++++H +HRD+KPDN L+ +N+ +I DFGL+K
Sbjct: 113 VALALDYLHRHGIIHRDLKPDNMLI-----SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 35/148 (23%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----NVKTKHPQLQYEAKLYKILQGGTG 63
+ + + IG G+FGE+ L + T + A+KL +K +E +
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 64 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS 122
+ L + + Y +V++ + DL N S + K +++ ++ +HS
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFG 150
F+HRD+KPDN L+ ++ + + DFG
Sbjct: 163 FIHRDVKPDNMLLD---KSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 29/128 (22%), Positives = 47/128 (36%), Gaps = 11/128 (8%)
Query: 296 QSQVSTPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADP------SRRRNSG 349
+ + P G + P+S PP AA A T + D SR
Sbjct: 464 DERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPA 523
Query: 350 PLGNSANLSKQKSPMANDPAFSKDAMMSSYNLLRSSG----SSR-RVAVPNSREAAVVGS 404
A ++ +P A PA ++ ++LR++G S R A ++ AA +
Sbjct: 524 AAAPPAPEARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAA 583
Query: 405 DTDPSRPR 412
P+ PR
Sbjct: 584 APKPAAPR 591
|
Length = 830 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 41/151 (27%), Positives = 70/151 (46%), Gaps = 16/151 (10%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-LN---VKTKHPQLQY-EAKLYKILQGGTGIPNL 67
+ IGSG+ G + + T + VAIK L+ H + Y E L K++ I L
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 68 RWFGVEGDYN-----VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 122
F + LV++L+ +L + L + + L QM+ ++ +HS
Sbjct: 82 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHSAG 138
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+HRD+KP N ++ + + I+DFGLA+
Sbjct: 139 IIHRDLKPSNIVV---KSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 174
++ +HS ++RD+KP+N L+ + + DFGL+K D H+ Y + G
Sbjct: 111 LDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESID---HEKKAY----SFCG 160
Query: 175 TARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 214
T Y + ++ D S G VLM+ L GSLP+QG
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 23/129 (17%)
Query: 96 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR- 154
L+ K ++ A Q+ +EF+ SK +HRD+ N L+ + + I DFGLA+
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED---HVMKIADFGLARDI 182
Query: 155 -----YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLR 207
YR T T+ +P K + A + + TH QS D+ S G VL++ F
Sbjct: 183 HHIDYYRKT-TNGRLPV---KWMAPEALFDRVYTH----QS---DVWSFG-VLLWEIFTL 230
Query: 208 GSLPWQGLK 216
G P+ G+
Sbjct: 231 GGSPYPGIP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 34/146 (23%), Positives = 69/146 (47%), Gaps = 10/146 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKI-LQGGTGIPN----LR 68
++G G+FG++Y N +T A K+ + TK + + E + +I + PN L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKV-IDTKSEE-ELEDYMVEIDILASCDHPNIVKLLD 69
Query: 69 WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 128
F E + +L+ G +++ + R L+ + ++ Q + + ++H +HRD+
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 129 KPDNFLMGLGRRANQVYIIDFGLAKR 154
K N L L + + DFG++ +
Sbjct: 130 KAGNILFTLD---GDIKLADFGVSAK 152
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 15/49 (30%), Positives = 30/49 (61%), Gaps = 3/49 (6%)
Query: 90 DLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 135
DL+ + + L L V +A Q+++ ++++H + +HRDIK +N L+
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV 293
|
Length = 461 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 43/158 (27%), Positives = 67/158 (42%), Gaps = 20/158 (12%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLNVKTKHPQLQYEAKLYKILQGGTG 63
+F+ + +GSG+FG +Y G I E+ VAIK + P+ E +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 64 IPNL-RWFGVEGDYNVLVIDLLGP-------SLEDLFNFCSRKLSLKTVLMLADQMINRV 115
P++ R G+ V +I L P E N S+ L L + +A M
Sbjct: 68 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAKGM---- 122
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
++ + +HRD+ N L+ + V I DFGLAK
Sbjct: 123 NYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 18/47 (38%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRY 155
Q+++ + ++H+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 38/162 (23%), Positives = 77/162 (47%), Gaps = 17/162 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNV-KTKHPQLQYEAKLYKILQGGTGIPN 66
F L +G+G++G++Y G +++T + AIK ++V + + +++ E + K I
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 67 LRWFGV--------EGDYNVLVIDLLGP-SLEDLF-NFCSRKLSLKTVLMLADQMINRVE 116
++G D LV++ G S+ DL N L + + +++ +
Sbjct: 78 --YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 117 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
+H+ +HRDIK N L+ +V ++DFG++ + T
Sbjct: 136 HLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRT 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 21/59 (35%), Positives = 33/59 (55%), Gaps = 1/59 (1%)
Query: 98 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRY 155
+L V L Q+++ + ++H+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 104 QLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 9/160 (5%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK---TKHPQLQYEAKLYKILQGGTG-- 63
F + + IG G+FGE+ + T + A+K+ K K + + +L G
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 64 IPNLRWFGVEGDYNVLVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 122
I NL + + + LV+D +G L L + +L +M+ ++ VH
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162
++HRDIKPDN L+ + + + DFG R T Q
Sbjct: 123 YVHRDIKPDNVLLD---KNGHIRLADFGSCLRLLADGTVQ 159
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 29/104 (27%), Positives = 49/104 (47%), Gaps = 12/104 (11%)
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRE 168
++++ +E++HS+ ++RDIK +N ++ + + I DFGL K D AT
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM------- 152
Query: 169 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 212
K GT Y + + R D LG V+ + G LP+
Sbjct: 153 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 473 | |||
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.43 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.33 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.12 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.96 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.76 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.71 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.63 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.51 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.51 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.48 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.36 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.34 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.24 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.15 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.1 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.0 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.92 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.89 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.88 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.8 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.72 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.61 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.58 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.49 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.44 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.42 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.41 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.39 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.35 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.31 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.21 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.2 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.12 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.07 | |
| PLN02236 | 344 | choline kinase | 97.04 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.77 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.48 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.42 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.16 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.97 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.95 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.67 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.46 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.13 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.02 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.0 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.57 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.4 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.89 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.57 |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-59 Score=425.13 Aligned_cols=293 Identities=71% Similarity=1.246 Sum_probs=285.3
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEE-cccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~-~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
-+++++|+++++||+|+||.+|+|....+|+.||||+ -.+..++++..|.++++.|++..+|+.+.+|+.+.++.++||
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 4678999999999999999999999999999999999 456678999999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|++|++|+++++.|.+.|+.++++.++.||+..|+|+|.+++|||||||+|+|++.+.....+.|+|||+|+.+.+..+.
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 99999999999999999999999999999999999999999999999999999999888899999999999999999999
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
.|+||++...++||.+|++...+.|.++++++|+.|+|++|+++..|.+||+++.+.++.+++++|.+++...+++.+|+
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~ 250 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK 250 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
++|.||.-++.+|..+.+++.|++..|.++|+-+|...+.++|+.|||+.++.+
T Consensus 251 G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk 304 (341)
T KOG1163|consen 251 GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQK 304 (341)
T ss_pred CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHH
Confidence 999999999999999999999999999999999999999999999999998754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-57 Score=431.39 Aligned_cols=290 Identities=61% Similarity=1.044 Sum_probs=281.2
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEE-cccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~-~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+++-.|+++++||+|+||++++|++..+++.||||+ -.+.+.+++..|.+.++.|.+..+|+.+++|+.++.+.+||||
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 678899999999999999999999999999999999 5667789999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEee--CCCCCcEEEEecCCcccccCCCC
Q 011988 83 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL--GRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~--~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
++|.||+|+++.|+++|+.+++++|+.||+.-++|+|++.+|.|||||+|+||+. ..+...|.|+|||+|+.+.++.+
T Consensus 105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 9999999999999999999999999999999999999999999999999999985 23456799999999999999999
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
++|+||++.+.+.||.+||+.+.++|.++++++|+.|||-|++++|.|.+||+++++.+.+++|++|.+++..++++.||
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc 264 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLC 264 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccccc
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 293 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 293 (473)
.++|.+|..++.+...+++++-|+|+.++.+|.+++.+.|...|+.|||..+.
T Consensus 265 ~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 265 EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 99999999999999999999999999999999999999999999999999875
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-50 Score=385.79 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=214.8
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEc----ccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN----VKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~----~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.+.+.++.||+|+.|+||++.++.+++.+|+|++ ......++.+|+++++.++++.+|.++..|...+....|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 3677889999999999999999999999999996 344466789999999999755555555555444446899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|| +|||.++++.. +.+++..+-.|+.+|++||.|||+ ++||||||||+|||| +..|.|||||||.++.+.+..
T Consensus 159 YMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS~- 233 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNSI- 233 (364)
T ss_pred hcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhhh-
Confidence 99 89999999854 579999999999999999999995 999999999999999 589999999999999887753
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHhhccccccHHH
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL--KAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~--~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
..+++||..|||||.+.|..|+.++||||||++|+||++|++||... ......+.+..|.....+ .
T Consensus 234 --------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP----~ 301 (364)
T KOG0581|consen 234 --------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP----R 301 (364)
T ss_pred --------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC----C
Confidence 26789999999999999999999999999999999999999999763 234556666666654433 3
Q ss_pred HhcC-CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 239 LCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 239 l~~~-~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
++.+ ++++|++||..||.+||.+||++.+| +++.|.+.-
T Consensus 302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qL---l~Hpfi~~~ 341 (364)
T KOG0581|consen 302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQL---LQHPFIKKF 341 (364)
T ss_pred CCcccCCHHHHHHHHHHhcCCcccCCCHHHH---hcCHHHhhc
Confidence 3444 89999999999999999999997766 777777643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-48 Score=385.53 Aligned_cols=268 Identities=25% Similarity=0.360 Sum_probs=225.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
-.++|.+++.||+|+|++||+|+++.+++.||||++.+ .+.+-+..|-.+|.+|.+|++|..++..+.+....|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 35789999999999999999999999999999998433 344557889999999999999999999999999999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+|+||+ +|+|.++|+.. +.|++..+..++.||+.||+|||++|||||||||+|||| +.++++||+|||.|+.+..
T Consensus 151 FvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCCh
Confidence 999999 99999999854 579999999999999999999999999999999999999 5899999999999998876
Q ss_pred CCCccccc----ccc--CCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011988 158 TATHQHIP----YRE--NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231 (473)
Q Consensus 158 ~~~~~~~p----~~~--~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 231 (473)
....+.-+ +.. ...++||..|.+||++.....++.+|||+||||||+|+.|.+||.+.+..-..+++..+ .
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l---~ 303 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL---D 303 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh---c
Confidence 54321111 111 25699999999999999999999999999999999999999999886554444443332 2
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccc
Q 011988 232 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 294 (473)
Q Consensus 232 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 294 (473)
. .+..++|+.+.+||.++|..||.+|++.++|.+. .+...+||+.+-.
T Consensus 304 y-----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H----------pFF~~Vdw~nlw~ 351 (604)
T KOG0592|consen 304 Y-----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH----------PFFEGVDWENLWQ 351 (604)
T ss_pred c-----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC----------cccccCChhhhhh
Confidence 2 3457899999999999999999999998766442 4455677777543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-49 Score=381.16 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=212.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----------chhHHHHHHHHHHhcCCCCCCeeEEeeEe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----------HPQLQYEAKLYKILQGGTGIPNLRWFGVE 73 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----------~~~l~~E~~il~~L~~~~~i~~~~~~~~~ 73 (473)
.+.+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+.. ...+.+|++||++|+|+ +|..++.+.+.
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP-~IV~~~d~f~~ 247 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHP-NIVRIKDFFEV 247 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCC-CEEEEeeeeec
Confidence 46778999999999999999999999999999999854432 22357999999999954 55566667777
Q ss_pred CCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 74 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 74 ~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
.++.||||||+ ||.|.+.+-. ++.+.+.....++.||+.||.|||++||+||||||+|||+..+..+..+||+|||+|
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred CCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 88889999999 8999999873 556889999999999999999999999999999999999987667789999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 229 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~---~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 229 (473)
+...... ...+++||+.|.|||++.+.. +..++|||||||+||-+++|.+||.+..... ...+.|..
T Consensus 327 K~~g~~s--------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~~ 396 (475)
T KOG0615|consen 327 KVSGEGS--------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQILK 396 (475)
T ss_pred hccccce--------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHhc
Confidence 9875332 136789999999999998765 3458899999999999999999998754332 12334444
Q ss_pred ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 230 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 230 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
.+.. ..+..+..++++..+||..||..||++||+++++ |++.|.+
T Consensus 397 G~y~-f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea---L~hpW~~ 441 (475)
T KOG0615|consen 397 GRYA-FGPLQWDRISEEALDLINWMLVVDPENRPSADEA---LNHPWFK 441 (475)
T ss_pred Cccc-ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH---hcChhhh
Confidence 3332 2234456788999999999999999999997766 6666654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=390.23 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=221.4
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.+|+..+.||+|||+.||.+++..+|+.||+|++.+ .....+.+|++|.+.|+ |++|+.++.|+++.++.|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence 579999999999999999999999999999999544 23456899999999999 55566777788999999999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
+|+| .++|..+++ ..+.+++.+++.++.||+.||.|||+++|||||||..|+|| +++.+|||+|||||..+..+.
T Consensus 97 LELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 97 LELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCcc
Confidence 9999 889999988 56789999999999999999999999999999999999999 478899999999999887553
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. ...+++||+.|.|||++.....+..+||||+|||||-||.|++||+. .+.++.|.+|.......
T Consensus 173 E-------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet---k~vkety~~Ik~~~Y~~----- 237 (592)
T KOG0575|consen 173 E-------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET---KTVKETYNKIKLNEYSM----- 237 (592)
T ss_pred c-------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc---chHHHHHHHHHhcCccc-----
Confidence 2 23678999999999999998999999999999999999999999976 34567777776655433
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCC
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 284 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~ 284 (473)
+..++.+.++||..+|..||.+||++++| |++-|-+.|+...
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~v---L~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDEV---LDHPFFKSGFTPA 279 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHHH---hcCHhhhCCCcCC
Confidence 34678999999999999999999997776 6676767766543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=375.43 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=207.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
...++|.+.++||.|+||+||+|+++.++..||||.+.+.. .+.+..|+.+|+.|+ |++|..+..+....++.|
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEE
Confidence 45678999999999999999999999999999999865553 445789999999999 556667777888889999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCC---CcEEEEecCCccc
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA---NQVYIIDFGLAKR 154 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~---~~vkL~DFGla~~ 154 (473)
+||||| ||+|.+++.. .+.+++.++..++.||+.||++||+++||||||||+||||+..... -.+||+|||+|+.
T Consensus 86 lVMEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999 8999999985 4479999999999999999999999999999999999999864222 5799999999998
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
+.... ...+.+|++.|||||++..+.|+.|+|+||+|+|||+|++|+.||...+. .+....+... ..
T Consensus 165 L~~~~--------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~---~eL~~~~~k~--~~ 231 (429)
T KOG0595|consen 165 LQPGS--------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP---KELLLYIKKG--NE 231 (429)
T ss_pred CCchh--------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH---HHHHHHHhcc--cc
Confidence 87543 23578999999999999999999999999999999999999999987443 3333333222 12
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
.+..+...+...+.+++...+..++.+|-++.+.
T Consensus 232 ~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 232 IVPVLPAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred ccCchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence 2233334456677799999999999999886543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=366.00 Aligned_cols=264 Identities=22% Similarity=0.297 Sum_probs=219.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++++.||+|+||.||+++.+.+++.+|+|++.+. .......|..||..++ |+.|+.+.+.+++.+..|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEE
Confidence 57899999999999999999999999999999985553 3455788999999987 5555556666677888899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
|+||+ ||.|...++. .+.|++..+..++..|+.||.|||++|||||||||+|||| +..|+++|+|||+|+.....
T Consensus 103 Vld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccC
Confidence 99999 8899999884 5579999999999999999999999999999999999999 58999999999999966554
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
... ..+++||+.|||||++.+..|+..+|+||||+++|||++|..||.+. +....+++|...+...
T Consensus 179 ~~~-------t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~---~~~~~~~~I~~~k~~~---- 244 (357)
T KOG0598|consen 179 GDA-------TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE---DVKKMYDKILKGKLPL---- 244 (357)
T ss_pred CCc-------cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc---cHHHHHHHHhcCcCCC----
Confidence 332 25689999999999999999999999999999999999999999873 4566777777666322
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCC----CHHHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKP----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 298 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RP----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 298 (473)
....++.+.++++..+|..||++|. ++.+| ....+....+|+.+.....+
T Consensus 245 ~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~i----------k~HpfF~~inW~~l~~k~l~ 298 (357)
T KOG0598|consen 245 PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEI----------KRHPFFKGINWEKLLAKKLS 298 (357)
T ss_pred CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHh----------hcCcccccCCHHHHHhcCCC
Confidence 1223789999999999999999995 33332 22355667899987655443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=363.22 Aligned_cols=243 Identities=24% Similarity=0.320 Sum_probs=206.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEc-----ccCCchhHHHHHHHHHHhcCCCCCCeeE-EeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-----VKTKHPQLQYEAKLYKILQGGTGIPNLR-WFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~-----~~~~~~~l~~E~~il~~L~~~~~i~~~~-~~~~~~~~~~lv 80 (473)
.+|+|+++||.|+||+||++.+..+|..||.|.+ ......++..|+.+|++|+|+|+|.++. .|..+.+..+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4599999999999999999999999999999963 3334566889999999999999888887 455566668999
Q ss_pred EecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh--CC--CcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 81 IDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS--KS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~--~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
||+| +|+|.++++. .++.+++.++|+++.|++.||..+|+ .. |+||||||.||+|+ .+|.|||+|||++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~---~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT---ANGVVKLGDFGLG 175 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc---CCCceeeccchhH
Confidence 9999 8999999863 34569999999999999999999999 45 99999999999995 8899999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
+.+....+. ..+++||+.||+||.+.+..|++++||||+||++|||+.-..||.+. ...+.-.+|.....
T Consensus 176 r~l~s~~tf-------A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 176 RFLSSKTTF-------AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQGDY 245 (375)
T ss_pred hHhcchhHH-------HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcCCC
Confidence 998776543 25689999999999999999999999999999999999999999985 33444455555444
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 265 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~ 265 (473)
++... ..++.++..||..|+..|++.||+.
T Consensus 246 ~~~p~---~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 246 PPLPD---EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCcH---HHhhhHHHHHHHHHccCCcccCCCc
Confidence 32221 3467899999999999999999984
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=352.76 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=206.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCch-----hHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP-----QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~-----~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
++|+.+.++|+|+||.||+|+++.||+.||||.+...... -..+|+++|++|.|.|.|..+.. +......++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-FrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-FRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-HHhcceeEEEe
Confidence 5799999999999999999999999999999996554432 25789999999997777665544 45566789999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|||..++.+.+......++.+.+..++.|++.|+.|+|++++|||||||+||||+ ..+.+||||||+|+.+..+..
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---QNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---cCCcEEeccchhhHhhcCCcc-
Confidence 9999988888887777899999999999999999999999999999999999996 889999999999998875332
Q ss_pred cccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc-------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------- 233 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 233 (473)
.-+.++.|.+|.|||.+.| .+|+..+||||+||++.||++|...|.+..+.+....+.+......+
T Consensus 157 ------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 157 ------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred ------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 1145688999999999998 56999999999999999999999999997665544444433222111
Q ss_pred ----------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 234 ----------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 234 ----------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.+++.-..+++.-+.+|++.||..||++|++.++|.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 122222234456788999999999999999988874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=368.66 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=208.6
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcE-EEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE-VAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~-vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
....+.+.||.|+||+||+|.+. |+. ||||++.... ...|.+|+.+|.+|+|+|+|..+..+.......+||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 34566777999999999999964 555 9999865544 347999999999999777776554443333368999
Q ss_pred EecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcccCCCCCcEEEeeCCCCC-cEEEEecCCccccc
Q 011988 81 IDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYR 156 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~-~~~~ls~~~~~~i~~qi~~aL~yLH~~g-IvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~ 156 (473)
|||+ +|+|.+++.. .+..+++..++.|+.||+.||+|||+++ ||||||||+|||++ ... ++||+|||+++...
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~---~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD---LKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc---CCCCEEEECCCccceeec
Confidence 9999 9999999986 3778999999999999999999999999 99999999999994 665 99999999998765
Q ss_pred CCCCccccccccCCCcccCcccccccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~--~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
.... ......||..|||||++. ...|+.|+||||||++||||+||+.||.++.. .+....+.......
T Consensus 196 ~~~~-------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~Rp 265 (362)
T KOG0192|consen 196 ISKT-------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGLRP 265 (362)
T ss_pred cccc-------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCCC
Confidence 4321 123468999999999999 55899999999999999999999999998764 33333343333333
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
. +...+|+.+..+|..||..||+.||++.+|...|+.+....
T Consensus 266 ~---~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 266 P---IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred C---CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 2 23458999999999999999999999999999999887644
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=370.75 Aligned_cols=263 Identities=23% Similarity=0.314 Sum_probs=214.6
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCC-eEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD-YNV 78 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~-~~~ 78 (473)
.+-++|.++++||.|.||.||+|+.+.+++.||||.+++.-. -.-.+|++.|++|+.|++|..+..+..+.+ ..+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 456789999999999999999999999999999998544322 124689999999995555555554444444 899
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 79 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 79 lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
+|||||.++|.++++..++.|++..+..|+.||++||+|+|.+|+.||||||+|||+. ....|||+|||+|+.....
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEecccccccccccC
Confidence 9999999999999998888999999999999999999999999999999999999994 5789999999999977654
Q ss_pred CCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc------
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------ 231 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~------ 231 (473)
. || +.++.|.+|.|||+++.. .|+.+.||||+|||++|+.+-++.|.|....+...++-.+....
T Consensus 164 p-----PY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 164 P-----PY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred C-----Cc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 3 33 457899999999998754 58999999999999999999999999976554444443333221
Q ss_pred ----------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 232 ----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 232 ----------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
....+..+...++.++.++|..|+.+||++|||+.++ |+..|-+.+
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~a---l~~pffq~~ 297 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQA---LQHPFFQVG 297 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHH---hcCcccccc
Confidence 1233455566678999999999999999999998887 555554444
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=361.19 Aligned_cols=259 Identities=24% Similarity=0.386 Sum_probs=207.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCC-eEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD-YNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~-~~~lv~e 82 (473)
.+|...+.||+|+||.||++.+.++|+.+|||...... ...+.+|+.+|..|+|+++|..+........ .++|.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45889999999999999999999999999999855554 4458999999999995444444433233333 7899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC-CCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~-~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +|+|.+++...+.+|++..+..++.||++||+|||++|||||||||+|||++ . ++.+||+|||+++.......
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~---~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD---PSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe---CCCCeEEeccCccccccccccc
Confidence 99 9999999997665899999999999999999999999999999999999995 5 68999999999987764111
Q ss_pred ccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. ......+.||+.|||||++.. ....+++|||||||++.||+||+.||.+. ......+..+.... ..+.+
T Consensus 174 ~----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~---~~P~i 244 (313)
T KOG0198|consen 174 K----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRED---SLPEI 244 (313)
T ss_pred c----ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccC---CCCCC
Confidence 1 122345789999999999995 34556999999999999999999999874 22223333333332 22256
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
+..++++.++|+..|+..||++|||+++| |++.|.+..
T Consensus 245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eL---L~hpf~~~~ 282 (313)
T KOG0198|consen 245 PDSLSDEAKDFLRKCFKRDPEKRPTAEEL---LEHPFLKQN 282 (313)
T ss_pred CcccCHHHHHHHHHHhhcCcccCcCHHHH---hhChhhhcc
Confidence 67789999999999999999999998877 667776543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=365.77 Aligned_cols=258 Identities=23% Similarity=0.289 Sum_probs=214.7
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEe-CCe
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDY 76 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~-~~~ 76 (473)
++-.+.|+.+++||+|.||.||+|++..+|+.||+|.+.... .....+|+.||++|.|+++|.....+... ...
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 345577999999999999999999999999999999743322 22367999999999988777766555554 578
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 77 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
.|||+|||..+|..++....-+|++.++..++.||+.||+|||++||+|||||.+|||| +..|.+||+|||||+.+.
T Consensus 193 iYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 193 IYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeecc
Confidence 99999999999999998666689999999999999999999999999999999999999 589999999999999887
Q ss_pred CCCCccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc----
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---- 231 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~---- 231 (473)
...... .+..+-|..|.|||+++|.. |+.++|+||.||||.||++|++.|++.+..+...++.++....
T Consensus 270 ~~~~~~------~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 270 PSGSAP------YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred CCCCcc------cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence 654322 24567899999999999975 9999999999999999999999999976655555554443211
Q ss_pred -----------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 -----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 -----------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
....+.+.++.+|....+|+..+|.+||++|.|+.+.+
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 11223444567889999999999999999999988764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=359.42 Aligned_cols=246 Identities=25% Similarity=0.330 Sum_probs=207.4
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
...++|.+.+.||+|+||.|++|.+..+++.||||++.+. ....+.+|+.+++.+.+|++|..+..+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3467899999999999999999999999999999985543 23456789999999997767777777777777
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCC-CcEEEEecCCcc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAK 153 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~-~~vkL~DFGla~ 153 (473)
..++||||+ ||+|.+++.. .+++.+.++..++.||+.||+|||++||+||||||+|||++ .+ +.+||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEecccccc
Confidence 799999999 7799999986 67899999999999999999999999999999999999995 55 899999999998
Q ss_pred ccc-CCCCccccccccCCCcccCccccccccccCCC-C-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011988 154 RYR-DTATHQHIPYRENKNLTGTARYASMNTHLGIE-Q-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 230 (473)
Q Consensus 154 ~~~-~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 230 (473)
... ... ...+.+||+.|+|||++.+.. | +.++||||+||+||.|++|..||.+.+ ....+.++...
T Consensus 170 ~~~~~~~--------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~---~~~l~~ki~~~ 238 (370)
T KOG0583|consen 170 ISPGEDG--------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN---VPNLYRKIRKG 238 (370)
T ss_pred ccCCCCC--------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc---HHHHHHHHhcC
Confidence 773 211 236789999999999999987 7 589999999999999999999998833 33334444443
Q ss_pred cccccHHHHhcCC-cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 KVSTSIEALCRGY-PTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 ~~~~~~~~l~~~~-p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.+. ++..+ ++++..++..||..||.+|+++.+|.
T Consensus 239 ~~~-----~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 EFK-----IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred Ccc-----CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 332 23445 89999999999999999999977774
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=336.27 Aligned_cols=268 Identities=22% Similarity=0.296 Sum_probs=224.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc------hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH------PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~------~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
-.++|++++.||.|+||.|.+++.+.+|..+|+|++.+... +...+|..+|+.+. ++.+..+.+.+.+....+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEE
Confidence 45789999999999999999999999999999999766542 33678999999999 667777777788899999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
|||||. ||-|..++..+ ++|++..++.++.||+.||+|||+++|++|||||+|||| +..|.+||+|||+|+....
T Consensus 121 mvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecC
Confidence 999999 88999999854 479999999999999999999999999999999999999 5899999999999998765
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
.. .+.|||+.|+|||++....|+.++|.|||||++|||+.|..||...+. .+.|++|.+.++.-
T Consensus 197 rT----------~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v~f--- 260 (355)
T KOG0616|consen 197 RT----------WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKVKF--- 260 (355)
T ss_pred cE----------EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCcccC---
Confidence 42 467999999999999999999999999999999999999999987543 77888888877643
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccccccccC
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 300 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~ 300 (473)
+..++.++++|+..+|+.|-.+|- ..+..--+++ .+.+|....+|........+.+
T Consensus 261 --P~~fs~~~kdLl~~LL~vD~t~R~--gnlknG~~dI---k~H~wF~~v~W~~i~~r~ie~P 316 (355)
T KOG0616|consen 261 --PSYFSSDAKDLLKKLLQVDLTKRF--GNLKNGVEDI---KNHPWFKGVDWEAILQRKIEPP 316 (355)
T ss_pred --CcccCHHHHHHHHHHHhhhhHhhh--cCcCCCcccc---ccCcccccccHHHHhhccccCC
Confidence 456789999999999999999982 1122111222 2345666889998766544433
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=355.49 Aligned_cols=260 Identities=19% Similarity=0.327 Sum_probs=201.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeE-EeeEeC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLR-WFGVEG 74 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~-~~~~~~ 74 (473)
-.++|++.++||.|+||.||+|.+. .+++.||||++.... ...+..|+.++..+.+|++|..+. .+....
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3578999999999999999999752 345689999865432 235788999999995455554444 444445
Q ss_pred CeEEEEEecC-CCCHHHHHHHcC---------------------------------------------------------
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCS--------------------------------------------------------- 96 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~--------------------------------------------------------- 96 (473)
...+++|||+ +++|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 6689999999 889999987431
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCc
Q 011988 97 ----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 172 (473)
Q Consensus 97 ----~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~ 172 (473)
..+++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++....... +......
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~---~~~~~kl~DfG~a~~~~~~~~-----~~~~~~~ 236 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPD-----YVRKGSA 236 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc---CCCcEEEeecccccccccCcc-----hhcccCC
Confidence 2478889999999999999999999999999999999994 678999999999986543221 1112234
Q ss_pred ccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHH
Q 011988 173 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYF 251 (473)
Q Consensus 173 ~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li 251 (473)
.++..|+|||++.+..++.++|||||||+||||++ |..||.+..... .....+..... ......+++++.+++
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~l~~li 310 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLKDGTR----MRAPENATPEIYRIM 310 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHhcCCC----CCCCCCCCHHHHHHH
Confidence 56788999999999999999999999999999997 999998754321 11122221111 112346789999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 252 HYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 252 ~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
..||+.||++||++.+|++.|++++.+
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=360.75 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=206.2
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc--CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK--TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~--~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+++++.||+|-||+||+|.+. ....||+|.+.. .....+.+|+++|+.|+|.++| .++.++..++..+|||||+ .
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV-~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLV-KLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhCcccCeE-EEEEEEecCCceEEEEEeccc
Confidence 456789999999999999974 344799998544 2345688999999999966555 5555666666899999999 8
Q ss_pred CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 86 PSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 86 ~sL~~~l~~-~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
|+|.+++.. .+..+...+.+.++.|||+|++||+++++|||||...||||+ ++..+||+|||+|+...++..
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~---~~~~vKIsDFGLAr~~~d~~Y---- 358 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD---EDLVVKISDFGLARLIGDDEY---- 358 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec---cCceEEEcccccccccCCCce----
Confidence 999999986 456799999999999999999999999999999999999994 788999999999996555433
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
.......-...|.|||.+....++.|||||||||+||||+| |+.||.++...+..+.+++..... -+.+|
T Consensus 359 --~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp-------~P~~C 429 (468)
T KOG0197|consen 359 --TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP-------RPEGC 429 (468)
T ss_pred --eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC-------CCCCC
Confidence 12222334568999999999999999999999999999999 999999876544333333322221 23579
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 244 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
|+++.++|..||..+|++||||+.|...|++++..
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 99999999999999999999999999999998753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=361.54 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=214.4
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchh-----HHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ-----LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~-----l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+....+ +.+|++|++.|+|+++|..+.+|. .....|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE-t~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE-TSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc-ccceEEEEe
Confidence 67999999999999999999999999999999987776655 899999999999888777776664 556679999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
||+-|+|..++.. ..+++++.+..|+.|++.||.|||+++|+|||+||.|||+ +..+.+|+||||+|+.......
T Consensus 81 e~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~- 155 (808)
T KOG0597|consen 81 EYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS- 155 (808)
T ss_pred hhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce-
Confidence 9998899999984 5689999999999999999999999999999999999999 5889999999999997655322
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
-.....||+.|||||+..+.+|+..+|+||||||+||++.|++||.. ....+....|.......+.
T Consensus 156 ------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---~si~~Lv~~I~~d~v~~p~----- 221 (808)
T KOG0597|consen 156 ------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---RSITQLVKSILKDPVKPPS----- 221 (808)
T ss_pred ------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH---HHHHHHHHHHhcCCCCCcc-----
Confidence 12456899999999999999999999999999999999999999965 3445555555555444332
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
..+..|.+|++.+|.+||..|.+..+| +.+.|.+..
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~L---l~HpF~k~~ 257 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDL---LGHPFWKGK 257 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHH---hcChHHhhh
Confidence 567899999999999999999996665 666666554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=354.95 Aligned_cols=272 Identities=22% Similarity=0.316 Sum_probs=214.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++++.||+|+||.||+|+.+.||+.+|+|++.+.. ...+..|-.+|... ..+.|+.+++.+.+.++.||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEE
Confidence 478999999999999999999999999999999966543 33467888999984 47778888888899999999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ ||++..+|.. ...|++..+..++.+++.||+.||+.|||||||||+|+|| |..|++||+|||||..+...
T Consensus 219 iMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhh
Confidence 99999 9999999984 5679999999999999999999999999999999999999 58999999999999754321
Q ss_pred CC------------------cccccc----c------------------cCCCcccCccccccccccCCCCCchhhHHHH
Q 011988 159 AT------------------HQHIPY----R------------------ENKNLTGTARYASMNTHLGIEQSRRDDLESL 198 (473)
Q Consensus 159 ~~------------------~~~~p~----~------------------~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSl 198 (473)
.. ....+. + .....+||+.|||||++++..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 00 000010 0 1235789999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 199 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 199 GviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
||||||||.|.+||.+.+. .+.+.+|..-+.....+ -...+.++.++||.+|+. ||++|....-+.++-.
T Consensus 375 G~ImyEmLvGyPPF~s~tp---~~T~rkI~nwr~~l~fP-~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~----- 444 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETP---QETYRKIVNWRETLKFP-EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK----- 444 (550)
T ss_pred HHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhhhccCC-CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc-----
Confidence 9999999999999988554 44444444322111000 012456899999999999 9999976333333222
Q ss_pred hCCCCCCccccccccc
Q 011988 279 EGFQFDYVFDWTILKY 294 (473)
Q Consensus 279 ~~~~~~~~~dw~~~~~ 294 (473)
.++...++|+.+..
T Consensus 445 --HPfF~~v~W~~l~~ 458 (550)
T KOG0605|consen 445 --HPFFKGVDWDHLRE 458 (550)
T ss_pred --CCccccCCcchhhc
Confidence 35566789998753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=360.91 Aligned_cols=267 Identities=22% Similarity=0.295 Sum_probs=223.5
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
-.++|.++++||+|+||.|+++..+.+++.+|||++++. .......|.+|+.....|+.+..++.++...++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 357899999999999999999999999999999986554 34568889999999999999999999999999999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+||||+ ||++..+. ....|++..+..++..|+.||+|||++|||+||||.+|||| |..|.+||+|||+|+....
T Consensus 446 fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCC
Confidence 999999 66643332 34679999999999999999999999999999999999999 5899999999999987553
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
... ...+++||+.|||||++.+..|+..+|+|||||+|||||.|..||.+.+ ..+..+.|.......
T Consensus 521 ~g~-------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd---Eee~FdsI~~d~~~y--- 587 (694)
T KOG0694|consen 521 QGD-------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD---EEEVFDSIVNDEVRY--- 587 (694)
T ss_pred CCC-------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCCCC---
Confidence 222 2468999999999999999999999999999999999999999999854 445555555544332
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCH-----HHHHHHHHHHHHHhCCCCCCccccccccccccccCC
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDY-----AYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVST 301 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~-----~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~~ 301 (473)
+..++.+..+||+.+|..+|++|..+ ++|. .+ .+....||+.+...+.+++.
T Consensus 588 --P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~---~h-------pFFr~i~w~~L~~r~i~PPf 644 (694)
T KOG0694|consen 588 --PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIK---KH-------PFFRSIDWDDLLNRRIKPPF 644 (694)
T ss_pred --CCcccHHHHHHHHHHhccCcccccCCCCCCchhhh---hC-------CccccCCHHHHhhccCCCCC
Confidence 34678999999999999999999865 2332 22 44556789998877666544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=358.38 Aligned_cols=253 Identities=21% Similarity=0.341 Sum_probs=210.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
...|...++||+|+.|.||.|....+++.||||.+.... .+-+..|+.+|+.++|.++|.++..|-.. +..|+|||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVME 350 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVME 350 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEe
Confidence 356888999999999999999999999999999854433 34478999999999988888888776655 77899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ |++|.|++.. ..+++.++..|+.+++.||+|||.+||+|||||.+|||++ .++.+||+|||+|..+.....
T Consensus 351 ym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---MDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred ecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---cCCcEEEeeeeeeeccccccC-
Confidence 99 8899999983 3599999999999999999999999999999999999995 778899999999998876544
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
...+.+||+.|||||+.....|++++||||||+|++||+.|.+||-..+. .+.+..|....... -....
T Consensus 425 ------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---lrAlyLIa~ng~P~--lk~~~ 493 (550)
T KOG0578|consen 425 ------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRALYLIATNGTPK--LKNPE 493 (550)
T ss_pred ------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---HHHHHHHhhcCCCC--cCCcc
Confidence 23678999999999999999999999999999999999999999976333 22222222221111 11234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.++++|++|+.+||..|+++|+++.+| |++-|.+.
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eL---L~HpFl~~ 528 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKEL---LEHPFLKM 528 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHH---hcChhhhh
Confidence 678999999999999999999998777 66666543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=333.89 Aligned_cols=252 Identities=20% Similarity=0.223 Sum_probs=205.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCch-----hHHHHHHHHHHhcCCCCCCeeEEe--eEeCCeEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP-----QLQYEAKLYKILQGGTGIPNLRWF--GVEGDYNV 78 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~-----~l~~E~~il~~L~~~~~i~~~~~~--~~~~~~~~ 78 (473)
.+.|+.+.+|++|+||.||+|+++.|++.||+|.+...... ...+|+.+|..++|+ +|+.+..+ +..-+..|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~-NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHP-NIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCC-CeeeeEEEEeccccceee
Confidence 35799999999999999999999999999999985443322 267999999999954 55555433 45667799
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 79 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 79 lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||||..+|..+++...++|...++..++.|++.||+|||.+.|+|||||++|+|++ +.|.+||+|||+|+.+...
T Consensus 154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~---~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS---HKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec---cCCcEEecccchhhhhcCC
Confidence 9999999999999998888999999999999999999999999999999999999995 8899999999999998775
Q ss_pred CCccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc----
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS---- 233 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---- 233 (473)
.. ..+..+-|..|.|||+++|.. |+...|+||+|||+.||+++++-|.|....+...++.++....-.
T Consensus 231 ~k-------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 231 LK-------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred cc-------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 32 224568899999999999875 999999999999999999999999997665555444443221100
Q ss_pred ---------------ccHHHHh---c--CCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 234 ---------------TSIEALC---R--GYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 234 ---------------~~~~~l~---~--~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
.+...+. . ++++.-.+|+..+|.+||.+|.|+.+.
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~ 358 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDG 358 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHh
Confidence 0001111 1 134778899999999999999998876
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=323.85 Aligned_cols=252 Identities=19% Similarity=0.217 Sum_probs=205.7
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.+|..+++||+|.||.||+|++..+|+.||||.+...+ .....+|++.|+.++|.++|..++. +......-||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-FPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-ccCCCceEEEE
Confidence 57899999999999999999999999999999854433 2347899999999996666655554 45556678999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
||+..+|+..++.....++..++..++.+++.||+|||++.|+||||||.|+||+ .++.+||+|||+|+.+......
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhccCCCCcc
Confidence 9999999999998778899999999999999999999999999999999999995 8899999999999998765542
Q ss_pred cccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc-------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------- 233 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 233 (473)
. ...+-|..|.|||.+.|.. |+..+||||.|||+.||+.|.+-|.|..+.+....+..+......
T Consensus 158 ~-------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 158 Q-------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred c-------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 2 2237799999999999865 899999999999999999999999886654443333333221111
Q ss_pred -------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 234 -------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 234 -------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.....+....+.+..+|+..||.+||.+|+++.++.
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL 279 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL 279 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh
Confidence 111223445577889999999999999999977663
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=337.58 Aligned_cols=252 Identities=19% Similarity=0.249 Sum_probs=198.6
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
++|++.++||.|+||.||+|.+..+++.||+|++... ....+.+|+.+++.++|++ |..+..+.......++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN-IVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCC-EeeEEEEEcCCCeEEEEEe
Confidence 5799999999999999999999999999999985432 2335778999999998655 4455556667778999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 83 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 83 ~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
|+.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN---EKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEECcCcceeeccCCCc--
Confidence 998899999886666789999999999999999999999999999999999994 778999999999976433211
Q ss_pred ccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc---------
Q 011988 163 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 232 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 232 (473)
......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+........
T Consensus 159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 159 -----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred -----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 1134578999999999876 4589999999999999999999999987543222222211111000
Q ss_pred -------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 -------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..........++.++.++|..||.+||.+|||+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 0011112235678999999999999999999988875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=354.23 Aligned_cols=251 Identities=21% Similarity=0.298 Sum_probs=212.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-C-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-K-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.+-|++++.||.|+-|.|-+|++..||+.+|||++.+. . ...+++|+-||+.|.|+|++..++ +.....+.|+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~Lyd-Vwe~~~~lyl 89 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYD-VWENKQHLYL 89 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeee-eeccCceEEE
Confidence 46799999999999999999999999999999996665 2 345899999999999776665554 4456667788
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
|.||+ ||-|.+++-. ++++++.++.+++.||+.|+.|+|..+|+||||||+|+||+ ..+.+||+|||+|..-...
T Consensus 90 vlEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd---~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD---VKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EEEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh---cccCEeeeccceeecccCC
Confidence 88888 9999999874 56899999999999999999999999999999999999994 6667999999999765433
Q ss_pred CCccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
. ...+.||++.|+|||++.|.+| +.++||||+|||||.||+|++||++ +.....+.++....+.
T Consensus 166 k--------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~f~---- 230 (786)
T KOG0588|consen 166 K--------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGVFE---- 230 (786)
T ss_pred c--------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCccc----
Confidence 2 2356799999999999999997 7999999999999999999999986 4556667777666654
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
++..++.+.++||.+||..||..|.|.++| |.+.|....
T Consensus 231 -MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI---~kHP~l~g~ 269 (786)
T KOG0588|consen 231 -MPSNISSEAQDLLRRMLDVDPSTRITTEEI---LKHPFLSGY 269 (786)
T ss_pred -CCCcCCHHHHHHHHHHhccCccccccHHHH---hhCchhhcC
Confidence 347889999999999999999999997766 667665443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=335.92 Aligned_cols=265 Identities=17% Similarity=0.226 Sum_probs=203.7
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.|++.+.||+|+||.||+|.+..+++.||||++.+.. ...+..|+.+++.+.|+++ ..+..+....+..+++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-v~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFV-VSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcE-EEEEEEEccCCeEEEEE
Confidence 4899999999999999999999999999999854322 2246789999999986544 44555556777899999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 82 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 82 e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ +++.+||+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~---~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD---DRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeCCCcEEcCCCC
Confidence 999 78998887643 34689999999999999999999999999999999999994 77899999999998654322
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. .....||..|+|||++.+..++.++|||||||+||||++|+.||.+.........+..... .....+
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~ 224 (285)
T cd05631 157 T--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK----EDQEEY 224 (285)
T ss_pred e--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh----cccccC
Confidence 1 1245789999999999999999999999999999999999999987554322222222111 111223
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAY--LKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~--l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
...++.++.+|+..||+.||++||++.+ +.+++++.+. ...+|..+...
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~-------~~~~~~~~~~~ 275 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF-------KNINFKRLEAN 275 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhh-------cCCCHHHHHhC
Confidence 4567899999999999999999997321 2333444432 23566666544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=342.35 Aligned_cols=254 Identities=18% Similarity=0.235 Sum_probs=195.9
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEe----CCeEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE----GDYNV 78 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~----~~~~~ 78 (473)
+|++.++||+|+||.||+|.+..+++.||||.+... ....+.+|+.+++.++|++++..+..+... ....+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999985421 223578899999999977666555443222 23579
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 79 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 79 lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
+||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 81 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccccc
Confidence 9999999999999874 4469999999999999999999999999999999999999 47889999999999865432
Q ss_pred CCccccccccCCCcccCccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH---------
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI--------- 227 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i--------- 227 (473)
.... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+...
T Consensus 157 ~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 157 TPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 2111 01134579999999999876 57899999999999999999999999764421111111110
Q ss_pred --------------hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 228 --------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 228 --------------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...............+++++.++|..||..||++||++++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 011111222233346788999999999999999999988774
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=348.33 Aligned_cols=254 Identities=21% Similarity=0.320 Sum_probs=210.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
...|...+.||.|+||.||+|.+..+++.||||++.- ....+++.|+.+|..+++ .+|..++.....+...+++|
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~-~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDS-PNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCc-chHHhhhhheeecccHHHHH
Confidence 4568889999999999999999999999999999433 334568899999999986 55656666677888999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||| ||++.++++ .+..+++..+..|+.+++.||.|||.++.+|||||+.|||+. ..+.|||+|||.+-.+.....
T Consensus 91 ey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 91 EYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechhh
Confidence 999 889999998 344568999999999999999999999999999999999996 559999999999987765433
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
...+++||+.|||||++.+..|+.|+||||||++.+||++|.+||..+.+..... +. .....+.+-
T Consensus 167 -------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----lI---pk~~PP~L~ 232 (467)
T KOG0201|consen 167 -------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----LI---PKSAPPRLD 232 (467)
T ss_pred -------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----ec---cCCCCCccc
Confidence 2268999999999999998899999999999999999999999998876622111 11 112222333
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCC
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 281 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 281 (473)
..+++.|++||..||++||+.||++.+| |.+-|++...
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~L---LKh~FIk~a~ 270 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKEL---LKHKFIKRAK 270 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHH---hhhHHHHhcC
Confidence 4788999999999999999999998877 5566666543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=333.15 Aligned_cols=253 Identities=19% Similarity=0.221 Sum_probs=197.7
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
++|++.+.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.++|++++. +..+.......++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVE-LKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccc-hhhhEecCCEEEEEE
Confidence 5799999999999999999999999999999985432 2345778999999998766555 444556777889999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
||+.+++.+.+......+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||+++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS---HNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccCcccccccccc
Confidence 9997766666655556799999999999999999999999999999999999994 7789999999999876432211
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc---------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 232 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 232 (473)
......||..|+|||++.+..++.++|||||||++|||++|+.||.+.........+..+.....
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 157 ------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 11245789999999999998999999999999999999999999987543222222211110000
Q ss_pred ---------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 ---------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 ---------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..........++.++.+||.+||..||++||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000111234678899999999999999999988774
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=344.36 Aligned_cols=245 Identities=22% Similarity=0.324 Sum_probs=198.2
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++.++||+|+||.||+|++..+++.||||++.+. ....+..|+.++..+.| ++|..+..+.......++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS-EWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCC-CCCccEEEEEEcCCEEEEE
Confidence 5799999999999999999999999999999985432 23457789999999985 4555555666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kL~Dfg~a~~~~~~- 154 (333)
T cd05600 80 MEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSKGIVTY- 154 (333)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEEEeCcCCcccccc-
Confidence 9999 8899999974 45689999999999999999999999999999999999994 7789999999999865431
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc---cccH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---STSI 236 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---~~~~ 236 (473)
.....||..|+|||++.+..++.++|||||||+||||++|..||.+... .+.+..+..... ....
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~ 222 (333)
T cd05600 155 ---------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENLKYWKETLQRPVY 222 (333)
T ss_pred ---------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHHHhccccccCCCC
Confidence 2346799999999999999999999999999999999999999987443 222222221110 0100
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
......+++++.++|..||..+|++||++.+|.
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll 255 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIK 255 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHH
Confidence 001125689999999999999999999977663
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=340.21 Aligned_cols=237 Identities=20% Similarity=0.292 Sum_probs=197.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++.+.||+|+||.||+|++..+++.||||++.+. ....+..|+.+++.++|++++.. ..+....+..++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~-~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM-MCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcE-EEEEEcCCEEEE
Confidence 47899999999999999999999999999999985432 23457889999999986655554 455567788999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
+|||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||||+ .++.+||+|||+++.....
T Consensus 96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD---NKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC---CCCCEEEeeccCceEcCCC
Confidence 99998 8899999874 45789999999999999999999999999999999999994 7789999999999866432
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
. ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+......
T Consensus 172 ~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~----- 233 (329)
T PTZ00263 172 T----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIYEKILAGRLK----- 233 (329)
T ss_pred c----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCcC-----
Confidence 2 23579999999999999999999999999999999999999997643 33444444433221
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDY 265 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~ 265 (473)
+...++.++.+||..||..||.+||+.
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 234578899999999999999999973
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=354.34 Aligned_cols=204 Identities=25% Similarity=0.353 Sum_probs=176.7
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhc-----CCCCCCeeEEeeEeCCeE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQ-----GGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~-----~~~~i~~~~~~~~~~~~~ 77 (473)
+.-+|.|++.||+|+||.|.+|.+..|++.||||+++... ..+...|+.+|..|+ +..++..+..++....+.
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 4458999999999999999999999999999999954443 566788999999998 234677778888899999
Q ss_pred EEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
|||+|++..+|.++++..+ ..|+...+..|+.||+.||.+||+.||||+||||+||||..- ....|||+|||.|+...
T Consensus 264 ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 264 CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEEecccccccC
Confidence 9999999999999998653 459999999999999999999999999999999999999643 34489999999998654
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 219 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~ 219 (473)
... ..+.-+..|.|||+++|.+|+.+.||||||||+.||++|.+.|.|.+..+
T Consensus 343 q~v----------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 343 QRV----------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred Ccc----------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 432 24577889999999999999999999999999999999999998765433
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=333.59 Aligned_cols=251 Identities=20% Similarity=0.244 Sum_probs=196.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.++|++.++||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|+++ ..+..+.......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI-VLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCc-CeEEEEEecCCeEEEEE
Confidence 478999999999999999999999999999999854322 2346789999999986554 45555666778899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
||++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECCCCcceeccCCCc-
Confidence 9999999999886666799999999999999999999999999999999999994 778999999999975432211
Q ss_pred cccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc--------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 232 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 232 (473)
......||..|+|||++.+. .++.++|||||||+||||++|..||.+... ....+..+.....
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred ------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhcc
Confidence 11345789999999998764 589999999999999999999999987543 1222222211000
Q ss_pred -----------------cccHHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 -----------------STSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 -----------------~~~~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
........ ..+++++.+|+..||+.||.+|||+.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 00001111 12457889999999999999999977763
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=340.34 Aligned_cols=239 Identities=21% Similarity=0.260 Sum_probs=200.0
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+|++++.||+|+||.||+|.+..+++.||||++.+. ....+..|..++..+.+++++..+..+....+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999985432 23446788899999998888888888888888999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---AEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc---CCCCEEEeecCcceecCCCCC
Confidence 999 8899988874 45689999999999999999999999999999999999994 678999999999875332211
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
......||..|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+..+..... .+.
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~-----~~~ 221 (324)
T cd05587 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIMEHNV-----SYP 221 (324)
T ss_pred -------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCC-----CCC
Confidence 1134579999999999999999999999999999999999999997643 3334444433222 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDY 265 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~ 265 (473)
..++.++.+++..||..||.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 4678999999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=335.05 Aligned_cols=235 Identities=22% Similarity=0.342 Sum_probs=195.4
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+.|++++ .+..+..+....+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFII-RLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHh-hhHhhhccCCeEEEE
Confidence 4799999999999999999999999999999985432 223477899999999865554 445556677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~---~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD---KEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEEecCcchhccCCc
Confidence 9998 7899999874 45799999999999999999999999999999999999994 67899999999998664321
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
....||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ....+..+..... .+
T Consensus 156 ----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~-----~~ 217 (291)
T cd05612 156 ----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIYEKILAGKL-----EF 217 (291)
T ss_pred ----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCc-----CC
Confidence 23579999999999999999999999999999999999999997743 3334444433322 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCC
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPD 264 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt 264 (473)
...++..+.++|.+||..||.+||+
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccC
Confidence 3456889999999999999999995
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=332.65 Aligned_cols=263 Identities=24% Similarity=0.439 Sum_probs=190.0
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCC---CcEEEEEEcccCCchhHHHH------------HH---HHHHhcCCCCC
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLNVKTKHPQLQYE------------AK---LYKILQGGTGI 64 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~~~~~~~~~l~~E------------~~---il~~L~~~~~i 64 (473)
...+++|++.++||+|+||.||+|.+..+ +..+|+|+...... .+..| +. .+..+.| .++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~-~~~~e~~~~~~~~~~~~~~~~~~~~~~~h-~~i 85 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE-TIVMETLVYNNIYDIDKIALWKNIHNIDH-LGI 85 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCC-chhhHHHHHHhhhhHHHHHHHHHhccCCC-CCC
Confidence 35678999999999999999999998777 67788887322221 11112 11 2222343 344
Q ss_pred CeeEEeeEeC----CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC
Q 011988 65 PNLRWFGVEG----DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 140 (473)
Q Consensus 65 ~~~~~~~~~~----~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 140 (473)
+.+..++... .+.+++++++..++.+++... ..+++..++.|+.||+.||+|||+++|+||||||+|||++ .
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~---~ 161 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD---G 161 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---C
Confidence 4444443332 255788999988998888743 3468889999999999999999999999999999999994 6
Q ss_pred CCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCH
Q 011988 141 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 220 (473)
Q Consensus 141 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~ 220 (473)
.+.++|+|||+|+.+..................||+.|+|||++.+..++.++|||||||+||||++|+.||.+......
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 78899999999987754322111111122345799999999999999999999999999999999999999987643222
Q ss_pred HHHHHHHh-hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011988 221 KQKYEKIS-EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 272 (473)
Q Consensus 221 ~~~~~~i~-~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 272 (473)
.....+.. ...... .......+|+++.+++..||..+|++||++.+|++.|
T Consensus 242 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKCDFIKRLHE-GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHHHHHHHhhh-hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11111100 000000 1112356789999999999999999999999999876
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=352.49 Aligned_cols=254 Identities=20% Similarity=0.276 Sum_probs=196.3
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeE-------eCCeE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-------EGDYN 77 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~-------~~~~~ 77 (473)
..++|++.++||+|+||.||+|.+..+++.||||.+... .....+|+.+++.++|++++..+..+.. ...+.
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 356899999999999999999999999999999986443 2345679999999998777766554432 12356
Q ss_pred EEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 78 VLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 78 ~lv~e~~g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
++||||++++|.+++.. ....+++..++.++.||+.||.|||++|||||||||+||||+ ...+.+||+|||+|+.
T Consensus 143 ~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 143 NVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccchh
Confidence 79999999999888753 345699999999999999999999999999999999999995 2345799999999986
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc--
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-- 231 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~-- 231 (473)
+..... .....||+.|+|||++.+. .++.++|||||||+||||++|.+||.+.........+..+....
T Consensus 221 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 221 LLAGQR--------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccCCCC--------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 643221 1345789999999998875 58999999999999999999999998754322222221111000
Q ss_pred -------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 -------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 -------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.......+....|+++.+||.+||..||.+||++.+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00011122345688999999999999999999988773
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=335.48 Aligned_cols=260 Identities=18% Similarity=0.254 Sum_probs=197.1
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcC----------------CCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ----------------TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGI 64 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~----------------~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i 64 (473)
..++|++.++||+|+||.||+|.+.. ++..||||++.... ...+.+|+.++..+.|+++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni- 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI- 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe-
Confidence 45789999999999999999998532 34479999865432 2357889999999986554
Q ss_pred CeeEEeeEeCCeEEEEEecC-CCCHHHHHHHcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 011988 65 PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS------------------RKLSLKTVLMLADQMINRVEFVHSKSFLH 125 (473)
Q Consensus 65 ~~~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvH 125 (473)
..+..+.......+++|||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 45555556667789999999 889999986421 23678899999999999999999999999
Q ss_pred cCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHH
Q 011988 126 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 205 (473)
Q Consensus 126 rDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~el 205 (473)
|||||+|||++ ..+.+||+|||+++.+..... +.......++..|+|||++.+..++.++|||||||++|||
T Consensus 162 ~dlkp~Nill~---~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 162 RDLATRNCLVG---ENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred cCcchhheEEc---CCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 99999999994 678999999999986543221 1112334567899999999988999999999999999999
Q ss_pred Hc--CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 206 LR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 206 lt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
++ +..||.+............................+|..+.++|.+||..||++||++.+|.+.|+
T Consensus 234 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 234 LMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 86 678887754322221111111111000011112457899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.37 Aligned_cols=252 Identities=22% Similarity=0.297 Sum_probs=203.6
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeC----CeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----DYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~----~~~~lv~e 82 (473)
=.|.-.+++|.|+||.||.|....+++.||||..-... .--.+|+++|+.+.|+|+|..++.|.... -+..+|||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 35888999999999999999999999999999732222 22357999999999888887777665432 24578999
Q ss_pred cCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 83 LLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 83 ~~g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|+..+|.++++. .+..++...+.-++.||++||.|||+.||+||||||+|+|++ .+.+.+||||||.|+.+...+
T Consensus 103 ymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 103 YMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeeccCC
Confidence 999999999984 366799999999999999999999999999999999999996 567999999999999887654
Q ss_pred CccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH--
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI-- 236 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-- 236 (473)
. ...+..|..|.|||.+.|.. |+.+.||||.|||+.||+.|++-|.|....+....+-++....-...+
T Consensus 181 p--------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 181 P--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred C--------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 3 34568899999999999875 999999999999999999999999996554433333333221111111
Q ss_pred -------------------HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 237 -------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 237 -------------------~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..+....+++..+|+.++|.++|.+|.++.++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 113345689999999999999999999987763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=331.56 Aligned_cols=265 Identities=18% Similarity=0.282 Sum_probs=212.3
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.-.+.|++...||.|..++||+|+.+.+++.||||++.-+ ....+.+|+..++.+.|+|++ .++..+..+...|+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv-~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIV-TYHCSFVVDSELWV 101 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcc-eEEEEEEecceeEE
Confidence 3467899999999999999999999999999999984332 235688999999988855555 55556677788899
Q ss_pred EEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 80 VIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
||.|+ +||+.++++.. ...|++..+..|++++++||.|||.+|.||||||+.|||| +.+|.|||+|||.+-.+.+
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeecc
Confidence 99999 99999999743 4459999999999999999999999999999999999999 5899999999999877766
Q ss_pred CCCccccccccCCCcccCccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc--
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-- 233 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-- 233 (473)
.... ..++. +.++||+.|||||++... .|+.|+||||||++..||++|..||..+.+. +..+.++......
T Consensus 179 ~G~R--~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 179 SGDR--QVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLLTLQNDPPTLL 253 (516)
T ss_pred cCce--eeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHHHhcCCCCCcc
Confidence 5422 22233 788999999999995533 4999999999999999999999999887542 3333444433321
Q ss_pred --ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 234 --TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 234 --~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
.....-.+.++..|.++|..||.+||.+||++++| |.+.|-+..
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskL---lkh~FFk~~ 299 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKL---LKHAFFKKA 299 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHH---hccHHHhhc
Confidence 11122235678899999999999999999998877 555555544
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=330.21 Aligned_cols=262 Identities=20% Similarity=0.251 Sum_probs=209.2
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc-----CCchhHHHHHHHHHHhcCCCCCCeeEEeeE----eCC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGV----EGD 75 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~-----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~----~~~ 75 (473)
+..+|..++.||.|+||.|+.+.+..+|+.||||.+.. .......+|+++|+.++|.|+|.....+.. .-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 45677778999999999999999999999999997442 223456799999999998887777766654 345
Q ss_pred eEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 76 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 76 ~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
..|+|+|+++.+|.++++ .++.++...+..++.||+.||.|+|+.+|+||||||.|+|+ +.+..+||||||+|+..
T Consensus 100 DvYiV~elMetDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHHhhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccceeec
Confidence 679999999999999998 34459999999999999999999999999999999999999 47788999999999987
Q ss_pred cCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH--------
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK-------- 226 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~-------- 226 (473)
....... ..+.++-|..|.|||++.. ..|+...||||+||||.||++|+.-|.|.+.....+.+..
T Consensus 176 ~~~~~~~-----~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 176 DKFFEDG-----FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred cccCccc-----chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 6431111 1256788999999998875 4699999999999999999999999988553322222211
Q ss_pred ----Hh-----------hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 227 ----IS-----------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 227 ----i~-----------~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
+. ......+...+.++.++...+|+++||.+||.+|+|+++. |.+.+..
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eA---L~hPYl~ 314 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEA---LAHPYLA 314 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHH---hcChhhh
Confidence 11 1122334455667788999999999999999999997765 6666543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=356.23 Aligned_cols=259 Identities=18% Similarity=0.239 Sum_probs=193.6
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCC------CCCeeEEeeEeCCeE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGT------GIPNLRWFGVEGDYN 77 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~------~i~~~~~~~~~~~~~ 77 (473)
.++|+++++||+|+||.||+|.+..+++.||||++... .......|+.+++.+.+.+ ++..+.++.......
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 47899999999999999999999999999999986432 2334677888888887544 223334444455678
Q ss_pred EEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCC-------------CCc
Q 011988 78 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRR-------------ANQ 143 (473)
Q Consensus 78 ~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~-------------~~~ 143 (473)
|+||+++|++|.+++.. ...+++..++.|+.||+.||+|||+ .|||||||||+||||+.++. ...
T Consensus 208 ~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 99999999999998874 3579999999999999999999998 59999999999999963221 125
Q ss_pred EEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 011988 144 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 223 (473)
Q Consensus 144 vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~ 223 (473)
+||+|||++...... ....+||..|+|||++.+..++.++|||||||+||||++|+.||.+.........
T Consensus 287 vkl~DfG~~~~~~~~----------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 287 VRICDLGGCCDERHS----------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred EEECCCCccccCccc----------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 999999988643221 2356899999999999999999999999999999999999999987543222222
Q ss_pred HHHHhhcccc---------------------------ccHHHHhc-------CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 224 YEKISEKKVS---------------------------TSIEALCR-------GYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 224 ~~~i~~~~~~---------------------------~~~~~l~~-------~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
+.++...... ..+..+.. ...+.+.+||..||.+||++||+++++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~- 435 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM- 435 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH-
Confidence 2221110000 00000000 013567899999999999999998877
Q ss_pred HHHHHHHHH
Q 011988 270 RLFRDLFIR 278 (473)
Q Consensus 270 ~~L~~l~~~ 278 (473)
|++.|..
T Consensus 436 --L~Hp~~~ 442 (467)
T PTZ00284 436 --TTHPYVL 442 (467)
T ss_pred --hcCcccc
Confidence 4555443
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=329.48 Aligned_cols=249 Identities=19% Similarity=0.255 Sum_probs=194.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcC-CCcEEEEEEcccC-----CchhHHHHHHHHHHhc--CCCCCCeeEEeeE-----e
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLNVKT-----KHPQLQYEAKLYKILQ--GGTGIPNLRWFGV-----E 73 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~--~~~~i~~~~~~~~-----~ 73 (473)
++|++.+.||+|+||.||+|++.. +++.||||++... ....+.+|+.+++.+. .|++|..+..++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999864 4688999984322 1234667888888774 2444444443332 3
Q ss_pred CCeEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 74 GDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 74 ~~~~~lv~e~~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
....+++||+++++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~---~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc---CCCCEEEccccce
Confidence 45689999999999999987543 4589999999999999999999999999999999999994 6789999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc--
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-- 230 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~-- 230 (473)
+...... ......||..|+|||++.+..++.++|||||||++|||++|..||.+.... ..+..+...
T Consensus 158 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~ 226 (290)
T cd07862 158 RIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIG 226 (290)
T ss_pred EeccCCc--------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhC
Confidence 8654321 123457899999999999989999999999999999999999999875432 222222211
Q ss_pred --------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 --------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
........+...+++.+.+++..||+.||++||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 111123344456788999999999999999999988875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=344.45 Aligned_cols=250 Identities=16% Similarity=0.180 Sum_probs=195.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecCC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLG 85 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~g 85 (473)
.++|+++++||+|+||.||+|.+..+++.||||... ...+.+|+++++.|+|++++. +..++......+++||+++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l~HpnIv~-~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAINHPSIIQ-LKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhCCCCCCCC-EeEEEEECCeeEEEEecCC
Confidence 467999999999999999999999999999999743 335789999999999665555 5555567788899999999
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|..++.. ...+++.+++.|+.||+.||.|||++|||||||||+|||++ ..+.+||+|||+|+........
T Consensus 167 ~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~---~~~~vkL~DFG~a~~~~~~~~~---- 238 (391)
T PHA03212 167 TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGDVCLGDFGAACFPVDINAN---- 238 (391)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc---CCCCEEEEeCCccccccccccc----
Confidence 999988874 45689999999999999999999999999999999999994 6788999999999754332111
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC----CHHHHHHHHhhcc----------
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISEKK---------- 231 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~----~~~~~~~~i~~~~---------- 231 (473)
......||+.|+|||++.+..++.++|||||||+||||++|..||...... .....+..+....
T Consensus 239 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 239 --KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred --ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 123468999999999999999999999999999999999999887542210 0011111111000
Q ss_pred --------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 --------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 --------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...........+|.++.+||.+||++||.+||++.+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 00000011124577899999999999999999988874
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=338.52 Aligned_cols=253 Identities=18% Similarity=0.253 Sum_probs=199.8
Q ss_pred ceEEEeeEeecCceEEEEEEEc---CCCcEEEEEEcccC-------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLNVKT-------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~~~~~-------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
+|+++++||+|+||.||++++. .+++.||+|++.+. ....+..|+.+++.+.++++|..+..+.......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 47899999985432 1234678999999998888888888888888899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~---~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD---SEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC---CCCCEEEeeCcCCcccc
Confidence 9999999 7899998864 45699999999999999999999999999999999999994 67899999999998654
Q ss_pred CCCCccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHH-HHHHHHhhccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVST 234 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~ 234 (473)
..... ......||..|+|||++.+.. ++.++|||||||+||||++|..||......... .....+....
T Consensus 157 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--- 227 (332)
T cd05614 157 SEEKE------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--- 227 (332)
T ss_pred ccCCC------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC---
Confidence 33221 113457999999999998754 789999999999999999999999754332222 2222222211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDL 275 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l 275 (473)
..+...+++.+.++|..||..||++||++. .+.+++++.
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 228 --PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 112345789999999999999999999544 344445443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=339.55 Aligned_cols=236 Identities=20% Similarity=0.277 Sum_probs=191.3
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|.+..+++.||||++.+. ....+..|+.+++.+.|++ |..+..++...+..++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~-i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPF-LTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCC-CCCEEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999985432 2234678999999998655 445555667778899999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||||+ .++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DfG~a~~~~~~~~----- 150 (323)
T cd05571 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD---KDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEeeCCCCcccccCCC-----
Confidence 899888874 45799999999999999999999999999999999999994 778999999999975432211
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcH
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 245 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 245 (473)
......||+.|+|||++.+..++.++|||||||++|||++|..||.... ....+..+..... .+...+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~~~~~~-----~~p~~~~~ 220 (323)
T cd05571 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEI-----RFPRTLSP 220 (323)
T ss_pred --cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCC-----CCCCCCCH
Confidence 1234679999999999999999999999999999999999999997632 2333333332221 23356789
Q ss_pred HHHHHHHHHhcCCCCCCC-----CHHHH
Q 011988 246 EFASYFHYCRSLRFDDKP-----DYAYL 268 (473)
Q Consensus 246 ~l~~li~~cl~~dp~~RP-----t~~~l 268 (473)
++.++|..||..||++|| ++.+|
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~l 248 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEI 248 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHH
Confidence 999999999999999999 65555
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=336.10 Aligned_cols=239 Identities=21% Similarity=0.260 Sum_probs=199.4
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+|.+.+.||+|+||.||+|.+..+++.||||++.+.. ...+..|..++..+.+++++..+..+....+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999854422 2235667888888888899988888888889999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC---CCCcEEEccCCCceecCCCCC
Confidence 999 7899988874 35699999999999999999999999999999999999994 778999999999975432211
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+..+...... +.
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~~~-----~p 221 (323)
T cd05616 157 -------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEHNVA-----YP 221 (323)
T ss_pred -------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC-----CC
Confidence 12346799999999999999999999999999999999999999987432 3344444433221 23
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDY 265 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~ 265 (473)
..++.++.+++..||..||++|++.
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 4678999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=344.38 Aligned_cols=256 Identities=21% Similarity=0.335 Sum_probs=201.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcCC-----CcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
++|++.+.||+|+||.||+|.+... ++.||||++.... ...+..|+.+++.+..|++|..+..++......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4699999999999999999986544 3579999865433 234778999999995566666666677777889
Q ss_pred EEEEecC-CCCHHHHHHHcC------------------------------------------------------------
Q 011988 78 VLVIDLL-GPSLEDLFNFCS------------------------------------------------------------ 96 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~------------------------------------------------------------ 96 (473)
+++|||+ +++|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999 889999885321
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccc
Q 011988 97 ---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167 (473)
Q Consensus 97 ---------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 167 (473)
..+++..++.|+.||+.||.|||++||+||||||+|||++ +.+.+||+|||+++.+...... .
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~---~~~~~kL~DfGla~~~~~~~~~-----~ 269 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNY-----V 269 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---CCCeEEEeeceeeeeccCCcce-----e
Confidence 2478889999999999999999999999999999999995 6788999999999865433211 1
Q ss_pred cCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHH
Q 011988 168 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 246 (473)
Q Consensus 168 ~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 246 (473)
......++..|+|||++.+..++.++|||||||++|||++ |+.||....... .+.......... .....+|++
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~ 343 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVKRGYQM---SRPDFAPPE 343 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHHcccCc---cCCCCCCHH
Confidence 1123345678999999999899999999999999999997 999998754322 111221111111 112346899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 247 FASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 247 l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
+.++|..||+.||++||++.+|.++|++++
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=343.99 Aligned_cols=249 Identities=21% Similarity=0.250 Sum_probs=216.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.++|.+++++|.|+||.+++++++..+..||+|.+.-.. .....+|+.+++++.|+++|.+...|..++.+.+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 478999999999999999999999999999999843322 335789999999999988888888888888889999
Q ss_pred EecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 81 IDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
|+|| ||+|.+.++..+ ..|+++.++.|+.||+.||+|||+++|+|||||+.|||++ +++.|||.|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhhcCCc
Confidence 9999 999999998665 5699999999999999999999999999999999999996 7778899999999988765
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. ...+..||+.||+||++.+.+|+.|+|||||||++|||++-+.+|...+ ....+.+|..... ..
T Consensus 160 ~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~---m~~Li~ki~~~~~----~P 225 (426)
T KOG0589|consen 160 DS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN---MSELILKINRGLY----SP 225 (426)
T ss_pred hh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc---hHHHHHHHhhccC----CC
Confidence 42 2356899999999999999999999999999999999999999998743 4445555555442 33
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 271 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~ 271 (473)
+...++.++..+|..||..+|+.||++.+|+..
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 456788999999999999999999999988654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=336.74 Aligned_cols=242 Identities=21% Similarity=0.290 Sum_probs=196.7
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCC
Q 011988 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 87 (473)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~s 87 (473)
||+|+||.||+|++..+++.||||++.+. ....+..|+.+++.++|++++. +..+.......++||||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVP-LKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEec-eeeEEecCCeEEEEEcCCCCCc
Confidence 69999999999999999999999985432 2234678999999998655555 555556778899999999 889
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccc
Q 011988 88 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167 (473)
Q Consensus 88 L~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 167 (473)
|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~------- 148 (312)
T cd05585 80 LFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDD------- 148 (312)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCC-------
Confidence 9999874 4579999999999999999999999999999999999999 4778999999999975433221
Q ss_pred cCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHH
Q 011988 168 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 247 (473)
Q Consensus 168 ~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 247 (473)
......||..|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+..... .+...+++++
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~~~~~~~~~~~~~-----~~~~~~~~~~ 220 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---VNEMYRKILQEPL-----RFPDGFDRDA 220 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCCC-----CCCCcCCHHH
Confidence 1234579999999999999999999999999999999999999997643 3333444433222 2335678999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 248 ASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 248 ~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
.++|..||..||++||++..+.++|.+.|
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 99999999999999998766777777654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.58 Aligned_cols=252 Identities=21% Similarity=0.241 Sum_probs=194.6
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeC----
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG---- 74 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~---- 74 (473)
.+.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.++|++++..+..+....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3568999999999999999999999999999999986432 2345678999999999777776665554322
Q ss_pred -CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 75 -DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 75 -~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
...+++|||++++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~---~~~~~kl~Dfg~a~ 171 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLAR 171 (359)
T ss_pred cceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEecCCCcc
Confidence 3579999999988888774 3589999999999999999999999999999999999994 77899999999997
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc-
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV- 232 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~- 232 (473)
....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.........+........
T Consensus 172 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 172 TACTNFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243 (359)
T ss_pred ccccCcc--------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence 5433211 1345789999999999999999999999999999999999999987543211111110000000
Q ss_pred ---------------------cccHHHH------------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 ---------------------STSIEAL------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 ---------------------~~~~~~l------------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
......+ ....++++.+||.+||..||++||++.+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 313 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence 0000000 112357889999999999999999988773
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=347.58 Aligned_cols=256 Identities=21% Similarity=0.326 Sum_probs=205.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.+...+...||+|.||+||+|++- | .||||++.... .+.|.+|+.+|++-+|.|++.++.+ +....+ .||
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~-~~~p~~-AIi 465 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGA-CMNPPL-AII 465 (678)
T ss_pred HHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehh-hcCCce-eee
Confidence 456778999999999999999974 3 58999854433 3458899999999997766655544 444444 888
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
..+| |.+|+.++.-...+|+..+.+.|+.||++|+.|||.++|||||||..||++ .+++.|||+|||++..-..-.
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeeeec
Confidence 8899 779999998777789999999999999999999999999999999999999 466999999999997533221
Q ss_pred CccccccccCCCcccCccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~---~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
..+. .....|...|||||+++.+ +|++.+||||||||+|||++|.+||... ...+.+..+.........
T Consensus 543 g~~q-----~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~---~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 543 GEQQ-----LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ---NRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred cccc-----cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC---ChhheEEEecccccCccc
Confidence 1111 1334688899999999854 5899999999999999999999999842 233444444444444555
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
......+|.++++|+..||.+++++||.+.+|+..|++++.
T Consensus 615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 66677899999999999999999999999999998888764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=321.58 Aligned_cols=253 Identities=14% Similarity=0.220 Sum_probs=201.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEc---CCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
.++|++.+.||+|+||.||+|.+. ..+..||+|+..... ...+..|+.+++.++|+ ++..+..+...+...+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHS-NIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCC-CcCeEEEEEecCCCcE
Confidence 457999999999999999999865 346789999855432 23477899999999755 4555566667778899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ .++.++|+|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~---~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc---CCCcEEECCCcccccccc
Confidence 999999 6799999886566799999999999999999999999999999999999994 678999999998765422
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
... .......++..|+|||.+.+..++.++|||||||++||+++ |..||.+... ...+..+......
T Consensus 160 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~~~~~~--- 227 (266)
T cd05064 160 EAI------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKAVEDGFRL--- 227 (266)
T ss_pred cch------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHHCCCCC---
Confidence 111 01122345678999999999999999999999999999775 9999987543 2223333322211
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
.....+|..+.+++.+||+.+|++||++.+|.+.|..+
T Consensus 228 -~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 12356889999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=353.06 Aligned_cols=261 Identities=19% Similarity=0.262 Sum_probs=201.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEE-eeE-----e-CCe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRW-FGV-----E-GDY 76 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~-~~~-----~-~~~ 76 (473)
.+++|.+.|.+|||+.||+|.+...|..||+|.+...+ ...+.+|+.+|+.|++|++|+.+.. ... . .-.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 45889999999999999999998888999999843333 3457899999999998887776654 211 1 234
Q ss_pred EEEEEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 77 NVLVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~-~~~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
++|.|||| |++|-|+++. ....|++.++++|+.|+++|+.+||... |||||||-+||||+ .++.+||||||.|
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKLCDFGSA 193 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEeCccccc
Confidence 68899999 5899999973 3445999999999999999999999988 99999999999995 7889999999999
Q ss_pred ccccCCC-Ccccccc-ccCCCcccCcccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 011988 153 KRYRDTA-THQHIPY-RENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 227 (473)
Q Consensus 153 ~~~~~~~-~~~~~p~-~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i 227 (473)
....... ....+.+ .......-|+.|+|||++. |...+.|+|||+|||+||.||....||.+-.. ..|
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------laI 266 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------LAI 266 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------eeE
Confidence 7543222 1111111 1112235689999999874 77899999999999999999999999987421 122
Q ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 228 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 228 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
...++..+. ...++..|.+||..||+.||++||++.++...+..+..+..
T Consensus 267 lng~Y~~P~---~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 267 LNGNYSFPP---FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred EeccccCCC---CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 222222211 14678999999999999999999998888777777665443
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=332.76 Aligned_cols=237 Identities=22% Similarity=0.274 Sum_probs=191.3
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhc--CCCCCCeeEEeeEeCCeEEEE
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~lv 80 (473)
|++.+.||+|+||.||+|.+..+++.||||++.+. ....+..|++++..+. .|++|..+..+.......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999985432 2234667777765443 255666666677788899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~---~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD---TEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCcEEeCcccCCccCCCCC
Confidence 9999 789988775 45799999999999999999999999999999999999994 77899999999987543221
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+.+..+...... +
T Consensus 156 ~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~---~~~~~~~i~~~~~~-----~ 220 (324)
T cd05589 156 D-------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD---EEEVFDSIVNDEVR-----Y 220 (324)
T ss_pred C-------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC-----C
Confidence 1 1235679999999999999999999999999999999999999997643 23333333332221 2
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCH
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDY 265 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~ 265 (473)
...++.++.++|.+||..||.+||+.
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 34678999999999999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=328.53 Aligned_cols=253 Identities=19% Similarity=0.240 Sum_probs=198.7
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.++|.+.++||+|+||.||+|++..+++.||||.+... ....+.+|+.+++.++|++++ .+..+.......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV-TLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcc-eEEEEEeeCCeEEEEE
Confidence 36799999999999999999999999999999985432 223567899999999865554 5555666778899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
||+.++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ ..+.+||+|||+++.......
T Consensus 84 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 84 EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECccccceecCCCcc-
Confidence 9999999999886666789999999999999999999999999999999999994 678999999999976433221
Q ss_pred cccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc--------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 232 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 232 (473)
......+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+........
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 160 ------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 1123467899999999876 4589999999999999999999999987544332222222111100
Q ss_pred --------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 --------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 --------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..........+++++.++|..||..||.+|||+.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 284 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence 0011112245688999999999999999999987774
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=332.40 Aligned_cols=240 Identities=20% Similarity=0.263 Sum_probs=200.1
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+|.+.+.||+|+||.||+|.+..+++.||||++.+. ....+..|..++..+.+++++..+..+....+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 488999999999999999999999999999985432 12346678889998988999988888888888999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~---~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD---SEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeccccccccCCCCc
Confidence 999 8899998874 45699999999999999999999999999999999999994 778999999999975432221
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
......||..|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+...... +.
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~-----~p 221 (323)
T cd05615 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQSIMEHNVS-----YP 221 (323)
T ss_pred -------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC-----CC
Confidence 1234579999999999999899999999999999999999999998743 23344444433221 23
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYA 266 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~ 266 (473)
..++.++.+++..||..+|.+|++..
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 46789999999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=332.17 Aligned_cols=254 Identities=19% Similarity=0.276 Sum_probs=200.1
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
..++|++.+.||+|+||.||++++..++..||+|+..... ...+.+|+++++.++|++++. +..+.......++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv 81 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG-FYGAFYSDGEISIC 81 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCe-EEEEEEECCEEEEE
Confidence 3578999999999999999999999999999999854432 245889999999998655554 54555667788999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
|||+ +++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||++..+...
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 82 MEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred eecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc---CCCcEEEccCccccccccc
Confidence 9999 7899999974 34689999999999999999999986 699999999999994 6788999999999765432
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc-------
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------- 231 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~------- 231 (473)
. .....||..|+|||++.+..++.++|||||||+||||++|+.||....... +..+....
T Consensus 158 ~---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~ 224 (331)
T cd06649 158 M---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVDGEEG 224 (331)
T ss_pred c---------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhcccccccccC
Confidence 2 134579999999999999999999999999999999999999996533211 11110000
Q ss_pred ------------------------------------ccccHHHH-hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 232 ------------------------------------VSTSIEAL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 232 ------------------------------------~~~~~~~l-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
........ ...+++++.+||.+||.+||++||++.+| |++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el---l~h 301 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML---MNH 301 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH---hcC
Confidence 00000000 11367899999999999999999998877 556
Q ss_pred HHHHh
Q 011988 275 LFIRE 279 (473)
Q Consensus 275 l~~~~ 279 (473)
.|.+.
T Consensus 302 ~~~~~ 306 (331)
T cd06649 302 TFIKR 306 (331)
T ss_pred hHHhh
Confidence 66554
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=330.84 Aligned_cols=235 Identities=22% Similarity=0.273 Sum_probs=191.4
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|.+..+++.||||++... ....+..|..++..+.+|++|..+..+.......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999985432 22335567777777666777777777777888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~a~~~~~~~~----- 151 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENMNGEG----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC---CCCCEEEccCcCCeECCCCCC-----
Confidence 899998874 44799999999999999999999999999999999999994 778999999999976433221
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcH
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 245 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 245 (473)
......||..|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+..... .+...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~~-----~~~~~~~~ 221 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSILNDRP-----HFPRWISK 221 (316)
T ss_pred --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCC-----CCCCCCCH
Confidence 12346799999999999999999999999999999999999999987543 333333332211 12345789
Q ss_pred HHHHHHHHHhcCCCCCCCCHH
Q 011988 246 EFASYFHYCRSLRFDDKPDYA 266 (473)
Q Consensus 246 ~l~~li~~cl~~dp~~RPt~~ 266 (473)
++.++|..||..||++||++.
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred HHHHHHHHHccCCHHHcCCCh
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=339.98 Aligned_cols=254 Identities=23% Similarity=0.310 Sum_probs=200.2
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|.+.+.||+|+||.||+|++..+++.||||++.+. ....+..|+.++..+.|.+ |..+..+..++...++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW-IVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCC-ccchhhheecCCeEEEE
Confidence 5799999999999999999999999999999985432 2345778999999998544 44555566778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+++.+....
T Consensus 80 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEeecCCCCccCcccC
Confidence 9999 88999999754 5799999999999999999999999999999999999994 77899999999998765433
Q ss_pred Ccc----------------------ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 011988 160 THQ----------------------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 217 (473)
Q Consensus 160 ~~~----------------------~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~ 217 (473)
... ...........||..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 000 0000112345799999999999999999999999999999999999999987542
Q ss_pred CCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC-HHHHHH
Q 011988 218 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKR 270 (473)
Q Consensus 218 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt-~~~l~~ 270 (473)
...+.++.........+ ....+++++.++|..||. ||.+||+ ++++++
T Consensus 236 ---~~~~~~i~~~~~~~~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 236 ---QETYNKIINWKESLRFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred ---HHHHHHHhccCCcccCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 33333333311111111 112368999999999997 9999999 888743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=335.81 Aligned_cols=247 Identities=21% Similarity=0.303 Sum_probs=197.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|.+.+.||+|+||.||+|.+..+++.||||++... ....+..|+.+++.+.| ++|..+..+.......++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~-~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS-PWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceeeEEecCCeEEEE
Confidence 5799999999999999999999999999999985432 22346788888888774 5555565666777889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ ..+.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~---~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID---RTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC---CCCCEEeccCCCCeECCCCC
Confidence 9999 8899999987667899999999999999999999999999999999999994 78899999999998765432
Q ss_pred CccccccccCCCcccCcccccccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~------~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
.. ......||..|+|||++. +..++.++|||||||+||||++|..||..... ...+..+......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~~~~ 227 (330)
T cd05601 157 MV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYNNIMNFQRF 227 (330)
T ss_pred ce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHHHHHcCCCc
Confidence 21 112347899999999987 45678999999999999999999999976432 2333333322111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
...+ ....++.++.+||..||. +|.+||+++++
T Consensus 228 ~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l 260 (330)
T cd05601 228 LKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGL 260 (330)
T ss_pred cCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHH
Confidence 1000 112468999999999997 99999998766
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.52 Aligned_cols=255 Identities=21% Similarity=0.317 Sum_probs=200.8
Q ss_pred CceEEEeeEeecCceEEEEEEE-----cCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
++|++.++||+|+||.||+|++ ..++..||||++.... ...+.+|+.++..+.+|++|..+..++......
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4799999999999999999974 3456789999864332 235778999999996677777777777888889
Q ss_pred EEEEecC-CCCHHHHHHHcC------------------------------------------------------------
Q 011988 78 VLVIDLL-GPSLEDLFNFCS------------------------------------------------------------ 96 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~------------------------------------------------------------ 96 (473)
++||||+ +++|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999 889999886422
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 97 --------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 97 --------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
..+++..++.|+.||+.||.|||++||+||||||+|||++ ..+.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~~~- 270 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSNY- 270 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccCcccc-
Confidence 1478889999999999999999999999999999999995 6778999999999866443211
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
.......++..|+|||++.+..++.++|||||||+||||++ |..||....... .....+... ... ....
T Consensus 271 ----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~-~~~---~~~~ 340 (375)
T cd05104 271 ----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEG-YRM---LSPE 340 (375)
T ss_pred ----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhC-ccC---CCCC
Confidence 11123345678999999999999999999999999999998 999997754322 112222211 111 1123
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
..|.++.+||..||+.||++||++.+|.+.|++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 4678999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=323.26 Aligned_cols=251 Identities=19% Similarity=0.234 Sum_probs=194.3
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhc--CCCCCCeeEEeeE-----eCC
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQ--GGTGIPNLRWFGV-----EGD 75 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~--~~~~i~~~~~~~~-----~~~ 75 (473)
+|++.+.||+|+||.||+|.+..+++.||||.+.... ...+..|+.+++.+. .|++|..+..++. ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5999999999999999999999999999999854321 234667888888774 2444444433332 234
Q ss_pred eEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..+++||++.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccCcccc
Confidence 579999999989999987543 3589999999999999999999999999999999999994 778999999999986
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc----
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---- 230 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~---- 230 (473)
+..... .....||..|+|||++.+..++.++|||||||++|||++|..||.+.........+......
T Consensus 158 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 158 YSCQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred ccCccc--------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 643221 12357899999999999989999999999999999999999999765432222222211100
Q ss_pred ---------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 ---------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 ---------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
........+...++.++.++|.+||+.||++||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 001122334456788999999999999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=333.55 Aligned_cols=270 Identities=18% Similarity=0.264 Sum_probs=205.4
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
..++|++.++||.|+||.||+|.+..++..||+|++.... ...+.+|+++++.++|++ |..+..++...+..++|
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-IVGFYGAFYSDGEISIC 81 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCc-ccceeEEEEECCEEEEE
Confidence 4678999999999999999999999999999999854332 245789999999998655 44555566677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
|||+ +++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ ..+.+||+|||++..+...
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 82 MEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc---CCCCEEEeeCCcchhhhhh
Confidence 9999 8899999974 34689999999999999999999985 799999999999994 6788999999999765432
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH-------------
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE------------- 225 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~------------- 225 (473)
.. ....||..|+|||++.+..++.++|||||||++|||++|+.||...........+.
T Consensus 158 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (333)
T cd06650 158 MA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228 (333)
T ss_pred cc---------ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccC
Confidence 21 34578999999999999889999999999999999999999997543211110000
Q ss_pred ------------------------HHhhccccccHHHHh-cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 226 ------------------------KISEKKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 226 ------------------------~i~~~~~~~~~~~l~-~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
.+...........+. ..++.++.+||.+||.+||++||++.+| |.+.|.+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~el---l~h~~~~~~ 305 (333)
T cd06650 229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQL---MVHAFIKRS 305 (333)
T ss_pred cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHH---hhCHHHhcC
Confidence 000000000000011 1357889999999999999999998877 455555544
Q ss_pred -CCCCCcccccc
Q 011988 281 -FQFDYVFDWTI 291 (473)
Q Consensus 281 -~~~~~~~dw~~ 291 (473)
....+.+.|..
T Consensus 306 ~~~~~~~~~~~~ 317 (333)
T cd06650 306 EAEEVDFAGWLC 317 (333)
T ss_pred ccccccHHHHHH
Confidence 33345566753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=344.15 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=205.3
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCCH
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSL 88 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL 88 (473)
-+||+|.||+||-|+|..+...+|||-+.... ...+..|+.+.+.|.|.|+|.++..+... .++-|+||-. ||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen-Gf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN-GFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCC-CeEEEEeecCCCCcH
Confidence 36899999999999999999999999854433 33488999999999988887777665544 4666777766 9999
Q ss_pred HHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccccc
Q 011988 89 EDLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166 (473)
Q Consensus 89 ~~~l~~~~~~l--s~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~ 166 (473)
.+++...-+++ .+.++-.+..||++||.|||++.|||||||-+||||. .-.|.+||.|||.++.+..-..
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP------ 731 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINP------ 731 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCc------
Confidence 99999777777 8899999999999999999999999999999999996 5678999999999987654322
Q ss_pred ccCCCcccCccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCc
Q 011988 167 RENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 244 (473)
Q Consensus 167 ~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 244 (473)
...++.||..|||||++..++ |+.++|||||||++.||.||++||..+... ...+.++..-+..++++ ..++
T Consensus 732 -~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--qAAMFkVGmyKvHP~iP---eels 805 (1226)
T KOG4279|consen 732 -CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--QAAMFKVGMYKVHPPIP---EELS 805 (1226)
T ss_pred -cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--hHhhhhhcceecCCCCc---HHHH
Confidence 236789999999999998765 899999999999999999999999876543 33344555545555443 3456
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 245 TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 245 ~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
.+.+.||.+|+..||.+||++.+| |.+.|.+.+
T Consensus 806 aeak~FilrcFepd~~~R~sA~~L---L~DpFlq~~ 838 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDL---LQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHh---ccCcccccC
Confidence 889999999999999999998776 666665544
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=334.59 Aligned_cols=253 Identities=20% Similarity=0.279 Sum_probs=199.4
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----------------chhHHHHHHHHHHhcCCCCCCe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------------HPQLQYEAKLYKILQGGTGIPN 66 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----------------~~~l~~E~~il~~L~~~~~i~~ 66 (473)
...|+|++++.||+|.||.|-+|++..+++.||||++.+.. .+...+|+.||++|.|.++|..
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 45789999999999999999999999999999999865532 1357899999999998665555
Q ss_pred eEEeeE-eCCeEEEEEecC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCc
Q 011988 67 LRWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 143 (473)
Q Consensus 67 ~~~~~~-~~~~~~lv~e~~-g~sL~~~l~~~~~~-ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 143 (473)
+..... ..+..|||+||| .|.+... . +... +++.+++.|+.+++.||+|||.+|||||||||+|+||+ ..++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~-p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~---~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC-P-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS---SDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC-C-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc---CCCc
Confidence 554433 557789999999 3333221 1 2334 89999999999999999999999999999999999995 7799
Q ss_pred EEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 011988 144 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 219 (473)
Q Consensus 144 vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~----~s~ksDVwSlGviL~elltG~~Pf~~~~~~~ 219 (473)
|||+|||.+..+........ ........||+.|+|||+..++. .+.+.||||+||+||.|+.|+.||.+ ..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~--d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~~ 323 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGS--DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---DF 323 (576)
T ss_pred EEeeccceeeecccCCcccc--HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---ch
Confidence 99999999987633211110 01123368999999999988743 36889999999999999999999977 34
Q ss_pred HHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 220 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 220 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..+.+.+|....+..+.. ..+.+.+++||.+||.+||+.|.+..+|+
T Consensus 324 ~~~l~~KIvn~pL~fP~~---pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 324 ELELFDKIVNDPLEFPEN---PEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred HHHHHHHHhcCcccCCCc---ccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 566777777665543322 24568999999999999999999976664
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=330.24 Aligned_cols=235 Identities=21% Similarity=0.265 Sum_probs=190.9
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|++..+++.||||++.+. ....+..|..++..+.++++|..+..+....+..++||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999985432 23346678888877766777777777778888999999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCKENVFGDN----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEeCccCCCeecccCCC-----
Confidence 899988874 45699999999999999999999999999999999999994 678999999999874322111
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcH
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 245 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 245 (473)
......||..|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+.... ..+...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~~~~-----~~~~~~~~~ 221 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIRVDT-----PHYPRWITK 221 (316)
T ss_pred --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-----CCCCCCCCH
Confidence 12346799999999999999999999999999999999999999976432 23333332211 112345788
Q ss_pred HHHHHHHHHhcCCCCCCCCHH
Q 011988 246 EFASYFHYCRSLRFDDKPDYA 266 (473)
Q Consensus 246 ~l~~li~~cl~~dp~~RPt~~ 266 (473)
++.++|..||..||++||++.
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~ 242 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVV 242 (316)
T ss_pred HHHHHHHHHccCCHHHcCCCh
Confidence 999999999999999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=337.34 Aligned_cols=267 Identities=19% Similarity=0.290 Sum_probs=201.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++++.||+|+||+||+|.+..+++.||||++.+. ....+..|+.++..++|.+ |..+.....+....++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~-iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW-VVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCC-cceEEEEEecCCeEEEE
Confidence 5799999999999999999999999999999986442 2235678999999998554 55555566677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||||+ .++.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~---~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 80 MEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCCEEEeeccCcccccccc
Confidence 9999 8899999874 45799999999999999999999999999999999999994 67899999999998654321
Q ss_pred Ccc-------cc---------------------ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 011988 160 THQ-------HI---------------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 211 (473)
Q Consensus 160 ~~~-------~~---------------------p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~P 211 (473)
... .. ........+||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 100 00 00001245799999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCC---CCCCHHHHHHHHHHHHHHhCCCCCCccc
Q 011988 212 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD---DKPDYAYLKRLFRDLFIREGFQFDYVFD 288 (473)
Q Consensus 212 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~---~RPt~~~l~~~L~~l~~~~~~~~~~~~d 288 (473)
|.+.. ....+.++.........+. ...+++++.++|..++. +|+ .||++++|+ ++ ++-...+
T Consensus 236 f~~~~---~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~---~h-------p~f~~~~ 300 (363)
T cd05628 236 FCSET---PQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK---TN-------PFFEGVD 300 (363)
T ss_pred CCCCC---HHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh---CC-------CCCCCCC
Confidence 98743 3344444433211111111 12357899999998664 444 457866663 33 3444567
Q ss_pred ccccc
Q 011988 289 WTILK 293 (473)
Q Consensus 289 w~~~~ 293 (473)
|....
T Consensus 301 ~~~~~ 305 (363)
T cd05628 301 WEHIR 305 (363)
T ss_pred HHHHH
Confidence 87654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=351.11 Aligned_cols=252 Identities=22% Similarity=0.252 Sum_probs=200.7
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC----
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG---- 74 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~---- 74 (473)
...++|.+.+.||+|+||.||+|.+..+++.||||++.... ...+..|+.++..+.|.+++.....+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 45689999999999999999999999999999999854432 234667888888888766665544332211
Q ss_pred ---CeEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEE
Q 011988 75 ---DYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 147 (473)
Q Consensus 75 ---~~~~lv~e~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~ 147 (473)
...++||||+ +++|.+++... ...+++..+..|+.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~---~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC---SNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe---CCCCEEEE
Confidence 1467999999 88999998643 34689999999999999999999999999999999999995 67899999
Q ss_pred ecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 011988 148 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 227 (473)
Q Consensus 148 DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i 227 (473)
|||+++.+....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ....+..+
T Consensus 186 DFGls~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~~~~~~~ 257 (496)
T PTZ00283 186 DFGFSKMYAATVSDD-----VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---MEEVMHKT 257 (496)
T ss_pred ecccCeecccccccc-----ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHH
Confidence 999998765432111 1235679999999999999999999999999999999999999997643 23333333
Q ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 228 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 228 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..... ..+...+++++.+++..||+.||++||++.++++
T Consensus 258 ~~~~~----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 258 LAGRY----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred hcCCC----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 32222 1234578899999999999999999999998864
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=336.71 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=216.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc------hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH------PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~------~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
.+...|++.+.||.|.||.||+|+.+.+|+.+|+|++.+... ..+.+|+.+|+.|.+|++|..+..........
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 356789999999999999999999999999999999655443 47899999999999888888888888888899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC-CCcEEEEecCCcccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKRY 155 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~-~~~vkL~DFGla~~~ 155 (473)
++|||+| |+.|.+.+... .+++..+..++.||+.++.|||+.||+||||||+|||+...+. .+.+|++|||+|..+
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999 89999998755 3999999999999999999999999999999999999975443 458999999999987
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
.... .....+||+.|+|||++.+..|+..+||||+||++|.|++|..||.+... .....++...... .
T Consensus 190 ~~~~--------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~---~~~~~~i~~~~~~-f 257 (382)
T KOG0032|consen 190 KPGE--------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE---FEIFLAILRGDFD-F 257 (382)
T ss_pred cCCc--------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh---hHHHHHHHcCCCC-C
Confidence 6621 12467999999999999999999999999999999999999999988543 3334455554442 2
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
....+..++..+.++|..|+..||..|+++.++++
T Consensus 258 ~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 258 TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 22334677899999999999999999999888754
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.22 Aligned_cols=231 Identities=20% Similarity=0.293 Sum_probs=187.3
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||++.+..+|+.||+|++... ....+..|+.+++.+.|++ |..+..++...+..++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF-LTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCC-CcceeeEEecCCEEEEEEeCCCC
Confidence 4799999999999999999999999985432 2234667999999998655 445555566778899999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~~~~----- 150 (323)
T cd05595 80 GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc---CCCCEEecccHHhccccCCCC-----
Confidence 899888864 45799999999999999999999999999999999999994 778999999999875432221
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcH
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 245 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 245 (473)
......||..|+|||++.+..++.++|||||||+||||++|+.||..... ...+..+..... .+...+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~~~~~~~-----~~p~~~~~ 220 (323)
T cd05595 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEI-----RFPRTLSP 220 (323)
T ss_pred --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCC-----CCCCCCCH
Confidence 11345799999999999999999999999999999999999999976432 233333322222 12356789
Q ss_pred HHHHHHHHHhcCCCCCCC
Q 011988 246 EFASYFHYCRSLRFDDKP 263 (473)
Q Consensus 246 ~l~~li~~cl~~dp~~RP 263 (473)
++.++|..||..||++||
T Consensus 221 ~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred HHHHHHHHHccCCHHHhC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=333.84 Aligned_cols=241 Identities=22% Similarity=0.308 Sum_probs=196.4
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCC-cEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
..++|.+.+.||+|+||.||+|.+..++ ..||||++.+ .....+..|+.+++.+.|++++ .+..+.......
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv-~~~~~~~~~~~~ 106 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV-NLYGSFKDESYL 106 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCc-ceEEEEEeCCEE
Confidence 3467999999999999999999876654 6899998532 2234577899999999865555 555566777889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 107 ~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEecCCCCeecC
Confidence 9999999 8899999874 45699999999999999999999999999999999999994 78899999999998654
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
... ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+.....
T Consensus 183 ~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~i~~~~~---- 245 (340)
T PTZ00426 183 TRT----------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIYQKILEGII---- 245 (340)
T ss_pred CCc----------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HHHHHHHHhcCCC----
Confidence 321 24579999999999999889999999999999999999999998643 2333444433322
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYL 268 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l 268 (473)
.+...+++++.++|.+||+.||++|+ ++++|
T Consensus 246 -~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 281 (340)
T PTZ00426 246 -YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNV 281 (340)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHH
Confidence 12345788999999999999999996 65554
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=332.48 Aligned_cols=233 Identities=21% Similarity=0.251 Sum_probs=192.1
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|++..+++.||||++.+. ....+..|.+++..+.+|++|..+..+.......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999985432 12346678888888877888888888888888999999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~----- 151 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGV----- 151 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCc-----
Confidence 899988874 4579999999999999999999999999999999999999 4778999999999976433221
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcH
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 245 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 245 (473)
......||..|+|||++.+..++.++|||||||++|||++|+.||.... ....+..+...... +...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i~~~~~~-----~p~~~~~ 221 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESILHDDVL-----YPVWLSK 221 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCC-----CCCCCCH
Confidence 1234579999999999999999999999999999999999999998743 33344444333221 1234689
Q ss_pred HHHHHHHHHhcCCCCCCCC
Q 011988 246 EFASYFHYCRSLRFDDKPD 264 (473)
Q Consensus 246 ~l~~li~~cl~~dp~~RPt 264 (473)
++.++|..||..||++||+
T Consensus 222 ~~~~ll~~~L~~dp~~R~~ 240 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLG 240 (321)
T ss_pred HHHHHHHHHhccCHHHcCC
Confidence 9999999999999999994
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.42 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=198.9
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++++.||.|+||.||+|++..+++.||||++.+. ....+..|+.+++.++| ++|..+..++..+...++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN-PWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCeEEEE
Confidence 5799999999999999999999999999999986432 12346789999999985 5555556666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 80 ~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 80 MEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred ECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccc
Confidence 9999 8899999874 4569999999999999999999999999999999999999 478899999999997653321
Q ss_pred Ccccc-----------------cc--------------ccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcC
Q 011988 160 THQHI-----------------PY--------------RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 208 (473)
Q Consensus 160 ~~~~~-----------------p~--------------~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG 208 (473)
..... +. ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 10000 00 001134799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 209 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 209 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
..||.+... .+.+..+........... ...+++++.++|..|+. +|.+|++...+.++|.+.|
T Consensus 236 ~~Pf~~~~~---~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 236 YPPFCSDNP---QETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred CCCCCCCCH---HHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 999987432 333333332111111110 12468899999999996 9999998444444455443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=334.05 Aligned_cols=259 Identities=19% Similarity=0.305 Sum_probs=201.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEcC-----CCcEEEEEEcccCC----chhHHHHHHHHHHhcCC-CCCCeeEEeeEeCC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGG-TGIPNLRWFGVEGD 75 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~-~~i~~~~~~~~~~~ 75 (473)
.++|++.+.||.|+||.||+|.+.. +++.||+|++.... ...+..|+.++..+.+| +++..+..+...+.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 5689999999999999999997543 45789999864332 23467899999999544 45555555555667
Q ss_pred eEEEEEecC-CCCHHHHHHHcC----------------------------------------------------------
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCS---------------------------------------------------------- 96 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~---------------------------------------------------------- 96 (473)
..+++|||+ +++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 788999999 889999886321
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCccc
Q 011988 97 --RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 174 (473)
Q Consensus 97 --~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~G 174 (473)
..+++..+..++.||+.||+|||++||+||||||+|||++ .++.++|+|||+++.+...... .......+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~~~ 237 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDY-----VRKGDARL 237 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcch-----hhccCCCC
Confidence 2578999999999999999999999999999999999995 6788999999999876432211 11233456
Q ss_pred CccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHH
Q 011988 175 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHY 253 (473)
Q Consensus 175 t~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~ 253 (473)
+..|+|||++.+..++.++|||||||+||||++ |..||.+...... ....+... ... .....+++++.+++..
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~~~~-~~~---~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRLKEG-TRM---RAPEYATPEIYSIMLD 311 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHHhcc-CCC---CCCccCCHHHHHHHHH
Confidence 778999999999999999999999999999997 9999987433221 11111111 111 1124567899999999
Q ss_pred HhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 254 CRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 254 cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
||+.+|++||++.+|.+.|++++..
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=331.38 Aligned_cols=236 Identities=19% Similarity=0.241 Sum_probs=193.9
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|++..+++.||||++.+. ....+..|..++..+.+|++|..+..+....+..++||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999985432 22345678888888777788888877888888999999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~---~~~~~kL~DfG~~~~~~~~~~----- 151 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGIFNGK----- 151 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeeCCCCeecCcCCC-----
Confidence 899988874 45799999999999999999999999999999999999994 778999999999875432211
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcH
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 245 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 245 (473)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+..+...... +...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~~~~~~-----~~~~~~~ 221 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEVV-----YPTWLSQ 221 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCCC-----CCCCCCH
Confidence 1234579999999999999899999999999999999999999998743 33344444332221 2345789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHH
Q 011988 246 EFASYFHYCRSLRFDDKPDYAY 267 (473)
Q Consensus 246 ~l~~li~~cl~~dp~~RPt~~~ 267 (473)
++.++|..||..||++||++.+
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCC
Confidence 9999999999999999999744
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=333.71 Aligned_cols=263 Identities=20% Similarity=0.271 Sum_probs=204.3
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|.+..+++.||||++.+.. ...+..|..++..+.++++|..+..+.......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999965432 2346789999999988888888888888889999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|.+++.. .+.+++..++.|+.||+.||+|||++||+||||||+|||++ ..+.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~----- 151 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD---ADGHIKLTDYGMCKEGLGPGD----- 151 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe---CCCCEEEeccccceeccCCCC-----
Confidence 899888863 45799999999999999999999999999999999999994 678899999999975332211
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC----CHHHHHHHHhhccccccHHHHhc
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~----~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
......||..|+|||++.+..++.++|||||||+||||++|..||...... ........+..... .+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~p~ 224 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-----RIPR 224 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-----CCCC
Confidence 113467999999999999999999999999999999999999999653221 11222222222211 1334
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
.++.++.+++..||..||++|+++.... .++++. ..++-...+|+.....
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~-~~~~i~---~h~~f~~~~~~~~~~~ 274 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQT-GFSDIK---SHTFFRSIDWDLLEKK 274 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCC-CHHHHH---cCCCCCCCCHHHHHhC
Confidence 5788999999999999999999854211 111211 2244556778876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=333.33 Aligned_cols=237 Identities=20% Similarity=0.283 Sum_probs=191.1
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||++.+..+++.||||++.+. ....+..|+.+++.+.|+ +|..+..+....+..++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP-FLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCC-CCcceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999985432 223567899999999865 4555556667788899999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+ ..+.+||+|||+++.......
T Consensus 80 g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kL~DfG~~~~~~~~~~----- 150 (328)
T cd05593 80 GELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD---KDGHIKITDFGLCKEGITDAA----- 150 (328)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC---CCCcEEEecCcCCccCCCccc-----
Confidence 899888864 45799999999999999999999999999999999999994 778999999999975432211
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcH
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 245 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 245 (473)
......||+.|+|||++.+..++.++|||||||+||||++|..||.+... ......+..... .+...+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~-----~~p~~~~~ 220 (328)
T cd05593 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEDI-----KFPRTLSA 220 (328)
T ss_pred --ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHHhccCCc-----cCCCCCCH
Confidence 11345799999999999998999999999999999999999999976432 222333222211 23456789
Q ss_pred HHHHHHHHHhcCCCCCCC-----CHHHHH
Q 011988 246 EFASYFHYCRSLRFDDKP-----DYAYLK 269 (473)
Q Consensus 246 ~l~~li~~cl~~dp~~RP-----t~~~l~ 269 (473)
++.++|..||..||++|+ ++.+|.
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il 249 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIM 249 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHh
Confidence 999999999999999997 666653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=321.43 Aligned_cols=253 Identities=19% Similarity=0.228 Sum_probs=201.7
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCC------e
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD------Y 76 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~------~ 76 (473)
.|..+++||+|+||+||+|+++.+|+.||+|.+.-. ......+|+.+|+.|+|.++|..+..+....+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 477788899999999999999999999999983322 22346899999999999886666666655544 7
Q ss_pred EEEEEecCCCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 77 NVLVIDLLGPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~~---~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
.++|+||+..+|.++++... ..++...++.++.||+.||+|||+++|+||||||+||||+ +.+.+||+|||+|+
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~---~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS---SSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC---CCCcEeeeccchHH
Confidence 88999999999999999776 4588899999999999999999999999999999999995 78999999999999
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
.+.-+ .+.-...++|..|.|||+++|. .|+...||||+|||+.||++++.-|.+....+....+.++....-
T Consensus 169 a~~ip-------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 169 AFSIP-------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred HhcCC-------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 65432 2233566899999999999998 599999999999999999999999998765333333333221110
Q ss_pred ----------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 233 ----------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 233 ----------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
........+...+...+++..||+++|.+|.++...++
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 00111111223358899999999999999999877643
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=330.45 Aligned_cols=254 Identities=21% Similarity=0.266 Sum_probs=196.2
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHH-HHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAK-LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~-il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
+.||+|+||.||+|++..+++.||+|++.+.. ...+..|.. +++.+.| ++|..+..++...+..+++|||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH-PFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCC-CCCCceeEEEEcCCeEEEEEeCCC
Confidence 47999999999999999999999999854321 122344444 3455665 55555666667788899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 85 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 85 g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 80 ~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~---~~~~~kl~DfG~a~~~~~~~~---- 151 (325)
T cd05602 80 GGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNG---- 151 (325)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEEccCCCCcccccCCC----
Confidence 7799998874 45688999999999999999999999999999999999994 678999999999975433221
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCc
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 244 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 244 (473)
......||..|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+...... +...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~-----~~~~~~ 220 (325)
T cd05602 152 ---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILNKPLQ-----LKPNIT 220 (325)
T ss_pred ---CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCcC-----CCCCCC
Confidence 1234679999999999999999999999999999999999999997643 33334444333221 234678
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHH-HHHHHHHHHHhCCCCCCcccccccc
Q 011988 245 TEFASYFHYCRSLRFDDKPDYAYL-KRLFRDLFIREGFQFDYVFDWTILK 293 (473)
Q Consensus 245 ~~l~~li~~cl~~dp~~RPt~~~l-~~~L~~l~~~~~~~~~~~~dw~~~~ 293 (473)
.++.++|..||..||.+||++.+. .+++++ .+...++|+...
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~-------~~~~~~~~~~~~ 263 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDFMEIKNH-------IFFSPINWDDLI 263 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCHHHHhcC-------cccCCCCHHHHH
Confidence 999999999999999999997643 233322 334567887664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=340.15 Aligned_cols=249 Identities=21% Similarity=0.306 Sum_probs=199.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEE-cccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~-~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
+..|+++++||+||.+.||++.... ...||+|. .... ....+..|+.+|.+|+++..|..++.|...+.+.|||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 4569999999999999999998643 44555554 2222 2344889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 81 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 81 ~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+-..+|..+|+.....+..-.+..+..||+.|+.++|..||||.||||.|||| -.|.+||+|||+|..+..+.+
T Consensus 439 mE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 439 MECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCcccc
Confidence 9999999999999766666656889999999999999999999999999999999 478999999999998877655
Q ss_pred ccccccccCCCcccCccccccccccCCC-----------CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIE-----------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 229 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-----------~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 229 (473)
... ...-+||+.||+||.+.... .++++||||||||||+|+.|+.||..... ...++..|..
T Consensus 515 sI~-----kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~aI~~ 587 (677)
T KOG0596|consen 515 SIV-----KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHAITD 587 (677)
T ss_pred cee-----eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHhhcC
Confidence 331 24568999999999986432 46899999999999999999999976432 3344444444
Q ss_pred ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 230 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 230 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
.......+.+.. +.++.++++.||.+||++||+..+|
T Consensus 588 P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eL 624 (677)
T KOG0596|consen 588 PNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPEL 624 (677)
T ss_pred CCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHH
Confidence 322222222222 2349999999999999999997766
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.71 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=193.1
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|.++++||.|+||.||+|.+..+++.||||++.+. ....+..|+++++.+.|++ |..+..++....+.++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW-VVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCC-cceEEEEEEcCCeeEEE
Confidence 5799999999999999999999999999999985432 2245678999999998554 55556666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~---~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 80 MEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEEeeccccccccccc
Confidence 9999 8899999874 45799999999999999999999999999999999999994 77899999999997543211
Q ss_pred Cccc-------ccc---------------------------------ccCCCcccCccccccccccCCCCCchhhHHHHH
Q 011988 160 THQH-------IPY---------------------------------RENKNLTGTARYASMNTHLGIEQSRRDDLESLG 199 (473)
Q Consensus 160 ~~~~-------~p~---------------------------------~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlG 199 (473)
.... ... ......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0000 000 000135799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCC---CHHHH
Q 011988 200 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYL 268 (473)
Q Consensus 200 viL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP---t~~~l 268 (473)
|+||||++|..||.+... ...+..+.........+ -...++.++.++|.+||. +|.+|+ ++.++
T Consensus 236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 236 AIMFECLIGWPPFCSENS---HETYRKIINWRETLYFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhhcCCCCCCCCCH---HHHHHHHHccCCccCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 999999999999976432 23333332211100000 012467899999999997 777764 75555
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=330.73 Aligned_cols=260 Identities=19% Similarity=0.268 Sum_probs=200.9
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|.+..+++.||+|++.+.. ...+..|+.++..+.+|++|..+..+.......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999865421 2236678888888866777777777788888999999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|..++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~---~~~~~kL~DfG~~~~~~~~~~----- 151 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCCEEEeeCCccccccCCCC-----
Confidence 899888764 45799999999999999999999999999999999999994 778999999999975432211
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC------CHHHHHHHHhhccccccHHHH
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~------~~~~~~~~i~~~~~~~~~~~l 239 (473)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... ........+..... .+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----~~ 224 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----RI 224 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-----CC
Confidence 123467999999999999999999999999999999999999999642211 11112222222221 13
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHH---HHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAY---LKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~---l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
...++.++.++|..||..||++||++.. +.++++ .++-..++|......
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~-------hp~f~~~~~~~~~~~ 276 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG-------HPFFRNVDWDLMEQK 276 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc-------CCCCCCCCHHHHHcC
Confidence 4567899999999999999999998421 122232 244455678766443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=323.69 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=201.7
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCC-----cEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
.++|++.+.||+|+||.||+|.+...+ ..||+|...... ...+.+|+.++..++|++++. +..+......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~-~~~~~~~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC-LLGVCTKEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccce-EEEEEcCCCc
Confidence 467999999999999999999976554 679999864433 234778999999998655554 4455566677
Q ss_pred EEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC
Q 011988 77 NVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 140 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 140 (473)
.+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+|+||||+|||++ +
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~---~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---E 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc---C
Confidence 89999999 789999987532 4588899999999999999999999999999999999994 6
Q ss_pred CCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 011988 141 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 219 (473)
Q Consensus 141 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~ 219 (473)
++.+||+|||+++....... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-- 232 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-- 232 (283)
T ss_pred CCcEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 78899999999976543221 111234467889999999998899999999999999999998 9999987543
Q ss_pred HHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 220 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 220 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
.+.+..+...... .....+|+++.+|+..||+.||++||++.+|.+.|+.
T Consensus 233 -~~~~~~i~~~~~~----~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 233 -QEVIEMIRSRQLL----PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHHHcCCcC----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2333333322221 2345789999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=336.76 Aligned_cols=252 Identities=22% Similarity=0.270 Sum_probs=193.7
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|+++++||+|+||.||+|++..+++.||||++.+. ....+..|+.+++.+.|++++ .+......++..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv-~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVV-KLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcc-eEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999985432 234577899999999865555 455556677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+|..+....
T Consensus 80 ~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 80 MDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC---CCCCEEEEeCCCCccccccc
Confidence 9999 8899999874 45689999999999999999999999999999999999994 77899999999986442110
Q ss_pred Cccc------------------------------------cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHH
Q 011988 160 THQH------------------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 203 (473)
Q Consensus 160 ~~~~------------------------------------~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ 203 (473)
.... .........+||+.|+|||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0000 0000112457999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCC---CHHHH
Q 011988 204 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYL 268 (473)
Q Consensus 204 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP---t~~~l 268 (473)
||++|+.||.+... ......+......... .....+++++.++|..|+ .+|.+|+ ++.++
T Consensus 236 ell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 236 EMLVGQPPFLADTP---AETQLKVINWETTLHI-PSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred ehhhCCCCCCCCCH---HHHHHHHhccCccccC-CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 99999999987543 2222222211111100 012357889999999977 5999999 65555
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=336.18 Aligned_cols=245 Identities=20% Similarity=0.258 Sum_probs=190.6
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.++|+++++||.|+||.||+|++..+++.||||++.... ...+.+|+++++.++|.+++ .+..+.......+++|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVV-KCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcc-eeeeEeccCCeEEEEE
Confidence 357899999999999999999999999999999964432 24578899999999865555 4555566777889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|.+. ..+.+..+..|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.+.....
T Consensus 152 e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 152 EFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN---SAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred ecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEcccccceecccccc
Confidence 999 6777543 2356788899999999999999999999999999999994 778999999999987643221
Q ss_pred ccccccccCCCcccCccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
......||..|+|||++.. ...+.++|||||||+||||++|+.||......+.......+.....
T Consensus 224 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 293 (353)
T PLN00034 224 -------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP--- 293 (353)
T ss_pred -------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC---
Confidence 1234579999999998743 2346799999999999999999999975433332222222221111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
......++.++.+||..||..||++||++.+|++
T Consensus 294 -~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 -PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123467899999999999999999999887743
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=330.72 Aligned_cols=263 Identities=22% Similarity=0.264 Sum_probs=201.1
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++.+.||+|+||.||++++..+++.||||++.+. ....+..|..+++.++ +++|..+..++..+...++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEEEE
Confidence 5799999999999999999999999999999986431 2334678888888886 55566666677788899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+||||+ .++.+||+|||++..+....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD---KNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC---CCCCEEEEECCceeecCCCC
Confidence 9998 8899999986667799999999999999999999999999999999999994 77899999999997654432
Q ss_pred CccccccccCCCcccCccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.. ..+.+..+.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~ 227 (331)
T cd05597 157 TV------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHKEHF 227 (331)
T ss_pred Cc------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCcc
Confidence 21 1123469999999999873 347889999999999999999999997643 233344443322211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 292 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 292 (473)
........+++++.++|..||..+++. |+++.++ +++.| ...++|...
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~---l~hp~-------~~~~~~~~~ 277 (331)
T cd05597 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDF---KDHPF-------FEGIDWDNI 277 (331)
T ss_pred cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHH---hcCCC-------CCCCCHHHH
Confidence 222223457899999999998753332 5665444 44432 334567664
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=333.84 Aligned_cols=258 Identities=19% Similarity=0.269 Sum_probs=201.3
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|.+..+++.||||++.+.. ...+..|..++..+.+|++|..+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999865421 2346789999999977777877877888888999999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||+++.......
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~~~~~~~----- 151 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD---AEGHIKLTDYGMCKEGIRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEECcCccccccccCCC-----
Confidence 899888863 45799999999999999999999999999999999999994 678999999999975322111
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC------HHHHHHHHhhccccccHHHH
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~------~~~~~~~i~~~~~~~~~~~l 239 (473)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... .......+..... .+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 224 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-----RI 224 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-----CC
Confidence 1234679999999999999999999999999999999999999996432111 1112222222221 13
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHH---HHHHHHHHHHHhCCCCCCcccccccc
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAY---LKRLFRDLFIREGFQFDYVFDWTILK 293 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~---l~~~L~~l~~~~~~~~~~~~dw~~~~ 293 (473)
...++.++.++|..||..||.+|+++.. +.+++++. +-...+|....
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp-------~~~~~~~~~~~ 274 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHP-------FFRNIDWDLLE 274 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCC-------CCCCCCHHHHH
Confidence 3567899999999999999999998432 23334332 23446777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=334.49 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=196.5
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeE-----e
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGV-----E 73 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~-----~ 73 (473)
.+.++|.+++.||.|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|.+++..+..+.. .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 46789999999999999999999999999999999864432 2346689999999998777666544432 2
Q ss_pred CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 74 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 74 ~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
....+++|++++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~---~~~~~kl~Dfg~~~ 166 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLAR 166 (343)
T ss_pred cCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC---CCCCEEEcCCccce
Confidence 24568999999999999886 45699999999999999999999999999999999999994 77899999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc-
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 231 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 231 (473)
...... ....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......
T Consensus 167 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 167 QADDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236 (343)
T ss_pred ecCCCc----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 654321 34578999999999987 468999999999999999999999997643221111111110000
Q ss_pred ----------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 ----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 ----------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.......+..++++.+.+||.+||..||++||++.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell 296 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00111222345677889999999999999999987774
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=318.27 Aligned_cols=254 Identities=20% Similarity=0.352 Sum_probs=204.6
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
..+|.+.++||.|+||.||+|.+..+++.||+|+..... ...+..|+++++.++|.+++..+ .+.......+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL-GVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheE-EEEcCCCCcEEEEEe
Confidence 456999999999999999999999999999999865443 34578899999999876555544 455566778999999
Q ss_pred C-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ +++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCcEEeCCCccccccccceee
Confidence 8 789999987543 4589999999999999999999999999999999999994 7789999999999876543211
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... ......+... .. ....
T Consensus 161 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~-~~---~~~~ 227 (263)
T cd05052 161 ------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKG-YR---MERP 227 (263)
T ss_pred ------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCC-CC---CCCC
Confidence 1122344678999999999999999999999999999998 9999976432 2222222221 11 1234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
..+|.++.+++.+||..||++||++.+|.+.|+.++
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 568899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=321.60 Aligned_cols=246 Identities=19% Similarity=0.228 Sum_probs=191.1
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCC
Q 011988 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 87 (473)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~s 87 (473)
||+|+||+||+|.+..+++.||||++.+.. ...+..|+.+++.+.| +++..+..++......+++|||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCC-CcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 699999999999999999999999854322 1345679999999975 55555666666777889999999 889
Q ss_pred HHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 88 LEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 88 L~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||++..+.....
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~~---- 152 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS---- 152 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCccceecCCCCc----
Confidence 9888743 234699999999999999999999999999999999999994 678899999999976644322
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHH-HHHHHHhhccccccHHHHhcCC
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
......||..|+|||++.+..++.++|||||||++|||++|+.||......... .....+.... ..+...+
T Consensus 153 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 224 (280)
T cd05608 153 ---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS-----VTYPDKF 224 (280)
T ss_pred ---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC-----CCCcccC
Confidence 123457999999999999999999999999999999999999999764332211 1112211111 1223467
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHH
Q 011988 244 PTEFASYFHYCRSLRFDDKPDYAY--LKRLFRDLF 276 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RPt~~~--l~~~L~~l~ 276 (473)
+.++.+++..||+.||++||++++ +.+++++.|
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~ 259 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL 259 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence 899999999999999999995432 333344444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=327.48 Aligned_cols=234 Identities=22% Similarity=0.285 Sum_probs=186.7
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHH-HHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAK-LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~-il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
+.||+|+||+||+|.+..+++.||||++.+.. ...+..|.. +++.+.|+ +|..+..+....+..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp-~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP-FLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCC-CCCCeeEEEEeCCEEEEEEcCCC
Confidence 47999999999999999999999999854321 223444544 34566654 4555555666778899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 85 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 85 g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.......
T Consensus 80 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~---~~~~~kl~Dfg~~~~~~~~~~---- 151 (323)
T cd05575 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGIEHSK---- 151 (323)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeccCCCcccccCCC----
Confidence 7899988874 45799999999999999999999999999999999999994 778999999999975432211
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCc
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 244 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 244 (473)
......||..|+|||++.+..++.++|||||||+||||++|..||.... ..+.+..+...... +...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~-----~~~~~~ 220 (323)
T cd05575 152 ---TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEMYDNILNKPLR-----LKPNIS 220 (323)
T ss_pred ---ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCCC-----CCCCCC
Confidence 1234579999999999999999999999999999999999999997643 33444444433221 234678
Q ss_pred HHHHHHHHHHhcCCCCCCCCHH
Q 011988 245 TEFASYFHYCRSLRFDDKPDYA 266 (473)
Q Consensus 245 ~~l~~li~~cl~~dp~~RPt~~ 266 (473)
.++.++|..||+.||.+||++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCC
Confidence 9999999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=334.20 Aligned_cols=247 Identities=21% Similarity=0.267 Sum_probs=194.0
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeE-----eC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGV-----EG 74 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~-----~~ 74 (473)
+.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.++|++++..+..+.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 568999999999999999999999999999999985432 23456789999999998777766655432 22
Q ss_pred CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 75 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
...++||||++++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC---CCCcEEEEeCCCccc
Confidence 4579999999999988875 3588999999999999999999999999999999999994 678999999999986
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
...... .....||..|+|||++.+..++.++|||||||+||||++|+.||.+.... ..+.++.......
T Consensus 176 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~ 244 (364)
T cd07875 176 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTP 244 (364)
T ss_pred cCCCCc--------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCC
Confidence 543211 13457899999999999999999999999999999999999999775432 2222221100000
Q ss_pred -------------------------cHHHH------------hcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 235 -------------------------SIEAL------------CRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 235 -------------------------~~~~l------------~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
....+ ....+.++.++|.+||..||.+|||+.++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~ 315 (364)
T cd07875 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315 (364)
T ss_pred CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH
Confidence 00000 01124578999999999999999998776
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=336.69 Aligned_cols=255 Identities=15% Similarity=0.183 Sum_probs=199.6
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEc--CCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNI--QTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.+..+|.++++||.|+||.||+|... .++..||||..... ....+|+++++.|+|++++..+. ++......+++|
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~-~~~~~~~~~lv~ 165 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRAIINLIH-AYRWKSTVCMVM 165 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcCCCCccceee-eEeeCCEEEEEe
Confidence 34567999999999999999999754 35678999986543 34578999999999766665554 455667889999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
++++++|.+++. ....+++.+++.|+.||+.||.|||++|||||||||+|||++ ..+.+||+|||+++.+......
T Consensus 166 e~~~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~---~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 166 PKYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hhcCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEccCccccccCccccc
Confidence 999999999985 456799999999999999999999999999999999999994 7789999999999866543221
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc--------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------- 233 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------- 233 (473)
.......||..|+|||++.+..++.++|||||||+||||++|+.||.+.........+..+......
T Consensus 242 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 242 -----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred -----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 1123567999999999999999999999999999999999999999876544333333332211000
Q ss_pred -------------------ccHHHH--hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 234 -------------------TSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 234 -------------------~~~~~l--~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
...+.+ ...++.++.++|.+||..||++||++.+++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000 1245678999999999999999999888743
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=322.29 Aligned_cols=261 Identities=19% Similarity=0.224 Sum_probs=202.2
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.|++.++||+|+||.||++.+..+++.||||++.... ...+..|+.+++.++|++++ .+...+..++..+++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV-SLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEe-eeeeeecCCCeEEEEE
Confidence 4899999999999999999999999999999854322 23456799999999865544 4555556677899999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 82 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 82 e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ +.+.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---DYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC---CCCCEEEeeCCCceecCCCC
Confidence 999 78999887643 34699999999999999999999999999999999999994 67899999999998654322
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. .....|+..|+|||++.+..++.++|||||||++|||++|..||.+.........+...... .....
T Consensus 157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05605 157 T--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----DQEEY 224 (285)
T ss_pred c--------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh----ccccc
Confidence 1 12347899999999999989999999999999999999999999875432222222211111 11122
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCccccccccc
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKY 294 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 294 (473)
...++..+.+||..||..||++|| ++++| +++ .+-..++|...+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l---~~~-------~~~~~~~~~~~~~ 274 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEV---KAH-------PFFRTANFKRLEA 274 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHH---hcC-------cCccCCCHHHHhh
Confidence 345789999999999999999999 55555 332 2233466776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=319.59 Aligned_cols=260 Identities=20% Similarity=0.253 Sum_probs=201.8
Q ss_pred CCCccCCceEEEeeEeecCceEEEEEEEcCCCc----EEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeE
Q 011988 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV 72 (473)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~ 72 (473)
|+....++|++.++||.|+||.||+|.+..+++ .||||+..... ...+..|+.+++.+.|++++..+ .++.
T Consensus 1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~-~~~~ 79 (279)
T cd05109 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLL-GICL 79 (279)
T ss_pred CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEE-EEEc
Confidence 667778899999999999999999999877766 48999854332 23467888889988865555444 4444
Q ss_pred eCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCC
Q 011988 73 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 151 (473)
Q Consensus 73 ~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 151 (473)
. ...+++|+++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ +.+.+||+|||+
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG~ 155 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFGL 155 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCCc
Confidence 3 3456788877 8899999876566799999999999999999999999999999999999994 677899999999
Q ss_pred cccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhc
Q 011988 152 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK 230 (473)
Q Consensus 152 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 230 (473)
++.+........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....+...
T Consensus 156 ~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~ 227 (279)
T cd05109 156 ARLLDIDETEYH-----ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEKG 227 (279)
T ss_pred eeecccccceee-----cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCC
Confidence 987654322111 112245678999999999899999999999999999998 999997644321 11212211
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 231 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 231 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
. ... ....++.++.+++..||..||++||++.+|.+.|+++..
T Consensus 228 ~-~~~---~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 228 E-RLP---QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred C-cCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1 111 124578999999999999999999999999988877753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=332.63 Aligned_cols=252 Identities=19% Similarity=0.208 Sum_probs=194.1
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEe-----
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVE----- 73 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~----- 73 (473)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|++++..+..+...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35689999999999999999999999999999999854322 23467899999999987777766655432
Q ss_pred CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 74 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 74 ~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
....+++|||+.++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~---~~~~~kl~Dfg~~~ 167 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLAR 167 (355)
T ss_pred cceeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC---CCCCEEEeeCcccc
Confidence 23579999999989888775 3589999999999999999999999999999999999994 67899999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc--
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-- 231 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~-- 231 (473)
....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.................
T Consensus 168 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (355)
T cd07874 168 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_pred cCCCccc--------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 6543211 134578999999999999999999999999999999999999997643211111110000000
Q ss_pred -----ccc---------------cHH------------HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 -----VST---------------SIE------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 -----~~~---------------~~~------------~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
... ... ......+.++.++|.+||..||++||++.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell 309 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh
Confidence 000 000 00112356789999999999999999988774
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=337.00 Aligned_cols=257 Identities=22% Similarity=0.288 Sum_probs=203.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCC-----CcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
.++|+++++||+|+||.||+|.+... +..||||++.... ...+.+|+.+++.+..|++|..+..++.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 45688999999999999999987533 3479999865432 23578899999999856677777777777888
Q ss_pred EEEEEecC-CCCHHHHHHHcC-----------------------------------------------------------
Q 011988 77 NVLVIDLL-GPSLEDLFNFCS----------------------------------------------------------- 96 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~----------------------------------------------------------- 96 (473)
.+|||||+ +++|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999 889998876421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC
Q 011988 97 ------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 140 (473)
Q Consensus 97 ------------------------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 140 (473)
..+++..++.++.||+.||.|||+++|+||||||+|||++ .
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~---~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA---Q 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe---C
Confidence 2477888999999999999999999999999999999995 6
Q ss_pred CCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 011988 141 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 219 (473)
Q Consensus 141 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~ 219 (473)
++.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||+||||++ |..||.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNY-----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred CCEEEEEeCCcceeccccccc-----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 788999999999866433211 11233457788999999999899999999999999999997 999997654322
Q ss_pred HHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 220 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 220 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
..+..+.... .. .....+|.++.+++.+||+.||++||++.+|.+.|+.++
T Consensus 348 --~~~~~~~~~~-~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 --TFYNKIKSGY-RM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --HHHHHHhcCC-CC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1122222211 11 123467899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=336.15 Aligned_cols=247 Identities=21% Similarity=0.287 Sum_probs=196.7
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++.++||+|+||.||+|++..+++.||||++.+. ....+..|+.+++.++|++ |..+..+.......++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~-iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW-IVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCC-cceEEEEEecCCEEEE
Confidence 46799999999999999999999999999999986432 2234678999999988554 5555566677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc---CCCCEEEEeccceeeccCC
Confidence 99999 8899999873 4689999999999999999999999999999999999994 7889999999999865432
Q ss_pred CCccccccccCCCcccCccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~----~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||.+... ...+.++.......
T Consensus 196 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~ 266 (370)
T cd05596 196 GMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMDHKNSL 266 (370)
T ss_pred Ccc------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---HHHHHHHHcCCCcC
Confidence 210 11345799999999998754 378999999999999999999999987432 33444444322111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYL 268 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l 268 (473)
..+. ...++.++.++|..||..+|++ |+++++|
T Consensus 267 ~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~el 301 (370)
T cd05596 267 TFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEI 301 (370)
T ss_pred CCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence 1111 1246899999999999999987 9997766
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=323.55 Aligned_cols=267 Identities=22% Similarity=0.332 Sum_probs=216.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
+.|++++.||.|.-|+||+|+...++..+|+|++.+.. ....+.|.+||..++ |+.++.++...+..++.|++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccceeEEE
Confidence 46889999999999999999999999999999966543 345778999999998 77888888888999999999
Q ss_pred EecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 81 IDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
|||| ||+|..+++.. ++.|++..+..++.+|+.||+|||-.|||.|||||+|||| .++|+|.|+||.|+......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence 9999 99999998755 4469999999999999999999999999999999999999 58999999999998654210
Q ss_pred CCc-------------------------------cc-----------------cc-cccCCCcccCccccccccccCCCC
Q 011988 159 ATH-------------------------------QH-----------------IP-YRENKNLTGTARYASMNTHLGIEQ 189 (473)
Q Consensus 159 ~~~-------------------------------~~-----------------~p-~~~~~~~~Gt~~Y~APE~~~~~~~ 189 (473)
.+. .. .| -.....++||-.|+|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 00 00 012356899999999999999999
Q ss_pred CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC----H
Q 011988 190 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD----Y 265 (473)
Q Consensus 190 s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt----~ 265 (473)
+.++|+|+|||+||||+.|..||.|.+. .+.+.+|..+....+-. ..++..+++||+.+|.+||.+|.. +
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~---~~Tl~NIv~~~l~Fp~~---~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNN---KETLRNIVGQPLKFPEE---PEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCc---hhhHHHHhcCCCcCCCC---CcchhHHHHHHHHHhccChhhhhccccch
Confidence 9999999999999999999999998544 45555555544332211 245688999999999999999987 5
Q ss_pred HHHHHHHHHHHHHhCCCCCCcccccccc
Q 011988 266 AYLKRLFRDLFIREGFQFDYVFDWTILK 293 (473)
Q Consensus 266 ~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 293 (473)
.+|++ ..+..-++|....
T Consensus 387 ~eIK~----------HpFF~gVnWaLir 404 (459)
T KOG0610|consen 387 AEIKR----------HPFFEGVNWALIR 404 (459)
T ss_pred HHhhc----------CccccCCChhhee
Confidence 55543 2455678899654
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=328.32 Aligned_cols=249 Identities=22% Similarity=0.270 Sum_probs=196.2
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++.++||+|+||.||++++..+++.||+|++.+. ....+..|+.++..+. ++++..+..+.......++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEEE
Confidence 5799999999999999999999999999999985432 1223667888888876 45566666677788889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~---~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEeecchheecccCC
Confidence 9998 8899999986666799999999999999999999999999999999999994 77899999999997654322
Q ss_pred CccccccccCCCcccCccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
.. ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.... ..+.+..+.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~ 227 (332)
T cd05623 157 TV------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHKERF 227 (332)
T ss_pred cc------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC---HHHHHHHHhCCCccc
Confidence 21 1123579999999999873 457899999999999999999999997643 344455554433222
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYL 268 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l 268 (473)
..+.....+++++.++|.+|+..+++. |++++++
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~ 263 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDF 263 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHH
Confidence 222333567899999999999765444 5675555
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.72 Aligned_cols=254 Identities=21% Similarity=0.247 Sum_probs=193.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
..|++++.||+|+||+||+|++..+++.||||++.+.. ...+..|+.+++.++|+ +|..+..+..+....++|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~-~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNE-WVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCC-CeeeeEEEEecCCEEEEE
Confidence 36999999999999999999999999999999864422 23477899999999855 555555666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||||+ ..+.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~---~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 80 MDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID---LDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC---CCCCEEEeeCcCCccccccc
Confidence 9999 8899999874 45699999999999999999999999999999999999994 67899999999986542111
Q ss_pred Ccccc----------------------------------------ccccCCCcccCccccccccccCCCCCchhhHHHHH
Q 011988 160 THQHI----------------------------------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 199 (473)
Q Consensus 160 ~~~~~----------------------------------------p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlG 199 (473)
..... ........+||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00000 00011346799999999999998999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHh--cCCCCCCCCHHHHH
Q 011988 200 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR--SLRFDDKPDYAYLK 269 (473)
Q Consensus 200 viL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl--~~dp~~RPt~~~l~ 269 (473)
|+||||++|..||..... ......+.........+ ....+++++.++|.+|+ ..++..||++++|+
T Consensus 236 ~il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP---TETQLKVINWENTLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hHHHHHHhCCCCCcCCCH---HHHHHHHHccccccCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999999976443 22222222111101010 01246899999999955 45555699987774
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=335.20 Aligned_cols=257 Identities=19% Similarity=0.256 Sum_probs=197.2
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeC----CeEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----DYNV 78 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~----~~~~ 78 (473)
+|++.++||+|+||.||+|.+..+++.||||.+... ....+.+|+.+++.++|.+++..+..+.... ...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 488999999999999999999999999999985432 1245778999999999777666655443322 2679
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 79 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 79 lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
++|||++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 81 lv~e~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQSDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN---SNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccccCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC---CCCCEEeccccceeecccC
Confidence 999999999998886 345799999999999999999999999999999999999994 7789999999999865432
Q ss_pred CCccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-------
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------- 230 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~------- 230 (473)
... ......+|..|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+......
T Consensus 157 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 157 ESK------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccc------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 211 112346789999999998754 799999999999999999999999875433222222111100
Q ss_pred -------------c-ccccHH---HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 231 -------------K-VSTSIE---ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 231 -------------~-~~~~~~---~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
. ...... .+...+++++.+||..||..||++||++.++ |.+.|.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~---l~hp~~ 291 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA---LAHPYL 291 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHH---hcCHhh
Confidence 0 000111 1223457899999999999999999998776 555543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=326.63 Aligned_cols=235 Identities=23% Similarity=0.285 Sum_probs=191.1
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|++..+++.||||++... .......|..++..+.+|++|..+..+....+..++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999985432 23345678888877656777777777778888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCKENMLGDA----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEccCCcceECCCCCC-----
Confidence 899999874 34689999999999999999999999999999999999994 678999999999975432211
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcH
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 245 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 245 (473)
......||..|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+..... .+...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~-----~~~~~~~~ 221 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIRMDNP-----CYPRWLTR 221 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC-----CCCccCCH
Confidence 12345799999999999999999999999999999999999999977432 333333322211 12235678
Q ss_pred HHHHHHHHHhcCCCCCCCCHH
Q 011988 246 EFASYFHYCRSLRFDDKPDYA 266 (473)
Q Consensus 246 ~l~~li~~cl~~dp~~RPt~~ 266 (473)
++.++|.+||..||++||++.
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~ 242 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVK 242 (316)
T ss_pred HHHHHHHHHhccCHhhcCCCh
Confidence 999999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.40 Aligned_cols=242 Identities=21% Similarity=0.200 Sum_probs=194.5
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeE---eCCeEEEEEec
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGV---EGDYNVLVIDL 83 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~---~~~~~~lv~e~ 83 (473)
..||+|++|.||+|.+ +|+.||||++.... ...+.+|+.+++.++|++++..+..+.. .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999986 78999999854432 2446699999999997755555544332 13567999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+ +++|.+++.. .+.+++...+.++.|++.||.|||+ .+++||||||+|||++ +++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~---~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT---ENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC---CCCcEEEcccchHhhhcccc--
Confidence 9 7899999974 4578999999999999999999998 4999999999999994 67899999999998654322
Q ss_pred cccccccCCCcccCccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.. ..+.+..+........ +
T Consensus 178 --------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~~---~ 243 (283)
T PHA02988 178 --------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYDLIINKNNSLK---L 243 (283)
T ss_pred --------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhcCCCCC---C
Confidence 23468899999999976 678999999999999999999999998753 2333344332222211 2
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
...+|+++.+++.+||+.||++||++.+|++.|+.+.
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 2357899999999999999999999999999998764
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=331.73 Aligned_cols=237 Identities=20% Similarity=0.278 Sum_probs=189.9
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|.+..+++.||+|++.+. ....+..|+++++.+.|+ +|..+..+.......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp-~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCC-CCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999985432 223456788888888755 5555566667778899999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
++|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~---~~~~~kL~Dfg~~~~~~~~~~---- 151 (325)
T cd05594 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGA---- 151 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC---CCCCEEEecCCCCeecCCCCc----
Confidence 899888763 4579999999999999999999997 8999999999999994 778999999999975432221
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCc
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 244 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 244 (473)
......||..|+|||++.+..++.++|||||||+||||++|..||.+... ......+..... .+...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~i~~~~~-----~~p~~~~ 220 (325)
T cd05594 152 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEI-----RFPRTLS 220 (325)
T ss_pred ---ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHHHhcCCC-----CCCCCCC
Confidence 11345799999999999999999999999999999999999999976432 222333322221 1235678
Q ss_pred HHHHHHHHHHhcCCCCCCC-----CHHHHH
Q 011988 245 TEFASYFHYCRSLRFDDKP-----DYAYLK 269 (473)
Q Consensus 245 ~~l~~li~~cl~~dp~~RP-----t~~~l~ 269 (473)
+++.++|..||..||++|+ ++.+++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il 250 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIM 250 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHh
Confidence 9999999999999999997 766653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=327.16 Aligned_cols=234 Identities=21% Similarity=0.264 Sum_probs=193.2
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|.+..+++.||||++.+. ....+..|..+++.+.+|++|..+..+....+..++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999985432 23346678888888877778888877778888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~----- 151 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGILGGV----- 151 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC---CCCcEEecccCCCeecCcCCC-----
Confidence 899988874 44799999999999999999999999999999999999994 778999999999975322211
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcH
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 245 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 245 (473)
......||..|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+..+...... +...++.
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i~~~~~~-----~~~~~~~ 221 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSILEDEVR-----YPRWLSK 221 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCC-----CCCcCCH
Confidence 1134579999999999999999999999999999999999999997643 23333333332221 2346789
Q ss_pred HHHHHHHHHhcCCCCCCCCH
Q 011988 246 EFASYFHYCRSLRFDDKPDY 265 (473)
Q Consensus 246 ~l~~li~~cl~~dp~~RPt~ 265 (473)
++.++|..||..||++||++
T Consensus 222 ~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred HHHHHHHHHccCCHHHcCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=322.34 Aligned_cols=288 Identities=43% Similarity=0.704 Sum_probs=241.9
Q ss_pred ccCC-ceEEEeeEeecCceEEEEEEEcCCC-cEEEEEEcccC---CchhHHHHHHHHHHhc---CCCCCCeeEEee-EeC
Q 011988 4 RVGN-KFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLNVKT---KHPQLQYEAKLYKILQ---GGTGIPNLRWFG-VEG 74 (473)
Q Consensus 4 ~i~~-~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAiK~~~~~---~~~~l~~E~~il~~L~---~~~~i~~~~~~~-~~~ 74 (473)
.... +|++.++||+|+||.||+|.+..++ ..+|+|+.... ....+..|..++..+. +..+++.+...+ ...
T Consensus 14 ~~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 14 DKVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred cccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 3445 8999999999999999999987774 68999984432 2336899999999998 467899999899 588
Q ss_pred CeEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCC--CCCcEEEEecCC
Q 011988 75 DYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGL 151 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~--~~~~vkL~DFGl 151 (473)
.+.+|||+++|.+|.++..... +.|+..+++.|+.|++.+|++||+.|+|||||||+|++++... ....++|+|||+
T Consensus 94 ~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 94 DFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred ceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 8999999999999999996554 7899999999999999999999999999999999999998543 226799999999
Q ss_pred cc--cccCCCCcccccccc-CCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011988 152 AK--RYRDTATHQHIPYRE-NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 228 (473)
Q Consensus 152 a~--~~~~~~~~~~~p~~~-~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 228 (473)
|+ .+.......+.+.+. ...+.||.+|++++++.+.+.++++|+|||++++.||+.|.+||.+.........+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99 444433322344444 356779999999999999999999999999999999999999998877666666665555
Q ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccc
Q 011988 229 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 294 (473)
Q Consensus 229 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 294 (473)
....... ++...|.++..++..+-..++.++|++..+..+|++.+.+.+...+.++||+....
T Consensus 254 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~~ 316 (322)
T KOG1164|consen 254 RKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKLR 316 (322)
T ss_pred hhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccccccc
Confidence 4444332 44557889999999999999999999999999999999999999999999998643
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=314.01 Aligned_cols=260 Identities=21% Similarity=0.272 Sum_probs=214.3
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcc-----cCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~-----~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
..+.+.|.+.+.||+|.|+.||++.+..+|+.+|+|++. ....+.+.+|++|.+.|+|++++ .+........+.
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~Iv-rL~~ti~~~~~~ 85 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV-RLHDSIQEESFH 85 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEe-ehhhhhccccee
Confidence 357789999999999999999999999999999999733 33466799999999999965554 444445566788
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+||+|++ |++|..-+-. ..-+++..+-.++.||+++|.|+|.+||||||+||+|+|+...+..--+||+|||+|..+.
T Consensus 86 ylvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999 7777554432 2458899999999999999999999999999999999999877777789999999999877
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
+.. ....+.||+.|||||++...+|+..+|||+.|||||-|+.|.+||.+. +....|+.|.......+.
T Consensus 165 ~g~--------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~---~~~rlye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 165 DGE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYEQIKAGAYDYPS 233 (355)
T ss_pred Ccc--------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc---cHHHHHHHHhccccCCCC
Confidence 322 135679999999999999999999999999999999999999999883 445667777766654433
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
+ .++.+.++.++|+++||..||.+|.|+.|. |++.|+++
T Consensus 234 ~-~w~~is~~Ak~LvrrML~~dP~kRIta~EA---L~HpWi~~ 272 (355)
T KOG0033|consen 234 P-EWDTVTPEAKSLIRRMLTVNPKKRITADEA---LKHPWICN 272 (355)
T ss_pred c-ccCcCCHHHHHHHHHHhccChhhhccHHHH---hCCchhcc
Confidence 2 346788999999999999999999997665 55555443
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=330.34 Aligned_cols=266 Identities=21% Similarity=0.275 Sum_probs=202.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++.+.||+|+||.||++++..+++.||||++.+. ....+..|..++..+. +++|..+..+....+..++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence 5799999999999999999999999999999985432 1223667788887776 56667777777888899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+++.+....
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~---~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD---MNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc---CCCCEEEEeccceeeccCCC
Confidence 9998 8999999986666899999999999999999999999999999999999994 77889999999998765432
Q ss_pred CccccccccCCCcccCccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
.. ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.... ..+.+..+.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~ 227 (331)
T cd05624 157 TV------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHEERF 227 (331)
T ss_pred ce------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC---HHHHHHHHHcCCCcc
Confidence 21 1123579999999999876 457899999999999999999999997643 233444443322211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccccc
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 293 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 293 (473)
..+.....+++++.++|.+||..++ +|+....+.+++.+.+ ....+|+...
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~-~~~~~~~~~~~~~h~~-------f~~~~~~~~~ 278 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRE-RRLGQNGIEDFKKHAF-------FEGIDWENIR 278 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCch-hhcCCCCHHHHhcCCC-------cCCCCHHHHh
Confidence 1222234578999999999998655 4443222333343333 2346677653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=334.29 Aligned_cols=270 Identities=19% Similarity=0.268 Sum_probs=204.4
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++++.||+|+||.||+|.+..+++.||||++... ....+..|+.++..++|+++ ..+..........++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-v~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWV-VKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCE-eeEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999985432 23457789999999986554 4555556677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||||+ ..+.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~---~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 80 MEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD---AKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEeeccCCccccccc
Confidence 9999 8899999874 45699999999999999999999999999999999999994 78899999999997653221
Q ss_pred Cccc----------------------------cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 011988 160 THQH----------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 211 (473)
Q Consensus 160 ~~~~----------------------------~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~P 211 (473)
.... .........+||+.|+|||++.+..++.++|||||||+||||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 1000 000011245799999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccc
Q 011988 212 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 291 (473)
Q Consensus 212 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~ 291 (473)
|.+... ...+.++.........+. ...+++++.++|.+|+ .||.+|++...+.+++.+. +-..++|..
T Consensus 236 f~~~~~---~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp-------~f~~~~~~~ 303 (360)
T cd05627 236 FCSETP---QETYRKVMNWKETLVFPP-EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHP-------FFEGVDWGH 303 (360)
T ss_pred CCCCCH---HHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCC-------CCCCCCHHH
Confidence 987443 333333332111111110 1136789999999977 5999999755455555543 334568887
Q ss_pred cc
Q 011988 292 LK 293 (473)
Q Consensus 292 ~~ 293 (473)
..
T Consensus 304 ~~ 305 (360)
T cd05627 304 IR 305 (360)
T ss_pred Hh
Confidence 64
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=336.54 Aligned_cols=258 Identities=22% Similarity=0.255 Sum_probs=194.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.+|+++++||+|+||.||+|++..+++.||||++.+.. ...+..|+.+++.+.|++ |..+..++......++|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~-iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW-VVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCc-CCeEEEEEEeCCEEEEE
Confidence 36999999999999999999999999999999864422 335778999999998655 55555556677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~---~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 80 MDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEeECCCCccccccc
Confidence 9999 7899999874 35689999999999999999999999999999999999994 78899999999986432110
Q ss_pred Cccc----------------------------------------cccccCCCcccCccccccccccCCCCCchhhHHHHH
Q 011988 160 THQH----------------------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 199 (473)
Q Consensus 160 ~~~~----------------------------------------~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlG 199 (473)
.... .........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0000 000011245799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 200 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 200 viL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
|+||||++|+.||.+... .+....+.........+ ....+++++.++|.+|+ .+|.+|++...+.+++++
T Consensus 236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 236 VILYEMLVGQPPFLAQTP---LETQMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHHHhCCCCCCCCCH---HHHHHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 999999999999987432 22222222211111111 11356789999998876 599999983323333444
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=323.82 Aligned_cols=244 Identities=23% Similarity=0.344 Sum_probs=207.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc------hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH------PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~------~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
+..+|++.+.||.|.||.|-+|.....|+.||||.+.+.+. -.+.+|++||..|+|+++|.. +.++...+..+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~I-yEVFENkdKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQI-YEVFENKDKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeeh-hhhhcCCceEE
Confidence 45689999999999999999999989999999998655443 237899999999997666654 45566777889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
|||||. +|.|+|++..+ +.+++.++..|+.||+.|+.|+|.++++|||||.+|||+ |.++.+||+|||++..|.+
T Consensus 130 ivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhcc
Confidence 999999 99999999865 469999999999999999999999999999999999999 5889999999999998876
Q ss_pred CCCccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
... ..+|+|++.|++||+..|.+| ++.+|-|||||+||-|+.|.+||++. +.+..+..|.......
T Consensus 206 ~kf--------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~---Dhk~lvrQIs~GaYrE-- 272 (668)
T KOG0611|consen 206 KKF--------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR---DHKRLVRQISRGAYRE-- 272 (668)
T ss_pred ccH--------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc---hHHHHHHHhhcccccC--
Confidence 543 257899999999999999998 79999999999999999999999984 4455555555444322
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
+.-|....-||+.||..||+.|.|+++|..
T Consensus 273 ----P~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 273 ----PETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred ----CCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 344778899999999999999999777743
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=328.45 Aligned_cols=249 Identities=20% Similarity=0.283 Sum_probs=212.6
Q ss_pred CCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCch-----hHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP-----QLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~-----~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
|..|.+=|.+.+.||+|.|..|-+|++.-+|+.||||++.+++.. .+..|++.|+.++|+|+|. ++.+-.....
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVR-LYEViDTQTK 91 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVR-LYEVIDTQTK 91 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeee-eeehhcccce
Confidence 456788899999999999999999999999999999998887654 4789999999999666554 4445556677
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
.|+++|+- +|+|.|+|-.+...+.+..+.+++.||+.|+.|+|...+|||||||+||.+- .+-|.|||.|||++..+
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccC
Confidence 89999998 7899999988888899999999999999999999999999999999999886 57899999999999877
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s-~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
.... ...+++|+..|-|||+++|..|+ +++||||||||||.|++|+.||+..++. +.+-.|...+...
T Consensus 170 ~PG~--------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---ETLTmImDCKYtv 238 (864)
T KOG4717|consen 170 QPGK--------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---ETLTMIMDCKYTV 238 (864)
T ss_pred CCcc--------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---hhhhhhhcccccC
Confidence 5432 34678999999999999999985 7899999999999999999999986553 3444555544432
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
+..++.+.++||..||..||.+|.+.++|.
T Consensus 239 -----PshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 239 -----PSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred -----chhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 345678999999999999999999988774
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.11 Aligned_cols=256 Identities=20% Similarity=0.319 Sum_probs=199.7
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcC-----CCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
-.++|.+.+.||+|+||.||+|.+.. ++..|++|...... ...+..|+.+++.++|. +|..+..++.+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ-NIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCC-CEeeEEEEEccCC
Confidence 35789999999999999999999876 67889999854332 23478899999999865 4445555556667
Q ss_pred eEEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEe
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 148 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 148 (473)
..+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+|||++.......+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 789999999 889999987543 2489999999999999999999999999999999999997443455799999
Q ss_pred cCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHH
Q 011988 149 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 227 (473)
Q Consensus 149 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i 227 (473)
||+++........ ........+..|+|||++.+..++.++|||||||++|||++ |..||.+... ......+
T Consensus 163 fg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~~ 234 (277)
T cd05036 163 FGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEFV 234 (277)
T ss_pred CccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence 9999876332210 11122234568999999999899999999999999999997 9999986433 2222222
Q ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 228 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 228 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
..... ......+|.++.+++..||+.+|++||++.+|++.|+
T Consensus 235 ~~~~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGR----LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCc----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 22111 1123567899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=319.51 Aligned_cols=256 Identities=20% Similarity=0.282 Sum_probs=202.8
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCc--EEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE--EVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++.+.||.|+||.||+|.+..++. .+++|...... ...+..|+.++.++.+|+++..+..+.......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999999877765 46888754322 235778999999996667777777777777888999
Q ss_pred EecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcE
Q 011988 81 IDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 144 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~v 144 (473)
|||+ +++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC---CCCeE
Confidence 9998 789999986432 2488999999999999999999999999999999999994 67889
Q ss_pred EEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHH
Q 011988 145 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 223 (473)
Q Consensus 145 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~ 223 (473)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||.+... ...
T Consensus 159 kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~ 227 (297)
T cd05089 159 KIADFGLSRGEEVYVK--------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AEL 227 (297)
T ss_pred EECCcCCCccccceec--------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 9999999864321110 111233567999999999889999999999999999997 9999977543 222
Q ss_pred HHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 224 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 224 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
...+..... ......++.++.+|+.+||..+|.+||+++++.+.|..++.+..
T Consensus 228 ~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 228 YEKLPQGYR----MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 333322111 11234578999999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=341.61 Aligned_cols=248 Identities=18% Similarity=0.193 Sum_probs=199.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcCC-CcEEEEEEcccCCc---hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLNVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~vAiK~~~~~~~---~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
..|.+.+.||.|+||.||+|.+..+ ++.||+|....... ..+..|+.+++.++|++++ .+..++...+..+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv-~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV-KHFDDFKSDDKLLLIME 145 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEe-EEEEEEEECCEEEEEEE
Confidence 3499999999999999999998877 78899997433332 3467799999999865544 55556677788999999
Q ss_pred cC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 83 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 83 ~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
|+ +++|.+++... ...+++.++..++.||+.||.|||++||+||||||+|||++ ..+.+||+|||+++.+...
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC---CCCcEEEEeCcCceecCCc
Confidence 99 88999887532 34689999999999999999999999999999999999994 7789999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+...... .
T Consensus 223 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~~~~~~~~~~----~ 290 (478)
T PTZ00267 223 VSL-----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVLYGKYD----P 290 (478)
T ss_pred ccc-----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC----C
Confidence 211 11245679999999999999999999999999999999999999997643 23333333332221 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
+...++.++.++|..||..||++||++.+++.
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 23457899999999999999999999988753
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=329.34 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=200.1
Q ss_pred EeeEeecCceEEEEEEEc---CCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 12 GRKIGSGSFGEIYLGTNI---QTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
++.||+|+||.||++++. .+++.||||++.+. ....+..|+++++.++|++++. +..+.......++||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK-LHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCccc-EEEEEEcCCEEEEEEcC
Confidence 367999999999999863 57899999985432 2234677999999998655554 55556677888999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 80 LRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC---CCCcEEEeeccCCcccCCCCC--
Confidence 9 7899998864 45699999999999999999999999999999999999994 678999999999986543321
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
......||..|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+.+..+...... +...
T Consensus 154 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~~i~~~~~~-----~p~~ 220 (318)
T cd05582 154 -----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMTMILKAKLG-----MPQF 220 (318)
T ss_pred -----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHHHHHcCCCC-----CCCC
Confidence 1234579999999999999889999999999999999999999997643 33344444332221 2345
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHhCCCCCCcccccccc
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAY--LKRLFRDLFIREGFQFDYVFDWTILK 293 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~--l~~~L~~l~~~~~~~~~~~~dw~~~~ 293 (473)
+++++.++|..||+.||++||++.+ +.+++.+.+ ...++|....
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~-------~~~~~~~~~~ 266 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF-------FSTIDWNKLY 266 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCC-------cCCCCHHHHH
Confidence 7899999999999999999999776 555554433 2335676543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=336.40 Aligned_cols=238 Identities=19% Similarity=0.332 Sum_probs=196.7
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCCHH
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLE 89 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~ 89 (473)
-++.||+|+-|.||+|+ -.++.||||.+.. .-+.+++-|++|+|.|+|. +..++.....+||+|||| .|-|.
T Consensus 128 ELeWlGSGaQGAVF~Gr--l~netVAVKKV~e----lkETdIKHLRkLkH~NII~-FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGR--LHNETVAVKKVRE----LKETDIKHLRKLKHPNIIT-FKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhhccCcccceeeee--ccCceehhHHHhh----hhhhhHHHHHhccCcceee-EeeeecCCceeEEeeeccccccHH
Confidence 36789999999999998 4688999996322 2345788899999776665 455667777889999999 88999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccC
Q 011988 90 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 169 (473)
Q Consensus 90 ~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~ 169 (473)
++++ ..+++.......|..+|+.|+.|||.+.|||||||.-||||+ .+..|||+|||.++...+..+.
T Consensus 201 ~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STk-------- 268 (904)
T KOG4721|consen 201 EVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKSTK-------- 268 (904)
T ss_pred HHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhhh--------
Confidence 9998 466899999999999999999999999999999999999996 6778999999999988776543
Q ss_pred CCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHH
Q 011988 170 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFAS 249 (473)
Q Consensus 170 ~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ 249 (473)
-.|.||..|||||++.+.+.+.|+|||||||||||||||..||.+.... ..+..+....+.-+ .+..||+.|+-
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwGVGsNsL~Lp---vPstcP~Gfkl 342 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWGVGSNSLHLP---VPSTCPDGFKL 342 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEeccCCccccc---CcccCchHHHH
Confidence 3679999999999999999999999999999999999999999775431 11112222222221 23578999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 250 YFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 250 li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
||++||+-.|..||+|.+|+..|+
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHh
Confidence 999999999999999999877663
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=313.64 Aligned_cols=253 Identities=22% Similarity=0.356 Sum_probs=200.2
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
..++|++.++||+|+||.||+|.+..+ ..||||+..... ...+..|+.+++.++|.+++..+. +. .....+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~-~~-~~~~~~lv~e 80 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV-SEEPIYIVTE 80 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEE-EE-CCCCcEEEEE
Confidence 357899999999999999999988655 469999865432 346889999999998666555443 33 3455789999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++ +++.++|+|||+++.+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~---~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc---CCCcEEeccCCceeecccccc
Confidence 99 67999999743 34589999999999999999999999999999999999995 678899999999976643321
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. ......++..|+|||+..+..++.++|||||||++|||++ |..||.+... .+.+..+..... . ..
T Consensus 158 ~------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~~~~~~~~~-~---~~ 224 (262)
T cd05071 158 T------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYR-M---PC 224 (262)
T ss_pred c------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHHhcCCC-C---CC
Confidence 1 1123456778999999998889999999999999999999 8899976432 233333322111 1 11
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
...+|..+.+++..||+.||++||++.++.+.|++.|
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 2457899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=317.50 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=205.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
.++|.+.+.||.|+||.||++.+. .++..||+|.+.... ...+..|+.+++.++| +++..+..++......
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCcc
Confidence 467999999999999999999853 345678999865433 3357889999999986 4555666667778889
Q ss_pred EEEEecC-CCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcE
Q 011988 78 VLVIDLL-GPSLEDLFNFCS------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 144 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~v 144 (473)
+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ +.+.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~---~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---cCCcE
Confidence 9999999 789999987432 2489999999999999999999999999999999999994 77899
Q ss_pred EEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHH
Q 011988 145 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 223 (473)
Q Consensus 145 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~ 223 (473)
||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ...
T Consensus 160 kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~ 231 (288)
T cd05093 160 KIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEV 231 (288)
T ss_pred EeccCCccccccCCcee-----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 99999999865432211 11123456788999999999889999999999999999998 9999976543 223
Q ss_pred HHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 224 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 224 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
+..+...... .....++.++.+++.+||+.||.+||++.++.+.|+++...
T Consensus 232 ~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 IECITQGRVL----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHcCCcC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 3333332221 12346789999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=325.51 Aligned_cols=237 Identities=20% Similarity=0.281 Sum_probs=189.3
Q ss_pred EeeEeecCceEEEEEEEc---CCCcEEEEEEcccC-------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 12 GRKIGSGSFGEIYLGTNI---QTNEEVAIKLNVKT-------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~~~~~-------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+++||+|+||.||++++. .+++.||||++.+. ....+..|+.+++.++|++++..+ .++..+...+++|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~-~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLI-YAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhcee-eEEecCCeEEEEE
Confidence 368999999999999864 46889999985432 123467899999999966655544 4556677889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|.+++.. ...+.+..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 80 EYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred eCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC
Confidence 999 7899998874 4568899999999999999999999999999999999999 4778999999999975433221
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
......||..|+|||++.+..++.++|||||||+||||++|+.||.+.. ....+..+..... .+.
T Consensus 156 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~---~~~~~~~~~~~~~-----~~~ 220 (323)
T cd05584 156 -------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN---RKKTIDKILKGKL-----NLP 220 (323)
T ss_pred -------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCC-----CCC
Confidence 1134579999999999999889999999999999999999999997743 2333344333222 223
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCC-----CHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKP-----DYAYL 268 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RP-----t~~~l 268 (473)
..+++++.++|..||..||++|| +++++
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 253 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEV 253 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHH
Confidence 56789999999999999999999 65555
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=318.77 Aligned_cols=254 Identities=19% Similarity=0.243 Sum_probs=198.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.++|.+.++||.|+||.||+|.+..+++.||+|.+.... ...+..|+.+++.|+|++++ .+..+.......+++|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~-~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV-TLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcc-eEEEEEecCCeEEEEE
Confidence 467999999999999999999999999999999854322 23567899999999865555 5555566778899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
||+.++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++........
T Consensus 84 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 84 EYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred eccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC---CCCcEEECcCcchhccCCCCC-
Confidence 9999999999886667799999999999999999999999999999999999994 678999999999975433221
Q ss_pred cccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc--------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 232 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 232 (473)
......++..|+|||++.+. .++.++|||||||++|||++|+.||...........+..+.....
T Consensus 160 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 160 ------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred ------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 11234678999999998764 478999999999999999999999987543211111111110000
Q ss_pred --------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 233 --------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 233 --------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..........+++++.+||.+||..||.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00112223457889999999999999999999887743
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=349.35 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=213.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcC-----CCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
.+.++.+.||+|.||+||+|+... ....||||.++.... .+|++|++++..|+| ++|+.+.+.+.+++..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H-~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQH-PNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccC-CCeEEEEEEEccCCee
Confidence 456788999999999999998543 335799998655443 469999999999995 5555666777889999
Q ss_pred EEEEecC-CCCHHHHHHHcCC---------C----CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSR---------K----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 143 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~---------~----ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 143 (473)
++|+||+ .|+|.++|..... . ++..+.+.|+.|||.|++||-++.+|||||-..|+||+ +...
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---e~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---ENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---cceE
Confidence 9999999 8999999975432 2 88899999999999999999999999999999999995 7889
Q ss_pred EEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHH
Q 011988 144 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 222 (473)
Q Consensus 144 vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~ 222 (473)
|||+|||+++..-..+. |+-.....-..+||+||.++.++|+.+||||||||+|||+++ |+.||.++.. .+
T Consensus 642 VKIsDfGLsRdiYssDY-----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~E 713 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDY-----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QE 713 (774)
T ss_pred EEecccccchhhhhhhh-----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HH
Confidence 99999999987655443 222223344689999999999999999999999999999998 9999999755 45
Q ss_pred HHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 223 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 223 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.++.+..... -..+++||.++++||..||+.+|.+||+|.+|...|++.....
T Consensus 714 VIe~i~~g~l----L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 VIECIRAGQL----LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHcCCc----ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 5555555444 2345789999999999999999999999999999999887543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=324.34 Aligned_cols=241 Identities=22% Similarity=0.265 Sum_probs=188.5
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHH-HHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAK-LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~-il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
+.||+|+||.||+|++..+++.||||++.+.. ...+..|.. +++.+.|+ +|..+..++...+..++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~-~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHP-FLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCC-CccceeeEEEcCCEEEEEEcCCC
Confidence 47999999999999999999999999854321 223445544 46667655 4555556667788899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 85 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 85 g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
+++|...+.. ...+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.......
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~~~---- 151 (321)
T cd05603 80 GGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGVEPEE---- 151 (321)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEccCCCCccCCCCCC----
Confidence 7899888763 45689999999999999999999999999999999999994 778999999999875432221
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCc
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 244 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 244 (473)
......||..|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+..... .+....+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~ 220 (321)
T cd05603 152 ---TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNILHKPL-----QLPGGKT 220 (321)
T ss_pred ---ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHHhcCCC-----CCCCCCC
Confidence 1234579999999999999899999999999999999999999997743 3344444443322 1234567
Q ss_pred HHHHHHHHHHhcCCCCCCCCHH-HHHHHHH
Q 011988 245 TEFASYFHYCRSLRFDDKPDYA-YLKRLFR 273 (473)
Q Consensus 245 ~~l~~li~~cl~~dp~~RPt~~-~l~~~L~ 273 (473)
.++.++|..||+.||.+||+.. ++.+.++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~ 250 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAKADFLEIKN 250 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCCCCHHHHhC
Confidence 8999999999999999999853 3333333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=320.29 Aligned_cols=260 Identities=19% Similarity=0.305 Sum_probs=205.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcC-------CCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
.++|.+.+.||+|+||.||+|.+.. +...||+|+..... ...+..|+.+++.+..|+++..+..++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3789999999999999999998643 23569999865432 234778999999996567777777777778
Q ss_pred CeEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 138 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~ 138 (473)
...+++|||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~-- 174 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-- 174 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc--
Confidence 8899999999 779999997532 2488899999999999999999999999999999999994
Q ss_pred CCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 011988 139 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 217 (473)
Q Consensus 139 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~ 217 (473)
.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 175 -~~~~~kL~dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 175 -EDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred -CCCcEEECCCcccccccccchhh-----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 67899999999997654322111 0112234578999999999889999999999999999998 8999976432
Q ss_pred CCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 218 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 218 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
.+....+..... ......++.++.+++..||..+|++||++.+|++.|++++...+
T Consensus 249 ---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 249 ---EELFKLLKEGHR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred ---HHHHHHHHcCCC----CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 222222222211 12234678999999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=322.22 Aligned_cols=256 Identities=21% Similarity=0.277 Sum_probs=199.6
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcE----EEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~----vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
-..+|++.+.||+|+||.||+|.+..+++. ||||+..... ...+..|+.+++.+.|.+++..+. ++... .
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g-~~~~~-~ 82 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLTS-T 82 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEE-EEcCC-C
Confidence 356799999999999999999998766654 8999854332 245778999999998776666554 44443 3
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
.+++++|+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.+
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~---~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK---TPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec---CCCcEEEccccccccc
Confidence 45777776 8899999986666789999999999999999999999999999999999994 6788999999999876
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... + +..+.......
T Consensus 160 ~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~-~~~~~~~~~~~ 230 (316)
T cd05108 160 GADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---E-ISSILEKGERL 230 (316)
T ss_pred cCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---H-HHHHHhCCCCC
Confidence 5432211 0122344678999999999999999999999999999997 99999774321 2 22222222111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
. ....++.++.+++..||..+|++||++.+|...|..+..
T Consensus 231 ~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 P---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred C---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1 124567899999999999999999999999998887763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=313.54 Aligned_cols=251 Identities=20% Similarity=0.356 Sum_probs=200.7
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.++|++.++||+|+||.||+|.+ .++..||+|..... ....+..|+.+++.++|.+++. +..+.......+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVR-LYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeee-EEEEEcCCCCcEEEEec
Confidence 46899999999999999999986 45677999985432 2456888999999998665554 45555667778999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+ +++|.+++... ...+++..++.++.||+.||.|||+++++||||||+||+++ ..+.++|+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec---CCCcEEECCCccceecCCCcee
Confidence 8 78999998643 45689999999999999999999999999999999999994 7789999999999876543211
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ......+...... ...
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~~ 226 (261)
T cd05072 160 ------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQRGYRM----PRM 226 (261)
T ss_pred ------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 1123346778999999998889999999999999999998 9999976433 2222322222111 122
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
..+|.++.+++.+||..+|++||+++++.++|++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 4578999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=316.37 Aligned_cols=254 Identities=20% Similarity=0.300 Sum_probs=198.6
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcC-----CCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
+..++|++.+.||+|+||.||+|.+.. ++..||||+..... ...+..|+.+++.+.|++++ .+..+...+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv-~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV-RLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCee-eEEEEEcCC
Confidence 457889999999999999999998642 35679999854332 23477899999999865544 555566677
Q ss_pred CeEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcE
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 144 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~---------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~v 144 (473)
...+++|||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+|||++ .++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~---~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc---CCCCE
Confidence 7889999998 789999986432 2357788999999999999999999999999999999995 67889
Q ss_pred EEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHH
Q 011988 145 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 223 (473)
Q Consensus 145 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~ 223 (473)
+|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+... ...
T Consensus 159 ~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~ 230 (277)
T cd05062 159 KIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQV 230 (277)
T ss_pred EECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 99999999765432221 11122356788999999999889999999999999999999 7899977532 222
Q ss_pred HHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 224 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 224 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
+..+...... .+...++..+.+++.+||+.+|++||++.++++.|+
T Consensus 231 ~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 LRFVMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 3322222211 223567899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=332.71 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=196.2
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+. ....+..|+.+++.+.|++ |..+..+...+...+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~-iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW-VVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCC-EeeEEEEEEcCCEEE
Confidence 357899999999999999999999999999999985431 2234678899999888555 445555667788899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+|+.+..
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~---~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD---KHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEEecccceeccc
Confidence 999999 8899999973 4689999999999999999999999999999999999994 778999999999987643
Q ss_pred CCCccccccccCCCcccCccccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~----~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
... .......||+.|+|||++.+.. ++.++|||||||+||||++|..||.+.. ....+..+......
T Consensus 195 ~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~---~~~~~~~i~~~~~~ 265 (370)
T cd05621 195 TGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS---LVGTYSKIMDHKNS 265 (370)
T ss_pred CCc------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCcc
Confidence 221 1123567999999999997643 7899999999999999999999997643 33344444432211
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHH
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRLFRDLF 276 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~~~L~~l~ 276 (473)
...+. ...++..+.+++..||..++.. |+++.++ +++.|
T Consensus 266 ~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~---l~hp~ 306 (370)
T cd05621 266 LNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEI---KQHPF 306 (370)
T ss_pred cCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHH---hcCcc
Confidence 11111 1246789999999999755433 7787665 44444
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=338.34 Aligned_cols=254 Identities=20% Similarity=0.232 Sum_probs=196.6
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
..+..|.+.+.||.|+||.||+|.+..+++.||||... ...+.+|+++++.|+|.+++. +..++..+...+++|++
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L~HpnIv~-l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRLSHPAVLA-LLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHCCCCCCCc-EEEEEEECCEEEEEEEc
Confidence 34668999999999999999999999999999999632 234678999999999665554 55566777888999999
Q ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 84 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 84 ~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+.++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||+ ..+.+||+|||+++.+......
T Consensus 242 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~---~~~~vkL~DFGla~~~~~~~~~-- 316 (461)
T PHA03211 242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN---GPEDICLGDFGAACFARGSWST-- 316 (461)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC---CCCCEEEcccCCceeccccccc--
Confidence 99999999876556799999999999999999999999999999999999994 6788999999999866432211
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-----CHHHHHHHHhhcccc-----
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKISEKKVS----- 233 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~-----~~~~~~~~i~~~~~~----- 233 (473)
.......||..|+|||++.+..++.++|||||||+||||++|..|+...... ...+....+......
T Consensus 317 ---~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 317 ---PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred ---ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 0113457999999999999999999999999999999999988765432211 111111111111100
Q ss_pred c-------------------------cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 234 T-------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 234 ~-------------------------~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
. .... ...++.++.+||..||..||.+||++.+|++
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0 0000 0134568999999999999999999888743
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=348.18 Aligned_cols=252 Identities=20% Similarity=0.292 Sum_probs=198.9
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeE-eCCe
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDY 76 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~-~~~~ 76 (473)
+...++|+++++||.|+||.||+|++..+++.||+|++.... ...+..|+.+++.|.|++++..+..|.. ....
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345679999999999999999999999999999999854322 3457889999999998877777765543 4567
Q ss_pred EEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CCcccCCCCCcEEEeeC-------
Q 011988 77 NVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-------SFLHRDIKPDNFLMGLG------- 138 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~-------gIvHrDIKP~NILl~~~------- 138 (473)
+||||||+ +++|.+++... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999 78999998743 34699999999999999999999984 49999999999999632
Q ss_pred -------CCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccC--CCCCchhhHHHHHHHHHHHHcCC
Q 011988 139 -------RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGS 209 (473)
Q Consensus 139 -------~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~elltG~ 209 (473)
+....+||+|||+++.+..... .....||+.|+|||++.+ ..++.++||||||||||||++|.
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc--------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 1234699999999986543221 134579999999999865 34889999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 210 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 210 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.||..... ..+.+..+..... . ....++.++.+||..||..+|++||++.+++
T Consensus 241 ~PF~~~~~--~~qli~~lk~~p~-l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 241 TPFHKANN--FSQLISELKRGPD-L----PIKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred CCCCcCCc--HHHHHHHHhcCCC-C----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 99976432 2222222222111 1 1235689999999999999999999988775
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=318.32 Aligned_cols=239 Identities=21% Similarity=0.242 Sum_probs=188.3
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCC
Q 011988 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 87 (473)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~s 87 (473)
||+|+||.||++.+..+|+.||+|.+.... ...+..|+++++.++|+ +|..+..+...+...+++|||+ |++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp-~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP-FIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCC-cEEEEEEEEecCCeEEEEEecCCCCC
Confidence 699999999999999999999999854321 22355699999999755 4555555666778899999999 889
Q ss_pred HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccccc
Q 011988 88 LEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166 (473)
Q Consensus 88 L~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~ 166 (473)
|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.++|+|||++........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD---DQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc---CCCCEEEeeceeeeecCCCce------
Confidence 98887543 33589999999999999999999999999999999999994 678899999999976643221
Q ss_pred ccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCH-HHHHHHHhhccccccHHHHhcCCcH
Q 011988 167 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEALCRGYPT 245 (473)
Q Consensus 167 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l~~~~p~ 245 (473)
.....|+..|+|||++.+..++.++|||||||++|||++|..||........ .+.......... ......+++
T Consensus 151 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 224 (277)
T cd05607 151 --ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV----KFEHQNFTE 224 (277)
T ss_pred --eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc----ccccccCCH
Confidence 1234689999999999998999999999999999999999999976433211 122222221111 111235789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 246 EFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 246 ~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
++.++|.+||+.||++||++.++.
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccch
Confidence 999999999999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=319.83 Aligned_cols=255 Identities=18% Similarity=0.233 Sum_probs=189.8
Q ss_pred EeeEeecCceEEEEEEEc--CCCcEEEEEEcccCC-chhHHHHHHHHHHhcCCCCCCeeEEeeE-eCCeEEEEEecCCCC
Q 011988 12 GRKIGSGSFGEIYLGTNI--QTNEEVAIKLNVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNVLVIDLLGPS 87 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~--~~~~~vAiK~~~~~~-~~~l~~E~~il~~L~~~~~i~~~~~~~~-~~~~~~lv~e~~g~s 87 (473)
.++||+|+||.||+|.+. .+++.||+|.+.... ...+.+|+.+++.++|++++..+..+.. .....+++|||++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 468999999999999965 467899999865433 4457899999999998877777665543 355689999999999
Q ss_pred HHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC-CCCCcEEEEecCCcccccCC
Q 011988 88 LEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 88 L~~~l~~~~--------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGla~~~~~~ 158 (473)
|.+++.... ..+++..+..|+.||+.||.|||++||+||||||+|||+... +..+.+||+|||+|+.+...
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCC
Confidence 999886431 248999999999999999999999999999999999999532 34578999999999876433
Q ss_pred CCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC------HHHHHHHHhhcc
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKK 231 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~------~~~~~~~i~~~~ 231 (473)
.. +........||..|+|||++.+. .++.++|||||||++|||++|+.||....... ....+..+....
T Consensus 166 ~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 166 LK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred Cc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 21 11122456789999999999874 58999999999999999999999997533211 011111111000
Q ss_pred -------------cc---c-----------------cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 232 -------------VS---T-----------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 232 -------------~~---~-----------------~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.. . ..+......+.++.++|..||..||++|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 0 000001123467889999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=316.23 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=198.6
Q ss_pred CceEEEeeEeecCceEEEEEEEc----CCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~----~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
..|++.++||+|+||.||+|.+. .++..|++|....... ..+..|+.+++.+.|++++ .+..+.......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV-CLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCee-eEEEEEecCCceE
Confidence 57999999999999999999853 4567899998643222 3577899999999865555 4555566777889
Q ss_pred EEEecC-CCCHHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCC
Q 011988 79 LVIDLL-GPSLEDLFNFCS----------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 141 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~----------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 141 (473)
++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ..
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~---~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc---CC
Confidence 999999 779999985321 2478899999999999999999999999999999999994 67
Q ss_pred CcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCH
Q 011988 142 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 220 (473)
Q Consensus 142 ~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~ 220 (473)
+.+||+|||+++........ .......++..|+|||++.+..++.++|||||||+||||++ |..||.+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--- 232 (283)
T cd05090 161 LHVKISDLGLSREIYSADYY-----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--- 232 (283)
T ss_pred CcEEeccccccccccCCcce-----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 88999999999876433211 11233456778999999998889999999999999999998 9999977532
Q ss_pred HHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 221 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 221 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
......+...... .....+++++.+++.+||..||++||++.+|.+.|+.
T Consensus 233 ~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 QEVIEMVRKRQLL----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 2222323222211 2345688999999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=327.59 Aligned_cols=259 Identities=20% Similarity=0.320 Sum_probs=200.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCee-EEeeEeCC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNL-RWFGVEGD 75 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~-~~~~~~~~ 75 (473)
.++|++.+.||.|+||.||+|.+. .+++.||||++.... ...+..|+.++..+.+|++|..+ ..+...+.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 468999999999999999999853 467889999864432 23477899999999766555554 44555666
Q ss_pred eEEEEEecC-CCCHHHHHHHcC----------------------------------------------------------
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCS---------------------------------------------------------- 96 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~---------------------------------------------------------- 96 (473)
..+++|||+ +++|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 789999999 889999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccccccc
Q 011988 97 --------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 168 (473)
Q Consensus 97 --------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~ 168 (473)
..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++....... +..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~---~~~~~kl~dfg~~~~~~~~~~-----~~~ 237 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPD-----YVR 237 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc---CCCcEEEEecccccccccCcc-----hhh
Confidence 2367888899999999999999999999999999999994 678999999999986543221 111
Q ss_pred CCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHH
Q 011988 169 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 247 (473)
Q Consensus 169 ~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 247 (473)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ......+..... . .....+++++
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~-~---~~~~~~~~~~ 311 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTR-M---RAPDYTTPEM 311 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHHHhccCC-C---CCCCCCCHHH
Confidence 123346678999999999899999999999999999996 99999765332 111222211111 1 1123467899
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 248 ASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 248 ~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
.+++..||..||++||++.+|++.|+.+++.
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=309.64 Aligned_cols=247 Identities=27% Similarity=0.437 Sum_probs=197.0
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchh-----HHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ-----LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~-----l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
|++++.||+|+||.||++.+..+++.||+|+........ ...|+.+++.+. +++|..+..+.......+++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccc-ccccccccccccccccccccccc
Confidence 899999999999999999999999999999966655433 234899999996 55566666677778889999999
Q ss_pred CCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 LGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~g~-sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+.+ +|.+++. ....+++.+++.++.||+.||.+||++||+|+||||+|||+ +.++.++|+|||.+........
T Consensus 80 ~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~-- 153 (260)
T PF00069_consen 80 CPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNE-- 153 (260)
T ss_dssp ETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTS--
T ss_pred ccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccc--
Confidence 966 9999998 34579999999999999999999999999999999999999 4789999999999976422111
Q ss_pred ccccccCCCcccCcccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh-
Q 011988 163 HIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC- 240 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~- 240 (473)
......++..|+|||++. +..++.++||||||+++|+|++|..||...........+........ .....
T Consensus 154 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 225 (260)
T PF00069_consen 154 -----NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL---PSSSQQ 225 (260)
T ss_dssp -----EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH---HHHTTS
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc---cccccc
Confidence 123567899999999998 78899999999999999999999999987522222222222222111 11111
Q ss_pred -cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 241 -RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 241 -~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
...+.++.++|..||+.||++||++.+|++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122489999999999999999999887753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=312.35 Aligned_cols=246 Identities=21% Similarity=0.316 Sum_probs=198.9
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
.+|++.+.||+|+||.||++.. .+..||+|...... ...+..|+.+++.++|.+.+..+..+.......+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 5799999999999999999975 47889999854433 3458899999999997777766655555667789999999
Q ss_pred CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 g~sL~~~l~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++..... .+++..++.++.||+.||+|||++||+||||||+||+++ +++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc---CCCcEEecCCccceeccccC----
Confidence 6799999875433 488999999999999999999999999999999999994 77899999999997554322
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+....+.... . ..+...
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~-~---~~~~~~ 223 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGY-K---MDAPDG 223 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCC-C---CCCCCC
Confidence 12345668999999998889999999999999999997 9999976432 22222222211 1 122356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
+|+.+.+++.+||..+|++||++.++.+.|++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 78999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=313.68 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=202.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++.+.||.|+||.||+|++..+++.||||...... ...+..|+.+++.++|++++. +..+.......+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK-YLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceee-eeeeEEECCeEEEE
Confidence 68999999999999999999999999999999743211 234678999999998665555 44455667788999
Q ss_pred EecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 81 IDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++ .++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~---~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc---CCCCEEECccccceecc
Confidence 9999 67999888632 34589999999999999999999999999999999999995 67889999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
..... .....|+..|+|||.+.+..++.++|||||||++|||++|..||..... ........+........
T Consensus 158 ~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~- 228 (267)
T cd08228 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQCDYPPL- 228 (267)
T ss_pred chhHH-------HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHhcCCCCCC-
Confidence 43211 1235688999999999988899999999999999999999999976432 22222333322221111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
....++..+.++|.+||..+|++||++.++++.|+.+
T Consensus 229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1234678999999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=316.65 Aligned_cols=241 Identities=21% Similarity=0.259 Sum_probs=192.4
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.|++.+.||+|+||.||+|.+..+++.||||.+.... ...+..|+.+++.++|++++.. ...+...+..+++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~-~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeee-eEEEecCCEEEEEE
Confidence 4889999999999999999999999999999854321 2346679999999987665554 44455667889999
Q ss_pred ecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 82 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++ ..+.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~---~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeccceeecCCCc
Confidence 998 789999886433 3599999999999999999999999999999999999994 67889999999987543322
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||..............+... ....+
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05630 157 T--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----VQEEY 224 (285)
T ss_pred c--------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh----hhhhc
Confidence 1 12347899999999999999999999999999999999999999875432222222222111 11223
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCC
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPD 264 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt 264 (473)
...+++++.+|+..||+.||++||+
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccC
Confidence 4567899999999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=314.93 Aligned_cols=253 Identities=19% Similarity=0.261 Sum_probs=197.3
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
....++|++.++||+|+||.||+|++..+++.||+|+.... ....+..|+.+++.++|++++.. ..++......++
T Consensus 5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~-~~~~~~~~~~~i 83 (267)
T cd06646 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY-FGSYLSREKLWI 83 (267)
T ss_pred cCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeee-eEEEEeCCEEEE
Confidence 34567799999999999999999999999999999985432 23346789999999987666654 445566778899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++ ..+.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 84 CMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEECcCccceeeccc
Confidence 99999 6799998864 45789999999999999999999999999999999999994 6788999999999866432
Q ss_pred CCccccccccCCCcccCcccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
.. ......|+..|+|||.+. ...++.++|||||||++|||++|..||....... ....+........
T Consensus 160 ~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~ 229 (267)
T cd06646 160 IA-------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMSKSNFQPP 229 (267)
T ss_pred cc-------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh---hheeeecCCCCCC
Confidence 21 113457889999999885 3447889999999999999999999996543211 1111111111111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.......++.++.++|..||..+|++||++++|++
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 11112356889999999999999999999998865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=317.28 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=200.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcC-----CCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
.++|.+.+.||+|+||.||+|.+.. +++.||||+..... ...+.+|+++++.+.|.+ +..+..+......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN-IVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCC-chheeeEEecCCC
Confidence 4579999999999999999998753 35789999854432 246889999999998655 4555556666788
Q ss_pred EEEEEecC-CCCHHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCC
Q 011988 77 NVLVIDLL-GPSLEDLFNFCS-------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 142 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~-------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~ 142 (473)
.+++|||+ +++|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc---CCC
Confidence 99999998 889999987432 3478899999999999999999999999999999999994 679
Q ss_pred cEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHH
Q 011988 143 QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 221 (473)
Q Consensus 143 ~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~ 221 (473)
.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+... .
T Consensus 160 ~~kl~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~ 231 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---E 231 (280)
T ss_pred eEEECCcccceecccCcce-----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---H
Confidence 9999999999765332211 11123356788999999999999999999999999999998 9999976543 2
Q ss_pred HHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 222 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 222 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
.....+...... .....++.++.+++.+||..||++||++.++++.|+
T Consensus 232 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 EVIECITQGRLL----QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 233333322221 123467899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=321.18 Aligned_cols=257 Identities=20% Similarity=0.270 Sum_probs=202.9
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcE--EEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
-++|++.+.||.|+||.||+|.+..++.. +++|...... ...+..|+.++..+.+|++|..+..++......++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 36899999999999999999998877764 5666543321 23577899999999667777777777788888999
Q ss_pred EEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCc
Q 011988 80 VIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 143 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 143 (473)
+|||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~---~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec---CCCc
Confidence 99999 789999987432 2578999999999999999999999999999999999994 6788
Q ss_pred EEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHH
Q 011988 144 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 222 (473)
Q Consensus 144 vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~ 222 (473)
+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... +
T Consensus 163 ~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~ 231 (303)
T cd05088 163 AKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---E 231 (303)
T ss_pred EEeCccccCcccchhh--------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---H
Confidence 9999999986432110 0112234678999999988889999999999999999998 99999765432 2
Q ss_pred HHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 223 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 223 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
....+..... ......+++++.+++.+||+.+|++||+++++++.|..++....
T Consensus 232 ~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 232 LYEKLPQGYR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHHHHhcCCc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 2222221110 11123468899999999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=316.02 Aligned_cols=242 Identities=21% Similarity=0.284 Sum_probs=192.8
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.|++.+.||.|+||+||+|.+..+++.||+|++.... ...+..|+.+++.++|++++ .+.++...++..+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~-~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVV-NLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCce-eEEEEEecCCEEEEEE
Confidence 4889999999999999999999999999999854322 23467899999999865555 4555566778899999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 82 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 82 e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++ +.+.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~---~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC---CCCCEEEecCCcceecCCCC
Confidence 999 77898887643 34699999999999999999999999999999999999994 67889999999997653321
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. .....|+..|+|||++.+..++.++|||||||++|||++|..||.+.......+ .+... .......+
T Consensus 157 ~--------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~---~~~~~-~~~~~~~~ 224 (285)
T cd05632 157 S--------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE---EVDRR-VLETEEVY 224 (285)
T ss_pred c--------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHh-hhcccccc
Confidence 1 123578999999999999899999999999999999999999998653322111 12111 11111223
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCH
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDY 265 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~ 265 (473)
...++.++.+|+..||..||++||+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCC
Confidence 45678999999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=310.38 Aligned_cols=248 Identities=20% Similarity=0.258 Sum_probs=197.8
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
++|++.+.||+|+||.||++.+. .+..+|+|..... ...++..|+.+++.++|++++ .+..++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV-QLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCce-eEEEEEccCCCEEEEEEcC
Confidence 57999999999999999999874 4567999985433 245688999999999865544 5555667777889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 -g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~d~g~~~~~~~~~~~-- 156 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYT-- 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc---CCCeEEECCCCCccccCCCcee--
Confidence 7899999875555689999999999999999999999999999999999994 6788999999999865432211
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.+..+...... .....
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~~~~----~~~~~ 225 (256)
T cd05114 157 ----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRGFRL----YRPKL 225 (256)
T ss_pred ----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCCC----CCCCC
Confidence 1123345678999999998889999999999999999999 9999976432 3333333322111 11234
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLF 272 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 272 (473)
.+.++.+++..||..+|++||++++|.+.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 578999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=330.55 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=195.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+. ....+..|+.+++.+.|++ |..+......+...++
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~-iv~~~~~~~~~~~~~l 120 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW-VVQLFYAFQDDRYLYM 120 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCC-CCeEEEEEEcCCEEEE
Confidence 47899999999999999999999999999999985431 1233667888888887555 4455556677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 121 v~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~---~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 121 VMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC---CCCCEEEEeCCceeEcCcC
Confidence 99999 8899999873 4589999999999999999999999999999999999994 7789999999999876432
Q ss_pred CCccccccccCCCcccCccccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~----~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
.. .......||+.|+|||++.+.. ++.++|||||||+||||++|..||.... ....+.++.......
T Consensus 196 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~ 266 (371)
T cd05622 196 GM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMNHKNSL 266 (371)
T ss_pred Cc------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCcc
Confidence 21 1123467999999999997643 7899999999999999999999997643 334445544322111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCC---CCCHHHHHHHHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDD---KPDYAYLKRLFRDLF 276 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~---RPt~~~l~~~L~~l~ 276 (473)
... ....++.++.++|..||. ++.. |+++++| +++.+
T Consensus 267 ~~~-~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei---~~h~~ 306 (371)
T cd05622 267 TFP-DDNDISKEAKNLICAFLT-DREVRLGRNGVEEI---KRHLF 306 (371)
T ss_pred cCC-CcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHH---hcCcc
Confidence 111 123578999999999998 5555 5565554 55544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=313.97 Aligned_cols=252 Identities=19% Similarity=0.325 Sum_probs=195.7
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCc--EEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEe-----CCe
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNE--EVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-----GDY 76 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~--~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~-----~~~ 76 (473)
|.+.++||+|+||.||+|.+..++. .||||..... ....+..|+.+++.++|.+++..+..+... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578999999999999999877765 6899985432 234577899999999876666665443221 234
Q ss_pred EEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecC
Q 011988 77 NVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 150 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~-----~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 150 (473)
.+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc---CCCCEEECCCC
Confidence 68899998 78999887432 23489999999999999999999999999999999999994 67899999999
Q ss_pred CcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhh
Q 011988 151 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 229 (473)
Q Consensus 151 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 229 (473)
+++.+..... +.......++..|++||.+.+..++.++|||||||++|||++ |..||.+... .+.+..+..
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~ 229 (272)
T cd05075 158 LSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLRQ 229 (272)
T ss_pred cccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc
Confidence 9987644321 111123356778999999999899999999999999999999 8999976432 233333332
Q ss_pred ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 230 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 230 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
.... .....++..+.++|.+||..||++||++.+|++.|+++
T Consensus 230 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GNRL----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2211 12346789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=314.45 Aligned_cols=252 Identities=17% Similarity=0.319 Sum_probs=196.5
Q ss_pred eEEEeeEeecCceEEEEEEEcCC---CcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC-----C
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG-----D 75 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~-----~ 75 (473)
|.+.+.||+|+||.||+|.+..+ +..||||++.... ...+..|+.+++.++|++++..+..+.... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987653 4789999854332 235778999999998766665544333222 2
Q ss_pred eEEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEec
Q 011988 76 YNVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 149 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~-----~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 149 (473)
..+++|||+ +++|..++... ...+++..++.++.||+.||.|||++||+||||||+||+++ +++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR---EDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC---CCCeEEECCc
Confidence 478999998 88999888532 23589999999999999999999999999999999999994 6789999999
Q ss_pred CCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHh
Q 011988 150 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS 228 (473)
Q Consensus 150 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~ 228 (473)
|+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+.+..+.
T Consensus 158 g~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLR 229 (273)
T ss_pred cceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH
Confidence 999876543321 11122345678999999998889999999999999999999 9999976443 23333333
Q ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 229 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 229 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
..... .....++.++.+++.+||..||++||++.+|++.|+++
T Consensus 230 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNRL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22211 12356789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=323.95 Aligned_cols=234 Identities=21% Similarity=0.269 Sum_probs=185.7
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHH-HHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKL-YKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~i-l~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
+.||+|+||+||+|.+..+|+.||||++.+. ....+..|..+ ++.+.| ++|..+..+....+..+++|||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-p~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH-PFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCC-CCCccEEEEEecCCEEEEEEcCCC
Confidence 4799999999999999999999999985432 12234455544 455665 45555656667788899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 85 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 85 g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
+++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~---~~~~~kL~DfG~~~~~~~~~~---- 151 (325)
T cd05604 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD---SQGHVVLTDFGLCKEGIAQSD---- 151 (325)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEeecCCcccCCCCCC----
Confidence 7899888763 45799999999999999999999999999999999999994 778999999999875432211
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCc
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 244 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 244 (473)
......||..|+|||++.+..++.++|||||||++|||++|..||.... ..+.+..+..... .+...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~~~~~~~-----~~~~~~~ 220 (325)
T cd05604 152 ---TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMYDNILHKPL-----VLRPGAS 220 (325)
T ss_pred ---CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHHHHHHHcCCc-----cCCCCCC
Confidence 1234579999999999999999999999999999999999999997643 2333344333221 1234578
Q ss_pred HHHHHHHHHHhcCCCCCCCCHH
Q 011988 245 TEFASYFHYCRSLRFDDKPDYA 266 (473)
Q Consensus 245 ~~l~~li~~cl~~dp~~RPt~~ 266 (473)
.++.++|..||..+|.+||++.
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCC
Confidence 8999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=311.57 Aligned_cols=254 Identities=16% Similarity=0.262 Sum_probs=202.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCC---CcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
.++|++.+.||+|+||.||+|.+..+ ...||||+..... ...+..|+.+++.++|++ +..+..+.......+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN-IIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCC-cceEeEEEecCCceE
Confidence 36799999999999999999998644 4579999854432 234678999999998654 445555666777889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
++|||+ +++|.+++......+++..++.++.|++.||.|||++||+|+||||+|||++ .++.++|+|||+++.+..
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCCEEECccchhhcccc
Confidence 999999 7899999986666899999999999999999999999999999999999994 678899999999987752
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+.......
T Consensus 159 ~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~-- 228 (266)
T cd05033 159 SEATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGYRLP-- 228 (266)
T ss_pred cccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCCC--
Confidence 22111 0112345678999999998899999999999999999998 9999976432 22333332211111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
....+|+.+.+++..||+.+|++||++.+|.+.|.++
T Consensus 229 --~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 --PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1245789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=311.80 Aligned_cols=247 Identities=21% Similarity=0.324 Sum_probs=193.6
Q ss_pred eEeecCceEEEEEEEc--CCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CC
Q 011988 14 KIGSGSFGEIYLGTNI--QTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GP 86 (473)
Q Consensus 14 ~LG~G~fG~Vy~a~~~--~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~ 86 (473)
.||+|+||.||+|.+. ..+..||+|+..... ...+.+|+.+++.++|.+++..+..+ .....++||||+ ++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~--~~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC--EAEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE--cCCCeEEEEEeCCCC
Confidence 4899999999999865 445679999854433 24478899999999877766665543 345678999999 78
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccccc
Q 011988 87 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166 (473)
Q Consensus 87 sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~ 166 (473)
+|.+++......+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||++..+.......
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~~~~~~---- 152 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADDSYY---- 152 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc---CCCcEEeccCCccccccCCccce----
Confidence 99999876566799999999999999999999999999999999999994 67889999999998654332211
Q ss_pred ccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcH
Q 011988 167 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 245 (473)
Q Consensus 167 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 245 (473)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... .....+..... ..+...+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~----~~~~~~~~~ 225 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSFIEQGKR----LDCPAECPP 225 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCC----CCCCCCCCH
Confidence 11112234678999999998889999999999999999996 99999875432 22222222111 112346789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 246 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 246 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
++.++|..||..+|++||++.+|.+.|+.++
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=316.09 Aligned_cols=257 Identities=23% Similarity=0.316 Sum_probs=204.8
Q ss_pred CCceEEEeeEeecCceEEEEEEEcC-----CCcEEEEEEcccCCc---hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLNVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~~~~~~~---~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
..+|.+.+.||.|+||.||+|.+.. ++..|++|....... ..+.+|+.+++.+.|+ ++..+..++......
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~ 82 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE-HIVKFYGVCGDGDPL 82 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCC-CcceEEEEEccCCce
Confidence 4579999999999999999998543 455689998544432 4578899999999865 555566666777889
Q ss_pred EEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCC
Q 011988 78 VLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 141 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 141 (473)
++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~---~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---AN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---cC
Confidence 9999999 889999987432 3488999999999999999999999999999999999994 67
Q ss_pred CcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCH
Q 011988 142 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 220 (473)
Q Consensus 142 ~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~ 220 (473)
+.++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--- 231 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--- 231 (291)
T ss_pred CcEEECCCCcccccCCCcee-----ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 89999999999765432211 11233457889999999999899999999999999999998 9999976543
Q ss_pred HHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 221 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 221 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
...+..+...... .....+|.++.+++.+||+.+|++||++.+|.+.|+++...
T Consensus 232 ~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 232 TEVIECITQGRVL----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHHHHhCCCCC----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 2233333222221 12345789999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=316.73 Aligned_cols=255 Identities=18% Similarity=0.306 Sum_probs=199.5
Q ss_pred ceEEEeeEeecCceEEEEEEEcC-----CCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
+|++.+.||+|+||.||+|.+.. ....|++|+..... ...+..|+.+++.+.|++++. +..++......+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK-LYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEee-EEEEEecCCCcE
Confidence 58899999999999999998753 23578899854433 235788999999998665555 445556677789
Q ss_pred EEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEE
Q 011988 79 LVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 134 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~-----------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NIL 134 (473)
++|||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999999 789999986421 24788999999999999999999999999999999999
Q ss_pred EeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 011988 135 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ 213 (473)
Q Consensus 135 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~ 213 (473)
++ +++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 160 l~---~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 160 VA---EGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred Ec---CCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 94 6789999999999865433221 11123355778999999998889999999999999999998 999997
Q ss_pred CCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 214 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 214 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
+... .. +........... ....++.++.+++..||+.+|++||++.++.+.|++++.+
T Consensus 232 ~~~~---~~-~~~~~~~~~~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 232 GIAP---ER-LFNLLKTGYRME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCH---HH-HHHHHhCCCCCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 6432 22 222222111111 2346789999999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=325.92 Aligned_cols=249 Identities=19% Similarity=0.244 Sum_probs=191.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecCC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLG 85 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~g 85 (473)
..+|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.++|.+++ .+..+.......++||+++.
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAMLLQNVNHPSVI-RMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHHHHHhCCCCCCc-ChhheEEeCCeeEEEEEccC
Confidence 45799999999999999999999999999999984332 345799999999966555 45555667778899999999
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||+ +..+.+||+|||+++.......
T Consensus 141 ~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~----- 212 (357)
T PHA03209 141 SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPA----- 212 (357)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCcc-----
Confidence 99999987667789999999999999999999999999999999999999 4778899999999975332111
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHH-------HHHHHHhhc-c-----c
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-------QKYEKISEK-K-----V 232 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~-------~~~~~i~~~-~-----~ 232 (473)
.....||..|+|||++.+..++.++|||||||+||||+++..|+......... ..+..+... . .
T Consensus 213 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 213 ---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred ---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 13457999999999999999999999999999999999865554332221100 001111000 0 0
Q ss_pred c-----ccHH-----------------HH-hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 S-----TSIE-----------------AL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 ~-----~~~~-----------------~l-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
. .... .+ ...++.++.++|.+||+.||.+|||+.+|+
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l 349 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL 349 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHh
Confidence 0 0000 00 124577788899999999999999988774
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=313.38 Aligned_cols=259 Identities=20% Similarity=0.308 Sum_probs=205.0
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcC----CCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ----TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~----~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
-.++|++.+.||+|+||.||+|.+.. ++..|++|.+.... ...+..|+.+++.+.|.+++..+..+...+..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35789999999999999999999876 35789999854332 23477899999999877777666555555677
Q ss_pred EEEEEecC-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEe
Q 011988 77 NVLVIDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 148 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~-------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 148 (473)
.+++++|+ +++|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+|||++ +.+.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCCcEEECC
Confidence 89999998 789999987542 3589999999999999999999999999999999999995 678999999
Q ss_pred cCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHH
Q 011988 149 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 227 (473)
Q Consensus 149 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i 227 (473)
||+++.+....... ......++..|+|||++.+..++.++|||||||++||+++ |+.||..... ......+
T Consensus 161 ~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~ 232 (280)
T cd05043 161 NALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYL 232 (280)
T ss_pred CCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHH
Confidence 99998764432211 0122356778999999999889999999999999999998 9999976533 2222222
Q ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 228 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 228 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
... .... ....+|+++.+++.+||..+|++||++.++++.|.++..+
T Consensus 233 ~~~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 233 KDG-YRLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HcC-CCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 211 1111 1235689999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=315.11 Aligned_cols=255 Identities=18% Similarity=0.218 Sum_probs=196.7
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcE----EEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~----vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
.++|++.+.||.|+||.||+|.+..+++. |++|...... ...+..|+.++..+.|++++..+. ++. +...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~-~~~-~~~~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLG-ICP-GASL 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEE-EEC-CCcc
Confidence 46799999999999999999998877764 6777643322 234556666778888666555444 443 3345
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++++||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~---~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK---SDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEEcCCccceecc
Confidence 6777777 8999999987667899999999999999999999999999999999999994 67899999999998654
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
...... ......++..|++||.+.+..++.++|||||||++|||++ |..||.+.... .+..+........
T Consensus 161 ~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~ 231 (279)
T cd05111 161 PDDKKY-----FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDLLEKGERLA 231 (279)
T ss_pred CCCccc-----ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHCCCcCC
Confidence 332111 1123457788999999998899999999999999999998 99999875432 2222222221111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
....++.++.+++..||..||++||++.++.+.|..+..
T Consensus 232 ---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 ---QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 123467889999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=316.60 Aligned_cols=256 Identities=20% Similarity=0.323 Sum_probs=202.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCC-----CcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
.++|++.+.||+|+||.||++.+... ...||+|+...... ..+..|+.+++.+..|++|..+..+......
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 46899999999999999999997643 36899998654332 3477899999999555666666666677778
Q ss_pred EEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC
Q 011988 77 NVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 140 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~---------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 140 (473)
.+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ +
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~---~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---E 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc---C
Confidence 89999998 88999998632 34689999999999999999999999999999999999994 6
Q ss_pred CCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 011988 141 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 219 (473)
Q Consensus 141 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~ 219 (473)
++.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 240 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 240 (293)
T ss_pred CCeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence 789999999999876543211 11122345678999999998889999999999999999997 9999976432
Q ss_pred HHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 220 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 220 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
.+.+..+...... .....++.++.+++..||..||++||++.+|++.|++++
T Consensus 241 -~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 -EELFKLLKEGYRM----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 2222222222111 122356889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=328.12 Aligned_cols=257 Identities=21% Similarity=0.356 Sum_probs=211.9
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
.....+||-|.||.||.|.|++....||||.++.+ ...+|+.|+.+|+.|.|++.|..+ .++...-.+||+.||| .
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLL-GVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL-GVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHh-hhhccCCCeEEEEecccC
Confidence 45668999999999999999999999999985544 356799999999999976666555 4555666678888887 8
Q ss_pred CCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 86 PSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 86 ~sL~~~l~~~~~~-ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
|+|.+++..|++. ++.-.++.++.||..|++||..+++|||||-..|+|++ .+..|||+|||+++.+..+...-|
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgDTYTAH- 423 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGDTYTAH- 423 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCCceecc-
Confidence 9999999988764 67777889999999999999999999999999999995 788999999999999877654332
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
....-...|.|||.+.-..++.|+|||+|||+|||+.| |.-||.+.... +.|. +.++.+.. .-..+|
T Consensus 424 -----AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS---qVY~-LLEkgyRM---~~PeGC 491 (1157)
T KOG4278|consen 424 -----AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYG-LLEKGYRM---DGPEGC 491 (1157)
T ss_pred -----cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH---HHHH-HHhccccc---cCCCCC
Confidence 22333567999999999999999999999999999998 99999986543 3332 22222221 224689
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCC
Q 011988 244 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 282 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~ 282 (473)
|+.+++||..||++.|.+||+|.++.+.|+.+|....+.
T Consensus 492 PpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis 530 (1157)
T KOG4278|consen 492 PPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS 530 (1157)
T ss_pred CHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence 999999999999999999999999999999999766543
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=317.40 Aligned_cols=256 Identities=18% Similarity=0.273 Sum_probs=197.6
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCC----------------cEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----------------EEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIP 65 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~----------------~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~ 65 (473)
.++|+++++||+|+||.||+|.+...+ ..||+|++.... ...+..|+++++.+.|++.+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~- 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA- 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe-
Confidence 468999999999999999999876543 468999865443 34577899999999866555
Q ss_pred eeEEeeEeCCeEEEEEecC-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEE
Q 011988 66 NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 134 (473)
Q Consensus 66 ~~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~----------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NIL 134 (473)
.+..++..+...+++||++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 4555556667889999998 789999987543 26899999999999999999999999999999999999
Q ss_pred EeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCC
Q 011988 135 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPW 212 (473)
Q Consensus 135 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt--G~~Pf 212 (473)
++ ..+.++|+|||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 163 i~---~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 163 VG---KNYTIKIADFGMSRNLYSSDYYR-----VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred ec---CCCceEEccccceeecccCccee-----ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 95 66899999999997654332111 1123456788999999998889999999999999999998 78888
Q ss_pred CCCCCCCHHHHHHHHhhc---cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 213 QGLKAGTKKQKYEKISEK---KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 213 ~~~~~~~~~~~~~~i~~~---~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
..... .+.+..+... ............+|.++.+++..||+.||++||++.+|.+.|+
T Consensus 235 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 235 EHLTD---QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCcCh---HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 76433 2222222211 0000001112356789999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=316.22 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=202.2
Q ss_pred cCCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
..++|.+.+.||+|+||.||+|.+. .++..||||+...... ..+..|+.+++.+..|++|..+..++....
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3468999999999999999999853 3456899998654332 347789999999955666666666777778
Q ss_pred eEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
..+++|||+ +++|.+++.... ..+++.+++.|+.||+.||+|||+++|+|+||||+|||++ ..+.++|+|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc---CCCeEEECCCcccc
Confidence 899999998 789999987433 2389999999999999999999999999999999999994 67889999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
.+...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||........ +.+......
T Consensus 190 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---~~~~~~~~~ 261 (302)
T cd05055 190 DIMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---FYKLIKEGY 261 (302)
T ss_pred cccCCCce-----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH---HHHHHHcCC
Confidence 66543211 01123456788999999999899999999999999999998 9999987543221 111111111
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
.. ......++++.+++.+||..+|++||++.+|.+.|+++
T Consensus 262 ~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11 11235688999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.14 Aligned_cols=252 Identities=22% Similarity=0.353 Sum_probs=201.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.++|++.+.||.|+||.||+|.+. .++.||||...... ..++..|+.+++.++|.+ +..+..+.......+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPK-LIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCC-ccceeEEEecCCCeeeeeec
Confidence 477999999999999999999964 55789999854432 356889999999998655 44555566777788999999
Q ss_pred C-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++ ..+.+||+|||+++.+......
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc---CCCCEEECCcceEEEccCCccc
Confidence 9 899999987543 4689999999999999999999999999999999999995 6788999999999877533211
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
. .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.+... ...+..+..... . ...
T Consensus 160 ~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~-~---~~~ 226 (261)
T cd05068 160 A------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQVDQGYR-M---PCP 226 (261)
T ss_pred c------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC-C---CCC
Confidence 1 112233468999999999899999999999999999999 9999977542 222333322211 1 112
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
..++..+.+++.+||+.+|++||++.+|.+.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 35789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=323.87 Aligned_cols=233 Identities=21% Similarity=0.246 Sum_probs=185.2
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhc--CCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
||+|+||+||+|++..+++.||||++.+.. ......|..++..+. ++++|..+..+.......++||||+ +
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999864321 122445666666554 6777777777778888999999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~a~~~~~~~~----- 151 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD---ATGHIALCDFGLSKANLTDNK----- 151 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEecCCcCcCCCCCCC-----
Confidence 899888874 45799999999999999999999999999999999999994 678999999999975432221
Q ss_pred cccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCc
Q 011988 166 YRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 244 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 244 (473)
......||..|+|||++.+. .++.++|||||||+||||++|..||.+.. ..+.+..+........ ...++
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~----~~~~~ 222 (330)
T cd05586 152 --TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQMYRNIAFGKVRFP----KNVLS 222 (330)
T ss_pred --CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---HHHHHHHHHcCCCCCC----CccCC
Confidence 12346799999999999765 48999999999999999999999997643 2333444433222111 12468
Q ss_pred HHHHHHHHHHhcCCCCCCCCH
Q 011988 245 TEFASYFHYCRSLRFDDKPDY 265 (473)
Q Consensus 245 ~~l~~li~~cl~~dp~~RPt~ 265 (473)
+++.++|..||..||++||++
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCC
Confidence 899999999999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=310.14 Aligned_cols=252 Identities=21% Similarity=0.359 Sum_probs=200.3
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+..++|+++++||+|+||.||+|.+ .+++.||+|...... ...+..|+.+++.++|.+++..+ .+. .....+++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~-~~~-~~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLY-AVV-TQEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEE-EEE-ccCCcEEEE
Confidence 3567899999999999999999985 467889999855433 35688999999999866655544 333 345679999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 82 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 82 e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|++ +++|.+++... ...+++.+++.++.|++.||+|||+.||+||||||+||+++ +++.++|+|||++..+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc---CCCCEEEccCcceeecCCCC
Confidence 998 78999988643 34689999999999999999999999999999999999994 77899999999997765322
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+... ......+..... . .
T Consensus 157 ~~------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~-~---~ 223 (260)
T cd05067 157 YT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNLERGYR-M---P 223 (260)
T ss_pred cc------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHcCCC-C---C
Confidence 11 1123356778999999998889999999999999999998 9999987543 222222222111 1 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
....+|.++.+++.+||..+|++||++++|...|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 234578999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=311.86 Aligned_cols=249 Identities=20% Similarity=0.334 Sum_probs=194.7
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEe------CCe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVE------GDY 76 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~------~~~ 76 (473)
..+.|.+.+.||.|+||.||+|.+..+++.||||+.... ....+..|+.+++.+.+|+++..+..++.. ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 357799999999999999999999999999999995433 344678899999999655555555444332 246
Q ss_pred EEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 77 NVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
.+++|||+ +++|.+++... ...+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.++|+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~---~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC---CCCCEEEccCCCcee
Confidence 79999999 67999998753 34689999999999999999999999999999999999994 678899999999986
Q ss_pred ccCCCCccccccccCCCcccCccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 229 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 229 (473)
...... ......|+..|+|||++.+ ..++.++|||||||++|||++|..||...... .....+..
T Consensus 161 ~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---~~~~~~~~ 230 (272)
T cd06637 161 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPR 230 (272)
T ss_pred cccccc-------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---HHHHHHhc
Confidence 543221 1234678999999999863 35788999999999999999999999764321 11111111
Q ss_pred ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 230 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 230 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.... ......++.++.++|.+||..+|.+||++.+++
T Consensus 231 ~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 267 (272)
T cd06637 231 NPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267 (272)
T ss_pred CCCC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 1111 111235788999999999999999999988774
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=307.62 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=200.9
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.++|++.+.||.|+||.||+|.+..+++.+++|+.... ....+..|+.+++.++|.+.+. +..+.......+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~-~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA-YFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhc-eEEEEEeCCEEEEEEe
Confidence 36899999999999999999999889999999985433 3456889999999998665555 5556677888999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++......+++.+++.++.|++.||.|||++||+|+||||+||+++ +.+.+||+|||++..+.....
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC---CCCCEEECccccchhhhhhhh-
Confidence 99 6799999876556899999999999999999999999999999999999994 678899999999976543221
Q ss_pred cccccccCCCcccCccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~---~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||.+... ......+...........
T Consensus 157 ------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 157 ------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP---MRALFLISKSNFPPPKLK 227 (262)
T ss_pred ------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCcccc
Confidence 12345788999999999877 789999999999999999999999976542 222222222211111111
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
....++.++.+++..||..+|.+||++.+|+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22346788999999999999999999988753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=310.88 Aligned_cols=246 Identities=20% Similarity=0.335 Sum_probs=192.4
Q ss_pred eeEeecCceEEEEEEE--cCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 13 RKIGSGSFGEIYLGTN--IQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~--~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
++||+|+||.||+|.+ ..++..||||+..... ...+..|+.+++.+.|.+++..+. +. ..+..+++|||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~-~~~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIG-IC-EAESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEE-EE-cCCCcEEEEecCC
Confidence 3689999999999965 4567899999854332 235788999999998766555544 33 345668999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 85 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 85 g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||.|||++ .++.+||+|||+++.........
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~---~~~~~kl~Dfg~~~~~~~~~~~~-- 152 (257)
T cd05116 79 LGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENYY-- 152 (257)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc---CCCeEEECCCccccccCCCCCee--
Confidence 6789999874 45699999999999999999999999999999999999994 67889999999998765432211
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+...... .+...+
T Consensus 153 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~~~~~~----~~~~~~ 223 (257)
T cd05116 153 --KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIESGERM----ECPQRC 223 (257)
T ss_pred --eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHCCCCC----CCCCCC
Confidence 11122344678999999988889999999999999999998 9999976543 2233333322211 133568
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 244 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
++++.++|..||+.||++||++++|.+.|++.
T Consensus 224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 89999999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=307.76 Aligned_cols=245 Identities=20% Similarity=0.312 Sum_probs=192.5
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCC
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 87 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~s 87 (473)
+.||+|+||.||+|.+..+++.||+|...... ...+..|+++++.+.|.+++ .+..++......++||||+ +++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV-RLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcc-eEEEEEcCCCCeEEEEeeccCCc
Confidence 46999999999999999999999999854332 24578899999999865544 5555666777889999998 789
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccc
Q 011988 88 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167 (473)
Q Consensus 88 L~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 167 (473)
|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~~----- 151 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYAS----- 151 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc---CCCcEEECccccCcccccccccc-----
Confidence 9999875555789999999999999999999999999999999999994 67889999999997654321100
Q ss_pred cCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHH
Q 011988 168 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 246 (473)
Q Consensus 168 ~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 246 (473)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+.. .... .....+|.+
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~~~~-~~~~---~~~~~~~~~ 224 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREAIEQ-GVRL---PCPELCPDA 224 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHHHHc-CCCC---CCcccCCHH
Confidence 0011123467999999999889999999999999999997 99999764331 11222211 1111 123456899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 247 FASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 247 l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
+.+++.+||..+|++||++.+|.+.|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=310.92 Aligned_cols=252 Identities=21% Similarity=0.226 Sum_probs=194.8
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+|++.+.||+|+||.||+|++..+++.||||++... ....+..|+.+++.+.|++ +..+..+...+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN-IVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCC-EeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999999999999985322 2345788999999998554 5555555667788899999
Q ss_pred cCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LLGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~g~sL~~~l~~~~--~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+.++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc---CCCcEEECcccceeecCCCcc
Confidence 99889999886433 5689999999999999999999999999999999999994 778999999999975533211
Q ss_pred ccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH------------
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI------------ 227 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i------------ 227 (473)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.............
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 157 -------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred -------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 11234678899999998764 4789999999999999999999999764321111110000
Q ss_pred ---------hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 228 ---------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 228 ---------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
...............+++++.++|.+||..||++||++.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000111112223457899999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=307.84 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=202.7
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++.+.||.|+||.||+|.+..+++.||+|.+.. .....+.+|+++++.++|.+.+..+ .++...+..+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~-~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL-ASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeee-eeeecCCeEEEE
Confidence 689999999999999999999988999999997432 1234578899999999865555444 445566788999
Q ss_pred EecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 81 IDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
|||+ +++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||+++ .++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~---~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT---ATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC---CCCcEEEeccceeeecc
Confidence 9999 77999998642 34589999999999999999999999999999999999994 67889999999987654
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
..... .....|+..|+|||.+.+..++.++|||||||++|+|++|..||..... ........+........
T Consensus 158 ~~~~~-------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~- 228 (267)
T cd08224 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEKCDYPPL- 228 (267)
T ss_pred CCCcc-------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhhcCCCCCC-
Confidence 33211 1234688999999999998899999999999999999999999965432 22222222222211111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
. ...++.++.++|.+||..+|++||++.+|.+.|+++
T Consensus 229 ~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 P--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 125678999999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=299.07 Aligned_cols=250 Identities=23% Similarity=0.322 Sum_probs=209.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++++.||.|-||.||+|+.++++-.||+|++.+.. ..++.+|++|...|+|+|++ .++.++.+....|+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnil-rlY~~fhd~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNIL-RLYGYFHDSKRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHH-hhhhheeccceeEE
Confidence 478999999999999999999999999999999954432 45688999999999965555 45556677788899
Q ss_pred EEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 80 VIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~-~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
++||. .|.|...+.. ...+|++.....++.|++.||.|+|.++||||||||+|+|++ ..+.+||+|||.+.....
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCCceeecCC
Confidence 99999 7788877763 344699999999999999999999999999999999999995 788999999999865432
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
. ...+++||..|.+||+..+..++..+|+|++|++.||++.|..||.... ..+.|.+|.......
T Consensus 177 ~---------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~--- 241 (281)
T KOG0580|consen 177 N---------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKF--- 241 (281)
T ss_pred C---------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccC---
Confidence 1 2367899999999999999999999999999999999999999998754 556666666555433
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
+..++.+..++|.+|+.++|.+|....++ +.+.++..
T Consensus 242 --p~~is~~a~dlI~~ll~~~p~~r~~l~~v---~~hpwI~a 278 (281)
T KOG0580|consen 242 --PSTISGGAADLISRLLVKNPIERLALTEV---MDHPWIVA 278 (281)
T ss_pred --CcccChhHHHHHHHHhccCccccccHHHH---hhhHHHHh
Confidence 25788999999999999999999995554 66666543
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=317.26 Aligned_cols=259 Identities=20% Similarity=0.292 Sum_probs=195.6
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCC--------------cEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCee
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN--------------EEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNL 67 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~--------------~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~ 67 (473)
.++|++.++||+|+||.||+|.+..++ ..||||+..... ...+.+|+++++.++|.+ +..+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~-i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPN-IIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCC-cCeE
Confidence 358999999999999999999875432 358999854432 235788999999998655 5555
Q ss_pred EEeeEeCCeEEEEEecC-CCCHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEE
Q 011988 68 RWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 135 (473)
Q Consensus 68 ~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~-----------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl 135 (473)
..++......+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|||+
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 55566777889999999 789999986432 136888999999999999999999999999999999999
Q ss_pred eeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCC
Q 011988 136 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPWQ 213 (473)
Q Consensus 136 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt--G~~Pf~ 213 (473)
+ +++.+||+|||++........ ........++..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 163 ~---~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 163 G---NHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred c---CCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 4 677899999999976543221 111223455788999999998899999999999999999988 778887
Q ss_pred CCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 214 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 214 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
.............................+|+.+.+|+..||..||++||++++|.+.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 235 LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 654322111111111110000001123356899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.28 Aligned_cols=255 Identities=16% Similarity=0.259 Sum_probs=202.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCc---EEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
.++|++.+.||+|+||.||+|.+..++. .||+|...... ...+..|+.+++.++|+ ++..+..+....+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHP-NIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCC-CcceEEEEEecCCccE
Confidence 4689999999999999999999865543 79999854432 23578899999999855 4555666667778899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
++|||+ +++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++ .++.++|+|||++..+..
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC---CCCeEEeCCCCccccccc
Confidence 999999 7899999986666799999999999999999999999999999999999994 678999999999987654
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
..... .......++..|++||.+.+..++.++|||||||++||+++ |..||.+.... +....+..... .
T Consensus 159 ~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~-~-- 228 (267)
T cd05066 159 DPEAA----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEGYR-L-- 228 (267)
T ss_pred cccee----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCCCc-C--
Confidence 32211 01122334568999999999889999999999999999886 99999775432 22333322211 1
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
.....+|+.+.+++.+||+.+|++||++.++.+.|+++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11245789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.04 Aligned_cols=259 Identities=21% Similarity=0.273 Sum_probs=196.5
Q ss_pred CCce-EEEeeEeecCceEEEEEEE----cCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEe-CC
Q 011988 6 GNKF-RLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE-GD 75 (473)
Q Consensus 6 ~~~y-~i~~~LG~G~fG~Vy~a~~----~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~-~~ 75 (473)
.++| ++.+.||.|+||+||++.. ..++..||+|+..... ...+.+|+++++.++|.+++..+..+... ..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 3555 9999999999999988653 3567899999865432 34577899999999866666555444333 45
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..+++|||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~ 156 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKA 156 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc---CCCcEEEeecccccc
Confidence 678999998 7899999874 4599999999999999999999999999999999999994 678999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHH-----------H
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-----------K 223 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~-----------~ 223 (473)
+....... .......++..|+|||.+.+..++.++|||||||++|||++|..||.......... .
T Consensus 157 ~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 157 VPEGHEYY----RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232 (283)
T ss_pred cCCcchhh----ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence 65432111 11122345677999999998889999999999999999999999986533210000 0
Q ss_pred HHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 224 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 224 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
........... .....+|.++.+++..||+.+|++||++++|.+.|+++.
T Consensus 233 ~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00000000000 112457899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=316.56 Aligned_cols=252 Identities=20% Similarity=0.236 Sum_probs=198.7
Q ss_pred CceEEEeeEeecCceEEEEEEEcCC-----CcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
.+|++.++||.|+||.||+|.+..+ ++.||||+...... ..+..|+.++..++|++++ .+..+.......
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv-~~~~~~~~~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV-CLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcC-eEEEEEcCCCce
Confidence 4688899999999999999987543 57899999654332 3477899999999865555 455556666778
Q ss_pred EEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCC
Q 011988 78 VLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 141 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~---------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 141 (473)
+++++|+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+. ++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~---~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---DK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec---CC
Confidence 9999998 78999988522 13478899999999999999999999999999999999994 67
Q ss_pred CcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCH
Q 011988 142 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 220 (473)
Q Consensus 142 ~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~ 220 (473)
+.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--- 232 (283)
T cd05091 161 LNVKISDLGLFREVYAADYY-----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--- 232 (283)
T ss_pred CceEecccccccccccchhe-----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 78999999999865432211 11123456789999999998889999999999999999998 8899977433
Q ss_pred HHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 221 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 221 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
.+.+..+...... .....+|.++.+++..||+.+|++||++.+|...|+.
T Consensus 233 ~~~~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 QDVIEMIRNRQVL----PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 3344444433322 2345789999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=316.83 Aligned_cols=259 Identities=17% Similarity=0.301 Sum_probs=204.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEc-------CCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE 73 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~ 73 (473)
..++|.+.+.||+|+||.||+|++. ..+..||+|+..... ...+..|+.+++.+..|++|..+..+...
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 4578999999999999999999753 234579999854322 34578999999999556666666666777
Q ss_pred CCeEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEee
Q 011988 74 GDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 137 (473)
Q Consensus 74 ~~~~~lv~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~ 137 (473)
....+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~- 171 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT- 171 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc-
Confidence 78889999999 779999987532 2478889999999999999999999999999999999994
Q ss_pred CCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 011988 138 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 216 (473)
Q Consensus 138 ~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~ 216 (473)
.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||+||||++ |..||.+..
T Consensus 172 --~~~~~kl~D~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 172 --ENNVMKIADFGLARDVNNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred --CCCcEEECCCccceecccccccc-----cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 67899999999998764432211 1123345678999999999889999999999999999998 889997643
Q ss_pred CCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 217 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 217 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
..+....+...... .....++.++.+++..||..+|++||++.+|.+.|++++.-
T Consensus 245 ---~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 ---VEELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ---HHHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 23333333222211 12346789999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=319.06 Aligned_cols=260 Identities=18% Similarity=0.303 Sum_probs=204.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCC-------CcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
..+|++.+.||+|+||.||+|.+... +..||+|+..... ...+..|+.+++.+..|++|..+..++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 45799999999999999999986432 2368999854322 245788999999996566666676667777
Q ss_pred CeEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 138 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~ 138 (473)
...+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~-- 168 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT-- 168 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc--
Confidence 7889999999 779999987421 2478889999999999999999999999999999999995
Q ss_pred CCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 011988 139 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 217 (473)
Q Consensus 139 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~ 217 (473)
.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||+||||++ |..||.+...
T Consensus 169 -~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 169 -EDNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred -CCCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 6789999999999866442211 11122344578999999999999999999999999999998 8999977432
Q ss_pred CCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 218 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 218 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
...+..+...... .....++.++.+++..||..+|++||++.+|++.|+.++....
T Consensus 243 ---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 243 ---EELFKLLKEGHRM----DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred ---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 2233333222111 1234578899999999999999999999999999999886554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=307.96 Aligned_cols=245 Identities=21% Similarity=0.254 Sum_probs=198.3
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
+|++.++||.|+||.||++.+..+++.||+|.+... ....+..|+.+++.++|.+ +..+..++......+++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN-IVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCC-cceEEEEEEECCEEEEEEee
Confidence 589999999999999999999999999999985332 2345778999999998655 45555566778899999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++ +.+.++|+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC---CCCcEEEcccCcceeeccccc-
Confidence 9 78999988643 34589999999999999999999999999999999999994 778999999999976644321
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
......|+..|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+...... .+..
T Consensus 156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~ 222 (255)
T cd08219 156 ------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLILKVCQGSYK----PLPS 222 (255)
T ss_pred ------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HHHHHHHHhcCCCC----CCCc
Confidence 1134578999999999999889999999999999999999999997633 22223333222211 1234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.++.++.++|.+||+.||++||++.+|..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 57889999999999999999999988854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=310.42 Aligned_cols=260 Identities=18% Similarity=0.252 Sum_probs=205.0
Q ss_pred CCCccCCceEEEeeEeecCceEEEEEEEcCCCc----EEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeE
Q 011988 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGV 72 (473)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~ 72 (473)
|.....++|++.+.||+|+||.||+|.+..+++ .||+|+...... ..+.+|+.+++.+.|.+++..+..+ .
T Consensus 1 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 79 (279)
T cd05057 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGIC-L 79 (279)
T ss_pred CcccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-e
Confidence 345567889999999999999999999877665 589998554432 3577899999999876666555443 3
Q ss_pred eCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCC
Q 011988 73 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 151 (473)
Q Consensus 73 ~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 151 (473)
. ...+++|||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kL~dfg~ 155 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK---TPQHVKITDFGL 155 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc---CCCeEEECCCcc
Confidence 3 6778899988 8899999986666799999999999999999999999999999999999994 678899999999
Q ss_pred cccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhc
Q 011988 152 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK 230 (473)
Q Consensus 152 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 230 (473)
++......... ......++..|+|||.+.+..++.++|||||||++||+++ |..||.+.... +....+...
T Consensus 156 ~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~ 227 (279)
T cd05057 156 AKLLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLLEKG 227 (279)
T ss_pred cccccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHhCC
Confidence 98765332211 0112234678999999988889999999999999999998 99999875432 222222221
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 231 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 231 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
.. . .....++.++.+++..||..+|.+||++.+|.+.|.+++.
T Consensus 228 ~~-~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 ER-L---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CC-C---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11 1 1123467899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=308.51 Aligned_cols=251 Identities=23% Similarity=0.401 Sum_probs=198.6
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
..++|.+.++||+|+||.||+|.+..+ ..||+|...... ...+.+|+++++.+.|+++++.+..+ .....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~v~e 80 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV--SEEPIYIVTE 80 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEE--cCCCcEEEEE
Confidence 347899999999999999999987544 468999854332 34578899999999987777665443 3456789999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +++|.+++... ...+++..+..++.||+.||.|||+.||+|+||||+|||++ +++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~---~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCeEEECCCccceEccCCcc
Confidence 99 67999999753 33589999999999999999999999999999999999994 778999999999976543221
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... ......+.... .. ..
T Consensus 158 ------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~-~~---~~ 224 (260)
T cd05069 158 ------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVERGY-RM---PC 224 (260)
T ss_pred ------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC-CC---CC
Confidence 11123356778999999998889999999999999999999 9999987543 22223332211 11 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
...+|..+.+++.+||..||++||++++|.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 34678999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.78 Aligned_cols=249 Identities=25% Similarity=0.348 Sum_probs=198.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
++|.+.+.||.|+||.||+|.+..+++.||||...... ...+..|+.+++.+.|++ |..+..+....+..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER-IVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCC-eeeeEEEEccCCeEE
Confidence 57999999999999999999999999999999854321 235778999999998555 445555666777999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+++|++ +++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++ .++.++|+|||+++.+..
T Consensus 81 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~---~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 81 IFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccceeccc
Confidence 999999 7899999874 34689999999999999999999999999999999999994 678899999999976543
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+..... ..
T Consensus 157 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~---~~ 226 (263)
T cd06625 157 ICSSG----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPT---NP 226 (263)
T ss_pred ccccc----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---HHHHHHHhccCC---CC
Confidence 21110 001235688899999999998999999999999999999999999976432 222222221111 12
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.+...++.++.++|..||..+|++||++.+|++
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 234567899999999999999999999888754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=304.57 Aligned_cols=245 Identities=24% Similarity=0.297 Sum_probs=199.4
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+|.+.+.||+|+||.||+|.+..+++.|++|.+... ....+..|+++++.++|++++.. ..++......+++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY-YESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehh-eeeeccCCEEEEEEE
Confidence 589999999999999999999999999999985332 23457789999999986655554 445566778899999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||+++.+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceeccCccc
Confidence 98 88999998754 45789999999999999999999999999999999999995 678999999999987654322
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.... .......+....... +.
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~----~~ 222 (256)
T cd08529 157 F-------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKIIRGVFPP----VS 222 (256)
T ss_pred h-------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCC----Cc
Confidence 1 134578899999999999889999999999999999999999997643 233333333322211 22
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..++.++.+++.+||+.+|++||++.+|.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 357899999999999999999999888754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=307.18 Aligned_cols=246 Identities=20% Similarity=0.269 Sum_probs=198.5
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.|++.+.||.|+||.||++.+..+++.||||.+.... ...+..|+.+++.++|.+++..+..+.......+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5999999999999999999999999999999854322 23577899999999877766655555445567899999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +++|.+++... ...+++.+++.++.||+.||.|||++||+|+||||+||+++ ..+.++|+|||++..+.....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~---~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe---cCCcEEEecccceEEecccCC
Confidence 99 78999988753 34589999999999999999999999999999999999994 678999999999987643321
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||.... .......+...... .+.
T Consensus 158 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~~~~~~~~~~~~~----~~~ 223 (257)
T cd08223 158 -------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MNSLVYRIIEGKLP----PMP 223 (257)
T ss_pred -------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCCC----CCc
Confidence 1234578999999999999999999999999999999999999997543 22222223222221 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..+++++.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 467899999999999999999999887753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=309.10 Aligned_cols=249 Identities=18% Similarity=0.268 Sum_probs=198.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.++|++.+.||+|+||.||+|.+. .+..||||.+.... ...+..|+.+++.++|+ +|..+..++......+++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHE-KLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCC-CeeeEEEEEccCCCcEEEEEc
Confidence 357999999999999999999864 34569999854432 35688999999999854 555666666777788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||+++.......
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD---DQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCCEEECCCccceecCCCce--
Confidence 9 7899999976555799999999999999999999999999999999999994 678999999999986543321
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
.......++..|++||.+.+..++.++|||||||++|||++ |..||..... ......+....... ...
T Consensus 156 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~----~~~ 224 (256)
T cd05113 156 ----TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVSQGLRLY----RPH 224 (256)
T ss_pred ----eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHhcCCCCC----CCC
Confidence 11123346678999999998889999999999999999998 9999976543 22233333222111 123
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 272 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 272 (473)
..+.++.+++..||..+|++||++.+|++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 4578999999999999999999999997765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=336.71 Aligned_cols=241 Identities=22% Similarity=0.314 Sum_probs=203.2
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.|.-++.||.|+||.||.|++..+.+.||||.+.-. +..++.+|+++|+.|.|++.| .+.+|+......|+||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPnti-eYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTI-EYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcc-cccceeeccchHHHHH
Confidence 366678999999999999999999999999984322 345689999999999966555 5677778888889999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|||-|+-.|++.-..+++-+.++..|+.+.+.||.|||+.+.||||||..|||++ +.+.|||+|||.|.....
T Consensus 106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhcCc----
Confidence 9999999999998888999999999999999999999999999999999999995 889999999999975533
Q ss_pred cccccccCCCcccCcccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 162 QHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.+.|+||+.|||||+++ .+.|+-++||||||++..||...++|+..+++..... .|.....++..
T Consensus 179 -------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY---HIAQNesPtLq-- 246 (948)
T KOG0577|consen 179 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNESPTLQ-- 246 (948)
T ss_pred -------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH---HHHhcCCCCCC--
Confidence 35789999999999987 4569999999999999999999999998887644332 22222222211
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...++..|..|+..||.+-|.+|||.++|+
T Consensus 247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred -CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 234678999999999999999999988773
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=315.81 Aligned_cols=259 Identities=19% Similarity=0.311 Sum_probs=203.7
Q ss_pred CCceEEEeeEeecCceEEEEEEEcC-------CCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
.++|.+.++||+|+||.||+|++.. ....||+|+...... ..+..|+.+++.+..|++|..+..++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 4689999999999999999998642 345799998554322 34678999999996566777776677777
Q ss_pred CeEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 138 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~ 138 (473)
...+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~-- 168 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT-- 168 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc--
Confidence 8889999999 789999987432 3488999999999999999999999999999999999994
Q ss_pred CCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 011988 139 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 217 (473)
Q Consensus 139 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~ 217 (473)
.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 169 -~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 169 -EDNVMKIADFGLARGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred -CCCcEEEcccccccccccccccc-----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 67889999999998664322111 0112234567999999999889999999999999999999 8999976432
Q ss_pred CCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 218 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 218 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
...+..+...... .....++.++.+++..||..+|++||++.++.+.|.++....
T Consensus 243 ---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 243 ---EELFKLLREGHRM----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 2223333222111 123467889999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.72 Aligned_cols=256 Identities=25% Similarity=0.326 Sum_probs=200.9
Q ss_pred CceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
++|.+.++||+|+||.||+|++. .+++.||||++..... ..+..|++++..+..|++|..+..++......
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46888999999999999999864 3456899999654322 25778999999998566666666677777788
Q ss_pred EEEEecC-CCCHHHHHHHcC------------------------------------------------------------
Q 011988 78 VLVIDLL-GPSLEDLFNFCS------------------------------------------------------------ 96 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~------------------------------------------------------------ 96 (473)
++||||+ +++|.+++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 9999999 889999986432
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCC
Q 011988 97 -------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 139 (473)
Q Consensus 97 -------------------------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~ 139 (473)
..+++..++.|+.||+.||+|||+++|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~--- 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC--- 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe---
Confidence 1367778899999999999999999999999999999995
Q ss_pred CCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 011988 140 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 218 (473)
Q Consensus 140 ~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~ 218 (473)
+.+.+||+|||+++.+...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred CCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 6788999999999865432211 11123467889999999999889999999999999999998 89999765322
Q ss_pred CHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 219 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 219 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
. .....+.. .... .....++.++.+|+..||..+|.+||++.+|++.|+.++
T Consensus 349 ~--~~~~~~~~-~~~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 E--QFYNAIKR-GYRM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H--HHHHHHHc-CCCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 11121211 1111 123457899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=314.91 Aligned_cols=259 Identities=18% Similarity=0.265 Sum_probs=195.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcC----------------CCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQ----------------TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIP 65 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~----------------~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~ 65 (473)
.++|++.++||+|+||.||++.+.. ++..||+|+..... ...+..|+.+++.++|.+ +.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPN-II 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCC-cc
Confidence 4679999999999999999986432 34468999865432 245788999999998654 55
Q ss_pred eeEEeeEeCCeEEEEEecC-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEE
Q 011988 66 NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 134 (473)
Q Consensus 66 ~~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~----------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NIL 134 (473)
.+..++......+++|||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 5555667777889999999 789999987432 23778899999999999999999999999999999999
Q ss_pred EeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCC
Q 011988 135 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPW 212 (473)
Q Consensus 135 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt--G~~Pf 212 (473)
++ .++.++|+|||+++.+...... .......++..|++||...+..++.++|||||||++|||++ |..||
T Consensus 163 i~---~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 163 VG---KNYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred Ec---CCCCEEeccCcccccccCCcce-----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 95 6788999999999865432211 11122345678999999988889999999999999999998 78999
Q ss_pred CCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 213 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 213 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
..............................+|+.+.+++..||..||++||++.+|.+.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred cccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7654322111111111000000000112457899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=308.25 Aligned_cols=256 Identities=16% Similarity=0.233 Sum_probs=201.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCc---EEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
..++|+..+.||+|+||.||+|.+..++. .||||...... ...+..|+.+++.+.|++ +..+..+....+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~ 81 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN-IIRLEGVVTKFKPA 81 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCC-eeEEEEEEccCCCc
Confidence 34689999999999999999999876554 79999854432 345778999999998665 55556666777788
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+++|||+ +++|.+++......+++..++.++.|++.||+|||+.||+|+||||+|||++ .++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN---SNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc---CCCcEEECCCccceecc
Confidence 9999999 7799999976666799999999999999999999999999999999999994 67889999999997664
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
....... .......+..|+|||++.+..++.++|||||||++|||++ |..||..... ......+.......
T Consensus 159 ~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~~~~~~- 230 (268)
T cd05063 159 DDPEGTY----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAINDGFRLP- 230 (268)
T ss_pred cccccce----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhcCCCCC-
Confidence 4322110 0111233567999999998889999999999999999997 9999976432 22333332211111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
....++.++.+++.+||..+|++||++.+|.+.|+++
T Consensus 231 ---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 ---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1235789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=311.40 Aligned_cols=256 Identities=21% Similarity=0.325 Sum_probs=198.9
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcC-----CCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
..++|++.++||+|+||.||+|.+.. .+..||+|....... ..+..|+.+++.+.|+ +|..+..+.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCC-CeeeEEEEEcCCC
Confidence 45789999999999999999997642 345799998543332 2366788899999855 5555666666777
Q ss_pred eEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEE
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 145 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~---------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vk 145 (473)
..+++|||+ +++|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||++ .++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~---~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc---CCCcEE
Confidence 889999999 889999997432 2356788999999999999999999999999999999995 678999
Q ss_pred EEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHH
Q 011988 146 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 224 (473)
Q Consensus 146 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~ 224 (473)
|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+.+
T Consensus 160 L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~ 231 (288)
T cd05061 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVL 231 (288)
T ss_pred ECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence 999999986543221 111123345778999999998889999999999999999998 8899976432 2222
Q ss_pred HHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 225 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 225 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
..+..... ......+++++.+++..||+.||++||++.++.+.|++.+
T Consensus 232 ~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 KFVMDGGY----LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHcCCC----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 22222111 1123456899999999999999999999999998888765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=312.12 Aligned_cols=250 Identities=20% Similarity=0.236 Sum_probs=194.9
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+|++.+.||.|+||.||+|.+..+|+.||+|.+.... ...+..|+.+++.++|++++. +..+.......++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR-LYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeee-HHHHhccCCceEEEEe
Confidence 5999999999999999999999999999999854321 234678999999998665554 4445566778899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 83 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 83 ~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
|++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+.....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc---CCCcEEECccchhhccCCCCC--
Confidence 999999998876666799999999999999999999999999999999999994 678999999999986543221
Q ss_pred ccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc---------
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 232 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 232 (473)
......++..|+|||++.+.. ++.++|||||||++|||++|..||..... ....+..+.....
T Consensus 155 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 155 -----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred -----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHH
Confidence 112346788999999988754 79999999999999999999988643221 1222222111000
Q ss_pred ---------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 233 ---------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 233 ---------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..........+++++.++|.+||..||.+|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00011223457889999999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=311.65 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=202.9
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
-..+|++.++||.|+||.||+|.+.. +..|++|++.... ...+..|+.+++.++|.+++ .+..+.......+++|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI-SLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchh-heeeeEecCCCeEEEE
Confidence 34679999999999999999999876 8899999955443 35688899999999865544 4555566777889999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 82 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 82 e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~---~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc---CCceEEEccccchhhcCCcc
Confidence 999 77999999743 34689999999999999999999999999999999999995 67899999999998764432
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. .....++..|++||.+.+..++.++|||||||++|+|++ |..||.+... .+.+..+..... . .
T Consensus 159 ~~-------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~-~---~ 224 (261)
T cd05148 159 YL-------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQITAGYR-M---P 224 (261)
T ss_pred cc-------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHHhCCc-C---C
Confidence 11 123356778999999998889999999999999999998 8999977542 233333332211 1 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
....+++++.++|..||..||++||++.+|.+.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 235678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=310.24 Aligned_cols=251 Identities=20% Similarity=0.244 Sum_probs=195.2
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe-----
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY----- 76 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~----- 76 (473)
++|++.+.||+|+||.||+|.+..+++.||||+.... ....+..|+.+++.+.+++++..+..+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5799999999999999999999999999999984332 224578899999999877777766665554443
Q ss_pred EEEEEecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 77 NVLVIDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~----~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
.+++|||+.++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++ ...+.+||+|||++
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~ 158 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLG 158 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccc
Confidence 7999999988999988643 23589999999999999999999999999999999999995 23789999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 231 (473)
+.+..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.... ..+.++....
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~ 228 (295)
T cd07837 159 RAFSIPVK-------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL---QQLLHIFKLL 228 (295)
T ss_pred eecCCCcc-------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHh
Confidence 86543211 1122356889999998875 45799999999999999999999999764332 1121111100
Q ss_pred -----------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 -----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 -----------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
....+....+.+++++.++|..||..||.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil 289 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence 01112222346789999999999999999999987774
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=308.27 Aligned_cols=257 Identities=15% Similarity=0.239 Sum_probs=200.9
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCc---EEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
.+.|++.+.||.|+||.||+|.+..+++ .||||+..... ...+..|+.+++.+.|+++ ..+..+...+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI-IHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCc-ceEEEEECCCCceE
Confidence 4579999999999999999999877664 59999865432 2357889999999986554 45555666777889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
++|||+ +++|.+++......+++.+++.++.|++.||.|||++|++|+||||+|||++ .++.+||+|||++..+..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~---~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc---CCCcEEECCCcccccccc
Confidence 999999 6799999986666799999999999999999999999999999999999994 678999999999976544
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
..... .+........+..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+.... ..
T Consensus 159 ~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~~~-~~-- 230 (269)
T cd05065 159 DTSDP--TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQDY-RL-- 230 (269)
T ss_pred Ccccc--ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHcCC-cC--
Confidence 22111 0111111122457999999999899999999999999999886 9999976543 22223322211 11
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
.....+|..+.+++..||..+|++||++.+|...|+.+
T Consensus 231 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 -PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11246789999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=310.00 Aligned_cols=255 Identities=25% Similarity=0.324 Sum_probs=202.4
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++.+.||.|+||.||+|.+..+++.||||..... ....+..|+.+++.+.|.+++. +..++...+..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~-~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK-YYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhh-hhheeEeCCeEEEE
Confidence 5799999999999999999999899999999974332 1235778999999998655554 44555667788999
Q ss_pred EecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 81 IDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEECcchhhhccc
Confidence 9999 77999988642 34589999999999999999999999999999999999994 67889999999988664
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
..... .....|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.... .......+........
T Consensus 158 ~~~~~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~- 228 (267)
T cd08229 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYPPL- 228 (267)
T ss_pred cCCcc-------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhhcCCCCCC-
Confidence 43221 12357889999999999888999999999999999999999999764321 1222222222111110
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
....+++++.+++.+||..||++|||+.+|.+.+.++.
T Consensus 229 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 --PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11346789999999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.85 Aligned_cols=251 Identities=22% Similarity=0.375 Sum_probs=198.6
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
..++|++.++||+|+||.||+|.+. .+..||+|..... ....+.+|+.+++.++|.+++..+..+ .....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~--~~~~~~lv~e 80 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV--SEEPIYIVTE 80 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEE--CCCCcEEEEE
Confidence 4578999999999999999999864 5667999985443 235688999999999977666655443 3345789999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++ +++.++|+|||++..+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeeccCccc
Confidence 99 78999998743 34589999999999999999999999999999999999995 678899999999986543221
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... ......+... ... ..
T Consensus 158 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~-~~~---~~ 224 (260)
T cd05070 158 T------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVERG-YRM---PC 224 (260)
T ss_pred c------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcC-CCC---CC
Confidence 1 1122345678999999998889999999999999999999 9999977543 2222322221 111 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
...++.++.+++.+||..+|++||++.++.++|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 34678999999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=307.69 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=197.7
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
.+|++.+.||+|+||.||+|.+. ++..+|||+..+. ....+..|+.+++.++|.+ +..+..++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPN-LVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCC-EEEEEEEEcCCCceEEEEecC
Confidence 56899999999999999999875 5668999986543 2346788999999998654 555566667777889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 -g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++...+....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~dfg~~~~~~~~~~~-- 156 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYT-- 156 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC---CCCcEEECCcccceeccccccc--
Confidence 8899999876556789999999999999999999999999999999999994 6788999999999765432211
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+..... ......
T Consensus 157 ----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~ 225 (256)
T cd05059 157 ----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVSAGYR----LYRPKL 225 (256)
T ss_pred ----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHHcCCc----CCCCCC
Confidence 1112234568999999999899999999999999999999 8999976433 222333322111 112245
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLF 272 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 272 (473)
+|.++.+++.+||..+|++||++.++.+.|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=311.28 Aligned_cols=243 Identities=20% Similarity=0.294 Sum_probs=190.4
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
++|++.+.||+|+||.||+|.+..+++.||||+..... ...+..|+++++.+.|++++.. ..++...+..+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~-~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF-YGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeE-EEEEEECCEEEEEEe
Confidence 47899999999999999999999999999999854432 2347789999999986555544 445566778899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|..+ ..+++..+..++.||+.||.|||++||+|+||||+|||++ .++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~---~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN---TRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC---CCCCEEEeeCCcceeccccc--
Confidence 99 6666543 2478899999999999999999999999999999999994 77899999999998664332
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHH----HHHHHHhhccccccHH
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK----QKYEKISEKKVSTSIE 237 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~----~~~~~i~~~~~~~~~~ 237 (473)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||......... .....+.......
T Consensus 150 -------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 219 (279)
T cd06619 150 -------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV--- 219 (279)
T ss_pred -------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC---
Confidence 13457899999999999989999999999999999999999999754322111 1111111111000
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.....+++++.++|.+||..+|++||+++++.+
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 012346789999999999999999999887743
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=301.16 Aligned_cols=264 Identities=18% Similarity=0.208 Sum_probs=201.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---CchhHHHHHHHHHHhcCCCCCCeeEEe----eEeCCeEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWF----GVEGDYNV 78 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---~~~~l~~E~~il~~L~~~~~i~~~~~~----~~~~~~~~ 78 (473)
+++|+|.++||+|||+-||++++..++..||+|.+... ..+...+|++..+++++++.+..+.+. .......|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 57899999999999999999999999999999984333 345578999999999987776655322 22445678
Q ss_pred EEEecC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 79 LVIDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~---~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
|+++|. .|+|.+.+.... ..+++.+++.|+.+|++||++||+.. +.||||||.|||++ +.+.++|.|||.+
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDLGSA 176 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEeccCc
Confidence 888887 889999987543 35999999999999999999999998 99999999999996 5799999999999
Q ss_pred ccccCCCC--ccccccccCCCcccCccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 011988 153 KRYRDTAT--HQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 227 (473)
Q Consensus 153 ~~~~~~~~--~~~~p~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i 227 (473)
+...-... .+.....+......|..|.|||.+.- ...+.++|||||||+||+|+.|..||...-.... .....+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-SlaLAv 255 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SLALAV 255 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eEEEee
Confidence 86543211 11111222334567999999999874 4478999999999999999999999954211000 000001
Q ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 228 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 228 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
....+..+. ...+++.+.++|+.||+.||.+||+..+|+..++++.
T Consensus 256 ~n~q~s~P~---~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 256 QNAQISIPN---SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eccccccCC---CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111111 1237899999999999999999999999999888764
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=309.42 Aligned_cols=252 Identities=19% Similarity=0.309 Sum_probs=195.2
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEee-----EeCCe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFG-----VEGDY 76 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~-----~~~~~ 76 (473)
...++|++.+.||+|+||.||+|.+..+++.||+|+..... ...+..|+.+++.+..|+++..+..++ ..+..
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 45689999999999999999999999999999999854422 356788999999996455555554443 23467
Q ss_pred EEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 77 NVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
.+++|||+ +++|.+++.. ....+++..++.++.|++.||.|||+++|+||||||+||+++ ..+.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~ 171 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGVS 171 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCEEEccCCce
Confidence 89999999 8899998753 234689999999999999999999999999999999999995 6778999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 227 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i 227 (473)
+.+..... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..+
T Consensus 172 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~~~ 241 (286)
T cd06638 172 AQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALFKI 241 (286)
T ss_pred eecccCCC-------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHhhc
Confidence 86643221 1123468999999999853 34788999999999999999999999765432 112121
Q ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 228 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 228 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..... ........++.++.++|.+||+.||++||++.+|++
T Consensus 242 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 242 PRNPP--PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred cccCC--CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11110 011112346789999999999999999999888854
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=312.34 Aligned_cols=248 Identities=20% Similarity=0.339 Sum_probs=196.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeE------eCCeE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGV------EGDYN 77 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~------~~~~~ 77 (473)
.+.|++.+.||.|+||.||+|.+..+++.||+|+.... ....+..|+.+++.+.+|+++..+..++. .....
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 47899999999999999999999999999999985443 34567889999999976677666655543 35678
Q ss_pred EEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 78 VLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++ +.+.++|+|||++...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~---~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCcchhhh
Confidence 9999999 66999998753 34588999999999999999999999999999999999994 6788999999998765
Q ss_pred cCCCCccccccccCCCcccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 230 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 230 (473)
..... ......|+..|+|||++. +..++.++|||||||++|||++|..||..... ...+..+...
T Consensus 172 ~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~~~~~~ 241 (282)
T cd06636 172 DRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP---MRALFLIPRN 241 (282)
T ss_pred hcccc-------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH---HhhhhhHhhC
Confidence 43211 123457899999999986 34578899999999999999999999976432 1222222211
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
... ......++.++.++|.+||..||.+||++.+|+
T Consensus 242 ~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 242 PPP---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred CCC---CCcccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 111 112245789999999999999999999988874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=306.38 Aligned_cols=252 Identities=18% Similarity=0.261 Sum_probs=193.8
Q ss_pred eeEeecCceEEEEEEEcC---CCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 13 RKIGSGSFGEIYLGTNIQ---TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~---~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
+.||+|+||.||+|.+.. .+..||||...... ...+..|+.+++.++|++.+..+..+...+...+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998754 34579999854322 2356789999999987777776665555566778999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 85 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 85 g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
+++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ ..+.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~---~~~~~kl~dfg~~~~~~~~~~~~-- 155 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD---ESFTVKVADFGLARDIYDKEYYS-- 155 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCccccccccCCccee--
Confidence 7899999986555678888999999999999999999999999999999994 67889999999998654322111
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
........++..|+|||.+.+..++.++|||||||++|||++| ..||..... ......+...... .....+
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~ 227 (262)
T cd05058 156 -VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLLQGRRL----LQPEYC 227 (262)
T ss_pred -ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhcCCCC----CCCCcC
Confidence 1111234567789999999988999999999999999999994 666765332 2222222221111 112346
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 244 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
|+.+.+++..||..+|++||++.+|.+.|++++.
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 8899999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=306.82 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=194.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
++|++.+.||+|+||.||+|.+..+++.||+|+..... ...+..|+.+++.++|.+.+ .+..+.......+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~-~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLV-NLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEe-eeeeEEeeCCEEEEEE
Confidence 57999999999999999999999899999999853321 23467899999999865544 4555566778889999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
||+.+.+.+.+......+++..++.++.||+.||+|||++||+|+||||+||+++ .++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc---CCCcEEECccccceecCCCccc
Confidence 9995544444433455799999999999999999999999999999999999994 6789999999999876543211
Q ss_pred cccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc----------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------- 230 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 230 (473)
.....++..|+|||.+.+ ..++.++|||||||++|||++|..||.+....+....+......
T Consensus 157 -------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 157 -------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred -------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 123467889999999886 45789999999999999999999999875432222221111100
Q ss_pred -------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 -------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 -------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
............++..+.+||.+||..+|++||++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 281 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHh
Confidence 001112233456789999999999999999999988774
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=343.74 Aligned_cols=262 Identities=25% Similarity=0.342 Sum_probs=202.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++.++||+|+||.||+|.+..+++.||||++.... ...+.+|+++++.++|++++ .+..++..++..+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIV-kl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV-PVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcC-eEEEEEeeCCEEEEE
Confidence 68999999999999999999999999999999854321 23578899999999965555 555566777889999
Q ss_pred EecC-CCCHHHHHHHc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEec
Q 011988 81 IDLL-GPSLEDLFNFC----------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 149 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~----------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 149 (473)
|||+ |++|.+++... ...++...++.++.||+.||+|||++||+||||||+|||++ ..+.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd---~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG---LFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc---CCCCEEEEec
Confidence 9999 88999998632 12356778899999999999999999999999999999994 7788999999
Q ss_pred CCcccccCCCCcc-----------ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 011988 150 GLAKRYRDTATHQ-----------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 218 (473)
Q Consensus 150 Gla~~~~~~~~~~-----------~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~ 218 (473)
|+++......... ...........||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998762211000 00011123457999999999999999999999999999999999999999763321
Q ss_pred CHHHHHHHHhhccccccHH-HHhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHHH
Q 011988 219 TKKQKYEKISEKKVSTSIE-ALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFIR 278 (473)
Q Consensus 219 ~~~~~~~~i~~~~~~~~~~-~l~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~l~~~ 278 (473)
... ... ....+.. .....+|+.+.+++.+||..||++|| +++++.+.|+..+..
T Consensus 238 ki~--~~~----~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 KIS--YRD----VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhh--hhh----hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 111 111 0111100 11246789999999999999999996 567788888877653
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=309.43 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=199.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCC-----CcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
..++|.+.+.||.|+||.||+|.+... +..||+|...... ...+.+|+.+++.+.|+ ++..+..+.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~-~i~~~~~~~~~~~ 82 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSTGQ 82 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCC-ceeEEEEEEcCCC
Confidence 357899999999999999999997643 3789999854332 23467899999999855 4555666666778
Q ss_pred eEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEE
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 145 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~---------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vk 145 (473)
..+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~---~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc---CCCCEE
Confidence 889999999 789999986432 2368889999999999999999999999999999999994 778999
Q ss_pred EEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHH
Q 011988 146 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 224 (473)
Q Consensus 146 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~ 224 (473)
|+|||+++....... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+..
T Consensus 160 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~ 231 (277)
T cd05032 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVL 231 (277)
T ss_pred ECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHH
Confidence 999999986544321 111234457889999999998889999999999999999998 9999976432 2223
Q ss_pred HHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 225 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 225 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
..+..... ..+...++.++.+++..||..+|++||++.+|.+.|+
T Consensus 232 ~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 232 KFVIDGGH----LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 33322211 1123457899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=311.19 Aligned_cols=249 Identities=18% Similarity=0.272 Sum_probs=195.6
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc---hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~---~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
..+.|+++++||.|+||.||+|++..+++.|++|+...... ..+..|+.+++.++|.+++ .+..++......++||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIV-KLLGAFYWDGKLWIMI 88 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEe-eeEEEEEeCCeEEEEE
Confidence 45779999999999999999999999999999999654432 3467899999999965544 4544555667889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|..++......+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT---LDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc---CCCCEEEccCccceecccccc
Confidence 999 7788888765566799999999999999999999999999999999999994 678999999999875433211
Q ss_pred ccccccccCCCcccCccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
......++..|+|||++.+ ..++.++|||||||++|||++|..||..... ...+.++......
T Consensus 166 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~-- 233 (292)
T cd06644 166 -------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPP-- 233 (292)
T ss_pred -------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHHHHHHhcCCCc--
Confidence 1134568899999999853 3468899999999999999999999976432 2222222221111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.......++.++.++|.+||..+|++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 267 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 1112245678999999999999999999988774
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=318.22 Aligned_cols=257 Identities=20% Similarity=0.211 Sum_probs=196.2
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeE----eCCe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGV----EGDY 76 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~----~~~~ 76 (473)
++++|++.++||+|+||.||+|.+..+++.||||++... ....+..|+.+++.++|.+++..+..+.. ....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 678999999999999999999999999999999985432 22346779999999997666655544322 2235
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 77 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
.+++|||++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||+++...
T Consensus 83 ~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~---~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEECcccceeecc
Confidence 79999999999998886 45799999999999999999999999999999999999994 77899999999998764
Q ss_pred CCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh------
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE------ 229 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~------ 229 (473)
....... ......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..+..
T Consensus 158 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 158 PEHDHTG----FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccC----CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 4322111 1234578999999998765 4589999999999999999999999976432111111100000
Q ss_pred -----------------ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 230 -----------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 230 -----------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.........+...+++++.++|.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00011112233456788999999999999999999877743
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.33 Aligned_cols=257 Identities=21% Similarity=0.243 Sum_probs=197.5
Q ss_pred ceEEEeeEeecCceEEEEEEE----cCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEe-CCeEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYNV 78 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~----~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~-~~~~~ 78 (473)
.|++++.||+|+||.||+|.. ..++..||+|.+.... ...+.+|+.+++.+.|.+.+..+..+... ....+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 479999999999999999974 3568899999854332 24578899999999876666555444333 36789
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
++|||+ +++|.+++......+++.+++.++.||+.||+|||++||+||||||+|||++ .++.++|+|||+++.+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECCCcccccccc
Confidence 999999 8999999975555689999999999999999999999999999999999995 678899999999987654
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC------------CHHHHHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------------TKKQKYE 225 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~------------~~~~~~~ 225 (473)
..... .......++..|+|||++.+..++.++|||||||++|||+++..|+...... .......
T Consensus 162 ~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 162 DKEYY----TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred Cccce----eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 32211 1123456778899999999888999999999999999999987765321100 0000011
Q ss_pred HHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 226 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 226 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
.+.... . ......++.++.+|+.+||+.+|++||++.++++.|+++
T Consensus 238 ~~~~~~-~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGK-R---LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCc-c---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111 0 112345789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=309.76 Aligned_cols=248 Identities=19% Similarity=0.332 Sum_probs=192.9
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
++|++.+.||+|+||.||+|.+..+|+.||||...... ..++..|..++.+..+++++..+..+.......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 57999999999999999999999999999999854432 23455676665555556666666666677788999999
Q ss_pred cCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 83 LLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 83 ~~g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
|+.++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccccc
Confidence 9999999888642 34689999999999999999999997 99999999999999 47789999999999866432
Q ss_pred CCccccccccCCCcccCccccccccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLG----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
.. .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ..+.+..+......
T Consensus 158 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~- 226 (283)
T cd06617 158 VA--------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVEEPSP- 226 (283)
T ss_pred cc--------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhcCCC-
Confidence 21 123468899999999865 4468999999999999999999999965322 12222222211111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.. ....+|.++.++|..||..+|++||++.+|.+
T Consensus 227 ~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 QL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 11347899999999999999999999887743
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=314.84 Aligned_cols=254 Identities=19% Similarity=0.228 Sum_probs=187.3
Q ss_pred EeeEeecCceEEEEEEEcC--CCcEEEEEEcccCC-chhHHHHHHHHHHhcCCCCCCeeEEeeE-eCCeEEEEEecCCCC
Q 011988 12 GRKIGSGSFGEIYLGTNIQ--TNEEVAIKLNVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNVLVIDLLGPS 87 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~--~~~~vAiK~~~~~~-~~~l~~E~~il~~L~~~~~i~~~~~~~~-~~~~~~lv~e~~g~s 87 (473)
..+||+|+||.||+|.+.. ++..||+|.+.... ...+.+|+.+++.++|++++..+..+.. .....+++|||++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 4689999999999999654 56789999865433 3457889999999998777766665543 456789999999999
Q ss_pred HHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC-CCCCcEEEEecCCcccccCC
Q 011988 88 LEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 88 L~~~l~~~--------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGla~~~~~~ 158 (473)
|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||+++.+...
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence 99987532 1248899999999999999999999999999999999999532 35678999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCH------HHHHHHHhhcc
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYEKISEKK 231 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~------~~~~~~i~~~~ 231 (473)
... ........||..|+|||++.+. .++.++|||||||++|||++|+.||........ ...+..+....
T Consensus 166 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 166 LKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred ccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 211 1122346789999999999874 589999999999999999999999975322110 00011100000
Q ss_pred c----------------c-------------cc----HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 V----------------S-------------TS----IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 ~----------------~-------------~~----~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
. . .. ........+..+.++|.+||..||.+|||+.+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l 312 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQAL 312 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHh
Confidence 0 0 00 0000112346788999999999999999988875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.75 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=195.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.++|.+.++||+|+||.||+|.+..+++.||+|++.... ...+..|+.+++.++|++++.. ..+....+..+++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~-~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY-FGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeE-EEEEEeCCEEEEEEe
Confidence 368999999999999999999999999999999854432 2346789999999986555554 445567788899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++.. ...+++.+++.++.||+.||.|||++||+|+||||+||+++ ..+.+||+|||++........
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 87 FCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECcceeeeEccCccc-
Confidence 99 6799999874 45799999999999999999999999999999999999994 678899999999876543211
Q ss_pred cccccccCCCcccCcccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 162 QHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
......|+..|+|||++. +..++.++|||||||++|+|++|..||........ +..............
T Consensus 162 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~ 232 (267)
T cd06645 162 ------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLMTKSNFQPPKLK 232 (267)
T ss_pred ------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---HHhhhccCCCCCccc
Confidence 123457899999999975 44588999999999999999999999976442211 111111111111111
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
....++..+.++|.+||..+|++||++++|++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11246789999999999999999999888753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=305.67 Aligned_cols=250 Identities=21% Similarity=0.222 Sum_probs=194.4
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC--CeEEEEEe
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG--DYNVLVID 82 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~--~~~~lv~e 82 (473)
|++.++||+|+||.||+|.+..+++.||||...... ......|+.++..+.+|+++..+..++.+. ...+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 789999999999999999999999999999854321 123456888888887566666666666655 78899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 83 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 83 ~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
|+.++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++ . +.+||+|||+++.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCCC--
Confidence 998899998876556799999999999999999999999999999999999995 4 9999999999986643321
Q ss_pred ccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-----------
Q 011988 163 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------- 230 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 230 (473)
.....++..|+|||.+.+ ..++.++|||||||++|||++|..||.+.+.......+......
T Consensus 155 ------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 155 ------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred ------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 123467899999997654 45789999999999999999999999775432211111111100
Q ss_pred ----------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 231 ----------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 231 ----------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.....+..+...++.++.++|.+||..+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0011123334567899999999999999999999887753
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=309.51 Aligned_cols=260 Identities=21% Similarity=0.233 Sum_probs=197.0
Q ss_pred CCceEEEeeEeecCceEEEEEEE----cCCCcEEEEEEcccCCc---hhHHHHHHHHHHhcCCCCCCeeEEee-EeCCeE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLNVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFG-VEGDYN 77 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~----~~~~~~vAiK~~~~~~~---~~l~~E~~il~~L~~~~~i~~~~~~~-~~~~~~ 77 (473)
.++|++.+.||+|+||.||+|.. ..+++.||||.+..... ..+..|+++++.++|++++..+..+. ......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46899999999999999999973 45788999998654432 35788999999998766655544332 334567
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+++|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE---SENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC---CCCeEEECCCccccccc
Confidence 8999999 8899999976556799999999999999999999999999999999999994 67889999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHH------------HHH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK------------QKY 224 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~------------~~~ 224 (473)
...... .......++..|+|||++.+..++.++|||||||++|||++|..|+......... ..+
T Consensus 160 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 160 QDKEYY----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred CCCcce----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 432210 0111223455699999999988999999999999999999988776442211000 000
Q ss_pred HHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 225 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 225 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
..+..... .......++.++.+++..||..+|++|||+.+|.+.|+.+
T Consensus 236 ~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNG---RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCC---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000 0011245788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=316.54 Aligned_cols=257 Identities=19% Similarity=0.282 Sum_probs=211.6
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEE-cccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~-~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
-|.++++||+|+||.||+|.++.+|+.||||. -...+..++.+|+.|++++.....|.++..|+. ....||||||| .
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFK-HSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhcc-CCceEeehhhcCC
Confidence 37788999999999999999999999999997 455667789999999999996666665555554 44569999999 6
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
|+..+++...++++++.++..++...+.||+|||...-||||||..|||+ +.+|..||+|||.|-.+.+....
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAK---- 185 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAK---- 185 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHHh----
Confidence 79999999888899999999999999999999999999999999999999 58899999999999887765432
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcH
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 245 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 245 (473)
.++..||+.|||||++....|+.++||||||++..||..|++||.+..+.. .+..|..+..++. .-+..++.
T Consensus 186 ---RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AIFMIPT~PPPTF--~KPE~WS~ 257 (502)
T KOG0574|consen 186 ---RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AIFMIPTKPPPTF--KKPEEWSS 257 (502)
T ss_pred ---hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---eeEeccCCCCCCC--CChHhhhh
Confidence 367899999999999999999999999999999999999999998765421 1111222211111 11234578
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCC
Q 011988 246 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQF 283 (473)
Q Consensus 246 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~ 283 (473)
+|.+|++.||.++|++|-|+.+ ++++.|+++....
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~---L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALR---LCEHTFIKNAPGC 292 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHH---HhhhhhhcCCCcc
Confidence 9999999999999999998554 5778887776544
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=306.58 Aligned_cols=253 Identities=21% Similarity=0.257 Sum_probs=198.9
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+|++.+.||.|+||.||+|.+..+++.||||+..... ...+..|+.+++.++|.+ +..+..+...+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY-VVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCC-CcceeeEEecCCeeEEEec
Confidence 5999999999999999999999999999999854332 346889999999998554 4555555667888999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 83 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 83 ~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
|++++|.+++......+++.+++.++.||+.||+|||++||+|+||||+||+++ ..+.++|+|||++........
T Consensus 80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~---~~~~~~l~dfg~~~~~~~~~~-- 154 (286)
T cd07832 80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEP-- 154 (286)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---CCCcEEEeeeeecccccCCCC--
Confidence 999999999986667799999999999999999999999999999999999995 678999999999987654321
Q ss_pred ccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-----------
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------- 230 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 230 (473)
.......|+..|+|||++.+.. ++.++|||||||++|||++|..||.+................
T Consensus 155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 ----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred ----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 1113357899999999987654 689999999999999999998888764322111111110000
Q ss_pred -----------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 231 -----------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 231 -----------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
........+...++.++.++|..||..+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0001122334567899999999999999999999887743
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=305.42 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=198.6
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
+|.+.+.||.|+||.||+|.+..+++.||+|.+.... ...+..|+.+++.++|++ +..+..+.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN-IVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCC
Confidence 5889999999999999999998899999999743321 134778999999998655 445555667778
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..+++|||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++ +.+.++|+|||+++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~---~~~~~~l~dfg~~~~ 155 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGISKK 155 (267)
T ss_pred ccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc---CCCCEEecccCCCcc
Confidence 889999999 7799999974 35689999999999999999999999999999999999994 778999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
+........ .........|+..|+|||.+.+..++.++|||||||++|+|++|..||.+... ...+..+....
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~--- 228 (267)
T cd06628 156 LEANSLSTK-TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGENA--- 228 (267)
T ss_pred cccccccCC-ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHHHHhccC---
Confidence 753221110 01112345688999999999998899999999999999999999999987432 22232222211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
...+...++.++.++|.+||+.||++||++.+|++
T Consensus 229 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 -SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11234567899999999999999999999888754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=304.10 Aligned_cols=244 Identities=27% Similarity=0.389 Sum_probs=198.6
Q ss_pred eeEeecCceEEEEEEEcCC---CcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 13 RKIGSGSFGEIYLGTNIQT---NEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~---~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
+.||+|+||.||+|.+... +..|+||+..... ...+..|+++++.+. ++++..+..+.......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEecc
Confidence 4799999999999998866 8899999854433 356888999999999 555555555556688899999999
Q ss_pred CCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 85 GPSLEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 85 g~sL~~~l~~~--------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+++|.+++... ...+++..++.++.||+.||+|||++||+|+||||+||+++ .++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC---CCCcEEEcccccccccc
Confidence 99999999865 46799999999999999999999999999999999999994 67899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
.... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+.....
T Consensus 157 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~--- 225 (262)
T cd00192 157 DDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRKGYR--- 225 (262)
T ss_pred cccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC---
Confidence 5332 112244567889999999998889999999999999999999 6999987633 233333332111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 272 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 272 (473)
......+|.++.+++..||..+|++||++.+|.+.|
T Consensus 226 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 226 -LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred -CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 112345689999999999999999999999998776
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=304.22 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=193.1
Q ss_pred eeEeecCceEEEEEEEcCCC---cEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 13 RKIGSGSFGEIYLGTNIQTN---EEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~---~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
++||+|+||.||+|.+...+ ..||+|....... ..+..|+.+++.+.|.+++..+. +.. ....+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIG-VCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEE-EEc-CCceEEEEEeCC
Confidence 47999999999999876555 7899998554433 35778999999998766555444 333 45578999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 85 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 85 g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
+++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~---~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 79 LGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc---CCCcEEeccccccceeecCCcc---
Confidence 78999999743 3799999999999999999999999999999999999994 7789999999999876443221
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
+.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+...... .....+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~ 223 (257)
T cd05060 152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGERL----PRPEEC 223 (257)
T ss_pred -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCcC----CCCCCC
Confidence 111122334578999999998899999999999999999998 9999976543 2222333222111 123467
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 244 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
+..+.++|.+||..+|++||++.+|.+.|+++
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 89999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=303.97 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=202.2
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+..++|.+.++||.|+||.||+|.+. .+..||||.+... ....+..|+.+++.++|.+ +..+..+.......+++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDK-LVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCC-EeeeeeeeecCCceEEEE
Confidence 45688999999999999999999974 5578999985543 3456889999999999654 555555566667889999
Q ss_pred ecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 82 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++ +++.+||+|||+++.+....
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc---CCCCEEECccccceeccchh
Confidence 998 789999987433 4689999999999999999999999999999999999994 67899999999998765321
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
. .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+... ...+..+..... . .
T Consensus 158 ~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~~-~---~ 224 (261)
T cd05034 158 Y------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVERGYR-M---P 224 (261)
T ss_pred h------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC-C---C
Confidence 1 11123345678999999999889999999999999999998 9999976432 233333322111 1 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
....+|.++.+++.+||..+|++||+++++.+.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 124568999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=308.69 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=198.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
..+|.+.++||+|+||.||++... .++..|++|...... ...+..|+++++.++|.+ |..+..++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH-IVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCC-CceEEEEEecCCce
Confidence 457999999999999999999743 346689999854433 345888999999998655 44555566777888
Q ss_pred EEEEecC-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCC
Q 011988 78 VLVIDLL-GPSLEDLFNFCS--------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 142 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~--------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~ 142 (473)
+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ +++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~---~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---QGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc---CCC
Confidence 9999998 789999987542 2488999999999999999999999999999999999995 678
Q ss_pred cEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHH
Q 011988 143 QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 221 (473)
Q Consensus 143 ~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~ 221 (473)
.+||+|||+++....... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .
T Consensus 160 ~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~ 231 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---T 231 (280)
T ss_pred CEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---H
Confidence 999999999976543221 111233456788999999999899999999999999999998 9999976433 2
Q ss_pred HHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 222 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 222 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
..+..+...... .....+|+++.+++.+||..||++||++.+|.+.|+
T Consensus 232 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 EAIECITQGREL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHcCccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 223333221111 122467899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=310.88 Aligned_cols=255 Identities=18% Similarity=0.166 Sum_probs=196.7
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeE-eCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~-~~~~~~ 78 (473)
-.++|++.+.||.|+||.||+|.+..+|+.||+|+..... ...+..|+.+++.++|.+++..+..+.. .....+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3578999999999999999999999999999999854221 2235689999999998776665554433 235689
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 79 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 79 lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
+||||++++|.+++......+++.+++.++.||+.||.|||++||+||||||+||+++ ..+.+||+|||++..+...
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccceeeecCCc
Confidence 9999999999999987667799999999999999999999999999999999999994 7789999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc------
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------ 231 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~------ 231 (473)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|..||.+.........+.......
T Consensus 162 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 162 AKP-------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred cCC-------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence 211 122345788999999876 457999999999999999999999997654322222221111000
Q ss_pred ----------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 ----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 ----------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...........+++++.++|..||..||++||++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 00001111223578899999999999999999988774
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=307.35 Aligned_cols=247 Identities=23% Similarity=0.412 Sum_probs=191.9
Q ss_pred EEEeeEeecCceEEEEEEEc----CCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 10 RLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~----~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.+.+.||.|.||.||+|.+. ..+..|+||++.... ...+..|+++++.++ |++|..+.++.......++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccc-ccccccccccccccccccccc
Confidence 57899999999999999987 346789999974432 346889999999996 555555656666767789999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 82 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 82 e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||+ +++|.+++... ...+++..++.|+.||+.||.|||+++|+|+||+++|||++ .++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~---~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD---SNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE---TTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccc
Confidence 999 68999999876 56799999999999999999999999999999999999995 68899999999998763222
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. .......+...|+|||.+.+..++.++||||||+++|||++ |+.||.+.. ..+....+...... .
T Consensus 158 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~~~~~~~----~ 225 (259)
T PF07714_consen 158 KY-----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKLKQGQRL----P 225 (259)
T ss_dssp SE-----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHHHTTEET----T
T ss_pred cc-----ccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccc----e
Confidence 11 11233457789999999999889999999999999999999 789997753 33334444332221 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 272 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 272 (473)
....+|..+.++|..||..||++||++.+|.+.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2346899999999999999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=305.75 Aligned_cols=256 Identities=21% Similarity=0.327 Sum_probs=201.9
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCC---CcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
.++|.+.++||.|+||.||+|.+... ...|+||...... ...+..|+.+++.+.|.+++..+..+ . ....+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~-~~~~~ 82 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI-T-ENPVW 82 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEE-c-CCCcE
Confidence 46799999999999999999987644 3468999854332 33578899999999976666655443 3 34567
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
++|||+ +++|.+++......+++..++.++.||+.||+|||++|++|+||||+|||++ ..+.+||+|||+++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeeccc
Confidence 999998 7899999986556799999999999999999999999999999999999995 678999999999986654
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... .....+......
T Consensus 160 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~~~~~--- 227 (270)
T cd05056 160 ESYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIENGERL--- 227 (270)
T ss_pred ccce------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCCcC---
Confidence 3211 1122344568999999988889999999999999999986 99999775432 222222222111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.....+|.++.++|.+||..+|++||++.++.+.|+++..++
T Consensus 228 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 228 -PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 123567899999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.03 Aligned_cols=251 Identities=22% Similarity=0.252 Sum_probs=195.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.++|++.+.||.|+||.||+|.+..+++.||||.+.... ...+..|+.+++.++|. +|..+..+....+..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHA-NIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCc-ceeeEEEEEecCCeEEEEE
Confidence 478999999999999999999998899999999853322 23467899999999865 4555666677888999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc---CCCCEEECccccccccCCCCc-
Confidence 9998899999886666799999999999999999999999999999999999994 678899999999875432111
Q ss_pred cccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh---cc------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---KK------ 231 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~---~~------ 231 (473)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ......+.. ..
T Consensus 159 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred ------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhh
Confidence 1122356889999999876 45899999999999999999999999764321 111111110 00
Q ss_pred ----------------ccccHHHHhcCCc--HHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 ----------------VSTSIEALCRGYP--TEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 ----------------~~~~~~~l~~~~p--~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
....+......+. .++.+++.+||+.+|++||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l 286 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHh
Confidence 0011111222334 7889999999999999999988775
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=309.85 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=197.1
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
...+|++.+.||.|+||.||+|.+..+++.|+||...... ...+..|+.+++.+.|.+.+. +..++..+...++||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~-~~~~~~~~~~~~lv~ 96 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN-YLDSYLVGDELWVVM 96 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEee-EEEEEEeCCEEEEee
Confidence 3578999999999999999999999999999999854433 345778999999988655544 444556677899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|.+++. ...+++.+++.++.||+.||.|||++||+||||||+|||++ .++.++|+|||++........
T Consensus 97 e~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~---~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 97 EYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEECccccchhcccccc
Confidence 999 789999986 34689999999999999999999999999999999999994 678999999999876543221
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....... ..+. +..... .. ....
T Consensus 172 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~-~~~~~~-~~-~~~~ 239 (296)
T cd06654 172 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYL-IATNGT-PE-LQNP 239 (296)
T ss_pred -------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHH-HhcCCC-CC-CCCc
Confidence 1123478899999999998889999999999999999999999997643311 1111 111111 01 1112
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..++..+.++|.+||..+|++||++.+|++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 457789999999999999999999888754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=320.22 Aligned_cols=257 Identities=23% Similarity=0.326 Sum_probs=196.6
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCC-eEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD-YNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~-~~~lv~e 82 (473)
++|.-...||+|+||.||+|.. .++..||||...... ..+|..|+.++..++ |+++..+.+|+.+.+ ..+||+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLR-HPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCC-CcCcccEEEEEecCCceEEEEEE
Confidence 5777889999999999999985 455899999854433 457999999999999 555555566666666 5999999
Q ss_pred cC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---CcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 83 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
|+ .|+|.+.+..... .++|...++|+.++|.||+|||+.. |||||||++|||+ |.+..+||+|||+|+....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCc
Confidence 99 7899999985555 8999999999999999999999843 9999999999999 5899999999999976543
Q ss_pred -CCCccccccccCCCc-ccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC---HHHHH-HHHhhcc
Q 011988 158 -TATHQHIPYRENKNL-TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKY-EKISEKK 231 (473)
Q Consensus 158 -~~~~~~~p~~~~~~~-~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~---~~~~~-~~i~~~~ 231 (473)
.... ... .||..|+|||++..+..+.|+|||||||+|+||++|+.+.+...... ..... ..+....
T Consensus 230 ~~~~~--------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~ 301 (361)
T KOG1187|consen 230 GDTSV--------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK 301 (361)
T ss_pred cccce--------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence 2111 112 79999999999998899999999999999999999998887543111 11111 1111111
Q ss_pred ccccHHH-Hh-cCCc-----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 232 VSTSIEA-LC-RGYP-----TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 232 ~~~~~~~-l~-~~~p-----~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
....+.. +. ..++ ..+..+...|+..+|.+||++.++.+.|+.+.
T Consensus 302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 1111111 11 1223 23667888999999999999999988885543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=329.02 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=205.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCc---E-EEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE---E-VAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~-vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
++-.+.++||+|+||+||+|.....+. . ||||.... ....++..|+++++.|+| ++|..++++......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H-~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNH-PNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEcCCCc
Confidence 445567999999999999999775422 3 89998442 224458899999999994 555666678888999
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
.+||||+| ||+|.++++.....++..+.+.++.+.+.||+|||++++|||||-..|+|++ ..+.+||+|||+++..
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCccccccCC
Confidence 99999999 8899999997766799999999999999999999999999999999999995 5677899999998754
Q ss_pred cCCCCccccccccCC-CcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 156 RDTATHQHIPYRENK-NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~-~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
..-.. .. ...-..+|+|||.+....|+.++|||||||++||+++ |..||.+....+.. .++......
T Consensus 313 ~~~~~--------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---~kI~~~~~r 381 (474)
T KOG0194|consen 313 SQYVM--------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---AKIVKNGYR 381 (474)
T ss_pred cceee--------ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH---HHHHhcCcc
Confidence 31111 11 1124578999999999999999999999999999999 89999997664333 333222222
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.. .....|.++..++..||..+|++||++.++.+.|+.+....
T Consensus 382 ~~---~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 382 MP---IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred CC---CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 21 12367899999999999999999999999999999987544
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=303.31 Aligned_cols=246 Identities=22% Similarity=0.324 Sum_probs=198.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.++|++.+.||.|+||.||+|.. .++.||||...... ...+..|+.+++.++|.+++.. ..+.......+++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~-~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQL-LGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeee-EEEEcCCCCeEEEEEe
Confidence 56899999999999999999985 48899999855443 3568889999999986665544 4445557788999999
Q ss_pred C-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+ +++|.+++..... .+++..++.++.|++.||.|||++||+|+||||+||+++ .++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~---~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe---CCCCEEEcccccccccccccc-
Confidence 9 5799999875432 689999999999999999999999999999999999994 778999999999986633211
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
...++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+..... ....
T Consensus 158 ---------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~ 221 (256)
T cd05039 158 ---------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKGYR----MEAP 221 (256)
T ss_pred ---------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcCCC----CCCc
Confidence 2244668999999998889999999999999999997 9999976432 222222222111 1123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
..+|+++.++|..||..+|++||++.+|.+.|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 4678999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=308.37 Aligned_cols=245 Identities=18% Similarity=0.275 Sum_probs=193.9
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
.|++.+.||.|+||.||+|.+..++..+++|...... ...+..|+.+++.+.|.+.+. +..++......+++|||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~-~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK-LLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeee-EEEEEeeCCEEEEEEEec
Confidence 4788999999999999999999999999999865433 234678999999998665554 444556677889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 -g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|..++......+++..+..++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++........
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~~~~~~~~--- 158 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQ--- 158 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---cCCCEEEcccccccccccccc---
Confidence 7788888765556799999999999999999999999999999999999994 678899999999976543221
Q ss_pred cccccCCCcccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 164 IPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
......|+..|+|||++. +..++.++|||||||++|||++|..||..... ...+..+....... ..
T Consensus 159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~--~~ 229 (282)
T cd06643 159 ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPT--LA 229 (282)
T ss_pred ----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHhhcCCCC--CC
Confidence 123457899999999984 44578899999999999999999999976432 22233322211111 11
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
....++.++.++|..||+.||++||+++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 259 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQL 259 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 123578999999999999999999998776
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=310.81 Aligned_cols=258 Identities=19% Similarity=0.259 Sum_probs=200.5
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCc----EEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
.-.++|++.+.||+|+||.||+|.+..+++ .||+|+...... ..+..|+.+++.+.|.+++..+..+ ...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-~~~- 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVC-LSP- 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE-cCC-
Confidence 345789999999999999999999887776 468887544332 2467899999999876666655544 333
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..+++++|+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~---~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK---SPNHVKITDFGLARL 158 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec---CCCceEEcccccccc
Confidence 356788888 7899999886666789999999999999999999999999999999999994 677899999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
+....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+..... +..+......
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~ 229 (303)
T cd05110 159 LEGDEKEY-----NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----IPDLLEKGER 229 (303)
T ss_pred ccCccccc-----ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHCCCC
Confidence 64322110 1123345778999999999899999999999999999997 999997753211 2222221111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
.. ....++..+.+++..||..+|++||++.+|.+.|+.+...
T Consensus 230 ~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 230 LP---QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11 1235678999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=310.02 Aligned_cols=260 Identities=18% Similarity=0.250 Sum_probs=202.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++.+.||+|+||.||++.+..+++.|+||.+.... ...+..|+++++.++|++ |..+...+......+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF-VVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC-eeeeEEEEecCCEEEEE
Confidence 57999999999999999999999999999999854432 234678999999998654 44555666677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ |++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++ ..+.+||+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~---~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 80 MEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC---CCCCEEEeeCCCccccCcCc
Confidence 9999 78999999743 5699999999999999999999999999999999999994 77899999999987432111
Q ss_pred Cccc--------cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011988 160 THQH--------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231 (473)
Q Consensus 160 ~~~~--------~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 231 (473)
.... ..........|+..|+|||.+.+..++.++|||||||++|||++|..||.+... .+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~~~~~~~~ 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDD 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcc
Confidence 1000 000111235678899999999988899999999999999999999999976432 23333322221
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 232 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 232 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
...+. ....+|.++.++|.+||+.+|++||+...+.++|++.+
T Consensus 233 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 233 IEWPE--GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred cCCCC--ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 11111 11257899999999999999999999888888787754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=302.52 Aligned_cols=249 Identities=20% Similarity=0.317 Sum_probs=200.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
.++|++.++||.|+||.||+|.+..+++.|++|...... ..++..|+++++.++|.+++ .+..+.......++++|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~-~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIV-KYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEe-eeeeeeecCCcEEEEEecC
Confidence 368999999999999999999998889999999854332 56788999999999755544 5555556678889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 -g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++......+++..++.++.||+.||.|||+.||+|+||+|+||+++ .++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~---~~~~~~l~dfg~~~~~~~~~~--- 154 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---EEGQAKLADFGVSGQLTDTMA--- 154 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC---CCCcEEEcccccchhcccCcc---
Confidence 6799999986677899999999999999999999999999999999999994 678899999999987654321
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||....... ....+..... . .......+
T Consensus 155 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~-~-~~~~~~~~ 225 (256)
T cd06612 155 ----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---AIFMIPNKPP-P-TLSDPEKW 225 (256)
T ss_pred ----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---hhhhhccCCC-C-CCCchhhc
Confidence 1133468899999999999899999999999999999999999997643321 1111111110 0 01112346
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 244 PTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
+.++.++|..||+.||++||++.+|++
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 789999999999999999999888753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=308.89 Aligned_cols=247 Identities=17% Similarity=0.256 Sum_probs=195.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
++|++++.||+|+||.||+|.+..++..||+|.+.... ...+.+|+.+++.++|++++..+ .++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~-~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY-GAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhh-hheecCCeEEEEEe
Confidence 47999999999999999999999899999999754321 24577899999999865555444 45566788899999
Q ss_pred cC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 83 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 83 ~~-g~sL~~~l~~~--~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
|+ +++|..++... ...+++..+..++.||+.||.|||+ .||+|+||||+|||++ ..+.+||+|||++..+...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCcccccCC
Confidence 99 77998888743 2369999999999999999999997 5999999999999995 6789999999999766432
Q ss_pred CCccccccccCCCcccCccccccccccCCC------CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~------~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
.. ....|+..|+|||.+.+.. ++.++|||||||++|+|++|..||...........+..+.....
T Consensus 157 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd06622 157 LA---------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP 227 (286)
T ss_pred cc---------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence 21 2346888999999986543 58899999999999999999999976443322223333322221
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
. .+...++.++.++|..||..+|++||++.+|.+
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 P----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred C----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1 223457899999999999999999999887754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=310.76 Aligned_cols=251 Identities=17% Similarity=0.268 Sum_probs=195.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
++|.+.++||+|+||.||++.+..+++.||||...... ...+..|+.++..+..+++|..+..+.......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 46778899999999999999999999999999854432 33577899999999755666666666667778899999
Q ss_pred cCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 83 LLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 83 ~~g~sL~~~l~~----~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
|++.+|.++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++ ..+.+||+|||+++.+..
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc---cCCcEEEeecchhHHhcc
Confidence 999888776542 23569999999999999999999997 5999999999999994 678899999999976544
Q ss_pred CCCccccccccCCCcccCccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~---~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
... .....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ...+.+..+.......
T Consensus 161 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~ 230 (288)
T cd06616 161 SIA--------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPI 230 (288)
T ss_pred CCc--------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCc
Confidence 321 1234688999999999876 68999999999999999999999997643 1222222222211111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
........++.++.+||..||..+|++||++++|+.
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111112347899999999999999999999888743
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=309.08 Aligned_cols=248 Identities=21% Similarity=0.303 Sum_probs=197.8
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.++|++.++||.|+||.||+|.+..+++.||+|+..... ...+..|+.+++.++| +++..+..++......++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH-PNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEecCCeEEEEee
Confidence 367999999999999999999998899999999854433 2357789999999995 555556556667888999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++......+++..++.++.|++.||.|||++||+|+||||+||+++ .++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~---~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT---LDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC---CCCCEEEccCccchhhccccc-
Confidence 99 7799999886667799999999999999999999999999999999999994 778999999999876543221
Q ss_pred cccccccCCCcccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 162 QHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
......|+..|+|||.+. +..++.++|||||||++|||++|..||..... ...+..+.......
T Consensus 159 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-- 227 (280)
T cd06611 159 ------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MRVLLKILKSEPPT-- 227 (280)
T ss_pred ------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HHHHHHHhcCCCCC--
Confidence 113457899999999975 34467899999999999999999999976532 22233332221111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
......++.++.++|..||..+|++||++.+++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 011235788999999999999999999988773
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=307.65 Aligned_cols=252 Identities=19% Similarity=0.205 Sum_probs=194.6
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc--------hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH--------PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~--------~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
+|.+.+.||.|+||.||+|.+..+++.||||.+..... ..+..|+.+++.++|.+++..+ .+.......++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~-~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLL-DVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhh-heeecCCEEEE
Confidence 58999999999999999999998999999998544322 2356799999999965555544 45555788999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 80 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 80 v~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||||++++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.++|+|||+++......
T Consensus 80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc---CCCCEEEccceeeeeccCCC
Confidence 999999999999975444699999999999999999999999999999999999995 67899999999998765432
Q ss_pred CccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc-------
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------- 231 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~------- 231 (473)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|..||.+........+........
T Consensus 157 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 157 R-------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred c-------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 1 1123356788999999865 457899999999999999999988887644322111111110000
Q ss_pred -------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 232 -------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 232 -------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.......+....+.++.++|..||..+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 011122233456789999999999999999999887744
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=302.72 Aligned_cols=252 Identities=20% Similarity=0.345 Sum_probs=198.8
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+..++|++.++||+|+||.||+|.+. .+..||+|...... ...+.+|+.+++.++|.+++..+..+ .. ...+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~-~~~~~v~ 79 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TK-EPIYIIT 79 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEE-cC-CCeEEEE
Confidence 45789999999999999999999854 55679999854432 34678899999999876666554443 33 6678999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 82 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 82 e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||+ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||+++ ..+.+||+|||++..+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCCcceeeccCCC
Confidence 999 67999998743 34588899999999999999999999999999999999994 77899999999997664322
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. ......++..|+|||++.+..++.++|||||||++|++++ |..||.+.... .....+...... .
T Consensus 157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~~~----~ 223 (260)
T cd05073 157 YT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERGYRM----P 223 (260)
T ss_pred cc------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCCCC----C
Confidence 11 1123345678999999998889999999999999999998 99999875432 222222221111 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
....++.++.+++.+||..+|++||++.+|.+.|+.
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 224678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=308.98 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=198.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcC-----CCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
.++|++.+.||.|+||.||+|.+.. ++..||||+..... ...+..|+.+++.+.|. ++..+..++..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~-~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP-NIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCC-chheEEEEEcCCCc
Confidence 4679999999999999999998743 67889999865433 24577899999999865 45555556667778
Q ss_pred EEEEEecC-CCCHHHHHHHcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEE
Q 011988 77 NVLVIDLL-GPSLEDLFNFCS---------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 134 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~---------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NIL 134 (473)
.+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 89999998 679999986321 24788899999999999999999999999999999999
Q ss_pred EeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 011988 135 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ 213 (473)
Q Consensus 135 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~ 213 (473)
++ .++.++|+|||++..+..... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 163 ~~---~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 163 VG---ENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred ec---CCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 94 678999999999876533221 111122345678999999998899999999999999999997 889997
Q ss_pred CCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 214 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 214 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
+... .+....+...... .....++.++.++|.+||+.+|++||++.+|.+.|+
T Consensus 235 ~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 235 GMAH---EEVIYYVRDGNVL----SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCH---HHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 6433 2333333322221 123467899999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=306.52 Aligned_cols=246 Identities=21% Similarity=0.283 Sum_probs=193.8
Q ss_pred eeEeecCceEEEEEEEcCCCc--EEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNE--EVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~--~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|.+..++. .+++|...... ...+..|+.++..+.+|++|..+..++......+++|||+ +
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999888775 46888754322 2457789999999976777777777777778889999998 7
Q ss_pred CCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecC
Q 011988 86 PSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 150 (473)
Q Consensus 86 ~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 150 (473)
++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~---~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc---CCCeEEECCCC
Confidence 89999986432 2478999999999999999999999999999999999994 77899999999
Q ss_pred CcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhh
Q 011988 151 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 229 (473)
Q Consensus 151 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 229 (473)
++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.+... ...+..+..
T Consensus 158 l~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~ 226 (270)
T cd05047 158 LSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQ 226 (270)
T ss_pred Cccccchhh--------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHHHhC
Confidence 986322110 0112234567999999988889999999999999999997 9999976432 222222222
Q ss_pred ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 230 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 230 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
.... .....++.++.+++.+||..+|.+||++.++...|+.++
T Consensus 227 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 GYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCC----CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111 122356789999999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=298.86 Aligned_cols=245 Identities=21% Similarity=0.259 Sum_probs=200.8
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+|++.+.||.|+||.||.+++..+++.|++|..... ....+.+|+.+++.++|. ++..+..+.......+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~-~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP-NIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCC-CeeEEEeEEecCCeEEEEEE
Confidence 699999999999999999999999999999974332 234578899999999754 55555556667788999999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +++|.+++... ...+++..+..++.|++.||.|||+.||+|+||||+||+++ ..+.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEEcccccc
Confidence 99 78999998754 34689999999999999999999999999999999999995 678899999999987644331
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
......|+..|+|||++.+..++.++|||||||++|||++|..||.... ..+....+....... ..
T Consensus 157 -------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~----~~ 222 (256)
T cd08221 157 -------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTP----VV 222 (256)
T ss_pred -------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCC----Cc
Confidence 1134578999999999998889999999999999999999999997633 333344443332222 12
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..++.++.++|.+||..+|++||++.++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 567899999999999999999999888865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=317.70 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=195.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEe-----
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE----- 73 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~----- 73 (473)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.+. ....+.+|+.+++.++|.+++..+..+...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4678999999999999999999999999999999986432 123466899999999977777666555432
Q ss_pred CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 74 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 74 ~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
....++||||++++|.+.+.. .++...+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~---~~~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEccCccce
Confidence 235799999999999998863 289999999999999999999999999999999999994 77899999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ..+..+......
T Consensus 167 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~ 235 (353)
T cd07850 167 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI---DQWNKIIEQLGT 235 (353)
T ss_pred eCCCCCC--------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCC
Confidence 6543221 12346889999999999999999999999999999999999999764321 112111110000
Q ss_pred -------------------------ccHHHH-------------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 234 -------------------------TSIEAL-------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 234 -------------------------~~~~~l-------------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.....+ ....+.++.++|..||..||++||++.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL 309 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh
Confidence 000010 112466789999999999999999987773
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=309.15 Aligned_cols=255 Identities=18% Similarity=0.266 Sum_probs=196.2
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
++|++.++||+|+||.||++.+..++..||+|...... ..++..|+++++.++|++++ .+..++..++..+++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV-GFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCC-eEEEEEeeCCEEEEEee
Confidence 47999999999999999999999999999999854332 23477899999999865544 55555677888999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +++|.+++... ..+++..+..++.||+.||.|||+ .+|+|+||||+|||++ .++.+||+|||++........
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~~ 155 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMA 155 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe---cCCcEEEccCCCccccccccc
Confidence 99 78999999754 568999999999999999999998 6999999999999995 678899999999876543221
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh-----------
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----------- 229 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~----------- 229 (473)
....|+..|+|||.+.+..++.++|||||||++|+|++|..||...........+.....
T Consensus 156 ---------~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 156 ---------NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ---------ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 345789999999999988899999999999999999999999965332111110100000
Q ss_pred ------------------ccccccHHHH-hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 230 ------------------KKVSTSIEAL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 230 ------------------~~~~~~~~~l-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
.........+ ...++.++.+++.+||..+|++||++.+| +++.|..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l---l~~~~~~ 291 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL---TKHPFIK 291 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHH---hcChhhh
Confidence 0000000000 01357889999999999999999997776 5555443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=307.15 Aligned_cols=246 Identities=21% Similarity=0.312 Sum_probs=196.8
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
..+|++.+.||.|+||.||+|.+..+++.|+||.+.... ...+..|+.+++.++|++++. +..+....+..++++|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e 96 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN-FLDSFLVGDELFVVME 96 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceee-eeeeEecCceEEEEEE
Confidence 357999999999999999999999999999999854322 345778999999998666554 4445566778899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++. ...+++.+++.++.|++.||.|||++||+|+||||+||+++ .++.+||+|||++........
T Consensus 97 ~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~---~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 97 YLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG---MDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred ecCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccchhcccccc-
Confidence 99 889999886 34689999999999999999999999999999999999994 678999999999876543221
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.... .....+..... . ......
T Consensus 171 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~---~~~~~~~~~~~-~-~~~~~~ 239 (296)
T cd06655 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLIATNGT-P-ELQNPE 239 (296)
T ss_pred ------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCC-c-ccCCcc
Confidence 112357889999999999888999999999999999999999999774331 11222211111 0 111234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.+++.+.++|.+||..||++||++.+|+
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 5789999999999999999999988773
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=305.31 Aligned_cols=243 Identities=22% Similarity=0.327 Sum_probs=197.9
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
++|++.+.||.|+||.||+|.+..+++.||+|+..... ...+..|+.+++.++|.+++ .+..+...+...++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT-KYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCee-eeeEEEEECCeEEEEEE
Confidence 57999999999999999999999999999999854332 23578899999999965544 45556667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++... .+++..++.++.||+.||.|||+++|+|+||+|+||+++ +++.++|+|||+++.+.....
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEcccccceeeccccc-
Confidence 99 77999998743 799999999999999999999999999999999999994 688999999999987754321
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+...... .+..
T Consensus 154 ------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~----~~~~ 220 (274)
T cd06609 154 ------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLIPKNNPP----SLEG 220 (274)
T ss_pred ------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHhhhcCCC----CCcc
Confidence 12345788999999999998899999999999999999999999976442 2222222222111 1112
Q ss_pred C-CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 242 G-YPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 242 ~-~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
. ++.++.+++.+||..+|++||+++++.
T Consensus 221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~il 249 (274)
T cd06609 221 NKFSKPFKDFVSLCLNKDPKERPSAKELL 249 (274)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 2 789999999999999999999988774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=303.52 Aligned_cols=252 Identities=21% Similarity=0.335 Sum_probs=196.2
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEe------CC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVE------GD 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~------~~ 75 (473)
.-.++|++.+.||.|+||.||+|.+..+++.|++|+..... ...+..|+.+++.+..|+++..+..+... +.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 34689999999999999999999998899999999854433 35688999999999655666555555433 34
Q ss_pred eEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCC
Q 011988 76 YNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 151 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 151 (473)
..+++|||+ +++|.+++... +..+++..++.++.||+.||.|||++||+|+||+|+||+++ .++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~---~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc---cCCeEEECCCcc
Confidence 589999999 67999988643 35799999999999999999999999999999999999995 678899999999
Q ss_pred cccccCCCCccccccccCCCcccCccccccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 011988 152 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 226 (473)
Q Consensus 152 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-----~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~ 226 (473)
+......... .....|+..|+|||++.+. .++.++|||||||+||+|++|..||...... ..+..
T Consensus 160 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~ 229 (275)
T cd06608 160 SAQLDSTLGR-------RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFK 229 (275)
T ss_pred ceecccchhh-------hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHH
Confidence 9765432211 1345689999999988643 4678999999999999999999999764322 22222
Q ss_pred HhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 227 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 227 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
+....... . .....++.++.++|..||..||++||++.+|++
T Consensus 230 ~~~~~~~~-~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNPPPT-L-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccCCCC-C-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 22211111 0 011236789999999999999999999888754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=304.13 Aligned_cols=251 Identities=20% Similarity=0.247 Sum_probs=194.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.+.|.+ +..+..+.......+++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHAN-IVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCC-EeEEEEEEecCCeEEEEE
Confidence 468999999999999999999999999999999854322 224678999999998655 556666677788899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
||++++|.+++......+++..+..++.||+.||.|||++||+|+||||+|||++ ..+.+||+|||+++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS---YLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc---CCCcEEEeccccccccCCCCC-
Confidence 9999999888765555688999999999999999999999999999999999994 678999999999975433211
Q ss_pred cccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc---------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 231 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 231 (473)
......++..|+|||.+.+. .++.++|||||||++|||++|..||.+... ..+.+.++....
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 159 ------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred ------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhh
Confidence 11234578999999998764 478999999999999999999999976432 122222211000
Q ss_pred ----------------ccccHHHHhc--CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 ----------------VSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 ----------------~~~~~~~l~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.......+.. ..+.++.+++.+|+..||.+||++.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 0001111111 1257899999999999999999988764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.37 Aligned_cols=256 Identities=20% Similarity=0.279 Sum_probs=206.1
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCc-----EEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~-----~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
.+-++.+.||.|.||.||.|......- .||||.+.+. +..+|.+|..+|..++|+|++..+..+.. ....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCCc
Confidence 457789999999999999999764322 4888875544 24458999999999997777666655544 7788
Q ss_pred EEEEecC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecC
Q 011988 78 VLVIDLL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 150 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 150 (473)
+|++||| ||+|..+|... ...++..+.+.|+.|||+|++||+++++|||||...|+||+ ....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---ERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---ccCcEEEcccc
Confidence 9999999 99999999977 55699999999999999999999999999999999999995 66999999999
Q ss_pred CcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhh
Q 011988 151 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 229 (473)
Q Consensus 151 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 229 (473)
+|+.+-+... |+......-...|||||.+....++.|+|||||||+|||+++ |..||.+.... +.+..+.+
T Consensus 848 lArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---~v~~~~~~ 919 (1025)
T KOG1095|consen 848 LARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---EVLLDVLE 919 (1025)
T ss_pred hhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---HHHHHHHh
Confidence 9995443332 222222233478999999999999999999999999999999 99999886543 22222222
Q ss_pred ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 230 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 230 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
... -..+..||+.++++|..||+.+|++||+|..|++.+..++..
T Consensus 920 ggR----L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 920 GGR----LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CCc----cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 221 112468999999999999999999999999999988877653
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=298.83 Aligned_cols=253 Identities=20% Similarity=0.334 Sum_probs=210.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
++.+++..||.|+.|+||+++.+.+|..+|||.+.+... ..+.+.++++.....++.|+...+|+..+...+|.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 445677889999999999999999999999999655443 3456666666666668999999999999989999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
++..-++.+++...+++++..+-++...++.||.||-+ +||||||+||+|||+ |..|++||||||++-.+.+...+
T Consensus 172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeeccccc
Confidence 99999999999888899999999999999999999986 689999999999999 58999999999999888776543
Q ss_pred cccccccCCCcccCccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~---~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
....|.+.|||||.+.-. .|+.++||||||++|+||+||..||.+.+ ...+.+-++..... +.+.
T Consensus 249 --------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~--tdFe~ltkvln~eP-P~L~- 316 (391)
T KOG0983|consen 249 --------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK--TDFEVLTKVLNEEP-PLLP- 316 (391)
T ss_pred --------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC--ccHHHHHHHHhcCC-CCCC-
Confidence 345899999999998743 58999999999999999999999999864 34555555555332 2221
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
...++++.|.+|+..||.+|+.+||.|.+| |++-|.
T Consensus 317 ~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~L---l~h~Fi 352 (391)
T KOG0983|consen 317 GHMGFSPDFQSFVKDCLTKDHRKRPKYNKL---LEHPFI 352 (391)
T ss_pred cccCcCHHHHHHHHHHhhcCcccCcchHHH---hcCcce
Confidence 124589999999999999999999999877 445443
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.75 Aligned_cols=262 Identities=22% Similarity=0.236 Sum_probs=198.3
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeE-------
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGV------- 72 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~------- 72 (473)
..++|.+.++||.|+||.||+|.+..+++.||||++.... ...+.+|+++++.++|++++..+..+..
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 3578999999999999999999999999999999843221 2346789999999998776665544432
Q ss_pred eCCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 73 EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 73 ~~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
.....+++|+|++.+|.+.+......+++..++.++.||+.||.|||++||+|+||||+|||+ ++++.++|+|||++
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~ 162 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLA 162 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCccc
Confidence 234579999999999988887556679999999999999999999999999999999999999 47889999999999
Q ss_pred ccccCCCCcccc----ccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 011988 153 KRYRDTATHQHI----PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 227 (473)
Q Consensus 153 ~~~~~~~~~~~~----p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i 227 (473)
+........... .........|+..|+|||.+.+. .++.++|||||||++|||++|+.||.+.......+.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 866543221110 01112345678899999988764 4789999999999999999999999765433222222111
Q ss_pred hh----------------------ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 228 SE----------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 228 ~~----------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.. .............+.+++.++|..||..||++||++.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 10 0011111222234567899999999999999999987774
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=302.94 Aligned_cols=244 Identities=20% Similarity=0.297 Sum_probs=195.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
.++|++.+.||.|+||.||++. .+++.||+|+.... ....+..|+.+++.++|++.+..+..+ .. +..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~-~~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI-LH-NGLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEE-cC-CCcEEEEECC
Confidence 4679999999999999999987 47888999985443 334678899999999977766665544 33 3468999998
Q ss_pred -CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 85 -GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 85 -g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|||++ .++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~---~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCcEEECCCccceeccccC---
Confidence 789999997543 3589999999999999999999999999999999999994 67899999999997643321
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
.....+..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+... ... ....
T Consensus 155 -------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~-~~~---~~~~ 220 (254)
T cd05083 155 -------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVKECVEKG-YRM---EPPE 220 (254)
T ss_pred -------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHHhCC-CCC---CCCC
Confidence 12234568999999998899999999999999999997 9999977543 2222222221 111 1235
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
.+|.++.+++..||+.+|++||++++|.+.|+
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 67899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=302.47 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=197.7
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ...+..|+++++.++|.+++..+ .+..+....+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~-~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRML-GATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhh-ceeccCCeEE
Confidence 5889999999999999999999999999999864332 24578899999999866655544 4556667788
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++ .....+||+|||++..+..
T Consensus 80 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 80 LFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccccccccccc
Confidence 999998 7899999874 44789999999999999999999999999999999999995 2334699999999987754
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
...... .......|+..|+|||.+.+..++.++|||||||++|+|++|..||..............+...... .
T Consensus 157 ~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 230 (268)
T cd06630 157 KGTGAG---EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA---P 230 (268)
T ss_pred ccccCC---ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC---C
Confidence 322111 0123456889999999999888999999999999999999999999754433322322222211111 1
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.+...+++++.+++.+||..+|++||++.+|+
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll 262 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 22345678999999999999999999988875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=308.38 Aligned_cols=248 Identities=21% Similarity=0.278 Sum_probs=195.9
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++.+.||.|+||.||+|.+..+++.||||.+.... ...+..|+++++.++|. +|..+..+.......+++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP-FLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCC-CchhheeeeecCCEEEEE
Confidence 47999999999999999999999899999999865433 23477899999999854 555555666778889999
Q ss_pred EecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 81 IDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
|||+ +++|.+++... ...+++..++.++.||+.||+|||+.||+|+||||+||||+ .++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc---CCCCEEEeecchhhccccc
Confidence 9998 88999998743 35699999999999999999999999999999999999995 6789999999998765432
Q ss_pred CCcccc----------------------ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 011988 159 ATHQHI----------------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 216 (473)
Q Consensus 159 ~~~~~~----------------------p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~ 216 (473)
...... .......+.||..|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 211000 0011234578999999999999889999999999999999999999997644
Q ss_pred CCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC
Q 011988 217 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 264 (473)
Q Consensus 217 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt 264 (473)
. ...+..+........ ....++.++.++|..||..||++||+
T Consensus 237 ~---~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~s 278 (316)
T cd05574 237 R---DETFSNILKKEVTFP---GSPPVSSSARDLIRKLLVKDPSKRLG 278 (316)
T ss_pred h---HHHHHHHhcCCccCC---CccccCHHHHHHHHHHccCCHhHCCC
Confidence 3 233333332222111 01226899999999999999999999
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=299.73 Aligned_cols=248 Identities=21% Similarity=0.229 Sum_probs=208.7
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----------chhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
-++|.-.+.||.|..+.|-.+.++.++..+|+|++.... .+.-..|+.||+++.+|++|..+..+...+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356778889999999999999999999999999843321 122457999999999999999999999999
Q ss_pred CeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
.+.++|+|+| .|.|.|++.. .-.++++....|+.|+++|++|||.++||||||||+|||+ +++.++||+|||+|+
T Consensus 96 sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFAC 171 (411)
T ss_pred chhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceee
Confidence 9999999999 8899999983 4569999999999999999999999999999999999999 588999999999999
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 227 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~------~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i 227 (473)
.+..... ....+||+.|+|||.+... .|+..+|+|++|||||.|+.|..||...+ ....+..|
T Consensus 172 ~l~~Gek--------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlMLR~I 240 (411)
T KOG0599|consen 172 QLEPGEK--------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLMLRMI 240 (411)
T ss_pred ccCCchh--------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHHHHHH
Confidence 8765432 2457999999999998743 37889999999999999999999996532 23344556
Q ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 228 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 228 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.+.+....-+ -+.+++.+.++||.+||..||.+|.|+++++
T Consensus 241 meGkyqF~sp-eWadis~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 241 MEGKYQFRSP-EWADISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred HhcccccCCc-chhhccccHHHHHHHHHeeCchhcccHHHHh
Confidence 6666544333 3467889999999999999999999988774
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=313.54 Aligned_cols=253 Identities=17% Similarity=0.217 Sum_probs=188.3
Q ss_pred EEeeEeec--CceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 11 LGRKIGSG--SFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 11 i~~~LG~G--~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
++++||+| +|++||++.+..+|+.||||.+.... ...+..|+.+++.++|++++ .+..++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIV-PYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCee-eEEEEEEECCEEEEEEec
Confidence 56789999 78999999999999999999864432 23467899999999865555 455566777889999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.++|+||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe---cCCcEEEcccchhhcccccccc
Confidence 9 78999998643 34599999999999999999999999999999999999995 6788999999876544322111
Q ss_pred cccccccCCCcccCccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------ 233 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------ 233 (473)
............++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ....+ .....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~ 234 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKL-NGTVPCLLDTT 234 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHh-cCCcccccccc
Confidence 1000001123457788999999986 3589999999999999999999999976432111 11111 00000
Q ss_pred -----------------------------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 234 -----------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 234 -----------------------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.........+++++.+|+..||+.||++||++++|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000112235678999999999999999999887743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=299.23 Aligned_cols=245 Identities=22% Similarity=0.273 Sum_probs=198.1
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+|++.+.||+|+||.||+|.+..+++.||||.+.... ...+..|+.+++.++|.+.+. +..........+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~-~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIE-YYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhh-eeeeEecCCEEEEEEe
Confidence 5999999999999999999999999999999854332 345788999999998655554 4445567788899999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++ ++.+.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCcc
Confidence 99 78999999754 34589999999999999999999999999999999999995 3456789999999987654321
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
.....|+..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+..... ..+.
T Consensus 158 --------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~----~~~~ 222 (256)
T cd08220 158 --------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMSGTF----APIS 222 (256)
T ss_pred --------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHHhcCC----CCCC
Confidence 1235688999999999988899999999999999999999999976433 222233222211 1233
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..++.++.+++..||..+|++||++.+|..
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 467899999999999999999999888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=305.95 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=199.9
Q ss_pred CCceEEEeeEeecCceEEEEEEEc----CCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEe--CC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVE--GD 75 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~----~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~--~~ 75 (473)
...|++.+.||+|+||.||+|... .+++.||||+...... ..+..|+++++.+.|.+++..+ .++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~-~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYK-GVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEE-eeeecCCCC
Confidence 356889999999999999999864 3478999998654433 4688999999999866555544 44444 55
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..+++|||+ +++|.+++......+++..++.++.||+.||+|||++||+|+||||+|||++ .++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE---SEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccccccc
Confidence 789999999 7899999986655799999999999999999999999999999999999994 678999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCH-----------HHH
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-----------KQK 223 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~-----------~~~ 223 (473)
....... +.......++..|++||.+.+..++.++|||||||++|||++|..||........ ...
T Consensus 159 ~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 159 LPEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred cccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 6532211 1111223456679999999988999999999999999999999999865332110 111
Q ss_pred HHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 224 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 224 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
........... .....+|.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 235 ~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERL---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcC---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111111110 11235678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=302.92 Aligned_cols=254 Identities=21% Similarity=0.241 Sum_probs=195.2
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
++|++.+.||.|+||.||+|.+..+++.||||..... ....+..|+++++.+.|+ ++..+..+.......++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG-NIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCC-CEeeEEEEEecCCeEEEEE
Confidence 6799999999999999999999989999999985332 224578899999999865 4555666667778999999
Q ss_pred ecCCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||++++|.+++..... .+++..++.++.||+.||+|||++||+|+||||+||+++ ...+.+||+|||++........
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCCcc
Confidence 9998899888864332 368889999999999999999999999999999999996 3456799999999976533211
Q ss_pred ccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc---------
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--------- 230 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~--------- 230 (473)
......++..|+|||.+.+. .++.++|||||||++|+|++|..||..................
T Consensus 159 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 159 -------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred -------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence 11234678899999998764 5789999999999999999999999764322111111110000
Q ss_pred ------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 231 ------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 231 ------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
............+++++.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011122223467889999999999999999999888754
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=303.44 Aligned_cols=251 Identities=20% Similarity=0.306 Sum_probs=194.9
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEe-----CCeE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-----GDYN 77 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~-----~~~~ 77 (473)
..++|.+.+.||+|+||.||+|.+..+++.||+|+.... ....+..|+.+++.+..|+++..+..++.. ....
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 457899999999999999999999999999999986443 234577899999999555666555544432 2457
Q ss_pred EEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 78 VLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
+++|||+ +++|.++++. ....+++..++.++.|++.||+|||++||+|+||||+||+++ ..+.+||+|||++.
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~---~~~~~kl~dfg~~~ 176 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT---TEGGVKLVDFGVSA 176 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEeecccch
Confidence 9999999 7899998863 345789999999999999999999999999999999999994 67889999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCC-----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 228 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-----~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 228 (473)
........ .....|+..|+|||.+.... ++.++|||||||++|||++|+.||..... ...+..+.
T Consensus 177 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~---~~~~~~~~ 246 (291)
T cd06639 177 QLTSTRLR-------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP---VKTLFKIP 246 (291)
T ss_pred hccccccc-------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH---HHHHHHHh
Confidence 65432211 12346889999999986433 68999999999999999999999976532 22222322
Q ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 229 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 229 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
....... .....++.++.++|.+||..+|++||++.+|.+
T Consensus 247 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 RNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2211110 012345678999999999999999999888754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=300.41 Aligned_cols=246 Identities=24% Similarity=0.317 Sum_probs=193.8
Q ss_pred eeEeecCceEEEEEEEcC-CC--cEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 13 RKIGSGSFGEIYLGTNIQ-TN--EEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~-~~--~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
+.||+|+||.||+|.+.. .+ ..||||.+..... ..+..|+.+++.++|++++..+..+. . ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-T-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-C-CeEEEEEEecC
Confidence 468999999999999865 33 3689998655433 35788999999999776666554443 3 7889999998
Q ss_pred CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+|||++ .++.+||+|||+++.+......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~-- 153 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH-- 153 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe---cCCEEEeccccccccccccccc--
Confidence 889999987544 4689999999999999999999999999999999999995 6689999999999876543221
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
+.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+...... ......
T Consensus 154 --~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~~---~~~~~~ 225 (257)
T cd05040 154 --YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKIDKEGER---LERPEA 225 (257)
T ss_pred --eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhcCCc---CCCCcc
Confidence 111223467789999999998899999999999999999998 9999976533 2223332221111 112245
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
+|..+.+++..||..+|++||++.+|.+.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 7899999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=303.81 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=204.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++.+.||+|+||.||++.+..+++.||||++... ....+..|+++++.+.|. +|..+..+...+...+++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP-FLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCC-CccceeeEEEcCCeEEEE
Confidence 5799999999999999999999999999999985432 234577899999999954 555555666777889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++... ..+++..++.++.||+.||.|||++||+|+||+|.||||+ .++.+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~dfg~~~~~~~~~ 155 (290)
T cd05580 80 MEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD---SDGYIKITDFGFAKRVKGRT 155 (290)
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEeeCCCccccCCCC
Confidence 9999 99999998753 5799999999999999999999999999999999999994 67899999999998764431
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
....|+..|+|||.+.+..++.++||||||+++|+|++|..||.... .......+..... .+
T Consensus 156 ----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~-----~~ 217 (290)
T cd05580 156 ----------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKILEGKV-----RF 217 (290)
T ss_pred ----------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCc-----cC
Confidence 24578999999999998889999999999999999999999997644 2233333332211 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCcccccccc
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILK 293 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 293 (473)
...++..+.++|.+||..||.+|+ +++++ +++ ++....+|....
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l---~~~-------~~~~~~~~~~~~ 266 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDI---KNH-------PWFAGIDWIALL 266 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcccCCHHHH---HcC-------cccccCCHHHHh
Confidence 345689999999999999999998 44444 322 334456677664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=305.94 Aligned_cols=259 Identities=19% Similarity=0.210 Sum_probs=195.0
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEe------
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVE------ 73 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~------ 73 (473)
..++|++.++||.|+||.||+|.+..+++.||||.+.... ...+..|+.+++.+.|++++..+..+...
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3467999999999999999999999999999999853321 22356799999999977777666544332
Q ss_pred -CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 74 -GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 74 -~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
....++||||++++|.+++......+++.+++.++.||+.||+|||++||+|+||||+|||++ ..+.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC---CCCcEEECcCCCc
Confidence 235699999999999999876555799999999999999999999999999999999999994 7789999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 231 (473)
..+....... ........++..|+|||.+.+.. ++.++|||||||++|||++|..||.+.........+..+....
T Consensus 167 ~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 167 RAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred ccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 8765432211 01113446788999999987654 7899999999999999999999997754322222222211100
Q ss_pred c------------------cc-----cHHHHh-cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 V------------------ST-----SIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 ~------------------~~-----~~~~l~-~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
. .. ....+. ...+..+.++|..||..||++||++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 0 00 000000 01246778999999999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=301.77 Aligned_cols=254 Identities=21% Similarity=0.277 Sum_probs=197.2
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
++|++.++||+|+||.||+|.+..+++.||||++... ....+..|+++++.+.|.+ +..+..++...+..+++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN-IVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCC-eeehhheEEECCEEEEEE
Confidence 5799999999999999999999999999999984332 2356889999999999555 445555566788899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
||+++++.+.+......+++..++.++.||+.||.|||++||+|+||+|+||+++ +.+.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~---~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEEeeecccccCCCccc
Confidence 9997776666554556799999999999999999999999999999999999994 6889999999999876543320
Q ss_pred cccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh-----------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----------- 229 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~----------- 229 (473)
......++..|+|||++.+. .++.++|||||||++|+|++|..||.+....+.......+..
T Consensus 157 ------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 157 ------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 11345788999999999988 789999999999999999999999976433211111111100
Q ss_pred ------------ccccccHHH-HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 230 ------------KKVSTSIEA-LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 230 ------------~~~~~~~~~-l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
......... ....++.++.++|..||..+|++||++++|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000001111 12235899999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.37 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=192.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--------chhHHHHHHHHHHhcCCCCCCeeEEeeE-eCCeE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--------HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYN 77 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--------~~~l~~E~~il~~L~~~~~i~~~~~~~~-~~~~~ 77 (473)
.+|++.+.||+|+||.||+|.+..++..|++|+..... ...+..|+.+++.++|++++..+..+.. .....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999853321 1347789999999987666655544433 24678
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+++|||+ +++|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+||++ +.++.+||+|||+++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccccc
Confidence 8999999 7799999874 3468999999999999999999999999999999999999 467889999999997654
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
...... .......++..|+|||.+.+..++.++|||||||++|||++|+.||..... .+.+........ .
T Consensus 158 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~~~~~~~~~~~~---~ 227 (266)
T cd06651 158 TICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQPT---N 227 (266)
T ss_pred cccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---HHHHHHHhcCCC---C
Confidence 321100 011234688999999999998899999999999999999999999976432 222222221111 1
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..+...+++.+.+++ .||..+|++||++++|+
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELL 259 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence 122334678888998 68889999999988874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=317.84 Aligned_cols=254 Identities=22% Similarity=0.312 Sum_probs=209.4
Q ss_pred EEEeeEeecCceEEEEEEEcCC--Cc--EEEEEEccc----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 10 RLGRKIGSGSFGEIYLGTNIQT--NE--EVAIKLNVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~--~~--~vAiK~~~~----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.+.++||.|-||.||+|..... |+ -||||..+. .+.+.|..|.-+|+.+.|+++|..+..+. ....||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~--e~P~Wivm 469 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV--EQPMWIVM 469 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee--ccceeEEE
Confidence 3457899999999999986532 33 488887443 33556899999999999877777665443 34579999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|++ -|-|..+++..+..++..+...++.||+.||.|||++.+|||||...|||++ ...+|||+|||+++.+.+...
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhhccccch
Confidence 999 8899999998888899999999999999999999999999999999999995 778999999999998877653
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
.......-..-|||||.+.-..++.++|||-|||++||++. |..||++.++.+....+++... ...
T Consensus 547 ------YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-------lP~ 613 (974)
T KOG4257|consen 547 ------YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-------LPC 613 (974)
T ss_pred ------hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC-------CCC
Confidence 22223333567999999999999999999999999999987 9999999887654444433222 223
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCC
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 281 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 281 (473)
++.||+.++.|+.+||.++|.+||++.+|+..|.++++.+..
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 568999999999999999999999999999999999986553
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=307.57 Aligned_cols=252 Identities=17% Similarity=0.267 Sum_probs=195.9
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.++|++.++||+|+||+||++.+..+++.||+|+..... ...+..|+++++.++|+ ++..+..+.......++||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSP-YIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCC-CcceEeeeEecCCEEEEEE
Confidence 367999999999999999999999999999999843322 34578899999999854 4555555566678899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||+ +++|.+++.. .+.+++..+..++.|++.||.|||+ .+|+||||||+||+++ +.+.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 83 EFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN---SRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred ecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC---CCCcEEEccCCcccchhhhc
Confidence 999 7799988874 4568999999999999999999997 6999999999999994 67899999999987553322
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC----HHHHHHHHhhcccccc
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT----KKQKYEKISEKKVSTS 235 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~----~~~~~~~i~~~~~~~~ 235 (473)
. ....|+..|+|||++.+..++.++|||||||++|+|++|..||....... ....+...........
T Consensus 159 ~---------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd06620 159 A---------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229 (284)
T ss_pred c---------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence 1 23578999999999998889999999999999999999999998644310 0000111111111010
Q ss_pred HHHHh-cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011988 236 IEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 271 (473)
Q Consensus 236 ~~~l~-~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~ 271 (473)
...+. ..++.++.+++.+||..||++||++.++.+.
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11111 1367899999999999999999999888653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=304.74 Aligned_cols=245 Identities=21% Similarity=0.331 Sum_probs=197.6
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
...|+..++||.|+||.||+|.+..++..||||+..... ...+..|+.+++.+.| +++..+..++......++||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEEEEE
Confidence 356889999999999999999998899999999855432 2347789999999975 55555666677788999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|.+++. ..++++..+..++.|++.||.|||+++++|+||+|+||+++ ..+.++|+|||++........
T Consensus 82 e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 82 EYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred ecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---CCCCEEEcccccceeccCCcc
Confidence 999 779999886 35689999999999999999999999999999999999995 678899999999976643221
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
......++..|+|||++.+..++.++|||||||++|||++|..||...... .....+..... ..+.
T Consensus 157 -------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~----~~~~ 222 (277)
T cd06640 157 -------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---RVLFLIPKNNP----PTLT 222 (277)
T ss_pred -------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---hHhhhhhcCCC----CCCc
Confidence 112346888999999999888999999999999999999999999865432 11111111111 1223
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..++.++.+++..||..+|++||++.+++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 356789999999999999999999988843
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=312.59 Aligned_cols=255 Identities=21% Similarity=0.223 Sum_probs=196.7
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEe----CC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE----GD 75 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~----~~ 75 (473)
+.++|.+.+.||.|+||.||+|.+..+++.||||.+... ....+..|+.+++.++|.+++..+..+... ..
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 678999999999999999999999999999999985432 233567899999999876666555433322 13
Q ss_pred eEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 76 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 76 ~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
..+++|||++++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++..
T Consensus 83 ~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~---~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICDFGLARTT 158 (337)
T ss_pred cEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECcCcccccc
Confidence 5799999999999999874 45799999999999999999999999999999999999994 6789999999999866
Q ss_pred cCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh-----
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----- 229 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~----- 229 (473)
..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 159 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 159 SEKGD-------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred CCCcc-------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 44321 1134568899999998875 4589999999999999999999999976432111111111000
Q ss_pred ------------------ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 230 ------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 230 ------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.............+++++.++|.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 00011122334567899999999999999999999877743
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=297.05 Aligned_cols=244 Identities=23% Similarity=0.336 Sum_probs=193.0
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCC
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 87 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~s 87 (473)
++||.|+||.||+|.+.. ++.||+|+...... ..+..|+++++.+.|. ++..+..++......+++|||+ +++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHP-NIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCC-CeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 479999999999999877 99999998554332 3578899999999855 5555666667778889999998 889
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccc
Q 011988 88 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167 (473)
Q Consensus 88 L~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 167 (473)
|.+++......+++..++.++.|++.||.|||+++|+||||||+|||++ .++.+||+|||++..........
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~~~~~~~~----- 150 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSREEEGGIYTV----- 150 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc---CCCcEEEeeccccccccCCccee-----
Confidence 9999876556789999999999999999999999999999999999994 77899999999997654221100
Q ss_pred cCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHH
Q 011988 168 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 246 (473)
Q Consensus 168 ~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 246 (473)
......++..|+|||.+.+..++.++|||||||++|||++ |..||......... ..+... ... .....+|.+
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~---~~~~~~-~~~---~~~~~~~~~ 223 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---ERIESG-YRM---PAPQLCPEE 223 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH---HHHhcC-CCC---CCCccCCHH
Confidence 0012234567999999998889999999999999999998 89999775432222 222111 111 113457899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 247 FASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 247 l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
+.+++.+||..+|++||++.+|++.|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=298.72 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=199.9
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
++|++.+.||.|+||+||+|.+..++..|++|+..... ...+..|+.+++.++|.++ ..+.......+..+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV-VKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCE-EEEEEEEeeCCEEEEEEe
Confidence 57999999999999999999998899999999854332 3557889999999986554 445555667788899999
Q ss_pred cC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 83 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~--~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
++ +++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++ +++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~---~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccchHHHhccCc
Confidence 99 889999987532 4689999999999999999999999999999999999995 67889999999998776543
Q ss_pred CccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
... ........|+..|++||++... .++.++|||||||++|+|++|+.||...... ..+.+....... ....
T Consensus 157 ~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-~~~~ 229 (267)
T cd06610 157 DRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPP-SLET 229 (267)
T ss_pred ccc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCC-CcCC
Confidence 221 0112445789999999998877 6899999999999999999999999765432 222222221111 1111
Q ss_pred H--hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 239 L--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 239 l--~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
. ...+++++.+++..||..||++||++.+|++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1 1357899999999999999999999887754
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=300.40 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=195.9
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
+|++.++||.|++|.||+|++..+++.||||++... ....+..|+.+++.++| +++..+..++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH-ENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcC-CCEeeeeeeEeeCCcEEEEEec
Confidence 599999999999999999999999999999985432 23456789999999975 5566666667777888999999
Q ss_pred CCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 84 LGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~g~sL~~~l~~~~--~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++ +++.++|+|||++........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~---~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCcEEEeecchhhhhcCCcc-
Confidence 9889999887543 4689999999999999999999999999999999999994 678999999999975543211
Q ss_pred cccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc--------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 232 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 232 (473)
......++..|++||++.+. .++.++|||||||++|+|++|+.||.+.........+........
T Consensus 156 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 156 ------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred ------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 11234678899999998764 478999999999999999999999987543222211111100000
Q ss_pred -------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 -------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
......+...++.++.++|..||+.||++||++.+|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 279 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHh
Confidence 0011222345678999999999999999999988775
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=300.16 Aligned_cols=246 Identities=22% Similarity=0.286 Sum_probs=199.5
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeE-eCCeEEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNVLVI 81 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~-~~~~~~lv~ 81 (473)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ...+..|+.+++.++|++++..+..+.. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999854322 2347789999999997776665554433 456679999
Q ss_pred ecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 82 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVH-----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 82 e~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH-----~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
||+ +++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||+++ ..+.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD---ANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe---cCCCEEEeccccc
Confidence 999 78999998754 457999999999999999999999 99999999999999995 6789999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
......... .....|+..|+|||++.+..++.++||||||+++|+|++|..||.... .......+.....
T Consensus 158 ~~~~~~~~~-------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~ 227 (265)
T cd08217 158 KILGHDSSF-------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGKF 227 (265)
T ss_pred ccccCCccc-------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHhcCCC
Confidence 876543211 123468999999999999889999999999999999999999998743 2233333332222
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..+...++.++.+++..||..+|++||++.+|++
T Consensus 228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1234567899999999999999999999988864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=296.01 Aligned_cols=243 Identities=20% Similarity=0.307 Sum_probs=190.6
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCC
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 87 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~s 87 (473)
++||.|+||.||+|.. .++..||+|+...... ..+..|+.+++.+.|.+++ .+..++......+++|||+ +++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIV-KLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcC-eEEEEEecCCccEEEEECCCCCc
Confidence 4689999999999985 4688999998554332 2477899999999865544 4555566677889999998 889
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccc
Q 011988 88 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167 (473)
Q Consensus 88 L~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 167 (473)
|.+++......+++..++.++.|++.||.|||++|++||||||+||+++ .++.+||+|||++.........
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~~~~~------ 149 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYS------ 149 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc---CCCeEEECCCccceeccccccc------
Confidence 9999875556789999999999999999999999999999999999994 6788999999999754332111
Q ss_pred cCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHH
Q 011988 168 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 246 (473)
Q Consensus 168 ~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 246 (473)
......++..|+|||++.+..++.++|||||||++|++++ |..||.+.... .....+..... . .....++.+
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~~~~~-~---~~~~~~~~~ 222 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVEKGYR-M---SCPQKCPDD 222 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCCC-C---CCCCCCCHH
Confidence 1112244677999999998889999999999999999998 99999875432 22222221111 1 123457899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 247 FASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 247 l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
+.+++.+||..+|++||++.++.+.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=301.92 Aligned_cols=251 Identities=20% Similarity=0.218 Sum_probs=194.5
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+|++++.||.|+||.||+|++..+++.||||.+.... ...+..|+++++.++|++++. +..+.......+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~-~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK-LLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcc-hhhhcccCCcEEEEee
Confidence 5899999999999999999999999999999854322 235788999999998665555 4445567778899999
Q ss_pred cCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+.++|.+++... ...+++..++.++.||+.||+|||++||+|+||+|+||+++ .++.+||+|||++..+.....
T Consensus 80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~---~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEeeccchhhcccCcc-
Confidence 9988999988743 35689999999999999999999999999999999999994 778999999999876543211
Q ss_pred cccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc----------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------- 230 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 230 (473)
......++..|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+......
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 112335688999999987754 588999999999999999999999764322111111110000
Q ss_pred -----------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 -----------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 -----------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
........+...+++++.++|.+||..||++||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 279 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 001112233345788999999999999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=306.95 Aligned_cols=247 Identities=22% Similarity=0.304 Sum_probs=195.7
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.++|.+.+.||.|+||.||+|.+..+++.||||.+.... ...+..|+.+++.+.|.++ ..+..++..+...++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i-~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI-VNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCE-eeEEEEEecCCEEEEeec
Confidence 478999999999999999999999999999999854322 3346788999999876554 445555567788899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++. ...+++..+..++.|++.||.|||+.||+||||||+|||++ .++.++|+|||++.........
T Consensus 97 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~---~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 97 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred ccCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEECcCccceEccCCccC
Confidence 99 889999986 34689999999999999999999999999999999999994 6789999999999765433211
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
.....++..|+|||.+.+..++.++|||||||++|+|++|..||.+...... ...+.... ........
T Consensus 172 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~---~~~~~~~~--~~~~~~~~ 239 (297)
T cd06656 172 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATNG--TPELQNPE 239 (297)
T ss_pred -------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh---eeeeccCC--CCCCCCcc
Confidence 1235788999999999998899999999999999999999999976433111 11111100 00011124
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.++..+.+++.+||..+|++||++.+|++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 56788999999999999999999887744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=303.34 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=193.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
++|++.++||+|+||.||+|.+..+++.||+|+..+.. ...+..|+++++.+.|.+++ .+..+...+...+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLV-NLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchh-hHHHhcccCCeEEEEE
Confidence 57999999999999999999998899999999843322 23577899999999865554 4445556778899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|..+.. ....+++..++.++.||+.||.|||+.||+|+||+|+||+++ +++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~---~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 80 EFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred ecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCcEEEEeeeeeeeccCCcc
Confidence 999 445555544 345699999999999999999999999999999999999994 678999999999986544321
Q ss_pred ccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc---------
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--------- 230 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~--------- 230 (473)
......++..|+|||++.+. .++.++|||||||++|||++|..||...........+......
T Consensus 156 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 156 -------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred -------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 11235688999999998764 4788999999999999999999999764321111111110000
Q ss_pred --------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 231 --------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 231 --------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
...........+++..+.+++..||..+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0011122234567899999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=312.81 Aligned_cols=257 Identities=19% Similarity=0.239 Sum_probs=195.5
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEe--------
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVE-------- 73 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~-------- 73 (473)
++++|.+.+.||.|+||.||+|.+..+++.||||++.... ...+..|+.+++.++|.+++..+..+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 5789999999999999999999999999999999854332 34578899999999877666555433322
Q ss_pred -----CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEe
Q 011988 74 -----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 148 (473)
Q Consensus 74 -----~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 148 (473)
....+++|||++++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+|||++ ...+.+||+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECC
Confidence 23578999999989998886 34699999999999999999999999999999999999995 3456799999
Q ss_pred cCCcccccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 011988 149 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 227 (473)
Q Consensus 149 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i 227 (473)
||+++......... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.............
T Consensus 159 fg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 159 FGLARIVDPHYSHK----GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred cccceecCCccccc----cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99997654321111 01123367889999998765 45889999999999999999999999765432111111000
Q ss_pred ----------------------hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 228 ----------------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 228 ----------------------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...........+...++.++.++|..||..||++||++.+|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 000111222333456788999999999999999999988774
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=312.11 Aligned_cols=258 Identities=18% Similarity=0.245 Sum_probs=198.6
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeE---eCCe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGV---EGDY 76 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~---~~~~ 76 (473)
++++|++.+.||.|+||.||+|.+..+++.||+|++... ....+..|+.+++.++|.+++..+..+.. ....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 568999999999999999999999999999999985432 23456789999999996665554443322 3457
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 77 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
.+++|||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 83 ~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 83 VYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEecccccceeec
Confidence 899999999999998863 45699999999999999999999999999999999999994 78899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH--------
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI-------- 227 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i-------- 227 (473)
...... ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.........+...
T Consensus 159 ~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 159 SSPTEH---KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred ccCcCC---CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 432211 011134578999999999876 45899999999999999999999999765432111111110
Q ss_pred ---------------hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 228 ---------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 228 ---------------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...........+...++.++.++|..||+.+|++||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 292 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 001111122334466789999999999999999999987663
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.55 Aligned_cols=255 Identities=20% Similarity=0.239 Sum_probs=184.6
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCC-cEEEEE------------------Eccc--CCchhHHHHHHHHHHhcCCCC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK------------------LNVK--TKHPQLQYEAKLYKILQGGTG 63 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAiK------------------~~~~--~~~~~l~~E~~il~~L~~~~~ 63 (473)
+.++|+++++||+|+||+||+|...... +.+++| .... .....+.+|+.+++.|+|+++
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998764322 222222 1111 112347889999999986655
Q ss_pred CCeeEEeeEeCCeEEEEEecCCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCC
Q 011988 64 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 139 (473)
Q Consensus 64 i~~~~~~~~~~~~~~lv~e~~g~sL~~~l~~~~----~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~ 139 (473)
+ .+..+....+..++++++++++|.+++.... .......++.|+.||+.||.|||++|||||||||+||||+
T Consensus 226 v-~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~--- 301 (501)
T PHA03210 226 L-KIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN--- 301 (501)
T ss_pred C-cEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---
Confidence 5 4555667778889999999999988875321 2244677889999999999999999999999999999994
Q ss_pred CCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 011988 140 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 219 (473)
Q Consensus 140 ~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~ 219 (473)
..+.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||+||||++|..++.......
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred CCCCEEEEeCCCceecCccccc------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 7789999999999876543221 1134679999999999999999999999999999999999876543322222
Q ss_pred HHHHHHHHhhc------cc-------------------cccHHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 220 KKQKYEKISEK------KV-------------------STSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 220 ~~~~~~~i~~~------~~-------------------~~~~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
....+.++... .+ ...+..+. ..++.++.++|.+||.+||.+||++.+++
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 22222221110 00 00111111 24677889999999999999999988874
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=299.40 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=192.8
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--------chhHHHHHHHHHHhcCCCCCCeeEEeeEe-CCeE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--------HPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYN 77 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--------~~~l~~E~~il~~L~~~~~i~~~~~~~~~-~~~~ 77 (473)
.+|++.+.||+|+||.||+|.+..++..||||...... ...+..|+.+++.+.|++++..+..+... ....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999999999999743211 12467799999999866666554433332 4567
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+++|||+ +++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++ ..+.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec---CCCCEEECcCccccccc
Confidence 8999999 78999998743 4689999999999999999999999999999999999994 67899999999998654
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
..... ........|+..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+.......
T Consensus 158 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~-- 228 (265)
T cd06652 158 TICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPTNP-- 228 (265)
T ss_pred ccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---HHHHHHHhcCCCCC--
Confidence 32110 0112345689999999999988899999999999999999999999976432 22222222211111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.+...++..+.++|..|| .+|++||++++|++
T Consensus 229 -~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 229 -VLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred -CCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 122345678999999999 49999999888753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=296.00 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=196.4
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
.+|++.+.||.|+||.||+|.+. .+..+|+|...... ...+..|+++++.+.|++++ .+..+.......+++|||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLV-QLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCee-eEEEEEccCCceEEEEEcC
Confidence 57999999999999999999874 46789999854432 35688999999999866544 4555556667789999998
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 -g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++......+++..++.++.|++.||+|||++||+|+||||+||+++ .++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~~~~~-- 156 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQYT-- 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc---CCCeEEECCCcceeecccCccc--
Confidence 7899999876566789999999999999999999999999999999999994 6788999999999765432211
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+...... .....
T Consensus 157 ----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~ 225 (256)
T cd05112 157 ----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETINAGFRL----YKPRL 225 (256)
T ss_pred ----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHhCCCCC----CCCCC
Confidence 1122345678999999998889999999999999999998 9999976332 2223332221110 01233
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLF 272 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 272 (473)
.+.++.+++.+||+.+|++||++.++++.|
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 678999999999999999999999997765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=300.09 Aligned_cols=249 Identities=20% Similarity=0.272 Sum_probs=185.8
Q ss_pred eeEeecCceEEEEEEEc--CCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNI--QTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~--~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|.+. .++..+|+|...... ...+.+|+.+++.++|++++. +..++.+....++||||+ +
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQ-CLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEee-EEEEEcCCCCcEEEEECCCC
Confidence 46899999999999864 345678999854332 235778999999998666554 445556667789999999 7
Q ss_pred CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 86 PSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 86 ~sL~~~l~~~~----~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++ ..+.+||+|||+++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~~~~~- 155 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKYKEDY- 155 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEECCccccccccCcce-
Confidence 89999986432 2467778889999999999999999999999999999995 678899999999975433221
Q ss_pred cccccccCCCcccCccccccccccCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGI-------EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~-------~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
+.......|+..|+|||++.+. .++.++|||||||++|||++ |..||......... ...+......
T Consensus 156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~--~~~~~~~~~~ 229 (269)
T cd05087 156 ----YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL--TYTVREQQLK 229 (269)
T ss_pred ----eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH--HHHhhcccCC
Confidence 1112345678899999998643 35789999999999999996 99999765432211 1112221122
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
.....+...+++.+.++|..|| .+|++||++++|...|.
T Consensus 230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222333456789999999999 68999999999987764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=303.80 Aligned_cols=258 Identities=21% Similarity=0.239 Sum_probs=195.3
Q ss_pred ceEEEeeEeecCceEEEEEEEcC--CCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeC--CeE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQ--TNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG--DYN 77 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~--~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~--~~~ 77 (473)
+|.+.++||+|+||.||+|.+.. +++.||||++... ....+..|+.+++.++|++++..+.. .... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEV-FLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEE-EeCCCCceE
Confidence 58999999999999999999988 8999999985542 23557889999999997666655544 4444 788
Q ss_pred EEEEecCCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEee-CCCCCcEEEEecCCc
Q 011988 78 VLVIDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLA 152 (473)
Q Consensus 78 ~lv~e~~g~sL~~~l~~~~----~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~-~~~~~~vkL~DFGla 152 (473)
++||||++++|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+|||++. ++..+.+||+|||++
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999999999988876432 26899999999999999999999999999999999999953 112789999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC------HHHHHH
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYE 225 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~------~~~~~~ 225 (473)
+........ ........++..|+|||++.+. .++.++|||||||+||+|++|..||.+..... ....+.
T Consensus 160 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 160 RLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred cccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 876443221 1122445788999999988774 47999999999999999999999998654332 001111
Q ss_pred HHhhc----------------------------ccc-ccHHH-Hh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 226 KISEK----------------------------KVS-TSIEA-LC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 226 ~i~~~----------------------------~~~-~~~~~-l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.+... ... ..... +. ...+.++.+++..||..||++||++.++.+
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11000 000 00111 11 146678999999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=298.40 Aligned_cols=238 Identities=18% Similarity=0.208 Sum_probs=183.7
Q ss_pred eeEeecCceEEEEEEEcCCC----------cEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 13 RKIGSGSFGEIYLGTNIQTN----------EEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~----------~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
+.||+|+||.||+|.+..++ ..|++|+..... ...+.+|+.+++.++|++++..+..+ .. ...+++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVC-VR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEE-ec-CCcEEE
Confidence 47899999999999988766 357888744333 45678899999999866665555444 44 667999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCC----CCCcEEEEecCCcccc
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR----RANQVYIIDFGLAKRY 155 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~----~~~~vkL~DFGla~~~ 155 (473)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+. ....+||+|||++...
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 9999 7899999886555799999999999999999999999999999999999996322 1127999999999865
Q ss_pred cCCCCccccccccCCCcccCccccccccccCC--CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
... ....++..|+|||++.+. .++.++|||||||++|||++ |..||...........+. ....
T Consensus 159 ~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~ 224 (259)
T cd05037 159 LSR-----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHR 224 (259)
T ss_pred ccc-----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCC
Confidence 431 234567789999999877 78999999999999999999 688887754322222221 1100
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 272 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 272 (473)
+.......+.++|.+||..+|++||++.+|.+.|
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 225 ------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0111127899999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=295.42 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=197.3
Q ss_pred eEEEeeEeecCceEEEEEEEcCCC----cEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
+.+.+.||.|+||.||+|.+...+ ..||+|+..... ...+..|+.+++.+. ++++..+..+.......+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeEEE
Confidence 467899999999999999988766 899999965443 346888999999996 55555666566666888999
Q ss_pred EecC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 81 IDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~-ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||++ +++|.+++...... +++..++.++.||+.||.|||++|++|+||||+||+++ ..+.++|+|||+++.....
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~---~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc---cCCeEEEcccCCceecccc
Confidence 9999 78999998754434 99999999999999999999999999999999999994 6779999999999876544
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
.... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.... ....+..+.......
T Consensus 157 ~~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~--- 224 (258)
T smart00219 157 DYYK------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---NEEVLEYLKKGYRLP--- 224 (258)
T ss_pred cccc------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcCCCCC---
Confidence 2211 112237789999999988889999999999999999998 889987633 233333333322221
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 272 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 272 (473)
....++.++.+++.+||..+|++||++.++++.|
T Consensus 225 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 -KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 2234789999999999999999999999987653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=311.96 Aligned_cols=263 Identities=18% Similarity=0.254 Sum_probs=200.9
Q ss_pred CCCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc-----CCchhHHHHHHHHHHh-cCCCCCCeeEEeeE-e
Q 011988 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK-----TKHPQLQYEAKLYKIL-QGGTGIPNLRWFGV-E 73 (473)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~-----~~~~~l~~E~~il~~L-~~~~~i~~~~~~~~-~ 73 (473)
.+..+.++|++.+.||.|+||.||+|.+..+++.||||.... .....+..|+.+++.+ +|.+++..+..+.. .
T Consensus 1 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 1 IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred CCchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 367889999999999999999999999988999999997432 2233467899999999 65555554444333 3
Q ss_pred CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 74 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 74 ~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
....++||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~---~~~~~kl~d~g~~~ 155 (337)
T cd07852 81 DKDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGLAR 155 (337)
T ss_pred CceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccchh
Confidence 446899999999999998873 3789999999999999999999999999999999999994 78899999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh---
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE--- 229 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~--- 229 (473)
.+....... .......+.|+..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 156 SLSELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred ccccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 765433211 01122345789999999988754 478999999999999999999999976433221111111100
Q ss_pred --------------------ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 230 --------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 230 --------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.........+.+.++.++.++|..||+.||++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 00111223344557899999999999999999999887754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=299.93 Aligned_cols=252 Identities=19% Similarity=0.248 Sum_probs=195.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeE-eCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~-~~~~~~lv~ 81 (473)
++|++.+.||.|++|.||+|.+..+++.||+|...... ...+.+|+++++.+.|++++..+..+.. .....+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 57999999999999999999999999999999855432 2457899999999987666665554433 345689999
Q ss_pred ecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 82 DLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 82 e~~-g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
||+ +++|.+++.. ....+++..+..|+.||+.||.|||+.|++|+||+|+||+++ ..+.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT---RKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---cCCeEEEeeccccccccc
Confidence 999 7899988753 234689999999999999999999999999999999999994 677899999999876543
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--CCHHHHHHHHhhcccccc
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~ 235 (473)
... ....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ....+....+........
T Consensus 158 ~~~---------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd06621 158 SLA---------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL 228 (287)
T ss_pred ccc---------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence 221 234678899999999998999999999999999999999999976532 122222222222111100
Q ss_pred HHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 236 IEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 236 ~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..... ..+++++.++|.+||..+|.+||++.+|.+
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00000 134678999999999999999999877743
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=303.83 Aligned_cols=255 Identities=20% Similarity=0.209 Sum_probs=195.5
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC--CeE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG--DYN 77 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~--~~~ 77 (473)
..++|++.+.||.|+||.||+|.+..+++.|+||.+.... ...+..|+.+++.+.|.++ ..+..+.... ...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNI-VTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCE-EEEEEEEEecCCCcE
Confidence 3468999999999999999999999899999999854322 2245689999999995554 4444444444 789
Q ss_pred EEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 78 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 78 ~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+++|||++++|.+++......+++..++.++.||+.||+|||++||+|+||||+|||++ ..+.++|+|||++..+..
T Consensus 82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN---NRGILKICDFGLAREYGS 158 (293)
T ss_pred EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCcEEEeecCceeeccC
Confidence 99999998899999986666799999999999999999999999999999999999994 678999999999987654
Q ss_pred CCCccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc----
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---- 232 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---- 232 (473)
... ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||..........++........
T Consensus 159 ~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 159 PLK-------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred Ccc-------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence 321 112346788999999987654 68999999999999999999999976543222221111100000
Q ss_pred ------------------cccHHHHhcC--CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 233 ------------------STSIEALCRG--YPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 233 ------------------~~~~~~l~~~--~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
...+...... +++.+.++|..||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000011111 4788999999999999999999888753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=301.35 Aligned_cols=246 Identities=19% Similarity=0.316 Sum_probs=197.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
++|++.+.||.|+||.||+|.+..+++.||+|.+.... ...+.+|+++++.+.|++ +..+..++......++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY-IVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCc-hhhhheeeecCCEEEEEEE
Confidence 47899999999999999999999999999999854432 245788999999998554 5455555566688999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +++|.+++......+++..+..++.||+.||.|||+ .||+|+||||+||+++ ..+.++|+|||++..+.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccchhhHHHHh
Confidence 99 589999998655789999999999999999999999 9999999999999995 678899999999876643221
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--CCHHHHHHHHhhccccccHHH
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~~~~ 238 (473)
....++..|+|||.+.+..++.++|||||||++|+|++|..||..... .........+.......
T Consensus 157 ---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 223 (265)
T cd06605 157 ---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR---- 223 (265)
T ss_pred ---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC----
Confidence 125788999999999998999999999999999999999999976421 11222222222221111
Q ss_pred HhcC-CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 239 LCRG-YPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 239 l~~~-~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
+... ++.++.++|..||..||++||++.+|+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 1122 788999999999999999999988774
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=301.10 Aligned_cols=233 Identities=23% Similarity=0.305 Sum_probs=180.8
Q ss_pred eEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhc--CCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
.||+|+||.||++.+..+++.||||+..+.. ......|..+++.+. +++++..+..+....+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999854322 112344555555443 4556666666667778889999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 85 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 85 g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
+++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++ .++.++|+|||++........
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~---~~~~~~l~dfg~~~~~~~~~~---- 152 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKP---- 152 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC---CCCCEEEccCCcceeccccCc----
Confidence 7899988874 45699999999999999999999999999999999999994 778999999999975543221
Q ss_pred ccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011988 165 PYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
....|+..|+|||.+.+ ..++.++|||||||++|||++|..||.......... ...... .....+...+
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~----~~~~~~~~~~ 222 (279)
T cd05633 153 -----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL----TVNVELPDSF 222 (279)
T ss_pred -----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhh----cCCcCCcccc
Confidence 23468999999999874 568999999999999999999999998654433222 221111 0111234567
Q ss_pred cHHHHHHHHHHhcCCCCCCCC
Q 011988 244 PTEFASYFHYCRSLRFDDKPD 264 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RPt 264 (473)
+.++.++|..||..||.+||+
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcC
Confidence 899999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=302.77 Aligned_cols=264 Identities=20% Similarity=0.276 Sum_probs=213.3
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
.-++|..++.||+|.||.|.+|+.+.+++.+|||++.+.. ...-..|-++|+... |+.+..+.+.+...+..|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEE
Confidence 4578999999999999999999999999999999855432 233456888888877 455556666778888999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+||||. ||.|.-.+.. .+.|++.....+...|+.||.|||+++||.||||.+|.|+ +++|++||+|||+|+.-..
T Consensus 245 FVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhccc
Confidence 999999 8888777763 4579999999999999999999999999999999999999 6899999999999986543
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
... ..++++||+.|+|||++....|++.+|.|.+||++|||++|++||...... ..++-|....+
T Consensus 321 ~g~-------t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeLIl~ed~----- 385 (516)
T KOG0690|consen 321 YGD-------TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFELILMEDL----- 385 (516)
T ss_pred ccc-------eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHHHHhhhc-----
Confidence 322 236899999999999999999999999999999999999999999874432 22222222211
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCC--HHHHHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPD--YAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt--~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
.++..++++.+.|+..+|.+||.+|.. .++.+++.++-|- ...+|+..-.+
T Consensus 386 kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF-------~~v~W~~~~~K 438 (516)
T KOG0690|consen 386 KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFF-------ASVDWEATYRK 438 (516)
T ss_pred cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhh-------ccCCHHHHHHh
Confidence 234678899999999999999999963 4566666666553 45788876444
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=298.88 Aligned_cols=248 Identities=18% Similarity=0.259 Sum_probs=184.4
Q ss_pred eeEeecCceEEEEEEEcC--CCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQ--TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~--~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|.... ....+++|...... ...+.+|+.+++.++|++++.. ...+......+++|||+ +
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~-~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC-LGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceE-EEEECCCCceEEEEEeCCC
Confidence 468999999999997533 34578888754332 2346789999999986665554 44556677889999999 7
Q ss_pred CCHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 86 PSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 86 ~sL~~~l~~~~~----~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~~~- 155 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT---ADLSVKIGDYGLALEQYPEDY- 155 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec---CCCcEEEeccccccccccchh-
Confidence 899999875432 256788899999999999999999999999999999994 678999999999875432211
Q ss_pred cccccccCCCcccCccccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHH-Hhhccc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK-ISEKKV 232 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~-------~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~-i~~~~~ 232 (473)
+.......++..|+|||++.. ..++.++|||||||++|||++ |..||..... .+.+.. +.....
T Consensus 156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~~ 228 (269)
T cd05042 156 ----YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQVLKQVVREQDI 228 (269)
T ss_pred ----eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhhccCc
Confidence 011123356778999998743 356889999999999999999 8899976532 222222 222222
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
......+...++..+.+++..|| .||++||++++|.++|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22223344568899999999999 59999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=298.09 Aligned_cols=251 Identities=20% Similarity=0.310 Sum_probs=196.0
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
+|++.+.||.|+||.||+|.+ .+++.||||...... ...+.+|+.+++.++|.+ +..+..++......+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN-IVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCC-EeeEeeEeecCCeEE
Confidence 588999999999999999986 578899999743221 134778999999998654 445555666778999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
++|||+ +++|.+++.. ...+++..+..++.||+.||+|||+.||+|+||||+||++ +..+.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 79 IFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhh
Confidence 999999 8899999874 3468999999999999999999999999999999999999 4778999999999986532
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+... .....
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~--~~~~~ 228 (265)
T cd06631 155 VGLHGTH-SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL---AAMFYIGAH--RGLMP 228 (265)
T ss_pred ccccccc-cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH---HHHHHhhhc--cCCCC
Confidence 2111100 01123457899999999999988999999999999999999999999764322 111111111 11122
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.+...++.++.++|..||..+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 344568899999999999999999999887753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=300.05 Aligned_cols=245 Identities=20% Similarity=0.325 Sum_probs=195.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----CchhHHHHHHHHHHhc--CCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~lv 80 (473)
+.|++.+.||.|+||.||+|.+..+++.||||++... ....+..|+.+++.+. .++++..+..++..+...+++
T Consensus 1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 3588999999999999999999999999999985432 2345788999999997 245555555566777889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||+++ ..+.++|+|||++..+....
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCCCc
Confidence 9999 8899999863 4799999999999999999999999999999999999995 67899999999998765433
Q ss_pred CccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. .....|+..|+|||.+.+. .++.++|||||||++|+|++|..||.+.... .....+.... . ..
T Consensus 156 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~-~---~~ 221 (277)
T cd06917 156 SK-------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF---RAMMLIPKSK-P---PR 221 (277)
T ss_pred cc-------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh---hhhhccccCC-C---CC
Confidence 11 1334789999999998754 4789999999999999999999999764321 1111111111 1 11
Q ss_pred Hhc-CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 239 LCR-GYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 239 l~~-~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
+.. .++.++.+++..||..||++||++.++..
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 222 37889999999999999999999888843
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=294.14 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=203.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
++|++.+.||.|++|.||+|.+..+++.|+||+..... ...+..|+.++..++| +++..+..+.......+++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCES-PYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEccCCeEEEEEE
Confidence 47999999999999999999999999999999854443 3568899999999984 455566666677788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +++|.+++... ..+++..++.++.||+.||.|||+ +|++|+||+|+||+++ .++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~---~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC---CCCCEEEccCccceecccCCC
Confidence 99 68999999754 679999999999999999999999 9999999999999994 788999999999987654322
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..||.........+....+..... ..+.
T Consensus 156 ~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 224 (264)
T cd06623 156 Q-------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP----PSLP 224 (264)
T ss_pred c-------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC----CCCC
Confidence 1 1244688999999999998899999999999999999999999987653333444444332221 1223
Q ss_pred cC-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 241 RG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 241 ~~-~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.. ++..+.++|..||..+|++||++.+|.+
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 34 7899999999999999999999887754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=306.06 Aligned_cols=251 Identities=20% Similarity=0.332 Sum_probs=198.7
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
-.++|++.+.||.|+||.||+|.+..+++.||||.+.+.. ...+..|+.++..+..|+++..+..++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3578999999999999999999998889999999965432 233566777777776677777777777888889999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||++++|.+++......+++..+..++.||+.||.|||+ .||+||||+|+||+++ .++.+||+|||++..+....
T Consensus 93 ~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~---~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD---ASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc---CCCCEEECccccchhccCCC
Confidence 9999999999988666789999999999999999999997 6999999999999994 67899999999997664432
Q ss_pred CccccccccCCCcccCccccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~----~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
.. ....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||..... ..+.+..+.......
T Consensus 170 ~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~- 238 (296)
T cd06618 170 AK--------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKILQEEPPS- 238 (296)
T ss_pred cc--------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHHhcCCCCC-
Confidence 21 2235788999999998654 78999999999999999999999965322 122232222221111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.. ....++.++.+++.+||..||++||+++++++
T Consensus 239 ~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 239 LP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred CC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 10 11246889999999999999999999888753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=297.14 Aligned_cols=245 Identities=20% Similarity=0.230 Sum_probs=199.0
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+|++.++||.|+||.||++.+..+++.||||.+... ....+..|+.+++.++|.+ +..+..+.......+++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN-IVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCC-eeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999984322 2346888999999998655 5556666677788999999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||+|+|||++ .++.++|+|||++..+.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~---~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEEeeccceeecCcchh
Confidence 99 78999998753 33589999999999999999999999999999999999994 678899999999986644321
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||... .....+..+...... ...
T Consensus 157 ~-------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~~----~~~ 222 (256)
T cd08218 157 L-------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKIIRGSYP----PVS 222 (256)
T ss_pred h-------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHHHHhcCCCC----CCc
Confidence 1 12346888999999999988999999999999999999999999753 233333333332221 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..++.++.++|.+||+.+|++||++.+|++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 467899999999999999999999888854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=306.36 Aligned_cols=250 Identities=22% Similarity=0.257 Sum_probs=197.9
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
.+.++|.+.+.||.|+||.||+|.+..+++.||||...+. ....+..|+.+++.+.|++++..+..+.......+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3678999999999999999999999999999999974321 23457789999999997776666655555567789
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 79 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 79 lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
++|||++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++ ..+.++|+|||++......
T Consensus 87 lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~---~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 87 FVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN---ENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred EEeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC---CCCCEEeCccccccccCCC
Confidence 999999999999886 34688999999999999999999999999999999999994 6789999999999754321
Q ss_pred CCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh---------
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS--------- 228 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~--------- 228 (473)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.+..
T Consensus 162 ----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 162 ----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 123467889999998876 568999999999999999999999997643211111111100
Q ss_pred --------------hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 229 --------------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 229 --------------~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
..............++.++.++|.+||+.+|++||+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el 285 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA 285 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 0011122333445678999999999999999999998876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=299.32 Aligned_cols=242 Identities=19% Similarity=0.251 Sum_probs=190.6
Q ss_pred CCceEEEeeE--eecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKI--GSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~L--G~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.++|.+.+.+ |+|+||.||++.+..+++.+|+|+......... |+.+...+.+++++..+..++...+..++||||
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~ 90 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY 90 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence 3567787777 999999999999999999999999655433322 344444455577777777777778899999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCC-cEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~~~~~ 161 (473)
+ +++|.+++... ..+++.+++.++.||+.||.|||+.||+||||||+||++. ..+ .++|+|||++......
T Consensus 91 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 91 IKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCCC---
Confidence 9 88999999754 3799999999999999999999999999999999999995 445 8999999998765432
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCH-HHHHHHHhhccccccHHHHh
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l~ 240 (473)
....|+..|+|||++.+..++.++|||||||++|||++|..||........ ...+..... . .....
T Consensus 164 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~-~~~~~ 230 (267)
T PHA03390 164 --------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ----K-KLPFI 230 (267)
T ss_pred --------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc----c-cCCcc
Confidence 234688999999999998999999999999999999999999985432211 111111111 1 11223
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCC-HHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPD-YAYLK 269 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt-~~~l~ 269 (473)
+.+++.+.++|..||+.+|.+||+ +++++
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 468899999999999999999995 57664
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=302.91 Aligned_cols=239 Identities=19% Similarity=0.222 Sum_probs=182.1
Q ss_pred eeEeecCceEEEEEEEcCCCc-------EEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 13 RKIGSGSFGEIYLGTNIQTNE-------EVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~-------~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+.||.|+||.||+|.+...+. .|++|+..... ...+..|+.+++.+.|++.+ .+..+...+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv-~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV-LNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChh-heeeEEEeCCCcEEEEe
Confidence 468999999999999865543 48888754432 23567888999999866555 45445556677899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC-----CCcEEEEecCCccccc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-----ANQVYIIDFGLAKRYR 156 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~-----~~~vkL~DFGla~~~~ 156 (473)
|+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. ...++|+|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99 77999999866667899999999999999999999999999999999999963221 1247999999986543
Q ss_pred CCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHhhccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~-~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
.. ....++..|+|||++.+. .++.++|||||||++|||++|. .||....... .. .+....
T Consensus 160 ~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~-~~~~~~--- 221 (258)
T cd05078 160 PK-----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KL-QFYEDR--- 221 (258)
T ss_pred Cc-----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HH-HHHHcc---
Confidence 21 235688899999999874 4799999999999999999984 6665433211 11 111111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 272 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 272 (473)
..+....+.++.++|..||+.||++||++++|++.|
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 --HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred --ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 112234557899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=304.85 Aligned_cols=245 Identities=22% Similarity=0.305 Sum_probs=195.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
..+.|.+.++||.|+||.||+|.+..+++.||+|++.... ...+..|+.+++.++|+ ++..+..++...+..+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~-niv~~~~~~~~~~~~~ 91 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP-NTIEYKGCYLREHTAW 91 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCC-CEEEEEEEEEeCCeEE
Confidence 3467999999999999999999998899999999854321 13477899999999855 4555556667778889
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 79 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 79 lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
+||||+.++|.+++......+++..+..++.||+.||.|||+.||+|+||+|+||+++ +++.++|+|||++......
T Consensus 92 lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~---~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 92 LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC---CCCCEEEeecCcceecCCC
Confidence 9999999999998876667799999999999999999999999999999999999994 6789999999998754322
Q ss_pred CCccccccccCCCcccCcccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
....|+..|+|||++. ...++.++|||||||++|||++|..||.+... ......+........
T Consensus 169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~ 234 (307)
T cd06607 169 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNDSPTL 234 (307)
T ss_pred -----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcCCCCCC
Confidence 2356888999999885 34588999999999999999999999976432 111122221111111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
....++.++.++|..||..+|++||++.+|+.
T Consensus 235 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 235 ---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred ---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 01246789999999999999999999888854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=311.94 Aligned_cols=268 Identities=22% Similarity=0.270 Sum_probs=216.0
Q ss_pred CCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
.|.-.+.|..-++||.||||+||-++...||+.+|+|.+.+.. .....+|..||..++. +.|+.+.+.+...+
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s-~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSS-PFIVSLAYAFETKD 258 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhcc-CcEEEEeeeecCCC
Confidence 4566788999999999999999999999999999999743322 2335789999999984 47777777778888
Q ss_pred eEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
..|+||.+| ||+|.-.|...+ ..|++..+..++.+|+.||++||..+||.|||||+|||+ |+.|+|.|+|+|+|.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAV 335 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEE
Confidence 999999999 889876665444 469999999999999999999999999999999999999 589999999999999
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
.+.+.... ...+||..|||||++.+..|+...|.|||||+||||+.|+-||...+...+.+.++ .. ..
T Consensus 336 ei~~g~~~--------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd---rr-~~ 403 (591)
T KOG0986|consen 336 EIPEGKPI--------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD---RR-TL 403 (591)
T ss_pred ecCCCCcc--------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH---HH-Hh
Confidence 88765432 34589999999999999999999999999999999999999997755433332222 22 22
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCH-----HHHHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDY-----AYLKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~-----~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
...+++...++++.++|++.+|..||.+|... +++.+ + .+...++|..+...
T Consensus 404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~---H-------pfFk~lnw~rleag 460 (591)
T KOG0986|consen 404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE---H-------PFFKDLNWRRLEAG 460 (591)
T ss_pred cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh---C-------cccccCCHhHHhcc
Confidence 33455667899999999999999999999753 23321 1 33344788876544
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=297.41 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=196.0
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCCc------hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH------PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~------~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||.|+||.||+|.+..+++.||||+..+... ..+..|..++.....++++..+..+....+..+++|||+ +
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999999999999998654321 123445555554445666667767777788999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+|||++ ..+.++|+|||+++.....
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~------- 150 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRNGLEN------- 150 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEeecccceecccc-------
Confidence 8999999743 4689999999999999999999999999999999999994 6788999999998754331
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcH
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 245 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 245 (473)
....|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ...+..+....... .......+++
T Consensus 151 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~ 222 (260)
T cd05611 151 ----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNILSRRINW-PEEVKEFCSP 222 (260)
T ss_pred ----ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcccCC-CCcccccCCH
Confidence 235688999999999988899999999999999999999999976432 23333332222111 1122346789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 246 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 246 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
++.++|.+||..+|++||++..+.++|.+.+.+
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~ 255 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHcChHhh
Confidence 999999999999999999988888888877653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=300.53 Aligned_cols=248 Identities=20% Similarity=0.310 Sum_probs=190.7
Q ss_pred eeEeecCceEEEEEEEcCCC------cEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 13 RKIGSGSFGEIYLGTNIQTN------EEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~------~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+.||.|+||.||+|++.... +.||||.+... ....+.+|+.+++.++|++++. +..++......+++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVK-LLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeee-EeeeecCCCCeEEEEe
Confidence 46899999999999976544 68999975433 2446788999999998665555 4445566777899999
Q ss_pred cC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCC--CCCcEEEEecCCcc
Q 011988 83 LL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAK 153 (473)
Q Consensus 83 ~~-g~sL~~~l~~~------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~--~~~~vkL~DFGla~ 153 (473)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++|+|+||||+|||++.++ ....++|+|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 98 78999998642 23478899999999999999999999999999999999996322 12389999999997
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+.....
T Consensus 160 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~ 231 (269)
T cd05044 160 DIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVTAGGR 231 (269)
T ss_pred cccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHhcCCc
Confidence 65433211 11123356788999999999899999999999999999998 9999976432 222222222111
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
......+|..+.++|.+||..+|++||++++|.+.|+
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 232 ----LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ----cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1123457899999999999999999999999988875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=296.94 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=196.2
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----C--------chhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----K--------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~--------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
+|.+.+.||.|+||.||+|.+..+++.||||..... . ...+..|+.+++.++|.+ +..+..++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLN-IVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCC-cceEEEEeccC
Confidence 689999999999999999999889999999974321 0 124677999999998655 44555667778
Q ss_pred CeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
...++||||+ +++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++ .++.++|+|||+++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~---~~~~~~l~d~~~~~ 156 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD---ADGICKISDFGISK 156 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc---CCCeEEEeeccccc
Confidence 8899999999 88999998754 5799999999999999999999999999999999999994 77899999999997
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 231 (473)
........ .......|+..|+|||.+.+.. ++.++|||||||++|||++|..||..... ...+..+....
T Consensus 157 ~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~ 228 (272)
T cd06629 157 KSDDIYDN-----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKLGNKR 228 (272)
T ss_pred cccccccc-----cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---HHHHHHhhccc
Confidence 65432111 1123456889999999988755 78999999999999999999999965322 22222222111
Q ss_pred -ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 232 -VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 232 -~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
...........++.++.++|..||..+|++||++++|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111122234567899999999999999999999888753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=298.58 Aligned_cols=239 Identities=17% Similarity=0.187 Sum_probs=180.2
Q ss_pred eeEeecCceEEEEEEEcC------------CCcEEEEEEcccCCc---hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 13 RKIGSGSFGEIYLGTNIQ------------TNEEVAIKLNVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~------------~~~~vAiK~~~~~~~---~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
+.||+|+||.||+|+... ....|++|+...... ..+..|+.++..++|++ |..+..++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~-iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKH-IVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCC-EeeEEEEEecCCCC
Confidence 468999999999998532 223588898544322 34677888999998654 55555566677778
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC----CCcEEEEecCCc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR----ANQVYIIDFGLA 152 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~----~~~vkL~DFGla 152 (473)
+++|||+ +++|..++......+++..++.|+.||+.||+|||++||+||||||+|||++.+.. ...++|+|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999 67888887755667999999999999999999999999999999999999963211 123899999998
Q ss_pred ccccCCCCccccccccCCCcccCcccccccccc-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCCCHHHHHHHHhhc
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEK 230 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSlGviL~ell-tG~~Pf~~~~~~~~~~~~~~i~~~ 230 (473)
...... ....++..|+|||.+. +..++.++|||||||+||||+ .|..||........ ......
T Consensus 160 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~~ 224 (262)
T cd05077 160 ITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ERFYEG 224 (262)
T ss_pred ccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HHHHhc
Confidence 754321 2346788999999887 456899999999999999998 58999876432211 111111
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011988 231 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 272 (473)
Q Consensus 231 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 272 (473)
.. .+....++++.++|.+||+.||++||++.+|++.|
T Consensus 225 ~~-----~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QC-----MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred Cc-----cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11 11223457899999999999999999999987655
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=297.56 Aligned_cols=251 Identities=19% Similarity=0.325 Sum_probs=198.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcC-----CCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
++|++.+.||.|+||.||+|++.. ..+.|++|....... ..+..|+++++.++|.+ +..+..++......
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKN-VVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcc-eeeeEEEECCCCcc
Confidence 679999999999999999999754 346799998544332 35788999999998655 44555566677788
Q ss_pred EEEEecC-CCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEe
Q 011988 78 VLVIDLL-GPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 148 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~--------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 148 (473)
+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ..+.++|+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS---SQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---CCCcEEEcc
Confidence 9999999 689999987433 1589999999999999999999999999999999999995 678899999
Q ss_pred cCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHH
Q 011988 149 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 227 (473)
Q Consensus 149 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i 227 (473)
||+++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ...+..+
T Consensus 161 ~~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~ 231 (275)
T cd05046 161 LSLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRL 231 (275)
T ss_pred cccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHH
Confidence 999875432211 11233466788999999998889999999999999999998 8899976432 2223333
Q ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 228 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 228 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
........ ....+|..+.+++.+||..+|++||++.+++..|.
T Consensus 232 ~~~~~~~~---~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QAGKLELP---VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCCcCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 22222111 12467899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=307.65 Aligned_cols=261 Identities=21% Similarity=0.264 Sum_probs=199.7
Q ss_pred CCCccCCceEE-EeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc-----------------hhHHHHHHHHHHhcCCC
Q 011988 1 MEPRVGNKFRL-GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH-----------------PQLQYEAKLYKILQGGT 62 (473)
Q Consensus 1 m~~~i~~~y~i-~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~-----------------~~l~~E~~il~~L~~~~ 62 (473)
|..-+.++|.. .+.||.|+||.||+|.+..+++.||||+...... ..+..|+.+++.++|.+
T Consensus 2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 81 (335)
T PTZ00024 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN 81 (335)
T ss_pred CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence 67788899975 5779999999999999999999999998543221 13678999999998655
Q ss_pred CCCeeEEeeEeCCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCC
Q 011988 63 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 142 (473)
Q Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~ 142 (473)
++ .+..++...++.+++|||+.++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||++ ..+
T Consensus 82 iv-~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~---~~~ 156 (335)
T PTZ00024 82 IM-GLVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---SKG 156 (335)
T ss_pred ee-eeeEEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC---CCC
Confidence 54 45555667788999999999999999873 45699999999999999999999999999999999999994 778
Q ss_pred cEEEEecCCcccccCCCCccc-------cccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCC
Q 011988 143 QVYIIDFGLAKRYRDTATHQH-------IPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG 214 (473)
Q Consensus 143 ~vkL~DFGla~~~~~~~~~~~-------~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~ 214 (473)
.++|+|||++..+........ ..........++..|+|||.+.+.. ++.++|||||||++|||++|..||.+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999987652211000 0001112335688999999998754 68999999999999999999999987
Q ss_pred CCCCCHHHHHHHHhhcc-----------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 215 LKAGTKKQKYEKISEKK-----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 215 ~~~~~~~~~~~~i~~~~-----------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.... ..+..+.... ...........++.++.++|..||..+|++||++++++
T Consensus 237 ~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 237 ENEI---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCHH---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 5432 2222221100 01112223345688999999999999999999987774
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.95 Aligned_cols=245 Identities=23% Similarity=0.315 Sum_probs=196.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.+.|++.+.||.|+||.||+|.+..+++.||||+..... ...+..|+.+++.+.|.+++ .+..++......++||
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT-RYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccH-hhhcccccCCceEEEE
Confidence 345778899999999999999998899999999854332 23478899999999855544 4555556777889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|.+++. ...+++..+..++.||+.||.|||++||+|+||+|+||+++ .++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 82 EYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEccccccccccCcch
Confidence 999 779998886 45689999999999999999999999999999999999995 678899999999986654321
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
. .....|+..|+|||++.+..++.++|||||||++|||++|..||......... ..+.... ...+.
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~~~----~~~~~ 222 (277)
T cd06642 157 K-------RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FLIPKNS----PPTLE 222 (277)
T ss_pred h-------hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hhhhcCC----CCCCC
Confidence 1 12346889999999999988999999999999999999999999765432211 1111111 11123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..++.++.++|..||..+|++||++.++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 456889999999999999999999998865
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=298.52 Aligned_cols=251 Identities=19% Similarity=0.214 Sum_probs=193.8
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
|++.+.||.|++|.||+|.+..+|..||||++.... ...+..|+.+++.++|.+.+. +..++......+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~-~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVR-LLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccC-HhheeccCCeEEEEEec
Confidence 678999999999999999999999999999854322 245778999999999665554 44455677889999999
Q ss_pred CCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 LGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
++++|.+++.... ..+++..++.++.||+.||+|||+++++|+||+|+||+++ .++.++|+|||++..+.....
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCCCcc--
Confidence 9889999987543 3689999999999999999999999999999999999995 678999999999975533211
Q ss_pred ccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh-------------
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS------------- 228 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~------------- 228 (473)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||...........+....
T Consensus 155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 11223568899999988764 47899999999999999999999997643211111110000
Q ss_pred --------hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 229 --------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 229 --------~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..............++.++.++|.+||+.||++||++.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000011222334567889999999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.92 Aligned_cols=254 Identities=19% Similarity=0.267 Sum_probs=193.4
Q ss_pred ceEEEeeEeecCceEEEEEEEcCC--CcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeE----eCCe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQT--NEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGV----EGDY 76 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~--~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~----~~~~ 76 (473)
+|++.+.||.|+||.||++.+..+ +..||||.+... ....+..|+.+++.+.+|++|..+..+.. ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999877 889999985432 13456789999999975666665544322 2345
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 77 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
.+++|++++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.+.
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~---~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN---ADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc---CCCCEEeCcCCCceecc
Confidence 789999999999999863 45799999999999999999999999999999999999994 67899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH-----------
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY----------- 224 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~----------- 224 (473)
...... ........||..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+
T Consensus 157 ~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 157 ENPGEN---AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccc---cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 432211 111234578999999998876 46899999999999999999999999764321111110
Q ss_pred -HHHhh-----------ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 225 -EKISE-----------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 225 -~~i~~-----------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
..+.. .........+...++.++.+++.+||+.||.+||++.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l 289 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA 289 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 00000 000112233344567899999999999999999998876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=295.88 Aligned_cols=247 Identities=21% Similarity=0.275 Sum_probs=191.4
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
+.....||+|+||.||+|.+..++..|++|...... ...+.+|+.+++.++|.+++ .+..++..++..++++||+
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIV-QYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCee-eeeeeeccCCEEEEEEecCC
Confidence 444568999999999999998899999999854433 23578999999999866555 4555666778899999998
Q ss_pred CCCHHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 85 GPSLEDLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 85 g~sL~~~l~~~~~~l--s~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+++|.+++......+ ++..+..++.||+.||.|||++||+||||||+||+++ ...+.++|+|||++..+.....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~-- 164 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINP-- 164 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCC--
Confidence 789999987544455 8889999999999999999999999999999999995 3367899999999976543221
Q ss_pred ccccccCCCcccCccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
......|+..|+|||.+.+.. ++.++|||||||++|+|++|..||........ ....... ......+.
T Consensus 165 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~---~~~~~~~~ 234 (268)
T cd06624 165 -----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGM---FKIHPEIP 234 (268)
T ss_pred -----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhh---hccCCCCC
Confidence 112346889999999987654 78999999999999999999999976432111 1111110 01111233
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..+++++.+++.+||..+|++||++.+|.+
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 467889999999999999999999888753
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=296.71 Aligned_cols=247 Identities=22% Similarity=0.270 Sum_probs=192.3
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhc--CCCCCCeeEEeeEeCCe-----
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDY----- 76 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~--~~~~i~~~~~~~~~~~~----- 76 (473)
|++.+.||.|+||.||+|++..+++.||||+..... ...+..|+.+++.+. .|+++..+..++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 789999999999999999998889999999854221 223567888888775 24555555555555554
Q ss_pred EEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 77 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
.+++||++.++|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.+||+|||++..+
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~---~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc---cCCCEEEeccCcceec
Confidence 89999999889999887543 3699999999999999999999999999999999999995 6689999999999876
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-----
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----- 230 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~----- 230 (473)
..... .....++..|+|||.+.+..++.++|||||||++|||++|..||.+..... .+.++...
T Consensus 158 ~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 226 (287)
T cd07838 158 SFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPS 226 (287)
T ss_pred cCCcc--------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCC
Confidence 44321 123357889999999999899999999999999999999999998754322 22222110
Q ss_pred -----------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 -----------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 -----------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
............+++++.++|..||+.||++||++.++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 011111222334568889999999999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=299.86 Aligned_cols=238 Identities=17% Similarity=0.224 Sum_probs=181.0
Q ss_pred eEeecCceEEEEEEEcCC------------------------CcEEEEEEcccCCc---hhHHHHHHHHHHhcCCCCCCe
Q 011988 14 KIGSGSFGEIYLGTNIQT------------------------NEEVAIKLNVKTKH---PQLQYEAKLYKILQGGTGIPN 66 (473)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~------------------------~~~vAiK~~~~~~~---~~l~~E~~il~~L~~~~~i~~ 66 (473)
+||+|+||.||+|....+ ...|++|++..... ..+..|+.+++.++| ++|..
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h-~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSH-IHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCC-CCeee
Confidence 699999999999975321 13588888544322 346678888888885 55556
Q ss_pred eEEeeEeCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC----CCC
Q 011988 67 LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----RRA 141 (473)
Q Consensus 67 ~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~----~~~ 141 (473)
+..++......++||||+ +++|..++......+++..++.|+.||+.||+|||++||+||||||+|||++.. ...
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 666777888889999999 788988887656679999999999999999999999999999999999999632 123
Q ss_pred CcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCCC
Q 011988 142 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGT 219 (473)
Q Consensus 142 ~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~ell-tG~~Pf~~~~~~~ 219 (473)
..+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.......
T Consensus 161 ~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 161 PFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 35899999998644221 12357788999998876 46899999999999999985 6999997754322
Q ss_pred HHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011988 220 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 272 (473)
Q Consensus 220 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 272 (473)
....+ ..... +....++++.++|.+||+.+|++||++.+|++.|
T Consensus 230 ~~~~~----~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERFY----EKKHR-----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHH----HhccC-----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 21111 11110 1123457899999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=305.63 Aligned_cols=246 Identities=18% Similarity=0.289 Sum_probs=193.6
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
+.|.....||.|+||.||++.+..++..||||...... ...+..|+.+++.++|.+++..+. .+..++..+++|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~-~~~~~~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN-SYLVGDELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHH-heecCCeEEEEEeC
Confidence 45666788999999999999998899999999854322 335778999999998665555444 45567788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+ +++|.+++. ...+++.+++.++.||+.||.|||++||+||||||+||+++ +++.++|+|||++........
T Consensus 101 ~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 101 LEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEccCcchhhcccccc--
Confidence 9 778988875 34689999999999999999999999999999999999994 678999999999976543221
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
......|+..|+|||.+.+..++.++|||||||++|||++|..||..... ...+..+... ..... .....
T Consensus 174 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~-~~~~~-~~~~~ 243 (292)
T cd06658 174 -----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIRDN-LPPRV-KDSHK 243 (292)
T ss_pred -----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhc-CCCcc-ccccc
Confidence 11345789999999999988899999999999999999999999976432 2222222111 11111 11234
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
++..+.+++..||..||.+||+++++++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 6789999999999999999999887753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.39 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=195.7
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC-----
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG----- 74 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~----- 74 (473)
+.++|++.+.||.|+||.||+|.+..++..||||+..... ...+..|+.+++.++|.+++..+..+....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 6789999999999999999999999999999999854321 234778999999999777666655544332
Q ss_pred CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 75 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
...++||++++++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+|||++ ..+.++|+|||++..
T Consensus 93 ~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccccc
Confidence 2468999999999999886 35799999999999999999999999999999999999995 678899999999976
Q ss_pred ccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc---
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 230 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 230 (473)
..... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+..+...
T Consensus 168 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 168 TDSEM----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccCc----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 53321 23467899999999876 35889999999999999999999999764322111111111000
Q ss_pred --------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 --------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
........+...++.++.++|..||..||++||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000112233356788899999999999999999988774
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.30 Aligned_cols=251 Identities=21% Similarity=0.295 Sum_probs=193.5
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEe-----
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVE----- 73 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~----- 73 (473)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|.+++..+..+...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 35689999999999999999999999999999999864432 23467899999999977766665544322
Q ss_pred CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 74 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 74 ~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
....++++++++++|.+++. ...+++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+|||+++
T Consensus 94 ~~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~dfg~~~ 168 (345)
T cd07877 94 FNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLAR 168 (345)
T ss_pred cccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc---CCCCEEEecccccc
Confidence 23468999999999999886 34699999999999999999999999999999999999994 67889999999997
Q ss_pred cccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc-
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 231 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 231 (473)
..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.......
T Consensus 169 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 169 HTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred ccccc----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 54322 123578899999999877 468899999999999999999999997643221111111110000
Q ss_pred ----------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 ----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 ----------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
............++++.++|..||..||++||++.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 298 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHh
Confidence 00011111224578899999999999999999977663
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=302.44 Aligned_cols=258 Identities=21% Similarity=0.233 Sum_probs=197.8
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEe-----
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVE----- 73 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~----- 73 (473)
+..++|++.+.||.|+||.||+|.+..+++.||||++.... ...+..|+.+++.++|++++..+..+...
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34678999999999999999999999999999999854321 23467899999999876666554443322
Q ss_pred ----CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEec
Q 011988 74 ----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 149 (473)
Q Consensus 74 ----~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 149 (473)
....++++||++++|.+++......+++..++.++.||+.||.|||+.||+|+||||+||+++ +.+.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCcEEeCcc
Confidence 237899999998899888875555799999999999999999999999999999999999994 7789999999
Q ss_pred CCcccccCCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011988 150 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 228 (473)
Q Consensus 150 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 228 (473)
|++..+...... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+....
T Consensus 161 g~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 161 GLARLYNSEESR------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred cccccccCCccc------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 999876543221 11223567889999988754 47899999999999999999999997643322222222221
Q ss_pred hcccc----------------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 229 EKKVS----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 229 ~~~~~----------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..... .........+|..+.+++..||..||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11100 0111223457899999999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=298.00 Aligned_cols=244 Identities=22% Similarity=0.332 Sum_probs=196.4
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+-|++.++||.|+||.||+|.+..+++.||||+..... ...+..|+.++..+.|++ +..+..+...+...++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY-VTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCC-EeEEEEEEEeCCeEEEEEE
Confidence 34888999999999999999998899999999854322 245778999999998655 4455556677788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++. ...+++..+..++.|++.||.|||++||+|+||||+||+++ .++.++|+|||++..+.....
T Consensus 83 ~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~---~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 83 YLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred eCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC---CCCCEEEeecccceecccchh-
Confidence 99 679998886 44689999999999999999999999999999999999994 678899999999876543221
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+.... ...+..
T Consensus 157 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~----~~~~~~ 223 (277)
T cd06641 157 ------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLIPKNN----PPTLEG 223 (277)
T ss_pred ------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHHhcCC----CCCCCc
Confidence 11234688899999999988899999999999999999999999976432 22222222111 112334
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.++.++.+++..||..+|++||++.++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 57899999999999999999999998866
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=295.73 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=194.6
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--------CchhHHHHHHHHHHhcCCCCCCeeEEeeEe-CCeE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYN 77 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~-~~~~ 77 (473)
.+|.+.+.||+|+||.||+|.+..+++.||+|+.... ....+.+|+.+++.++|.+++..+..+... ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5799999999999999999999999999999984321 123577899999999876666555444332 4567
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECccccccccc
Confidence 8999998 7899999874 34589999999999999999999999999999999999994 67889999999998654
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
...... .......|+..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+.. ....
T Consensus 158 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~---~~~~ 227 (264)
T cd06653 158 TICMSG----TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIAT---QPTK 227 (264)
T ss_pred cccccC----ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHHHHHHc---CCCC
Confidence 321100 111245689999999999998899999999999999999999999976432 222222221 1112
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..++..+++++.++|.+||. ++..||++.++.
T Consensus 228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~ 259 (264)
T cd06653 228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLL 259 (264)
T ss_pred CCCCcccCHHHHHHHHHHhc-CcccCccHHHHh
Confidence 23456778999999999999 579999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=296.68 Aligned_cols=253 Identities=20% Similarity=0.254 Sum_probs=194.8
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEe-CCeEEEEEe
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYNVLVID 82 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~-~~~~~lv~e 82 (473)
|++.++||.|+||.||+|.+..+++.||+|.+.... ...+..|+.+++.+.|.+.+..+..+... ....+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 789999999999999999999899999999965432 23577899999999966655555444333 278999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 83 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 83 ~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
|++++|.+++......+++..++.++.||+.||+|||+.|++|+||||+|||++ +++.+||+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~---~~~~~~l~d~g~~~~~~~~~~~- 156 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPYTKRNSA- 156 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc---CCCCEEEccccceeeccCCCcc-
Confidence 998899999875546799999999999999999999999999999999999994 7889999999999876554310
Q ss_pred ccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-----------
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------- 230 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 230 (473)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+......
T Consensus 157 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 157 -----DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred -----cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 11233567889999988764 4789999999999999999999999765432211111111000
Q ss_pred -----------cccccHHHHhcC-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 231 -----------KVSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 231 -----------~~~~~~~~l~~~-~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
............ ++.++.+++..||..+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000111122233 3889999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=294.38 Aligned_cols=246 Identities=22% Similarity=0.283 Sum_probs=196.8
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc-----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~-----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+|.+.+.||.|+||.||+|.+..++..||+|.+.. .....+..|+.+++.++|.+.+. +..+.......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~-~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT-FFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhh-hhheeccCCeEEEEEe
Confidence 58999999999999999999999999999998533 23456789999999998665554 4445667788899999
Q ss_pred cC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+||+++ ++...+||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhccCCcc
Confidence 99 889999987533 3589999999999999999999999999999999999995 3335679999999987654322
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
. .....|+..|+|||++.+..++.++|||||||++|||++|..||..... .+.+..+..... ..+.
T Consensus 158 ~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~ 223 (257)
T cd08225 158 L-------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL---HQLVLKICQGYF----APIS 223 (257)
T ss_pred c-------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhcccC----CCCC
Confidence 1 1234688999999999888899999999999999999999999976432 222222222221 1223
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..++.++.++|.+||..+|++||++.+|++
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 467889999999999999999999888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=299.05 Aligned_cols=251 Identities=22% Similarity=0.221 Sum_probs=197.3
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
|++.+.||.|++|.||+|.+..+++.+++|...... ...+..|+.+++.++|. ++..+..+...+...++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHP-NIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCC-CcchHHHhhccCCCEEEEEec
Confidence 678899999999999999998899999999854432 23577899999999854 555555555667888999999
Q ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 84 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 84 ~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+.++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||.+........
T Consensus 80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~df~~~~~~~~~~~--- 153 (283)
T cd05118 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN---TEGVLKLADFGLARSFGSPVR--- 153 (283)
T ss_pred cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC---CCCcEEEeeeeeeEecCCCcc---
Confidence 98899999886666899999999999999999999999999999999999994 678999999999987654321
Q ss_pred cccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc------------
Q 011988 164 IPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------------ 230 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~------------ 230 (473)
......++..|+|||.+.+. .++.++|||||||++|+|++|+.||......+...........
T Consensus 154 ----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 154 ----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence 11234678899999999877 6899999999999999999999999764322111111110000
Q ss_pred ----------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 231 ----------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 231 ----------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
........+...++.++.++|..||..||.+||++.+|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0011122334467899999999999999999999888753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=297.30 Aligned_cols=241 Identities=25% Similarity=0.293 Sum_probs=196.5
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+|++.+.||.|+||.||+|.+..+++.||+|+..+. ....+..|+++++.++|+++ ..+..+...+...++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFL-VNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCCh-HHHHHhhcCCCeEEEEE
Confidence 599999999999999999999989999999985432 23457889999999986554 44545556778899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|.+++... ..+++..++.|+.||+.||.|||++||+|+||||+||+++ +++.++|+|||++........
T Consensus 80 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 80 DLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD---EQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred eCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc---CCCCEEEeecccccccCCCcc
Confidence 999 88999998754 5799999999999999999999999999999999999994 778999999999986654321
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
.....|+..|+|||.+.+..++.++|||||||++|+|++|..||................. ......
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~ 222 (258)
T cd05578 156 --------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-----ADVLYP 222 (258)
T ss_pred --------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-----ccccCc
Confidence 1235688899999999988899999999999999999999999987654322222222111 122234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYA 266 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~ 266 (473)
..+|.++.++|.+||..||++||++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCcc
Confidence 56789999999999999999999984
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=320.20 Aligned_cols=249 Identities=20% Similarity=0.350 Sum_probs=208.0
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEE---EEE--cccC--CchhHHHHHHHHHHhcCCCCCCeeEEe-eEeCCeEEEE
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKL--NVKT--KHPQLQYEAKLYKILQGGTGIPNLRWF-GVEGDYNVLV 80 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vA---iK~--~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~-~~~~~~~~lv 80 (473)
.+...+||+|+|-+||+|.|..+|..|| ||+ +.+. ....|..|+.+|+.|+|.++|.++..+ ........+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 3566789999999999999999999887 555 2222 235688999999999999998888544 4556677888
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
.|++ .|+|..|+++. +.++.+.+..|+.||+.||.|||++. |||||||.+||+|+ ...|.|||+|+|||+....
T Consensus 122 TEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhc
Confidence 9988 99999999854 46999999999999999999999875 99999999999997 7789999999999998776
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
... ....||+.|||||++. ..|+..+||||||++|+||+|+.+||..+. ...+.|.++.....+..+.
T Consensus 199 s~a---------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 199 SHA---------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSGIKPAALS 266 (632)
T ss_pred ccc---------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcCCCHHHhh
Confidence 543 3479999999999998 579999999999999999999999999875 4577888888777665544
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.+ -.+++++||.+||.. ..+||++.+| |.+.|-..
T Consensus 267 kV---~dPevr~fIekCl~~-~~~R~sa~eL---L~d~Ff~~ 301 (632)
T KOG0584|consen 267 KV---KDPEVREFIEKCLAT-KSERLSAKEL---LKDPFFDE 301 (632)
T ss_pred cc---CCHHHHHHHHHHhcC-chhccCHHHH---hhChhhcc
Confidence 43 368999999999999 9999997766 55555433
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=303.85 Aligned_cols=246 Identities=17% Similarity=0.277 Sum_probs=195.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
..|....+||.|+||.||+|.+..+++.||||++... ....+..|+.+++.+.|++ +..+..++..++..+++|||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~-i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQN-VVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCc-hhhhhhheeeCCeEEEEEec
Confidence 4466677899999999999999889999999985332 2345778999999998654 44455556677888999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+.....
T Consensus 100 ~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~---~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 100 LQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc---cCCcEEEeechhHhhcccccc--
Confidence 9 779988876 34689999999999999999999999999999999999994 778999999999976543221
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+...... .......
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~--~~~~~~~ 242 (297)
T cd06659 173 -----KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPPP--KLKNAHK 242 (297)
T ss_pred -----cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccCCC--CccccCC
Confidence 11345789999999999998899999999999999999999999976432 2333333221111 1112345
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
++.++.++|..||..+|++||++.+|++
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 7889999999999999999999888755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=292.58 Aligned_cols=244 Identities=25% Similarity=0.354 Sum_probs=195.9
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
+|+..+.||+|+||.||+|.+..+++.|+||+..... ...+..|+.+++.++|.+++ .+..+.......++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~-~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV-QYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCch-heeeeEecCCeEEE
Confidence 5888999999999999999998899999999853322 24578899999999865544 45556677788899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
+|||+ +++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++ .++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~---~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 80 FLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD---TNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccceecccc
Confidence 99999 77999998743 4689999999999999999999999999999999999994 6789999999999765443
Q ss_pred CCccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
.. .....|+..|++||.+.... ++.++|||||||++|+|++|..||..... ......+.... ...
T Consensus 156 ~~--------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~---~~~ 221 (258)
T cd06632 156 SF--------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGRSK---ELP 221 (258)
T ss_pred cc--------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHHHHhcc---cCC
Confidence 21 13457899999999998776 89999999999999999999999976542 22222222111 112
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.+...+++++.+++.+||..+|++||++.+++.
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 233467899999999999999999999888753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=305.28 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=192.5
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEe-----
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVE----- 73 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~----- 73 (473)
++.++|.+.+.||+|+||.||+|.+..+++.||||++.+.. ...+..|+.+++.+.|.+++..+..+...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 45689999999999999999999999999999999854321 23477899999999877766655544322
Q ss_pred CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 74 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 74 ~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
....+++++|+..+|..++ ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 92 ~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~---~~~~~kL~dfg~~~ 165 (342)
T cd07879 92 FQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLAR 165 (342)
T ss_pred CceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCCCCc
Confidence 1346899999988887765 34689999999999999999999999999999999999994 67899999999997
Q ss_pred cccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc--
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-- 230 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~-- 230 (473)
...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..+..+...
T Consensus 166 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~ 232 (342)
T cd07879 166 HADAEM----------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTG 232 (342)
T ss_pred CCCCCC----------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcC
Confidence 543211 23467889999999876 45899999999999999999999999864321 111111110
Q ss_pred ------------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 ------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 ------------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
........+...++.++.++|..||+.||++||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 001112222345678899999999999999999988885
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=298.60 Aligned_cols=263 Identities=18% Similarity=0.281 Sum_probs=205.5
Q ss_pred ceEEEeeEeecCceEEEEEEEc---CCCcEEEEEEcccCC-------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLNVKTK-------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~~~~~~-------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
+|++.+.||.|+||.||++++. .+++.||||+..+.. ...+..|+.++..+.+++++..+......+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 467889999854321 234678999999998788777777777778889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ +++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||.||+++ .++.++|+|||+++.+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD---SEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEEECccccccc
Confidence 9999999 7799988864 35689999999999999999999999999999999999994 67889999999987654
Q ss_pred CCCCccccccccCCCcccCccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHH-HHHHHHhhcccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVS 233 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~ 233 (473)
..... ......|+..|+|||.+.+.. .+.++||||||+++|||++|..||......... .....+....
T Consensus 157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-- 228 (288)
T cd05583 157 AEEEE------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK-- 228 (288)
T ss_pred ccccc------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--
Confidence 43211 112356899999999988765 788999999999999999999999643222111 1111111111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 292 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 292 (473)
......++.++.+++.+||+.||++||++.++.++|++.+. ...+|...
T Consensus 229 ---~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~-------~~~~~~~~ 277 (288)
T cd05583 229 ---PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF-------QGIDWDDL 277 (288)
T ss_pred ---CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc-------ccCCHHHH
Confidence 11234578899999999999999999999999888887653 34567654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=339.34 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=214.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|.|++.||.|+||.|.+++++.+++.||+|++.+. ...-|..|-.+|-.-+ ..-|..+++.+.+..+.|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceEE
Confidence 46899999999999999999999999999999986552 2334666777766544 6677778888899999999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ ||+|-.++.... +++++.+..++..|+.||.-||+.|+|||||||+|||| +..|++||+|||.|-.+..+
T Consensus 153 VMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCC
Confidence 99999 999999998666 89999999999999999999999999999999999999 58999999999999888765
Q ss_pred CCccccccccCCCcccCcccccccccc----C-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHL----G-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~----~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
.... ....+|||-|.|||++. + +.|++.+|+||+||++|||+.|..||.. ....+.|.+|...+-.
T Consensus 229 G~V~------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa---dslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 229 GTVR------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA---DSLVETYGKIMNHKES 299 (1317)
T ss_pred CcEE------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH---HHHHHHHHHHhchhhh
Confidence 4422 24569999999999986 3 4699999999999999999999999976 4556778888776443
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHHHHHhCCCCCCcccccccc
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD---YAYLKRLFRDLFIREGFQFDYVFDWTILK 293 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt---~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 293 (473)
...+.. ..++++.++||...+. +|+.|.. ++++. .+ +|..-.||...+
T Consensus 300 l~FP~~-~~VSeeakdLI~~ll~-~~e~RLgrngiedik---~H-------pFF~g~~W~~iR 350 (1317)
T KOG0612|consen 300 LSFPDE-TDVSEEAKDLIEALLC-DREVRLGRNGIEDIK---NH-------PFFEGIDWDNIR 350 (1317)
T ss_pred cCCCcc-cccCHHHHHHHHHHhc-ChhhhcccccHHHHH---hC-------ccccCCChhhhh
Confidence 333321 2378999999999874 6888877 55443 22 445567897654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=294.07 Aligned_cols=238 Identities=22% Similarity=0.263 Sum_probs=184.6
Q ss_pred eEeecCceEEEEEEEcCCCcEEEEEEcccCCc------hhHHHHHHHHHHhc--CCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH------PQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~------~~l~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
.||+|+||.||+|.+..+++.||||++.+... .....|..+++.+. +++++..+..+....+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999998544321 12344544444443 3566666677777788899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 85 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 85 g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
|++|.+++.. ...+++..++.|+.|++.||.|||+.+|+||||||+|||++ .++.+||+|||++..+.....
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~---~~~~~kl~dfg~~~~~~~~~~---- 152 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKP---- 152 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC---CCCCEEEccCcCccccCccCC----
Confidence 8899988864 45699999999999999999999999999999999999994 678899999999976543221
Q ss_pred ccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011988 165 PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
....|+..|+|||++.+. .++.++|||||||++|||++|..||.+................. ..+...+
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 222 (278)
T cd05606 153 -----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-----VELPDSF 222 (278)
T ss_pred -----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccC-----CCCCCcC
Confidence 245789999999999754 68999999999999999999999998754322222221111111 1123456
Q ss_pred cHHHHHHHHHHhcCCCCCCC-----CHHHHH
Q 011988 244 PTEFASYFHYCRSLRFDDKP-----DYAYLK 269 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RP-----t~~~l~ 269 (473)
+.++.+++.+||..+|.+|| ++.++.
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 253 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 253 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHH
Confidence 89999999999999999999 777664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=304.31 Aligned_cols=251 Identities=20% Similarity=0.258 Sum_probs=196.7
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeC----CeEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----DYNV 78 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~----~~~~ 78 (473)
+|++.+.||.|+||.||+|.+..+++.||||.+... ....+..|+.+++.++|.+++..+..+.... ...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 699999999999999999999888999999985432 2346888999999998655555444333322 3679
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 79 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 79 lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
++|+|++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.++|+|||++......
T Consensus 81 lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~---~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN---SNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccCceEeeccc
Confidence 9999999899998873 44799999999999999999999999999999999999994 6789999999999876554
Q ss_pred CCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc------
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------ 231 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~------ 231 (473)
.... .......++..|+|||++.+. .++.++|||||||++|+|++|..||.+.... +.+..+....
T Consensus 157 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 157 EDEK----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI---DQLNLIVEVLGTPSEE 229 (330)
T ss_pred cccc----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHhcCCCChh
Confidence 2110 112345688999999999988 7899999999999999999999999775432 1122111100
Q ss_pred --------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 --------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 --------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.......+...++.++.++|..||+.+|++||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 287 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 01112223345789999999999999999999988774
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=304.86 Aligned_cols=260 Identities=19% Similarity=0.270 Sum_probs=203.1
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc--CCchhHHHHHHHHHHhcCC-----CCCCeeEEeeEeCCe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK--TKHPQLQYEAKLYKILQGG-----TGIPNLRWFGVEGDY 76 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~--~~~~~l~~E~~il~~L~~~-----~~i~~~~~~~~~~~~ 76 (473)
.+.++|.++.+||+|.||.|-.+.+..++..||||++.. .-.+...-|+++|++|... +-+.++..++.....
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 357899999999999999999999999999999998433 3344567799999999532 234445555667778
Q ss_pred EEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCC----------------
Q 011988 77 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR---------------- 139 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~---------------- 139 (473)
.|||+|.+|.|+.+++...+ .+|+...+..|+.||+++++|||+.+++|-||||+|||+...+
T Consensus 166 iCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 166 ICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred eEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 89999999999999998533 4699999999999999999999999999999999999996321
Q ss_pred -CCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 011988 140 -RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 218 (473)
Q Consensus 140 -~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~ 218 (473)
+...|+|+|||.|+.-.... ...+.|..|.|||+++|..++.++||||+||||+|+++|...|+...+.
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred CCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 13468999999998544322 3568899999999999999999999999999999999999999987655
Q ss_pred CHHHHHHHHhhccccccHHHH----------------------------hc-------C---CcHHHHHHHHHHhcCCCC
Q 011988 219 TKKQKYEKISEKKVSTSIEAL----------------------------CR-------G---YPTEFASYFHYCRSLRFD 260 (473)
Q Consensus 219 ~~~~~~~~i~~~~~~~~~~~l----------------------------~~-------~---~p~~l~~li~~cl~~dp~ 260 (473)
+....++.|........+..- |+ . --.+|.+||+.||.+||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 545455555432211111111 00 0 014588999999999999
Q ss_pred CCCCHHHHHHHHHHHH
Q 011988 261 DKPDYAYLKRLFRDLF 276 (473)
Q Consensus 261 ~RPt~~~l~~~L~~l~ 276 (473)
+|+|+.|+ |.+.|
T Consensus 396 ~RiTl~EA---L~HpF 408 (415)
T KOG0671|consen 396 RRITLREA---LSHPF 408 (415)
T ss_pred ccccHHHH---hcCHH
Confidence 99996665 54444
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=300.95 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=195.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.+.|.+.+.||+|+||.||+|.+..+++.||||++.... ...+..|+.+++.++|++ +..+..+.......++
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~l 102 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN-SIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCC-EEEEEEEEeeCCeEEE
Confidence 345889999999999999999999999999999854321 234778999999998554 5555566677788899
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 80 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 80 v~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
+|||+.++|.+++.....++++..+..++.||+.||.|||++||+||||+|+||+++ .++.++|+|||++......
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~---~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPA- 178 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC---CCCCEEEecCCCccccCCc-
Confidence 999998899998876677799999999999999999999999999999999999994 6789999999998754321
Q ss_pred CccccccccCCCcccCcccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
....|+..|+|||.+. +..++.++|||||||++|||++|..||..... ...+..+........
T Consensus 179 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~- 244 (317)
T cd06635 179 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPTL- 244 (317)
T ss_pred ----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhccCCCC-
Confidence 2346889999999974 34688999999999999999999999976432 222222222111111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
....+++.+.+++.+||..+|.+||++.+|.+
T Consensus 245 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 245 --QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred --CCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 12346788999999999999999999888854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=295.55 Aligned_cols=252 Identities=18% Similarity=0.290 Sum_probs=190.9
Q ss_pred eEEEeeEeecCceEEEEEEEc---CCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC-----C
Q 011988 9 FRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG-----D 75 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~-----~ 75 (473)
|.+.+.||+|+||.||+|.+. .+++.||||+..... ..++..|+++++.+.|++++..+..+.... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999865 357899999854432 234778999999998665555444332211 1
Q ss_pred eEEEEEecC-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEec
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 149 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~-----~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 149 (473)
..+++++|+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~---~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc---CCCCEEECcc
Confidence 346778887 789988864221 2478999999999999999999999999999999999994 6788999999
Q ss_pred CCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHh
Q 011988 150 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS 228 (473)
Q Consensus 150 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~ 228 (473)
|+++....... +.......++..|++||.+.+..++.++|||||||++|||++ |..||.+... ...+..+.
T Consensus 158 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~ 229 (273)
T cd05074 158 GLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI 229 (273)
T ss_pred cccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH
Confidence 99986543221 111123355678999999998889999999999999999999 8999976433 22222222
Q ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 229 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 229 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
..... .....++..+.+++..||+.+|++||++.++.+.|+.+
T Consensus 230 ~~~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 21110 11235778999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.40 Aligned_cols=247 Identities=19% Similarity=0.318 Sum_probs=199.4
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
+.|.|+..||.|+||.||+|.++.++...|-|++... ...++..|+.||..+.|+.++..+..|+.+ +..+|.+||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-nkLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-NKLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-CceEEEEee
Confidence 4588999999999999999999988888888985443 345678899999999966666655555544 456888899
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
| ||-...++-..++.+.+.++..+++|++.||.|||+++|||||||..|||++ -+|.|+|+|||.+-.......
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~~t~q-- 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKNKSTRQ-- 185 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccchhHHh--
Confidence 9 6677777777888999999999999999999999999999999999999997 678999999999865433211
Q ss_pred ccccccCCCcccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 163 HIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
....|.||++|||||+.. ..+|+.++||||||++|.||..+.+|...++.. ..+.+|.....++.+
T Consensus 186 -----kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---RVllKiaKSePPTLl- 256 (1187)
T KOG0579|consen 186 -----KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSEPPTLL- 256 (1187)
T ss_pred -----hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---HHHHHHhhcCCCccc-
Confidence 235789999999999876 457999999999999999999999999887653 233333333322221
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
-+..++..|.+|+..||.+||+.||++++|+
T Consensus 257 -qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 257 -QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred -CcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 2345778999999999999999999998874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.60 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=194.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeC-----
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----- 74 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~----- 74 (473)
+.++|.+.+.||.|+||.||+|.+..+++.||||+.... ....+..|+.+++.+.|++++..+..+....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 678999999999999999999999999999999985432 1234668999999998766665554333222
Q ss_pred CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 75 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
...++|+||++++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||++..
T Consensus 93 ~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~---~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEcccccccc
Confidence 2479999999999999987 35699999999999999999999999999999999999995 678899999999986
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc--
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-- 231 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~-- 231 (473)
.... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||.+... ...+..+....
T Consensus 168 ~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~ 234 (343)
T cd07851 168 TDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVGT 234 (343)
T ss_pred cccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCC
Confidence 5432 1234678899999998763 578999999999999999999999976433 22222221110
Q ss_pred ------------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 ------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 ------------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.......+...+++++.++|..||+.||++|||+.+|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell 296 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHh
Confidence 00111223345688999999999999999999988774
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=286.45 Aligned_cols=246 Identities=25% Similarity=0.396 Sum_probs=198.5
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
+|.+.+.||+|++|.||++.+..+++.|++|+.... ....+..|+.+++.+. ++++..+..+.......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEEecC
Confidence 488999999999999999999889999999985443 3456889999999999 455555666666778889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 -g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||+++ +.+.++|+|||++........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeecccccccccccc---
Confidence 5899999986556799999999999999999999999999999999999995 678999999999987654321
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
.....|+..|++||.+.+..++.++|||||||++|+|++|..||...... ............... ....+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~--~~~~~ 223 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKIATNGPPGLR--NPEKW 223 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHhcCCCCcC--ccccc
Confidence 13457889999999999888999999999999999999999999765322 222222211111110 01124
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 244 PTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
+.++.++|..||..||++||++.++++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 789999999999999999999888753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=289.15 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=196.6
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+|.+.+.||+|+||.||+|.+..+++.|+||+..... ...+..|+.+++.++|.+ |..+..+....+..++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN-LVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCC-hhheeeeEecCCEEEEEEe
Confidence 6999999999999999999998899999999854433 345788999999998654 4555556677788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++.. ...+++..+..|+.|++.||.|||++||+|+||+|+||+++ ..+.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEcccccccccCCCCCc
Confidence 98 7899999874 34589999999999999999999999999999999999995 6789999999999876554321
Q ss_pred cccccccCCCcccCccccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~---~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
... ......++..|+|||++.+.. ++.++|||||||++|||++|..||..... .......+.... ...++.
T Consensus 156 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~-~~~~~~ 229 (264)
T cd06626 156 MGE---EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGAGH-KPPIPD 229 (264)
T ss_pred ccc---cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHHHHHhcCC-CCCCCc
Confidence 100 012356889999999998776 88999999999999999999999976532 122222222111 111111
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...++..+.++|..||..+|++||++.++.
T Consensus 230 -~~~~~~~~~~li~~~l~~~p~~R~~~~~i~ 259 (264)
T cd06626 230 -SLQLSPEGKDFLDRCLESDPKKRPTASELL 259 (264)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 123578999999999999999999988874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=298.03 Aligned_cols=243 Identities=23% Similarity=0.330 Sum_probs=194.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.+.|...++||+|+||.||+|.+..+++.|+||++.... ...+..|+.+++.++|. ++..+..++......++
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHP-NTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCC-CCccEEEEEEeCCEEEE
Confidence 345777889999999999999999999999999854322 13467899999999855 45555666677888999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 80 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 80 v~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
+|||+.++|.+++......+++.+++.++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++.....
T Consensus 99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~---~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC---CCCCEEEeecCCCcccCC--
Confidence 999999999999876667799999999999999999999999999999999999994 678899999999864321
Q ss_pred CccccccccCCCcccCcccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
.....|+..|+|||++. +..++.++|||||||++|||++|..||....... ....+.......
T Consensus 174 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~~~~~~-- 239 (313)
T cd06633 174 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNDSPT-- 239 (313)
T ss_pred ---------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcCCCC--
Confidence 13457899999999985 3568899999999999999999999997754322 222222211111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.....++..+.+++.+||+.+|.+||++.++.
T Consensus 240 -~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l 271 (313)
T cd06633 240 -LQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271 (313)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11235678899999999999999999988775
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=293.63 Aligned_cols=249 Identities=21% Similarity=0.310 Sum_probs=195.7
Q ss_pred ceEEEeeEeecCceEEEEEEEcC-CCcEEEEEEcccCC-------------chhHHHHHHHHHHhcCCCCCCeeEEeeEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLNVKTK-------------HPQLQYEAKLYKILQGGTGIPNLRWFGVE 73 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~~~~~~-------------~~~l~~E~~il~~L~~~~~i~~~~~~~~~ 73 (473)
.|++.+.||+|+||.||+|.+.. .++.+|+|.+.... ...+..|+.++.....|+++..+..++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999887 67899999743211 12355677777664445666666666677
Q ss_pred CCeEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEe
Q 011988 74 GDYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIID 148 (473)
Q Consensus 74 ~~~~~lv~e~~-g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~D 148 (473)
....+++|||+ +++|.+++.. ....+++..++.++.|++.||.|||+ .||+|+||||+|||++ ..+.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~---~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC---CCCcEEEec
Confidence 88999999998 7899998753 34568999999999999999999996 7899999999999994 778999999
Q ss_pred cCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011988 149 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 228 (473)
Q Consensus 149 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 228 (473)
||++........ .....|+..|++||.+.+..++.++|||||||++|||++|+.||..... ......+.
T Consensus 158 fg~~~~~~~~~~--------~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~ 226 (269)
T cd08528 158 FGLAKQKQPESK--------LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIV 226 (269)
T ss_pred ccceeecccccc--------cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHHHHh
Confidence 999986544321 1345789999999999998899999999999999999999999965432 22222332
Q ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 229 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 229 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
....... ....+++++.++|.+||..||++||++.++...+.
T Consensus 227 ~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 EAVYEPL---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hccCCcC---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 2222111 11256789999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=293.35 Aligned_cols=236 Identities=21% Similarity=0.248 Sum_probs=185.7
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCC
Q 011988 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 87 (473)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~s 87 (473)
||+|+||.||+|.+..+++.||+|++.... ...+..|+.+++.++| +++..+.......+..+++|||+ +++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCC-CCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999999999999999854321 2335679999999984 55555555556677889999999 789
Q ss_pred HHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccccc
Q 011988 88 LEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166 (473)
Q Consensus 88 L~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~ 166 (473)
|.+++.... ..+++..++.++.||+.||.|||++||+|+||+|+||+++ .++.++|+|||++........
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~------ 150 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD---DHGNVRISDLGLAVELKGGKK------ 150 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEccCcchhhhccCCc------
Confidence 999987543 3699999999999999999999999999999999999994 678999999999976543211
Q ss_pred ccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHH
Q 011988 167 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 246 (473)
Q Consensus 167 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 246 (473)
.....++..|++||.+.+..++.++|||||||++|+|++|+.||...........+... .. .....+...++++
T Consensus 151 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~ 224 (277)
T cd05577 151 --IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR---TL-EMAVEYPDKFSPE 224 (277)
T ss_pred --cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc---cc-cccccCCccCCHH
Confidence 13446788999999999888999999999999999999999999775442222222111 11 1111233457899
Q ss_pred HHHHHHHHhcCCCCCCCCHH
Q 011988 247 FASYFHYCRSLRFDDKPDYA 266 (473)
Q Consensus 247 l~~li~~cl~~dp~~RPt~~ 266 (473)
+.++|.+||..+|++||++.
T Consensus 225 ~~~li~~~l~~~p~~R~~~~ 244 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCR 244 (277)
T ss_pred HHHHHHHHccCChhHccCCC
Confidence 99999999999999999443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=299.16 Aligned_cols=246 Identities=22% Similarity=0.305 Sum_probs=194.8
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.++|++.+.||+|+||.||++.+..++..||+|...... ...+..|+.+++.+.|+ ++..+..++...+..++|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp-~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHP-NIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCC-CeeehhheeeeCCcEEEEEe
Confidence 478999999999999999999998899999999854322 33577899999999854 55555556667788899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++ ..+.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~---~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred cCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc---CCCCEEEccCcceeccccccc-
Confidence 99 8899999873 4688999999999999999999999999999999999994 678899999999876543322
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
......|+..|++||.+.+..++.++|||||||++|++++|..||....... .+..+..... .. .....
T Consensus 171 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~---~~~~~~~~~~-~~-~~~~~ 239 (293)
T cd06647 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIATNGT-PE-LQNPE 239 (293)
T ss_pred ------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh---heeehhcCCC-CC-CCCcc
Confidence 1133578899999999998889999999999999999999999997643211 1111111000 00 01123
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.++..+.++|..||..+|++||++.+++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELL 267 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 4678899999999999999999988774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=288.80 Aligned_cols=245 Identities=23% Similarity=0.285 Sum_probs=199.6
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+|.+.+.||.|+||.||++.+..+++.|++|++... ....+..|+++++.++|++.+. +..........++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~-~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK-YYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhh-eEEEEecCCEEEEEEE
Confidence 589999999999999999999989999999985443 2345788999999999555554 4444555688899999
Q ss_pred cC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 83 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 83 ~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
++ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||+|+||+++ ..+.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT---SNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc---CCCcEEECCccceeecccC
Confidence 99 67999998754 36799999999999999999999999999999999999994 6789999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.... ............ ...
T Consensus 157 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~----~~~ 222 (258)
T cd08215 157 VD-------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQ----YPP 222 (258)
T ss_pred cc-------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHhcCC----CCC
Confidence 31 1134578999999999999889999999999999999999999997643 223333322222 122
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
+...++.++.+++..||..+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 34467899999999999999999999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=294.30 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=199.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|.+.+.||.|+||.||+|.+..+++.||+|+..+. ....+..|..+++.+..+++|..+..+.......+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 5799999999999999999999999999999985442 1245778899999998455666666566777889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||++ +++|.+++... ..+++..++.|+.||+.||.|||++|++|+||||+||+++ .++.++|+|||++..+....
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~---~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEecCCccccccCCcc
Confidence 9999 99999999753 4799999999999999999999999999999999999994 67899999999998765433
Q ss_pred Cccc-------------cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 011988 160 THQH-------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 226 (473)
Q Consensus 160 ~~~~-------------~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~ 226 (473)
.... ........+.|+..|+|||++.+..++.++|||||||++|++++|..||.... ....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~ 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLTFQK 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHH
Confidence 2110 01123345678899999999998889999999999999999999999998653 2222333
Q ss_pred HhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 011988 227 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 265 (473)
Q Consensus 227 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~ 265 (473)
+..... .+...+++.+.++|..||+.+|++||++
T Consensus 234 ~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 234 ILKLEY-----SFPPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred HHhcCC-----CCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 322111 1234568999999999999999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=295.94 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=200.6
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
..+.|++.+.||+|+||.||+|.+..++..|++|++.... ...+..|+.+++.++|. ++..+..+.......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHP-NIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCC-CeeEEEEEEEECCEEEEEEe
Confidence 4567999999999999999999998889999999865544 45688999999999864 55556666677788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++......+++..++.++.||+.||.|||+.||+|+||||+||+++ .++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS---KDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc---CCCCEEECccchhhhhccchh-
Confidence 99 5899999986544799999999999999999999999999999999999994 678999999999876543221
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
......++..|++||.+.+..++.++|||||||++|+|++|..||..... ......+....... .. ...
T Consensus 172 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~~-~~~ 240 (286)
T cd06614 172 ------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLITTKGIPP-LK-NPE 240 (286)
T ss_pred ------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCC-Cc-chh
Confidence 11234678899999999988899999999999999999999999976432 22222222221111 11 123
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.++.++.++|..||+.+|.+||++.+|+
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 4789999999999999999999988773
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=294.22 Aligned_cols=251 Identities=23% Similarity=0.285 Sum_probs=193.3
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
|.+.+.||.|+||.||+|.+..+++.|+||...... .....+|+..++.+..++++..+..+...+...+++|||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 788999999999999999998899999999854332 2234568889999984455555555556688889999999
Q ss_pred CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++.... ..+++..++.++.||+.+|.|||++||+|+||||+||+++ +.+.++|+|||+++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~---~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS---GPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCCEEEeecccceeccCCCC---
Confidence 999999887543 4689999999999999999999999999999999999994 788999999999986544221
Q ss_pred cccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc-----------
Q 011988 164 IPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------- 231 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------- 231 (473)
.....++..|+|||++.+ ..++.++||||||+++|||++|..||......+.......+....
T Consensus 155 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 -----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred -----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 123568899999998864 447899999999999999999999997654322221111111000
Q ss_pred -----------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 232 -----------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 232 -----------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.......+....+.++.++|..||..+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 001112222334688999999999999999999887743
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=286.13 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=200.3
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC--CeEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG--DYNVLV 80 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~--~~~~lv 80 (473)
+|.+.+.||+|++|.||+|.+..+++.|++|+..... ...+..|+.+++.++|++++ .+..+.... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV-RYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEe-eEEEEEecCCCCeEEEE
Confidence 5899999999999999999998899999999855444 45688899999999955554 444444555 788999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
+|++ +++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++ ..+.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEeccccc
Confidence 9999 899999998544 899999999999999999999999999999999999995 67899999999998776543
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
.. .......++..|++||.+.+..++.++|||||||++|+|++|..||.... ........+... .....+
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~---~~~~~~ 225 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSS---GEPPEI 225 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhcccc---CCCcCC
Confidence 21 01134578899999999998889999999999999999999999998754 222222222211 111223
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
...++.++.++|.+||..+|++||++.++.+
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 4456899999999999999999999888753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=293.73 Aligned_cols=243 Identities=17% Similarity=0.273 Sum_probs=192.0
Q ss_pred ceEEEeeEeecCceEEEEEEEc---CCCcEEEEEEcccCC-------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLNVKTK-------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~~~~~~-------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
+|++.+.||.|+||.||+|.+. .+|+.||+|++.... ...+..|+.+++.+.++++|..+..+...+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999875 478999999854321 244678999999998888888888777888889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+++|||+ +++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++ .++.+||+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC---CCCCEEEeeCccceecc
Confidence 9999999 7899999874 45689999999999999999999999999999999999994 67899999999998664
Q ss_pred CCCCccccccccCCCcccCccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
..... ......|+..|+|||.+.+. .++.++|||||||++|+|++|..||...........+........
T Consensus 157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-- 228 (290)
T cd05613 157 EDEVE------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-- 228 (290)
T ss_pred ccccc------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--
Confidence 43211 11245689999999998764 367899999999999999999999975332211121211111111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCC
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPD 264 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt 264 (473)
..+...+++.+.+++.+||..||++||+
T Consensus 229 --~~~~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 229 --PPYPQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred --CCCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence 1123457889999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=317.70 Aligned_cols=267 Identities=22% Similarity=0.299 Sum_probs=202.7
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEe------C
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVE------G 74 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~------~ 74 (473)
....|...+.||+|+||.||+|+++.+|+.||||...+ ...+...+|+++|++|+|.|+|..+ ..... .
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f-~iee~~~~~~~~ 89 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLF-DIEETKFLGLVT 89 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhc-ccCCccccCccc
Confidence 35568888999999999999999999999999998544 2345578999999999955555443 33222 3
Q ss_pred CeEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC-CCcEEEEecC
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFG 150 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~--~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~-~~~vkL~DFG 150 (473)
...+++|||| ||||..+++... ..+++.+++.++.+++.||.|||++|||||||||.||++-.+.+ .-..||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 4568999999 999999997432 35999999999999999999999999999999999999965443 3346999999
Q ss_pred CcccccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC-HHHHHHHHh
Q 011988 151 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKIS 228 (473)
Q Consensus 151 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~-~~~~~~~i~ 228 (473)
.|+.+.+... ...++||..|.+||++.. ..|+..+|.|||||++|+++||.+||-...... ..+....+.
T Consensus 170 ~Arel~d~s~--------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~ 241 (732)
T KOG4250|consen 170 AARELDDNSL--------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHII 241 (732)
T ss_pred ccccCCCCCe--------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhh
Confidence 9998877652 357899999999999995 789999999999999999999999996543321 122222222
Q ss_pred hccccc--------------------cHHHHhcCCcHHHHHHHHHHhcCCCCCCC--CHHHHHHHHHHHHHHhC
Q 011988 229 EKKVST--------------------SIEALCRGYPTEFASYFHYCRSLRFDDKP--DYAYLKRLFRDLFIREG 280 (473)
Q Consensus 229 ~~~~~~--------------------~~~~l~~~~p~~l~~li~~cl~~dp~~RP--t~~~l~~~L~~l~~~~~ 280 (473)
.++... ....++..+-..+...+..+|..+|.+|- .+.+....+.+++...-
T Consensus 242 tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v 315 (732)
T KOG4250|consen 242 TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV 315 (732)
T ss_pred ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence 111111 01112222234566778888889999998 77777777777776554
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.85 Aligned_cols=258 Identities=22% Similarity=0.337 Sum_probs=207.9
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEc-----ccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-----VKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~-----~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.-+|.-..+||.|.||.||.|.+..+|+..|+|-+ .....+.+..|..++..|+|++ ++.++++.++.+..+|.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpN-lV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPN-LVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCcc-ccccCceeecHHHHHHH
Confidence 44688889999999999999999999999999952 2333456889999999999554 55666677888889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||| ||+|.+++. .++..++.....+..|++.||.|||+.|||||||||+|||++ .++.+|++|||.|..+....
T Consensus 1313 MEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld---~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD---FNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee---cCCcEEeecccceeEecCch
Confidence 9999 999999998 566678888888999999999999999999999999999994 77899999999999887653
Q ss_pred CccccccccCCCcccCccccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~---~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
+.+| .+.....||+.|||||++.|.. -..++||||||||+.||+||+.||..++. ..+.+.++.....+.
T Consensus 1389 --~~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~aIMy~V~~gh~Pq-- 1461 (1509)
T KOG4645|consen 1389 --QTMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EWAIMYHVAAGHKPQ-- 1461 (1509)
T ss_pred --hcCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hhHHHhHHhccCCCC--
Confidence 1222 3446789999999999998754 56789999999999999999999988754 344444443333222
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
++..++.+-.+||..||..||+.|.++.+ +|++.|-+.+
T Consensus 1462 --~P~~ls~~g~dFle~Cl~~dP~~Rw~~~q---lle~~f~~~~ 1500 (1509)
T KOG4645|consen 1462 --IPERLSSEGRDFLEHCLEQDPKMRWTASQ---LLEHAFGKSC 1500 (1509)
T ss_pred --CchhhhHhHHHHHHHHHhcCchhhhHHHH---HHHhhccccc
Confidence 23347889999999999999999977654 4666665443
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=293.93 Aligned_cols=244 Identities=20% Similarity=0.285 Sum_probs=193.9
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
.|...++||+|++|.||++.+..+++.|+||+.... ....+.+|+.+++.+.|++.+ .+..+....+..++++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv-~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV-EMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChh-eEEEEEEcCCeEEEEEecc
Confidence 566778999999999999999889999999985332 233477899999999865544 4555556778889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 -g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++.. .++++..++.++.||+.||.|||++||+||||||+||+++ .++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~d~g~~~~~~~~~~--- 170 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGFCAQVSKEVP--- 170 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc---CCCcEEEcccccchhhccCCc---
Confidence 8899999874 5699999999999999999999999999999999999994 678999999999875543221
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
......|+..|+|||.+.+..++.++|||||||++|||++|..||..... ...+..+....... .. ....+
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~~~~~~~~~~-~~-~~~~~ 241 (285)
T cd06648 171 ----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKRIRDNLPPK-LK-NLHKV 241 (285)
T ss_pred ----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHhcCCCC-Cc-ccccC
Confidence 11235689999999999988899999999999999999999999976432 23333333221111 11 12237
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 244 PTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
+..+.++|.+||..+|++||++.+++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHc
Confidence 88999999999999999999987774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=298.35 Aligned_cols=244 Identities=21% Similarity=0.312 Sum_probs=194.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---C---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---K---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.+.|.+.+.||.|+||.||+|.+..+++.||||..... . ...+..|+++++.++|++.+. +..+.......++
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~l 92 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ-YRGCYLREHTAWL 92 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCccc-EEEEEEcCCeeEE
Confidence 45688889999999999999999999999999985422 1 234678999999998665555 4455566788899
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 80 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 80 v~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||||+.++|.+++......+++.+++.++.|++.||.|||+++++||||||+|||++ .++.++|+|||++......
T Consensus 93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC---CCCcEEECCcccceeecCc-
Confidence 999998899988876667799999999999999999999999999999999999994 6789999999998765322
Q ss_pred CccccccccCCCcccCccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||....... ....+.......
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~-- 233 (308)
T cd06634 169 ----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNESPA-- 233 (308)
T ss_pred ----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHHHhhcCCCC--
Confidence 23568899999999853 457889999999999999999999997654321 111222111111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.....++..+.++|.+||..+|++||++.++++
T Consensus 234 -~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 234 -LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred -cCcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 112357789999999999999999999888754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=311.29 Aligned_cols=245 Identities=24% Similarity=0.305 Sum_probs=203.1
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc-----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~-----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
...+.|.+.+.||+|.|+.|.+|++..++..||||++.++.. ..+.+|+++|+.|+|+++| .++.+-......|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIv-kl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIV-KLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCccee-eeeeeeeecceeE
Confidence 445779999999999999999999999999999999776553 3368999999999965554 4555556677889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+||||+ ++.+.+++...++ ..+.++..++.|++.|++|||+++|||||||.+|||| +.+..+||+|||++..+..
T Consensus 132 lV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeecc
Confidence 999999 9999999986554 5569999999999999999999999999999999999 4777899999999988864
Q ss_pred CCCccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
... ..+++|++.|+|||++.|.+| ++.+|+||+|++||-|+.|.+||++..- +..-.++...++..
T Consensus 208 ~~~--------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l---k~Lr~rvl~gk~rI-- 274 (596)
T KOG0586|consen 208 GLM--------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL---KELRPRVLRGKYRI-- 274 (596)
T ss_pred ccc--------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc---ccccchheeeeecc--
Confidence 332 257899999999999999986 7999999999999999999999987432 22223333333332
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.-.++.+..++|.++|.++|.+|++.+++.
T Consensus 275 ---p~~ms~dce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 275 ---PFYMSCDCEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred ---cceeechhHHHHHHhhccCccccCCHHHhh
Confidence 224567899999999999999999987763
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=285.15 Aligned_cols=243 Identities=24% Similarity=0.352 Sum_probs=198.4
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+|++.+.||+|+||.||++.+..+++.|+||...... ...+..|+++++.+.|++ +..+..+.......+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN-IVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCC-ccEEEEEEEeCCEEEEEEe
Confidence 5899999999999999999998899999999854443 245788999999998654 5555555667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
++ +++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++ ..+.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCccc
Confidence 99 67999998754 5799999999999999999999999999999999999995 5789999999999876543321
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ...+..+..... ..+..
T Consensus 156 -------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~ 221 (254)
T cd06627 156 -------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRIVQDDH----PPLPE 221 (254)
T ss_pred -------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhccCC----CCCCC
Confidence 1345788999999999888889999999999999999999999976442 222222221111 12335
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.++.++.+++..||..+|++||++.+++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l 249 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLL 249 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHh
Confidence 6789999999999999999999988875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=290.72 Aligned_cols=260 Identities=17% Similarity=0.207 Sum_probs=206.3
Q ss_pred ccCCceEEE-eeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeE----eCCeEE
Q 011988 4 RVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV----EGDYNV 78 (473)
Q Consensus 4 ~i~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~----~~~~~~ 78 (473)
.|.++|.+- ++||-|-.|.|-.|.++.+++.+|+|++.. .+...+|+++.-....|++|+.+..+.. ......
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 466788875 679999999999999999999999998533 3446789999988888888877654432 345678
Q ss_pred EEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 79 LVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+|||++ ||.|...+...+ ..|++.++..|+.||+.|+.|||+.+|.||||||+|+|.+....+-.+||+|||+|+.-.
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 999999 999999988554 469999999999999999999999999999999999999877777889999999998654
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC-HHHHHHHHhhcccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISEKKVSTS 235 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~-~~~~~~~i~~~~~~~~ 235 (473)
.... ..+.+-|+.|.|||++-...|+...|+||+||++|-|++|.+||....... ....-.+|.......+
T Consensus 216 ~~~~--------L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 216 EPGD--------LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred CCcc--------ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 3222 234578999999999998889999999999999999999999997654321 1112223333333222
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
..-+..+++..+++|+.+|..+|.+|.|+.++ +.+.|+
T Consensus 288 -~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~---m~hpwi 325 (400)
T KOG0604|consen 288 -EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEV---MDHPWI 325 (400)
T ss_pred -ChhHhHHHHHHHHHHHHHhcCCchhheeHHHh---hcCchh
Confidence 22345678899999999999999999996655 555554
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=288.95 Aligned_cols=243 Identities=19% Similarity=0.276 Sum_probs=197.2
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+|++.++||.|+||.||++.+..+++.++||.+.... ...+..|+.+++.++| ++|..+..+.......+++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCC-CCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999854322 3346789999999985 455555556666788999999
Q ss_pred cC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 83 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 83 ~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.|++|+||+|+||+++ ..+.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhccC
Confidence 98 88999988642 35689999999999999999999999999999999999995 5788999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. ....++..|++||.+.+..++.++||||||+++|||++|+.||..... ......+...... .
T Consensus 157 ~~---------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----~ 220 (256)
T cd08530 157 MA---------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKVQRGKYP----P 220 (256)
T ss_pred Cc---------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCC----C
Confidence 11 234678899999999998899999999999999999999999976532 2222222222221 2
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
+...++.++.+++.+||..+|++||++.++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 23357899999999999999999999888754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=289.39 Aligned_cols=259 Identities=21% Similarity=0.265 Sum_probs=208.5
Q ss_pred ceEEE-eeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 8 KFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 8 ~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
-|++. +.||+|+|+.|--|....++.+||||++.+.. ...+.+|++++..+++|.+|..+..|+.++..+|+|||-
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 34443 57999999999999999999999999976653 456889999999999999999998899999999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+ ||.|...|.. ...|++.++..+..+|+.||.|||.+||.||||||+|||....+.-.-||||||.+...+.......
T Consensus 158 m~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 158 MRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred ccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9 8888887763 4569999999999999999999999999999999999999654445568999999987544332222
Q ss_pred ccccccCCCcccCcccccccccc---CC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC------------HHHHHH
Q 011988 163 HIPYRENKNLTGTARYASMNTHL---GI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------KKQKYE 225 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~---~~--~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~------------~~~~~~ 225 (473)
....-+..+.+|+..|||||+.. +. .|+.+.|+||||||||-||.|.+||.+.-..+ ....++
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 22222345668999999999754 32 38999999999999999999999998754321 334456
Q ss_pred HHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 226 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 226 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
.|++.+...+- +-+..++.+.+++|..+|..|+.+|.++..+
T Consensus 317 sIQEGkYeFPd-kdWahIS~eakdlisnLlvrda~~rlsa~~v 358 (463)
T KOG0607|consen 317 SIQEGKYEFPD-KDWAHISSEAKDLISNLLVRDAKQRLSAAQV 358 (463)
T ss_pred HHhccCCcCCh-hhhHHhhHHHHHHHHHHHhccHHhhhhhhhc
Confidence 67776664443 3345678999999999999999999886655
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=289.03 Aligned_cols=248 Identities=19% Similarity=0.262 Sum_probs=181.8
Q ss_pred eeEeecCceEEEEEEEcCC--CcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 13 RKIGSGSFGEIYLGTNIQT--NEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~--~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.||+|+||.||+|..... ...+++|...... ...+.+|+.+++.++|++++..+. ++......+++|||+ +
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~-~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG-QCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEE-EecCCCccEEEEecCCC
Confidence 3699999999999975433 2356677643322 345788889999998666555554 455667889999999 7
Q ss_pred CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 86 PSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 86 ~sL~~~l~~~~---~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~---~~~~~~l~Dfg~~~~~~~~~~-- 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT---SDLTVKVGDYGIGPSRYKEDY-- 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc---CCccEEecccccccccCcchh--
Confidence 89999987432 3467778899999999999999999999999999999994 678899999999864322111
Q ss_pred ccccccCCCcccCccccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhc-ccc
Q 011988 163 HIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK-KVS 233 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~-------~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~-~~~ 233 (473)
........|+..|+|||++.+ ..++.++|||||||++|||++ |..||..... ...+..+... ...
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~~~ 228 (268)
T cd05086 155 ---IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHVIKDQQVK 228 (268)
T ss_pred ---hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhhcccc
Confidence 011234578899999998753 245789999999999999997 6778866432 2233332221 111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
.....+...+++.+.+++..|| .+|++||++++|.+.|.
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1112333457889999999999 68999999999987763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=288.58 Aligned_cols=233 Identities=18% Similarity=0.243 Sum_probs=186.8
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCC
Q 011988 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 87 (473)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~s 87 (473)
||.|+||.||+|.+..+++.||||++.+.. ...+..|+.+++.+.|.+++. +..+...+...+++|||+ +++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVK-LYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEee-eeeeEEcCCccEEEEecCCCCc
Confidence 699999999999999889999999854322 245788999999998655554 444566778889999997 889
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccc
Q 011988 88 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167 (473)
Q Consensus 88 L~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 167 (473)
|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++ .++.++|+|||++........
T Consensus 80 L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~---~~~~~~l~df~~~~~~~~~~~------- 148 (262)
T cd05572 80 LWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKLKSGQK------- 148 (262)
T ss_pred HHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc---CCCCEEEeeCCcccccCcccc-------
Confidence 9999974 34689999999999999999999999999999999999994 678999999999987654321
Q ss_pred cCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHH
Q 011988 168 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 247 (473)
Q Consensus 168 ~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 247 (473)
.....|+..|++||.+.+..++.++|||||||++|+|++|..||..... +....+..+....... .....+++++
T Consensus 149 -~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~ 223 (262)
T cd05572 149 -TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKL---EFPNYIDKAA 223 (262)
T ss_pred -cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCC---CCCcccCHHH
Confidence 1234688999999999888899999999999999999999999987543 2233333333111111 1123457899
Q ss_pred HHHHHHHhcCCCCCCCC
Q 011988 248 ASYFHYCRSLRFDDKPD 264 (473)
Q Consensus 248 ~~li~~cl~~dp~~RPt 264 (473)
.++|.+||..+|++||+
T Consensus 224 ~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 224 KDLIKQLLRRNPEERLG 240 (262)
T ss_pred HHHHHHHccCChhhCcC
Confidence 99999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.63 Aligned_cols=251 Identities=21% Similarity=0.219 Sum_probs=195.6
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
|++.+.||+|+||.||+|++..+++.||+|+.... ....+..|+.+++.++|.+ +..+..+.......+++||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPN-IVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCC-HHHHHhhhhcCCceEEEecC
Confidence 67889999999999999999999999999985443 2345678999999998544 44555555666889999999
Q ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 84 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 84 ~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
++++|.+++......+++..++.++.|++.||.|||++||+||||+|+||+++ +++.++|+|||+++.......
T Consensus 80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~---~~~~~~l~d~g~~~~~~~~~~--- 153 (282)
T cd07829 80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFGIPLR--- 153 (282)
T ss_pred cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc---CCCCEEEecCCcccccCCCcc---
Confidence 99999999986556799999999999999999999999999999999999994 678999999999986644321
Q ss_pred cccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh-------------
Q 011988 164 IPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE------------- 229 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~------------- 229 (473)
......++..|+|||.+.+. .++.++|||||||++|||++|..||...........+.....
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 ----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred ----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence 11234567889999999877 789999999999999999999999976442211111111100
Q ss_pred --------ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 230 --------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 230 --------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.............++.++.++|..||..||++||++.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00011111223345789999999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=299.64 Aligned_cols=270 Identities=21% Similarity=0.250 Sum_probs=221.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc------hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH------PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~------~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
..+|.++..||.|+||.|.+|..+.+.+.+|||++.+... +--..|.++|.....++.+..++.++..-+..|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 4578999999999999999999999999999998655432 2235688888888888888899999999999999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ ||+|--.++. -++|.+..+..++..|+-||-|||++|||.||||.+|||+ +..+++||+|||+++.-.-.
T Consensus 428 VMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccC
Confidence 99999 8888777764 4579999999999999999999999999999999999999 58999999999999864433
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. ...+++||+.|+|||++.-++|+..+|+||+||+||||+.|+.||.+.+ ..+.+..|.+..+.
T Consensus 504 ~~-------TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD---E~elF~aI~ehnvs----- 568 (683)
T KOG0696|consen 504 GV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQAIMEHNVS----- 568 (683)
T ss_pred Cc-------ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHHccCc-----
Confidence 22 2367899999999999999999999999999999999999999999854 45566666666553
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHhCCCCCCccccccccccccccCC
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAY--LKRLFRDLFIREGFQFDYVFDWTILKYQQSQVST 301 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~--l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~~ 301 (473)
.++.++.|..+++...|.+.|.+|....- -.++-++ .+-.-.||+.+...+.+++.
T Consensus 569 yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H-------~FFR~iDWek~E~~eiqPPf 626 (683)
T KOG0696|consen 569 YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREH-------PFFRRIDWEKLERREIQPPF 626 (683)
T ss_pred CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhC-------cchhhccHHHHhhccCCCCC
Confidence 35678899999999999999999964210 0111122 23345799998877776554
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=306.13 Aligned_cols=262 Identities=21% Similarity=0.304 Sum_probs=209.5
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEE--cccCC--------chhHHHHHHHHHHhcCCCCCCeeEEeeE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--NVKTK--------HPQLQYEAKLYKILQGGTGIPNLRWFGV 72 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~--~~~~~--------~~~l~~E~~il~~L~~~~~i~~~~~~~~ 72 (473)
|.+.++|-++.+||.|||++||+|.|....+.||||+ +.+.- +....+|.+|.+.|.|+.+|..+.+|..
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 5678899999999999999999999999999999998 22221 2336789999999999999999999999
Q ss_pred eCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcccCCCCCcEEEeeCCCCCcEEEEec
Q 011988 73 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDF 149 (473)
Q Consensus 73 ~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~--gIvHrDIKP~NILl~~~~~~~~vkL~DF 149 (473)
+.+.+|.|+||| |.+|.-+++ ..+-++++++..|+.||+.||.||.+. .|||-||||.|||+-.+...|.+||+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccccceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 999999999999 667777776 456799999999999999999999975 5999999999999987778899999999
Q ss_pred CCcccccCCCCccccccccCCCcccCccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 011988 150 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 225 (473)
Q Consensus 150 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~----~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~ 225 (473)
|+++...++.........-...+.||.+|++||.|.-. ..+.|+||||+|||+|.++.|+.||...........+.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 99999887765544444445678899999999998743 26889999999999999999999997633211111111
Q ss_pred HHhhc-cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 226 KISEK-KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 226 ~i~~~-~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
.|... .+.. ...+.++.+..+||++||.+.-++|.+..+|
T Consensus 698 TIlkAtEVqF---P~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 698 TILKATEVQF---PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred chhcceeccC---CCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 11110 0000 0123467899999999999999999885544
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=308.03 Aligned_cols=241 Identities=21% Similarity=0.323 Sum_probs=201.8
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecCCC
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGP 86 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~g~ 86 (473)
.+.||+|.||+||-|+++++|+.||||++.+. ...++..|+.||+.+. |++|..+...++..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~-HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH-HPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC-CCCeeEEEEeecCCceEEEEehhhcc
Confidence 37899999999999999999999999996543 3467899999999997 77888888888999999999999966
Q ss_pred CHHHH-HHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 87 SLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 87 sL~~~-l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++.++ +....+.+++.....++.||+.||.|||.++|||+||||+|||+...+.-.++||||||+|+.+.+...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF----- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF----- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-----
Confidence 65555 555667899999999999999999999999999999999999998777778999999999998876543
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcH
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 245 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 245 (473)
....+||+.|+|||+++.+.|.+.-|+||.|||+|--+.|.+||....+ ..++++.....-... -++.+++
T Consensus 723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~----PW~eis~ 793 (888)
T KOG4236|consen 723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPN----PWSEISP 793 (888)
T ss_pred ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCC----chhhcCH
Confidence 2467999999999999999999999999999999999999999976432 233333322222222 2356789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHH
Q 011988 246 EFASYFHYCRSLRFDDKPDYAY 267 (473)
Q Consensus 246 ~l~~li~~cl~~dp~~RPt~~~ 267 (473)
+..+||..+|+..-.+|-+.+.
T Consensus 794 ~AidlIn~LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVDK 815 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchHh
Confidence 9999999999999999977543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.43 Aligned_cols=251 Identities=15% Similarity=0.210 Sum_probs=183.6
Q ss_pred eeEeec--CceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 13 RKIGSG--SFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 13 ~~LG~G--~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
..||.| +||+||++++..+++.||||+..... ...+.+|+.+++.++|++ |..+..++..+...+++|||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~n-iv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN-IMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCC-cceEeeeEecCCceEEEEeccc
Confidence 456666 99999999999999999999954332 244778888888888655 555555666778889999998
Q ss_pred CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++ ..+.++|+||+.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccCcccc
Confidence 67999998753 34589999999999999999999999999999999999995 678899999987654332221111
Q ss_pred cccccCCCcccCccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc--------
Q 011988 164 IPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------- 233 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------- 233 (473)
..+.......++..|+|||++.+. .++.++|||||||++|||++|..||.+..... .....+......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence 111111223456789999999874 47899999999999999999999997643211 111111100000
Q ss_pred ---------------------------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 234 ---------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 234 ---------------------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.........+++++.+||..||..||++|||+.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000011123567899999999999999999988873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=287.61 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=195.5
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCC
Q 011988 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 87 (473)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~s 87 (473)
||.|+||.||+|++..+++.|++|++.... ...+..|+++++.+.|.+++ .+..+.......+++||++ +++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVV-KLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchh-HHHHheecCcEEEEEEecCCCCc
Confidence 689999999999998899999999864432 34578899999999855544 4555566778889999999 779
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc-cccc
Q 011988 88 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ-HIPY 166 (473)
Q Consensus 88 L~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~-~~p~ 166 (473)
|.+++.... .+++..++.++.||+.||.|||++||+|+||+|+||+++ .++.++|+|||++.......... ....
T Consensus 80 L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 80 LASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc---CCCCEEEEecccchhcccCccccccccc
Confidence 999998544 799999999999999999999999999999999999994 77899999999987654321100 0000
Q ss_pred ccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHH
Q 011988 167 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 246 (473)
Q Consensus 167 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 246 (473)
.......++..|++||.+.+..++.++|||||||++|+|++|..||.... ....+..+........ .. ..++..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~--~~-~~~~~~ 229 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIFQNILNGKIEWP--ED-VEVSDE 229 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCcCCC--cc-ccCCHH
Confidence 11234568889999999998889999999999999999999999997643 2333333332221111 11 124899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 247 FASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 247 l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
+.+++..||+.+|++||++..+.++|++-|
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 230 AIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred HHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 999999999999999999988887777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.44 Aligned_cols=259 Identities=17% Similarity=0.266 Sum_probs=208.8
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+...+.++||+|-||+|.+|+- ..+..||+|.+.... ...|.+|+++|.+|+ +++|..+...+..++..++++|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchHHHHH
Confidence 4567899999999999999984 456899999854433 356899999999997 5556666677788888999999
Q ss_pred cC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~-ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ .|+|.+++..+..+ +..+....|+.||+.||+||.+.+||||||.+.|+|+ +.++++||+|||+++.+-....
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccccCCc
Confidence 99 89999999865433 3556677899999999999999999999999999999 5889999999999996554433
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
|+.....+-..+|||+|.+..++++.++|||+||++|||+++ ...||..+......+....+....-......
T Consensus 693 -----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 693 -----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred -----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence 233344566789999999999999999999999999999865 8899988765444443333333333333333
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
.+.-||.++.++|..||..|-.+||+|++|...|++.
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 3467899999999999999999999999998888764
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=291.87 Aligned_cols=242 Identities=19% Similarity=0.269 Sum_probs=190.7
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CC
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GP 86 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~ 86 (473)
...+||+|+||.||++.+..+++.||||..... ....+..|+.+++.+.|+ ++..+..++...+..+++|||+ ++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE-NVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCc-chhheeeEEEeCCEEEEEEecCCCC
Confidence 346799999999999999999999999985322 234577899999999865 4445555667788999999999 77
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccccc
Q 011988 87 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166 (473)
Q Consensus 87 sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~ 166 (473)
+|.+++. ...+++..++.++.||+.||+|||++||+|+||||+||+++ .++.++|+|||++........
T Consensus 103 ~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~---~~~~~~l~dfg~~~~~~~~~~------ 171 (292)
T cd06657 103 ALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVP------ 171 (292)
T ss_pred cHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEcccccceecccccc------
Confidence 8988775 34689999999999999999999999999999999999994 678899999999876543221
Q ss_pred ccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHH
Q 011988 167 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 246 (473)
Q Consensus 167 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 246 (473)
......|+..|++||.+.+..++.++|||||||++|+|++|..||.+... ......+... ...... ....++..
T Consensus 172 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~~~-~~~~~~-~~~~~~~~ 245 (292)
T cd06657 172 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDN-LPPKLK-NLHKVSPS 245 (292)
T ss_pred -cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhh-CCcccC-CcccCCHH
Confidence 11335688999999999888899999999999999999999999976432 2222222111 111111 12356889
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 247 FASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 247 l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
+.+++.+||..+|.+||++.++++
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 999999999999999999888744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=318.78 Aligned_cols=144 Identities=24% Similarity=0.430 Sum_probs=124.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|.++++||.|+||.||+|.+..+++.||||++.... ...+..|+.++..++|++++ .+..++......||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv-~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIV-HLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcC-eEEEEEEECCEEEE
Confidence 378999999999999999999999999999999865432 24578899999988865544 55566677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
||||+ +++|.+++.. ...+++..++.|+.||+.||.|||.+|||||||||+||||+ ..+.+||+|||+++.
T Consensus 82 VmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~---~~g~vkL~DFGls~~ 153 (669)
T cd05610 82 VMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLSKV 153 (669)
T ss_pred EEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc---CCCCEEEEeCCCCcc
Confidence 99999 8899999874 34689999999999999999999999999999999999994 678999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.50 Aligned_cols=248 Identities=21% Similarity=0.259 Sum_probs=197.8
Q ss_pred CceEEEeeEeecCceEEEEEEEcCC-C--cEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQT-N--EEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~--~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
++.++.++||+|.||.|+.|.|... | ..||||.+... ...+|.+|+.+|..|+|.+.|..+..+ .+ ....+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvV-l~-qp~mM 187 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVV-LD-QPAMM 187 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeee-cc-chhhH
Confidence 4567789999999999999998753 3 36899985433 345799999999999976665544333 33 66789
Q ss_pred EEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 80 VIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~-~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
|||++ .|+|.+.+.. ....|.......++.||+.||.||.++++|||||-..|+|+. ....||||||||.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceeccCC
Confidence 99999 8899999886 445688899999999999999999999999999999999995 678999999999998866
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
.... |.......-...|+|||.+....++.++|||+|||+||||++ |..||.+.... +.+++|......
T Consensus 265 ned~----Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---qIL~~iD~~erL--- 334 (1039)
T KOG0199|consen 265 NEDM----YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---QILKNIDAGERL--- 334 (1039)
T ss_pred CCcc----eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---HHHHhccccccC---
Confidence 4431 111122233567999999999999999999999999999999 99999997654 333443322211
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.-.+.||+.+++++..||..+|.+||+|..|++
T Consensus 335 -pRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 335 -PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred -CCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 123578999999999999999999999999973
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=287.26 Aligned_cols=244 Identities=23% Similarity=0.279 Sum_probs=190.7
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc--------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK--------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~--------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
+|.+.++||.|+||.||++.+...+..+++|+... ....++..|+.+++.++|++++..+ .+.......++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFH-ASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHH-HHHhcCCceEE
Confidence 69999999999999999999887777676666322 1223456788999999866655544 44456667899
Q ss_pred EEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 80 VIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
+|||+ +++|.+++.. ....+++..++.++.|++.||.|||++||+|+||||+||+++ .+.++|+|||+++.+
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence 99998 7899988863 245699999999999999999999999999999999999994 356999999999776
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
..... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.... .......+.....
T Consensus 156 ~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~--- 222 (260)
T cd08222 156 MGSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVVLRIVEGPT--- 222 (260)
T ss_pred CCCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCCC---
Confidence 44322 1134568899999999988889999999999999999999999996532 2222333322211
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..+...++.++.++|..||..+|++||++.++.+
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 -PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1123467889999999999999999999888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=283.16 Aligned_cols=267 Identities=21% Similarity=0.260 Sum_probs=204.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCC----cEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
...|+++++||+|.||.||+|....++ +.+|||.+..++ .....+|+.+++.|+|++.|..+..|-..+..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 357999999999999999999765543 368999855442 34578999999999999888887777666888
Q ss_pred EEEEEecCCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEee-CCCCCcEEEEecCC
Q 011988 77 NVLVIDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGL 151 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~~----~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~-~~~~~~vkL~DFGl 151 (473)
.++++||...+|.++++... +.++...+..|+.||+.|+.|||++=|+||||||.|||+.- +...|.|||+|||+
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 99999999999999998653 35899999999999999999999999999999999999963 23458999999999
Q ss_pred cccccCCCCccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCC------HHHHH
Q 011988 152 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKY 224 (473)
Q Consensus 152 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~------~~~~~ 224 (473)
|+.+.+.-. |.......+-|..|.|||.++|.. |+.+.|||++|||+.||++-++-|.+..... ....+
T Consensus 183 aR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 183 ARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred HHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999876532 334456678899999999999875 9999999999999999999888886532211 11122
Q ss_pred HHHhh---cc----------cccc---HHHH----------------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011988 225 EKISE---KK----------VSTS---IEAL----------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 272 (473)
Q Consensus 225 ~~i~~---~~----------~~~~---~~~l----------------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 272 (473)
.+|.+ .. ++.. +..+ .+.-++...+|+.++|.+||.+|.|+++. |
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA---l 335 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA---L 335 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH---h
Confidence 22211 00 0000 0000 01124457899999999999999997765 5
Q ss_pred HHHHHHh
Q 011988 273 RDLFIRE 279 (473)
Q Consensus 273 ~~l~~~~ 279 (473)
++.+-.+
T Consensus 336 eh~yF~~ 342 (438)
T KOG0666|consen 336 EHPYFTE 342 (438)
T ss_pred ccccccc
Confidence 5555433
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=309.65 Aligned_cols=249 Identities=20% Similarity=0.364 Sum_probs=207.2
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEE--cccCCchhHHHHHHHHHHhcCCCCCCeeEEeeE-----eCCeE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--NVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-----EGDYN 77 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~--~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~-----~~~~~ 77 (473)
-.+.|+|.+.||.|.+|.||+++++.+++.+|+|+ ...+...+++.|.++|+.+.+|++++.+++++. .++..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 35779999999999999999999999999999998 445566778999999999999999998877765 35678
Q ss_pred EEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 78 VLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
||||||| |||.-|+++.. +..+.+..+..|++.++.||.+||.+.+||||||-.|||++ .++.|||+|||++..+
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQL 173 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEeeeeeeeee
Confidence 9999999 88999999743 56799999999999999999999999999999999999996 8899999999999877
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCC-----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 230 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-----~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 230 (473)
...-. ...+++||+.|||||++...+ |+.++|+||||++..||..|.+|+.++.+.- .+..|...
T Consensus 174 dsT~g-------rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---aLF~IpRN 243 (953)
T KOG0587|consen 174 DSTVG-------RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFLIPRN 243 (953)
T ss_pred ecccc-------cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---hhccCCCC
Confidence 55432 236789999999999998653 6889999999999999999999998876521 12222222
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 231 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 231 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
..+.. .-++.+..+|.++|..||.+|.+.||...++
T Consensus 244 PPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~l 279 (953)
T KOG0587|consen 244 PPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEEL 279 (953)
T ss_pred CCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence 21111 1134567899999999999999999996655
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=290.81 Aligned_cols=251 Identities=18% Similarity=0.233 Sum_probs=181.9
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
+.+.+|. +|.||++++..+++.||||++... ....+..|+.+++.++|.+++.. ..+....+..+++|||+
T Consensus 6 i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~-~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY-VTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhh-hheeecCCeEEEEEeccC
Confidence 3444444 455566666679999999985433 23458899999999996655554 44556777889999999
Q ss_pred CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||.+..+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeecccccccc
Confidence 68999998743 34689999999999999999999999999999999999995 678999999999976654322111
Q ss_pred cccccCCCcccCccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc----------
Q 011988 164 IPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------- 231 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 231 (473)
..........++..|+|||++.+. .++.++|||||||++|||++|..||...... .....++....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchh
Confidence 111222345678899999998763 4789999999999999999999999864321 11111111000
Q ss_pred -----c-------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 -----V-------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 -----~-------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
. ..........++.++.+++..||..||++||++.+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 293 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHh
Confidence 0 0000011123356889999999999999999987774
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=286.82 Aligned_cols=250 Identities=18% Similarity=0.287 Sum_probs=199.6
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
+.+-+..||.|+||+|++-.++.+|+..|||.+.. ....++..|.+...+-..+++|+.+++........||.||+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 34456789999999999999999999999998433 23456888888888888888887776665566667999999
Q ss_pred CCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 84 LGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 84 ~g~sL~~~l~~~----~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
+.-||..+.+.. +..+++..+-.|....+.||.||-. ..||||||||+|||+ +..|.|||||||++-.+.++
T Consensus 145 Md~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred HhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHH
Confidence 999998886532 4569999999999999999999985 689999999999999 58899999999999877665
Q ss_pred CCccccccccCCCcccCccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
... +.-.|...|||||.+... .|+-++||||||++|||+.||.+||.+... ..+++..+.....+...
T Consensus 222 iAk--------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 222 IAK--------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILL 291 (361)
T ss_pred HHh--------hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeec
Confidence 332 234789999999998743 489999999999999999999999987543 34444444443332221
Q ss_pred -HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 237 -EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 237 -~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..-+-.++..+..+|..||.+|-.+||.|.+|++
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1223457889999999999999999999998864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=258.33 Aligned_cols=251 Identities=21% Similarity=0.247 Sum_probs=200.6
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.+|.-.++||+|.||+||+|++..+++.||+|...-.+ .....+|+-+++.|+|.+++..+ ..-..+...-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~-dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH-DVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehh-hhhccCceeEEeH
Confidence 35778899999999999999999999999999733222 33578999999999976655544 4445566778999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|||..+|..+++.+++.++.+.+..++.|++.||.|+|+++++||||||+|.|| +.++.+||+|||+|+.+.-
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgi---- 153 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGI---- 153 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCC----
Confidence 999999999999999999999999999999999999999999999999999999 5899999999999987653
Q ss_pred cccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccc---c--
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS---T-- 234 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~---~-- 234 (473)
|.+.-...+-|..|.+|.++.|.. |+...|+||.|||+.|+.. |.+.|.+.+..+...++.+....... +
T Consensus 154 ---pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 154 ---PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred ---ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 333344557799999999999876 8999999999999999997 88888886555444444443321111 1
Q ss_pred ----------------cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 235 ----------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 235 ----------------~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
....+.+.+...-+++++.+|.-+|..|.+++..
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaa 280 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAA 280 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHH
Confidence 1112223334455789999999999999998765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=301.78 Aligned_cols=241 Identities=20% Similarity=0.237 Sum_probs=202.0
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
..+.|.+...+|.|+|+.|-.+.+..+++..++|++.+. ..+..+|+.++....+|+++..+.....++...++|||++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 467899999999999999999999999999999997666 4456788889998998999999988889999999999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 -g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
|+-|.+.+.. . +....++..|+.+|+.|+.|||++|||||||||+|||+. +..++++|+|||.++.....-
T Consensus 399 ~g~ell~ri~~-~-~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~~---- 470 (612)
T KOG0603|consen 399 DGGELLRRIRS-K-PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERSC---- 470 (612)
T ss_pred cccHHHHHHHh-c-chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchhh----
Confidence 5555555442 2 333377888999999999999999999999999999995 478899999999998776541
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
.+.+-|..|.|||+....+|++++||||||++||+||+|+.||..-... .+.+.++...+.. ..+
T Consensus 471 ------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s-------~~v 535 (612)
T KOG0603|consen 471 ------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFS-------ECV 535 (612)
T ss_pred ------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccc-------ccc
Confidence 1235688999999999999999999999999999999999999875543 3444444443332 467
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 244 PTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
+.+.++|+.+||+.||.+||++.++.
T Consensus 536 S~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 536 SDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred CHHHHHHHHHhccCChhhCcChhhhc
Confidence 89999999999999999999988873
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=277.83 Aligned_cols=233 Identities=23% Similarity=0.299 Sum_probs=188.7
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCC
Q 011988 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 87 (473)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~s 87 (473)
||.|+||.||++.+..+++.||+|++.... ...+..|+.+++.+.|.+.+ .+......+...+++||++ +++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIV-KLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHH-HHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999998889999999854432 23578899999999855544 4445556778899999999 999
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccc
Q 011988 88 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167 (473)
Q Consensus 88 L~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 167 (473)
|.+++... ..+++..++.++.||+.||.|||+.+++|+||||+||+++ ..+.++|+|||++........
T Consensus 80 L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~------- 148 (250)
T cd05123 80 LFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGS------- 148 (250)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CCCcEEEeecCcceecccCCC-------
Confidence 99999743 4689999999999999999999999999999999999995 678899999999987654321
Q ss_pred cCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHH
Q 011988 168 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 247 (473)
Q Consensus 168 ~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 247 (473)
......++..|++||.+.+...+.++|||||||++|+|++|..||..... ...+..+..... .+...++.++
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~-----~~~~~~~~~l 220 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKDPL-----RFPEFLSPEA 220 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCC-----CCCCCCCHHH
Confidence 11345788999999999988889999999999999999999999965432 233333332111 2334568999
Q ss_pred HHHHHHHhcCCCCCCCCHHH
Q 011988 248 ASYFHYCRSLRFDDKPDYAY 267 (473)
Q Consensus 248 ~~li~~cl~~dp~~RPt~~~ 267 (473)
.+++.+||..||++||++.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 99999999999999999855
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=309.65 Aligned_cols=256 Identities=16% Similarity=0.239 Sum_probs=211.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCC---cEEEEEEccc----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLNVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAiK~~~~----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
....|.+.||.|.||+||+|+.+..+ ..||||.++. ....+|+.|+.||-++.|+| |..+..+.......+|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPN-IIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPN-IIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCc-EEEEEEEEecCceeEE
Confidence 44678999999999999999987665 4699998543 33556999999999999555 5567777788889999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
+.||| +++|..+|....+.|+..++..+++.|+.|+.||-+.++|||||...|||+ +.+-.+|++|||+++.+.++
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecccC
Confidence 99999 999999999888889999999999999999999999999999999999999 57788999999999987665
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
... +.....-.-..+|.|||.+.-..++.++||||||++|||.+. |..||.++.+. +.+..|.+.-..++
T Consensus 785 ~~~----~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---dVIkaIe~gyRLPp-- 855 (996)
T KOG0196|consen 785 PEA----AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIKAIEQGYRLPP-- 855 (996)
T ss_pred CCc----cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---HHHHHHHhccCCCC--
Confidence 411 111111122478999999999999999999999999999887 99999887653 33333333222211
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
+-+||..|..||..||++|-.+||.|.+|+..|++++.
T Consensus 856 --PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 856 --PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred --CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 24789999999999999999999999999999999874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=283.35 Aligned_cols=273 Identities=20% Similarity=0.276 Sum_probs=217.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|.+++.||.|+|..|.+++.+++.+.+|+|++++.. ..=.+.|..+..+..+++.+.-++.++......++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 478999999999999999999999999999999854432 22366788888888888888888889998899999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
|.||. |++|--.++ ..++++++.+..+...|+.||.|||++|||.||||.+|+|+ +..+++||+|+|+++.-..+
T Consensus 329 vieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCC
Confidence 99999 778765555 45689999999999999999999999999999999999999 58999999999999865443
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----CCCHHHHHHHHhhcccc
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK-----AGTKKQKYEKISEKKVS 233 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~-----~~~~~~~~~~i~~~~~~ 233 (473)
.. ...+++||+.|.|||++.|.+|+..+|.|+|||+++||+.|+.||.-.. ..+....++.|.++.+.
T Consensus 405 gd-------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 405 GD-------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR 477 (593)
T ss_pred Cc-------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence 32 2368999999999999999999999999999999999999999996321 12333445555555543
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 298 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 298 (473)
. ++.++-....+++..|++||.+|....- ..-|.++ .+.++....||+.+..+|.-
T Consensus 478 i-----prslsvkas~vlkgflnkdp~erlgc~~-~~g~~di---k~h~ffr~idwd~leqk~v~ 533 (593)
T KOG0695|consen 478 I-----PRSLSVKASHVLKGFLNKDPKERLGCRP-QTGFSDI---KSHAFFRSIDWDLLEQKQVL 533 (593)
T ss_pred c-----cceeehhhHHHHHHhhcCCcHHhcCCCc-ccchhhh---hcchhhhhCCHHHHhhcccC
Confidence 3 4566777889999999999999854210 0012222 22334446799998765443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=300.19 Aligned_cols=266 Identities=19% Similarity=0.280 Sum_probs=211.6
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.+++++..||-||||.|-++........+|+|++.+.. ...+..|-+||..+. .+.|+.++-.+.+..+.|+.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhh
Confidence 46778889999999999999865555558888754432 233667889999888 55666665566788899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||-| ||.|+.++.. .+.|+..++..++..+++|++|||++|||.|||||+|+|+ +..|-+||.|||+|+.+....
T Consensus 499 mEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 499 MEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCC
Confidence 9988 9999999984 5579999999999999999999999999999999999999 588999999999999887654
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. .-+++||+.|.|||++++...+.++|.||||+++|||++|.+||.+.+.. ..|..|.... ..-.+
T Consensus 575 K--------TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm---ktYn~ILkGi---d~i~~ 640 (732)
T KOG0614|consen 575 K--------TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM---KTYNLILKGI---DKIEF 640 (732)
T ss_pred c--------eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHhhh---hhhhc
Confidence 3 34789999999999999999999999999999999999999999986553 3333332211 12234
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDY--AYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 298 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~--~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 298 (473)
++.++....++|..+...+|.+|..+ ..|.++-.+ .|..-|||+.++..+.+
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH-------~Wf~gfdweglr~~~L~ 694 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH-------RWFEGFDWEGLRSRTLP 694 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh-------hhhhcCChhhhhhccCC
Confidence 56778899999999999999999762 233333222 34567999999866544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=279.97 Aligned_cols=258 Identities=20% Similarity=0.243 Sum_probs=198.9
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEc-c----cCCchhHHHHHHHHHHhcCCCCCCeeEEeeE-------e
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-V----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-------E 73 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~-~----~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~-------~ 73 (473)
.+.|+-..+||+|.||+||+|+...+|+.||+|+. . ..-.....+|+++|..|+|.+.+..+..+.. +
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 46688889999999999999999999999999862 1 1123346799999999998877666543321 2
Q ss_pred CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 74 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 74 ~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
...+++||++|..+|..++.....+|+..++..++.+++.||.|+|...|+|||+||+|+||+ .++.+||+|||+++
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt---~dgilklADFGlar 172 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT---KDGILKLADFGLAR 172 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc---CCceEEeecccccc
Confidence 334799999999999999987767899999999999999999999999999999999999994 78999999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc-
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 231 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 231 (473)
.+..........| ...+-|..|.+||.++|. +|+++.|||..|||+.||++|.+-|++.........+..+....
T Consensus 173 ~fs~~~n~~kpry---tnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 173 AFSTSKNVVKPRY---TNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred ceecccccCCCCc---ccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 8776544332212 344669999999999986 48999999999999999999999998855433222222221111
Q ss_pred --ccccH----------------------HHHhc--CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 --VSTSI----------------------EALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 --~~~~~----------------------~~l~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..+.. +...+ .-.++..+|+.+++.+||.+|++++++.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 00000 00000 1135778999999999999999998873
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.55 Aligned_cols=251 Identities=17% Similarity=0.184 Sum_probs=167.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCC----CcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEE----e-eEeCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQT----NEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRW----F-GVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~----~-~~~~~~ 76 (473)
.++|.+.++||+|+||.||+|++..+ +..||||........+...+..+.. ..+......+.. . ......
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~-~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRR-ACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHh-hchhhHHHHHHhhhcccccccCCc
Confidence 46899999999999999999999888 8999999854433222221111111 111111111111 1 245567
Q ss_pred EEEEEecC-CCCHHHHHHHcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEe
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRK-------------------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 136 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~-------------------ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~ 136 (473)
.+++|||+ +++|.+++...... .....+..|+.||+.||.|||++|||||||||+|||++
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~ 289 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS 289 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEe
Confidence 89999999 77899988643211 12344678999999999999999999999999999995
Q ss_pred eCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCC----------------------CCchhh
Q 011988 137 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----------------------QSRRDD 194 (473)
Q Consensus 137 ~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~----------------------~s~ksD 194 (473)
++.+.+||+|||+|+.+...... ....+.||+.|+|||.+.... ++.++|
T Consensus 290 --~~~~~~KL~DFGlA~~l~~~~~~------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 290 --EGSGSFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred --CCCCcEEEEeCCCcccccccccc------CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 34578999999999865432211 124568899999999764322 344679
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc-------------ccccHH---HHhcCCcHHHHHHHHHHhcCC
Q 011988 195 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-------------VSTSIE---ALCRGYPTEFASYFHYCRSLR 258 (473)
Q Consensus 195 VwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~-------------~~~~~~---~l~~~~p~~l~~li~~cl~~d 258 (473)
|||||||||||+++.+++... ..+....+.... ...... .+........++||..||.+|
T Consensus 362 VwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 999999999999987775431 111111111100 000000 011112334568999999999
Q ss_pred CCCCCCHHHHH
Q 011988 259 FDDKPDYAYLK 269 (473)
Q Consensus 259 p~~RPt~~~l~ 269 (473)
|++||++.+++
T Consensus 438 P~kR~ta~e~L 448 (566)
T PLN03225 438 GRQRISAKAAL 448 (566)
T ss_pred cccCCCHHHHh
Confidence 99999987774
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=316.69 Aligned_cols=256 Identities=21% Similarity=0.225 Sum_probs=186.3
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEe----------
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWF---------- 70 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~---------- 70 (473)
..++|+.++.||+||||.||+++++-+|+.||||.+.-. ....+.+|+.+|.+|+|+|.|.++..+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 457889999999999999999999999999999985443 233478999999999987777654200
Q ss_pred -----------------------------------------------e--------------------------E-----
Q 011988 71 -----------------------------------------------G--------------------------V----- 72 (473)
Q Consensus 71 -----------------------------------------------~--------------------------~----- 72 (473)
. .
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0 0
Q ss_pred -----------------------e-------CCeEEEEEecCCCCHHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHhC
Q 011988 73 -----------------------E-------GDYNVLVIDLLGPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSK 121 (473)
Q Consensus 73 -----------------------~-------~~~~~lv~e~~g~sL~~~l~~~~~~l-s~~~~~~i~~qi~~aL~yLH~~ 121 (473)
+ ..+.||-||||..+|...+...+... .....|+++.||++||.|+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 02458899999665555544333322 4788999999999999999999
Q ss_pred CCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc------CC--C--Cccc-cccccCCCcccCccccccccccCCC--
Q 011988 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR------DT--A--THQH-IPYRENKNLTGTARYASMNTHLGIE-- 188 (473)
Q Consensus 122 gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~------~~--~--~~~~-~p~~~~~~~~Gt~~Y~APE~~~~~~-- 188 (473)
|||||||||.||++ +..+.|||+|||+|+... +. . +... -..-..+..+||..|+|||++.+..
T Consensus 717 giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred ceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999 488999999999998722 00 0 0000 0111345679999999999998765
Q ss_pred -CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 011988 189 -QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 267 (473)
Q Consensus 189 -~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~ 267 (473)
|+.|+|+|||||||+||+. ||.. ..+....+..+....++.+ ..+...--+.-..+|+.|++.||.+|||+.+
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 9999999999999999984 5642 2223333333333332222 2222222245678999999999999999988
Q ss_pred HH
Q 011988 268 LK 269 (473)
Q Consensus 268 l~ 269 (473)
|+
T Consensus 868 LL 869 (1351)
T KOG1035|consen 868 LL 869 (1351)
T ss_pred Hh
Confidence 75
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=281.12 Aligned_cols=265 Identities=22% Similarity=0.295 Sum_probs=209.0
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHH--hcCCCCCCeeEEeeEeC---CeE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKI--LQGGTGIPNLRWFGVEG---DYN 77 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~--L~~~~~i~~~~~~~~~~---~~~ 77 (473)
..|..+..+.+.||+|.||+||+|.+ .|+.||||++...+...+.+|.+|++. |+|.|++.++..=..+. ...
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 45788899999999999999999986 589999999988888889999999985 57666665543221111 346
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCcccCCCCCcEEEeeCCCCCcEEEEe
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------KSFLHRDIKPDNFLMGLGRRANQVYIID 148 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~--------~gIvHrDIKP~NILl~~~~~~~~vkL~D 148 (473)
+||.+|- .|||.|++.. ..++.+..++++..++.||++||- -.|.|||||..|||+ .+++.+.|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEee
Confidence 8999998 8999999984 679999999999999999999994 249999999999999 5899999999
Q ss_pred cCCcccccCCCCccccccccCCCcccCccccccccccCCC----C--CchhhHHHHHHHHHHHHc----------CCCCC
Q 011988 149 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----Q--SRRDDLESLGYVLMYFLR----------GSLPW 212 (473)
Q Consensus 149 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~----~--s~ksDVwSlGviL~ellt----------G~~Pf 212 (473)
||||-..........++ .+..+||.+|||||++...- + -..+||||||.||||++. -++||
T Consensus 360 LGLAv~h~~~t~~idi~---~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIP---PNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred ceeeEEecccCCcccCC---CCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 99998877654433333 45679999999999987532 1 246899999999999985 26788
Q ss_pred CCCCCCC--HHHHHHHHhhccccccHHHHhcCCc--HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 213 QGLKAGT--KKQKYEKISEKKVSTSIEALCRGYP--TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 213 ~~~~~~~--~~~~~~~i~~~~~~~~~~~l~~~~p--~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
.+..+.+ ..+..+.+...+..+.++......| ..+.++|+.||..+|.-|-|+--|++.|.++.+
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 7765433 2223333344455555555554443 468899999999999999999999999998873
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=279.19 Aligned_cols=131 Identities=28% Similarity=0.542 Sum_probs=110.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc--hhHHHHHHHHHHhcCCC-------C-CCeeEEe---e
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH--PQLQYEAKLYKILQGGT-------G-IPNLRWF---G 71 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~--~~l~~E~~il~~L~~~~-------~-i~~~~~~---~ 71 (473)
.+++|.+.++||.|.|++||+|.|.++.+.||+|+.+...+ +....|+++|+.+..+. . |..+..| +
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 35899999999999999999999999999999999554432 34678999999986432 2 3333444 4
Q ss_pred EeCCeEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEE
Q 011988 72 VEGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLM 135 (473)
Q Consensus 72 ~~~~~~~lv~e~~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl 135 (473)
..+.+.|||+|++|.+|..+|.+++ +.++...+..|+.||+.||.|||. .||||-||||+|||+
T Consensus 156 pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 5678899999999999999998664 459999999999999999999996 799999999999999
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=304.14 Aligned_cols=256 Identities=21% Similarity=0.335 Sum_probs=204.5
Q ss_pred ceEEEeeEeecCceEEEEEEEcC-------CCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
+..+.+.||+|.||.|++|.-.. ....||||...... ...+..|+++|+.+.+|+++..+..++.....
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 34567799999999999997431 14579999854333 45689999999999988888888777777888
Q ss_pred EEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC
Q 011988 77 NVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 140 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 140 (473)
.++++||+ .|+|.+++..+. ..++..+.+.++.||+.|++||+++++|||||-..|||++ .
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~---~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT---K 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec---C
Confidence 99999999 889999998665 2489999999999999999999999999999999999995 6
Q ss_pred CCcEEEEecCCcccccCCCCccccccccCCCccc--CccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 011988 141 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG--TARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 217 (473)
Q Consensus 141 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~G--t~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~ 217 (473)
+..+||+|||+|+....... |. .+...| ...|||||.+....|+.++||||||++|||+++ |..||.+...
T Consensus 454 ~~~~kIaDFGlar~~~~~~~-----y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDY-----YR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred CCEEEEccccceeccCCCCc-----eE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 78999999999986544332 11 111222 345999999999999999999999999999999 9999988442
Q ss_pred CCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 218 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 218 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
. ...++.+..... ...+..|+++++++|..||+.+|++||++.++.+.|...+..
T Consensus 528 ~--~~l~~~l~~G~r----~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 528 T--EELLEFLKEGNR----MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred H--HHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 1 122332322221 123456789999999999999999999999999999997654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=271.78 Aligned_cols=219 Identities=17% Similarity=0.160 Sum_probs=173.0
Q ss_pred cCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCCHHHHHHHcC
Q 011988 18 GSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS 96 (473)
Q Consensus 18 G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~ 96 (473)
|.||.||++++..+++.||+|.+.... ....|...+.... ++++..+..++...+..+++|||+ +++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF- 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-
Confidence 899999999999999999999865543 2334444444444 455666666667788899999999 78999998743
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCc
Q 011988 97 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 176 (473)
Q Consensus 97 ~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~ 176 (473)
..+++..+..++.||+.||+|||++||+||||||+||+++ .++.++|+|||++....... ....++.
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~df~~~~~~~~~~----------~~~~~~~ 146 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD---DRGHIQLTYFSRWSEVEDSC----------DGEAVEN 146 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEecccchhcccccc----------ccCCcCc
Confidence 4699999999999999999999999999999999999994 67889999999886554321 1235577
Q ss_pred cccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhc
Q 011988 177 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRS 256 (473)
Q Consensus 177 ~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~ 256 (473)
.|+|||.+.+..++.++|||||||++|||++|..||...... +.. ... ..+...+++++.++|.+||+
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------~~~-~~~---~~~~~~~~~~~~~li~~~l~ 214 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------INT-HTT---LNIPEWVSEEARSLLQQLLQ 214 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------ccc-ccc---cCCcccCCHHHHHHHHHHcc
Confidence 899999998888999999999999999999999987542211 000 000 01234578899999999999
Q ss_pred CCCCCCCCH
Q 011988 257 LRFDDKPDY 265 (473)
Q Consensus 257 ~dp~~RPt~ 265 (473)
.||++||++
T Consensus 215 ~dp~~R~~~ 223 (237)
T cd05576 215 FNPTERLGA 223 (237)
T ss_pred CCHHHhcCC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=290.26 Aligned_cols=204 Identities=23% Similarity=0.285 Sum_probs=171.9
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCC-----CCCCeeEEeeEeCCe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGG-----TGIPNLRWFGVEGDY 76 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~-----~~i~~~~~~~~~~~~ 76 (473)
.+.++|.+....|.|-|++|..|.+...|..||||++... .+..-+.|++||++|+.. .++..+.-.+....+
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 4678999999999999999999999999999999995443 355567899999999732 222233333456778
Q ss_pred EEEEEecCCCCHHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 77 NVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~~~~--ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
.|||+|.+..+|.++++..+.. |.+..+..++.||..||..|-.+||+|.||||+|||+. .....+||||||.|..
T Consensus 509 LClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 509 LCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSASF 586 (752)
T ss_pred eEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccCccccc
Confidence 8999999999999999876654 78899999999999999999999999999999999996 5667899999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 218 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~ 218 (473)
..+... +.+.-+..|.|||+++|.+|+...|+||.||+||||.||+..|.|.+..
T Consensus 587 ~~enei---------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 587 ASENEI---------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred cccccc---------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 655432 2235567899999999999999999999999999999999999886543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=279.03 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=194.9
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHh--cCCCCCCeeEEeeEe----CCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKIL--QGGTGIPNLRWFGVE----GDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L--~~~~~i~~~~~~~~~----~~~~~lv 80 (473)
....+.+.||+|.||.||+|. -+++.||||++.......++.|.+|+... +|.+++ .+...... ...++||
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl-~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENIL-QFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHH-HhhchhccCCccccceeEE
Confidence 346778899999999999998 46799999999999999999999999864 444444 33333322 2367899
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---------CCCcccCCCCCcEEEeeCCCCCcEEEEecC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---------KSFLHRDIKPDNFLMGLGRRANQVYIIDFG 150 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~---------~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 150 (473)
++|. .|+|.++++ ...+++....+|+..|+.||+|||+ ..|+|||||..|||| ..+.+..|+|||
T Consensus 287 t~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccc
Confidence 9988 999999998 4579999999999999999999996 359999999999999 588999999999
Q ss_pred CcccccCCCCccccccccCCCcccCccccccccccCCC-CC-----chhhHHHHHHHHHHHHcCCC------------CC
Q 011988 151 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QS-----RRDDLESLGYVLMYFLRGSL------------PW 212 (473)
Q Consensus 151 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s-----~ksDVwSlGviL~elltG~~------------Pf 212 (473)
+|..+..... .......+||.+|||||++.|.. +. .+.||||+|.|||||++... ||
T Consensus 362 LAl~~~p~~~-----~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 362 LALRLEPGKP-----QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeEEecCCCC-----CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 9998864332 12234579999999999998753 22 46899999999999997432 33
Q ss_pred C---CCCCCCHHHHHHHHhhccccccHHHHhc--CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 213 Q---GLKAGTKKQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 213 ~---~~~~~~~~~~~~~i~~~~~~~~~~~l~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
+ +.. .+..+.-..+..++..+.+..... ....-+.+.++.||..|++.|.|+.-+.+.+.++.
T Consensus 437 e~evG~h-Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 437 EAEVGNH-PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred hHHhcCC-CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 2 111 122222233344444444433332 23467899999999999999999999988888775
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=314.18 Aligned_cols=249 Identities=14% Similarity=0.162 Sum_probs=185.5
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CC
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GP 86 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~ 86 (473)
.|...+.||+|+||.||+|++..++..||||....... ....|+++++.++|++++ .+..++......++||||+ ++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv-~~~~~~~~~~~~~lv~Ey~~~g 768 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIV-KLIGLCRSEKGAYLIHEYIEGK 768 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcc-eEEEEEEcCCCCEEEEeCCCCC
Confidence 45667889999999999999988999999998654332 234678899999865544 5555666777889999999 89
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 87 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 87 sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+|.+++. .+++..+..|+.||+.||+||| +.+|+||||||+||+++ ..+..++. ||........
T Consensus 769 ~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~---~~~~~~~~-~~~~~~~~~~----- 835 (968)
T PLN00113 769 NLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLR-LSLPGLLCTD----- 835 (968)
T ss_pred cHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC---CCCceEEE-eccccccccC-----
Confidence 9999996 4899999999999999999999 67999999999999994 55566654 6665433211
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC--HHHHHHHHhhc-cc----cccH
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--KKQKYEKISEK-KV----STSI 236 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~i~~~-~~----~~~~ 236 (473)
....||..|+|||++.+..++.++|||||||++|||++|+.||....... ........... .. ...+
T Consensus 836 ------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 836 ------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred ------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc
Confidence 22368899999999999999999999999999999999999995432111 11111100000 00 0000
Q ss_pred H---HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 237 E---ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 237 ~---~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
. ........++.+++..||+.||++||++.++.+.|+++..
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 0 0000112467889999999999999999999999988754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=283.88 Aligned_cols=275 Identities=22% Similarity=0.266 Sum_probs=205.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.-|..++.||-|+||+|.++....|...||+|.+.+.+ ...+..|-.||.... .+-|+.+++-+.+.+..|+|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEEE
Confidence 34889999999999999999998999999999754432 334667888888877 55666677777888899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ ||++-.+|-. -+-|.+..+..++..+..|+++.|..|+|||||||+|||| |.+|++||+|||||+-+.-..
T Consensus 708 MdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceecc
Confidence 9999 9999999874 3479999999999999999999999999999999999999 589999999999997653210
Q ss_pred --------Ccccc----c-----------------------cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHH
Q 011988 160 --------THQHI----P-----------------------YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 204 (473)
Q Consensus 160 --------~~~~~----p-----------------------~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~e 204 (473)
.+... + ......++||..|+|||++....|+..+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 00000 0 001245789999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCC
Q 011988 205 FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 284 (473)
Q Consensus 205 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~ 284 (473)
|+.|+.||..........++.... .... -..|.+++.+..++|.+++ -++++|..-.- .+ .-....|.
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~--~~l~--~~~~~~ls~e~~~li~kLc-~sad~RLGkng-~d------~vKaHpfF 931 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWR--NFLH--IPYQGNLSKEALDLIQKLC-CSADSRLGKNG-AD------QVKAHPFF 931 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehh--hccc--cccccccCHHHHHHHHHHh-cChhhhhcccc-hh------hhhcCccc
Confidence 999999998876654433322111 1111 1124567888888887754 45777753211 11 11223556
Q ss_pred Cccccccccccccc
Q 011988 285 YVFDWTILKYQQSQ 298 (473)
Q Consensus 285 ~~~dw~~~~~~~~~ 298 (473)
.-.||..+..+.++
T Consensus 932 kgIDfsslRkq~Ap 945 (1034)
T KOG0608|consen 932 KGIDFSSLRKQRAP 945 (1034)
T ss_pred cccchHhhhhccCC
Confidence 67888886554333
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=289.60 Aligned_cols=253 Identities=21% Similarity=0.273 Sum_probs=204.8
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCc----EEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.+..++||+|+||+||+|.+.-.|+ +||||++... ...++..|+-+|..|.|.+.+..+..+.... ..||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHHH
Confidence 4457899999999999999876665 6888884332 2456889999999999777776665443332 5677
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
.+|+ +|+|.|+++..+.++-.+..+.|..||++||.|||++++|||||-..|||+ .....+||.|||+|+.+..+.
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCccc
Confidence 7887 999999999988899999999999999999999999999999999999999 488999999999999887654
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
..-+. ....-.+.|||-|.+....|+.++|||||||++||++| |..||++....+....+++... - .
T Consensus 853 ~ey~~-----~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR----L---s 920 (1177)
T KOG1025|consen 853 KEYSA-----PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER----L---S 920 (1177)
T ss_pred ccccc-----cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc----C---C
Confidence 42221 12223567999999999999999999999999999999 9999999876554444433222 1 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
-++.++.+++-++.+||..|++.||+|+++...|..+...
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1346789999999999999999999999999999887643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=294.15 Aligned_cols=245 Identities=20% Similarity=0.242 Sum_probs=191.4
Q ss_pred EeeEeecCceE-EEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecCCCCHHH
Q 011988 12 GRKIGSGSFGE-IYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLED 90 (473)
Q Consensus 12 ~~~LG~G~fG~-Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~ 90 (473)
.+.+|.|+.|+ ||+|. ..|+.||||.+......-..+|+..|+.-..|++|..++....+..+.||+.|+|.++|.+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~d 591 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQD 591 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHH
Confidence 45678999885 79998 4688999999777777788999999999998998877777777888999999999999999
Q ss_pred HHHHcCCC---CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCC--CCCcEEEEecCCcccccCCCCccccc
Q 011988 91 LFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 91 ~l~~~~~~---ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~--~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
++...... ......+.++.|++.||++||+.+||||||||+||||+..+ ....++|+|||+++.+..... .
T Consensus 592 lie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s----S 667 (903)
T KOG1027|consen 592 LIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS----S 667 (903)
T ss_pred HHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc----h
Confidence 99853111 11145678899999999999999999999999999998532 335789999999998865433 2
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCc
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 244 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 244 (473)
++...+..||..|+|||++.....+.++|||||||++|+.++ |.+||..... .-.+|......- ..+.....
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-----R~~NIl~~~~~L--~~L~~~~d 740 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-----RQANILTGNYTL--VHLEPLPD 740 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH-----hhhhhhcCccce--eeeccCch
Confidence 334567889999999999999888899999999999999999 5999965322 212222211110 01111111
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 245 TEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 245 ~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.+..+||..|++.+|..||++.+|+
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHh
Confidence 2889999999999999999988873
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=252.07 Aligned_cols=235 Identities=26% Similarity=0.342 Sum_probs=185.8
Q ss_pred CceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecCCC-CHHHHHH
Q 011988 19 SFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGP-SLEDLFN 93 (473)
Q Consensus 19 ~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~g~-sL~~~l~ 93 (473)
+||.||+|.+..+++.||+|+..... ...+..|++.++.++ ++++..+..+.......++++|++++ +|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 68999999998889999999954433 467889999999996 44555555566667888999999955 9999987
Q ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcc
Q 011988 94 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 173 (473)
Q Consensus 94 ~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~ 173 (473)
... .++...++.++.+++.+|.|||+.+|+|+||+|.||+++ ..+.++|+|||++........ .....
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~--------~~~~~ 147 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGL--------LTTFV 147 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeeccccc--------ccccc
Confidence 543 389999999999999999999999999999999999995 668999999999987655321 13456
Q ss_pred cCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHH
Q 011988 174 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHY 253 (473)
Q Consensus 174 Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~ 253 (473)
++..|++||.+.+..++.++||||||+++|+|++|..||..... .......+....... ......++.++.+++.+
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~ 223 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKPKPPF--PPPEWKISPEAKDLIRK 223 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCC--ccccccCCHHHHHHHHH
Confidence 88899999999988899999999999999999999999976321 122222222211111 11111278999999999
Q ss_pred HhcCCCCCCCCHHHHHH
Q 011988 254 CRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 254 cl~~dp~~RPt~~~l~~ 270 (473)
||..+|++||++.++.+
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999888864
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=255.62 Aligned_cols=265 Identities=20% Similarity=0.313 Sum_probs=201.7
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCC-CeeEEeeEeCCeEEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGI-PNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i-~~~~~~~~~~~~~~lv~ 81 (473)
+.+.|.|.+.||+|-||.+-+|+++.++..+++|.+.+. ...+|.+|...--.|.+|.+| ..+...+...++++++|
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 567899999999999999999999999999999985443 345677777665566655544 44555567778999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ .++|..-+. ...+-+.....++.|+++||.|||++++||||||.+||||-. .+...|||||||+.+......
T Consensus 102 E~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~-~df~rvKlcDFG~t~k~g~tV- 177 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD-ADFYRVKLCDFGLTRKVGTTV- 177 (378)
T ss_pred ccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec-CCccEEEeeecccccccCcee-
Confidence 999 788877665 345888999999999999999999999999999999999953 345699999999987654321
Q ss_pred ccccccccCCCcccCccccccccccCCC-----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHH-HHHHHHhhccccc
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVST 234 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-----~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~ 234 (473)
....-+..|.+||...... ..+.+|||.||+++|.+++|++||+.....+.. ..+.+....+. .
T Consensus 178 ---------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~-~ 247 (378)
T KOG1345|consen 178 ---------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN-P 247 (378)
T ss_pred ---------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC-c
Confidence 1223456799999876432 467899999999999999999999853322221 12222222222 2
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCC
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQF 283 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~ 283 (473)
..+...+-+++.+..++++-|..++++|--..+..+....++.+..+..
T Consensus 248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t 296 (378)
T KOG1345|consen 248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKT 296 (378)
T ss_pred cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhcc
Confidence 3444556678999999999999999999777777777777777765543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=250.22 Aligned_cols=250 Identities=20% Similarity=0.331 Sum_probs=192.8
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeE--eCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV--EGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~--~~~~~~lv~e~ 83 (473)
.++|++.+++|.|-|++||.|.+..+++.++||+++..+...+.+|++||+.|.++++|..+..+.. ......+++|+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 4679999999999999999999999999999999988888999999999999997777766654433 34556788998
Q ss_pred CC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 LG-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~g-~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
.. .+...+. ..++..++..++.+++.||.|+|+.||+|||+||.|++|+ .....++|+|+|+|..+.....
T Consensus 117 v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~e-- 188 (338)
T KOG0668|consen 117 VNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKE-- 188 (338)
T ss_pred hccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCce--
Confidence 84 4444443 3688899999999999999999999999999999999996 4567899999999988765432
Q ss_pred ccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCC-CCCCCCHHHHHHHHhhc----------
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQ-GLKAGTKKQKYEKISEK---------- 230 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~-~~~~~~~~~~~~~i~~~---------- 230 (473)
-+-.+.+..|--||.+...+ |+..-|+|||||+|..|+..+.||. |..+.+...++.++...
T Consensus 189 ------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 189 ------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred ------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 12335677788999987654 7899999999999999999988874 33333333233222110
Q ss_pred --cccccHHHHh----------------cC-CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 --KVSTSIEALC----------------RG-YPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 --~~~~~~~~l~----------------~~-~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.+.+....+. .. ..++..+|+..+|..|-.+|+|+.|..
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 0111111110 01 258899999999999999999988763
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=246.31 Aligned_cols=211 Identities=21% Similarity=0.275 Sum_probs=170.4
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
....+..||+|+||.|-+-++..+|...|+|.+.. ....++.+|+.+......++.+.+++.........+|+||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 34456789999999999999999999999997332 33445777888877777777776665544556667999999
Q ss_pred CCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 84 LGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 84 ~g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
+..||..+... .+..+++..+-+|+..++.||.|||++ .|||||+||+|||| +..|+|||||||++-.+.++.
T Consensus 127 M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhh
Confidence 99999888652 366799999999999999999999984 89999999999999 588999999999998877654
Q ss_pred CccccccccCCCcccCccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~----~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 231 (473)
.. +.-.|...|||||.+..+ .|+-++||||||++++||.++++||..- .+..+++..+.+..
T Consensus 204 Ak--------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w--~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 204 AK--------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW--GTPFQQLKQVVEEP 269 (282)
T ss_pred HH--------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc--CCHHHHHHHHhcCC
Confidence 32 124788999999988643 5899999999999999999999999753 34566666655543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=273.08 Aligned_cols=252 Identities=19% Similarity=0.206 Sum_probs=172.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEc----------------CCCcEEEEEEcccCC-----------------chhHHHHH
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI----------------QTNEEVAIKLNVKTK-----------------HPQLQYEA 52 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~----------------~~~~~vAiK~~~~~~-----------------~~~l~~E~ 52 (473)
.++|++.++||+|+||.||+|.+. ..++.||||.+.... ......|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999753 234679999853321 11123466
Q ss_pred HHHHHhcCCCCCC-----eeEEeeE-------eCCeEEEEEecC-CCCHHHHHHHcC-----------------------
Q 011988 53 KLYKILQGGTGIP-----NLRWFGV-------EGDYNVLVIDLL-GPSLEDLFNFCS----------------------- 96 (473)
Q Consensus 53 ~il~~L~~~~~i~-----~~~~~~~-------~~~~~~lv~e~~-g~sL~~~l~~~~----------------------- 96 (473)
.++..+.+.+++. .+.++.. .....++||||+ +++|.+++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 6777777655422 1222211 234579999999 789999886321
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCc
Q 011988 97 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 176 (473)
Q Consensus 97 ~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~ 176 (473)
..+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++........ ......+|+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~---~~~~~kL~DFGla~~~~~~~~~------~~~~g~~tp 374 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINF------NPLYGMLDP 374 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC---CCCcEEEEeCcCccccccCCcc------CccccCCCc
Confidence 1246678899999999999999999999999999999994 6788999999999755332110 011224578
Q ss_pred cccccccccCCCC----------------------CchhhHHHHHHHHHHHHcCCC-CCCCCCCCCHH--------HHHH
Q 011988 177 RYASMNTHLGIEQ----------------------SRRDDLESLGYVLMYFLRGSL-PWQGLKAGTKK--------QKYE 225 (473)
Q Consensus 177 ~Y~APE~~~~~~~----------------------s~ksDVwSlGviL~elltG~~-Pf~~~~~~~~~--------~~~~ 225 (473)
.|+|||++..... ..+.||||+|||||+|++|.+ ||.+....... ....
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r 454 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR 454 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence 9999999864321 124699999999999999986 77643221111 0011
Q ss_pred HHhhccccccHHHHhcCCcHHHHHHHHHHhcCCC---CCCCCHHHHH
Q 011988 226 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF---DDKPDYAYLK 269 (473)
Q Consensus 226 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp---~~RPt~~~l~ 269 (473)
.+...... . .....+++..++|+.+||..+| .+|+++++++
T Consensus 455 ~~~~~~~~--~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 455 MYKGQKYD--F-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred hhcccCCC--c-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 11111111 1 1234567899999999999866 6899987763
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=260.93 Aligned_cols=254 Identities=19% Similarity=0.275 Sum_probs=187.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc-----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeC----C
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----D 75 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~-----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~----~ 75 (473)
...+.+-.+-||.|+||.||.++|..+|+.||+|.+.. .....+.+|+++|..++|.|.+..++...... .
T Consensus 51 qq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 51 QQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred ccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 33445567889999999999999999999999997432 22345778999999998777665554433211 1
Q ss_pred eEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 76 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 76 ~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
..|++.|++..+|..++- ..+.++...+.-+++||+.||+|||+.+|+||||||.|.|+ +.+..+||||||+|+..
T Consensus 131 EiYV~TELmQSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 131 ELYVLTELMQSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHHHHhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEeccccccccc
Confidence 246788888889988876 45679999999999999999999999999999999999999 47788999999999876
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
..... .+ .+..+-|..|.|||+++|.. |+.+.||||.|||+.||+..+..|+...+....+.+-.+....-..
T Consensus 207 e~d~~-~h-----MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 207 DQRDR-LN-----MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE 280 (449)
T ss_pred chhhh-hh-----hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence 54332 11 12345688999999999865 8999999999999999999999998765543333333322221111
Q ss_pred cHHHHhcC--------------------------CcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 235 SIEALCRG--------------------------YPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 235 ~~~~l~~~--------------------------~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
.+..-|.+ -.-+...++..++..||++|.+.++.
T Consensus 281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A 340 (449)
T KOG0664|consen 281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEA 340 (449)
T ss_pred HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhh
Confidence 11111111 12346678888889999999875443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=253.39 Aligned_cols=259 Identities=18% Similarity=0.248 Sum_probs=199.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCC-----cEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
..++++...+-+|.||.||.|.+++.. +.|.+|....... ..+..|.-.+..+.|++........-.+...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 356888889999999999999876432 3455665322221 2355677777777777766666666667777
Q ss_pred EEEEEecC-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEe
Q 011988 77 NVLVIDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 148 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~-------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 148 (473)
.++++.+. -++|..++..|+ +.++..+...++.|++.|++|||++||||.||...|++| ++.-+|||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEecc
Confidence 88888888 579999998553 347778889999999999999999999999999999999 4778999999
Q ss_pred cCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHH
Q 011988 149 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 227 (473)
Q Consensus 149 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i 227 (473)
=.+++.+-..+.+.- ..+......||+||.+....|+.++|||||||+||||++ |+.||.+.++.+ ....+
T Consensus 440 saLSRDLFP~DYhcL-----GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE---m~~yl 511 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCL-----GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE---MEHYL 511 (563)
T ss_pred chhccccCccccccc-----CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---HHHHH
Confidence 999987655443221 122234578999999999999999999999999999999 999998865432 22222
Q ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 228 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 228 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
..... -.-+-+||+++..+|..||...|++||+++++...|.++....
T Consensus 512 kdGyR----laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 512 KDGYR----LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred hccce----ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 22111 1123479999999999999999999999999999999886543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=266.94 Aligned_cols=194 Identities=24% Similarity=0.387 Sum_probs=167.3
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----------chhHHHHHHHHHHhc--CCCCCCeeEEeeEeC
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------HPQLQYEAKLYKILQ--GGTGIPNLRWFGVEG 74 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----------~~~l~~E~~il~~L~--~~~~i~~~~~~~~~~ 74 (473)
.|..++.||+|+||.|++|.++.+...|+||.+.+.. ...+-.|+.||..|+ .|.+|..+..|++++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 4999999999999999999999999999999865543 233668999999998 234555566778889
Q ss_pred CeEEEEEecC--CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 75 DYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 75 ~~~~lv~e~~--g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
+++||+||-- |-+|.+++.. +..+++.++..|+.||+.|+++||+.||||||||-+|+.+ +.+|.+||+|||.|
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa 717 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA 717 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence 9999999988 5688888874 5579999999999999999999999999999999999999 58999999999998
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCC
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQG 214 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~ 214 (473)
....... ...++||..|+|||++.|..| +..-|||+||++||.++....||..
T Consensus 718 a~~ksgp---------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGP---------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCC---------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 7554321 246899999999999999887 7888999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-29 Score=230.66 Aligned_cols=207 Identities=29% Similarity=0.420 Sum_probs=177.6
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecCC-CCHH
Q 011988 15 IGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLG-PSLE 89 (473)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~g-~sL~ 89 (473)
||+|++|.||++.+..+++.++||+...... ..+.+|+++++.+.+ .++..+..+.......+++||+++ ++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCC-CCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999888899999999665544 578999999999986 666666667777788999999995 9999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC-CCcEEEEecCCcccccCCCCcccccccc
Q 011988 90 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKRYRDTATHQHIPYRE 168 (473)
Q Consensus 90 ~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~-~~~vkL~DFGla~~~~~~~~~~~~p~~~ 168 (473)
+++......++...++.++.+++.+|.+||++|++|+||+|.||+++ . .+.++|+|||.+........ .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcc-------h
Confidence 99985545689999999999999999999999999999999999995 4 68999999999987654321 1
Q ss_pred CCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHH
Q 011988 169 NKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 247 (473)
Q Consensus 169 ~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 247 (473)
.....+...|++||.+... .++.+.|+|+||+++++| ..+
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------~~~ 190 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------PEL 190 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------HHH
Confidence 1234678899999999887 788999999999999999 578
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHH
Q 011988 248 ASYFHYCRSLRFDDKPDYAYLKRL 271 (473)
Q Consensus 248 ~~li~~cl~~dp~~RPt~~~l~~~ 271 (473)
.+++..|+..+|++||++.++.+.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 899999999999999998887653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=255.46 Aligned_cols=206 Identities=28% Similarity=0.447 Sum_probs=169.4
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcC---CCcEEEEEEcccCC-chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLNVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAiK~~~~~~-~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
|.+.+.|.++++||+|.|+.||++.+.. ..+.||+|.+.... ...+..|+++|..+.+..+|..+..+...++..+
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 4567889999999999999999999887 78899999855544 4458899999999999999999998999999999
Q ss_pred EEEecCC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLLG-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~g-~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+||+|++ ..-.+++. .++..++..+++.++.||.++|.+|||||||||.|||.+ ...+.-.|+|||+|..+..
T Consensus 112 ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred EEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhHHHHHh
Confidence 9999994 45555554 578999999999999999999999999999999999997 5567788999999973211
Q ss_pred CC------C-------c---c---------------------ccccccCCCcccCccccccccccCCC-CCchhhHHHHH
Q 011988 158 TA------T-------H---Q---------------------HIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLG 199 (473)
Q Consensus 158 ~~------~-------~---~---------------------~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlG 199 (473)
.. . . . ...........||++|.|||++...+ ++.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 0 0 00011123457999999999998765 79999999999
Q ss_pred HHHHHHHcCCCCCCC
Q 011988 200 YVLMYFLRGSLPWQG 214 (473)
Q Consensus 200 viL~elltG~~Pf~~ 214 (473)
||++-++++.+||..
T Consensus 266 VI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFK 280 (418)
T ss_pred ceeehhhcccccccc
Confidence 999999999999954
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=245.04 Aligned_cols=255 Identities=21% Similarity=0.230 Sum_probs=194.6
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc-----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEe-----C
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVE-----G 74 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~-----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~-----~ 74 (473)
+..+|.-++.+|.|.- .|..+.|.-.++.||+|.... ...+...+|..++..++|.++|..+..|... -
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4568888999999998 788888888999999997322 2334567899999999988888877666432 2
Q ss_pred CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 75 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
...|+|||++..+|.+.+. -.++-+++..|+.|++.|++|||+.||+||||||+||++ ..+..+||+|||+|+.
T Consensus 94 ~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 94 QEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLART 167 (369)
T ss_pred HhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhhcc
Confidence 3468999999999999987 347889999999999999999999999999999999999 5788999999999985
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc--
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-- 232 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-- 232 (473)
.... . ..+.++.|..|.|||++.|..|...+||||+||++.||++|..-|.+....+...++.......-
T Consensus 168 e~~~--~------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 168 EDTD--F------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred cCcc--c------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 4432 1 12456889999999999999999999999999999999999999987543222222211111100
Q ss_pred --------------------cccHHHHhcC------------CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 233 --------------------STSIEALCRG------------YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 233 --------------------~~~~~~l~~~------------~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
.....++.+. -.....+++.+||..||++|.+++++ |++.+.
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da---L~HPY~ 313 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA---LRHPYI 313 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH---hcCCee
Confidence 0111111110 12457899999999999999996555 666543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=263.75 Aligned_cols=263 Identities=17% Similarity=0.254 Sum_probs=206.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc---CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~---~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.++|.++..+|.|.||.||+++++.+++..|+|+++- ....-++.|+-+++.++|++++.++..|- ..+..+|+||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl-r~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL-RRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh-hhcCcEEEEE
Confidence 4689999999999999999999999999999998433 34455788999999999888888776553 4456799999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|| |++|++... ...++++.++..+.+..+.||+|||+.|-+|||||-.|||++ +.+.+||.|||.+-.+.....
T Consensus 93 ycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqitati~- 167 (829)
T KOG0576|consen 93 YCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQITATIA- 167 (829)
T ss_pred ecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhhhhhhh-
Confidence 99 778888765 456899999999999999999999999999999999999995 889999999999987665433
Q ss_pred cccccccCCCcccCcccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 162 QHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
..+.+.||+.|||||+-. .+.|...+|||++|++..|+-.-+.|-...... +.+.-.....+..+..+
T Consensus 168 ------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---r~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 168 ------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---RALFLMTKSGFQPPTLK 238 (829)
T ss_pred ------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---HHHHHhhccCCCCCccc
Confidence 236789999999999764 456899999999999999999888886554321 11111111112222112
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH-----------HHHHHHHHHhCCCC
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK-----------RLFRDLFIREGFQF 283 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~-----------~~L~~l~~~~~~~~ 283 (473)
-.....+.|.+|++.||.++|++||+++.++ .+..+++.+.+...
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~ 294 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPN 294 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCC
Confidence 2234678899999999999999999988663 34556666666443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=220.28 Aligned_cols=167 Identities=17% Similarity=0.184 Sum_probs=128.1
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
|+|.+++...+..+++.+++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~---~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT---WDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc---Cccceee--ccceEeeccc-------
Confidence 6899999866677999999999999999999999998 99999994 6788888 9999765432
Q ss_pred cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH--HHhcCC
Q 011988 166 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE--ALCRGY 243 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--~l~~~~ 243 (473)
...||..|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+.......... .....+
T Consensus 63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCccccccHHHH
Confidence 1268999999999999999999999999999999999999997643211 2222221111111000 001122
Q ss_pred cH--HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 244 PT--EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 244 p~--~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
+. ++.++|..||..+|++||++.+|++.+..+..
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 23 79999999999999999999999877765543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=223.24 Aligned_cols=196 Identities=31% Similarity=0.452 Sum_probs=163.4
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
|.+.+.||.|++|.||+|.+..+++.++||..... ....+..|+..++.+.+. ++..+..+.......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~-~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHP-NIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCC-ChhhheeeeecCCceEEEEecc
Confidence 67889999999999999999888999999996554 345688899999999755 4555555566667889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 -g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++......+++..+..++.|++.+|.+||+++++|+||+|.||+++ ..+.++|+|||++..+......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~~~~~~-- 154 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---MDGLVKLADFGLARFIHRDLAA-- 154 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeCceeeEecCcccc--
Confidence 4499999985433389999999999999999999999999999999999995 5689999999999877554210
Q ss_pred cccccCCCcccCccccccccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 011988 164 IPYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~-~~~~~s~ksDVwSlGviL~elltG~~Pf~~ 214 (473)
......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus 155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11345678899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=274.72 Aligned_cols=188 Identities=14% Similarity=0.170 Sum_probs=135.2
Q ss_pred CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEee----------------
Q 011988 74 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL---------------- 137 (473)
Q Consensus 74 ~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~---------------- 137 (473)
...++++||+++.+|.+++......+++.+++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 52 ~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 52 DDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred cchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 3457888999999999999855567999999999999999999999999999999999999952
Q ss_pred CCCCCcEEEEecCCcccccCCCC--------cccccc-ccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcC
Q 011988 138 GRRANQVYIIDFGLAKRYRDTAT--------HQHIPY-RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 208 (473)
Q Consensus 138 ~~~~~~vkL~DFGla~~~~~~~~--------~~~~p~-~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG 208 (473)
.+..+.+||+|||+++....... ....++ .......||+.|||||++.+..++.++|||||||+||||++|
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~ 211 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP 211 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence 12344567777777764321100 000000 001224689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 209 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 209 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..||.... ..+..+....... ..... .++...++..||..+|.+||++.+|++
T Consensus 212 ~~~~~~~~-----~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 212 VSSREEKS-----RTMSSLRHRVLPP---QILLN-WPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCchhhHH-----HHHHHHHHhhcCh---hhhhc-CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 88875321 1122221111111 11111 345678999999999999999998843
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=225.74 Aligned_cols=179 Identities=20% Similarity=0.224 Sum_probs=136.2
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcC-CCcEEEEEEcccC--------CchhHHHHHHHHHHhcCCCCCCeeEEeeEe
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLNVKT--------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE 73 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~~~~~--------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~ 73 (473)
+.+.++|.+.+.||+|+||+||+|.+.. +++.||||+.... ....+.+|+++|+.|.|+++++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 4567889999999999999999999876 6788899984322 123478999999999988888766543
Q ss_pred CCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC-CCCcEEEeeCCCCCcEEEEecCC
Q 011988 74 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI-KPDNFLMGLGRRANQVYIIDFGL 151 (473)
Q Consensus 74 ~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDI-KP~NILl~~~~~~~~vkL~DFGl 151 (473)
...++||||+ |++|.. +. ... ...++.|++.||.|||++||+|||| ||+|||++ .++.+||+|||+
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~---~~~~ikLiDFGl 158 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-AR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG---PDGEAAVIDFQL 158 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc---CCCCEEEEECcc
Confidence 3469999999 677852 21 111 1467899999999999999999999 99999994 567899999999
Q ss_pred cccccCCCCcccc-ccccCCCcccCccccccccccCCC------CCchhhHH
Q 011988 152 AKRYRDTATHQHI-PYRENKNLTGTARYASMNTHLGIE------QSRRDDLE 196 (473)
Q Consensus 152 a~~~~~~~~~~~~-p~~~~~~~~Gt~~Y~APE~~~~~~------~s~ksDVw 196 (473)
|+.+........+ .+.......++..|+|||.+.-.+ .+...|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9988665433222 122234678899999999987543 23446665
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-24 Score=206.87 Aligned_cols=256 Identities=30% Similarity=0.406 Sum_probs=189.8
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
|.+.+.||.|+||.||++.+. ..+++|.+.... ...+.+|+.++..+.+++.+..+..+.......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999976 778888743322 44588899999999988655555555566666799999
Q ss_pred cC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCC-cEEEEecCCcccccCC
Q 011988 83 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDT 158 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~--~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~~ 158 (473)
++ +++|.+++.... ..+....+..++.|++.+|.|+|+.+++||||||+||++. ..+ .++++|||+++.+...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCCC
Confidence 99 788887776433 2699999999999999999999999999999999999995 455 7999999999865543
Q ss_pred CCccccccccCCCcccCccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-CHHHHHHHHhhccccc
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVST 234 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~ 234 (473)
....... .......||..|++||.+.+ ..++...|+||+|++++++++|..||...... ........+.......
T Consensus 156 ~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 156 GSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred Ccccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 3211000 12356789999999999998 57899999999999999999999998765431 1122222222221110
Q ss_pred cHHHHhcCC----cHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011988 235 SIEALCRGY----PTEFASYFHYCRSLRFDDKPDYAYLKRL 271 (473)
Q Consensus 235 ~~~~l~~~~----p~~l~~li~~cl~~dp~~RPt~~~l~~~ 271 (473)
......... ...+.+++..|+..+|..|.+.......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 011111111 2578999999999999999987665443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=232.81 Aligned_cols=259 Identities=20% Similarity=0.249 Sum_probs=186.9
Q ss_pred EEEeeEeecCceEEEEEEEcCCCcEEEEEEcc----cCCc-hh----HHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNV----KTKH-PQ----LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~----~~~~-~~----l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.....+|.|.+|.|+.+......+.++.|... .... .. +..|.-+-..|.|.+.+..+..+.........
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~- 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS- 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh-
Confidence 45778999999999988877666666666422 1111 11 23344444456666655554433333333333
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 81 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 81 ~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||||..+|..++.. ...+...++..++.|++.||+|||+.||.||||||+|+++. ..+.+||+|||.+..+.-...
T Consensus 400 mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---ENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cCCceEEeecCcceeeccCcc
Confidence 99996699999873 34689999999999999999999999999999999999995 778999999999987654432
Q ss_pred ccccccccCCCcccCccccccccccCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCCCHHH-HHHHHhhccccccHHH
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSR-RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-KYEKISEKKVSTSIEA 238 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~-ksDVwSlGviL~elltG~~Pf~~~~~~~~~~-~~~~i~~~~~~~~~~~ 238 (473)
.. ......++|+..|+|||++.+.+|.+ ..||||.|++++.|++|+.||......+... ................
T Consensus 476 ~~---~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 476 KN---IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred hh---hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 11 12346789999999999999999965 5799999999999999999997654433221 1111122223334455
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
+...+|.+-+.+|-.||+.||.+|.|+++| |++-|.+.
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i---~~d~W~~~ 590 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQI---LNDEWIRS 590 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHH---hhChHhhh
Confidence 667789999999999999999999997766 55555443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=199.47 Aligned_cols=230 Identities=23% Similarity=0.272 Sum_probs=146.3
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcC----------CCCCCeeEEee
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQG----------GTGIPNLRWFG 71 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~----------~~~i~~~~~~~ 71 (473)
.+...+.||.|+|+.||.+++..+++.+|||+..... ..++.+|.-....+.+ ...+..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3567889999999999999999999999999832221 1223333322222111 01111111111
Q ss_pred --------Ee---CCe-----EEEEEecCCCCHHHHHHHc---CCC---CCHHHHHHHHHHHHHHHHHHHhCCCcccCCC
Q 011988 72 --------VE---GDY-----NVLVIDLLGPSLEDLFNFC---SRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIK 129 (473)
Q Consensus 72 --------~~---~~~-----~~lv~e~~g~sL~~~l~~~---~~~---ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIK 129 (473)
.. ... .++.|+.+.++|.+++... ... +.....+.+..|++..+++||..||||+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 11 111 2677888899999986532 221 2233446677999999999999999999999
Q ss_pred CCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccC--------CCCCchhhHHHHHHH
Q 011988 130 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYV 201 (473)
Q Consensus 130 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~--------~~~s~ksDVwSlGvi 201 (473)
|+|||+ +.+|.++|+||+........... ...+..|.+||.... ..++.+.|.|+||++
T Consensus 173 ~~nfll---~~~G~v~Lg~F~~~~r~g~~~~~----------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 173 PENFLL---DQDGGVFLGDFSSLVRAGTRYRC----------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp GGGEEE----TTS-EEE--GGGEEETTEEEEG----------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred eeeEEE---cCCCCEEEcChHHHeecCceeec----------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 999999 47899999999887655432210 234577999997643 247899999999999
Q ss_pred HHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCC
Q 011988 202 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 262 (473)
Q Consensus 202 L~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~R 262 (473)
||.|++|.+||........... .-..|.++|+.++.||..+|+.||++|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999986543211110 122466889999999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=220.59 Aligned_cols=255 Identities=23% Similarity=0.319 Sum_probs=185.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhc--CCCCCCeeEEeeEeCCeEEEEEe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
-++.|.|.+.||.|+||.||+|.... |+.||||+......=++---.+++.+|+ -.+.|..+.......+..++|++
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 36789999999999999999999866 9999999966555433333334444444 11222233333445666789999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEee----CCCCCcEEEEecCCcccccC
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL----GRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~----~~~~~~vkL~DFGla~~~~~ 157 (473)
|. .|+|.++++ ..+.+++..+..|+.||+.-|+.||..+|||+||||+|+||.. +.+...++|+|||.+..+.-
T Consensus 775 y~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l 853 (974)
T KOG1166|consen 775 YSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL 853 (974)
T ss_pred ccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence 98 899999998 5667999999999999999999999999999999999999964 22345699999999965432
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
-.... ..+..++|-.+-.+|+..|.+++...|.|.|..+++-||.|++-= ...+... .....+.
T Consensus 854 fp~~~-----~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~g~~~---------~~~~~~~ 917 (974)
T KOG1166|consen 854 FPDGT-----KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKNGSSW---------MVKTNFP 917 (974)
T ss_pred cCCCc-----EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcCCcce---------eccccch
Confidence 22111 224568899999999999999999999999999999999986532 1111000 0001011
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.+.. -+-..+|+..+|+.|-..=|...+|+..|+..+.+.
T Consensus 918 Ry~~--~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 918 RYWK--RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred hhhh--HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 1111 023457888888877777788999999999888664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=186.18 Aligned_cols=135 Identities=23% Similarity=0.241 Sum_probs=102.3
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc------------hh-----------------HHHHHHHHHHhcCCC
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH------------PQ-----------------LQYEAKLYKILQGGT 62 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~------------~~-----------------l~~E~~il~~L~~~~ 62 (473)
.+.||+|+||.||+|.+. +|+.||||++..... .. ...|++++..|.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 568999999999999986 899999998543211 11 234999999997543
Q ss_pred CCCeeEEeeEeCCeEEEEEecCCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCcccCCCCCcEEEeeCCC
Q 011988 63 GIPNLRWFGVEGDYNVLVIDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDNFLMGLGRR 140 (473)
Q Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~g~-sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yL-H~~gIvHrDIKP~NILl~~~~~ 140 (473)
+.....+... ..+|||||+++ +|...+. ....++..+++.++.||+.+|.|| |+.||+||||||+|||++
T Consensus 81 -v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---- 152 (190)
T cd05147 81 -IPCPEPILLK--SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---- 152 (190)
T ss_pred -CCCCcEEEec--CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence 2222222222 23899999955 4443322 245799999999999999999999 799999999999999994
Q ss_pred CCcEEEEecCCcccc
Q 011988 141 ANQVYIIDFGLAKRY 155 (473)
Q Consensus 141 ~~~vkL~DFGla~~~ 155 (473)
.+.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 367999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=188.06 Aligned_cols=170 Identities=14% Similarity=0.206 Sum_probs=125.8
Q ss_pred CCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--ch----------hHHHHHHHHHHhcCCCCCCeeEE
Q 011988 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HP----------QLQYEAKLYKILQGGTGIPNLRW 69 (473)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~----------~l~~E~~il~~L~~~~~i~~~~~ 69 (473)
+..+.++|++.+.||.|+||.||++.+ ++..+|||++.... .+ .+.+|++.+.+|.++ +++.+..
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~-GI~~~~d 102 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE-GLASLND 102 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC-CCCcceE
Confidence 456789999999999999999999764 46689999954321 11 157888899999754 5555555
Q ss_pred eeEeC--------CeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC
Q 011988 70 FGVEG--------DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 140 (473)
Q Consensus 70 ~~~~~--------~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 140 (473)
++... ...+|+|||+ |.+|.++.. +++ ....+|+.+|..||..||+||||||+||+++ .
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~---~ 170 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS---K 170 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---C
Confidence 53322 3578999999 668887742 333 2456999999999999999999999999995 4
Q ss_pred CCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 011988 141 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 206 (473)
Q Consensus 141 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ell 206 (473)
++ ++|+|||..+........ -...+...|..++|||+|||++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------------HHHHHHhHhcccccccceeEeehHHH
Confidence 55 999999998755332110 11344445677999999999987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=218.39 Aligned_cols=216 Identities=23% Similarity=0.359 Sum_probs=152.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecCC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLG 85 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~g 85 (473)
..+|..++.|-.|+||.||+++++.+.+.+|+|+.+... +.+. ++... +..++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l---ilRn--ilt~a----------------~npfvv----- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL---ILRN--ILTFA----------------GNPFVV----- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch---hhhc--ccccc----------------CCccee-----
Confidence 467999999999999999999999999999998633221 1111 11111 111111
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc---
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ--- 162 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~--- 162 (473)
++-..+++. -++++.. ++.+++|||+.||+|||+||+|.||+ .-+++|+.|||+++...-..+..
T Consensus 136 gDc~tllk~-~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 136 GDCATLLKN-IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred chhhhhccc-CCCCcch--------hhHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhhhhccchhhh
Confidence 333444442 2234433 27899999999999999999999995 78999999999997643211110
Q ss_pred -ccc----cccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 163 -HIP----YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 163 -~~p----~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
++. ..-.+..+||+.|.|||++..+.|+..+|+|++|+|+||++.|+.||.+.+.. +.+..+....+.. .+
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe---elfg~visd~i~w-pE 279 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISDDIEW-PE 279 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH---HHHhhhhhhhccc-cc
Confidence 000 01135679999999999999999999999999999999999999999986543 3332222221111 11
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCC
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPD 264 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt 264 (473)
. -..+++|.+++|.++|..+|.+|--
T Consensus 280 ~-dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 280 E-DEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred c-CcCCCHHHHHHHHHHHHhChHhhcc
Confidence 1 3457899999999999999999963
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=177.85 Aligned_cols=192 Identities=17% Similarity=0.123 Sum_probs=137.3
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc--h-----hHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH--P-----QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~--~-----~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+.+...|+.|+||+||++.. .+.+++.+.+..... . .+.+|+++|+.|.++++++.+..+ ...+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678899999999998874 677777665322221 1 467899999999988888888654 3358999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC-CCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI-KPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDI-KP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
+|+ |.+|.+.+.. ....++.|++.+|.+||++||+|||| ||+|||++ .++.++|+|||+|.......
T Consensus 78 eyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCCcc
Confidence 998 7677654321 12457889999999999999999999 79999995 66789999999998544322
Q ss_pred Cccc-ccccc-----CCCcccCccccccccccCC-CCC-chhhHHHHHHHHHHHHcCCCCCCCCCC
Q 011988 160 THQH-IPYRE-----NKNLTGTARYASMNTHLGI-EQS-RRDDLESLGYVLMYFLRGSLPWQGLKA 217 (473)
Q Consensus 160 ~~~~-~p~~~-----~~~~~Gt~~Y~APE~~~~~-~~s-~ksDVwSlGviL~elltG~~Pf~~~~~ 217 (473)
.... ..++. ......++.|++|+...-. ..+ .+.+.++.|+.+|.++|+..++.+...
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 1000 00000 0012357788888865433 233 567888999999999999998866543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=177.77 Aligned_cols=137 Identities=20% Similarity=0.264 Sum_probs=104.4
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc-----------------------------hhHHHHHHHHHHhcCC
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH-----------------------------PQLQYEAKLYKILQGG 61 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~-----------------------------~~l~~E~~il~~L~~~ 61 (473)
+.+.||+|+||.||+|.+. +|+.||||+...... ..+..|...+..+.+.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 899999998543311 1135788889888855
Q ss_pred CCCCeeEEeeEeCCeEEEEEecCCCC-HH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeC
Q 011988 62 TGIPNLRWFGVEGDYNVLVIDLLGPS-LE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLG 138 (473)
Q Consensus 62 ~~i~~~~~~~~~~~~~~lv~e~~g~s-L~-~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~ 138 (473)
. +.....+... ..+|||||+++. +. ..+. ...++..++..++.|++.+|.+||+ +||+||||||+|||++
T Consensus 80 ~-i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-- 152 (190)
T cd05145 80 G-VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-- 152 (190)
T ss_pred C-CCCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE--
Confidence 4 3333223222 248999999553 33 3333 3468889999999999999999999 9999999999999994
Q ss_pred CCCCcEEEEecCCcccccC
Q 011988 139 RRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 139 ~~~~~vkL~DFGla~~~~~ 157 (473)
++.++|+|||+|+....
T Consensus 153 --~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 --DGKPYIIDVSQAVELDH 169 (190)
T ss_pred --CCCEEEEEcccceecCC
Confidence 57899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-22 Score=213.80 Aligned_cols=248 Identities=17% Similarity=0.146 Sum_probs=170.1
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
+|...+.||.+.|=.|.+|++. .|. |+||++.+.. ..+...|++ ...+++++.+++. .........|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfq-k~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQ-KVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchH-HHHHhhHHHHHH
Confidence 6889999999999999999863 455 8999965544 223334444 3334444444443 335566677888
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 81 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 81 ~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
-+|...+|.|.+. ...-+..-+.+.|+.||+.||..+|..||+|+|||.+||||+ .-+=+.|+||..-+..--+..
T Consensus 100 RqyvkhnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHhhhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCccCCCC
Confidence 8999999999987 223367788999999999999999999999999999999996 556688999987654221111
Q ss_pred c-cccccccCCCcccCccccccccccCC----------C-CCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHH
Q 011988 161 H-QHIPYRENKNLTGTARYASMNTHLGI----------E-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 227 (473)
Q Consensus 161 ~-~~~p~~~~~~~~Gt~~Y~APE~~~~~----------~-~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i 227 (473)
. ..+.|.. .+...-..|.|||.|... . .+++-||||+||++.||++ |++||.- ...-.|...
T Consensus 176 NPadf~fFF-DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~ 250 (1431)
T KOG1240|consen 176 NPADFTFFF-DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSG 250 (1431)
T ss_pred CcccceEEE-ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhcc
Confidence 0 0010100 111123469999987641 1 5788999999999999998 8899842 111111111
Q ss_pred hhccccccHHHHhcCC-cHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011988 228 SEKKVSTSIEALCRGY-PTEFASYFHYCRSLRFDDKPDYAYLKRLF 272 (473)
Q Consensus 228 ~~~~~~~~~~~l~~~~-p~~l~~li~~cl~~dp~~RPt~~~l~~~L 272 (473)
. ....+.+...+ ...++.+|..|++.||.+|.++++.++.-
T Consensus 251 ---~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 251 ---N-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ---C-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 1 22222333332 35789999999999999999999886653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.6e-22 Score=204.16 Aligned_cols=249 Identities=19% Similarity=0.266 Sum_probs=188.5
Q ss_pred eEeecCceEEEEEEEc---CCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 14 KIGSGSFGEIYLGTNI---QTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 14 ~LG~G~fG~Vy~a~~~---~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
.+|+|.||.|+++.-. ..+.-+|+|+..+.. ......|..++..++.++.+..+..........++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3799999999987532 345668888733321 1234568888888887888878877777777788888888
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 85 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 85 g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
|+.|...+. ....+.+..+..+...++.+++++|+.+|+|||+|++||++ +..|++++.|||+++...+...
T Consensus 81 gg~lft~l~-~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLS-KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccc-cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhh----
Confidence 667776665 34568889999999999999999999999999999999999 5889999999999987765432
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCc
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 244 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 244 (473)
.+||..|||||++. .....+|.||||++++||++|..||.+ +....|...+... ...+.
T Consensus 153 -------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~~-----p~~l~ 211 (612)
T KOG0603|consen 153 -------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELEM-----PRELS 211 (612)
T ss_pred -------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccCC-----chhhh
Confidence 28999999999998 457789999999999999999999987 2233333322221 22345
Q ss_pred HHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 011988 245 TEFASYFHYCRSLRFDDKPDY--AYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 298 (473)
Q Consensus 245 ~~l~~li~~cl~~dp~~RPt~--~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 298 (473)
.+..+++.+++..+|..|--. ..+.+..++.+ -...+|+.+...+.+
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f-------~~~i~~~~l~~r~~~ 260 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEF-------FQSIDWNELEARSRP 260 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhccCcchhHHHhccch-------heeeeHhhHhhcCCC
Confidence 778899999999999999754 34444444433 456788877655433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.9e-21 Score=185.08 Aligned_cols=196 Identities=18% Similarity=0.210 Sum_probs=145.8
Q ss_pred CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC-CCcEEEEecCCc
Q 011988 74 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLA 152 (473)
Q Consensus 74 ~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~-~~~vkL~DFGla 152 (473)
+...|+||.-...+|.+++. .+..+..+...|+.|+++|+.|||.+||.|||+|.+||||-.+++ ...+.|.|||.|
T Consensus 315 ~~tlylvMkrY~~tLr~yl~--~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLW--TRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CceEEEehhcchhhHHHHHh--cCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 44569999999999999997 456788889999999999999999999999999999999977543 346789999988
Q ss_pred ccccCCCCccccccccC-CCcccCccccccccccCCC------CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 011988 153 KRYRDTATHQHIPYREN-KNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 225 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~-~~~~Gt~~Y~APE~~~~~~------~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~ 225 (473)
-.-. ......||... -...|....||||+....+ --.|+|.|+.|.+.||++....||.+....... ..
T Consensus 393 LAd~--~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~--~r 468 (598)
T KOG4158|consen 393 LADD--NHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD--TR 468 (598)
T ss_pred eecc--ccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec--hh
Confidence 5322 22233444322 2346788999999987543 124899999999999999999999873221110 01
Q ss_pred HHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 226 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 226 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
...+ ..++.+...+|+.+.+++..+|+.||.+|++..-..+.|+=.+...
T Consensus 469 ~Yqe----~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~ 518 (598)
T KOG4158|consen 469 TYQE----SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRM 518 (598)
T ss_pred hhhh----hhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcC
Confidence 1111 2234456788999999999999999999999876666665444433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6e-19 Score=165.46 Aligned_cols=134 Identities=16% Similarity=0.225 Sum_probs=100.6
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccC---CchhHHHHHHHHHHhcC----CCCCCeeEEeeEeCC---e-EEEE
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQG----GTGIPNLRWFGVEGD---Y-NVLV 80 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---~~~~l~~E~~il~~L~~----~~~i~~~~~~~~~~~---~-~~lv 80 (473)
.+.||+|+||.||. +..++.. +||+.... ....+.+|+.+++.|.+ +++|..++.+...+. + +.+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 56899999999995 6777666 68985443 34568999999999953 445555555544432 3 4478
Q ss_pred EecCC---CCHHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHhCCCcccCCCCCcEEEeeCC-CCCcEEEEecCCc
Q 011988 81 IDLLG---PSLEDLFNFCSRKLSLKTVLMLADQMINRV-EFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA 152 (473)
Q Consensus 81 ~e~~g---~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL-~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~DFGla 152 (473)
|||+| ++|.++++. ..+++. ..++.|++.++ +|||+++||||||||+|||++..+ ....++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99965 799999974 346655 36688888888 999999999999999999997433 3458999995544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=171.51 Aligned_cols=140 Identities=19% Similarity=0.219 Sum_probs=107.5
Q ss_pred ceEEEeeEeecCceEEEEEE-EcCCCcEEEEEEcccCCc---------------------------hhHHHHHHHHHHhc
Q 011988 8 KFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLNVKTKH---------------------------PQLQYEAKLYKILQ 59 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~-~~~~~~~vAiK~~~~~~~---------------------------~~l~~E~~il~~L~ 59 (473)
-|.+.+.||+|+||.||+|. +..+|+.||||+...... ..+..|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 667999999998543210 12468999999997
Q ss_pred CCCCCCeeEEeeEeCCeEEEEEecCCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-CcccCCCCCcEEEee
Q 011988 60 GGTGIPNLRWFGVEGDYNVLVIDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGL 137 (473)
Q Consensus 60 ~~~~i~~~~~~~~~~~~~~lv~e~~g~-sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g-IvHrDIKP~NILl~~ 137 (473)
+ .++.....+... ..++||||+++ +|..+.. ....+...++..++.||+.+|.+||++| |+||||||+|||++
T Consensus 109 ~-~~i~~p~~~~~~--~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 E-AGVPVPKPIAWR--RNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred h-cCCCCCeeeEec--CceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 5 333333333222 24799999955 5655432 2335667778899999999999999999 99999999999994
Q ss_pred CCCCCcEEEEecCCcccc
Q 011988 138 GRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 138 ~~~~~~vkL~DFGla~~~ 155 (473)
.+.++|+|||+|...
T Consensus 184 ---~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 ---DGKVVIIDVSQSVEL 198 (237)
T ss_pred ---CCCEEEEEChhhhcc
Confidence 578999999998754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-19 Score=168.54 Aligned_cols=241 Identities=12% Similarity=0.155 Sum_probs=176.1
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEc-----ccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-----VKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~-----~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
..++-+|.+...|+.|+|++.. ..++.|++ ......+|..|.-.|+.+.|+++++.+..+....+. +++..|
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnl-v~isq~ 268 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL-VIISQY 268 (448)
T ss_pred hhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCc-eEeeee
Confidence 4466788899999999999753 34556652 222345688898899999988888887776655544 455555
Q ss_pred C-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEEeeCCCCCcEE--EEecCCcccccC
Q 011988 84 L-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVY--IIDFGLAKRYRD 157 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vk--L~DFGla~~~~~ 157 (473)
+ .++|..++..... .++..++.+++.+|+.|+.|||+.. |.---|....++|+ ++.+.+ .+|--++...
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid---edltarismad~kfsfqe-- 343 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID---EDLTARISMADTKFSFQE-- 343 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec---chhhhheecccceeeeec--
Confidence 5 8999999984332 3678899999999999999999864 33446788889994 444444 3443333211
Q ss_pred CCCccccccccCCCcccCccccccccccCCCC---CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~---s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
....-.+.||+||.+...+- -+++|+|||.++||||.|...||.+..+.+-..++ . +..
T Consensus 344 ------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---a---leg 405 (448)
T KOG0195|consen 344 ------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---A---LEG 405 (448)
T ss_pred ------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---h---hcc
Confidence 12234678999999987764 36789999999999999999999887664333222 1 122
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
....++++++..+..||..|++.||.+||.|+.|+-+|+++
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 23345678889999999999999999999999999888875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.9e-20 Score=186.03 Aligned_cols=242 Identities=19% Similarity=0.208 Sum_probs=159.0
Q ss_pred CceEEEeeEeecCceEEEEEEEcCC---CcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeE-----E--e---
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLR-----W--F--- 70 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~-----~--~--- 70 (473)
..+.+.+..+..+++.++...-... .+.++-|...... .....+++..+....+++...... . +
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~ 323 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRN 323 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccc
Confidence 3455566666677776665543322 2333333321111 122334444444455555443322 0 0
Q ss_pred -eEeCCeEEEEEecC-CCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEE
Q 011988 71 -GVEGDYNVLVIDLL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 146 (473)
Q Consensus 71 -~~~~~~~~lv~e~~-g~sL~~~l~~--~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL 146 (473)
.....+.+|.|++| ..+|.+++.. .....+....+.++.|++.|++| +|.+|||+||.||++. .+.++||
T Consensus 324 ~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kI 397 (516)
T KOG1033|consen 324 KVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKI 397 (516)
T ss_pred ccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhh
Confidence 01134678999999 7899999962 23357788899999999999999 9999999999999995 5668999
Q ss_pred EecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHH
Q 011988 147 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYE 225 (473)
Q Consensus 147 ~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~ 225 (473)
.|||+........+ ...++.......||..||+||.+.|..|+.++||||||+||+|++. -...|.-. ....
T Consensus 398 gDFgl~ts~~~~~~-~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------~t~~ 470 (516)
T KOG1033|consen 398 GDFGLVTSQDKDET-VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------ATLT 470 (516)
T ss_pred hhhhheeecccCCc-ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------Hhhh
Confidence 99999987665541 1112333456789999999999999999999999999999999997 33333221 1112
Q ss_pred HHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 011988 226 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 265 (473)
Q Consensus 226 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~ 265 (473)
.+....++ +.+..++| +-..|+.+++...|.+||++
T Consensus 471 d~r~g~ip---~~~~~d~p-~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 471 DIRDGIIP---PEFLQDYP-EEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred hhhcCCCC---hHHhhcCc-HHHHHHHHhcCCCcccCchH
Confidence 22222221 12223343 44689999999999999943
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.6e-18 Score=160.44 Aligned_cols=130 Identities=25% Similarity=0.435 Sum_probs=103.5
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+.||+|++|.||+|.+ .+..|+||+..... ...+.+|+.++..+.+.+ +.....++......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAG-VNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCC-CCCCeEEEEeCCCCEEEE
Confidence 6799999999999986 67889999743221 123667899999998544 443344444556678999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
||+ |.+|.+++.... . ....++.+|+.+|.+||+.|++|+|++|.|||++ .+.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 999 789999987422 2 7889999999999999999999999999999994 57899999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-18 Score=177.72 Aligned_cols=212 Identities=17% Similarity=0.226 Sum_probs=160.6
Q ss_pred HhcCCCCCCeeEEeeEeCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCC-cccCCCCCcEE
Q 011988 57 ILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-LHRDIKPDNFL 134 (473)
Q Consensus 57 ~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gI-vHrDIKP~NIL 134 (473)
.+. |.++..+.+...++...+++.+|| .++|.|.+.....+++..-...++.+|+.||+|||...| .|+.|+..|++
T Consensus 3 ~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nCl 81 (484)
T KOG1023|consen 3 QLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCL 81 (484)
T ss_pred ccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccce
Confidence 455 445556666667778889999999 889999998767788999999999999999999998766 99999999999
Q ss_pred EeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCC-------CCchhhHHHHHHHHHHHHc
Q 011988 135 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-------QSRRDDLESLGYVLMYFLR 207 (473)
Q Consensus 135 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-------~s~ksDVwSlGviL~ellt 207 (473)
+ +....+||.|||+......... +.......-...|.|||.+.+.. .+.+.||||||++++|+++
T Consensus 82 v---d~~w~lklt~~Gl~~~~~~~~~-----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 82 V---DSRWVLKLTDFGLNSLLEETAE-----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred e---eeeEEEEechhhhccccccccc-----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 9 5889999999999877643110 00111223456799999998742 3677999999999999999
Q ss_pred CCCCCCCCCCCCH-HHHHHHHhh---ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 208 GSLPWQGLKAGTK-KQKYEKISE---KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 208 G~~Pf~~~~~~~~-~~~~~~i~~---~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
.+.||........ .+.+..+.. ....+.+.... .+++++..++..||..+|++||+++.+...++.+...
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccCccccccccCChHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9999976333221 233333322 22334444333 6677999999999999999999999999888877654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=155.66 Aligned_cols=126 Identities=25% Similarity=0.391 Sum_probs=99.1
Q ss_pred eEeecCceEEEEEEEcCCCcEEEEEEcccCC-----------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.||+|+||.||+|. .++..|++|+..... ...+.+|++++..+.+.. +.....+.......+++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAG-VNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEECCCCEEEEE
Confidence 47999999999998 467889999833211 133567999999998553 3333444555666789999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
|+ |.+|.+++.... . .++.|++.+|.+||+.||+|+|++|.|||++ .+.++|+|||++..
T Consensus 78 ~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcC
Confidence 99 889998876321 1 7899999999999999999999999999994 67899999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=153.52 Aligned_cols=135 Identities=21% Similarity=0.310 Sum_probs=102.8
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-------------------------chhHHHHHHHHHHhcCCC
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-------------------------HPQLQYEAKLYKILQGGT 62 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-------------------------~~~l~~E~~il~~L~~~~ 62 (473)
.|.+.+.||.|+||.||+|.+ .+|+.||||+..... ......|..++..+.+..
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 488899999999999999986 489999999743221 012567888888887542
Q ss_pred -CCCeeEEeeEeCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC
Q 011988 63 -GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 140 (473)
Q Consensus 63 -~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 140 (473)
.++.. +. ....+++|||+ |++|..+.. ......++.+|+.+|.++|+.||+||||||+||+++ .
T Consensus 95 i~v~~~--~~--~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~---~ 160 (198)
T cd05144 95 FPVPKP--ID--WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD---D 160 (198)
T ss_pred CCCCce--ee--cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc---C
Confidence 22222 22 23458999999 667765532 134567899999999999999999999999999994 6
Q ss_pred CCcEEEEecCCcccccC
Q 011988 141 ANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 141 ~~~vkL~DFGla~~~~~ 157 (473)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 78999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=171.47 Aligned_cols=132 Identities=24% Similarity=0.425 Sum_probs=102.2
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEc-cc-CC---------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-VK-TK---------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~-~~-~~---------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
..|...+.||+|+||+||+|.+.. ..+++|+. .+ .. ...+.+|+++++.+++++ +.....+.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAG-VPTPVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccC-CCeeEEEEEeCC
Confidence 345668899999999999998643 33444431 11 11 134678999999998655 444445555566
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..+++|||+ |++|.+++. ....++.|++.+|.|||+.||+||||||+|||+ +.+.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCccccc
Confidence 678999999 889998875 356789999999999999999999999999999 356899999999964
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-16 Score=144.21 Aligned_cols=134 Identities=24% Similarity=0.338 Sum_probs=94.3
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc-----hh----------------------HHHHHHHHHHhcCCC-C
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH-----PQ----------------------LQYEAKLYKILQGGT-G 63 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~-----~~----------------------l~~E~~il~~L~~~~-~ 63 (473)
.+.||+|+||.||+|.+. +++.||||+...... .. ...|...+..+.+.. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999975 899999998543211 00 134566666665332 2
Q ss_pred CCeeEEeeEeCCeEEEEEecCCC-CH-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCC
Q 011988 64 IPNLRWFGVEGDYNVLVIDLLGP-SL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRR 140 (473)
Q Consensus 64 i~~~~~~~~~~~~~~lv~e~~g~-sL-~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~ 140 (473)
++....+ ...+++|||+.+ .+ ...+.... .. ..+..++.+++.++.++|. .||+|+||||+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~---- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD---- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----
Confidence 3333222 235899999954 21 11122111 11 6788999999999999999 9999999999999994
Q ss_pred CCcEEEEecCCcccccC
Q 011988 141 ANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 141 ~~~vkL~DFGla~~~~~ 157 (473)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 68899999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.1e-15 Score=141.10 Aligned_cols=131 Identities=16% Similarity=0.210 Sum_probs=95.7
Q ss_pred eeEe-ecCceEEEEEEEcCCCcEEEEEEccc----------------CCchhHHHHHHHHHHhcCCCC-CCeeEEeeE-e
Q 011988 13 RKIG-SGSFGEIYLGTNIQTNEEVAIKLNVK----------------TKHPQLQYEAKLYKILQGGTG-IPNLRWFGV-E 73 (473)
Q Consensus 13 ~~LG-~G~fG~Vy~a~~~~~~~~vAiK~~~~----------------~~~~~l~~E~~il~~L~~~~~-i~~~~~~~~-~ 73 (473)
..|| .||.|+||.+.. .+..++||.... .....+.+|+.++..|.+..+ ++....+.. .
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 899999999875 477889986432 112346789999999985543 333333322 2
Q ss_pred CCe---EEEEEecCC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEe
Q 011988 74 GDY---NVLVIDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 148 (473)
Q Consensus 74 ~~~---~~lv~e~~g--~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 148 (473)
... .++|||++. .+|.+++.. ..++... +.||+.+|.+||++||+||||||.|||++ .++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEEEEE
Confidence 222 259999884 589988863 3455543 57899999999999999999999999995 556899999
Q ss_pred cCCccc
Q 011988 149 FGLAKR 154 (473)
Q Consensus 149 FGla~~ 154 (473)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.3e-15 Score=130.27 Aligned_cols=131 Identities=19% Similarity=0.314 Sum_probs=105.1
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-chhHHHHHHHHHHhcCC-CCCCeeEEeeEeCCeEEEEEecCC-CC
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-HPQLQYEAKLYKILQGG-TGIPNLRWFGVEGDYNVLVIDLLG-PS 87 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-~~~l~~E~~il~~L~~~-~~i~~~~~~~~~~~~~~lv~e~~g-~s 87 (473)
+++.||.|.++.||++... +..++||...... ...+..|+.+++.+.+. ..++.+..+.......+++|||+. ..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4678999999999999964 3789999864443 35688999999999876 556666666666678899999984 44
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 88 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 88 L~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
+..+ +......++.+++.+|.+||.. +++|+||+|.|||++ ..+.++|+|||.+..
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY 138 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence 4432 5566778899999999999984 799999999999995 468899999999863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.1e-17 Score=174.34 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=186.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCC-CcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
...|.+.+.||+|+|+.|-+.....+ ...+|.|.+.... ......|..+-+.+..|.++..+.......+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 45689999999999999998886433 3456666533222 12234577777777767777777667778888899
Q ss_pred EEecC-CCCHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCCCcEEEeeCCCCC-cEEEEecCCcccc
Q 011988 80 VIDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRY 155 (473)
Q Consensus 80 v~e~~-g~sL~~~l-~~~~~~ls~~~~~~i~~qi~~aL~yLH-~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~ 155 (473)
++++. |+++.+.+ .......+...+-.++.|+..+|.|+| ..++.||||||+|.+++ ..+ .+++.|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhccc
Confidence 99998 77887777 322225677788899999999999999 99999999999999995 555 8999999999988
Q ss_pred cC-CCCccccccccCCCccc-CccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 156 RD-TATHQHIPYRENKNLTG-TARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 156 ~~-~~~~~~~p~~~~~~~~G-t~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
.. ..... .....+| ++.|+|||.+.+.. ..+..|+||+|+++.-+++|..||....... ..+......+.
T Consensus 176 ~~~~g~~~-----~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~ 248 (601)
T KOG0590|consen 176 RNKNGAER-----SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNKG 248 (601)
T ss_pred cccCCcce-----eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeeccccc
Confidence 77 33211 1234567 99999999999854 5788999999999999999999997643322 11222222211
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
. ........+.....+++..++..+|..|.+.+++
T Consensus 249 ~-~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 249 R-FTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred c-cccCccccCChhhhhcccccccCCchhccccccc
Confidence 1 0112345677889999999999999999996655
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.6e-15 Score=153.23 Aligned_cols=252 Identities=17% Similarity=0.157 Sum_probs=187.6
Q ss_pred CCceEEEeeEee--cCceEEEEEEE--cCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 6 GNKFRLGRKIGS--GSFGEIYLGTN--IQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~--G~fG~Vy~a~~--~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
.+.|.+.+.+|. |.+|.||.+.. ..++..+|+|.-... ....-.+|+.-.+.+..+...............
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 455778889999 99999999988 788899999972111 112234566666666655555554445567788
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHH----HHHHHHhCCCcccCCCCCcEEEeeCCCC-CcEEEEecCC
Q 011988 77 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN----RVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGL 151 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~----aL~yLH~~gIvHrDIKP~NILl~~~~~~-~~vkL~DFGl 151 (473)
.++-.|+|+.+|..+......-++...++.++.+... ||.++|+.+|+|-|+||+||++. .+ ..++++|||+
T Consensus 193 lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 193 LFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLTDFGL 269 (524)
T ss_pred ceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecCCcce
Confidence 8999999999999988755556888999999999999 99999999999999999999996 44 7899999999
Q ss_pred cccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011988 152 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231 (473)
Q Consensus 152 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 231 (473)
...+.+...... +.......|...|++||...+ -++..+|||+||.++.+..+|..++..-.... ...+...
T Consensus 270 v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~r~~---- 341 (524)
T KOG0601|consen 270 VSKISDGNFSSV--FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQLRQG---- 341 (524)
T ss_pred eEEccCCccccc--eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC-ccccccc----
Confidence 998876543221 112233467889999999876 57889999999999999999877765432111 1111111
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 232 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 232 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
....++|.+...++...+..++..++-.|++.+.+..
T Consensus 342 --~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 --YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1234567777788888999999999999988766543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.8e-14 Score=146.16 Aligned_cols=138 Identities=20% Similarity=0.301 Sum_probs=96.7
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCCchh-------------------------------------------HH
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ-------------------------------------------LQ 49 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~-------------------------------------------l~ 49 (473)
+.||.|++|+||+|+. .+|+.||||+........ +.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999985 589999999854433222 23
Q ss_pred HHHHHHHHhc----CCCCCCeeEEeeEeCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 011988 50 YEAKLYKILQ----GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN-RVEFVHSKSF 123 (473)
Q Consensus 50 ~E~~il~~L~----~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~-aL~yLH~~gI 123 (473)
+|...+..+. +.+.+.....+.......+|||||+ |.+|.++.......++ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 3444444432 3344443344444445579999999 7788887653222232 3456666665 4788999999
Q ss_pred cccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 124 vHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+|+|+||.||++. .++.++|+|||++..+..
T Consensus 279 ~H~D~hPgNilv~---~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVL---KDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEEC---CCCcEEEEeCCCeeECCH
Confidence 9999999999994 678999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.4e-13 Score=119.64 Aligned_cols=125 Identities=19% Similarity=0.285 Sum_probs=95.1
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCCH
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSL 88 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL 88 (473)
++.|+.|.++.||++.. .+..|+||+..... ...+..|+.+++.+.+...++.+..+.. ...+++||++ |.++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 46789999999999985 47889999954432 3457899999999987666666655543 3357999999 5455
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----cccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 89 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-----LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 89 ~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gI-----vHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
.+. . .....++.+++.+|..||..++ +|+|++|.||+++ .+.++|+|||.+.
T Consensus 79 ~~~------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE------D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAG 135 (170)
T ss_pred ccc------c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEeccccc
Confidence 432 0 1123457899999999999885 9999999999994 4579999999985
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.3e-12 Score=131.96 Aligned_cols=142 Identities=18% Similarity=0.283 Sum_probs=92.2
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCch-----------------------------------------
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP----------------------------------------- 46 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~----------------------------------------- 46 (473)
.|.. +.||+|++|+||+|+...+|+.||||+..+....
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4565 7899999999999998877999999985433211
Q ss_pred --hHHHHHHHHHHhc----CCCCCCeeEEeeEeCCeEEEEEecC-CCCHHHHHHHcCCC-----CCHHHHHHHHHHHHHH
Q 011988 47 --QLQYEAKLYKILQ----GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK-----LSLKTVLMLADQMINR 114 (473)
Q Consensus 47 --~l~~E~~il~~L~----~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~~~-----ls~~~~~~i~~qi~~a 114 (473)
++.+|+..+.++. +.+.+.....|.......+|||||+ |..+.++....... +....+..++.||
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 1333444444443 3333333344444455679999999 77887753211222 3333333444444
Q ss_pred HHHHHhCCCcccCCCCCcEEEeeC-CCCCcEEEEecCCcccccC
Q 011988 115 VEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 115 L~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGla~~~~~ 157 (473)
+..|++|+|+||.||+++.+ ...+.++++|||++..+..
T Consensus 277 ----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 46999999999999999622 1123899999999976643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-12 Score=120.94 Aligned_cols=135 Identities=19% Similarity=0.223 Sum_probs=96.8
Q ss_pred EeeEeecCceEEEEEEEcC------CCcEEEEEEcccC-------------C------------chhH----HHHHHHHH
Q 011988 12 GRKIGSGSFGEIYLGTNIQ------TNEEVAIKLNVKT-------------K------------HPQL----QYEAKLYK 56 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~------~~~~vAiK~~~~~-------------~------------~~~l----~~E~~il~ 56 (473)
...||.|--+.||.|.... .+..+|||+.... . ...+ .+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998543 3578999972110 0 0112 37999999
Q ss_pred HhcCC-CCCCeeEEeeEeCCeEEEEEecCCCC-H-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCcccCCCCCc
Q 011988 57 ILQGG-TGIPNLRWFGVEGDYNVLVIDLLGPS-L-EDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDN 132 (473)
Q Consensus 57 ~L~~~-~~i~~~~~~~~~~~~~~lv~e~~g~s-L-~~~l~~~~~~ls~~~~~~i~~qi~~aL~yL-H~~gIvHrDIKP~N 132 (473)
+|... -.+|.+..+ ...+|||||++++ + ...++ ...++..++..+..|++.+|..| |..||||+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 98743 234444332 4568999999763 2 11222 22356667788899999999999 89999999999999
Q ss_pred EEEeeCCCCCcEEEEecCCccccc
Q 011988 133 FLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 133 ILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
||+. .+.++|+|||.|....
T Consensus 156 IL~~----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWH----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEE----CCcEEEEECCCceeCC
Confidence 9994 4679999999987553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.4e-11 Score=108.78 Aligned_cols=141 Identities=21% Similarity=0.268 Sum_probs=109.2
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEE-c-ccCCchh---------HHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL-N-VKTKHPQ---------LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~-~-~~~~~~~---------l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.+..|-+|+-+.|+++. ..|+.++||. . +.-.++. ..+|+++|.++..- +|+....+..+.....|
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEecCCCeE
Confidence 67788999999999998 4789999997 2 2233333 46799999888733 66666667777777889
Q ss_pred EEecCCC--CHHHHHHHcCCCCCH-HHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 80 VIDLLGP--SLEDLFNFCSRKLSL-KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 80 v~e~~g~--sL~~~l~~~~~~ls~-~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
+|||..+ ++.+++...-..-.. .-...++.+|-+.|.-||..+|||+||..+||++..++....+.|+|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999966 888888644333233 33378889999999999999999999999999997655566679999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.1e-11 Score=109.54 Aligned_cols=126 Identities=25% Similarity=0.407 Sum_probs=97.3
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEE-ccc-CCchh---------HHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKL-NVK-TKHPQ---------LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~-~~~-~~~~~---------l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
..|++|+-+.||.+.+ -|..+++|. ..+ -.+++ -.+|++++..+. ..+|+....|..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence 4578999999999965 455688887 322 22332 457899999887 447777777888888889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
||. |..|.+++... ...++..+-.-+.-||..||||+||.++||+++ .+.++++|||++.
T Consensus 79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~ 139 (204)
T COG3642 79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGE 139 (204)
T ss_pred EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCccc
Confidence 999 55677787733 245666677777889999999999999999995 4559999999996
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.3e-12 Score=139.96 Aligned_cols=270 Identities=18% Similarity=0.157 Sum_probs=183.9
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEe---eEeCC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWF---GVEGD 75 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~---~~~~~ 75 (473)
-.+.+.+.+-+-+|.++.++.+.-..++...++|+.... .......+-. +..++..+.+..+ .....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~----~~i~p~~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSN----ILITPRSPAVVRSFPSFPCRS 877 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccC----ccccCCCCceecccCCCCCCC
Confidence 346688888999999999999987677766666652111 1111111111 1111122222211 23556
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..+|+|+|+ +++|...+... ...+.+-....+..+..+++|||...++|+|++|.|+|+. ..+..++.|||....
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPLTDFGTLSK 953 (1205)
T ss_pred CcchhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCcccCccccccc
Confidence 678999998 77888887743 3567777788888899999999999999999999999994 788999999984433
Q ss_pred ccCC---------------------CCcccc---ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 011988 155 YRDT---------------------ATHQHI---PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSL 210 (473)
Q Consensus 155 ~~~~---------------------~~~~~~---p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~ 210 (473)
...- ...... ..+......||+.|.+||...+...+..+|+|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 2110 000000 1123456789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccc
Q 011988 211 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWT 290 (473)
Q Consensus 211 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~ 290 (473)
||.... ..+.++.+.......+. -....+.+..+++...+..++.+|-.+.-- ....+-.+....+|+
T Consensus 1034 p~na~t---pq~~f~ni~~~~~~~p~--g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~-------~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1034 PFNAET---PQQIFENILNRDIPWPE--GPEEGSYEAQDLINRLLTEEPTQRLGAKGA-------AEVKGHPFFQDVDWE 1101 (1205)
T ss_pred CCCCcc---hhhhhhccccCCCCCCC--CccccChhhhhhhhhhhccCchhccCcccc-------cccccCCccCCCCcc
Confidence 997644 34444555544443322 123457889999999999999999775421 122344566778999
Q ss_pred cccc
Q 011988 291 ILKY 294 (473)
Q Consensus 291 ~~~~ 294 (473)
.+..
T Consensus 1102 ~l~~ 1105 (1205)
T KOG0606|consen 1102 NLAL 1105 (1205)
T ss_pred cccc
Confidence 8754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.9e-12 Score=130.37 Aligned_cols=239 Identities=19% Similarity=0.137 Sum_probs=163.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEc-CCCcEEEEEEcccCCch-----hHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLNVKTKHP-----QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAiK~~~~~~~~-----~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
..+|.++..||.|.|+.|+.+... .++..|++|...+.... .-..|+.+...+..+.++..+..-....+..++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457889999999999999998755 67888999863332211 124566666667655555553222223333458
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
-.||| ++++...+ .....+++...+.+..|++.++.++|++.++|+|+||+||++.. +.+..++.|||.++.+.-.
T Consensus 344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~--~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISN--DGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeecc--chhhhhcccccccccccee
Confidence 88999 66665544 34567889999999999999999999999999999999999962 2277889999998753221
Q ss_pred CCccccccccCCCcccCcccc--ccccccCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCCCCCHHHHHHHHhhcccccc
Q 011988 159 ATHQHIPYRENKNLTGTARYA--SMNTHLGIEQSRRDDLESLGYVLMYFLRGSL-PWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~--APE~~~~~~~s~ksDVwSlGviL~elltG~~-Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
. ..+.+..++. +++......+..+.|++|||..+.+.++|.. ++.+... ..+....
T Consensus 421 ~----------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-------~~i~~~~---- 479 (524)
T KOG0601|consen 421 S----------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-------LTIRSGD---- 479 (524)
T ss_pred c----------ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-------eeeeccc----
Confidence 1 1123333444 5666666678999999999999999999753 3333211 1111111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.+ ...+...++..+.+.+...++..||.+.++.
T Consensus 480 ~p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~ 512 (524)
T KOG0601|consen 480 TP-NLPGLKLQLQVLLKVMINPDRKRRPSAVELS 512 (524)
T ss_pred cc-CCCchHHhhhhhhhhhcCCccccchhhhhhc
Confidence 11 1223346788888889999999999876654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.8e-10 Score=116.94 Aligned_cols=181 Identities=17% Similarity=0.181 Sum_probs=128.2
Q ss_pred eEEEeeEeecCceEEE-EEEEcCCCcEEEEEEcccCCc---hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 9 FRLGRKIGSGSFGEIY-LGTNIQTNEEVAIKLNVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy-~a~~~~~~~~vAiK~~~~~~~---~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
|.| ...+-++.+ || .|..+.++.+|.|++.+.... ....+-++-|+.|+|++++.++..+..++ ..|||.|-+
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-~~ylvTErV 91 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-TLYLVTERV 91 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC-ceEEEeecc
Confidence 555 444444444 44 466678888998888554444 44667788899999887777776555444 779999988
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH-~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
.+ |..+++. +....+...+.||+.||.||| +++++|++|.-+.|++ +..|..||++|-++.........
T Consensus 92 ~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~-- 161 (690)
T KOG1243|consen 92 RP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAP-- 161 (690)
T ss_pred cc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcc--
Confidence 53 5566663 346778888999999999998 6789999999999999 48899999999998655432210
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCC
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS 209 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~ 209 (473)
.....--..|..|+.+.... -..|.|-|||+++|++.|.
T Consensus 162 -----~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 162 -----AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -----cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 01112222356666544322 3469999999999999993
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.2e-11 Score=114.83 Aligned_cols=176 Identities=12% Similarity=0.141 Sum_probs=116.0
Q ss_pred eEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcccCCCCCcEEEeeCCCCCcEEEEec
Q 011988 76 YNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDF 149 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~--gIvHrDIKP~NILl~~~~~~~~vkL~DF 149 (473)
..+++.||+ -++|..+|++ +...+..+...+|+.||+.||.|||+. -|+|+++..+-|++. .++.+||.--
T Consensus 146 rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq---~ngLIkig~~ 222 (458)
T KOG1266|consen 146 RVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ---HNGLIKIGSV 222 (458)
T ss_pred ceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec---CCceEEeccc
Confidence 457788888 8899999863 445688999999999999999999986 499999999999994 6676665321
Q ss_pred CCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC-CCCCCCCHHHHHHHHh
Q 011988 150 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW-QGLKAGTKKQKYEKIS 228 (473)
Q Consensus 150 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf-~~~~~~~~~~~~~~i~ 228 (473)
-... .... .......+.....+-+.|.+||.-.....+-++|||+||++.+||..+..-- .........+. +.
T Consensus 223 ap~s-~h~s--~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~---ia 296 (458)
T KOG1266|consen 223 APDS-THPS--VNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEEN---IA 296 (458)
T ss_pred Cccc-cchh--hhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhh---hh
Confidence 1110 0000 0000011223345678899999877666788999999999999999876542 11111111111 11
Q ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 229 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 229 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
.. +..+. ..--+.++..|++-.|..||++.++
T Consensus 297 ~~-----i~~le---n~lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 297 NV-----IIGLE---NGLQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred hh-----eeecc---CccccCcCcccccCCCCCCcchhhh
Confidence 10 00011 1223578899999999999998765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.6e-10 Score=104.49 Aligned_cols=137 Identities=20% Similarity=0.270 Sum_probs=98.2
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCC-CCeeEEeeEeC---CeEEEEEecC
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTG-IPNLRWFGVEG---DYNVLVIDLL 84 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~-i~~~~~~~~~~---~~~~lv~e~~ 84 (473)
+.|+.|.++.||++... +|+.+++|+.... ....+..|..+++.+.+... ++.+..+.... ...+++||++
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 57899999999999863 3688999985432 24568999999999986432 55555554443 2568999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 011988 85 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS------------------------------------------- 120 (473)
Q Consensus 85 -g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~------------------------------------------- 120 (473)
|.++.+.+. ...++......++.+++..|.+||+
T Consensus 83 ~G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLL--RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 555655432 1346667777777777777777773
Q ss_pred -------------CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 121 -------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 121 -------------~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
..++|+|+.|.|||++.+ ..+.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEeccccc
Confidence 236899999999999521 14568999999885
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2e-09 Score=107.29 Aligned_cols=255 Identities=12% Similarity=0.178 Sum_probs=157.3
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCe-eEE-----ee-EeCCeEEEEE
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPN-LRW-----FG-VEGDYNVLVI 81 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~-~~~-----~~-~~~~~~~lv~ 81 (473)
....+.||+|+.+.+|-.- .-+. .+-|+..+.-...-...+..|...-.++.+.. +.| ++ ..+....+.|
T Consensus 13 i~~gr~LgqGgea~ly~l~--e~~d-~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLG--EVRD-QVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred cCCCccccCCccceeeecc--hhhc-hhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3456789999999999654 2222 34577444332222223333333333333332 111 12 2334466777
Q ss_pred ecCCC--CHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 82 DLLGP--SLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 82 e~~g~--sL~~~l~~~-----~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..+.+ -..+++.-. -..+.+..+++.+..|+.+...||..|.+-+|+.++|||++ +...|.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEcccceee
Confidence 77622 333333211 12378899999999999999999999999999999999996 778888888443222
Q ss_pred ccCCCCccccccccCCCcccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCC----HHH-H
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGT----KKQ-K 223 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~elltG-~~Pf~~~~~~~----~~~-~ 223 (473)
..+.. . .-..+|...|.+||.-. +-+-+...|.|.||+++++++.| ++||.+..... ..+ .
T Consensus 167 ~~ng~--~------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 167 NANGT--L------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred ccCCc--e------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 11111 1 12457899999999754 44557789999999999999986 99998754211 111 0
Q ss_pred HH--------HHhhccccccHHHHhcCCcHHHHHHHHHHhcC--CCCCCCCHHHHHHHHHHHHH
Q 011988 224 YE--------KISEKKVSTSIEALCRGYPTEFASYFHYCRSL--RFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 224 ~~--------~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~--dp~~RPt~~~l~~~L~~l~~ 277 (473)
+. +-.......+...-..-+|+.+..++.+|+.. ++.-||+++.-...|..+-.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 00 00001111122212234689999999999964 36689999877666666543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.7e-09 Score=100.74 Aligned_cols=133 Identities=20% Similarity=0.147 Sum_probs=93.2
Q ss_pred CceEEEEEEEcCCCcEEEEEEcccCC------------ch--hHHHHHHHHHHhcCCC-CCCeeEEeeEe-----CCeEE
Q 011988 19 SFGEIYLGTNIQTNEEVAIKLNVKTK------------HP--QLQYEAKLYKILQGGT-GIPNLRWFGVE-----GDYNV 78 (473)
Q Consensus 19 ~fG~Vy~a~~~~~~~~vAiK~~~~~~------------~~--~l~~E~~il~~L~~~~-~i~~~~~~~~~-----~~~~~ 78 (473)
....|+.+. -.|+.|.||...... .+ ...+|...+..|.... .++....++.. ....+
T Consensus 34 ~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 34 EGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred CCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence 334455654 357789999632222 11 3678999998885221 12222334432 23468
Q ss_pred EEEecCCC--CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEee----CCCCCcEEEEecCC
Q 011988 79 LVIDLLGP--SLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL----GRRANQVYIIDFGL 151 (473)
Q Consensus 79 lv~e~~g~--sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~----~~~~~~vkL~DFGl 151 (473)
||+|++++ +|.+++... ....+......++.+|+..+.-||..||+|+|+++.|||+.. .+....+.|+||+.
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 99999955 799998632 345667788899999999999999999999999999999963 12357899999998
Q ss_pred cc
Q 011988 152 AK 153 (473)
Q Consensus 152 a~ 153 (473)
+.
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 85
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.1e-09 Score=97.85 Aligned_cols=124 Identities=24% Similarity=0.351 Sum_probs=78.7
Q ss_pred EEEEEEEcCCCcEEEEEEcccCC-----------------------------chhHHHHHHHHHHhcCCC-CCCeeEEee
Q 011988 22 EIYLGTNIQTNEEVAIKLNVKTK-----------------------------HPQLQYEAKLYKILQGGT-GIPNLRWFG 71 (473)
Q Consensus 22 ~Vy~a~~~~~~~~vAiK~~~~~~-----------------------------~~~l~~E~~il~~L~~~~-~i~~~~~~~ 71 (473)
.||.|.. ..|..||||+..... .....+|.+.|..+.... .+|.+..+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899986 567899999722110 012567999999998553 35555433
Q ss_pred EeCCeEEEEEecCC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHhCCCcccCCCCCcEEEeeCCCCCcEEEEe
Q 011988 72 VEGDYNVLVIDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEF-VHSKSFLHRDIKPDNFLMGLGRRANQVYIID 148 (473)
Q Consensus 72 ~~~~~~~lv~e~~g--~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~y-LH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 148 (473)
. ..+|||||++ +.....+... .++......++.+++..+.. +|..||||+||.+.|||++ .+.++|+|
T Consensus 79 -~--~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~~iID 149 (188)
T PF01163_consen 79 -N--RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKVYIID 149 (188)
T ss_dssp -E--TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCEEE--
T ss_pred -e--CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceEEEEe
Confidence 2 3479999997 5333333311 12245567788888886665 5799999999999999995 34899999
Q ss_pred cCCccccc
Q 011988 149 FGLAKRYR 156 (473)
Q Consensus 149 FGla~~~~ 156 (473)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99986543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.6e-09 Score=114.07 Aligned_cols=154 Identities=13% Similarity=0.189 Sum_probs=105.4
Q ss_pred HHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccccccc--CCCcccCccccccccc
Q 011988 108 ADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE--NKNLTGTARYASMNTH 184 (473)
Q Consensus 108 ~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~--~~~~~Gt~~Y~APE~~ 184 (473)
+.+++.||.|+|. .++||++|.|++|.+ +..+.+||+.|+++.............|.. .....-...|.|||++
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 3455599999995 689999999999999 588999999999987554422211111111 1122345679999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCC
Q 011988 185 LGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 263 (473)
Q Consensus 185 ~~~~~s~ksDVwSlGviL~ell-tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP 263 (473)
.+...+.++|+|||||++|.+. .|+.-+.......... . ...............+|+|+.+-+.+++..+..-||
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~---~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp 257 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-F---SRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP 257 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-h---hhcccccccccccccCcHHHHHHHHHHhcCCcccCc
Confidence 9988899999999999999998 4555554432211111 1 111111111122257899999999999999999999
Q ss_pred CHHHH
Q 011988 264 DYAYL 268 (473)
Q Consensus 264 t~~~l 268 (473)
++.++
T Consensus 258 ~~~~l 262 (700)
T KOG2137|consen 258 TLDLL 262 (700)
T ss_pred chhhh
Confidence 76554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.3e-07 Score=88.83 Aligned_cols=109 Identities=20% Similarity=0.295 Sum_probs=81.5
Q ss_pred chhHHHHHHHHHHhcCCCCC--CeeEEeeEeC----CeEEEEEecCCC--CHHHHHHHcCCCCCHHHHHHHHHHHHHHHH
Q 011988 45 HPQLQYEAKLYKILQGGTGI--PNLRWFGVEG----DYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVE 116 (473)
Q Consensus 45 ~~~l~~E~~il~~L~~~~~i--~~~~~~~~~~----~~~~lv~e~~g~--sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~ 116 (473)
.....+|...+..|.. .+| +....++... ...++++|++.+ +|.+++..... ++......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~-~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLRE-AGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHH-cCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHH
Confidence 3457889998888863 233 3334444432 235788998843 79999874332 677788899999999999
Q ss_pred HHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 117 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 117 yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
-||++||+|+|+++.|||+..++....+.|+||+.++..
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999974444458999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.7e-07 Score=83.74 Aligned_cols=136 Identities=12% Similarity=0.090 Sum_probs=98.3
Q ss_pred eecCceEEEEEEEcCCCcEEEEEEcc---------cCCchhHHHHHHHHHHhcCCCC-CCeeEEeeEe----CCeEEEEE
Q 011988 16 GSGSFGEIYLGTNIQTNEEVAIKLNV---------KTKHPQLQYEAKLYKILQGGTG-IPNLRWFGVE----GDYNVLVI 81 (473)
Q Consensus 16 G~G~fG~Vy~a~~~~~~~~vAiK~~~---------~~~~~~l~~E~~il~~L~~~~~-i~~~~~~~~~----~~~~~lv~ 81 (473)
|.||.+-|+.... .|+.+-||... .-..+.+.+|...++.|..... ++.+.++... .-..+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 6688888998763 34467888622 2245679999999999973322 3333433322 12357888
Q ss_pred ecCC--CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 82 DLLG--PSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 82 e~~g--~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
|-++ .+|.+++.... .+.+......++.+|+..|.-||+.|+.|+|+-+.|||+..+ ....|+++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence 9886 69999876322 246777888999999999999999999999999999999522 123499999987764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.2e-06 Score=89.93 Aligned_cols=208 Identities=18% Similarity=0.193 Sum_probs=142.0
Q ss_pred ceEEEEEEEcCCCcEEEEEEcccC---CchhHHHHHHHHHHhcCCCCCCeeEEee---EeCCeEEEEEecC--CCCHHHH
Q 011988 20 FGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFG---VEGDYNVLVIDLL--GPSLEDL 91 (473)
Q Consensus 20 fG~Vy~a~~~~~~~~vAiK~~~~~---~~~~l~~E~~il~~L~~~~~i~~~~~~~---~~~~~~~lv~e~~--g~sL~~~ 91 (473)
-.+.|++....+|..|++|.+... .......-++.++++.|.+.|+.-..|. ..+...++|++|. .++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 347799999999999999986221 1112345577889999887776654443 2345678999998 5578777
Q ss_pred HHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 92 FNFC--------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 92 l~~~--------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
.-.. +.+.++..+|.++.||..||.++|+.|+.-+-|.|.+||++ ....++|..-|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccceeeecC
Confidence 5211 23478899999999999999999999999999999999995 444788877776654433
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCCCHHHHHHHHhhccccccH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
+.+ |.+. .-.+-|.=.||.+++.|.+|..- |.... .+.. .+
T Consensus 446 d~~---------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~----~~~s----------~~ 487 (655)
T KOG3741|consen 446 DPT---------------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDS----TQSS----------HL 487 (655)
T ss_pred CCC---------------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccc----hHHH----------HH
Confidence 210 1111 12357999999999999998543 22111 1111 12
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..+...++.++++++.+....++++ -+..+|.
T Consensus 488 ~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ll 519 (655)
T KOG3741|consen 488 TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLL 519 (655)
T ss_pred HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence 2344566788888888888888886 3444443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.5e-07 Score=85.46 Aligned_cols=136 Identities=18% Similarity=0.243 Sum_probs=89.9
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc------------hhHHHHHHHHHHhc--CCCCCCeeE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH------------PQLQYEAKLYKILQ--GGTGIPNLR 68 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~------------~~l~~E~~il~~L~--~~~~i~~~~ 68 (473)
..+.++|.+.+.+-......|.+.. -+|+.+++|....... +...+++..+..+. +......+.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 4567889999999998888777776 5678999997333221 11223333333443 122222211
Q ss_pred EeeE-----eCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCC
Q 011988 69 WFGV-----EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 142 (473)
Q Consensus 69 ~~~~-----~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~ 142 (473)
.+.. .....+++|||+ |..|.++.. +++ .+...|.++|.-||+.|++|+|+.|.||+++ ++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~ 171 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NN 171 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CC
Confidence 1111 223457899999 666766543 222 2456677889999999999999999999994 45
Q ss_pred cEEEEecCCcc
Q 011988 143 QVYIIDFGLAK 153 (473)
Q Consensus 143 ~vkL~DFGla~ 153 (473)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 69999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.4e-07 Score=88.43 Aligned_cols=132 Identities=19% Similarity=0.322 Sum_probs=95.4
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----------------C--------chhHHHHHHHHHHhcCC-C
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----------------K--------HPQLQYEAKLYKILQGG-T 62 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----------------~--------~~~l~~E~~il~~L~~~-~ 62 (473)
+.+..+||-|--+.||.|.+ ..|.++|||+-... . ....++|.++|+.|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45678999999999999996 47889999961110 0 11256899999999744 2
Q ss_pred CCCeeEEeeEeCCeEEEEEecCCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCC
Q 011988 63 GIPNLRWFGVEGDYNVLVIDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 141 (473)
Q Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~g~-sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 141 (473)
.|+.. ...+..++|||+..+ -|..+ +++.+..-.|+..|+.-+.-+-..||||+|+.+=|||++ ++
T Consensus 172 ~VP~P----~~~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~---~d 238 (304)
T COG0478 172 KVPKP----IAWNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---ED 238 (304)
T ss_pred CCCCc----cccccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe---cC
Confidence 34433 234567899999955 33222 224555666777777777777799999999999999995 77
Q ss_pred CcEEEEecCCccc
Q 011988 142 NQVYIIDFGLAKR 154 (473)
Q Consensus 142 ~~vkL~DFGla~~ 154 (473)
+.++++||=-+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 8999999977653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.3e-07 Score=95.14 Aligned_cols=139 Identities=19% Similarity=0.289 Sum_probs=92.7
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCCchh-------------------------------------------HH
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ-------------------------------------------LQ 49 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~-------------------------------------------l~ 49 (473)
.-|+.++-|+||.|+. .+|+.||||+....-.+. +.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 4688999999999996 569999999844432221 23
Q ss_pred HHHHHHHHhc----CCCCCCeeEEeeEeCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 011988 50 YEAKLYKILQ----GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 124 (473)
Q Consensus 50 ~E~~il~~L~----~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIv 124 (473)
+|...+..+. +.+.+..-..|-.-....+|+|||+ |-.+.++.......++.+.+...+.++. +..+-..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 3444444432 3333433344444456679999999 6677777433334566554444333332 3444458999
Q ss_pred ccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 125 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 125 HrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
|.|..|.||++. .++.+.+.|||+...+..
T Consensus 288 HaDpHpGNi~v~---~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILVR---SDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEEe---cCCcEEEEcCcceecCCH
Confidence 999999999994 679999999999876654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=7.2e-07 Score=80.01 Aligned_cols=126 Identities=25% Similarity=0.394 Sum_probs=93.8
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEE-cccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCCH
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSL 88 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~-~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL 88 (473)
+.+.|++|.+|.||+|.+ .|..+|+|+ ........++.|+++|..++....-+.++.|+.+. +.|||. |..|
T Consensus 26 v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcch
Confidence 457899999999999985 566899998 44455677999999999999998889888876553 449999 5588
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCC--CcEEEeeCCCCCcEEEEecCCccc
Q 011988 89 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP--DNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 89 ~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP--~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
.++... .+-+.+ ..+++.---|-..||-|..|.- .||++ .++.+.|+||..|+.
T Consensus 100 ~~~~~~----~~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIG----GDRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhc----ccHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence 777552 123333 3344444445668999998864 46666 345899999999873
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.2e-06 Score=82.77 Aligned_cols=135 Identities=20% Similarity=0.236 Sum_probs=90.5
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----------------------chh-----HHHHHHHHHHhcCCCCC
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----------------------HPQ-----LQYEAKLYKILQGGTGI 64 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----------------------~~~-----l~~E~~il~~L~~~~~i 64 (473)
...|.+|--+.||+|.. .++..||||+..... ..+ ..+|...|+++... +|
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eA-GV 130 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEA-GV 130 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHc-CC
Confidence 34566777779999984 568899999732211 001 24577777777522 22
Q ss_pred CeeEEeeEeCCeEEEEEecCCCCHH--HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCC
Q 011988 65 PNLRWFGVEGDYNVLVIDLLGPSLE--DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRA 141 (473)
Q Consensus 65 ~~~~~~~~~~~~~~lv~e~~g~sL~--~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~ 141 (473)
....-+. -...+|+|||+|.... -.|+ .-.+...++..+..++++.+.-|-. .++||+||..=|||+. .
T Consensus 131 rvP~Pi~--~~~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~----~ 202 (268)
T COG1718 131 RVPEPIA--FRNNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH----D 202 (268)
T ss_pred CCCCcee--ecCCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----C
Confidence 2221111 1345899999976511 0111 1123444788889999999998887 9999999999999993 7
Q ss_pred CcEEEEecCCccccc
Q 011988 142 NQVYIIDFGLAKRYR 156 (473)
Q Consensus 142 ~~vkL~DFGla~~~~ 156 (473)
+.++|+|||-|....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 889999999987544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.48 E-value=3e-06 Score=80.71 Aligned_cols=70 Identities=17% Similarity=0.125 Sum_probs=53.8
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccC-CchhHHHHHHHHHHhcCCCC-CCeeEEeeEeCCeEEEEEecCCC
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-KHPQLQYEAKLYKILQGGTG-IPNLRWFGVEGDYNVLVIDLLGP 86 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~~~~-i~~~~~~~~~~~~~~lv~e~~g~ 86 (473)
..||.|..+.||+. .+..+++|+.... ....+.+|.++++.+..... ++.+..++.......++|+++.|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 57899999999984 2456789985442 34568899999999986555 67777787777778899999955
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.4e-06 Score=79.12 Aligned_cols=74 Identities=18% Similarity=0.262 Sum_probs=52.6
Q ss_pred EeecCc-eEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCCHHH
Q 011988 15 IGSGSF-GEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLED 90 (473)
Q Consensus 15 LG~G~f-G~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~ 90 (473)
|-.|.. ..||+... .+..++||+........+..|+++++.|...-.++.+..++......+++|+++ |.+|..
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444544 78999874 346889998554434568899999999986655666766666666678999998 555543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.34 E-value=7e-06 Score=77.38 Aligned_cols=138 Identities=19% Similarity=0.278 Sum_probs=80.3
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccC-CchhHHHHHHHHHHhcCCCC-CCeeEEee---EeCCeEEEEEecC-C
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-KHPQLQYEAKLYKILQGGTG-IPNLRWFG---VEGDYNVLVIDLL-G 85 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~~~~-i~~~~~~~---~~~~~~~lv~e~~-g 85 (473)
++.|+.|..+.||++.... ..+++|+.... ....+..|..+++.|..... ++.+..+. ......+++|+++ |
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 5789999999999998643 58999985444 44568899999999985544 55555533 3344578899998 5
Q ss_pred CCHHH----------------HHH---HcC---CCCCHHH------HHHH---------------HHHHHH-HHHHHH--
Q 011988 86 PSLED----------------LFN---FCS---RKLSLKT------VLML---------------ADQMIN-RVEFVH-- 119 (473)
Q Consensus 86 ~sL~~----------------~l~---~~~---~~ls~~~------~~~i---------------~~qi~~-aL~yLH-- 119 (473)
..+.. .+. ... ..+.... ...+ ...+.. .+..++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 55555 111 110 0111000 0000 111222 233333
Q ss_pred -----hCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 120 -----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 120 -----~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
...++|+|+.|.|||++ +.++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~--~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVD--PSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEE--SSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceee--eccceeEEEecccce
Confidence 24599999999999995 356667899999874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.7e-05 Score=71.45 Aligned_cols=132 Identities=21% Similarity=0.300 Sum_probs=94.0
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-------------------chhHHHHHHHHHHhc-C----CCCCCee
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-------------------HPQLQYEAKLYKILQ-G----GTGIPNL 67 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-------------------~~~l~~E~~il~~L~-~----~~~i~~~ 67 (473)
...||.|+.-.||.- ..+...+||+..... ..+..+|+..+..+. . ..+|+.+
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999999964 244556889865555 567788888888777 3 3356666
Q ss_pred EEeeEeCCeEEEEEecC-------CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC
Q 011988 68 RWFGVEGDYNVLVIDLL-------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 140 (473)
Q Consensus 68 ~~~~~~~~~~~lv~e~~-------g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 140 (473)
+++...+....+|+|.. ..+|.+++. ...++. .+... +-+-..||-+.+|+.+||+|.||++...++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 67767777778888865 458888886 334655 33333 334457888999999999999999987655
Q ss_pred CC-cEEEEe-cCCc
Q 011988 141 AN-QVYIID-FGLA 152 (473)
Q Consensus 141 ~~-~vkL~D-FGla 152 (473)
.. .+.|+| ||..
T Consensus 157 ~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 157 GEFRLVLIDGLGEK 170 (199)
T ss_pred CceEEEEEeCCCCc
Confidence 55 788888 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.6e-05 Score=83.79 Aligned_cols=142 Identities=19% Similarity=0.232 Sum_probs=89.7
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCCch----------------------------------------hHHHHH
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP----------------------------------------QLQYEA 52 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~----------------------------------------~l~~E~ 52 (473)
+-||.-+.|+||+|+- .+|+.||||+....-.. ++..|+
T Consensus 167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5689999999999996 45999999984332111 122333
Q ss_pred HHHHH----hcCCCC---CCeeEEeeEeCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 011988 53 KLYKI----LQGGTG---IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 124 (473)
Q Consensus 53 ~il~~----L~~~~~---i~~~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIv 124 (473)
+.... +.+-.. |.....|.......+|+|||+ |.-+.|+-.-....++...+..-+.++.. +-|=..|++
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~Gff 323 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGFF 323 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCCc
Confidence 33222 222221 112223334445679999999 55555553333456777765555544433 334457899
Q ss_pred ccCCCCCcEEEeeC-CCCCcEEEEecCCcccccC
Q 011988 125 HRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 125 HrDIKP~NILl~~~-~~~~~vkL~DFGla~~~~~ 157 (473)
|+|=.|.||++..+ .....+.|.|||+...+..
T Consensus 324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999632 2467899999999986654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=5e-07 Score=94.71 Aligned_cols=186 Identities=13% Similarity=0.046 Sum_probs=134.5
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecCCCC-
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPS- 87 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~g~s- 87 (473)
|.....+++|+++.+++.+...+...+ .+++... .....++++|.++++++-...+..-+..+.+.+++|+++++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 445566789999999999876555544 6664433 445678889999998873333333344567789999999443
Q ss_pred -HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccccc
Q 011988 88 -LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166 (473)
Q Consensus 88 -L~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~ 166 (473)
.........-.|..-+...+...-+.+|++||+.-=+|+| ||+. ..+..++.||+....+....
T Consensus 321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~------- 385 (829)
T KOG0576|consen 321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVPPQLTRTM------- 385 (829)
T ss_pred cccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCCcccCccc-------
Confidence 2222211111244455666777778899999998778999 8887 45789999999988776543
Q ss_pred ccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 011988 167 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 213 (473)
Q Consensus 167 ~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~ 213 (473)
....+.+|+.++|||+..+..+....|+|++|+-..++.-|..|-.
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2356789999999999999999999999999988888887877754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.00 E-value=9.7e-05 Score=68.43 Aligned_cols=123 Identities=18% Similarity=0.267 Sum_probs=84.0
Q ss_pred CceEEEeeEeecCc-eEEEEEEEcCCCcEEEEEEccc-----C-------------------CchhHHHHHHHHHHhcCC
Q 011988 7 NKFRLGRKIGSGSF-GEIYLGTNIQTNEEVAIKLNVK-----T-------------------KHPQLQYEAKLYKILQGG 61 (473)
Q Consensus 7 ~~y~i~~~LG~G~f-G~Vy~a~~~~~~~~vAiK~~~~-----~-------------------~~~~l~~E~~il~~L~~~ 61 (473)
.+++.++.||.|.- |.||+++ ..|+.+|||+... . ....|..|.+.+-+|+..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 9999998 4788999998111 0 012367788888888744
Q ss_pred CC-----CCeeEEeeEeC-----------------CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 011988 62 TG-----IPNLRWFGVEG-----------------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119 (473)
Q Consensus 62 ~~-----i~~~~~~~~~~-----------------~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH 119 (473)
.. +..+.++.... ....||.||....- .+.. .-+.+|..-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 33 33333332221 12356666552211 1222 33467778889999
Q ss_pred hCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 120 ~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
..||+-+|+|+.|..= -||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccC--------CEEEecccC
Confidence 9999999999999863 279999975
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.0025 Score=65.62 Aligned_cols=72 Identities=19% Similarity=0.331 Sum_probs=50.8
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEccc----------CCchhHHHHHHHHHHhcC--CCCCCeeEEeeEeCCeEEE
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK----------TKHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~----------~~~~~l~~E~~il~~L~~--~~~i~~~~~~~~~~~~~~l 79 (473)
.+.||.|.+..||++.+...++.|+||.... ........|.+.|+.+.. +..+|.+..+. .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 4678999999999999754446899997321 123346778888888753 24567666654 455789
Q ss_pred EEecCC
Q 011988 80 VIDLLG 85 (473)
Q Consensus 80 v~e~~g 85 (473)
|||++.
T Consensus 109 VME~L~ 114 (401)
T PRK09550 109 VMEDLS 114 (401)
T ss_pred EEecCC
Confidence 999984
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.89 E-value=7.6e-05 Score=71.34 Aligned_cols=67 Identities=16% Similarity=0.185 Sum_probs=42.3
Q ss_pred eeEeecCce-EEEEEEEcCCCcEEEEEEcccC-CchhHHHHHHHHHHhcCCC--CCCeeEEeeEeC---CeEEEEEecC
Q 011988 13 RKIGSGSFG-EIYLGTNIQTNEEVAIKLNVKT-KHPQLQYEAKLYKILQGGT--GIPNLRWFGVEG---DYNVLVIDLL 84 (473)
Q Consensus 13 ~~LG~G~fG-~Vy~a~~~~~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~~~--~i~~~~~~~~~~---~~~~lv~e~~ 84 (473)
+.|+.|+.. .||+.. ..+++|+.... ....+..|.+++..|.... -++.+...+... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777776 489752 35788985443 2346899999999997532 244444333332 2347889987
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00016 Score=81.73 Aligned_cols=76 Identities=11% Similarity=0.165 Sum_probs=51.0
Q ss_pred EEeeEeecCceEEEEEEEcCCC--cEEEEEEcccC----CchhHHHHHHHHHHhcCCCCC--CeeEEeeEeC---CeEEE
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTN--EEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGI--PNLRWFGVEG---DYNVL 79 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~--~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i--~~~~~~~~~~---~~~~l 79 (473)
-++.|+.|.+..+|+......+ ..+++|+.... ....+.+|.++++.|..+..+ +.+..++.+. ...|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3677899999999998764332 46778874332 224688999999999744444 4444444432 35689
Q ss_pred EEecCCC
Q 011988 80 VIDLLGP 86 (473)
Q Consensus 80 v~e~~g~ 86 (473)
|||++.+
T Consensus 122 VME~v~G 128 (822)
T PLN02876 122 IMEYLEG 128 (822)
T ss_pred EEEecCC
Confidence 9999844
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00019 Score=71.66 Aligned_cols=137 Identities=23% Similarity=0.287 Sum_probs=96.8
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----c------------------hh------HHHHHHHHHHhcCC
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----H------------------PQ------LQYEAKLYKILQGG 61 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~------------------~~------l~~E~~il~~L~~~ 61 (473)
|-..|..|--+.||.|. ..+|..+|||+..... . +. .+.|++.|++|...
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 45678889999999998 4678889999733210 0 00 35788888888733
Q ss_pred CCCCeeEEeeEeCCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCCCcEEEeeCCC
Q 011988 62 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRR 140 (473)
Q Consensus 62 ~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH-~~gIvHrDIKP~NILl~~~~~ 140 (473)
+|+...-+.. ...+|||+|+|.+-+-.-....-.++...+..+-.|++.-+.-|. .+++||.||.-=|+|+ .
T Consensus 227 -GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----h 299 (520)
T KOG2270|consen 227 -GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----H 299 (520)
T ss_pred -CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----E
Confidence 3444322222 234899999976543322212345777788888888888887775 5899999999999999 5
Q ss_pred CCcEEEEecCCcccc
Q 011988 141 ANQVYIIDFGLAKRY 155 (473)
Q Consensus 141 ~~~vkL~DFGla~~~ 155 (473)
.|.++|+|-+-+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 799999999987644
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.0037 Score=63.22 Aligned_cols=69 Identities=12% Similarity=0.204 Sum_probs=46.1
Q ss_pred eEeecCceEEEEEEEcCCCcEEEEEEcc---c-------CCchhHHHHHHHHHHhcC--CCCCCeeEEeeEeCCeEEEEE
Q 011988 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNV---K-------TKHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAiK~~~---~-------~~~~~l~~E~~il~~L~~--~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.||.|....||++.+...++.|+||.-. . -.......|...|+.+.. +..++.++ ..+.+..+++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 5799999999999975444689999611 1 112345678888877653 23455554 44556667899
Q ss_pred ecC
Q 011988 82 DLL 84 (473)
Q Consensus 82 e~~ 84 (473)
|++
T Consensus 80 EdL 82 (370)
T TIGR01767 80 EDL 82 (370)
T ss_pred hhC
Confidence 987
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00093 Score=63.56 Aligned_cols=69 Identities=14% Similarity=0.156 Sum_probs=46.9
Q ss_pred EeeEeecCceEEEEEEEcC-CCcEEEEEEcccCCc--hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 12 GRKIGSGSFGEIYLGTNIQ-TNEEVAIKLNVKTKH--PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~~~~~~~--~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
++.|..|-...+|++.... .++.|++|+...... -....|..+++.+......+.+..... ..++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEee
Confidence 4677888888999997432 357889998543221 234589999999976666666644332 24799988
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0013 Score=65.29 Aligned_cols=76 Identities=13% Similarity=0.079 Sum_probs=53.2
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-CchhHHHHHHHHHHhcCCC--CCCeeEEeeEe---CCeEEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-KHPQLQYEAKLYKILQGGT--GIPNLRWFGVE---GDYNVLVI 81 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~~~--~i~~~~~~~~~---~~~~~lv~ 81 (473)
.-.-.+.||.|..+.||.... .++ .+++|+.... ....+..|...|+.|.... .++.+..++.. ....+|||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hhheeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 344467899999999999863 223 5777885432 3457899999999998653 35555544432 35579999
Q ss_pred ecCC
Q 011988 82 DLLG 85 (473)
Q Consensus 82 e~~g 85 (473)
|++.
T Consensus 93 E~i~ 96 (297)
T PRK10593 93 ERLR 96 (297)
T ss_pred eccC
Confidence 9984
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0021 Score=64.30 Aligned_cols=73 Identities=15% Similarity=0.138 Sum_probs=45.1
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCC-CCeeEE------eeEeCCeEEEEEecC
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTG-IPNLRW------FGVEGDYNVLVIDLL 84 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~-i~~~~~------~~~~~~~~~lv~e~~ 84 (473)
.+.|+.|....+|+... ..| .+++|+........+..|..+++.|..... ++.+.. +.......+++++++
T Consensus 27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred cchhccccccceEEEEe-CCC-cEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 45677787789999874 333 688998653344566778888888863321 222221 122345568899988
Q ss_pred CC
Q 011988 85 GP 86 (473)
Q Consensus 85 g~ 86 (473)
.|
T Consensus 105 ~G 106 (319)
T PRK05231 105 EG 106 (319)
T ss_pred CC
Confidence 43
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00087 Score=64.85 Aligned_cols=130 Identities=17% Similarity=0.152 Sum_probs=76.1
Q ss_pred eEeecCceEEEEEEEcCCCcEEEEEEcccCCc---hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecCCC-CHH
Q 011988 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGP-SLE 89 (473)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~---~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~g~-sL~ 89 (473)
.+..|-.+.+|+.. .+++.+++|+...... -....|..+++.+......+.+.++.. .++||+|+.| .+.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 34567788999887 4577889998433221 246789999999986655666554432 3688999833 322
Q ss_pred --------------HHHHHc-C-----CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCCcccCCCCC
Q 011988 90 --------------DLFNFC-S-----RKLSLK-TVLMLADQM---------INRVEFVHS--------KSFLHRDIKPD 131 (473)
Q Consensus 90 --------------~~l~~~-~-----~~ls~~-~~~~i~~qi---------~~aL~yLH~--------~gIvHrDIKP~ 131 (473)
+.+... . .+++.. .+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 111111 1 112222 111221111 111222211 25899999999
Q ss_pred cEEEeeCCCCCcEEEEecCCcc
Q 011988 132 NFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 132 NILl~~~~~~~~vkL~DFGla~ 153 (473)
|||++ +++ ++|+||..|.
T Consensus 157 Nil~~---~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVT---PQG-LKLIDWEYAS 174 (256)
T ss_pred cEEEe---CCC-CEEEeccccC
Confidence 99995 333 7899999885
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00012 Score=71.86 Aligned_cols=131 Identities=21% Similarity=0.360 Sum_probs=90.1
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEE--c-------ccCCc----------------hhHHHHHHHHHHhcCCC-
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--N-------VKTKH----------------PQLQYEAKLYKILQGGT- 62 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~--~-------~~~~~----------------~~l~~E~~il~~L~~~~- 62 (473)
+.++++||-|--+.||.+-+ ..|.+.++|+ + .+.+. -...+|...|+.|..+.
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 56789999999999999986 5688889995 1 11111 11357888899887432
Q ss_pred CCCeeEEeeEeCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCC
Q 011988 63 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 141 (473)
Q Consensus 63 ~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 141 (473)
-|+.. .+....++|||++ |..|...-+ ...+-.+...++.-+.-|-.+|+||+|..-=||+|. ++
T Consensus 173 pVPkp----iD~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~---dd 238 (465)
T KOG2268|consen 173 PVPKP----IDHNRHCVVMELVDGYPLRQVRH-------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK---DD 238 (465)
T ss_pred CCCCc----ccccceeeHHHhhcccceeeeee-------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEe---cC
Confidence 22222 2345568999988 555554432 112334445555556778889999999999999994 67
Q ss_pred CcEEEEecCCccc
Q 011988 142 NQVYIIDFGLAKR 154 (473)
Q Consensus 142 ~~vkL~DFGla~~ 154 (473)
+.++++||--+..
T Consensus 239 ~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 DKIVVIDFPQMVS 251 (465)
T ss_pred CCEEEeechHhhc
Confidence 8899999976543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00055 Score=63.19 Aligned_cols=95 Identities=25% Similarity=0.365 Sum_probs=73.0
Q ss_pred HHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecCC-CCHH-------HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 011988 49 QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLG-PSLE-------DLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120 (473)
Q Consensus 49 ~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~g-~sL~-------~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~ 120 (473)
..|.-+++.+++..+++.+. |..++ +++.|+.+ +++. +++ ..++....+|+.++++.+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~l--G~CG~--~~v~E~~~~~~~~~~~~~l~~~~-----~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLL--GSCGR--FYVVEYVGAGSLYGIYRPLSQFL-----QSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCee--eECCC--EEEEEeecCcccccccccccccc-----ccCHHHHHHHHHHHHHHHHHHhc
Confidence 35888999999877666664 33444 56778875 3443 332 36899999999999999999997
Q ss_pred ---CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 121 ---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 121 ---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
..+.-.|++++||-++ +++.+|++|...+...
T Consensus 78 ~~~~~~~lcDv~~~nfgv~---~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVN---DDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCCcEEEeecchHHeEEe---CCCcEEEEechhcchh
Confidence 3477899999999995 6788999999987644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.013 Score=59.99 Aligned_cols=71 Identities=18% Similarity=0.314 Sum_probs=48.1
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEc---cc------CCchhHHHHHHHHHHhcC--CCCCCeeEEeeEeCCeEEEE
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLN---VK------TKHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~---~~------~~~~~l~~E~~il~~L~~--~~~i~~~~~~~~~~~~~~lv 80 (473)
.+.||.|.-..||++.+...+..|+||.- .+ -.......|..+|+.+.. +..+|.++.| +.+..++|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 67889999999999997444567999961 11 112345678888887653 3456666544 45556778
Q ss_pred EecC
Q 011988 81 IDLL 84 (473)
Q Consensus 81 ~e~~ 84 (473)
||++
T Consensus 112 MEdL 115 (409)
T PRK12396 112 MEDL 115 (409)
T ss_pred HHhC
Confidence 8876
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00055 Score=70.97 Aligned_cols=162 Identities=20% Similarity=0.191 Sum_probs=95.4
Q ss_pred chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 011988 45 HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 124 (473)
Q Consensus 45 ~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIv 124 (473)
..++.-...+++.++|.+...++..........++|||+++.||++++.... +-..... .+++.
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~--------------~~~~~ 89 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL--------------AHGVL 89 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc--------------ccccc
Confidence 3456677788888986655555544444455589999999999999987432 1111111 22222
Q ss_pred ccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHH
Q 011988 125 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 204 (473)
Q Consensus 125 HrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~e 204 (473)
| -|| ++++| -++..+ .. ..++|+|||++|.++.|
T Consensus 90 ~-----~~~----------~~~td-~~~t~~--------------~~----------------~~~pKsdVwsl~~i~~e 123 (725)
T KOG1093|consen 90 H-----LNI----------IYITD-HFLTKY--------------PS----------------PIGPKSDVWSLGFIILE 123 (725)
T ss_pred e-----ehh----------hhccc-cccccC--------------CC----------------CCCcchhhhhHHHHHHH
Confidence 2 222 23344 111100 00 11249999999999999
Q ss_pred HHcCCCCCCCCCCCCHHHHHHHHhhccc---cccHH-HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 205 FLRGSLPWQGLKAGTKKQKYEKISEKKV---STSIE-ALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 205 lltG~~Pf~~~~~~~~~~~~~~i~~~~~---~~~~~-~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
+..|..-|...........+.+...... ....+ .+...++..+..+...|+-..|..||...++
T Consensus 124 l~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 124 LYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 9999988876544333333322221111 01111 1223567888999999999999999876654
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0021 Score=63.75 Aligned_cols=69 Identities=13% Similarity=0.063 Sum_probs=46.5
Q ss_pred EeeEeecCceEEEEEEEcC------CCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 12 GRKIGSGSFGEIYLGTNIQ------TNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~------~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
++.|..|-...||++.... .++.|++|+.... .......|..++..+......+.+..+... .+|++|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 4556667777999987532 2578999995443 234578899999999866666666555432 356777
Q ss_pred C
Q 011988 84 L 84 (473)
Q Consensus 84 ~ 84 (473)
+
T Consensus 79 i 79 (302)
T cd05156 79 I 79 (302)
T ss_pred e
Confidence 6
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0029 Score=62.44 Aligned_cols=137 Identities=16% Similarity=0.181 Sum_probs=79.4
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCC-CCeeEE------eeEeCCeEEEEEecC
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTG-IPNLRW------FGVEGDYNVLVIDLL 84 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~-i~~~~~------~~~~~~~~~lv~e~~ 84 (473)
.+.|..|....+|+... .+..+++|+........+..|+.++..|..... ++.+.. +....+..+++++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 56777788789999863 345788998655445668889999999864321 222211 112334567889988
Q ss_pred -CCCHH-----------HHHH---HcCCCC----------CHHHH----------HHHHHHHHHHHHHHHh-------CC
Q 011988 85 -GPSLE-----------DLFN---FCSRKL----------SLKTV----------LMLADQMINRVEFVHS-------KS 122 (473)
Q Consensus 85 -g~sL~-----------~~l~---~~~~~l----------s~~~~----------~~i~~qi~~aL~yLH~-------~g 122 (473)
|..+. ..+. .....+ .+... ......+..++.++.. .+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 33321 1111 000001 00000 0011122334444443 47
Q ss_pred CcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 123 IvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
++|+|+.|.|||++ +.+.+.|+||+.+.
T Consensus 177 l~HgD~~~~Nil~~---~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFD---GDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEe---CCceEEEeehhhhc
Confidence 99999999999995 44556899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0039 Score=62.05 Aligned_cols=138 Identities=18% Similarity=0.266 Sum_probs=77.8
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-CchhHHHHHHHHHHhcCCCC-CCeeEE------eeEeCCeEEEEEe
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-KHPQLQYEAKLYKILQGGTG-IPNLRW------FGVEGDYNVLVID 82 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~~~~-i~~~~~------~~~~~~~~~lv~e 82 (473)
-++.|+.|....+|++.. .++ .+++|+.... ....+..|..++..|..... ++.+.. +.......+++++
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred eccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 356677777789999863 334 6778985442 23457788888888863321 222211 1122445688999
Q ss_pred cCCC-C-----HH------HHHH---HcCCCC--------CHHH---HH------------HHHHHHHHHHHHHHh----
Q 011988 83 LLGP-S-----LE------DLFN---FCSRKL--------SLKT---VL------------MLADQMINRVEFVHS---- 120 (473)
Q Consensus 83 ~~g~-s-----L~------~~l~---~~~~~l--------s~~~---~~------------~i~~qi~~aL~yLH~---- 120 (473)
++.| . .. ..+. .....+ .... .. .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 8733 1 11 1111 001111 0000 00 001123334555542
Q ss_pred ---CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 121 ---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 121 ---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
.++||+|+.+.||+++ .++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence 6899999999999995 44556899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0017 Score=73.04 Aligned_cols=202 Identities=16% Similarity=0.142 Sum_probs=125.5
Q ss_pred HHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE----ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 011988 48 LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI----DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 122 (473)
Q Consensus 48 l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~----e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 122 (473)
.+.|...+..+.|.+... +..|+.+....-+++ ++| ..++...+. .-..++..+++.+..++++||.|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~-~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGG-YFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhccccccc-eeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 455666777777555444 444444433332333 344 556666665 3446889999999999999999999985
Q ss_pred CcccCCCCCcEEEeeCCCCCcEEEE--ecCCcccccCCCCccccccccCCCcccCccccccccccCCCCC--chhhHHHH
Q 011988 123 FLHRDIKPDNFLMGLGRRANQVYII--DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS--RRDDLESL 198 (473)
Q Consensus 123 IvHrDIKP~NILl~~~~~~~~vkL~--DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s--~ksDVwSl 198 (473)
..|.-|...-..-...+..+.+.+. ||+..+.+.+.... ....-+..|.++|......+. ...|+|.+
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--------~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--------FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccc--------hhhcCccccccccccccccchhhhhhHHHHH
Confidence 5554443331111112344556655 99888877654321 122345567788877766554 44799999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 199 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 199 GviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
|..+..+..|..+-.... ....-++..+..+..+....|+.-+.++|+...++ +.+.|.+
T Consensus 379 gll~~~~~~~~~i~~~~~-----------------~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~l---l~~~f~~ 438 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA-----------------VPVSLLDVLSTSELLDALPKCLDEDSEERLSALEL---LTHPFLR 438 (1351)
T ss_pred HHHHhhhhhcCccccccc-----------------chhhhhccccchhhhhhhhhhcchhhhhccchhhh---hhchhcc
Confidence 999999988765532110 00111112223378889999999999999997766 5555554
Q ss_pred h
Q 011988 279 E 279 (473)
Q Consensus 279 ~ 279 (473)
.
T Consensus 439 ~ 439 (1351)
T KOG1035|consen 439 F 439 (1351)
T ss_pred c
Confidence 4
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0027 Score=62.34 Aligned_cols=30 Identities=30% Similarity=0.517 Sum_probs=23.7
Q ss_pred CCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 122 gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
.++|+|+.|.|||++ ++....-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~--~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILID--EDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEe--CCCCEEEEECcHhcc
Confidence 489999999999995 223345699999885
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.00012 Score=83.87 Aligned_cols=152 Identities=11% Similarity=-0.055 Sum_probs=106.1
Q ss_pred HHHHHHHhcCCCCCCeeEEe-eEeCCeEEEEEecC-CCCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC----
Q 011988 51 EAKLYKILQGGTGIPNLRWF-GVEGDYNVLVIDLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---- 121 (473)
Q Consensus 51 E~~il~~L~~~~~i~~~~~~-~~~~~~~~lv~e~~-g~sL~~~l~~~~~---~ls~~~~~~i~~qi~~aL~yLH~~---- 121 (473)
|...++.+.|......+.-. ..+....+.+++++ +|.+.+.+-..-. .++..-+.....+.+.+..-+|+.
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 43444445544333322211 22444557888888 8888888764322 244444555555547778887753
Q ss_pred -CCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHH
Q 011988 122 -SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 200 (473)
Q Consensus 122 -gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGv 200 (473)
--+|++||+-|.+|. .+..+|+.++|+.+....... ......+++.|+++++.....++.++|+|..|+
T Consensus 1359 ~T~v~~~Lkf~lpmIV---tny~v~~gk~gLdKIknp~~s-------f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIV---TNYNVKLGKGGLDKIKNPVLS-------FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred ccchhhhhhhhcccee---cCCcccccccccccccCchHh-------hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 279999999999994 778899999999983322211 124567889999999999889999999999999
Q ss_pred HHHHHHcCCCCC
Q 011988 201 VLMYFLRGSLPW 212 (473)
Q Consensus 201 iL~elltG~~Pf 212 (473)
-+|+...|..+|
T Consensus 1429 ~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHhcccHHH
Confidence 999999998887
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.016 Score=58.83 Aligned_cols=137 Identities=12% Similarity=0.147 Sum_probs=78.7
Q ss_pred EEeeEeecCceEEEEEEEcC----CCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 11 LGRKIGSGSFGEIYLGTNIQ----TNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~----~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
-+..|-.|-...+|++.... .++.|++|+..... .-.-..|..+++.+.....-+.+.++...+ .+++|+
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 34455558888999987432 24689999854332 122467999999998777776766554332 456666
Q ss_pred -CCCHHH-----------H---HHH-cCCC------CC-HHHHHHHHHHH-----------------HHHHHHH----H-
Q 011988 85 -GPSLED-----------L---FNF-CSRK------LS-LKTVLMLADQM-----------------INRVEFV----H- 119 (473)
Q Consensus 85 -g~sL~~-----------~---l~~-~~~~------ls-~~~~~~i~~qi-----------------~~aL~yL----H- 119 (473)
+.+|.. + +.. +... +. ...+..++.++ ...+..| .
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 333321 1 110 0101 11 22222332111 1112222 1
Q ss_pred ---hCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 120 ---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 120 ---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
...++|+|+++.|||++ +..+.++|+||..|.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence 23589999999999996 334689999998874
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.018 Score=58.07 Aligned_cols=69 Identities=13% Similarity=0.040 Sum_probs=43.1
Q ss_pred EeeEeecCceEEEEEEEcCC---CcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 12 GRKIGSGSFGEIYLGTNIQT---NEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
++.|..|=...+|++..... +..|++|+..... .-.-..|..+++.+.....-+.+.++...+ ++.+|+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi 92 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFI 92 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhh
Confidence 34454477778998874332 3479999843322 123468999999998776666665554322 466665
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.057 Score=55.67 Aligned_cols=72 Identities=15% Similarity=0.299 Sum_probs=47.4
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEEcc------cC----CchhHHHHHHHHHHhcC--CCCCCeeEEeeEeCCeEE
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNV------KT----KHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~------~~----~~~~l~~E~~il~~L~~--~~~i~~~~~~~~~~~~~~ 78 (473)
..+.||.|....||+..+ .+..|+||... .. .......|...|+.+.. +..++.++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 467889999999999986 34569999732 11 22334556777766653 235666655554 5568
Q ss_pred EEEecCCC
Q 011988 79 LVIDLLGP 86 (473)
Q Consensus 79 lv~e~~g~ 86 (473)
++||++.+
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88998844
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.054 Score=53.45 Aligned_cols=73 Identities=19% Similarity=0.253 Sum_probs=52.8
Q ss_pred EEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhc--CCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
+-.+.|+.|....+|... .+++.+.||+........+..|..-|+.|. ..-.++.+..++...+..+|+|||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 345678889999999987 678899999977666678999999999994 4556777888887777789999998
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.02 Score=57.51 Aligned_cols=74 Identities=23% Similarity=0.263 Sum_probs=59.8
Q ss_pred EeCCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecC
Q 011988 72 VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFG 150 (473)
Q Consensus 72 ~~~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 150 (473)
.++.|.|++|++-|++|.-+- .-..++++.|+.+.+.-|.-+.. -.+-|||+.-.|||| +.|+|.|+||-
T Consensus 296 de~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI----d~GnvtLIDfk 366 (488)
T COG5072 296 DETLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI----DEGNVTLIDFK 366 (488)
T ss_pred CCceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee----ecCceEEEEee
Confidence 567788999999998876332 24578889999988877766664 368899999999999 38999999999
Q ss_pred Cccc
Q 011988 151 LAKR 154 (473)
Q Consensus 151 la~~ 154 (473)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9984
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.19 Score=50.48 Aligned_cols=67 Identities=12% Similarity=0.093 Sum_probs=40.2
Q ss_pred cCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCC--CCCCee----EEeeEeCCeEEEEEecCC
Q 011988 18 GSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGG--TGIPNL----RWFGVEGDYNVLVIDLLG 85 (473)
Q Consensus 18 G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~--~~i~~~----~~~~~~~~~~~lv~e~~g 85 (473)
+.-..||+... .++..+++|+.... ...++..|..++..|... +.+..+ ..+...+.+.+.++++.+
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 34457898873 45678999986433 345678899999888642 211111 011223456677887773
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.017 Score=58.67 Aligned_cols=59 Identities=24% Similarity=0.307 Sum_probs=43.9
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCCCcEEEee
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGL 137 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH-~~gIvHrDIKP~NILl~~ 137 (473)
.+++.+|. |-++..+++. ...+++.+..++.-.+.||--|- -.+++|.|+.|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~--~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW--KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhc--ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 46777777 7788888873 33556667777777777765554 468999999999999964
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.25 Score=50.79 Aligned_cols=70 Identities=14% Similarity=0.116 Sum_probs=44.0
Q ss_pred EEeeEeecCceEEEEEEEcCCC-c-----EEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTN-E-----EVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~-~-----~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.++.|..|-...+|++...... . .|++.+.... ..-.-.+|..+++.|.....-+.+...+. .+++.|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e 129 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE 129 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence 4456656888899999753321 2 2555542111 11223679999999998888888766553 257778
Q ss_pred cC
Q 011988 83 LL 84 (473)
Q Consensus 83 ~~ 84 (473)
|+
T Consensus 130 fI 131 (383)
T PTZ00384 130 WV 131 (383)
T ss_pred Ee
Confidence 77
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.031 Score=52.30 Aligned_cols=30 Identities=37% Similarity=0.707 Sum_probs=20.4
Q ss_pred CCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 122 gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
.++|.||.|.|||+. ...+.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEET--SSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEec--cCCCeEEEecHHHHh
Confidence 489999999999993 467899999999885
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.34 Score=48.41 Aligned_cols=31 Identities=23% Similarity=0.461 Sum_probs=25.5
Q ss_pred CCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 122 gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
.++|+|+.+.||+|. ..+-+=|+||+++..-
T Consensus 199 ~lvHGD~~~gNlii~---~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIID---PGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEe---CCCeeEEEeccccccC
Confidence 489999999999996 4444889999998643
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.24 Score=49.88 Aligned_cols=134 Identities=16% Similarity=0.216 Sum_probs=75.5
Q ss_pred eEeecCceEEEEEEEcCCCcEEEEEEcccC-CchhHHHHHHHHHHhcCCCCCCee-----E--EeeEeCC--eEEEEEec
Q 011988 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-KHPQLQYEAKLYKILQGGTGIPNL-----R--WFGVEGD--YNVLVIDL 83 (473)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~~~~i~~~-----~--~~~~~~~--~~~lv~e~ 83 (473)
.|.+ .-..||+... .+|+ +++|+.... ...++..|..+++.|....+.+.. . ....-.. +.+-+++|
T Consensus 33 ~l~s-~eN~~f~~~~-~~g~-~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 33 GLNS-EENSNFRVQT-EDGR-YILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred cccc-ccCceEEEEe-cCCC-eEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 3444 4557888874 3444 499996654 667788999999988644332211 1 1112223 66777777
Q ss_pred C-CCCHHH------------HH---HHcCCC-----------CCHH----H---------HHHHHHHHHHHHHHHHh---
Q 011988 84 L-GPSLED------------LF---NFCSRK-----------LSLK----T---------VLMLADQMINRVEFVHS--- 120 (473)
Q Consensus 84 ~-g~sL~~------------~l---~~~~~~-----------ls~~----~---------~~~i~~qi~~aL~yLH~--- 120 (473)
+ |..+.. ++ ....+. ..+. . -.....++...+..+.+
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 7 434431 11 000111 1111 0 01123344444555553
Q ss_pred -----CC--CcccCCCCCcEEEeeCCCCC-cEEEEecCCcc
Q 011988 121 -----KS--FLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 153 (473)
Q Consensus 121 -----~g--IvHrDIKP~NILl~~~~~~~-~vkL~DFGla~ 153 (473)
.+ +||+|+.|.|||++ ... .+.++||+-|.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d---~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFD---DDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEc---CCCCeeeEEEccccc
Confidence 23 99999999999995 333 47899999875
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.32 Score=48.38 Aligned_cols=29 Identities=24% Similarity=0.462 Sum_probs=25.5
Q ss_pred CCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 122 gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
+++|+|+.+.|||++ .++.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~---~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD---ETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEc---CCCCEEEEEhhhcc
Confidence 799999999999994 56679999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.49 Score=49.65 Aligned_cols=70 Identities=16% Similarity=0.024 Sum_probs=44.7
Q ss_pred EEeeEeecCceEEEEEEEcC--------CCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 11 LGRKIGSGSFGEIYLGTNIQ--------TNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~--------~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
-++.|..|=.-.+|++.... .++.|++++..... .-.-..|..+++.+....+-+.+..... .+.+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 45667667777899987542 15689999843322 2234679999999987666666654332 2456
Q ss_pred EecC
Q 011988 81 IDLL 84 (473)
Q Consensus 81 ~e~~ 84 (473)
.+|+
T Consensus 185 ~efi 188 (442)
T PTZ00296 185 EEWL 188 (442)
T ss_pred EEee
Confidence 6776
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.42 Score=46.67 Aligned_cols=44 Identities=23% Similarity=0.396 Sum_probs=31.7
Q ss_pred HHHHHHHHHHHHHhC--CCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 107 LADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 107 i~~qi~~aL~yLH~~--gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
.+..+-.++.-+|.. -++|.|+.|+|+|++ +.+.++|+||-.|.
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t---~~~~l~LIDWEyAg 182 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLT---DKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEc---CCCcEEEEecccCC
Confidence 333444444444433 489999999999994 55899999998875
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.89 E-value=0.11 Score=51.41 Aligned_cols=29 Identities=38% Similarity=0.729 Sum_probs=24.7
Q ss_pred CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 121 ~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
.+++|+|+.+.|||++ . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence 5789999999999995 3 568999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.57 E-value=1.4 Score=51.16 Aligned_cols=46 Identities=9% Similarity=0.120 Sum_probs=30.7
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccC-CchhHHHHHHHHHHhcC
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-KHPQLQYEAKLYKILQG 60 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~ 60 (473)
+.|+ |..-.+|+... .+|..+++|+.... ....+..|..++..|..
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~ 77 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAA 77 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHh
Confidence 4564 45577888873 56778999996543 33456667778877753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 473 | ||||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 0.0 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-135 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-135 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-135 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 7e-95 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-94 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 1e-93 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 1e-93 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 2e-92 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 2e-92 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-92 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 1e-26 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 6e-26 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 7e-26 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 9e-26 | ||
| 2jii_A | 352 | Structure Of Vaccinia Related Kinase 3 Length = 352 | 5e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 7e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 9e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 5e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 9e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-04 |
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 673 bits (1738), Expect = 0.0
Identities = 373/475 (78%), Positives = 416/475 (87%), Gaps = 5/475 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL NVKTKHPQL YE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV+TSIEAL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 299
CRGYPTEFASYFHYCRSLRFDDKPDY+YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 300 -STPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 358
S P RA+G GAGPS PPA N DRQSG +EGR +GWSS D RRR P+ + L+
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQN-DRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLA 357
Query: 359 KQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASP 418
KQK+P+ ND +FSK+ ++S+ N L S S R +S + ++PSR R TDASP
Sbjct: 358 KQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEPSRTRATDASP 417
Query: 419 GAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 473
GAF++ S Q+SSPV S+E +H++S R +SN+KN+ES L+GIE L+F+ +ERV +
Sbjct: 418 GAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 568 bits (1465), Expect = 0.0
Identities = 229/294 (77%), Positives = 268/294 (91%), Gaps = 1/294 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKL VKTKHPQL E+K+YK++Q
Sbjct: 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 293
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK
Sbjct: 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 568 bits (1466), Expect = 0.0
Identities = 171/326 (52%), Positives = 223/326 (68%), Gaps = 4/326 (1%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQGGT 62
VG FR+G+KIG G+FGE+ LG N+ TNE VAIKL +K++ PQL E + YK L G
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 63 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 122
GIP + +FG G YN +V++LLGPSLEDLF+ C R SLKTVLM+A Q+I+R+E+VHSK+
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 123 FLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 180
++RD+KP+NFL+G + ++IIDF LAK Y D T +HIPYRE+K+LTGTARY S
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 181 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240
+NTHLG EQSRRDDLE+LG++ MYFLRGSLPWQGLKA T K++Y+KI + K +T IE LC
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLC 245
Query: 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 300
+P E A+Y Y R L F +KPDY YL++LF DLF R+G+ FDY +DW + +
Sbjct: 246 ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGA 304
Query: 301 TPARAIGPGAGPSSGMPPAAANVDRQ 326
+ Q
Sbjct: 305 VQQDPALSSNREAHQHRDKMQQSKNQ 330
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 562 bits (1451), Expect = 0.0
Identities = 174/295 (58%), Positives = 214/295 (72%), Gaps = 3/295 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-NVKTKHPQLQYEAKLYKILQ 59
VG +++GR+IG GSFG I+ GTN+ N++VAIK ++ PQL+ E + YK+L
Sbjct: 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
G TGIPN+ +FG EG +NVLVIDLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 120 SKSFLHRDIKPDNFLMGL--GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 177
KS ++RDIKPDNFL+G + AN +Y++DFG+ K YRD T QHIPYRE KNL+GTAR
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 178 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237
Y S+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKYE+I EKK ST +
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243
Query: 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 292
LC G+P EF Y HY R+L FD PDY YL+ LF + R D FDW +L
Sbjct: 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 524 bits (1352), Expect = 0.0
Identities = 82/330 (24%), Positives = 147/330 (44%), Gaps = 28/330 (8%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLG-----TNIQTNEEVAIKLNVKTKHPQLQYEAKLY 55
+ +++G IG G FG IYL ++ ++ +K+ + + L E K Y
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE-PSDNGPLFTELKFY 87
Query: 56 KILQ--------------GGTGIPNLRWFGVEG----DYNVLVIDLLGPSLEDLFNFCSR 97
+ G+P G+ Y +++D G L+ ++ ++
Sbjct: 88 QRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK 147
Query: 98 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
+ S KTVL L+ ++++ +E++H ++H DIK N L+ +QVY++D+GLA RY
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN-PDQVYLVDYGLAYRYCP 206
Query: 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 217
H+ + GT + S++ H G+ SRR DLE LGY ++ +L G LPW+
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266
Query: 218 GTKKQKYEKISEKKVSTSIEALC---RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274
K + KI ++ S+ C P E A Y + L + +KP Y L+ +
Sbjct: 267 DPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326
Query: 275 LFIREGFQFDYVFDWTILKYQQSQVSTPAR 304
G + D D ++++ + T +
Sbjct: 327 GLKAIGSKDDGKLDLSVVENGGLKAKTITK 356
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 497 bits (1281), Expect = e-176
Identities = 93/323 (28%), Positives = 144/323 (44%), Gaps = 33/323 (10%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK---TKHPQLQYEAKLYKI 57
++ GN++ LG+KIGSG FG IYL E+ A + VK ++ L E K Y+
Sbjct: 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHV-VKVEYQENGPLFSELKFYQR 89
Query: 58 LQGGT--------------GIPNLRWFGV----EGDYNVLVIDLLGPSLEDLFNFCSRKL 99
+ GIP G+ Y +V++ LG L+ + +
Sbjct: 90 VAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG-QNGTF 148
Query: 100 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159
TVL L +M++ +E++H ++H DIK N L+G +QVY+ D+GL+ RY
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQVYLADYGLSYRYCPNG 207
Query: 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL---K 216
H+ K GT + S++ H G+ SRR D+E LGY ++ +L G LPW+
Sbjct: 208 NHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267
Query: 217 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276
+ K + E S A E A + SL +D+KP+Y LK++
Sbjct: 268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327
Query: 277 IREGFQFDYVFDWTILKYQQSQV 299
I G D++ K Q V
Sbjct: 328 IPLGP-----LDFST-KGQSINV 344
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 487 bits (1255), Expect = e-172
Identities = 73/316 (23%), Positives = 125/316 (39%), Gaps = 34/316 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT--------NEEVAIKL--------------NVK 42
G +++L + G +Y T ++ ++KL
Sbjct: 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRA 99
Query: 43 TKHPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNVLVIDLLGPSLEDLFNFCSRK-LS 100
K Q+ KLY IP FGV + Y LV+ LG SL+ + + LS
Sbjct: 100 AKPLQVNKWKKLYST--PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLS 157
Query: 101 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160
++VL +A ++++ +EF+H ++H ++ +N + + +QV + +G A RY +
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCPS-- 214
Query: 161 HQHIPYRENKN--LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 218
+H+ Y E G + SM+ H G SRR DL+SLGY ++ +L G LPW
Sbjct: 215 GKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274
Query: 219 TKKQKYEKISEKKVSTSIEALCRGY---PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275
T+ +K C + Y +L +++KP YA L+ L
Sbjct: 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334
Query: 276 FIREGFQFDYVFDWTI 291
+
Sbjct: 335 LQDLRVSPYDPIGLPM 350
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 36/247 (14%), Positives = 69/247 (27%), Gaps = 54/247 (21%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP------QLQYEAKLYKILQG- 60
K +L + G ++L +++ E+ A+K+ +L L G
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 61 -------------------GTGIPN-LRWFGVEGDYNV----LVIDLLGPSLEDLFNFCS 96
P + + DY V L++ LE LF+
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 97 R------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 150
+ + +L Q+I + SK +H PDN + ++ + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGDVS 239
Query: 151 LAKRYRDTATHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLR 207
+ + YA + + LG + +Y
Sbjct: 240 ALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLG-LSIYRVWC 288
Query: 208 GSLPWQG 214
LP+
Sbjct: 289 LFLPFGL 295
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 51/259 (19%), Positives = 91/259 (35%), Gaps = 52/259 (20%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP-----QLQYEAKLYKILQG 60
G + + ++IGSG +++ N + + AIK + + E LQ
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 61 GTGIPN---LRWFGVEGDYNVLVIDLLGPSLE----DLFNFCSRK--LSLKTVLMLADQM 111
+ +R + E + + +E DL ++ +K + M
Sbjct: 67 ----HSDKIIRLYDYEITDQYIYM-----VMECGNIDLNSWLKKKKSIDPWERKSYWKNM 117
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 171
+ V +H +H D+KP NFL+ G + +IDFG+A + + T +
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DS 168
Query: 172 LTGTARYAS-----------MNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQGLKA 217
GT Y N + S + D+ SLG Y + Y G P+Q +
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQII- 224
Query: 218 GTKKQKYEKISEKKVSTSI 236
+ K I +
Sbjct: 225 -NQISKLHAIIDPNHEIEF 242
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 50/257 (19%), Positives = 91/257 (35%), Gaps = 48/257 (18%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP-----QLQYEAKLYKILQG 60
G + + ++IGSG +++ N + + AIK + + E LQ
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 61 GTGIPN---LRWFGVEGDYNVLVIDLLGPSLE----DLFNFCSRK--LSLKTVLMLADQM 111
+ +R + E + + +E DL ++ +K + M
Sbjct: 86 ----HSDKIIRLYDYEITDQYIYM-----VMECGNIDLNSWLKKKKSIDPWERKSYWKNM 136
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 171
+ V +H +H D+KP NFL+ G + +IDFG+A + + T +
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DS 187
Query: 172 LTGTARYAS-----------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGT 219
GT Y N + S + D+ SLG ++Y G P+Q +
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQII--N 244
Query: 220 KKQKYEKISEKKVSTSI 236
+ K I +
Sbjct: 245 QISKLHAIIDPNHEIEF 261
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 48/276 (17%), Positives = 82/276 (29%), Gaps = 48/276 (17%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP------QLQYEAKLYKILQGG 61
G +G T+ +T E + + T+ P Q++ E ++L+G
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 62 ---------------------TGIPNL-RWFGVEGDYNVLVIDLLGPS--------LEDL 91
+ R E D VL L P E L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 92 FNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 149
+ S + L L L Q+I + +H +H ++P + ++ + V++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGF 250
Query: 150 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRG 208
R E L S + + D +LG +++Y
Sbjct: 251 EHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG-LVIYWIWCA 309
Query: 209 SLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 242
LP E I S K + + AL G
Sbjct: 310 DLPITK---DAALGGSEWIFRSCKNIPQPVRALLEG 342
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 65/333 (19%), Positives = 113/333 (33%), Gaps = 66/333 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LNVKTKHPQLQYEAKLYKILQGGT 62
+ + L +G G+ ++ G + +T + AIK ++ E ++ K L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-- 66
Query: 63 GIPN-LRWFGVEGDYN----VLVIDLL--GPSLEDLFNFCSRK-----LSLKTVLMLADQ 110
N ++ F +E + VL+++ G L+ L L++
Sbjct: 67 --KNIVKLFAIEEETTTRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYREN 169
++ + + +HR+IKP N + +G VY + DFG A+ D
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-------- 172
Query: 170 KNLTGTARYAS--------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAG-T 219
+L GT Y + + DL S+G V Y GSLP++ +
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRR 231
Query: 220 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL---F 276
K+ KI K S +I + + D P L R + L
Sbjct: 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVSCSLSRGLQVLLTPV 282
Query: 277 IREGFQFD----YVFD------WTILKYQQSQV 299
+ + D + FD IL S
Sbjct: 283 LANILEADQEKCWGFDQFFAETSDILHRGNSHH 315
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 55/238 (23%), Positives = 94/238 (39%), Gaps = 48/238 (20%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---------HPQLQYEA 52
E +RLG +G G FG ++ G + +VAIK+ + + E
Sbjct: 27 EAFEAE-YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 53 KLYKILQGGTGIPN----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL--M 106
L + G G P L WF + + +LV++ P+ +DLF++ + K L
Sbjct: 86 ALLWKVGAGGGHPGVIRLLDWFETQEGF-MLVLERPLPA-QDLFDYITEKGPLGEGPSRC 143
Query: 107 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166
Q++ ++ HS+ +HRDIK +N L + R +IDFG D
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENIL--IDLRRGCAKLIDFGSGALLHDEPYT----- 196
Query: 167 RENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 214
GT Y+ S + + + + SLG Y ++ G +P++
Sbjct: 197 ------DFDGTRVYSPPEWISRHQYHALPA----TVWSLGILLYDMVC---GDIPFER 241
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 50/256 (19%), Positives = 90/256 (35%), Gaps = 46/256 (17%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ-----LQYEAKLYKILQG 60
G + + ++IGSG +++ N + + AIK + + E LQ
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 61 GTGIPN---LRWFGVEGDYNVLVIDLLGPSLE----DLFNFCSRK--LSLKTVLMLADQM 111
+ +R + E + + +E DL ++ +K + M
Sbjct: 114 ----HSDKIIRLYDYEITDQYIYM-----VMECGNIDLNSWLKKKKSIDPWERKSYWKNM 164
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 171
+ V +H +H D+KP NFL+ G + +IDFG+A + + T +
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DS 215
Query: 172 LTGTARYAS-----------MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 220
G Y N + S + D+ SLG +L Y G P+Q + +
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQ 273
Query: 221 KQKYEKISEKKVSTSI 236
K I +
Sbjct: 274 ISKLHAIIDPNHEIEF 289
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 59/325 (18%), Positives = 104/325 (32%), Gaps = 76/325 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LNVKTKHPQLQYE----------- 51
+ + L +G G+ ++ G + +T + AIK ++ E
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 52 -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRK-----LSLKT 103
KL+ I + T + VL+++ G L+ L
Sbjct: 69 IVKLFAIEEETT-----------TRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESE 113
Query: 104 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQ 162
L++ ++ + + +HR+IKP N + +G VY + DFG A+ D
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED----- 168
Query: 163 HIPYRENKNLT---GTARYAS--------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSL 210
++ GT Y + + DL S+G V Y GSL
Sbjct: 169 ------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSL 221
Query: 211 PWQGLKAG-TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269
P++ + K+ KI K S +I + + D P L
Sbjct: 222 PFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVSCSLS 272
Query: 270 RLFRDL---FIREGFQFDYVFDWTI 291
R + L + + D W
Sbjct: 273 RGLQVLLTPVLANILEADQEKCWGF 297
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 7e-23
Identities = 44/281 (15%), Positives = 80/281 (28%), Gaps = 61/281 (21%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP------QLQYEAKLYKILQG-- 60
G +G T+ +T E + + T+ P Q++ E ++L+G
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 61 -------------------GTGIPNL-RWFGVEGDYNVLVIDLLGP----SLEDLFNFCS 96
+ R E D VL L P +L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 97 RK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 150
L L L Q+I + +H +H ++P + ++ + V++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFE 256
Query: 151 LAKRY-RDTATHQHIPYRENKNLTGTARYAS-----MNTHLGIEQSRRDDLESLGYVLMY 204
R + + + H + D +LG + +Y
Sbjct: 257 HLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHHPTLMTFAFDTWTLG-LAIY 308
Query: 205 F-LRGSLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 242
+ LP E I S K + + AL G
Sbjct: 309 WIWCADLPNTD---DAALGGSEWIFRSCKNIPQPVRALLEG 346
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 8e-23
Identities = 52/238 (21%), Positives = 88/238 (36%), Gaps = 36/238 (15%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGG 61
E + N + +G GS G + VA+K + E K +L
Sbjct: 10 EQSLKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDIALMEIK---LLTES 65
Query: 62 TGIPN-LRWFGVEGDYNV--LVIDLLGPSLEDL------FNFCSRKLSLKTVLMLADQMI 112
PN +R++ E + ++L +L+DL + + + L Q+
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 113 NRVEFVHSKSFLHRDIKPDNFL----------MGLGRRANQVYIIDFGLAKRYRDTATHQ 162
+ V +HS +HRD+KP N L G ++ I DFGL K+ Q
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG---Q 182
Query: 163 HIPYRENKNLTGTARYA-------SMNTHLGIEQSRRDDLESLGYVLMYFL--RGSLP 211
N +GT+ + S N +R D+ S+G + Y++ +G P
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHP 239
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 45/232 (19%), Positives = 85/232 (36%), Gaps = 39/232 (16%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--NVKTKHPQLQYEA--------- 52
R + F +G G+FG++ N + AIK + + K + E
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 53 ---KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLA 108
+ Y + + ++ +L DL + + L
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 109 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP--- 165
Q++ + ++HS+ +HRD+KP N + + V I DFGLAK + +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 166 -YRENKNLT---GTARYAS--MNTHLGIEQSRRDDLE----SLG---YVLMY 204
+ NLT GTA Y + + ++ + + + SLG + ++Y
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEV-----LDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 58/238 (24%), Positives = 96/238 (40%), Gaps = 50/238 (21%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---------HPQLQYEA 52
EP +++G +GSG FG +Y G + N VAIK K + ++ E
Sbjct: 39 EPLESQ-YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 97
Query: 53 KLYKILQGGTGIPN----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLM 106
L K + +G L WF + VL+++ P +DLF+F + + L +
Sbjct: 98 VLLKKVS--SGFSGVIRLLDWFERPDSF-VLILERPEPV-QDLFDFITERGALQEELARS 153
Query: 107 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166
Q++ V H+ LHRDIK +N L + ++ +IDFG +DT
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYT----- 206
Query: 167 RENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 214
GT Y+ + + G + SLG Y ++ G +P++
Sbjct: 207 ------DFDGTRVYSPPEWIRYHRYHGRSA----AVWSLGILLYDMVC---GDIPFEH 251
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 5e-22
Identities = 52/333 (15%), Positives = 108/333 (32%), Gaps = 74/333 (22%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP----QLQYE----- 51
+ + + + ++G+G FG + + T E+VAIK + P + E
Sbjct: 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 52 -------AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-----L 99
++ G + D +L ++ DL + ++ L
Sbjct: 68 KLNHPNVVSAREVPDGLQKLA-------PNDLPLLAMEYC--EGGDLRKYLNQFENCCGL 118
Query: 100 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159
+ L + + + ++H +HRD+KP+N ++ G + IID G AK
Sbjct: 119 KEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-- 176
Query: 160 THQHIPYRENKNLT---GTARYAS--MNTHLGIEQSRRD---DLESLGYVLMYFL-RGSL 210
+ T GT +Y + + +EQ + D S G L + G
Sbjct: 177 ---------GELCTEFVGTLQYLAPEL-----LEQKKYTVTVDYWSFG-TLAFECITGFR 221
Query: 211 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF-DDKPDYAYLK 269
P+ + ++ +K + I Y +++F P +L
Sbjct: 222 PFLP---NWQPVQWHGKVREKSNEHIVV-----------YDDLTGAVKFSSVLPTPNHLS 267
Query: 270 RLFRDL---FIREGFQFDYVFDWTILKYQQSQV 299
+ +++ + T +
Sbjct: 268 GILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 6e-22
Identities = 49/222 (22%), Positives = 86/222 (38%), Gaps = 20/222 (9%)
Query: 4 RVGN-KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGT 62
VG F +G G+ G I + N +VA+K + E + +L+
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQ---LLRESD 75
Query: 63 GIPN-LRWFGVEGDYNV--LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
PN +R+F E D + I+L +L++ + L Q + + +H
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 120 SKSFLHRDIKPDNFL--MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 177
S + +HRD+KP N L M + I DFGL K+ + + GT
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPGTEG 191
Query: 178 YAS---MNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQG 214
+ + ++ + D+ S G + Y++ GS P+
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGK 232
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 44/222 (19%), Positives = 81/222 (36%), Gaps = 29/222 (13%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKH--PQLQYEAKLYKILQGGT 62
+ +K+G G F + L + A+K + + + Q EA ++++
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH-- 85
Query: 63 GIPN----LRWFGVEGDYNVLVIDLL----GPSLEDLFNFCSRK---LSLKTVLMLADQM 111
PN + + E LL +L + K L+ +L L +
Sbjct: 86 --PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT--HQHIPYREN 169
+E +H+K + HRD+KP N L+G Q ++D G + Q + ++
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 170 KNLTGTARYAS---MNTHLGIEQSRRDDLESLG---YVLMYF 205
T Y + + R D+ SLG Y +M+
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 72/248 (29%), Positives = 109/248 (43%), Gaps = 52/248 (20%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQG 60
F +GR +G G FG +YL Q+ +A+K+ K + QL+ E ++ L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 61 GTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVLMLADQM 111
PN LR +G V +I LE ++ + K + ++
Sbjct: 69 ----PNILRLYGYFHDATRVYLI------LEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 171
N + + HSK +HRDIKP+N L+G A ++ I DFG + H P +
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTD 166
Query: 172 LTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYE 225
L GT Y M IE D DL SLG VL Y FL G P++ A T ++ Y+
Sbjct: 167 LCGTLDYLPPEM-----IEGRMHDEKVDLWSLG-VLCYEFLVGKPPFE---ANTYQETYK 217
Query: 226 KISEKKVS 233
+IS + +
Sbjct: 218 RISRVEFT 225
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 51/243 (20%), Positives = 92/243 (37%), Gaps = 56/243 (23%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------HPQLQY 50
+ +GSG+FG ++ + + N+EV +K K K ++
Sbjct: 20 GEYSQK-YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78
Query: 51 EAKLYKILQGGTGIPN-LRWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTV 104
E + ++ N ++ + +G + LV++ G L+ LF F R L
Sbjct: 79 EIAILSRVEH----ANIIKVLDIFENQGFF-QLVMEKHGSGLD-LFAFIDRHPRLDEPLA 132
Query: 105 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164
+ Q+++ V ++ K +HRDIK +N + + + +IDFG A
Sbjct: 133 SYIFRQLVSAVGYLRLKDIIHRDIKDENIV--IAEDFT-IKLIDFGSAAYLER------- 182
Query: 165 PYRENKNLT---GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQ 213
K GT Y N + G E ++ SLG Y L++ P+
Sbjct: 183 ----GKLFYTFCGTIEYCAPEVLMGNPYRGPEL----EMWSLGVTLYTLVF---EENPFC 231
Query: 214 GLK 216
L+
Sbjct: 232 ELE 234
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 33/171 (19%), Positives = 67/171 (39%), Gaps = 20/171 (11%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQG 60
+ +G G+F ++Y T + + ++ +K+ + +L + L+
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 61 GT--GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFN----FCSRKLSLKTVLMLADQMIN 113
+ + +VLV +L +L + N + + V+ A +M+
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--------VYIIDFGLAKRYR 156
+E VH +H DIKPDNF++G G + +ID G + +
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 63/250 (25%), Positives = 108/250 (43%), Gaps = 45/250 (18%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKLYK 56
++++ R +G GSFGE+ L + T +E A+K + KT L E +L K
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 57 ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK-LSLKTVLMLAD 109
L PN ++ + E LV ++ G +LF+ SRK S +
Sbjct: 82 QLDH----PNIMKLYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARIIR 133
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 169
Q+++ + ++H +HRD+KP+N L+ + + IIDFGL+ + +
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-------- 185
Query: 170 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQK 223
K+ GTA Y + E D+ S G V++Y L G P+ G +
Sbjct: 186 KDKIGTAYYIAP------EVLHGTYDEKCDVWSTG-VILYILLSGCPPFNG---ANEYDI 235
Query: 224 YEKISEKKVS 233
+K+ + K +
Sbjct: 236 LKKVEKGKYT 245
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 5e-20
Identities = 55/252 (21%), Positives = 96/252 (38%), Gaps = 56/252 (22%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LNVKTKHPQLQYEAKL 54
+PR ++ GR +G G F + + ++ T E A K L + ++ E +
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISI 68
Query: 55 YKILQGGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTVL 105
++ L + + + G E + V V+ LE L R+ L+
Sbjct: 69 HRSLAH----QHVVGFHGFFEDNDFVFVV------LELCRRRSLLELHKRRKALTEPEAR 118
Query: 106 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165
Q++ +++H +HRD+K N + +V I DFGLA + +
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLATK---------VE 166
Query: 166 YRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA 217
Y + GT Y S H S D+ S+G +MY L G P++
Sbjct: 167 YDGERKKVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---T 217
Query: 218 GTKKQKYEKISE 229
K+ Y +I +
Sbjct: 218 SCLKETYLRIKK 229
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 50/201 (24%), Positives = 76/201 (37%), Gaps = 37/201 (18%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQG 60
++ R G F+ IGSG FG+++ + + IK VK + + + E K L
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR-VKYNNEKAEREVKALAKLDH 63
Query: 61 GTGIPNL-----RWFGVEGDYNVLVIDLLGPSLEDLF---NFCS-------------RKL 99
N+ W G + D + + LF FC KL
Sbjct: 64 ----VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 100 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159
L L +Q+ V+++HSK ++RD+KP N + QV I DFGL ++
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDG 176
Query: 160 THQHIPYRENKNLTGTARYAS 180
GT RY S
Sbjct: 177 KRTRS--------KGTLRYMS 189
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 9e-20
Identities = 60/238 (25%), Positives = 91/238 (38%), Gaps = 39/238 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LNVKTKHPQLQYEAKLYKILQ 59
F++G +G GSF +Y +I T EVAIK ++Q E K++ L+
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-RVQNEVKIHCQLK 69
Query: 60 GGTGIPN-LRWFGV-EGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
P+ L + E V LV+++ + + S Q+I +
Sbjct: 70 H----PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT-- 173
++HS LHRD+ N L+ R + I DFGLA + K+ T
Sbjct: 126 LYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLA---------TQLKMPHEKHYTLC 173
Query: 174 GTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKIS 228
GT Y S + T D+ SLG + Y L G P+ T K K+
Sbjct: 174 GTPNYISPEIAT--RSAHGLESDVWSLG-CMFYTLLIGRPPFD---TDTVKNTLNKVV 225
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 35/167 (20%), Positives = 59/167 (35%), Gaps = 8/167 (4%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLY--KIL 58
E F+ ++G GS+GE++ + + A+K ++ KL
Sbjct: 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH 110
Query: 59 QGGTGIPNL-RWFG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
+ P R EG L +L GPSL+ L V + +
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162
+HS+ +H D+KP N +G + + DFGL +
Sbjct: 171 AHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGE 214
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 61/248 (24%), Positives = 115/248 (46%), Gaps = 44/248 (17%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKIL 58
+ ++ +K+GSG++GE+ L + T+ E AIK+ KT + +L E + K+L
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 59 QGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK-LSLKTVLMLADQM 111
PN ++ + E N LV++ G +LF+ R + ++ Q+
Sbjct: 94 DH----PNIMKLYDFFEDKRNYYLVMECYKGG----ELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 171
++ V ++H + +HRD+KP+N L+ + + I+DFGL+ + + K
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--------KE 197
Query: 172 LTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 225
GTA Y + E R+ D+ S+G V+++ L G P+ G T ++
Sbjct: 198 RLGTAYYIAP------EVLRKKYDEKCDVWSIG-VILFILLAGYPPFGG---QTDQEILR 247
Query: 226 KISEKKVS 233
K+ + K +
Sbjct: 248 KVEKGKYT 255
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 59/248 (23%), Positives = 102/248 (41%), Gaps = 52/248 (20%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQG 60
+ F +GR +G G FG +YL Q +A+K+ K++ QL+ E ++ L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 61 GTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVLMLADQM 111
PN LR + + ++ LE +L+ + + + +++
Sbjct: 74 ----PNILRMYNYFHDRKRIYLM------LEFAPRGELYKELQKHGRFDEQRSATFMEEL 123
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 171
+ + + H + +HRDIKP+N LMG ++ I DFG + H P +
Sbjct: 124 ADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSV---------HAPSLRRRT 171
Query: 172 LTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYE 225
+ GT Y M IE D DL G VL Y FL G P+ + + + +
Sbjct: 172 MCGTLDYLPPEM-----IEGKTHDEKVDLWCAG-VLCYEFLVGMPPFD---SPSHTETHR 222
Query: 226 KISEKKVS 233
+I +
Sbjct: 223 RIVNVDLK 230
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 66/248 (26%), Positives = 114/248 (45%), Gaps = 43/248 (17%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----NVKTKHPQLQYEAKLYKILQG 60
+ + F RK+GSG+FG+++L + E IK + Q++ E ++ K L
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 61 GTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLF------NFCSRKLSLKTVLMLAD 109
PN+ + F V E +N+ +V++ G +L + LS V L
Sbjct: 80 ----PNIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELMK 131
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 169
QM+N + + HS+ +H+D+KP+N L + + IIDFGLA+ ++
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-------- 183
Query: 170 KNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 225
N GTA Y + + + D+ S G V+MYF L G LP+ G + ++ +
Sbjct: 184 TNAAGTALYMAPEVFKRDVTFKC----DIWSAG-VVMYFLLTGCLPFTG---TSLEEVQQ 235
Query: 226 KISEKKVS 233
K + K+ +
Sbjct: 236 KATYKEPN 243
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 56/252 (22%), Positives = 94/252 (37%), Gaps = 56/252 (22%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LNVKTKHPQLQYEAKL 54
+PR ++ GR +G G F + + ++ T E A K L + ++ E +
Sbjct: 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISI 94
Query: 55 YKILQGGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVL 105
++ L + + + G E + V V+ LE L R L+
Sbjct: 95 HRSLAH----QHVVGFHGFFEDNDFVFVV------LELCRRRSLLELHKRRKALTEPEAR 144
Query: 106 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165
Q++ +++H +HRD+K N L V I DFGLA + +
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATK---------VE 192
Query: 166 YRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA 217
Y + GT Y S H S D+ S+G +MY L G P++
Sbjct: 193 YDGERKKVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---T 243
Query: 218 GTKKQKYEKISE 229
K+ Y +I +
Sbjct: 244 SCLKETYLRIKK 255
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 66/247 (26%), Positives = 111/247 (44%), Gaps = 46/247 (18%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLY 55
+P +GN +RL + IG G+F ++ L +I T EVAIK+ KT+ +L E ++
Sbjct: 10 EQPHIGN-YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM 68
Query: 56 KILQGGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVLM 106
KIL PN ++ F V E + + +I +E ++F++ ++ K
Sbjct: 69 KILNH----PNIVKLFEVIETEKTLYLI------MEYASGGEVFDYLVAHGRMKEKEARS 118
Query: 107 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166
Q+++ V++ H K +HRD+K +N L L N + I DFG + +
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLL--LDADMN-IKIADFGFSNEFTV--------- 166
Query: 167 RENKNLT---GTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 222
L G YA+ G + D+ SLG +L + GSLP+ G K+
Sbjct: 167 --GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---QNLKE 221
Query: 223 KYEKISE 229
E++
Sbjct: 222 LRERVLR 228
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 59/250 (23%), Positives = 107/250 (42%), Gaps = 44/250 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYK 56
+ ++ + +G GSFGE+ + T +E A+K+ K + E +L K
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 57 ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK-LSLKTVLMLAD 109
L PN ++ F + E + +V +L G +LF+ RK S +
Sbjct: 77 KLDH----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIK 128
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 169
Q+ + + ++H + +HRD+KP+N L+ + + IIDFGL+ ++
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------- 180
Query: 170 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQK 223
K+ GTA Y + E R D+ S G V++Y L G+ P+ G +
Sbjct: 181 KDRIGTAYYIAP------EVLRGTYDEKCDVWSAG-VILYILLSGTPPFYG---KNEYDI 230
Query: 224 YEKISEKKVS 233
+++ K +
Sbjct: 231 LKRVETGKYA 240
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 45/229 (19%), Positives = 83/229 (36%), Gaps = 30/229 (13%)
Query: 4 RVGN-KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKH--PQLQYEAKLYKILQ 59
+G + R+ R + G F +Y ++ + E A+K L + + E K L
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS 83
Query: 60 GGTGI-------PNLRWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRK--LSLKTVLMLAD 109
G I + G L++ +L L + + LS TVL +
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 110 QMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-----TATHQ 162
Q V+ +H + +HRD+K +N L+ + + DFG A + +
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 163 HIPYRENKNLTGTARYAS---MNTHLGIEQSRRDDLESLG---YVLMYF 205
E T Y + ++ + + D+ +LG Y+L +
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 9e-19
Identities = 34/187 (18%), Positives = 76/187 (40%), Gaps = 27/187 (14%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTK-HPQLQYEAKLYKILQGG 61
+ K+ + +G G FG ++ + + K + VK ++ E + I +
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH- 60
Query: 62 TGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMIN 113
N+ E + ++ + + D+F + L+ + ++ Q+
Sbjct: 61 ---RNILHLHESFESMEELVMIFEFISGL----DIFERINTSAFELNEREIVSYVHQVCE 113
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 173
++F+HS + H DI+P+N + RR++ + II+FG A++ + P + L
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLK--------PGDNFRLLF 164
Query: 174 GTARYAS 180
Y +
Sbjct: 165 TAPEYYA 171
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 41/173 (23%), Positives = 72/173 (41%), Gaps = 22/173 (12%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQLQYEAKLYKILQGGTGIPNL- 67
+G G++G +Y G ++ +AIK L E L+K L+ N+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH----KNIV 82
Query: 68 RWFGVEGDYNVLVIDL---LGPSLEDL--FNFCSRKLSLKTVLMLADQMINRVEFVHSKS 122
++ G + + I + G SL L + K + +T+ Q++ ++++H
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 175
+HRDIK DN L + + + I DFG +KR + TGT
Sbjct: 143 IVHRDIKGDNVL--INTYSGVLKISDFGTSKRLAGINPC-------TETFTGT 186
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 64/281 (22%), Positives = 117/281 (41%), Gaps = 30/281 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQL----QYEAKLYKILQGG 61
+ +G++IGSGSFG +Y G + +VA+K LNV PQ + E + + +
Sbjct: 24 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 79
Query: 62 TGIPNLRWF-GV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 117
N+ F G +V G SL + K +K ++ +A Q +++
Sbjct: 80 ---VNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 118 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 177
+H+KS +HRD+K +N + N V I DFGLA + + + L+G+
Sbjct: 136 LHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLAT-----EKSRWSGSHQFEQLSGSIL 187
Query: 178 YAS---MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234
+ + + S + D+ + G VL + G LP+ + + Q E + +S
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSP 245
Query: 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275
+ + P C + D++P + + +L
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 65/252 (25%), Positives = 98/252 (38%), Gaps = 45/252 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP----QLQYEAKLYKI 57
P V + L + +G G++GE+ L N T E VA+K+ + ++ E + K+
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM 61
Query: 58 LQGGTGIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTVLML 107
L N ++++G EG+ L LE +LF+ +
Sbjct: 62 LNH----ENVVKFYGHRREGNIQYLF-------LEYCSGGELFDRIEPDIGMPEPDAQRF 110
Query: 108 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167
Q++ V ++H HRDIKP+N L L R N + I DFGLA +R + +
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL--- 164
Query: 168 ENKNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 222
+ GT Y D+ S G VL L G LPW Q
Sbjct: 165 --NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDSCQ 216
Query: 223 KYEKISEKKVST 234
+Y EKK
Sbjct: 217 EYSDWKEKKTYL 228
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 43/189 (22%), Positives = 84/189 (44%), Gaps = 30/189 (15%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP----QLQYEAKLYKILQ 59
V + + + ++G+G+FG ++ T T A K V T H ++ E + +L+
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF-VMTPHESDKETVRKEIQTMSVLR 212
Query: 60 GGTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQM 111
P L E D + ++ + + G +LF + + +S + Q+
Sbjct: 213 H----PTLVNLHDAFEDDNEMVMIYEFMSGG----ELFEKVADEHNKMSEDEAVEYMRQV 264
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 171
+ +H +++H D+KP+N + +R+N++ +IDFGL P + K
Sbjct: 265 CKGLCHMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLD--------PKQSVKV 315
Query: 172 LTGTARYAS 180
TGTA +A+
Sbjct: 316 TTGTAEFAA 324
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 40/228 (17%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQL----------QYEAKL 54
+ ++++ K+G G +YL + N +VAIK + E
Sbjct: 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA----IFIPPREKEETLKRFEREVHN 64
Query: 55 YKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN 113
L I ++ E D LV++ + GP+L + LS+ T + +Q+++
Sbjct: 65 SSQLSH-QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILD 122
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 173
++ H +HRDIKP N L+ + I DFG+AK +T+ Q ++
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQ------TNHVL 173
Query: 174 GTARYASMNTHLGIEQSR------RDDLESLGYVLMY-FLRGSLPWQG 214
GT +Y S EQ++ D+ S+G +++Y L G P+ G
Sbjct: 174 GTVQYFSP------EQAKGEATDECTDIYSIG-IVLYEMLVGEPPFNG 214
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 47/247 (19%), Positives = 100/247 (40%), Gaps = 45/247 (18%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-------HPQLQYEAKLYK 56
+G K+ +G +G GS+G++ + +T A+K+ K K ++ E +L +
Sbjct: 3 LIG-KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 57 ILQGGTGIPN-LR----WFGVEGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQ 110
L+ N ++ + E +V++ ++++ + ++ + Q
Sbjct: 62 RLRH----KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ 117
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 170
+I+ +E++HS+ +H+DIKP N L L + I G+A+ P+ +
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLL--LTTGGT-LKISALGVAEALH--------PFAADD 166
Query: 171 NLT---GTARYAS------MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 221
G+ + ++T G + D+ S G L G P++G
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKV----DIWSAGVTLYNITTGLYPFEG---DNIY 219
Query: 222 QKYEKIS 228
+ +E I
Sbjct: 220 KLFENIG 226
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 39/219 (17%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ----LQYEAKLYKILQ 59
V + + + ++GSG+FG ++ T K + T +P ++ E + L
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLDKYTVKNEISIMNQLH 106
Query: 60 GGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQM 111
P L + VL+++ L G +LF+ + + +S V+ Q
Sbjct: 107 H----PKLINLHDAFEDKYEMVLILEFLSGG----ELFDRIAAEDYKMSEAEVINYMRQA 158
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 171
++ +H S +H DIKP+N + ++A+ V IIDFGLA + P K
Sbjct: 159 CEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLN--------PDEIVKV 209
Query: 172 LTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYFL 206
T TA +A+ +G D+ ++G VL Y L
Sbjct: 210 TTATAEFAAPEIVDREPVGFYT----DMWAIG-VLGYVL 243
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 36/180 (20%), Positives = 75/180 (41%), Gaps = 25/180 (13%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYK---ILQGGTGIPNL 67
+++G G F + + T +E A K +K + A++ +L+ P +
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKF-LKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 68 -RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEFV 118
V +L+++ G ++F+ C + +S V+ L Q++ V ++
Sbjct: 92 INLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 178
H + +H D+KP N L+ + I+DFG++++ E + + GT Y
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--------HACELREIMGTPEY 199
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 46/179 (25%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----------------- 44
+ +G + + +G GSFG++ L T+ +T ++VA+K +
Sbjct: 5 KRHIGP-YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63
Query: 45 ----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-- 98
HP + KLY ++ T I V+VI+ G +LF++ K
Sbjct: 64 KLLRHPHI---IKLYDVITTPTDI-------------VMVIEYAG---GELFDYIVEKKR 104
Query: 99 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
++ Q+I +E+ H +HRD+KP+N L L N V I DFGL+ D
Sbjct: 105 MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL--LDDNLN-VKIADFGLSNIMTD 160
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 39/173 (22%), Positives = 71/173 (41%), Gaps = 15/173 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPN 66
+ ++G GSFGE++ + QT + A+K V+ + +++ E L P
Sbjct: 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK-VRLEVFRVE-ELVACAGLSS----PR 111
Query: 67 L-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 122
+ +G + + I + G SL L L L Q + +E++H++
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 175
LH D+K DN L L ++ + DFG A + + + + GT
Sbjct: 171 ILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSLLTG--DYIPGT 219
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 9e-18
Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 30/177 (16%)
Query: 4 RVGNKFRLGR-----KIGSGSFGEIYLGTNIQTNEEVAIKL--NVKTKHPQLQYEAKLYK 56
G ++ R K+G G F ++L ++ N VA+K+ K + E KL +
Sbjct: 11 FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70
Query: 57 IL-------QGGTGIPN----LRWF---GVEGDYNVLVIDLLGPSLEDL---FNFCSRKL 99
+ + G + L F G G + V+V ++LG +L L + R +
Sbjct: 71 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGI 128
Query: 100 SLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRR---ANQVYIIDFGLA 152
L V ++ Q++ ++++H + +H DIKP+N LM + Q+ I D G A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 29/227 (12%)
Query: 2 EPRVGNKF---RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQL---------- 48
E R G +F RL R +G G G++Y + VA+KL L
Sbjct: 26 ESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKL----MSETLSSDPVFRTRM 81
Query: 49 QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLML 107
Q EA+ LQ + + FG + + L+ G L + L+ + +
Sbjct: 82 QREARTAGRLQE-PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAI 139
Query: 108 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167
Q+ + ++ H+ HRD+KP+N L+ + Y++DFG+A D Q
Sbjct: 140 VRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQ----- 191
Query: 168 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
N GT Y + + R D+ +L VL L GS P+QG
Sbjct: 192 -LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 65/252 (25%), Positives = 98/252 (38%), Gaps = 45/252 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP----QLQYEAKLYKI 57
P V + L + +G G++GE+ L N T E VA+K+ + ++ E + K+
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM 61
Query: 58 LQGGTGIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTVLML 107
L N ++++G EG+ L LE +LF+ +
Sbjct: 62 LNH----ENVVKFYGHRREGNIQYLF-------LEYCSGGELFDRIEPDIGMPEPDAQRF 110
Query: 108 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167
Q++ V ++H HRDIKP+N L L R N + I DFGLA +R + +
Sbjct: 111 FHQLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL--- 164
Query: 168 ENKNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 222
+ GT Y D+ S G VL L G LPW Q
Sbjct: 165 --NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDSCQ 216
Query: 223 KYEKISEKKVST 234
+Y EKK
Sbjct: 217 EYSDWKEKKTYL 228
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 20/169 (11%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ-----LQYEAKLYK 56
+ ++ + +G GSFGE+ + T +E A+K+ K + E +L K
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 57 ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSR-KLSLKTVLMLAD 109
L PN ++ F + E + +V +L G +LF+ R + S +
Sbjct: 77 KLDH----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIK 128
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
Q+ + + ++H + +HRD+KP+N L+ + + IIDFGL+ ++
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 38/171 (22%), Positives = 77/171 (45%), Gaps = 25/171 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------LNVKTKHPQLQYEAK 53
+ +++ + + +GSG+ GE+ L +T ++VAI+ ++ E +
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 54 LYKILQGGTGIPN-LRWFGVEGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLML 107
+ K L P ++ + +V++L+ G +LF+ +L T +
Sbjct: 193 ILKKLNH----PCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLY 244
Query: 108 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
QM+ V+++H +HRD+KP+N L+ + I DFG +K +T
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 33/188 (17%), Positives = 74/188 (39%), Gaps = 30/188 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQY---------EAKLYK 56
N+ ++IG G FG ++ G ++ VAIK L + + + E +
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 57 ILQGGTGIPN-LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 114
L PN ++ +G+ + +V++ + L + + L L +
Sbjct: 79 NLNH----PNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 115 VEFVHSKS--FLHRDIKPDNFLMGLGRRANQVY--IIDFGLAKRYRDTATHQHIPYRENK 170
+E++ +++ +HRD++ N + V + DFGL+++ + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS---------- 184
Query: 171 NLTGTARY 178
L G ++
Sbjct: 185 GLLGNFQW 192
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 37/171 (21%), Positives = 67/171 (39%), Gaps = 23/171 (13%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYK------ 56
+ +G G + + T +E A+K+ T E
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 57 ---ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLM 106
IL+ +G PN ++ E + LV DL+ G +LF++ + LS K
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVTLSEKETRK 128
Query: 107 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
+ ++ + +H + +HRD+KP+N L L N + + DFG + +
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENIL--LDDDMN-IKLTDFGFSCQLDP 176
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 2e-17
Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 20/167 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKI 57
+ + + + ++G G+F + + T E A K+ K +L+ EA++ +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 58 LQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQ 110
LQ PN +R + + LV DL+ G +LF +R S Q
Sbjct: 62 LQH----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQ 113
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
++ + + HS +HR++KP+N L+ + V + DFGLA D
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 43/200 (21%), Positives = 63/200 (31%), Gaps = 26/200 (13%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQ-LQYEAKLYKILQ 59
R F + +G G FG ++ N + AIK L + + + E K L+
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 60 ---------GGTGIPNLRWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSL--KTVL 105
L I + +L+D N L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 106 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165
+ Q+ VEF+HSK +HRD+KP N + V + DFGL Q +
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 166 YRENKNLT-----GTARYAS 180
GT Y S
Sbjct: 179 TPMPAYARHTGQVGTKLYMS 198
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 1 MEP----RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---------HPQ 47
MEP +V + + +G ++GSG F + T E A K K + +
Sbjct: 2 MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 48 LQYEAKLYKILQGGTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSL- 101
++ E + + + N+ V E +V L+++L+ G +LF+F ++K SL
Sbjct: 62 IEREVSILRQVLH----HNVITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLS 113
Query: 102 -KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKRYRDT 158
+ Q+++ V ++H+K H D+KP+N ++ L + + +IDFGLA D
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 159 ATHQHIPYRENKNLTGTARY 178
KN+ GT +
Sbjct: 173 VEF--------KNIFGTPEF 184
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 61/243 (25%), Positives = 97/243 (39%), Gaps = 38/243 (15%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGG 61
+ + L IG GS+GE+ + T A K K + + E ++ K L
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH- 65
Query: 62 TGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRK--LSLKTVLMLADQMINR 114
PN +R + E + ++ LV++L G +LF K + +++
Sbjct: 66 ---PNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 174
V + H + HRD+KP+NFL + + +IDFGLA R++ + G
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--------RTKVG 170
Query: 175 TARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEK 230
T Y S + G E D S G V+MY L G P+ T + KI E
Sbjct: 171 TPYYVSPQVLEGLYGPEC----DEWSAG-VMMYVLLCGYPPFSA---PTDSEVMLKIREG 222
Query: 231 KVS 233
+
Sbjct: 223 TFT 225
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 39/171 (22%), Positives = 77/171 (45%), Gaps = 25/171 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------LNVKTKHPQLQYEAK 53
+ +++ + + +GSG+ GE+ L +T ++VAIK ++ E +
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 54 LYKILQGGTGIPN-LRWFGVEGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLML 107
+ K L P ++ + +V++L+ G +LF+ +L T +
Sbjct: 68 ILKKLNH----PCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLY 119
Query: 108 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
QM+ V+++H +HRD+KP+N L+ + I DFG +K +T
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 51/280 (18%), Positives = 96/280 (34%), Gaps = 58/280 (20%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------------------- 44
+ K+ L IG GS+G + + QT AIK+ K K
Sbjct: 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82
Query: 45 ----HPQL--QYEA-----KLYKIL---QGG--------------TGIPNLRWFGVEGDY 76
HP + YE + ++ GG
Sbjct: 83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 77 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 136
+ + S+ K + + Q+ + + ++H++ HRDIKP+NFL
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF- 201
Query: 137 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDD 194
++ ++ ++DFGL+K + ++ GT + + + + D
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT---KAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 195 LESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKKVS 233
S G VL++ L G++P+ G ++ KK+
Sbjct: 259 AWSAG-VLLHLLLMGAVPFPG---VNDADTISQVLNKKLC 294
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-17
Identities = 39/171 (22%), Positives = 81/171 (47%), Gaps = 29/171 (16%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLY 55
++G+ + LG +G G+FG++ +G + T +VA+K+ + K +++ E +
Sbjct: 7 RVKIGH-YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 56 KILQGGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTVLM 106
K+ + P+ ++ + V + ++ +E +LF++ + +
Sbjct: 66 KLFRH----PHIIKLYQVISTPTDFFMV------MEYVSGGELFDYICKHGRVEEMEARR 115
Query: 107 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
L Q+++ V++ H +HRD+KP+N L L N I DFGL+ D
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 163
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 41/227 (18%), Positives = 86/227 (37%), Gaps = 31/227 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQL----QYEAKLYKILQGG 61
+ +G IG G FG++Y G + EVAI+ ++++ + + E Y+ +
Sbjct: 33 EQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH- 88
Query: 62 TGIPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 117
N+ + G + ++ L G +L + L + +A +++ + +
Sbjct: 89 ---ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 118 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 177
+H+K LH+D+K N G+ V I DFGL + + + G
Sbjct: 146 LHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRR--EDKLRIQNGWLC 199
Query: 178 Y---------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 215
+ + + S+ D+ +LG + P++
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 61/257 (23%), Positives = 107/257 (41%), Gaps = 47/257 (18%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGG 61
E ++G + RK+GSG++GE+ L + E AIK+ K++ + +Y I +
Sbjct: 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90
Query: 62 TGI------------PN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK-LSLK 102
I PN ++ F V E LV + G +LF +R
Sbjct: 91 EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGG----ELFEQIINRHKFDEC 146
Query: 103 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162
+ Q+++ + ++H + +HRDIKP+N L+ + I+DFGL+ +
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLK 216
++ GTA Y + E ++ D+ S G V+MY L G P+ G
Sbjct: 206 -------RDRLGTAYYIAP------EVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGG-- 249
Query: 217 AGTKKQKYEKISEKKVS 233
+ +K+ + K
Sbjct: 250 -QNDQDIIKKVEKGKYY 265
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 32/208 (15%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWF 70
+ +G GSF + ++N+ A+K+ K Q E K+ +G I L
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 71 GVEGDYNVLVIDLL--GPSLEDLF-------NFCSRKLSLKTVLMLADQMINRVEFVHSK 121
+ + LV++LL G +LF +F + S + ++++ V +H
Sbjct: 75 FHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEAS-----YIMRKLVSAVSHMHDV 125
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT---GTARY 178
+HRD+KP+N L ++ IIDFG A+ +N+ L T Y
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLKTPCFTLHY 175
Query: 179 ASMNTHLGIEQSRRDDLESLGYVLMYFL 206
A+ DL SLG V++Y +
Sbjct: 176 AAPELLNQNGYDESCDLWSLG-VILYTM 202
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 6e-17
Identities = 44/188 (23%), Positives = 82/188 (43%), Gaps = 27/188 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGI 64
V + + +G ++GSG F + T +E A K +K + + ++ I
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKF-IKKRRLSSSRRGVSREEIEREVNI 61
Query: 65 ------PNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQM 111
PN+ + E +V L+++L+ G +LF+F + K SL Q+
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGG----ELFDFLAEKESLTEDEATQFLKQI 117
Query: 112 INRVEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 170
++ V ++HSK H D+KP+N ++ ++ +IDFG+A + K
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--------K 169
Query: 171 NLTGTARY 178
N+ GT +
Sbjct: 170 NIFGTPEF 177
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 9e-17
Identities = 42/227 (18%), Positives = 80/227 (35%), Gaps = 41/227 (18%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE-EVAIKLNVKTKHPQLQ----YEAKLYKIL 58
V ++ + I G G IYL + N V +K V + + Q E + +
Sbjct: 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV 136
Query: 59 QGGTGIPNLRWFGVEGDYNV-----LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 112
I + F D + +V++ + G SL+ +KL + + +++
Sbjct: 137 VH-PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEIL 192
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 172
+ ++HS ++ D+KP+N ++ Q+ +ID G R L
Sbjct: 193 PALSYLHSIGLVYNDLKPENIML----TEEQLKLIDLGAVSRINSFGY-----------L 237
Query: 173 TGTARYASMNTHLGIEQSR-----RDDLESLGYVLMYFLRGSLPWQG 214
GT + + E R D+ ++G L G
Sbjct: 238 YGTPGFQAP------EIVRTGPTVATDIYTVGRTLAALTLDLPTRNG 278
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 52/263 (19%), Positives = 89/263 (33%), Gaps = 53/263 (20%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPN 66
N++ L +IG GS+G + L N N A+K+ K K L +A + P
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKK---LIRQAGFPRRPPPRGTRPA 69
Query: 67 LRWFGVEGDY-----------------NVL----VIDLLGPS-----LE-----DLFNFC 95
NV+ V+D E +
Sbjct: 70 PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP 129
Query: 96 SR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154
+ LS +I +E++H + +HRDIKP N L+G + I DFG++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNE 186
Query: 155 YRDTATHQHIPYRENKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYFLRGSL 210
++ + N GT + + T + D+ ++G L F+ G
Sbjct: 187 FKGSDALLS-------NTVGTPAFMAPESLSETRKIFS-GKALDVWAMGVTLYCFVFGQC 238
Query: 211 PWQGLKAGTKKQKYEKISEKKVS 233
P+ + KI + +
Sbjct: 239 PFMD---ERIMCLHSKIKSQALE 258
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 55/268 (20%), Positives = 96/268 (35%), Gaps = 44/268 (16%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKL 54
M R + + IG+GS+G + + K + K L E L
Sbjct: 1 MPSRA-EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ-MLVSEVNL 58
Query: 55 YKILQGGTGIPNL-----RWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK---LSLKTVL 105
+ L+ PN+ R +V++ G L + +++ L + VL
Sbjct: 59 LRELKH----PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 106 MLADQMINRVEFVHSKSF-----LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160
+ Q+ ++ H +S LHRD+KP N + V + DFGLA+ +
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTS 171
Query: 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQG----- 214
K GT Y S + + + D+ SLG L+Y L P+
Sbjct: 172 F-------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG-CLLYELCALMPPFTAFSQKE 223
Query: 215 LKAGTKKQKYEKISEKKVSTSIEALCRG 242
L ++ K+ +I + S + +
Sbjct: 224 LAGKIREGKFRRIPY-RYSDELNEIITR 250
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 41/169 (24%), Positives = 74/169 (43%), Gaps = 20/169 (11%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYK 56
+ + + + ++G G+F + + T E A K+ K +L+ EA++ +
Sbjct: 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 83
Query: 57 ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLAD 109
LQ PN +R + + LV DL+ G +LF +R S
Sbjct: 84 KLQH----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQ 135
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
Q++ + + HS +HR++KP+N L+ + V + DFGLA D+
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 44/184 (23%), Positives = 72/184 (39%), Gaps = 28/184 (15%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPN-LRW 69
L IG G FGE++ G EEVA+K+ + EA++Y+ + N L +
Sbjct: 46 LQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRH--ENILGF 101
Query: 70 FGVEGDYNVLVIDLL-------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK- 121
+ N L SL D N ++++ ++ LA + + +H +
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 122 -------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 174
+ HRD+K N L+ ++ I D GLA R+ I + G
Sbjct: 160 VGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIA---PNHRVG 213
Query: 175 TARY 178
T RY
Sbjct: 214 TKRY 217
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 39/180 (21%), Positives = 72/180 (40%), Gaps = 26/180 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQGGTGIP 65
+ + +G G+FG + ++VAIK + +++ E + + P
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKAFIVELRQLSRVNH----P 61
Query: 66 N-LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS- 120
N ++ +G + LV++ G SL ++ + + + Q V ++HS
Sbjct: 62 NIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 121 --KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 178
K+ +HRD+KP N L L + I DFG A + T N G+A +
Sbjct: 122 QPKALIHRDLKPPNLL--LVAGGTVLKICDFGTACDIQTHMT----------NNKGSAAW 169
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 42/209 (20%), Positives = 68/209 (32%), Gaps = 44/209 (21%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKL 54
M+ R +F KIGSG FG ++ AIK + L+
Sbjct: 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 55 YKILQGGTGIPN-LRWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSL---KTVLML 107
+ Q + +R+F E D+ ++ + G SL D + R +S + L
Sbjct: 65 AVLGQ----HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 108 ADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYII---------------DFGL 151
Q+ + ++HS S +H DIKP N F+ D G
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 152 AKRYRDTATHQHIPYRENKNLTGTARYAS 180
R G +R+ +
Sbjct: 181 VTRISSPQV-----------EEGDSRFLA 198
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 46/190 (24%), Positives = 84/190 (44%), Gaps = 29/190 (15%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTG 63
+V + + +G ++GSG F + T E A K +K + + + ++
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKF-IKKRQSRASRRGVCREEIEREVS 67
Query: 64 I------PNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQ 110
I PN+ V VL+++L+ G +LF+F ++K SL + Q
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSFIKQ 123
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKRYRDTATHQHIPYRE 168
+++ V ++H+K H D+KP+N ++ L + + +IDFGLA D
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGVEF------- 175
Query: 169 NKNLTGTARY 178
KN+ GT +
Sbjct: 176 -KNIFGTPEF 184
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 49/251 (19%), Positives = 92/251 (36%), Gaps = 50/251 (19%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--------HPQLQYEAKLYKILQ 59
+ L IG G F + N +T ++ A+K+ K L+ EA + +L+
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 60 GGTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLAD----- 109
P++ D + +V + + DL ++ V A
Sbjct: 85 H----PHIVELLETYSSDGMLYMVFEFMDGA----DLCFEIVKRADAGFVYSEAVASHYM 136
Query: 110 -QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 168
Q++ + + H + +HRD+KP L+ + V + FG+A + +
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-------SGLV 189
Query: 169 NKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLP-WQGLKAGTKKQ 222
GT + + G D+ G V+++ L G LP + GTK++
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPV----DVWGCG-VILFILLSGCLPFY-----GTKER 239
Query: 223 KYEKISEKKVS 233
+E I + K
Sbjct: 240 LFEGIIKGKYK 250
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 47/192 (24%), Positives = 77/192 (40%), Gaps = 44/192 (22%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYK--------ILQ--- 59
+ ++IG G +GE+++G E+VA+K+ T+ E ++Y+ IL
Sbjct: 41 MVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 60 ----GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 114
G L + L+ D SL D S L K++L LA ++
Sbjct: 99 ADIKGTGSWTQL-Y---------LITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSG 146
Query: 115 VEFVHSKSF--------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166
+ +H++ F HRD+K N L+ ++ I D GLA ++ IP
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIP- 202
Query: 167 RENKNLTGTARY 178
GT RY
Sbjct: 203 --PNTRVGTKRY 212
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 46/188 (24%), Positives = 81/188 (43%), Gaps = 27/188 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGI 64
V + + G ++GSG F + T + A K +K + + + ++ I
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKF-IKKRRTKSSRRGVSREDIEREVSI 67
Query: 65 ------PNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQM 111
PN+ V E +V L+++L+ G +LF+F + K SL + Q+
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQI 123
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMG-LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 170
+N V ++HS H D+KP+N ++ ++ IIDFGLA + K
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--------K 175
Query: 171 NLTGTARY 178
N+ GT +
Sbjct: 176 NIFGTPEF 183
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 36/178 (20%), Positives = 65/178 (36%), Gaps = 49/178 (27%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------------HP 46
++ + IGSG+FG L + T E VA+K + HP
Sbjct: 18 DSD-RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHP 76
Query: 47 QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLE-----DLFNF-CSR-KL 99
+ + +++ T + ++ E +L+ C+ +
Sbjct: 77 NI---VRFKEVILTPTHL-----------AIIM---------EYASGGELYERICNAGRF 113
Query: 100 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
S Q+++ V + HS HRD+K +N L+ G A ++ I DFG +K
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL 170
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 31/167 (18%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--NVKTKHPQLQYEAKLYKILQGGT 62
V ++ + + IG GSFG++ + + ++ VA+K+ N K H Q E + IL+
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR---ILE--- 148
Query: 63 GIPNLRWFGVEGDYNV--------------LVIDLLGPSLEDLF---NFCSRKLSLKTVL 105
+LR + NV + +LL +L +L F + SL V
Sbjct: 149 ---HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF--QGFSLPLVR 203
Query: 106 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152
A ++ ++ +H +H D+KP+N L+ R + + +IDFG +
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVIDFGSS 249
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 38/169 (22%), Positives = 66/169 (39%), Gaps = 22/169 (13%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLY--------K 56
K+ IG G + + T E A+K+ T + +
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 57 ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLAD 109
IL+ G P+ + E + LV DL+ G +LF++ + LS K +
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTEKVALSEKETRSIMR 207
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
++ V F+H+ + +HRD+KP+N L L + + DFG +
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENIL--LDDNMQ-IRLSDFGFSCHLEPG 253
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 5/160 (3%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGI 64
+ ++L RK+G G + E++ NI NE+V +K+ K +++ E K+ + L+GG I
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNI 93
Query: 65 PNLRWFGVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 123
L + D L+ + + F + L+ + +++ +++ HS
Sbjct: 94 ITL--ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGI 151
Query: 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163
+HRD+KP N ++ R ++ +ID+GLA+ Y +
Sbjct: 152 MHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNV 189
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 39/165 (23%), Positives = 77/165 (46%), Gaps = 18/165 (10%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---NVKTKHPQLQYEAKLYKILQ 59
+ F +GSG+F E++L T + A+K + + L+ E + K ++
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 60 GGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQMI 112
N + + E + LV+ L+ G +LF+ R + K ++ Q++
Sbjct: 65 H----ENIVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERGVYTEKDASLVIQQVL 116
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
+ V+++H +HRD+KP+N L +++ I DFGL+K ++
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 40/185 (21%), Positives = 74/185 (40%), Gaps = 17/185 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY---EAKLYKILQGGTG 63
+ G +G G FG+ T+ +T E + +K ++ + E K+ + L+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH--- 66
Query: 64 IPN-LRWFGV---EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 118
PN L++ GV + N + + + G +L + + + A + + + ++
Sbjct: 67 -PNVLKFIGVLYKDKRLN-FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 178
HS + +HRD+ N L+ V + DFGLA R Q R K RY
Sbjct: 125 HSMNIIHRDLNSHNCLVR---ENKNVVVADFGLA-RLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 179 ASMNT 183
+
Sbjct: 181 TVVGN 185
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 41/191 (21%), Positives = 64/191 (33%), Gaps = 42/191 (21%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYK--------ILQ--- 59
L +G G +GE++ G+ E VA+K+ E +LY IL
Sbjct: 12 LLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 60 ---GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
W L+ SL D L + L + + + +
Sbjct: 70 SDMTSRHSSTQLW---------LITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGL 118
Query: 116 EFVHSKSF--------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167
+H + F HRD+K N L+ ++ Q I D GLA + + +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVG-- 173
Query: 168 ENKNLTGTARY 178
N GT RY
Sbjct: 174 -NNPRVGTKRY 183
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 53/236 (22%), Positives = 99/236 (41%), Gaps = 48/236 (20%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQL----------QYEAK 53
+ +++ LG +G G E++L +++ + +VA+K+ L + EA+
Sbjct: 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV----LRADLARDPSFYLRFRREAQ 64
Query: 54 LYKILQGGTGIPNL-------RWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVL 105
L P + G +V++ + G +L D+ + ++ K +
Sbjct: 65 NAAALNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAI 119
Query: 106 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165
+ + F H +HRD+KP N ++ N V ++DFG+A+ D+
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGN----S 172
Query: 166 YRENKNLTGTARYASMNTHLGIEQSR------RDDLESLGYVLMY-FLRGSLPWQG 214
+ + GTA+Y S EQ+R R D+ SLG ++Y L G P+ G
Sbjct: 173 VTQTAAVIGTAQYLSP------EQARGDSVDARSDVYSLG-CVLYEVLTGEPPFTG 221
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 39/167 (23%), Positives = 72/167 (43%), Gaps = 20/167 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKI 57
R +++L ++G G+F + + +E A + K H +L+ EA++ ++
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 58 LQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQ 110
L+ PN +R + + L+ DL+ G +LF +R S Q
Sbjct: 67 LKH----PNIVRLHDSISEEGHHYLIFDLVTGG----ELFEDIVAREYYSEADASHCIQQ 118
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
++ V H +HR++KP+N L+ + V + DFGLA
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 37/169 (21%), Positives = 69/169 (40%), Gaps = 29/169 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKLYKILQG 60
K+ +KIG GSFG+ L + + + IK ++ K + + + E + ++
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE-ESRREVAVLANMKH 82
Query: 61 GTGIPN-LRWFGVEGDYNVLVIDLLGPSLE-----DLFNFCSRK----LSLKTVLMLADQ 110
PN +++ + L I ++ DLF + + +L Q
Sbjct: 83 ----PNIVQYRESFEENGSLYI-----VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ 133
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159
+ ++ VH + LHRDIK N + + V + DFG+A+ T
Sbjct: 134 ICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTV 179
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 58/247 (23%), Positives = 96/247 (38%), Gaps = 39/247 (15%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGT 62
+ + + + IG GS+ + TN E A+K+ K+K + L + Q
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQH-- 75
Query: 63 GIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN--FCSRKLSLKTVLMLADQMINRV 115
PN + V + V +V +L+ G +L + + S + + + V
Sbjct: 76 --PNIITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQKFFSEREASAVLFTITKTV 129
Query: 116 EFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT- 173
E++H++ +HRD+KP N L + I DFG AK+ R EN L
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA----------ENGLLMT 179
Query: 174 --GTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEK 226
TA + + D+ SLG VL+Y L G P+ T ++ +
Sbjct: 180 PCYTANFVAPEVLERQGYDAAC----DIWSLG-VLLYTMLTGYTPFANGPDDTPEEILAR 234
Query: 227 ISEKKVS 233
I K S
Sbjct: 235 IGSGKFS 241
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 42/259 (16%), Positives = 87/259 (33%), Gaps = 50/259 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGI-- 64
N +R+ R + G F +I L N+ A+K K+ + + K
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 65 --------------PN-LRWFGVEGD----YNVL-------VIDLLGPSLEDLFNFCSRK 98
L G+ + Y + ++ L +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-EYFFVLDKNYTCF 147
Query: 99 LSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
+ ++ + + ++N ++H+ K+ HRD+KP N LM + +V + DFG ++ D
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESEYMVD 204
Query: 158 TATHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 214
GT + ++ + D+ SLG + +Y +P+
Sbjct: 205 KKIK---------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLG-ICLYVMFYNVVPFSL 254
Query: 215 LKAGTKKQKYEKISEKKVS 233
+ + + I K +
Sbjct: 255 --KISLVELFNNIRTKNIE 271
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 44/170 (25%), Positives = 71/170 (41%), Gaps = 24/170 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LNVKTKHPQLQYEAKLYKILQ 59
FR+ +KIG G F E+Y + VA+K ++ K + E L K L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLN 90
Query: 60 GGTGIPN-LRWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSL---KTVLMLADQMI 112
PN ++++ + N L I L L + ++ L +TV Q+
Sbjct: 91 H----PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 113 NRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATH 161
+ +E +HS+ +HRDIKP N F+ V + D GL + + T
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTA 192
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 48/225 (21%), Positives = 89/225 (39%), Gaps = 34/225 (15%)
Query: 3 PRVGNKFRLGRK-IGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYK---IL 58
R + ++L +G G+ + N+ T++E A+K+ K +++++ +L
Sbjct: 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEML 64
Query: 59 QGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLF-------NFCSRKLSLKTVLM 106
G N L E + LV + + G + +F + S +
Sbjct: 65 YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG----SILSHIHKRRHFNELEAS-----V 115
Query: 107 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166
+ + + ++F+H+K HRD+KP+N L + + V I DF L + I
Sbjct: 116 VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 167 RENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYFL 206
E G+A Y + + DL SLG V++Y L
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYIL 219
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 40/228 (17%), Positives = 75/228 (32%), Gaps = 47/228 (20%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYK--------IL 58
+ +L IG G +G +Y G+ VA+K+ E +Y+ I
Sbjct: 13 DNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIA 70
Query: 59 Q------GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM 111
+ T + + LV++ SL + + LA +
Sbjct: 71 RFIVGDERVTADGRMEYL--------LVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHSV 120
Query: 112 INRVEFVHS---------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162
+ ++H+ + HRD+ N L+ + I DFGL+ R +
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVR 177
Query: 163 HIPY-RENKNLTGTARY-------ASMNTHLGIEQSRRDDLESLGYVL 202
+ GT RY ++N ++ D+ +LG +
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 44/184 (23%), Positives = 78/184 (42%), Gaps = 55/184 (29%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----------------- 44
++G+ + LG +G G+FG++ +G + T +VA+K+ + K
Sbjct: 12 RVKIGH-YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70
Query: 45 ----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLE-----DLFNFC 95
HP + KLY+++ + I +V +E +LF++
Sbjct: 71 KLFRHPHI---IKLYQVISTPSDI-------------FMV-------MEYVSGGELFDYI 107
Query: 96 SRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+ L K L Q+++ V++ H +HRD+KP+N L L N I DFGL+
Sbjct: 108 CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSN 164
Query: 154 RYRD 157
D
Sbjct: 165 MMSD 168
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 32/189 (16%)
Query: 4 RVGNKFRLGRK--IGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ----LQYEAKLYKI 57
V + + + + +G G FG+++ T ++A K+ +KT+ + ++ E +
Sbjct: 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKI-IKTRGMKDKEEVKNEISVMNQ 142
Query: 58 LQGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLAD 109
L NL + + + VLV++ + G +LF+ + L+ ++
Sbjct: 143 LDH----ANLIQLYDAFESKNDIVLVMEYVDGG----ELFDRIIDESYNLTELDTILFMK 194
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 169
Q+ + +H LH D+KP+N L + R A Q+ IIDFGLA+RY+ P +
Sbjct: 195 QICEGIRHMHQMYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYK--------PREKL 245
Query: 170 KNLTGTARY 178
K GT +
Sbjct: 246 KVNFGTPEF 254
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 49/238 (20%), Positives = 77/238 (32%), Gaps = 51/238 (21%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYK--------IL 58
+L G FG ++ NE VA+K+ Q E ++Y IL
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 59 Q------GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM 111
Q GT + W L+ SL D + +S + +A+ M
Sbjct: 82 QFIGAEKRGTSVDVDLW---------LITAFHEKGSLSDFLK--ANVVSWNELCHIAETM 130
Query: 112 INRVEFVHSKSF----------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161
+ ++H HRDIK N L+ + I DFGLA ++ +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSA 187
Query: 162 QHIPYRENKNLTGTARY-----ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
+ GT RY + + R D+ ++G VL G
Sbjct: 188 G-----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 41/192 (21%), Positives = 77/192 (40%), Gaps = 38/192 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKL-------NVKTKHPQLQYEAKLYKIL 58
+ L IG G FG++Y +EVA+K ++ ++ EAKL+ +L
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 59 QGGTGIPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 114
+ PN+ GV + LV++ G L + + +++ ++ A Q+
Sbjct: 64 KH----PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARG 117
Query: 115 VEFVHSK---SFLHRDIKPDNFLMGLGRRANQVY-----IIDFGLAKRYRDTATHQHIPY 166
+ ++H + +HRD+K N L+ + I DFGLA+ + T
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-------- 169
Query: 167 RENKNLTGTARY 178
+ G +
Sbjct: 170 -TKMSAAGAYAW 180
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 31/149 (20%), Positives = 64/149 (42%), Gaps = 8/149 (5%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWF 70
+ +G G G++ N +T E+ A+K + P+ + E +L+ I +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 71 ---GVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 124
G + +V++ L G + + + + + + + ++++HS +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 139
Query: 125 HRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
HRD+KP+N L R + + DFG AK
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 23/164 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--NVKTKHPQLQYEAKLYKILQGGT 62
+++ + IG GSFG++ + E VAIK+ N K Q Q E +L +++
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHD 111
Query: 63 G------IPNLRWFGVEGDYN---VLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQ 110
+ R F + LV ++L +L DL NF R +SL A Q
Sbjct: 112 TEMKYYIVHLKRHF----MFRNHLCLVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQ 165
Query: 111 MINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152
M + F+ + S +H D+KP+N L+ +R + + I+DFG +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKR-SAIKIVDFGSS 208
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 41/170 (24%), Positives = 68/170 (40%), Gaps = 24/170 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY--------EAKLYKIL 58
K+ KIG GS+G ++ N T + VAIK K + E ++ K L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 59 QGGTGIPNL-RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
+ PNL V LV + ++ + R + V + Q + V
Sbjct: 60 KH----PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAV 115
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQ 162
F H + +HRD+KP+N L+ + + + + DFG A+ D +
Sbjct: 116 NFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDE 162
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 20/160 (12%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ-----LQYEAKLYKILQGG 61
F R+IG GSFG +Y +++ +E VAIK ++ K + E + + L+
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 113
Query: 62 TGIPNL-RWFG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 118
PN ++ G + LV++ S DL + L + + + + ++
Sbjct: 114 ---PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG----LAKR 154
HS + +HRD+K N L+ V + DFG +A
Sbjct: 171 HSHNMIHRDVKAGNILLSE---PGLVKLGDFGSASIMAPA 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 16/164 (9%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ-LQYEAKLYKILQGG 61
+ + F + ++G G+ +Y T + A+K+ KT + ++ E + L
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH- 107
Query: 62 TGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQMINR 114
PN ++ + E + LV++L+ G +LF+ + S + Q++
Sbjct: 108 ---PNIIKLKEIFETPTEISLVLELVTGG----ELFDRIVEKGYYSERDAADAVKQILEA 160
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
V ++H +HRD+KP+N L + I DFGL+K
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 40/206 (19%), Positives = 80/206 (38%), Gaps = 15/206 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP--QLQYEAKLYKILQ----- 59
++ + RK+G G F ++L +IQ + VA+K+ +H E +L K ++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 60 --GGTGIPNLR-WF---GVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMI 112
+ L F GV G + +V ++LG L + L L V + Q++
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 113 NRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 171
++++H+K +H DIKP+N L+ + + + + +R
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 172 LTGTARYASMNTHLGIEQSRRDDLES 197
+ + + DL +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGN 242
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-14
Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 24/169 (14%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LNVKTKHPQLQYEAKLYKILQGGTG 63
+ +IG GSF +Y G + +T EVA K++ + + EA++ K LQ
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH--- 84
Query: 64 IPNL-----RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
PN+ W +V+ +L+ + + +K + Q++ +
Sbjct: 85 -PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGL 142
Query: 116 EFVHSKS--FLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATH 161
+F+H+++ +HRD+K DN F+ G V I D GLA R +
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLGLATLKRASFAK 188
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 9e-14
Identities = 49/231 (21%), Positives = 93/231 (40%), Gaps = 43/231 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIK-LNVKTKHPQL----QYEAKLYKILQG 60
+ KIG+GSFG ++ + +VA+K L + H + E + K L+
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 61 GTGIPN-LRWFGV--EGDYNVLVIDLL-GPSLEDLF--NFCSRKLSLKTVLMLADQMINR 114
PN + + G + +V + L SL L + +L + L +A +
Sbjct: 94 ----PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 115 VEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 172
+ ++H+++ +HR++K N L+ + V + DFGL++ T + +K+
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKAST-------FLSSKSA 199
Query: 173 TGTARYASM------NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 217
GT + M + + + D+ S G +L PW L
Sbjct: 200 AGTPEW--MAPEVLRDEPS----NEKSDVYSFGVILWELATLQQPWGNLNP 244
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 44/170 (25%), Positives = 66/170 (38%), Gaps = 24/170 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY--------EAKLYKIL 58
K+ +G GS+G + N T VAIK K E KL K L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 59 QGGTGIPNL-RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
+ NL V LV + + ++ D L + V Q+IN +
Sbjct: 82 RH----ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQ 162
F HS + +HRDIKP+N L+ ++ V + DFG A+ + +
Sbjct: 138 GFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDE 184
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 47/179 (26%), Positives = 72/179 (40%), Gaps = 31/179 (17%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-HPQLQY----------E 51
++ +G G F +Y + TN+ VAIK K K + + E
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK---KIKLGHRSEAKDGINRTALRE 62
Query: 52 AKLYKILQGGTGIPN-LRWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTV--LM 106
KL + L PN + G + LV D + LE + S L+ + M
Sbjct: 63 IKLLQELSH----PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM 118
Query: 107 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 162
L + +E++H LHRD+KP+N L+ + + DFGLAK + THQ
Sbjct: 119 L--MTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYTHQ 172
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 31/153 (20%), Positives = 64/153 (41%), Gaps = 8/153 (5%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWF 70
+ +G G G++ N +T E+ A+K + P+ + E +L+ I +
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 71 ---GVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 124
G + +V++ L G + + + + + + + ++++HS +
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 183
Query: 125 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
HRD+KP+N L R + + DFG AK
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 34/149 (22%), Positives = 68/149 (45%), Gaps = 8/149 (5%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNL 67
+ + ++G G+FG++Y N +T A K+ +L+ +IL P +
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH-PYI 78
Query: 68 -RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 123
+ G ++I+ G +++ + R L+ + ++ QM+ + F+HSK
Sbjct: 79 VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 138
Query: 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLA 152
+HRD+K N LM + + DFG++
Sbjct: 139 IHRDLKAGNVLMT---LEGDIRLADFGVS 164
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 43/170 (25%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY--------EAKLYKIL 58
K+ KIG G++G ++ N +T+E VA+K + + E L K L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKEL 58
Query: 59 QGGTGIPN-LRWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
+ N +R V LV + L+ F+ C+ L + V Q++ +
Sbjct: 59 KH----KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 162
F HS++ LHRD+KP N L+ R ++ + +FGLA+ + + +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRCYSAE 161
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 30/161 (18%), Positives = 69/161 (42%), Gaps = 9/161 (5%)
Query: 4 RVGNKFRLGRK-IGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGT 62
V + ++L ++ +G G G++ + +T ++ A+K + P+ + E + GG
Sbjct: 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK--LLYDSPKARQEVDHHWQASGGP 82
Query: 63 GIPNLRWF---GVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 116
I + G + ++++ + G + + + + + + ++
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 117 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
F+HS + HRD+KP+N L + + + DFG AK
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 35/156 (22%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQGGTGIPN 66
F + K+G GS+G +Y + +T + VAIK + V++ ++ E + + P+
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS----PH 85
Query: 67 L-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 122
+ +++G + +V++ S+ D+ ++ L+ + + + +E++H
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
+HRDIK N L+ + DFG+A + DT
Sbjct: 146 KIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDT 178
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 43/173 (24%), Positives = 69/173 (39%), Gaps = 31/173 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY---EAKLYKIL 58
+ + + IG+GSFG +Y + E VAIK K + ++ E ++ + L
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KVLQDK-RFKNRELQIMRKL 104
Query: 59 QGGTGIPN---LRWF------GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD 109
N LR+F + Y LV+D + E ++ K L +
Sbjct: 105 DH----CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVIY 157
Query: 110 ------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156
Q+ + ++HS HRDIKP N L L + + DFG AK+
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQLV 208
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 33/164 (20%), Positives = 73/164 (44%), Gaps = 15/164 (9%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIP 65
F L +G+G++G++Y G +++T + AIK+ + + + + +L+ +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEEIKQEINMLKKYSHHR 81
Query: 66 N--------LRWFGVEGDYNV-LVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINR 114
N ++ D + LV++ S+ DL L + + + +++
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
+ +H +HRDIK N L+ +V ++DFG++ + T
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRT 182
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 42/180 (23%), Positives = 70/180 (38%), Gaps = 22/180 (12%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQL---QYEAKLYKIL 58
+ + L IGSG+ + E+VAIK +N++ + E +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 59 QGGTGIPN-LRWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM--I 112
PN + ++ V D LV+ LL G S+ D+ K K+ ++ + I
Sbjct: 71 HH----PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 113 NR-----VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167
R +E++H +HRD+K N L+G V I DFG++ R
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVR 183
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 41/194 (21%), Positives = 77/194 (39%), Gaps = 48/194 (24%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--NVKTKHPQLQYEAKLYKILQ--- 59
+ N F + RK+G G+FG + L +I + A+K+ N+K + EA + K +Q
Sbjct: 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDD 92
Query: 60 -GGTGIPNLR-WFGVEGDYN---VLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQM 111
I F Y L+ + LGPSL ++ N+ ++ + + ++
Sbjct: 93 INNNNIVKYHGKF----MYYDHMCLIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEI 146
Query: 112 INRVEFVHSKSFLHRDIKPDNFLM----------------------GLGRRANQVYIIDF 149
+ + ++ S H D+KP+N L+ ++ + +IDF
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 150 GLAKRYRDTATHQH 163
G AT +
Sbjct: 207 G-------CATFKS 213
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 37/172 (21%), Positives = 72/172 (41%), Gaps = 29/172 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY----------EAKLYK 56
+ K+G G++ +Y G + T+ VA+K + + L++ E L K
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALK---EIR---LEHEEGAPCTAIREVSLLK 55
Query: 57 ILQGGTGIPN-LRWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 113
L+ N + + LV + L L+ + C +++ V + Q++
Sbjct: 56 DLKH----ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 162
+ + H + LHRD+KP N L+ ++ + DFGLA+ T ++
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNE 160
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 41/158 (25%), Positives = 79/158 (50%), Gaps = 17/158 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQL---QYEAKLYKILQGGTGI 64
F KIG GSFGE++ G + +T + VAIK ++++ ++ Q E +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS---- 79
Query: 65 PNL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
P + +++G ++ ++++ L G S DL L + + +++ ++++HS
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHS 137
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
+ +HRDIK N L+ +V + DFG+A + DT
Sbjct: 138 EKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDT 172
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 41/173 (23%), Positives = 69/173 (39%), Gaps = 31/173 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQLQYEAKLYKIL 58
+ ++F++ R G G+FG + LG T VAIK + + ++ +LQ + +L
Sbjct: 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVL 76
Query: 59 QGGTGIPN---LRWF----GVEGD---YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA 108
PN L+ + G Y +V++ + + L C +
Sbjct: 77 HH----PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPPI 129
Query: 109 D------QMINRVEFVHSKSF--LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
Q+I + +H S HRDIKP N L + + + DFG AK
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL--VNEADGTLKLCDFGSAK 180
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 57/262 (21%), Positives = 94/262 (35%), Gaps = 75/262 (28%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------NVKT--------KH 45
+ F + R IG GSFG++ + T + A+K NV +H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 46 P---QLQY----EAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCS 96
P L Y E ++ +V+DLL G DL
Sbjct: 75 PFLVNLWYSFQDEEDMF-----------------------MVVDLLLGG----DLRYHLQ 107
Query: 97 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154
+ +TV + +++ ++++ ++ +HRD+KPDN L+ V+I DF +A
Sbjct: 108 QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAM 164
Query: 155 YRDTATHQHIPYRENKNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMY-FLRGSL 210
+ GT Y + ++ G S D SLG V Y LRG
Sbjct: 165 LPRETQI--------TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG-VTAYELLRGRR 215
Query: 211 PWQGLKAGTKKQKYEKISEKKV 232
P+ + + K+ V
Sbjct: 216 PYHIRSSTSSKEIVHTFETTVV 237
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 24/172 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY--------EAKLYKIL 58
+++R K+G G++GE+Y + TNE VAIK + + + E L K L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 59 QGGTGIPN-LRWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
Q N + V + L+ + L+ + +S++ + Q+IN V
Sbjct: 91 QH----RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN-PDVSMRVIKSFLYQLINGV 145
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKRYRD---TATHQ 162
F HS+ LHRD+KP N L+ + + + I DFGLA+ + TH+
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 3e-12
Identities = 47/171 (27%), Positives = 71/171 (41%), Gaps = 25/171 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY--------EAKLYKIL 58
F+ KIG G++G +Y N T E VA+K K + E L K L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALK---KIRLDTETEGVPSTAIREISLLKEL 59
Query: 59 QGGTGIPN-LRWFGVEGDYN--VLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINR 114
PN ++ V N LV + L L+ + + + L + Q++
Sbjct: 60 NH----PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 162
+ F HS LHRD+KP N L+ + + DFGLA+ + T TH+
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHE 163
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQLQYEAKLYKILQGGTGI 64
K+ KIG G+ G +Y ++ T +EVAI+ L + K + E + + +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN---- 76
Query: 65 PNL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
PN+ + + GD +V++ L G SL D+ + + + + + +EF+HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS 134
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152
+HRDIK DN L+G V + DFG
Sbjct: 135 NQVIHRDIKSDNILLG---MDGSVKLTDFGFC 163
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 43/180 (23%), Positives = 72/180 (40%), Gaps = 31/180 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA--------------------IKLNVKTKHP 46
+K+ KIG G+FGE++ + +T ++VA IK+ KH
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 47 QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 106
+ L +I + N + Y LV D L L + K +L +
Sbjct: 77 NV---VNLIEICRTKASPYNRCKGSI---Y--LVFDFCEHDLAGLLSNVLVKFTLSEIKR 128
Query: 107 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 166
+ ++N + ++H LHRD+K N L+ R + + DFGLA+ + Q Y
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY 185
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 34/169 (20%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY---EAKLYKILQG 60
+ + + IG+GSFG ++ ++++E VAIK K + ++ E ++ +I++
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIK---KVLQDK-RFKNRELQIMRIVKH 91
Query: 61 GTGIPN---LRWF-------GVEGDYNVLVIDLLGPSLEDL------FNFCSRKLSLKTV 104
PN L+ F E N LV++ + E + + + + + +
Sbjct: 92 ----PNVVDLKAFFYSNGDKKDEVFLN-LVLEYVP---ETVYRASRHYAKLKQTMPMLLI 143
Query: 105 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+ Q++ + ++HS HRDIKP N L L + + +IDFG AK
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLL--LDPPSGVLKLIDFGSAK 190
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 5e-12
Identities = 54/258 (20%), Positives = 97/258 (37%), Gaps = 74/258 (28%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------NV--KTKHP- 46
F+ G+ +G GSF + L + T+ E AIK+ +V + HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 47 --QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 97
+L + + KLY L + G +L + +
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNG----------------------------ELLKYIRK 123
Query: 98 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155
++++ +E++H K +HRD+KP+N L+ + I DFG AK
Sbjct: 124 IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVL 180
Query: 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 214
+ + GTA+Y S + DL +LG ++Y + G P+
Sbjct: 181 SPESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPF-- 232
Query: 215 LKAGTKKQKYEKISEKKV 232
+AG + ++KI + +
Sbjct: 233 -RAGNEYLIFQKIIKLEY 249
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 7e-12
Identities = 22/187 (11%), Positives = 50/187 (26%), Gaps = 37/187 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIK-LNVKTKHPQL----QYEAKLYKILQG 60
+ K+ GE++ G ++ +K L V+ + E +I
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 61 GTGIPN-LRWFGV----EGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMIN 113
PN L G + L+ + SL + L + + + A M
Sbjct: 67 ----PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 114 RVEFVHSKSF--LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 171
+ F+H+ + + ++ I + ++
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKFSFQSPGR----------- 168
Query: 172 LTGTARY 178
+
Sbjct: 169 -MYAPAW 174
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 35/182 (19%), Positives = 64/182 (35%), Gaps = 47/182 (25%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKL--NVKTKHPQLQYEAKLYKILQGG 61
+ ++ + +G G+FG++ + + VA+K+ NV + E + +L+
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VLE-- 66
Query: 62 TGIPNLRWFGVEGDYNV--------------LVIDLLGPSLEDL---FNFCSRKLSLKTV 104
+L + +V +LLG S D F L +
Sbjct: 67 ----HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGF--LPFRLDHI 120
Query: 105 LMLADQMINRVEFVHSKSFLHRDIKPDNFLM----------------GLGRRANQVYIID 148
+A Q+ V F+HS H D+KP+N L + ++D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 149 FG 150
FG
Sbjct: 181 FG 182
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 8e-12
Identities = 38/170 (22%), Positives = 67/170 (39%), Gaps = 27/170 (15%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY-----------EAKLYKILQGGT 62
+IG G++G +Y + + VA+K + P E L + L+
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALK---SVRVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 63 --GIPNLR----WFGVEGDYNV-LVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINR 114
+ L + + V LV + + L + L +T+ L Q +
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD--TATHQ 162
++F+H+ +HRD+KP+N L+ V + DFGLA+ Y T
Sbjct: 133 LDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIYSYQMALTPV 179
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 9e-12
Identities = 33/152 (21%), Positives = 70/152 (46%), Gaps = 16/152 (10%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQLQYEAKLYKILQGGTGI 64
KIG GS G + L + +VA+K L + + L E + + Q
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH---- 101
Query: 65 PNL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
N+ + + G+ ++++ L G +L D+ + +L+ + + + + ++ + ++H+
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHA 159
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152
+ +HRDIK D+ L+ +V + DFG
Sbjct: 160 QGVIHRDIKSDSILLT---LDGRVKLSDFGFC 188
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 1e-11
Identities = 45/180 (25%), Positives = 70/180 (38%), Gaps = 45/180 (25%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---------------------KH 45
K+ KIG G++G +Y N E A+K ++ KH
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALK-KIRLEKEDEGIPSTTIREISILKELKH 59
Query: 46 PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL 105
KLY ++ + VLV + L L+ L + C L T
Sbjct: 60 S---NIVKLYDVIHTKKRL-------------VLVFEHLDQDLKKLLDVCEGGLESVTAK 103
Query: 106 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 162
Q++N + + H + LHRD+KP N L+ R ++ I DFGLA+ + TH+
Sbjct: 104 SFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHE 160
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 32/182 (17%), Positives = 66/182 (36%), Gaps = 47/182 (25%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKL--NVKTKHPQLQYEAKLYKILQGG 61
+ ++ + +G G+FG++ + + +VA+K+ NV + E +L+
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VLK-- 71
Query: 62 TGIPNLRWFGVEGDYNV--------------LVIDLLGPSLEDL---FNFCSRKLSLKTV 104
++ E + + +LLG + + NF + L V
Sbjct: 72 ----KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF--QPYPLPHV 125
Query: 105 LMLADQMINRVEFVHSKSFLHRDIKPDNFLM----------------GLGRRANQVYIID 148
+A Q+ + + F+H H D+KP+N L + + + D
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 149 FG 150
FG
Sbjct: 186 FG 187
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 20/174 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQ---YEAKLYKILQGGT 62
LG +IG G+FGE++ G N VA+K EA++ K
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-- 171
Query: 63 GIPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 118
PN+ R GV + +V++L+ G +L +KT+L + +E++
Sbjct: 172 --PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH-----IPYR 167
SK +HRD+ N L+ N + I DFG+++ D +P +
Sbjct: 230 ESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 3e-11
Identities = 38/170 (22%), Positives = 66/170 (38%), Gaps = 25/170 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY--------EAKLYKIL 58
K++ K+G G++G +Y + VA+K + + E L K L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKD-SQGRIVALK---RIRLDAEDEGIPSTAIREISLLKEL 76
Query: 59 QGGTGIPN-LRWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
PN + V LV + + L+ + + L + + Q++ V
Sbjct: 77 HH----PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 162
H LHRD+KP N L+ + + DFGLA+ + + TH+
Sbjct: 133 AHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLARAFGIPVRSYTHE 179
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 43/196 (21%), Positives = 78/196 (39%), Gaps = 49/196 (25%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNV--KTKHPQLQY-EAKLYKILQG 60
+ + F+L +G G++G + T+ T E VAIK + K E K+
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI------ 62
Query: 61 GTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD---------- 109
L+ F E N++ + ++ P + FN ++ + LM D
Sbjct: 63 ------LKHFKHE---NIITIFNIQRPDSFENFN----EVYIIQELMQTDLHRVISTQML 109
Query: 110 ----------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDT 158
Q + V+ +H + +HRD+KP N L+ +N + + DFGLA+ ++
Sbjct: 110 SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCDFGLARIIDES 165
Query: 159 ATHQHIPYRENKNLTG 174
A P + +
Sbjct: 166 AADNSEPTGQQSGMVE 181
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 34/177 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY----------EAKLYK 56
++F+ K+G+G++ +Y G N T VA+K + K L E L K
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALK---EVK---LDSEEGTPSTAIREISLMK 58
Query: 57 ILQGGTGIPN-LRWFGVEGDYN--VLVIDLLGPSLEDL-----FNFCSRKLSLKTVLMLA 108
L+ N +R + V N LV + + L+ R L L V
Sbjct: 59 ELKH----ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 109 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 162
Q++ + F H LHRD+KP N L+ + Q+ + DFGLA+ + T + +
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFGIPVNTFSSE 168
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 36/195 (18%), Positives = 64/195 (32%), Gaps = 49/195 (25%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LNVKT------------KHP- 46
K+ LG+ +G+GSFG + +I++ + A+K L H
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVN 61
Query: 47 ----------------------QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84
+ + N ++++ +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN-VIMEYV 120
Query: 85 GPSLEDL------FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 138
+ L F R + + + + Q+ V F+HS HRDIKP N L +
Sbjct: 121 P---DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL--VN 175
Query: 139 RRANQVYIIDFGLAK 153
+ N + + DFG AK
Sbjct: 176 SKDNTLKLCDFGSAK 190
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 57/262 (21%), Positives = 91/262 (34%), Gaps = 78/262 (29%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LN--------------------VKTKHP- 46
+ + + IG G+FGE+ L + T + A+K L+ P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 47 --QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 97
QL Y + LY +++ GG DL N S
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGG----------------------------DLVNLMSN 162
Query: 98 -KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156
+ K +++ ++ +HS F+HRD+KPDN L+ ++ + + DFG +
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMN 219
Query: 157 DTATHQHIPYRENKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLP 211
+ GT Y S + R D S+G V +Y L G P
Sbjct: 220 KEGMVR------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG-VFLYEMLVGDTP 272
Query: 212 WQGLKAGTKKQKYEKISEKKVS 233
+ A + Y KI K S
Sbjct: 273 F---YADSLVGTYSKIMNHKNS 291
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 22/171 (12%)
Query: 3 PRVGNKF-RLGRKIGSGSFGEIYLGTN--IQTNEEVAIK-LNVKTKHPQLQYEAKLYKIL 58
RV + F G K+G G++G +Y + +++ A+K + E L + L
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL 75
Query: 59 QGGTGIPN----LRWFGVEGDYNV-LVID--------LLGPSLEDLFNFCSRKLSLKTVL 105
+ PN + F D V L+ D ++ N +L V
Sbjct: 76 KH----PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 106 MLADQMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRY 155
L Q+++ + ++H+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 33/168 (19%), Positives = 72/168 (42%), Gaps = 25/168 (14%)
Query: 14 KIGSGSFGEIYLGTNIQ-TNEEVAIKLNVKTKHPQLQY--------EAKLYKILQGGT-- 62
+IG G++G+++ +++ VA+K + + + E + + L+
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 63 GIPNLR----WFGVEGDYNV-LVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVE 116
+ L + + + LV + + L + + +T+ + Q++ ++
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 117 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD--TATHQ 162
F+HS +HRD+KP N L+ + Q+ + DFGLA+ Y T
Sbjct: 135 FLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV 179
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 26/85 (30%), Positives = 34/85 (40%), Gaps = 10/85 (11%)
Query: 102 KTVLMLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTAT 160
L + Q+ VEF+HSK +HRD+KP N F + V + DFGL
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MDDVVKVGDFGLVTAMDQDEE 219
Query: 161 HQHIPYRENKNLT-----GTARYAS 180
Q + T GT Y S
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMS 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 12/56 (21%), Positives = 22/56 (39%), Gaps = 1/56 (1%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKIL 58
R F + +G G FG ++ N + AIK + + + + + K L
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKAL 58
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 64/298 (21%), Positives = 115/298 (38%), Gaps = 56/298 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ-LQYEAKLYKILQGGTGI 64
+ K+G G +GE+Y G + + VA+K L T + EA + K ++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH---- 275
Query: 65 PNL-RWFGV--EGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 118
PNL + GV ++ + + G +L D L +++S +L +A Q+ + +E++
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYRENKNLTG 174
K+F+HR++ N L+G + V + DFGL++ P +
Sbjct: 335 EKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW------ 385
Query: 175 TARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKV 232
TA + S + D+ + G VL++ G P Y I +V
Sbjct: 386 TAPESLAYNKF----SIKSDVWAFG-VLLWEIATYGMSP------------YPGIDLSQV 428
Query: 233 STSIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 282
E L + Y P + C D+P +A + + F +F
Sbjct: 429 ---YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 483
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 21/160 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLG----TNIQTNEEVAIKL---NVKTKHPQ-LQYEAKLYKIL 58
+ R +G G FG++ L TN T E VA+K + +H + E + + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 59 QGGTGIPNL-RWFGV---EGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMIN 113
++ ++ G G ++ ++ P L L ++ + L +L+ A Q+
Sbjct: 91 YH----EHIIKYKGCCEDAGAASLQLVMEYVP-LGSLRDYLPRHSIGLAQLLLFAQQICE 145
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+ ++H++ ++HRD+ N L+ V I DFGLAK
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAK 182
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 41/177 (23%), Positives = 70/177 (39%), Gaps = 38/177 (21%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP-QLQYEAK---------- 53
+ + +GSG++G + + ++ E+VAIK K P Q + AK
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK---KLSRPFQSEIFAKRAYRELLLLK 78
Query: 54 ---------LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTV 104
L + P Y LV+ + DL K S + +
Sbjct: 79 HMQHENVIGLLDVF-----TPASSLRNFYDFY--LVMPFMQ---TDLQKIMGLKFSEEKI 128
Query: 105 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT 160
L QM+ ++++HS +HRD+KP N + + ++ I+DFGLA+ T
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDFGLARHADAEMT 181
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 39/177 (22%), Positives = 71/177 (40%), Gaps = 46/177 (25%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNV--KTKHPQLQY-EAKLYKILQGG 61
+G+++ + +G G G ++ + ++ VAIK V + + E K+
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKI------- 61
Query: 62 TGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTV-----LMLAD------ 109
+R + N++ V ++LGPS L + L +V M D
Sbjct: 62 -----IRRLDHD---NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE 113
Query: 110 --------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152
Q++ ++++HS + LHRD+KP N + + I DFGLA
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF--INTEDLVLKIGDFGLA 168
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 41/158 (25%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ-LQYEAKLYKILQGGTGI 64
+ K+G G +GE+Y G + + VA+K L T + EA + K ++
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH---- 68
Query: 65 PNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
PNL + GV ++ + + G L+ L +++S +L +A Q+ + +E++
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
K+F+HRD+ N L+G + V + DFGL++
Sbjct: 129 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTG 163
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 20/160 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIK-LNVKTKHPQ--LQYEAKLYKILQ 59
+ +++G G+FG + + T E VA+K L T+ + E ++ K LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 60 GGTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMIN 113
N+ ++ GV G N+ +I P SL D ++ +L Q+
Sbjct: 101 H----DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+E++ +K ++HRD+ N L+ N+V I DFGL K
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 193
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 5e-10
Identities = 34/155 (21%), Positives = 67/155 (43%), Gaps = 18/155 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ-LQYEAKLYKILQGGTGI 64
++ ++IGSG FG ++LG ++VAIK + + EA++ L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH---- 62
Query: 65 PNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFV 118
P L + +GV E LV + + L ++ + +T+L + + + ++
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFM--EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+HRD+ N L+G + + DFG+ +
Sbjct: 121 EEACVIHRDLAARNCLVG---ENQVIKVSDFGMTR 152
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 34/156 (21%), Positives = 68/156 (43%), Gaps = 20/156 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ--LQYEAKLYKILQGGTG 63
+++G+G FG + G + +VAIK + + ++ EAK+ L
Sbjct: 24 KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSH--- 78
Query: 64 IPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEF 117
L + +GV + ++ + + + L N+ + + +L + + +E+
Sbjct: 79 -EKLVQLYGVCTKQRPIFIITEYM--ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 118 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+ SK FLHRD+ N L+ V + DFGL++
Sbjct: 136 LESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSR 168
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 21/161 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL---NVKTKHPQ-LQYEAKLYKIL 58
+ R +G G FG++ L T E+VA+K H L+ E ++ + L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 59 QGGTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMI 112
N+ ++ G+ +G + +I P SL++ K++LK L A Q+
Sbjct: 81 YH----ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
++++ S+ ++HRD+ N L+ +QV I DFGL K
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK 174
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 7e-10
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 20/160 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIK-LNVKTKHPQ--LQYEAKLYKILQ 59
+ +++G G+FG + + T E VA+K L T+ + E ++ K LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 60 GGTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMIN 113
N+ ++ GV G N+ +I P SL D ++ +L Q+
Sbjct: 70 H----DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+E++ +K ++HRD+ N L+ N+V I DFGL K
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 162
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 9e-10
Identities = 39/161 (24%), Positives = 70/161 (43%), Gaps = 20/161 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ--LQYEAKLYKILQGGTG 63
+ L +++GSG FG + LG + +VA+K + + Q EA+ L
Sbjct: 8 EEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQ-EAQTMMKLSH--- 62
Query: 64 IPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEF 117
P L +++GV + +V + + S L N+ + L +L + + + F
Sbjct: 63 -PKLVKFYGVCSKEYPIYIVTEYI--SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 118 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
+ S F+HRD+ N L+ R V + DFG+ + D
Sbjct: 120 LESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDD 157
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 60/265 (22%), Positives = 90/265 (33%), Gaps = 81/265 (30%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LN--------------------VKTKHP- 46
F + + IG G+FGE+ + ++ A+K LN V
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 47 --QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 97
L Y + LY ++ GG DL S+
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGG----------------------------DLLTLLSK 167
Query: 98 ---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154
+L + +M+ ++ VH ++HRDIKPDN LM + + DFG +
Sbjct: 168 FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLK 224
Query: 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMY-FLRG 208
+ T Q + GT Y S +E + D SLG V MY L G
Sbjct: 225 LMEDGTVQ------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG-VCMYEMLYG 277
Query: 209 SLPWQGLKAGTKKQKYEKISEKKVS 233
P+ A + + Y KI K
Sbjct: 278 ETPFY---AESLVETYGKIMNHKER 299
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 62/308 (20%), Positives = 99/308 (32%), Gaps = 100/308 (32%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LN--------------------VKTKHP- 46
F + + IG G+F E+ + QT + A+K +N V
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 47 --QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 97
QL + E LY +++ GG DL S+
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGG----------------------------DLLTLLSK 154
Query: 98 ---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154
++ + +++ ++ VH ++HRDIKPDN L+ R + + DFG +
Sbjct: 155 FGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGSCLK 211
Query: 155 YRDTATHQHIPYRENKNLTGTARY-------ASMNTHLGIEQSRRDDLESLGYVLMY-FL 206
R T + + GT Y A D +LG V Y
Sbjct: 212 LRADGTVR------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG-VFAYEMF 264
Query: 207 RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 266
G P+ A + + Y KI K S+ + G P E R
Sbjct: 265 YGQTPFY---ADSTAETYGKIVHYKEHLSLPLVDEGVPEE-------ARDF--------- 305
Query: 267 YLKRLFRD 274
++RL
Sbjct: 306 -IQRLLCP 312
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 38/161 (23%), Positives = 67/161 (41%), Gaps = 22/161 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLNVKTKHPQ----LQYEAKLYKIL 58
+ ++G G+FG + L T VA+K ++ P Q E ++ K L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKAL 81
Query: 59 QGGTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMI 112
+ ++ GV G ++ ++ P L D +L +L+ + Q+
Sbjct: 82 HS----DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+E++ S+ +HRD+ N L+ V I DFGLAK
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAK 175
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 63/290 (21%), Positives = 113/290 (38%), Gaps = 54/290 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK--TKHPQLQYEAKLYKILQGGTGI 64
RL K+G G FGE+++GT VAIK EA++ K L+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 238
Query: 65 PNL-RWFGVEGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
L + + V + + ++ SL D L + L L ++ +A Q+ + + +V
Sbjct: 239 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYRENKNLTGTA 176
+++HRD++ N L+G + DFGLA+ D P + TA
Sbjct: 299 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 349
Query: 177 RYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVST 234
A++ + + D+ S G +L+ +G +P Y + ++V
Sbjct: 350 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVP------------YPGMVNREV-- 390
Query: 235 SIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276
++ + RGY P C +++P + YL+ D F
Sbjct: 391 -LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 40/178 (22%), Positives = 69/178 (38%), Gaps = 55/178 (30%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LNV--KTKHPQLQY-EAKLYKILQ 59
+ +++ + IG+GS+G + + VAIK L V + E +
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAI----- 105
Query: 60 GGTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------- 109
L + +V+ V+D++ P + F+ +L + + +D
Sbjct: 106 -------LNRLNHD---HVVKVLDIVIPKDVEKFD----ELYVVLEIADSDFKKLFRTPV 151
Query: 110 ------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLA 152
++ V++VHS LHRD+KP N L NQ V + DFGLA
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL------VNQDCSVKVCDFGLA 203
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 38/174 (21%), Positives = 66/174 (37%), Gaps = 49/174 (28%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNV--KTKHPQLQY-EAKLYKILQG 60
VG ++ IG G++G + + VAIK ++ + Q E K+
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI------ 78
Query: 61 GTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD---------- 109
L F E N++ + D++ + + + LM D
Sbjct: 79 ------LLRFRHE---NIIGINDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHL 125
Query: 110 ----------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 152
Q++ ++++HS + LHRD+KP N L+ + I DFGLA
Sbjct: 126 SNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLA 175
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 28/181 (15%), Positives = 63/181 (34%), Gaps = 19/181 (10%)
Query: 7 NKFRLGRKIGSG--SFGEIYLGTNIQTNEEVAIK-LNVKTKHP----QLQYEAKLYKILQ 59
+ L IG G + L T E V ++ +N++ LQ E + K+
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 60 GGTGIPN-LRWFG--VEGDYNVLVIDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINR 114
PN + + + + +V + S +DL ++ + + ++
Sbjct: 85 H----PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 174
++++H ++HR +K + L+ +VY+ Q + + K
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 175 T 175
Sbjct: 198 V 198
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 38/174 (21%), Positives = 67/174 (38%), Gaps = 28/174 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQGGTGIP 65
+ +L + IG G FG++ LG +VA+K + EA + L+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 74
Query: 66 NL-RWFGV--EGDYNVLVIDLLGPSLE-----DLFNF----CSRKLSLKTVLMLADQMIN 113
NL + GV E + ++ E L ++ L +L + +
Sbjct: 75 NLVQLLGVIVEEKGGLYIV------TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167
+E++ +F+HRD+ N L+ N + DFGL K T +P +
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 179
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 43/177 (24%), Positives = 73/177 (41%), Gaps = 37/177 (20%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP-QLQYEAK---------- 53
V +++ +GSG++G + + +T VA+K K P Q AK
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLK 83
Query: 54 ---------LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTV 104
L + P Y LV L+G L ++ +KL+ V
Sbjct: 84 HMKHENVIGLLDVF-----TPARSLEEFNDVY--LVTHLMGADLNNIVK--CQKLTDDHV 134
Query: 105 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT 160
L Q++ ++++HS +HRD+KP N + + ++ I+DFGLA+ D T
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFGLARHTADEMT 187
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 38/169 (22%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP-QLQYEAK---------- 53
V +++ + IGSG+ G + + VAIK K P Q Q AK
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMK 79
Query: 54 ---------LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTV 104
L + P + Y +V++L+ +L +L + +
Sbjct: 80 CVNHKNIIGLLNVF-----TPQKSLEEFQDVY--IVMELMD---ANLCQVIQMELDHERM 129
Query: 105 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 152
L QM+ ++ +HS +HRD+KP N ++ +++ + I+DFGLA
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 174
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 43/213 (20%), Positives = 76/213 (35%), Gaps = 60/213 (28%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTG- 63
V + + + IG GS+G +YL + T + VAIK K+ ++ +
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--------------KVNRMFEDLIDC 69
Query: 64 ------IPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD------- 109
I L + ++ + DL+ P F+ +L + + +D
Sbjct: 70 KRILREITILNRLKSD---YIIRLYDLIIPDDLLKFD----ELYIVLEIADSDLKKLFKT 122
Query: 110 --------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLA 152
++ F+H +HRD+KP N L NQ V + DFGLA
Sbjct: 123 PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL------LNQDCSVKVCDFGLA 176
Query: 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHL 185
R ++ +I +N ++ L
Sbjct: 177 -RTINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 63/290 (21%), Positives = 113/290 (38%), Gaps = 54/290 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK--TKHPQLQYEAKLYKILQGGTGI 64
RL K+G G FGE+++GT VAIK EA++ K L+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 321
Query: 65 PNL-RWFGVEGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
L + + V + + ++ SL D L + L L ++ +A Q+ + + +V
Sbjct: 322 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYRENKNLTGTA 176
+++HRD++ N L+G + DFGLA+ D P + TA
Sbjct: 382 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 432
Query: 177 RYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVST 234
A++ + + D+ S G +L+ +G +P Y + ++V
Sbjct: 433 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVP------------YPGMVNREV-- 473
Query: 235 SIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276
++ + RGY P C +++P + YL+ D F
Sbjct: 474 -LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 43/185 (23%), Positives = 74/185 (40%), Gaps = 53/185 (28%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTG- 63
V +R + +GSG++G + + +T +VAIK KLY+ Q
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--------------KLYRPFQSELFA 68
Query: 64 ------IPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD------- 109
+ L+ E NV+ ++D+ P E L +F L M D
Sbjct: 69 KRAYRELRLLKHMRHE---NVIGLLDVFTPD-ETLDDF--TDFYLVMPFMGTDLGKLMKH 122
Query: 110 -------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRY 155
QM+ + ++H+ +HRD+KP N + + ++ I+DFGLA++
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLARQA 178
Query: 156 RDTAT 160
T
Sbjct: 179 DSEMT 183
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 20/164 (12%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ-LQYEAKLYKILQG 60
PR +L ++G+G FGE+++G + +VA+K L + P EA L K LQ
Sbjct: 11 PR--ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH 67
Query: 61 GTGIPNL-RWFGV---EGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINR 114
L R + V E Y ++ + + SL D L KL++ +L +A Q+
Sbjct: 68 ----QRLVRLYAVVTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
+ F+ ++++HRD++ N L+ I DFGLA+ D
Sbjct: 122 MAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDN 162
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 42/163 (25%), Positives = 73/163 (44%), Gaps = 26/163 (15%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LNV--KTKHPQLQY-EAKLYK--- 56
V +++ + IGSG+ G + + + VAIK H + Y E L K
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 57 ------ILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 110
+L T L F + Y LV++L+ +L +L + + L Q
Sbjct: 120 HKNIISLLNVFTPQKTLEEF--QDVY--LVMELMD---ANLCQVIQMELDHERMSYLLYQ 172
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 152
M+ ++ +HS +HRD+KP N ++ +++ + I+DFGLA
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 211
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 30/161 (18%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LNVK-TKHPQLQYEAKLYKILQGGT 62
N ++GSG+ G+++ +T +A+K + ++ ++ + ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD---LDVVLKSH 81
Query: 63 GIPNL-RWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 118
P + + FG D + ++L+G E L + + + + ++ + ++
Sbjct: 82 DCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 119 HSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
K +HRD+KP N L+ Q+ + DFG++ R D
Sbjct: 141 KEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGRLVDD 178
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 42/169 (24%), Positives = 70/169 (41%), Gaps = 18/169 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQGGTGIP 65
+ +L + IG G FG++ LG +VA+K + EA + L+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 246
Query: 66 NL-RWFGV---EGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 118
NL + GV E +V + + G SL D L + L +L + + +E++
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167
+F+HRD+ N L+ N + DFGL K T +P +
Sbjct: 306 EGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 351
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 40/179 (22%), Positives = 62/179 (34%), Gaps = 48/179 (26%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTG- 63
+ + + + R I SGS+G + G + VAIK + + + IL
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIK-----RVFNTVSDGRTVNILSDSFLC 73
Query: 64 ------IPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD------- 109
I L F N+L + D+ E + KL L T LM D
Sbjct: 74 KRVLREIRLLNHFHHP---NILGLRDIFVHFEEPAMH----KLYLVTELMRTDLAQVIHD 126
Query: 110 ---------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 152
++ + +H +HRD+ P N L+ N + I DF LA
Sbjct: 127 QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL----ADNNDITICDFNLA 181
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 14/159 (8%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LNV--KTKHPQLQY-EAKLYK 56
+ V K+ L +K+G G++G ++ + +T E VA+K + + Q + E +
Sbjct: 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT 63
Query: 57 ILQGGTGIPNLR-WFGVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 114
L G I NL + D +V LV D + L + + L + Q+I
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR--ANILEPVHKQYVVYQLIKV 121
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 152
++++HS LHRD+KP N L+ A V + DFGL+
Sbjct: 122 IKYLHSGGLLHRDMKPSNILL----NAECHVKVADFGLS 156
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 22/160 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIK-LNVKTKHPQLQ---YEAKLYKIL 58
+F+ + +GSG+FG +Y G I E+ VAIK L T + EA + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 59 QGGTGIPNL-RWFGV-EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 113
P++ R G+ L+ L+ L ++ + + +L Q+
Sbjct: 75 DN----PHVCRLLGICLTSTVQLITQLM--PFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+ ++ + +HRD+ N L+ V I DFGLAK
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 29/169 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK-LNVKTKHPQLQ---YEAKLYKILQ 59
+ LGR IG G FG+++ G + VAIK T + EA +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 60 GGTGIPNL-RWFGVEGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLADQ 110
P++ + GV + V +I +E +L +F L L ++++ A Q
Sbjct: 75 H----PHIVKLIGVITENPVWII------MELCTLGELRSFLQVRKYSLDLASLILYAYQ 124
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159
+ + ++ SK F+HRDI N L+ + V + DFGL++ D+
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDST 170
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 33/181 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK-LNVKTKHPQLQ---YEAKLYKILQ 59
+ LGR IG G FG+++ G + VAIK T + EA +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 60 GGTGIPNL-RWFGVEGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLADQ 110
P++ + GV + V +I +E +L +F L L ++++ A Q
Sbjct: 450 H----PHIVKLIGVITENPVWII------MELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 111 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPY 166
+ + ++ SK F+HRDI N L+ + V + DFGL++ D A+ +P
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 167 R 167
+
Sbjct: 557 K 557
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 62/280 (22%), Positives = 89/280 (31%), Gaps = 85/280 (30%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------------------------ 42
N F + R IG G FGE+Y T + A+K K
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 43 TKHP---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF 92
P + Y KL IL GG DL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGG----------------------------DLH 280
Query: 93 NFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 150
S+ S + A ++I +E +H++ ++RD+KP N L+ V I D G
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLG 337
Query: 151 LAKRYRDTATHQHIPYRENKNLTGTARY-ASMNTHLGIEQSRRDDLESLGYVLMY-FLRG 208
LA + H GT Y A G+ D SLG +++ LRG
Sbjct: 338 LACDFSKKKPH---------ASVGTHGYMAPEVLQKGVAYDSSADWFSLG-CMLFKLLRG 387
Query: 209 SLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 242
P++ K K + V S + +L G
Sbjct: 388 HSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 22/218 (10%), Positives = 49/218 (22%), Gaps = 50/218 (22%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQ-------LQYEAKLYKI 57
++RL G + + + + +VA+ V +
Sbjct: 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTF-VDPQGVLPDDVLQETLSRTLRLSR 87
Query: 58 LQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 116
+ G+ + ++V + + G SL+++ S + + +
Sbjct: 88 IDK-PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAAD 143
Query: 117 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 176
H P + V + A
Sbjct: 144 AAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA----TMPDANP--------------- 181
Query: 177 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
+DD+ +G L L P
Sbjct: 182 ---------------QDDIRGIGASLYALLVNRWPLPE 204
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 42/169 (24%), Positives = 68/169 (40%), Gaps = 31/169 (18%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK-LNVKTKHPQLQ---YEAKLY 55
P R IG G FG +Y G I + AIK L+ T+ Q++ E L
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 56 KILQGGTGIPNL-RWFGV--EGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTV 104
+ L PN+ G+ + V+ L DL F R ++K +
Sbjct: 77 RGLNH----PNVLALIGIMLPPEGLPHVL------LPYMCHGDLLQFIRSPQRNPTVKDL 126
Query: 105 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+ Q+ +E++ + F+HRD+ N ++ V + DFGLA+
Sbjct: 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES---FTVKVADFGLAR 172
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 3e-08
Identities = 34/203 (16%), Positives = 60/203 (29%), Gaps = 60/203 (29%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------------- 39
K + KIG G FGE++ + VAIK+
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 40 -------------------------NVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG 74
V+ +P L +A + G+ +F +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 75 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNF 133
+ VL + G LE ++ SL T + Q+ + + F HRD+ N
Sbjct: 137 LFIVLEFEFGGIDLE---QMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 134 LMGLGRRANQVYIIDFGLAKRYR 156
L+ ++ + + K
Sbjct: 194 LL---KKTSLKKLHYTLNGKSST 213
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 51/181 (28%), Positives = 75/181 (41%), Gaps = 37/181 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE-----VAIK-LNVKTKHPQ---LQYEAK 53
PR N + G+ +G+G+FG++ T +E VA+K L + L E K
Sbjct: 44 PR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 54 LYKILQGGTGIPNLRWFGV--EGDYNVLVI-------DLL--------GPSLEDLFNFCS 96
+ L I NL G G VLVI DLL + F +
Sbjct: 102 IMSHLGQHENIVNL--LGACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 97 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156
S + +L + Q+ + F+ SK+ +HRD+ N L+ G + I DFGLA R
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLA---R 212
Query: 157 D 157
D
Sbjct: 213 D 213
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 34/166 (20%), Positives = 67/166 (40%), Gaps = 25/166 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIK-LNVKTKHPQ----LQYEAKLYKI 57
+ + IG+G FGE+Y G + + VAIK L Q L EA +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-EAGIMGQ 102
Query: 58 LQGGTGIPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQM 111
N+ R GV + +++ + + L F + S+ ++ + +
Sbjct: 103 FSH----HNIIRLEGVISKYKPMMIITEYM--ENGALDKFLREKDGEFSVLQLVGMLRGI 156
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
++++ + +++HRD+ N L+ + DFGL++ D
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 199
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 45/183 (24%), Positives = 75/183 (40%), Gaps = 38/183 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIK-LNVKTKHPQ---LQYEAK 53
PR ++ +LG+ +G G+FG++ I VA+K L H + L E K
Sbjct: 25 PR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 54 LYKILQGGTGIPNLRWFGV--EGDYNVLVI-------DLL----------GPSLEDLFNF 94
+ + + NL G + ++VI +L P +
Sbjct: 83 ILIHIGHHLNVVNL--LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 95 CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154
L+L+ ++ + Q+ +EF+ S+ +HRD+ N L+ N V I DFGLA
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLA-- 195
Query: 155 YRD 157
RD
Sbjct: 196 -RD 197
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 35/164 (21%), Positives = 65/164 (39%), Gaps = 22/164 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT---NIQTNEEVAIK-LNVKTKHPQLQ---YEAKLYKILQ 59
++ + + IGSG GE+ G Q + VAIK L Q + EA +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 60 GGTGIPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 113
PN+ R GV G ++V + + L F + ++ ++ + +
Sbjct: 109 H----PNIIRLEGVVTRGRLAMIVTEYM--ENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
+ ++ ++HRD+ N L+ + DFGL++ D
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLED 203
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 42/183 (22%), Positives = 71/183 (38%), Gaps = 46/183 (25%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK-LNVKTKHPQ----LQYEAKL 54
R N LG+ +G G FG + G Q + VA+K + + + EA
Sbjct: 32 DR--NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89
Query: 55 YKILQGGTGIPN-LRWFGV------EGDYNVLVIDLLGPSLE-----DLFNF-------- 94
K PN +R GV +G +VI L DL +
Sbjct: 90 MKDFSH----PNVIRLLGVCIEMSSQGIPKPMVI------LPFMKYGDLHTYLLYSRLET 139
Query: 95 CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154
+ + L+T+L + +E++ +++FLHRD+ N ++ V + DFGL+
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD---MTVCVADFGLS-- 194
Query: 155 YRD 157
+
Sbjct: 195 -KK 196
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 7e-08
Identities = 50/183 (27%), Positives = 87/183 (47%), Gaps = 41/183 (22%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIK-LNVKTKHPQ--LQYEAKL 54
R L R++G G+FG+++L N+ ++ VA+K L T + Q EA+L
Sbjct: 13 KR--RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 55 YKILQGGTGIPNL-RWFGV--EGDYNVLVI-------DLL------GPSLEDLFNFCSR- 97
LQ ++ +++GV +GD ++++ DL GP L + R
Sbjct: 71 LTNLQH----EHIVKFYGVCGDGD-PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 98 ---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154
+L L +L +A Q+ + + ++ S+ F+HRD+ N L+G V I DFG++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN---LLVKIGDFGMS-- 180
Query: 155 YRD 157
RD
Sbjct: 181 -RD 182
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 38/153 (24%), Positives = 68/153 (44%), Gaps = 14/153 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK--TKHPQLQYEAKLYKILQGGTGI 64
+L +K+G+G FGE+++ T + +VA+K EA + K LQ
Sbjct: 188 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH---- 242
Query: 65 PNL-RWFGVEGDYNVLVIDLLGP--SLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
L + V + +I SL D L + K L ++ + Q+ + F+
Sbjct: 243 DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
++++HRD++ N L+ + I DFGLA+
Sbjct: 303 RNYIHRDLRAANILVS---ASLVCKIADFGLAR 332
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 45/158 (28%), Positives = 64/158 (40%), Gaps = 21/158 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGT-NIQTNEE--VAIK-LNVKTKHPQLQY-----EAKLYKILQ 59
RL K+G GSFG + G + + + VA+K L E L
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 60 GGTGIPNL-RWFGV-EGDYNVLVIDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
NL R +GV +V +L LG SL D L T+ A Q+ +
Sbjct: 80 H----RNLIRLYGVVLTPPMKMVTELAPLG-SLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
++ SK F+HRD+ N L+ + V I DFGL +
Sbjct: 135 GYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR 169
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 39/154 (25%), Positives = 74/154 (48%), Gaps = 20/154 (12%)
Query: 11 LGRKIGSGSFGEIYLGT--NIQTNEEVAIK-LNVKTKHPQLQY----EAKLYKILQGGTG 63
+++GSG+FG + G + + VA+K L + P L+ EA + + L
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN--- 77
Query: 64 IPNL-RWFGV-EGDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVH 119
P + R G+ E + +LV+++ L L + +R + K ++ L Q+ ++++
Sbjct: 78 -PYIVRMIGICEAESWMLVMEMA--ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+F+HRD+ N L+ + I DFGL+K
Sbjct: 135 ESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 44/183 (24%), Positives = 73/183 (39%), Gaps = 36/183 (19%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE---VAIK-LNVKTKHPQLQ---YEAKLYKILQGGT 62
IG G FG +Y GT + + + A+K LN T ++ E + K
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 85
Query: 63 GIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLADQM 111
PN L G+ + + LV+ L DL NF + ++K ++ Q+
Sbjct: 86 --PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 171
++++ SK F+HRD+ N ++ V + DFGLA RD + Y +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEK---FTVKVADFGLA---RD--MYDKEYYSVHNK 189
Query: 172 LTG 174
Sbjct: 190 TGA 192
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 35/163 (21%), Positives = 69/163 (42%), Gaps = 20/163 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEE--VAIK-LNVKTKHPQ----LQYEAKLYKIL 58
+ + +G+G FGE+ G + + +E VAIK L V Q L EA +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG-EASIMGQF 103
Query: 59 QGGTGIPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 114
PN+ R GV + ++V + + SL+ + ++ ++ + + +
Sbjct: 104 DH----PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
++++ ++HRD+ N L+ + DFGL + D
Sbjct: 160 MKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLED 199
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 36/157 (22%), Positives = 66/157 (42%), Gaps = 17/157 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT---NIQTNEEVAIK-LNVKTKHPQLQ---YEAKLYKILQ 59
L R +G G FGE+Y G + VA+K + EA + K L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 60 GGTGIPNL-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 116
P++ + G+ E + ++++L L L + T+++ + Q+ +
Sbjct: 72 H----PHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 117 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
++ S + +HRDI N L+ V + DFGL++
Sbjct: 128 YLESINCVHRDIAVRNILVA---SPECVKLGDFGLSR 161
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 36/162 (22%), Positives = 70/162 (43%), Gaps = 19/162 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LNVKT-KHPQLQYEAKLYKILQGGTGI 64
++G G++G + ++ + + +A+K V + + +L + I
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD---LDISMRTVDC 65
Query: 65 PNL-RWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA---DQMINRVEF 117
P ++G EGD + ++L+ SL+ + K +L ++ +E
Sbjct: 66 PFTVTFYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 118 VHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
+HSK S +HRD+KP N L+ QV + DFG++ D
Sbjct: 125 LHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGISGYLVDD 163
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 40/180 (22%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIK-LNVKTKHPQ---LQYEAK 53
R K + R++G GSFG +Y G + VAIK +N + EA
Sbjct: 23 AR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 54 LYKILQGGTGIPNL-RWFGV--EGDYNVLVI-------DLL------GPSLEDLFNFCSR 97
+ K ++ R GV +G LVI DL P++ + N
Sbjct: 81 VMKEFNC----HHVVRLLGVVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMAN--NPVLA 133
Query: 98 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
SL ++ +A ++ + + ++++ F+HRD+ N ++ V I DFG+ RD
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF---TVKIGDFGMT---RD 187
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 43/186 (23%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLNVKTKHPQ-----LQYEA 52
PR N+ G+ +G+G+FG++ T + ++ VA+K+ +K L E
Sbjct: 21 PR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSEL 77
Query: 53 KLYKILQGGTGIPNLRWFGV--EGDYNVLVI-------DLL------------GPSLEDL 91
K+ L I NL G G LVI DLL + +
Sbjct: 78 KVLSYLGNHMNIVNL--LGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 92 FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 151
L L+ +L + Q+ + F+ SK+ +HRD+ N L+ G I DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG---RITKICDFGL 191
Query: 152 AKRYRD 157
A RD
Sbjct: 192 A---RD 194
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 22/160 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIK-LNVKTKHPQLQ---YEAKLYKIL 58
+F+ + +GSG+FG +Y G I E+ VAIK L T + EA + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 59 QGGTGIPNL-RWFGV-EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 113
P++ R G+ L+ L+ L ++ + + +L Q+
Sbjct: 75 DN----PHVCRLLGICLTSTVQLITQLM--PFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+ ++ + +HRD+ N L+ V I DFGLAK
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 52.1 bits (126), Expect = 1e-07
Identities = 52/275 (18%), Positives = 95/275 (34%), Gaps = 100/275 (36%)
Query: 3 PRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------NV- 41
P+ F++ R +G+GSFG ++L + A+K+ +
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 42 -KTKHP---QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLED 90
HP ++ +++ I+ +GG +
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG----------------------------E 92
Query: 91 LFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 148
LF+ + + A ++ +E++HSK ++RD+KP+N L L + + + I D
Sbjct: 93 LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL--LDKNGH-IKITD 149
Query: 149 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY-------- 200
FG AK D L GT Y + E + + Y
Sbjct: 150 FGFAKYVPDVT----------YTLCGTPDY------IAPEV-----VSTKPYNKSIDWWS 188
Query: 201 --VLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKV 232
+L+Y L G P+ + YEKI ++
Sbjct: 189 FGILIYEMLAGYTPFY---DSNTMKTYEKILNAEL 220
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 42/184 (22%), Positives = 65/184 (35%), Gaps = 47/184 (25%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK-LNVKTKHPQ----LQYEAKL 54
P +F LGR +G G FG + Q + VA+K L EA
Sbjct: 21 PE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78
Query: 55 YKILQGGTGIPN-LRWFGV-------EGDYNVLVIDLLGPSLE-----DLFNF------- 94
K P+ + GV +VI L DL F
Sbjct: 79 MKEFDH----PHVAKLVGVSLRSRAKGRLPIPMVI------LPFMKHGDLHAFLLASRIG 128
Query: 95 -CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
L L+T++ + +E++ S++F+HRD+ N ++ V + DFGL+
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED---MTVCVADFGLS- 184
Query: 154 RYRD 157
R
Sbjct: 185 --RK 186
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 29/168 (17%), Positives = 60/168 (35%), Gaps = 27/168 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-------NIQTNEEVAIK-LNVKTKHPQLQY--EAKLYK 56
+G G+F +I+ G EV +K L+ ++ + A +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 57 ILQGGTGIPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQ 110
L +L +GV GD N+LV + + L + +++ L +A Q
Sbjct: 68 KLSH----KHLVLNYGVCVCGDENILVQEFV--KFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 111 MINRVEFVHSKSFLHRDIKPDNFL-----MGLGRRANQVYIIDFGLAK 153
+ + F+ + +H ++ N L + + D G++
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 60/259 (23%), Positives = 98/259 (37%), Gaps = 81/259 (31%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LN----VKTK----------------HP- 46
F + +G+GSFG + L + ++ A+K L+ VK K P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 47 --QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF--C 95
+L++ + LY ++ GG ++F+
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGG----------------------------EMFSHLRR 134
Query: 96 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155
+ S A Q++ E++HS ++RD+KP+N L+ + + + DFG AKR
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRV 191
Query: 156 RD-TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQ 213
+ T T L GT + L ++ D +LG VL+Y G P+
Sbjct: 192 KGRTWT-----------LCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPPF- 238
Query: 214 GLKAGTKKQKYEKISEKKV 232
A Q YEKI KV
Sbjct: 239 --FADQPIQIYEKIVSGKV 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 2e-07
Identities = 41/259 (15%), Positives = 78/259 (30%), Gaps = 79/259 (30%)
Query: 36 AIKLNVKTKHPQLQYEAKLYK---ILQGGTGIPNLRWFGVEGDYNVLVI---DLLGPSLE 89
I+ ++ P K++ + IP +L + D++ +
Sbjct: 358 IIESSLNVLEPAEYR--KMFDRLSVFPPSAHIP----------TILLSLIWFDVIKSDVM 405
Query: 90 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI--KPDNFLMGLGRRANQVYII 147
+ N + SL + Q + S ++ ++ K +N L R Y I
Sbjct: 406 VVVNKLHKY-SL-----VEKQPKESTISIPS---IYLELKVKLEN-EYALHRSIVDHYNI 455
Query: 148 -----DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYV 201
L Y D + HI + HL IE R L + ++
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGH-----------------HLKNIEHPERMTLFRMVFL 498
Query: 202 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDD 261
FL +K +++ + + + L + Y Y D+
Sbjct: 499 DFRFLE------------QKIRHDSTAWNASGSILNTL-----QQLKFYKPYI----CDN 537
Query: 262 KPDYAYLKRLFRDL--FIR 278
P Y +RL + F+
Sbjct: 538 DPKY---ERLVNAILDFLP 553
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 3e-06
Identities = 40/292 (13%), Positives = 89/292 (30%), Gaps = 60/292 (20%)
Query: 28 NIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY----NVLVID- 82
+ + +V K NV P L+ L + L+ + ++G + +D
Sbjct: 118 RLYNDNQVFAKYNVSRLQPYLKLRQALLE-LRPAKNV------LIDGVLGSGKTWVALDV 170
Query: 83 LLGPSLEDLFNF---------CSRKLS----LKTVLMLADQMINRVEFVHSKSFLHR--D 127
L ++ +F C+ + L+ +L D HS + R
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD-HSSNIKLRIHS 229
Query: 128 IKP-DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN--KNLTGTARYASMNTH 184
I+ L+ N + ++ + + K L T R+ +
Sbjct: 230 IQAELRRLLKSKPYENCLLVLL--------NVQNAKAWNAFNLSCKILL-TTRFKQVTDF 280
Query: 185 LGIEQSRRDDLE------SLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238
L + L+ + V L+ + + ++ + +++S I
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLK----YLDCRPQDLPREVLTTNPRRLSI-IAE 335
Query: 239 LCRGYPTEFASYFHY-CRSLR-----FDDKPDYAYLKRLFRDLFIREGFQFD 284
R + ++ H C L + + A +++F L + F
Sbjct: 336 SIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV---FPPS 384
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 56/282 (19%), Positives = 87/282 (30%), Gaps = 89/282 (31%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------NV--KTKH 45
N FR R +G G FGE+ T + A K + K
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 46 P---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF--- 92
L Y + L +L GG DL
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGG----------------------------DLKFHI 275
Query: 93 -NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIID 148
+ + A ++ +E +H + ++RD+KP+N L+ G + I D
Sbjct: 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG------HIRISD 329
Query: 149 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLR 207
GLA + T K GT Y + + D +LG L+Y +
Sbjct: 330 LGLAVHVPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALG-CLLYEMIA 380
Query: 208 GSLPWQGLKAGTKKQK-YEKISEKKV----STSIEA--LCRG 242
G P+Q K K+++ + E S +A LC
Sbjct: 381 GQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQ 422
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 40/182 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIK-LNVKTKHPQ--LQYEAKL 54
R L ++G G+FG+++L N+ ++ VA+K L ++ + Q EA+L
Sbjct: 39 KR--RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 55 YKILQGGTGIPNL-RWFGV--EGDYNVLVI-------DLL---------GPSLEDLFNFC 95
+LQ ++ R+FGV EG +L++ DL L +
Sbjct: 97 LTMLQH----QHIVRFFGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 96 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155
L L +L +A Q+ + ++ F+HRD+ N L+G G V I DFG++
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMS--- 205
Query: 156 RD 157
RD
Sbjct: 206 RD 207
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 32/158 (20%), Positives = 59/158 (37%), Gaps = 18/158 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIK-LNVKTKHPQLQ---YEAKLYKIL 58
+ R + +GSG FG ++ G V IK + K+ Q L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 59 QGGTGIPNL-RWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRV 115
++ R G+ ++ ++ P SL D L + +L Q+ +
Sbjct: 73 DH----AHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
++ +HR++ N L+ +QV + DFG+A
Sbjct: 129 YYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVAD 163
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 50/285 (17%), Positives = 93/285 (32%), Gaps = 92/285 (32%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------NV--KTKH 45
+ F R +G G FGE++ T + A K + K
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 46 P---QLQY----EAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLF---- 92
L Y + L LV+ ++ G D+
Sbjct: 245 RFIVSLAYAFETKTDLC-----------------------LVMTIMNGG----DIRYHIY 277
Query: 93 --NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYII 147
+ + + Q+++ +E +H ++ ++RD+KP+N L+ G V I
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG------NVRIS 331
Query: 148 DFGLAKRYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY- 204
D GLA + + K GT + + LG E D +LG V +Y
Sbjct: 332 DLGLAV---------ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG-VTLYE 381
Query: 205 FLRGSLPWQGLKAGTKKQK-YEKISEKKV----STSIEA--LCRG 242
+ P++ + ++ +++ E+ V S + C
Sbjct: 382 MIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 29/158 (18%), Positives = 70/158 (44%), Gaps = 20/158 (12%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LNVK-TKHPQLQYEAKLYKILQGGTGIPNL-R 68
+IG G++G + + + + +A+K V + QL + ++ + P + +
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD---LDVVMRSSDCPYIVQ 85
Query: 69 WFG---VEGDYNVLVIDLLGPSLEDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
++G EGD + ++L+ S + ++ + + + + + + +
Sbjct: 86 FYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 122 -SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158
+HRDIKP N L+ R+ + + DFG++ + D+
Sbjct: 145 LKIIHRDIKPSNILLD---RSGNIKLCDFGISGQLVDS 179
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 44/176 (25%), Positives = 71/176 (40%), Gaps = 34/176 (19%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE---VAIK-LNVKTKHPQLQ---YEAKLYKILQGGT 62
IG G FG +Y GT + + + A+K LN T ++ E + K
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 149
Query: 63 GIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLADQM 111
PN L G+ + + LV+ L DL NF + ++K ++ Q+
Sbjct: 150 --PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 112 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 167
++F+ SK F+HRD+ N ++ V + DFGLA RD +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEK---FTVKVADFGLA---RDMYDKEFDSVH 251
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 44/178 (24%), Positives = 70/178 (39%), Gaps = 36/178 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIK-LNVKTKHPQLQ---YEAK 53
PR L R +G G+FGE+Y G N + +VA+K L EA
Sbjct: 28 PR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 54 LYKILQGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNF---------CSRKL 99
+ N+ R GV + ++++L+ G DL +F L
Sbjct: 86 IISKFNH----QNIVRCIGVSLQSLPRFILMELMAGG----DLKSFLRETRPRPSQPSSL 137
Query: 100 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
++ +L +A + +++ F+HRDI N L+ I DFG+A RD
Sbjct: 138 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RD 192
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 43/214 (20%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LNVK-TKHPQLQYEAKLYKILQGGTGI 64
F ++G+G+ G ++ ++ + +A K L +K Q+ E ++L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE---LQVLHECNS- 90
Query: 65 PNL-RWFG---VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
P + ++G +G+ + ++ + G SL+ + R + + + ++ +I + ++
Sbjct: 91 PYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR 148
Query: 120 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 178
K +HRD+KP N L+ ++ + DFG++ + D+ + + GT Y
Sbjct: 149 EKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSY 196
Query: 179 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 212
S G S + D+ S+G L+ G P
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 58/283 (20%), Positives = 94/283 (33%), Gaps = 99/283 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LNVKTKHP 46
F +G GSFG++ L T+E A+K L + K P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 47 QL-------QYEAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 96
L Q +LY +++ GG DL
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGG----------------------------DLMYHIQ 434
Query: 97 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 151
+ + + A ++ + F+ SK ++RD+K DN ++ G + I DFG+
Sbjct: 435 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFGM 488
Query: 152 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 205
K T T GT Y + + D + G VL+Y
Sbjct: 489 CKENIWDGVTTK------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEM 535
Query: 206 LRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 242
L G P++G + + ++ I E V S A+C+G
Sbjct: 536 LAGQAPFEG---EDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 99/283 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LNVKTKHP 46
F L + +G GSFG+++L +TN+ AIK L++ +HP
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 47 QL-------QYEAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 96
L Q + L+ +++ GG DL
Sbjct: 79 FLTHMFCTFQTKENLFFVMEYLNGG----------------------------DLMYHIQ 110
Query: 97 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 151
K L A ++I ++F+HSK ++RD+K DN L+ G + I DFG+
Sbjct: 111 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG------HIKIADFGM 164
Query: 152 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 205
K T GT Y + LG + + D S G VL+Y
Sbjct: 165 CKENMLGDAKTN------------TFCGTPDYIAPEILLGQKYNHSVDWWSFG-VLLYEM 211
Query: 206 LRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 242
L G P+ G +++ + I + L
Sbjct: 212 LIGQSPFHG---QDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 251
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 44/178 (24%), Positives = 70/178 (39%), Gaps = 36/178 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIK-LNVKTKHPQLQ---YEAK 53
PR L R +G G+FGE+Y G N + +VA+K L EA
Sbjct: 69 PR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 54 LYKILQGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNF---------CSRKL 99
+ N+ R GV + ++++L+ G DL +F L
Sbjct: 127 IISKFNH----QNIVRCIGVSLQSLPRFILLELMAGG----DLKSFLRETRPRPSQPSSL 178
Query: 100 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
++ +L +A + +++ F+HRDI N L+ I DFG+A RD
Sbjct: 179 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RD 233
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 37/152 (24%), Positives = 69/152 (45%), Gaps = 16/152 (10%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEE--VAIK-LNVKTKHPQLQ---YEAKLYKILQGGTGI 64
++G G+FG + G ++ VAIK L T+ + EA++ L
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN---- 395
Query: 65 PNL-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
P + R GV + + +LV+++ G L ++ + V L Q+ ++++ K
Sbjct: 396 PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+F+HR++ N L+ + I DFGL+K
Sbjct: 456 NFVHRNLAARNVLLV---NRHYAKISDFGLSK 484
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 60/283 (21%), Positives = 96/283 (33%), Gaps = 99/283 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LNVKTKHP 46
F +G GSFG++ L T+E A+K L + K P
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 47 ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 96
QL +LY +++ GG DL
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYVNGG----------------------------DLMYHIQ 113
Query: 97 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 151
+ + + A ++ + F+ SK ++RD+K DN ++ G + I DFG+
Sbjct: 114 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFGM 167
Query: 152 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 205
K T T GT Y + + D + G VL+Y
Sbjct: 168 CKENIWDGVTTK------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEM 214
Query: 206 LRGSLPWQGLKAGTKKQKYEKISEKKV----STSIEA--LCRG 242
L G P++G + + ++ I E V S S EA +C+G
Sbjct: 215 LAGQAPFEG---EDEDELFQSIMEHNVAYPKSMSKEAVAICKG 254
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 39/181 (21%), Positives = 74/181 (40%), Gaps = 38/181 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIK-LNVKTKHPQLQ---YE 51
PR ++ LG+ +G G+FG++ L + ++ VA+K L L E
Sbjct: 67 PR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 52 AKLYKILQGGTGIPNL-RWFGV--EGDYNVLVI------DLL----------GPSLEDLF 92
++ K++ N+ G + +++ +L +
Sbjct: 125 MEMMKMIGKH---KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 93 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152
+ +LS K ++ A Q+ +E++ SK +HRD+ N L+ N + I DFGLA
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED---NVMKIADFGLA 238
Query: 153 K 153
+
Sbjct: 239 R 239
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 40/181 (22%), Positives = 64/181 (35%), Gaps = 36/181 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEEVAIKLNVKTKHPQLQY-----EAKLY 55
N + IG G+FG++ + AIK +K + + E ++
Sbjct: 23 DW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVL 79
Query: 56 KILQGGTGIPNLRWFGV--EGDYNVLVI------DLL----------GPSLEDLFNFCSR 97
L I NL G Y L I +LL + N +
Sbjct: 80 CKLGHHPNIINL--LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 98 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
LS + +L A + ++++ K F+HRD+ N L+G I DFGL+ R
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLS---RG 191
Query: 158 T 158
Sbjct: 192 Q 192
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 43/188 (22%), Positives = 64/188 (34%), Gaps = 50/188 (26%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIK-LNVKTKHPQ---LQYEAK 53
+ R ++G FG++Y G E+ VAIK L K + P ++EA
Sbjct: 7 SL--SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 54 LYKILQGGTGIPNL-RWFGV--EGDYNVLVI-------DLL----------GPSLEDLFN 93
L LQ PN+ GV + + +I DL D
Sbjct: 65 LRARLQH----PNVVCLLGVVTKDQ-PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 94 FCSRKLSLKTVLMLADQ----MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 149
L + L Q M E++ S +H+D+ N L+ V I D
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGM----EYLSSHHVVHKDLATRNVLVYDK---LNVKISDL 172
Query: 150 GLAKRYRD 157
GL R+
Sbjct: 173 GLF---RE 177
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 34/182 (18%), Positives = 63/182 (34%), Gaps = 71/182 (39%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LNVKTKHP 46
F L R IG GS+ ++ L +T+ A+K + HP
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 47 ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 96
L E++L+ +++ GG DL
Sbjct: 71 FLVGLHSCFQTESRLFFVIEYVNGG----------------------------DLMFHMQ 102
Query: 97 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 151
R KL + + ++ + ++H + ++RD+K DN L+ G + + D+G+
Sbjct: 103 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYGM 156
Query: 152 AK 153
K
Sbjct: 157 CK 158
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 41/184 (22%), Positives = 75/184 (40%), Gaps = 39/184 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIK-LNVKTKHPQ---LQYE 51
PR +K LG+ +G G+FG++ + I ++ VA+K L L E
Sbjct: 33 PR--DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 52 AKLYKILQGGTGIPNLRWFGV--EGDYNVLVI------DLL----------GPSLEDLFN 93
++ K++ I NL G + +++ +L D+
Sbjct: 91 MEMMKMIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 94 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+++ K ++ Q+ +E++ S+ +HRD+ N L+ N + I DFGLA
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLA- 204
Query: 154 RYRD 157
RD
Sbjct: 205 --RD 206
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 38/157 (24%), Positives = 73/157 (46%), Gaps = 17/157 (10%)
Query: 7 NKFRLGR-KIGSGSFGEIYLGT-NIQTNE-EVAIK-LNVKTKHPQLQ---YEAKLYKILQ 59
+ + ++G G+FG + G ++ + +VAIK L T+ + EA++ L
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 68
Query: 60 GGTGIPNL-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 116
P + R GV + + +LV+++ G L ++ + V L Q+ ++
Sbjct: 69 N----PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 124
Query: 117 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
++ K+F+HRD+ N L+ + I DFGL+K
Sbjct: 125 YLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSK 158
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 33/182 (18%), Positives = 63/182 (34%), Gaps = 71/182 (39%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LNVKTKHP 46
F L R IG GS+ ++ L +T+ A++ + HP
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 47 ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 96
L E++L+ +++ GG DL
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGG----------------------------DLMFHMQ 145
Query: 97 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 151
R KL + + ++ + ++H + ++RD+K DN L+ G + + D+G+
Sbjct: 146 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYGM 199
Query: 152 AK 153
K
Sbjct: 200 CK 201
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 35/158 (22%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTK--HPQLQYEAKLYKILQGGTG 63
N F IG G FG++Y G ++ +VA+K ++ + + E + +
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRH--- 94
Query: 64 IPNL-RWFG--VEGDYNVLVIDLL--GPSLED-LF--NFCSRKLSLKTVLMLADQMINRV 115
P+L G E + +L+ + G +L+ L+ + + +S + L + +
Sbjct: 95 -PHLVSLIGFCDERNEMILIYKYMENG-NLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 116 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
++H+++ +HRD+K N L+ I DFG++K
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVPK---ITDFGISK 187
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 53/283 (18%), Positives = 91/283 (32%), Gaps = 99/283 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LNVKTKHP 46
F R +G GSFG++ L +T + A+K L++ HP
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 47 ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 96
QL +L+ +++ GG DL
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGG----------------------------DLMFHIQ 116
Query: 97 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 151
+ + A ++I+ + F+H K ++RD+K DN L+ G + DFG+
Sbjct: 117 KSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG------HCKLADFGM 170
Query: 152 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 205
K T T GT Y + + D ++G VL+Y
Sbjct: 171 CKEGICNGVTTA------------TFCGTPDYIAPEILQEMLYGPAVDWWAMG-VLLYEM 217
Query: 206 LRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 242
L G P++ + +E I +V + +
Sbjct: 218 LCGHAPFEA---ENEDDLFEAILNDEVVYPTWLHEDATGILKS 257
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 41/184 (22%), Positives = 74/184 (40%), Gaps = 39/184 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIK-LNVKTKHPQ---LQYE 51
PR +K LG+ +G G FG++ + I ++ VA+K L L E
Sbjct: 79 PR--DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 52 AKLYKILQGGTGIPNLRWFGV--EGDYNVLVI------DLL----------GPSLEDLFN 93
++ K++ I NL G + +++ +L D+
Sbjct: 137 MEMMKMIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 94 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
+++ K ++ Q+ +E++ S+ +HRD+ N L+ N + I DFGLA
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLA- 250
Query: 154 RYRD 157
RD
Sbjct: 251 --RD 252
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 58/283 (20%), Positives = 90/283 (31%), Gaps = 99/283 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LNVKTKHP 46
F + IG GSFG++ L + A+K L KHP
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 47 ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 96
L + KLY +L GG +LF
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGG----------------------------ELFYHLQ 131
Query: 97 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 151
R A ++ + + ++HS + ++RD+KP+N L+ G + + DFGL
Sbjct: 132 RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG------HIVLTDFGL 185
Query: 152 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 205
K + T + T GT Y + R D LG ++Y
Sbjct: 186 CKENIEHNSTTS------------TFCGTPEYLAPEVLHKQPYDRTVDWWCLG-AVLYEM 232
Query: 206 LRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 242
L G P+ + Y+ I K + + S L G
Sbjct: 233 LYGLPPFYS---RNTAEMYDNILNKPLQLKPNITNSARHLLEG 272
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 7e-06
Identities = 59/282 (20%), Positives = 101/282 (35%), Gaps = 98/282 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------NV--KTKHP- 46
F + +G G+FG++ L T A+K+ V T+HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 47 --QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 97
L+Y +L +++ GG +LF SR
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGG----------------------------ELFFHLSR 98
Query: 98 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 152
+ + ++++ +E++HS+ ++RDIK +N ++ G + I DFGL
Sbjct: 99 ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG------HIKITDFGLC 152
Query: 153 K---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FL 206
K T T GT Y + + R D LG V+MY +
Sbjct: 153 KEGISDGATMK------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMM 199
Query: 207 RGSLPWQGLKAGTKKQKYEKISEKKV----STSIEA--LCRG 242
G LP+ ++ +E I +++ + S EA L G
Sbjct: 200 CGRLPFYN---QDHERLFELILMEEIRFPRTLSPEAKSLLAG 238
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 38/196 (19%), Positives = 70/196 (35%), Gaps = 58/196 (29%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLNVKTKHPQ-----LQYEA 52
PR LG+ +G G FG++ T +++ VA+K+ +K L E
Sbjct: 21 PR--KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-LKENASPSELRDLLSEF 77
Query: 53 KLYKILQGGTGIPNL-RWFGV---------------EGD-----------YNVLVIDLLG 85
+ K + P++ + +G G +
Sbjct: 78 NVLKQVNH----PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 86 PSLEDLFNFCSRKLSLKTVLMLADQ----MINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 141
+ L + R L++ ++ A Q M +++ +HRD+ N L+ G
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGM----QYLAEMKLVHRDLAARNILVAEG--- 186
Query: 142 NQVYIIDFGLAKRYRD 157
++ I DFGL+ RD
Sbjct: 187 RKMKISDFGLS---RD 199
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 52/262 (19%), Positives = 94/262 (35%), Gaps = 81/262 (30%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------NV--KTKHPQ 47
F + +G G+FG++ L T A+K+ V ++HP
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 48 L-------QYEAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 97
L Q +L ++ GG +LF SR
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGG----------------------------ELFFHLSR 241
Query: 98 --KLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154
S ++++ ++++HS K+ ++RD+K +N ++ + + I DFGL K
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCK- 297
Query: 155 YRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLP 211
+ I T GT Y + + R D LG V+MY + G LP
Sbjct: 298 -------EGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLP 348
Query: 212 WQGLKAGTKKQKYEKISEKKVS 233
+ ++ +E I +++
Sbjct: 349 FYN---QDHEKLFELILMEEIR 367
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 46/195 (23%), Positives = 67/195 (34%), Gaps = 56/195 (28%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIK-LNVKTKHPQ---LQYEAK 53
PR N R IG G+FG ++ + E VA+K L + Q EA
Sbjct: 45 PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 54 LYKILQGGTGIPNL-RWFGV--EGDYNVLVI------DLL------------------GP 86
L PN+ + GV G L+ DL
Sbjct: 103 LMAEFDN----PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 87 SLEDLFNFCSRKLSLKTVLMLADQ----MINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 142
+ + + LS L +A Q M ++ + F+HRD+ N L+G
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGM----AYLSERKFVHRDLATRNCLVGENM--- 211
Query: 143 QVYIIDFGLAKRYRD 157
V I DFGL+ R+
Sbjct: 212 VVKIADFGLS---RN 223
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 50/191 (26%), Positives = 70/191 (36%), Gaps = 48/191 (25%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLNVKTKHPQ-----LQYEA 52
PR G+ +GSG+FG++ T I VA+K+ +K K L E
Sbjct: 43 PR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALMSEL 99
Query: 53 KLYKILQGGTGIPNLRWFGV--EGDYNVLVI-------DLL-----------------GP 86
K+ L I NL G + +I DLL
Sbjct: 100 KMMTQLGSHENIVNL--LGACTLSG-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 87 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 146
L+ + +L A Q+ +EF+ KS +HRD+ N L+ G V I
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG---KVVKI 213
Query: 147 IDFGLAKRYRD 157
DFGLA RD
Sbjct: 214 CDFGLA---RD 221
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 62/266 (23%), Positives = 105/266 (39%), Gaps = 88/266 (33%)
Query: 9 FRLGRKIGSGSFGEIYL---GTNIQTNEEVAIKL------------------NV--KTKH 45
F L + +G GSFG+++L + + A+K+ ++ + H
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 46 P---QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC 95
P +L Y E KLY IL +GG DLF
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGG----------------------------DLFTRL 117
Query: 96 SR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFG 150
S+ + + V ++ ++ +HS ++RD+KP+N L+ G + + DFG
Sbjct: 118 SKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG------HIKLTDFG 171
Query: 151 LAKRYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLR 207
L+K + I + E K + GT Y + ++ D S G VLM+ L
Sbjct: 172 LSK--------ESIDH-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLT 221
Query: 208 GSLPWQGLKAGTKKQKYEKISEKKVS 233
G+LP+QG +K+ I + K+
Sbjct: 222 GTLPFQG---KDRKETMTMILKAKLG 244
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 1e-04
Identities = 64/270 (23%), Positives = 98/270 (36%), Gaps = 94/270 (34%)
Query: 9 FRLGRKIGSGSFGEIYL---GTNIQTNEEVAIKL--------------------NV--KT 43
F L R +G G +G+++ T T + A+K+ N+ +
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 44 KHP---QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFN 93
KHP L Y KLY IL GG +LF
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGG----------------------------ELFM 110
Query: 94 FCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIID 148
R T ++ + +H K ++RD+KP+N ++ G V + D
Sbjct: 111 QLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG------HVKLTD 164
Query: 149 FGLAKR--YRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY 204
FGL K + T TH T GT Y + + +R D SLG LMY
Sbjct: 165 FGLCKESIHDGTVTH-----------TFCGTIEYMAPEILMRSGHNRAVDWWSLG-ALMY 212
Query: 205 -FLRGSLPWQGLKAGTKKQKYEKISEKKVS 233
L G+ P+ G +K+ +KI + K++
Sbjct: 213 DMLTGAPPFTG---ENRKKTIDKILKCKLN 239
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 21/73 (28%), Positives = 36/73 (49%), Gaps = 4/73 (5%)
Query: 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 145
E + L+L+ ++ + Q+ +EF+ S+ +HRD+ N L+ V
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVK 233
Query: 146 IIDFGLAKR-YRD 157
I DFGLA+ Y+D
Sbjct: 234 ICDFGLARDIYKD 246
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 55/274 (20%), Positives = 99/274 (36%), Gaps = 94/274 (34%)
Query: 9 FRLGRKIGSGSFGEIYL---GTNIQTNEEVAIK-----------------------LNVK 42
F L + +G+G++G+++L + T + A+K L
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 43 TKHP---QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF 92
+ P L Y E KL+ IL GG +LF
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGG----------------------------ELF 147
Query: 93 NFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYII 147
S+ + + V + +++ +E +H ++RDIK +N L+ G V +
Sbjct: 148 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG------HVVLT 201
Query: 148 DFGLAKRYRDTATHQHIPYRENKNLT--GTARYAS----MNTHLGIEQSRRDDLESLGYV 201
DFGL+K + + + GT Y + G +++ D SLG V
Sbjct: 202 DFGLSK--------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLG-V 250
Query: 202 LMY-FLRGSLPWQGLKAG-TKKQKYEKISEKKVS 233
LMY L G+ P+ ++ + +I + +
Sbjct: 251 LMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 7e-04
Identities = 44/184 (23%), Positives = 66/184 (35%), Gaps = 52/184 (28%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTG--- 63
+ F +G G FG++Y G + VA+K +L+ E QGG
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVK--------RLKEERT-----QGGELQFQ 75
Query: 64 -----I-----PNL-RWFG--VEGDYNVLVIDLL--GPSLED-LFNFCSRKLSL------ 101
I NL R G + +LV + G S+ L + L
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG-SVASCLRERPESQPPLDWPKRQ 134
Query: 102 KTVLMLADQMINR-VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157
+ L A R + ++H +HRD+K N L+ + + DFGLAK
Sbjct: 135 RIALGSA-----RGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKLMDY 186
Query: 158 TATH 161
TH
Sbjct: 187 KDTH 190
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 473 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.02 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.75 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.63 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.38 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.37 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.19 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.04 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.78 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.77 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.72 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.63 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.6 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.59 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.45 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.17 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.1 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.07 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.06 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.9 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.27 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.62 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.45 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.23 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-80 Score=650.50 Aligned_cols=469 Identities=80% Similarity=1.271 Sum_probs=275.5
Q ss_pred CCCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcc-cCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNV-KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~-~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
|+++++++|+++++||+|+||.||+|++..+++.||||++. .....++..|+++++.|.++++++.+.+++......+|
T Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 89999999999999999999999999999999999999843 34456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 80 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 80 v~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||||++++|.+++..+...+++.+++.|+.||+.||+|||++|||||||||+||||+.++..+.+||+|||+++.+....
T Consensus 81 vme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99999999999999888889999999999999999999999999999999999999655578899999999999988777
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
.....++.......||..|+|||++.+..++.++||||||||||||++|+.||.+.......+.+.++........++.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 76677777778899999999999999999999999999999999999999999998888888899999888888889999
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccccccccCC-CCCcCCCCCCCCCCCCC
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVST-PARAIGPGAGPSSGMPP 318 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~~-p~~~~~~~~~~s~~~~~ 318 (473)
+.++|+++.+||..||..||++||++.+|+++|++++.+.++++++.+||+..+..+.+... |++..++..++++.. +
T Consensus 241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p~~~~~~~~~~s~~~-~ 319 (483)
T 3sv0_A 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLA-P 319 (483)
T ss_dssp HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-------------------------
T ss_pred hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccccccCCCCCCCCCCCCCCCCC-C
Confidence 99999999999999999999999999999999999999999999999999999877655544 444444444444433 4
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCcCCCCCCCCCCCCCccCCCCCCCCCCCCccccccccccc-cCCCccccccccCCC
Q 011988 319 AAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSR 397 (473)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 397 (473)
+....+++++..+.+.++|++.+ +|+.++++...|+++++++|+.+++..++|.+.++++++ |++++||+.++|++|
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (483)
T 3sv0_A 320 PALQNDRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSR 397 (483)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccccccCccccccccCCcccc--cccCCcccccccccccccCCCCCCccccccccccccccccccCCccccccccccc
Confidence 44556777888888888887764 677889999999999999999999999999999988877 999999999999999
Q ss_pred CcccCCCCCCCCCCCCCCCCCCCCCCCCCCcccCCcccCCCcccccccccCCccccccccccccceeccCCCccCC
Q 011988 398 EAAVVGSDTDPSRPRTTDASPGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 473 (473)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 473 (473)
++.. +.+.+|+++|++++.+++..+.++.|+.+|..+.++|+++|+|++++++|||+||||||+|+|++|+|++|
T Consensus 398 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 472 (483)
T 3sv0_A 398 DVMP-IDTSEPSRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472 (483)
T ss_dssp ----------------------------------------------------------------------------
T ss_pred cccC-CCCCCcccccccccCchhhhcCCCCcccCCCCccccccccccccccccccHHHHhhhhhhcccCCchHHHH
Confidence 9866 66778899999999988878999999999999999999999999999999999999999999999999987
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-56 Score=446.40 Aligned_cols=252 Identities=21% Similarity=0.231 Sum_probs=205.2
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
++|+++++||+|+||+||+|+++.+|+.||||++.+.. ...+.+|+++|+.|+|+++ ..++.++.+....||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-V~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI-VQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTB-CCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCC-CcEEEEEEECCEEEEEE
Confidence 68999999999999999999999999999999965443 2458899999999986554 55555667888999999
Q ss_pred ecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 82 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||| |++|.+++...+ ..+++.+++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC---TTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCCEEEcccccceeecCCc
Confidence 999 889999997543 4589999999999999999999999999999999999994 77899999999998765422
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. .....+||+.|||||++.+..|+.++||||||||||||++|+.||.+. +..+.+.++....... +
T Consensus 180 ~-------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~~----~ 245 (350)
T 4b9d_A 180 E-------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKIISGSFPP----V 245 (350)
T ss_dssp H-------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCC----C
T ss_pred c-------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCC----C
Confidence 1 113468999999999999999999999999999999999999999874 4455555665544322 3
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
...+++++.+||..||..||++||++++| |++.|.+.
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~---l~hp~~~~ 282 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSI---LEKGFIAK 282 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHH---HTSHHHHT
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHH---hcCHHhhc
Confidence 45689999999999999999999998877 55555544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-55 Score=432.70 Aligned_cols=267 Identities=19% Similarity=0.302 Sum_probs=219.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++++.||+|+||+||+|+++.+++.||||++.+ .....+.+|+++|+.|+|++ |..++.++.+.+..||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF-FVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTT-BCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCC-CCeEEEEEEeCCEEEE
Confidence 3579999999999999999999999999999998643 33456889999999998555 5555566677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||| ||+|.+++... +.+++.++..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+...
T Consensus 110 vmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCC
Confidence 99999 88999999854 579999999999999999999999999999999999999 47889999999999987543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.... ...+++||+.|||||++.+..|+.++|||||||+||||++|+.||.+. +..+.+.++......
T Consensus 186 ~~~~-----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~----- 252 (311)
T 4aw0_A 186 SKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKIIKLEYD----- 252 (311)
T ss_dssp TTCC-----CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCC-----
T ss_pred CCcc-----cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCC-----
Confidence 3211 235679999999999999999999999999999999999999999874 445556666554432
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccc
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 294 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 294 (473)
+...+++++.+||..||..||++||+++++.. ..+.++ .+|-..+||+.+..
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~---~~~i~~-Hp~F~~idw~~l~~ 304 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG---YGPLKA-HPFFESVTWENLHQ 304 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC---HHHHHT-SGGGTTCCCTTGGG
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChHHHcC---CHHHHC-CCCcCCCCHHHhcC
Confidence 23568899999999999999999999887632 112221 23445678998753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-55 Score=435.78 Aligned_cols=260 Identities=21% Similarity=0.233 Sum_probs=212.4
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-C
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 85 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g 85 (473)
+.|++.++||+|+||.||+|+++.+|+.||||++..... ..+|+.+++.|+|++ |..++.++.+....||||||| |
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--~~~E~~il~~l~Hpn-IV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--RVEELVACAGLSSPR-IVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CTHHHHTTTTCCCTT-BCCEEEEEEETTEEEEEECCCTT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--HHHHHHHHHhCCCCC-CCcEEEEEEECCEEEEEEeccCC
Confidence 569999999999999999999999999999999765433 357999999998655 455556667888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCC-cEEEEecCCcccccCCCCcccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~~~~~~~~ 164 (473)
++|.+++... +.+++.+++.|+.||+.||+|||++|||||||||+||||+ .++ .+||+|||+|+.+........
T Consensus 135 g~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~~~~~~~- 209 (336)
T 4g3f_A 135 GSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQPDGLGKS- 209 (336)
T ss_dssp CBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC---------
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccCCCcccc-
Confidence 8999999854 4799999999999999999999999999999999999995 454 699999999997754332111
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCc
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 244 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 244 (473)
......++||+.|||||++.+..|+.++|||||||+||||++|+.||.+........ ++.... .....+...++
T Consensus 210 -~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i~~~~--~~~~~~~~~~s 283 (336)
T 4g3f_A 210 -LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL---KIASEP--PPIREIPPSCA 283 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH---HHHHSC--CGGGGSCTTSC
T ss_pred -eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHHcCC--CCchhcCccCC
Confidence 111245689999999999999999999999999999999999999998865544333 333322 12234556889
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 245 TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 245 ~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
+++.+||..||..||++|||+.+|++.|...+...+
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 999999999999999999999999999998887654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-54 Score=420.01 Aligned_cols=292 Identities=78% Similarity=1.362 Sum_probs=256.8
Q ss_pred CCCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEc-ccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLN-VKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~-~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
|+..++++|++.+.||+|+||.||+|++..+++.||||+. .......+..|+.+++.+.|++++..+..++......++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 6678899999999999999999999999999999999983 334456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 80 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 80 v~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
+|||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||+++.+....
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999999999998777789999999999999999999999999999999999999544467889999999999887766
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
.....++.......||..|+|||++.+..++.++|||||||++|||++|+.||.+.......+.+..+...........+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 65556666667789999999999999999999999999999999999999999987766666666677676677777888
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 292 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 292 (473)
+..+|+++.++|..||+.||++||++.+|.+.|++++.+.+..+++.+||+.+
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 88999999999999999999999999999999999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=435.67 Aligned_cols=244 Identities=18% Similarity=0.255 Sum_probs=205.2
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc---CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~---~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
+.|+++++||+|+||.||+|+++.+|+.||||++.. .....+.+|+.+|+.|+|++ |..++.++.+.+..||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~Hpn-IV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN-VVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTT-BCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCC-CCcEEEEEEECCEEEEEEeC
Confidence 569999999999999999999999999999998532 33456889999999998554 55555666778899999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
| |++|.+++.. ..+++.+++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+......
T Consensus 153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~~~~~~- 226 (346)
T 4fih_A 153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPR- 226 (346)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCSSSCC-
T ss_pred CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC---CCCCEEEecCcCceecCCCCCc-
Confidence 9 7899999974 4699999999999999999999999999999999999994 7889999999999877554321
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
...++||+.|||||++.+..|+.++||||||||||||++|+.||.+.. ..+.+..+....... . .....
T Consensus 227 ------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~-~-~~~~~ 295 (346)
T 4fih_A 227 ------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPPR-L-KNLHK 295 (346)
T ss_dssp ------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSSCCC-C-SCGGG
T ss_pred ------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCC-C-Ccccc
Confidence 246799999999999999999999999999999999999999998743 344444444322111 1 12346
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
+++++.+||..||..||++|||+++|
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~ 321 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAEL 321 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 78999999999999999999998776
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=417.45 Aligned_cols=292 Identities=78% Similarity=1.358 Sum_probs=262.1
Q ss_pred CCCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcc-cCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNV-KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~-~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
|+..++++|++.+.||+|+||.||+|++..+++.||||++. ......+.+|+.+++.+.|+++++.+..++......++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 67789999999999999999999999999999999999843 34456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 80 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 80 v~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||+++......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999999999998777789999999999999999999999999999999999999654567899999999999887766
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
.....++.......||..|+|||++.+..++.++|||||||+||||++|+.||.+.......+.+..+...........+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 55555556667789999999999999999999999999999999999999999987665555666666666666777778
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 292 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 292 (473)
+..+|+++.++|..||+.||++||++.+|.+.|++++.+.+...++.+||+.+
T Consensus 243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 3uzp_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGC
T ss_pred HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence 88999999999999999999999999999999999999999999999999865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-54 Score=419.20 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=197.8
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++++.||+|+||+||+|++..+|+.||||++.+.. ...+.+|+.+++.|+|++ |..+..++.+.+..||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH-IIKLYDVIKSKDEIIM 90 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTT-BCCEEEEEECSSEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCC-CCeEEEEEEECCEEEE
Confidence 368999999999999999999999999999999864432 345889999999998554 5555556677888999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 80 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 80 v~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||||+++|.+++.. ...+++.+++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+...+..
T Consensus 91 vmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 91 VIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTCCEEECCSSCC-------
T ss_pred EEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC---CCCCEEEeecCCCeecCCCC
Confidence 999999999999975 45799999999999999999999999999999999999994 78899999999998765432
Q ss_pred CccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
. ..+.+||+.|||||++.+..| +.++|||||||+||||++|+.||.+. +..+.+..+......
T Consensus 167 ~--------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i~~~~~~----- 230 (275)
T 3hyh_A 167 F--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNISNGVYT----- 230 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCC-----
T ss_pred c--------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCC-----
Confidence 2 245689999999999999886 68999999999999999999999774 344455555544332
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
+...+++++.+||..||+.||++|||++++ |++.|.+..
T Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~ei---l~hpw~k~~ 269 (275)
T 3hyh_A 231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEI---MQDDWFKVD 269 (275)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHH---HHCHHHHTT
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHH---HcCcccccC
Confidence 235689999999999999999999998776 667666553
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=419.83 Aligned_cols=285 Identities=60% Similarity=1.056 Sum_probs=257.2
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc-CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK-TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~-~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.+++++|++.+.||+|+||.||+|++..+++.||||++.. .....+..|+.+++.|.+|++|..+..++......++||
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 3578899999999999999999999999999999999543 345568999999999977888888888888999999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCc-----EEEEecCCccccc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ-----VYIIDFGLAKRYR 156 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~-----vkL~DFGla~~~~ 156 (473)
||++++|.+++......+++.+++.|+.||+.||+|||++||+||||||+|||++ ..+. +||+|||+++.+.
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 85 ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEESB
T ss_pred EeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEcccceeee
Confidence 9999999999997777899999999999999999999999999999999999995 4444 9999999999887
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
........+++......||+.|+|||++.+..++.++|||||||+||||++|..||.+.......+.+..+.........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 76666666666667889999999999999999999999999999999999999999998877777888888777777777
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccc
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 291 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~ 291 (473)
..++..+| ++.++|..||..||.+||++++|.+.|++++.+.++..+..+||+.
T Consensus 242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 88888888 9999999999999999999999999999999999999999999984
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=422.08 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=210.7
Q ss_pred CCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
.++|.+.++||+|+||+||+|++. .++..||||++.... ..++.+|+++|+.|+|+| |..+..++.+.+..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~Hpn-IV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH-IVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTT-BCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCC-CccEEEEEeeCCEE
Confidence 468999999999999999999875 357889999965543 345889999999998555 45555566677888
Q ss_pred EEEEecC-CCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcE
Q 011988 78 VLVIDLL-GPSLEDLFNFCS------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 144 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~v 144 (473)
+|||||| +|+|.+++...+ ..+++.+++.|+.||+.||+|||+++||||||||+||||+ .++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~---~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC---CCCcE
Confidence 9999999 899999997532 4699999999999999999999999999999999999994 77899
Q ss_pred EEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHH
Q 011988 145 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 223 (473)
Q Consensus 145 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~ 223 (473)
||+|||+|+........ .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.. ..+.
T Consensus 168 Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~~ 239 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEV 239 (299)
T ss_dssp EECCCSCHHHHTGGGCE-----EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHH
T ss_pred EECCcccceecCCCCce-----eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHH
Confidence 99999999876543221 12234579999999999999999999999999999999998 999998854 3444
Q ss_pred HHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 224 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 224 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
+..+....... .+..+|+++.+||..||+.||++||++.+|.+.|+++....
T Consensus 240 ~~~i~~~~~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 240 IECITQGRVLQ----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HHHHHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHcCCCCC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 45554433221 24578999999999999999999999999999999886543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=438.48 Aligned_cols=249 Identities=18% Similarity=0.256 Sum_probs=207.4
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc---CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~---~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
+.|+++++||+|+||.||+|+++.+|+.||||++.. .....+.+|+.+|+.|+|++ |..++.++...+..||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~Hpn-IV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN-VVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTT-BCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC-CCceEEEEEECCEEEEEEeC
Confidence 569999999999999999999999999999998543 23456889999999998655 55555566778889999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
| |++|.+++.. ..+++.++..|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~---~~g~vKl~DFGla~~~~~~~~-- 302 (423)
T 4fie_A 230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVP-- 302 (423)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC---TTCCEEECCCTTCEECCSSCC--
T ss_pred CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEecCccceECCCCCc--
Confidence 9 8899999974 4699999999999999999999999999999999999994 788999999999987755432
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
....++||+.|||||++.+..|+.++||||||||||||++|+.||.+.. ..+.+..+....... ......
T Consensus 303 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~--~~~~~~ 372 (423)
T 4fie_A 303 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPPR--LKNLHK 372 (423)
T ss_dssp -----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCC--CSCTTS
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCC--Cccccc
Confidence 1246799999999999999999999999999999999999999998743 344444444332111 112356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
+++++.+||..||..||++||++++| |++-|
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~el---l~Hp~ 403 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAEL---LKHPF 403 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHH---TTCGG
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHH---hcCHH
Confidence 89999999999999999999998776 44444
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=422.94 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=201.9
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.++|++.++||+|+||+||+|++. ..||||++.... ...+.+|+.+++.|+|+|+|..+. ++.+ +..+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g-~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG-YMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEE-EECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEE-EEEC-CeEEEE
Confidence 367889999999999999999853 359999864322 245889999999999777666554 4443 457899
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||| |++|.+++......+++.+++.|+.||+.||+|||+++||||||||+||||+ .++.+||+|||+|+......
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~---~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---TTEEEEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---CCCcEEEeeccCceecccCC
Confidence 9999 8999999986667899999999999999999999999999999999999995 77899999999998765432
Q ss_pred CccccccccCCCcccCccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~---~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
... .....+||+.|||||++.+. .|+.++|||||||+||||++|+.||.+.... ......+......+..
T Consensus 187 ~~~-----~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 187 GSQ-----QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYASPDL 259 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCCCCS
T ss_pred cce-----eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCCc
Confidence 211 12456899999999999754 5899999999999999999999999875432 2222333333333334
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
..+...+|+++.+||..||+.||++||++.+|++.|+.+
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 445668899999999999999999999999999988765
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=415.66 Aligned_cols=246 Identities=21% Similarity=0.316 Sum_probs=200.6
Q ss_pred CCce-EEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEe---CCe
Q 011988 6 GNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVE---GDY 76 (473)
Q Consensus 6 ~~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~---~~~ 76 (473)
.++| ++.++||+|+||+||+|.+..+++.||||++.... ...+.+|+.+++.|+|+++|..+..+... ...
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 3455 88899999999999999999999999999854322 24588999999999977777766655432 356
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
.+|||||| |++|.+++.. ...+++..++.|+.||+.||+|||++| ||||||||+||||+ +.++.+||+|||+|+
T Consensus 104 ~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred EEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCE
Confidence 79999999 8899999985 457999999999999999999999998 99999999999995 346899999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
...... ....+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+.. ...+.+..+......
T Consensus 181 ~~~~~~---------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~--~~~~~~~~i~~~~~~ 248 (290)
T 3fpq_A 181 LKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVKP 248 (290)
T ss_dssp GCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCCC
T ss_pred eCCCCc---------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC--cHHHHHHHHHcCCCC
Confidence 644322 135689999999999876 69999999999999999999999997643 233444444443322
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
. .+...+++++.+||..||..||++|||+++|+
T Consensus 249 ~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l 281 (290)
T 3fpq_A 249 A---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp G---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred C---CCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 2 23456789999999999999999999988773
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-53 Score=421.80 Aligned_cols=256 Identities=22% Similarity=0.297 Sum_probs=203.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
.++|.+.++||+|+||+||+|++. .+++.||||++.... ...|.+|+++|+.|+|+|+ ..+..++.+....
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnI-V~l~g~~~~~~~~ 118 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI-VRFFGVCTEGRPL 118 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTB-CCEEEEECSSSSE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCC-CcEEEEEEECCEE
Confidence 357999999999999999999865 368899999975543 3458899999999985554 4555566677888
Q ss_pred EEEEecC-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCC
Q 011988 78 VLVIDLL-GPSLEDLFNFCS--------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 142 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~--------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~ 142 (473)
+|||||| +++|.+++.... .++++.+++.|+.||+.||+|||+++||||||||+||||+ .++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~---~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC---CCC
Confidence 9999999 899999997432 3589999999999999999999999999999999999995 788
Q ss_pred cEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHH
Q 011988 143 QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 221 (473)
Q Consensus 143 ~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~ 221 (473)
.+||+|||+|+........ .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+... .
T Consensus 196 ~~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~ 267 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---T 267 (329)
T ss_dssp EEEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---H
T ss_pred cEEEcccccceeccCCCcc-----eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---H
Confidence 9999999999876443221 12245679999999999999999999999999999999999 9999987543 3
Q ss_pred HHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 222 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 222 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
+.+..+...... .....+|+++.+||..||+.||++||++.+|.+.|+.+.+
T Consensus 268 ~~~~~i~~g~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 268 EAIDCITQGREL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHHHTCCC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 444444433221 1245789999999999999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=406.63 Aligned_cols=289 Identities=60% Similarity=1.016 Sum_probs=258.8
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc-CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK-TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~-~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
..++++|++.+.||+|+||.||+|.+..+++.||||++.. .....+.+|+.+++.+.++++++.+..++......++||
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 4578999999999999999999999999999999998543 345568999999999988888888888889999999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC--CCCCcEEEEecCCcccccCCC
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~--~~~~~vkL~DFGla~~~~~~~ 159 (473)
||++++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++.+ .....+||+|||+++.+....
T Consensus 86 e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 86 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred EecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 999999999999777789999999999999999999999999999999999999632 123349999999999887765
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
.....++.......||..|+|||++.+..++.++|||||||+||||++|+.||.+.......+.+..+...........+
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH
Confidence 55555555667788999999999999999999999999999999999999999988777777777777777777777888
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccc
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 291 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~ 291 (473)
+..+|+++.++|..||+.||++||++++|.+.|++++.+.+...+..+||+.
T Consensus 246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 8899999999999999999999999999999999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=425.36 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=207.2
Q ss_pred CceEEEeeEeecCceEEEEEEEc---CCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
++|++++.||+|+||+||+|++. .+++.||||++.+. ....+.+|+.+++.|+|++ |..++.++.+.+..|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF-IVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTT-EECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCC-CCeEEEEEEECCEEE
Confidence 67999999999999999999974 46789999985432 2335788999999998555 555556667788999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
|||||| |++|.+++... +.+++.++..|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+...+
T Consensus 103 ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTSCEEEESSEEEEC---
T ss_pred EEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc---CCCCEEecccccceeccC
Confidence 999999 88999999854 4799999999999999999999999999999999999994 788999999999986544
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+. +..+.+..+......
T Consensus 179 ~~~-------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~---- 244 (304)
T 3ubd_A 179 HEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILKAKLG---- 244 (304)
T ss_dssp --C-------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC----
T ss_pred CCc-------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHHHcCCCC----
Confidence 322 124578999999999999999999999999999999999999999874 344555555554432
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHhCCCCCCccccccccccc
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQ 296 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~ 296 (473)
+...+++++.+||..||+.||++||++. .+.+++++.| -..+||+.+..++
T Consensus 245 -~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~-------f~~idw~~l~~~~ 297 (304)
T 3ubd_A 245 -MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF-------FSTIDWNKLYRRE 297 (304)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG-------GTTCCHHHHHTTC
T ss_pred -CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc-------ccCCCHHHHHhCC
Confidence 2356899999999999999999999863 2344455544 3346898775443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=415.07 Aligned_cols=253 Identities=20% Similarity=0.237 Sum_probs=207.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
..++++.++||+|+||+||+|+.. .+++.||||++... ....|.+|+.+++.|+|+|+|. +..++.....
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~-l~g~~~~~~~ 103 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC-LLGVVTKDQP 103 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCC-EEEEECSSSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCC-cceEEEECCE
Confidence 357899999999999999999863 46789999996433 2356899999999998665555 4555666778
Q ss_pred EEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC
Q 011988 77 NVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 140 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 140 (473)
.+|||||| +|+|.+++.... ..+++.+++.|+.||+.||+|||+++||||||||+||||+ +
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~---~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---D 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---G
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC---C
Confidence 89999999 899999996431 3589999999999999999999999999999999999994 7
Q ss_pred CCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 011988 141 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 219 (473)
Q Consensus 141 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~ 219 (473)
++.+||+|||+|+....... +.......||+.|||||++.+..|+.++|||||||+||||+| |..||.+...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-- 253 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-- 253 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--
T ss_pred CCCEEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--
Confidence 78999999999987654322 112345689999999999999999999999999999999998 8999988643
Q ss_pred HHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 220 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 220 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
.+.+..+....... ....+|+++.+||..||+.||++||++.+|.+.|+.
T Consensus 254 -~~~~~~i~~~~~~~----~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 254 -QDVVEMIRNRQVLP----CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -HHHHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -HHHHHHHHcCCCCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 44445554433322 245789999999999999999999999999988874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=421.65 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=212.1
Q ss_pred CceEEEeeEeecCceEEEEEEEcCC-----CcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEee-EeCCe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFG-VEGDY 76 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~-~~~~~ 76 (473)
++|++.++||+|+||+||+|.+..+ ++.||||++.... ...+.+|+++|..|.||++|..+..++ ..+..
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 6799999999999999999997654 3679999865543 235889999999999987776666555 44567
Q ss_pred EEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC
Q 011988 77 NVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 140 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~---------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 140 (473)
.+|||||| +|+|.+++... ...+++.+++.|+.||+.||+|||+++||||||||+|||++ .
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~---~ 220 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---E 220 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---G
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC---C
Confidence 89999999 89999999743 23489999999999999999999999999999999999994 7
Q ss_pred CCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 011988 141 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 219 (473)
Q Consensus 141 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~ 219 (473)
++.+||+|||+|+.+...... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.....
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred CCCEEECcchhhhhcccCCCc-----eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 789999999999876543321 12245689999999999999999999999999999999998 999998865432
Q ss_pred HHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 220 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 220 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.....+...... .....+|+++.++|..||+.||++|||+.+|++.|+.+++.+
T Consensus 296 --~~~~~i~~g~~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 296 --EFCRRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp --HHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --HHHHHHHcCCCC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 222223222211 123568999999999999999999999999999999998654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=420.92 Aligned_cols=264 Identities=21% Similarity=0.266 Sum_probs=207.7
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeE-----e
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGV-----E 73 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~-----~ 73 (473)
.++++|+++++||+|+||+||+|++..+|+.||||++.+.. ...+.+|+++|+.|+|+++|..+..+.. +
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 35789999999999999999999999999999999965433 2346789999999997766666554432 3
Q ss_pred CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 74 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 74 ~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
....|||||||+++|.+++.. .+.+++..+..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+
T Consensus 131 ~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred CCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecceee
Confidence 356899999999999999973 5679999999999999999999999999999999999999 478899999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc--
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-- 230 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~-- 230 (473)
.+....... ......++||+.|||||++.+.. ++.++||||||||||||++|+.||.+.+.......+......
T Consensus 207 ~~~~~~~~~---~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 207 GLCTSPAEH---QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp CC----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ecccCcccc---ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 765432111 11235679999999999998864 699999999999999999999999885433322222222111
Q ss_pred ---------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 231 ---------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 231 ---------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
........+...+++++.+||.+||.+||++|||++++ |++.|.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~---L~Hp~f 348 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA---LRHPFL 348 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH---TTSGGG
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH---hcCHhh
Confidence 11122344556788999999999999999999998776 555554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=407.52 Aligned_cols=267 Identities=22% Similarity=0.260 Sum_probs=199.4
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHH--HHHhcCCCCCCeeEEeeEeC---CeEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKL--YKILQGGTGIPNLRWFGVEG---DYNVL 79 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~i--l~~L~~~~~i~~~~~~~~~~---~~~~l 79 (473)
|..+|.+.++||+|+||+||+|++ +|+.||||++.......+..|.++ +..|+|+|+|..+..+...+ ...+|
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 457899999999999999999986 689999999766655555555544 45677766666665555443 25799
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccCCCCCcEEEeeCCCCCcEEEEecC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIIDFG 150 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~--------gIvHrDIKP~NILl~~~~~~~~vkL~DFG 150 (473)
||||+ +++|.++++. ..+++..++.|+.|++.||+|||++ +||||||||+|||| +.++.+||+|||
T Consensus 79 V~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DFG 153 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCT
T ss_pred EecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeCC
Confidence 99999 8999999974 4699999999999999999999987 99999999999999 478999999999
Q ss_pred CcccccCCCCccccccccCCCcccCccccccccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCC----------
Q 011988 151 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPWQG---------- 214 (473)
Q Consensus 151 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~------~~s~ksDVwSlGviL~elltG~~Pf~~---------- 214 (473)
+|+.......... ......+||+.|||||++.+. .++.++|||||||+||||++|..||..
T Consensus 154 la~~~~~~~~~~~---~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 154 LAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp TCEEEETTTTEES---CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred CCccccCCCCcee---eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 9987655432111 112346899999999999865 367899999999999999999776532
Q ss_pred CCCC--CHHHHHHHHhhccccccHHHHhc--CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCC
Q 011988 215 LKAG--TKKQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 281 (473)
Q Consensus 215 ~~~~--~~~~~~~~i~~~~~~~~~~~l~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 281 (473)
.... ...+....+......+.++.... .++..+.+||..||+.||++|||+.+|.+.|+++..+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i 301 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence 2111 12223333333333322222221 2346799999999999999999999999999998876654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=403.89 Aligned_cols=252 Identities=22% Similarity=0.254 Sum_probs=185.6
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCC------
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD------ 75 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~------ 75 (473)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ..+.+|+.+|+.|+|+++|..+..+...+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4579999999999999999999999999999998654332 357899999999997777777666654332
Q ss_pred -----eEEEEEecC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEE
Q 011988 76 -----YNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 147 (473)
Q Consensus 76 -----~~~lv~e~~-g~sL~~~l~~~~~--~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~ 147 (473)
+.||||||| |++|.+++..... ..++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~---~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC---CCCcEEEc
Confidence 479999999 8899999974322 255677899999999999999999999999999999994 77899999
Q ss_pred ecCCcccccCCCCccc-----cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHH
Q 011988 148 DFGLAKRYRDTATHQH-----IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 222 (473)
Q Consensus 148 DFGla~~~~~~~~~~~-----~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~ 222 (473)
|||+|+.+........ .........+||+.|||||++.+..|+.++|||||||+||||++ ||.... ....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence 9999998765432111 01112345689999999999999999999999999999999996 885421 1222
Q ss_pred HHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 223 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 223 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.+..+.....+. .....++++.+||..||+.||++||++.+|+
T Consensus 236 ~~~~~~~~~~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 278 (299)
T 4g31_A 236 TLTDVRNLKFPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINII 278 (299)
T ss_dssp HHHHHHTTCCCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHhcCCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 233333333322 2223456788999999999999999988774
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=405.73 Aligned_cols=285 Identities=28% Similarity=0.549 Sum_probs=223.4
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCC-----CcEEEEEEcccCCchhHHHHHHHHHHhcC--------------CCCCC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLNVKTKHPQLQYEAKLYKILQG--------------GTGIP 65 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~~~~~~~~~l~~E~~il~~L~~--------------~~~i~ 65 (473)
..++|++.++||+|+||.||+|.+..+ ++.||||++.... ..+..|+++++.+.+ |++|.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 456999999999999999999998764 5789999965543 356677777776654 55666
Q ss_pred eeEEeeEeC----CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCC
Q 011988 66 NLRWFGVEG----DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 141 (473)
Q Consensus 66 ~~~~~~~~~----~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 141 (473)
.+..++... .+.+|||||+|++|.+++......+++.+++.|+.||+.||.|||++||+||||||+||||+. +..
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-SCT
T ss_pred eEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-CCC
Confidence 655554432 568999999999999999877678999999999999999999999999999999999999952 256
Q ss_pred CcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHH
Q 011988 142 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 221 (473)
Q Consensus 142 ~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~ 221 (473)
+.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||||++|+.||.+.......
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 89999999999877654333222222334567999999999999999999999999999999999999999864332221
Q ss_pred HHHHHHhhccccccHHHH---h---cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccc
Q 011988 222 QKYEKISEKKVSTSIEAL---C---RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 294 (473)
Q Consensus 222 ~~~~~i~~~~~~~~~~~l---~---~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 294 (473)
..... ......+..+ + ..+|+++.++|..||..||++||++.+|.+.|++++.+.+...+..+||+....
T Consensus 271 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 346 (364)
T 3op5_A 271 VRDSK---IRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVEN 346 (364)
T ss_dssp HHHHH---HHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-----
T ss_pred HHHHH---HHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEeccC
Confidence 11111 1111222222 2 578999999999999999999999999999999999999999999999998654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=404.28 Aligned_cols=259 Identities=22% Similarity=0.320 Sum_probs=201.6
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEc---CCCcEEEEEEcccC-CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLNVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
|.+.++|++.++||+|+||+||+|++. .+++.||||.+.+. ....+.+|+++|+.+.+|++|..+..++...+..|
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 567889999999999999999999875 46789999985444 34568899999999987888888888888899999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
|||||+ |++|.++++ .+++.++..|+.||+.||+|||++|||||||||+||||+ .+.+.+||+|||+|+...+
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECTT
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcccCC
Confidence 999999 789999985 599999999999999999999999999999999999996 3457999999999986654
Q ss_pred CCCccc---------------------cccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 011988 158 TATHQH---------------------IPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGL 215 (473)
Q Consensus 158 ~~~~~~---------------------~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~ 215 (473)
...... .........+||+.|+|||++.+.. |+.++||||+|||||||++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 321100 0001123468999999999998865 899999999999999999999999653
Q ss_pred CCCCHHHHHHHHhhccc----------------------c---------------------------ccHHHHhcCCcHH
Q 011988 216 KAGTKKQKYEKISEKKV----------------------S---------------------------TSIEALCRGYPTE 246 (473)
Q Consensus 216 ~~~~~~~~~~~i~~~~~----------------------~---------------------------~~~~~l~~~~p~~ 246 (473)
.. ....+..+....- . .........++++
T Consensus 251 ~~--~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 251 SD--DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp SS--HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CC--HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 32 2222222211000 0 0000112457889
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHH
Q 011988 247 FASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 247 l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
+.+||.+||.+||++|||+++++
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL 351 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEAL 351 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHH
T ss_pred HHHHHHHHCcCChhHCcCHHHHh
Confidence 99999999999999999988763
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=420.55 Aligned_cols=267 Identities=22% Similarity=0.280 Sum_probs=216.5
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhc--CCCCCCeeEEeeEeCC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGD 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~--~~~~i~~~~~~~~~~~ 75 (473)
.-.++|++++.||+|+||.||+|+++.+|+.||||++.+. ....+..|..++..+. +|++|..++.++.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 3457899999999999999999999999999999986432 2233556666666554 4667777777788889
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..||||||| ||+|.+++... +.|++..+..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeee
Confidence 999999999 89999999854 579999999999999999999999999999999999999 4789999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
+..... .+.+||+.|||||++.+ ..|+.++||||||||||||++|..||.+....+..+.+..+......
T Consensus 342 ~~~~~~---------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~ 412 (689)
T 3v5w_A 342 FSKKKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412 (689)
T ss_dssp CSSCCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC
T ss_pred cCCCCC---------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC
Confidence 654322 45799999999999974 57999999999999999999999999876555544444444443332
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 298 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 298 (473)
+...+++++.+||..||..||.+|++ +++| +++. |-..+||+.+...+.+
T Consensus 413 -----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei---~~Hp-------fF~~idW~~l~~~~~~ 467 (689)
T 3v5w_A 413 -----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV---KESP-------FFRSLDWQMVFLQKYP 467 (689)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHH---TTSG-------GGTTCCHHHHHTTCSC
T ss_pred -----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHH---hcCc-------cccCCCHHHHHcCCCC
Confidence 23568999999999999999999998 4444 4443 3456899987655443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=415.67 Aligned_cols=249 Identities=19% Similarity=0.288 Sum_probs=208.8
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.++|++++.||+|+||.||+|+++.+|+.||||++.... ...+.+|+.+|+.|+|++ |..+..++.+....+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT-LVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTT-BCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCC-CCeEEEEEEECCEEEEEEe
Confidence 468999999999999999999999999999999865543 345788999999998655 5555566678889999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|| |++|.+++......|++.++..|+.||+.||+|||++||+||||||+||||+. +..+.+||+|||+|+.+.....
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~- 312 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS- 312 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSE-
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCc-
Confidence 99 88999999755567999999999999999999999999999999999999952 2347899999999998754322
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.. ..+.+..+........ .....
T Consensus 313 -------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~---~~~~~~~i~~~~~~~~-~~~~~ 381 (573)
T 3uto_A 313 -------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCDWNMD-DSAFS 381 (573)
T ss_dssp -------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTTCCCCC-SGGGT
T ss_pred -------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHhCCCCCC-ccccc
Confidence 134589999999999999999999999999999999999999998743 3455555554433221 22346
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
.+++++.+||..||..||.+||++.++
T Consensus 382 ~~s~~~~dli~~~L~~dp~~R~t~~e~ 408 (573)
T 3uto_A 382 GISEDGKDFIRKLLLADPNTRMTIHQA 408 (573)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 789999999999999999999998876
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=382.57 Aligned_cols=281 Identities=23% Similarity=0.408 Sum_probs=221.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCC--------CcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCC------------
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQT--------NEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIP------------ 65 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--------~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~------------ 65 (473)
+++|++.+.||+|+||.||+|++..+ ++.||||++... ..+.+|+.+++.++|++++.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 68999999999999999999999874 889999996544 46889999999998654432
Q ss_pred --eeEEeeEe-CCeEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCC
Q 011988 66 --NLRWFGVE-GDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 141 (473)
Q Consensus 66 --~~~~~~~~-~~~~~lv~e~~g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 141 (473)
.+..++.. ....++||||++++|.+++... ...+++.+++.|+.||+.||.|||++||+||||||+|||++ .+
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~---~~ 195 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD---PE 195 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE---TT
T ss_pred ccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc---CC
Confidence 24445544 7889999999999999999854 35799999999999999999999999999999999999995 45
Q ss_pred C--cEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 011988 142 N--QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 219 (473)
Q Consensus 142 ~--~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~ 219 (473)
+ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||||++|..||.+.....
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 5 89999999998776543222111122245689999999999999999999999999999999999999998754221
Q ss_pred HHHHHHHHh--hccccccHH--HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 011988 220 KKQKYEKIS--EKKVSTSIE--ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 292 (473)
Q Consensus 220 ~~~~~~~i~--~~~~~~~~~--~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 292 (473)
........ ......... .....+++++.++|..||..||++||++++|++.|++++.+.+...+..+||+..
T Consensus 276 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 351 (352)
T 2jii_A 276 -EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPMV 351 (352)
T ss_dssp -HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC-
T ss_pred -HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcCC
Confidence 11111111 000000000 0013568999999999999999999999999999999999999999999999863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=363.07 Aligned_cols=263 Identities=22% Similarity=0.351 Sum_probs=211.9
Q ss_pred CCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
...+.++|++++.||+|+||.||+|++..+++.||||++.... ...+.+|+.+++.++|+ +|..+..++....
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp-~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ-NIVSMIDVDEEDD 84 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBT-TBCCEEEEEECSS
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCC-CCceEEEeeeeCC
Confidence 4567889999999999999999999999999999999853321 23577899999999854 5555666677888
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..++||||+ |++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCSSSTT
T ss_pred eEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEEeCCCccc
Confidence 899999999 77999999854 4799999999999999999999999999999999999994 778999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ......+........
T Consensus 161 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~ 231 (294)
T 4eqm_A 161 LSETSL------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET---AVSIAIKHIQDSVPN 231 (294)
T ss_dssp C-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC---HHHHHHHHHSSCCCC
T ss_pred cccccc------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhhccCCC
Confidence 654321 11234579999999999999999999999999999999999999998743 233333333444444
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFIR 278 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~l~~~ 278 (473)
....+...+|+.+.++|.+||+.||.+|| +++++.+.|+.++.+
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 44556678999999999999999999999 888888888876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=372.43 Aligned_cols=269 Identities=19% Similarity=0.262 Sum_probs=218.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|+++++||+|+||.||+|++..+++.||||++.+. ....+..|..++..+..|++|..+..++......++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 46899999999999999999999999999999985432 234578899999998777888888888888899999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ |++|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccC
Confidence 99999 78999998753 579999999999999999999999999999999999999 47889999999999864332
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC------CHHHHHHHHhhccc
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYEKISEKKV 232 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~------~~~~~~~~i~~~~~ 232 (473)
.. .....+||+.|+|||++.+..++.++|||||||+||||++|+.||...... .....+..+.....
T Consensus 207 ~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 279 (396)
T 4dc2_A 207 GD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279 (396)
T ss_dssp TC-------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC
T ss_pred CC-------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc
Confidence 21 124678999999999999999999999999999999999999999754321 12223333433332
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH---HHHHHHHHHHHHhCCCCCCcccccccccccc
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA---YLKRLFRDLFIREGFQFDYVFDWTILKYQQS 297 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~---~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~ 297 (473)
. +...+++++.+||..||..||.+||++. .+.+++++. +-..+||+.+...+.
T Consensus 280 ~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp-------ff~~i~w~~l~~~~~ 335 (396)
T 4dc2_A 280 R-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP-------FFRNVDWDMMEQKQV 335 (396)
T ss_dssp C-----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST-------TTTTCCHHHHHTTCS
T ss_pred C-----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc-------cccCCCHHHHHcCCC
Confidence 2 2356789999999999999999999963 345555543 345689998765443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=372.08 Aligned_cols=266 Identities=20% Similarity=0.255 Sum_probs=214.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++++.||+|+||.||+|++..+++.||||++.+ .....+..|..+++.+.+|++|..+..++......++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 4789999999999999999999999999999998543 2344577899999999778888888888888899999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ |++|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 102 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccC
Confidence 99999 78999999753 569999999999999999999999999999999999999 47889999999999854332
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+. +..+.+..+.......
T Consensus 178 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~~---- 243 (353)
T 3txo_A 178 GV-------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAILNDEVVY---- 243 (353)
T ss_dssp ---------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCC----
T ss_pred Cc-------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCC----
Confidence 21 124568999999999999989999999999999999999999999874 3445555555544322
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHH---HHHHHHHHHHHhCCCCCCcccccccccccc
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAY---LKRLFRDLFIREGFQFDYVFDWTILKYQQS 297 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~---l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~ 297 (473)
...+++++.++|..||..||.+||++.+ ..+++++.| -..++|..+...+.
T Consensus 244 -p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~-------f~~~~w~~l~~~~~ 297 (353)
T 3txo_A 244 -PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF-------FKEIDWAQLNHRQI 297 (353)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG-------GTTCCHHHHHTTCS
T ss_pred -CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc-------ccCCCHHHHhcCcC
Confidence 2457899999999999999999999721 133344443 34568988755443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=364.03 Aligned_cols=260 Identities=20% Similarity=0.285 Sum_probs=212.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++++.||+|+||.||+|++..+++.||||++.+ .....+..|+.+++.++| ++|..+..++......++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCC-CcCcceEEEEEeCCEEEE
Confidence 4789999999999999999999999999999998543 334567889999999974 556666667777888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 83 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCT
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccC
Confidence 99999 7899999874 3579999999999999999999999999999999999999 47889999999999864332
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+......
T Consensus 159 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~----- 223 (337)
T 1o6l_A 159 GA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIR----- 223 (337)
T ss_dssp TC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC-----
T ss_pred CC-------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCC-----
Confidence 21 1245689999999999999999999999999999999999999997643 34444444443322
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
+...+++++.++|..||..||.+|| ++++| +++.| -..++|..+...
T Consensus 224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei---~~h~~-------f~~~~~~~~~~~ 275 (337)
T 1o6l_A 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV---MEHRF-------FLSINWQDVVQK 275 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH---HTSGG-------GTTCCHHHHHTT
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH---HcCCC-------cCCCCHHHHHhC
Confidence 2346789999999999999999999 76665 44333 335688876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=360.32 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=202.1
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcc---cCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNV---KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~---~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
..++|++.++||+|+||.||+|.+..+++.||||++. ......+.+|+.+++.++|++ |..+..++...+..++||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN-IVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTT-BCCEEEEEEETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCC-CCeEeEEEEECCEEEEEE
Confidence 3568999999999999999999999999999999843 233455789999999998655 555555666788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++........
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCSTTC
T ss_pred ECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC---CCCCEEEeeCCCceecCCccc
Confidence 999 8999999974 3699999999999999999999999999999999999994 778999999999987654332
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||.+... ......+....... ....
T Consensus 172 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~--~~~~ 239 (297)
T 3fxz_A 172 K-------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPE--LQNP 239 (297)
T ss_dssp C-------BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCC--CSCG
T ss_pred c-------cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCC--CCCc
Confidence 1 2456899999999999999999999999999999999999999977433 22222222211111 0113
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..+++.+.++|..||..||++||++.+++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell 268 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELL 268 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 46789999999999999999999988773
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=368.05 Aligned_cols=268 Identities=19% Similarity=0.245 Sum_probs=219.5
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
..++|++++.||+|+||.||+|++..+++.||||++.+ .....+..|..++..+.+|++|..+..+.......+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 45789999999999999999999999999999998543 334557789999988877888988888888889999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+||||+ |++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+....
T Consensus 98 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCccccccc
Confidence 999999 78999999754 469999999999999999999999999999999999999 4788999999999986433
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. +..+.+..+......
T Consensus 174 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~---- 239 (353)
T 2i0e_A 174 DGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVA---- 239 (353)
T ss_dssp TTC-------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC----
T ss_pred CCc-------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCC----
Confidence 221 124568999999999999999999999999999999999999999874 344555555554332
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDY--AYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 298 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~--~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 298 (473)
+...+++++.+||..||..||.+||++ ..+.+++++.| -..+||..+...+.+
T Consensus 240 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~-------f~~~~w~~l~~~~~~ 294 (353)
T 2i0e_A 240 -YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF-------FRYIDWEKLERKEIQ 294 (353)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG-------GTTCCHHHHHTTCSC
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc-------ccCCCHHHHHhCCCC
Confidence 235688999999999999999999964 22334444433 335789887554433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=357.32 Aligned_cols=256 Identities=17% Similarity=0.222 Sum_probs=200.2
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--------chhHHHHHHHHHHhc---CCCCCCeeEEee
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--------HPQLQYEAKLYKILQ---GGTGIPNLRWFG 71 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--------~~~l~~E~~il~~L~---~~~~i~~~~~~~ 71 (473)
..+.++|++.++||+|+||.||+|++..+++.||||++.... ...+.+|+.+++.+. |++++..+..+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 356789999999999999999999999999999999854221 346788999988887 555554444444
Q ss_pred EeCC----eEEEEEecCCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEE
Q 011988 72 VEGD----YNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 146 (473)
Q Consensus 72 ~~~~----~~~lv~e~~g~sL~~~l~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL 146 (473)
.... ..+++||+++++|.+++..... .+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl 161 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKL 161 (308)
T ss_dssp ECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC---TTSCEEE
T ss_pred ccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEE
Confidence 3332 5799999999999999985433 399999999999999999999999999999999999994 7789999
Q ss_pred EecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 011988 147 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 226 (473)
Q Consensus 147 ~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~ 226 (473)
+|||+++.+..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+..
T Consensus 162 ~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 162 ADFGLARIYSYQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp CSCSCTTTSTTCCC--------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred eeCccccccCCCcc--------cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999986643322 2345799999999999999999999999999999999999999987543322222222
Q ss_pred Hhhc-------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 227 ISEK-------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 227 i~~~-------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.... ........+...+++++.+||..||..||++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 1110 111233445567899999999999999999999988773
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=358.47 Aligned_cols=254 Identities=19% Similarity=0.242 Sum_probs=205.7
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
.+.++|+++++||+|+||.||+|.+. +++.||||++.... ...+.+|+.+++.++|++ |..+..+.......+
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN-IVSLIDVIHSERCLT 95 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTT-BCCEEEEECCSSCEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCC-EeeeeeEEccCCEEE
Confidence 46789999999999999999999984 58999999854332 245789999999998554 555555566777889
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 79 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 79 lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
+||||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEETTSC
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC---CCCCEEEccCcCceecCCC
Confidence 9999999999999986666799999999999999999999999999999999999994 7789999999999876433
Q ss_pred CCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc-----
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 232 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 232 (473)
.. ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..+.....
T Consensus 173 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 173 VR-------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp CC----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred cc-------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 22 1234578999999999987 4589999999999999999999999988776655554444322111
Q ss_pred -----------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 -----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 -----------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
......+...+++++.+||..||..||++|||+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 299 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 1123344567889999999999999999999988774
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=365.61 Aligned_cols=272 Identities=19% Similarity=0.266 Sum_probs=218.4
Q ss_pred CCCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
|++.-.++|++++.||+|+||.||+|++..+++.||||++.+.. ...+..|..+++.+.+|++|..+..++...
T Consensus 3 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CCCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 56667789999999999999999999999999999999965432 234678999999986677777787788888
Q ss_pred CeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
...++||||+ |++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCK 158 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCB
T ss_pred CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccc
Confidence 8999999999 78999998753 479999999999999999999999999999999999999 478899999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC------CHHHHHHHH
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYEKI 227 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~------~~~~~~~~i 227 (473)
....... .....+||+.|+|||++.+..++.++|||||||+||||++|..||...... .....+..+
T Consensus 159 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i 231 (345)
T 3a8x_A 159 EGLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231 (345)
T ss_dssp CSCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred cccCCCC-------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence 6433221 124568999999999999999999999999999999999999999753221 122233333
Q ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH---HHHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 228 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA---YLKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 228 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~---~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
...... +...++.++.++|..||..||.+||++. .+.+++++.| -..++|+.+...
T Consensus 232 ~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~-------f~~~~w~~~~~~ 290 (345)
T 3a8x_A 232 LEKQIR-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF-------FRNVDWDMMEQK 290 (345)
T ss_dssp HHCCCC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG-------GTTCCHHHHHTT
T ss_pred HcCCCC-----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc-------cCCCCHHHHHhC
Confidence 333222 2356789999999999999999999962 3444454443 345789876544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=369.07 Aligned_cols=259 Identities=17% Similarity=0.307 Sum_probs=211.6
Q ss_pred CCceEEEeeEeecCceEEEEEEEc-------CCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
.++|++.+.||+|+||.||+|++. .++..||||++..... ..+.+|+.+++.+..|++|..+..++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999975 3456799999655432 35789999999995566677777777777
Q ss_pred CeEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 138 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~ 138 (473)
...++||||+ +++|.+++.... ..+++.+++.|+.||+.||+|||++||+||||||+||||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~-- 237 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-- 237 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC--
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC--
Confidence 8889999999 779999998543 3489999999999999999999999999999999999994
Q ss_pred CCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 011988 139 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 217 (473)
Q Consensus 139 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~ 217 (473)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||||++ |..||.+...
T Consensus 238 -~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 238 -ENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp -TTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred -CCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 7789999999999876543221 12234567899999999999999999999999999999999 9999987654
Q ss_pred CCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 218 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 218 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
... +..+...... .....++.++.++|..||..||++||++.+|++.|+.++...
T Consensus 312 ~~~---~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 312 EEL---FKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp GGH---HHHHHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHH---HHHHhcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 322 2222222211 123468899999999999999999999999999999988654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=365.95 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=208.9
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---------chhHHHHHHHHHHhcCCCCCCeeEEeeEe
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---------HPQLQYEAKLYKILQGGTGIPNLRWFGVE 73 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---------~~~l~~E~~il~~L~~~~~i~~~~~~~~~ 73 (473)
..+.++|++.+.||+|+||.||+|.+..+|+.||||++.+.. ...+.+|+.+++.+.|+ +|..+..++..
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP-NIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCT-TBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCc-CCCcEEEEEEe
Confidence 356788999999999999999999999999999999854432 24688999999999855 55555666677
Q ss_pred CCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC-CCcEEEEecCC
Q 011988 74 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGL 151 (473)
Q Consensus 74 ~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~-~~~vkL~DFGl 151 (473)
....++||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..++. ...+||+|||+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 88899999999 8999999973 457999999999999999999999999999999999999952111 12799999999
Q ss_pred cccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011988 152 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231 (473)
Q Consensus 152 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 231 (473)
++.+..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...+.+..+....
T Consensus 166 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~ 234 (361)
T 2yab_A 166 AHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANITAVS 234 (361)
T ss_dssp CEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTC
T ss_pred ceEcCCCCc--------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcC
Confidence 987654321 23568999999999999999999999999999999999999999874 3344555555443
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.... ......+++++.+||..||..||.+||++.+++
T Consensus 235 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 235 YDFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp CCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCC-chhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 3322 344568899999999999999999999987763
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=366.52 Aligned_cols=253 Identities=18% Similarity=0.219 Sum_probs=207.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
.+.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.|+|++ |..+..++....
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~ 99 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH-IVELLETYSSDG 99 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTT-BCCEEEEEEETT
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCC-CCcEEEEEEeCC
Confidence 4567899999999999999999999999999999985321 3456889999999998555 555555667788
Q ss_pred eEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCC
Q 011988 76 YNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 151 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 151 (473)
..++||||+ |++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 899999999 78998887532 33589999999999999999999999999999999999997544456699999999
Q ss_pred cccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011988 152 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231 (473)
Q Consensus 152 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 231 (473)
++.+..... ......||+.|+|||++.+..++.++|||||||+||+|++|..||.+. ....+..+....
T Consensus 180 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~i~~~~ 248 (351)
T 3c0i_A 180 AIQLGESGL-------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKGK 248 (351)
T ss_dssp CEECCTTSC-------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHHHHHHHHTC
T ss_pred eeEecCCCe-------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHHHHHHHcCC
Confidence 987654322 123457999999999999999999999999999999999999999763 233444444433
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.... ......+++++.+||..||..||++||++.+++
T Consensus 249 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l 285 (351)
T 3c0i_A 249 YKMN-PRQWSHISESAKDLVRRMLMLDPAERITVYEAL 285 (351)
T ss_dssp CCCC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCC-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 3322 233467899999999999999999999988774
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=359.20 Aligned_cols=263 Identities=17% Similarity=0.245 Sum_probs=210.8
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.++|++.++||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++.++| ++|..+..++......++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-cCcccEEEEEecCCeeEEEEE
Confidence 478999999999999999999999999999999854433 3457899999999985 555556666678888999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++......+++.+++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.+......
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC---TTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC---CCCCEEEeecccceeccccccc
Confidence 99 7899999997777899999999999999999999999999999999999994 7789999999999876543321
Q ss_pred ccc-------ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHH--HHHHHhhccc
Q 011988 162 QHI-------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ--KYEKISEKKV 232 (473)
Q Consensus 162 ~~~-------p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~--~~~~i~~~~~ 232 (473)
... .........||+.|+|||++.+..++.++|||||||+||||++|..||.......... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~---- 240 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL---- 240 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH----
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc----
Confidence 100 0011125689999999999999999999999999999999999999997643321110 000000
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.......+|+++.++|..||+.||++||++.+|.+.|+.+....
T Consensus 241 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 241 ---DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ---HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 01123578899999999999999999999999999999887543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=369.26 Aligned_cols=270 Identities=29% Similarity=0.457 Sum_probs=198.4
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcC---CCcEEEEEEcccCCc--------------hhHHHHHHHHHHhcCCCCCCe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLNVKTKH--------------PQLQYEAKLYKILQGGTGIPN 66 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAiK~~~~~~~--------------~~l~~E~~il~~L~~~~~i~~ 66 (473)
..+++|++.+.||+|+||.||+|.+.. ++..||||+...... ..+.+|+.+++.+.|.+++..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 456899999999999999999999987 788999998654432 224455566666665555554
Q ss_pred eEEeeEe---CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCc
Q 011988 67 LRWFGVE---GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 143 (473)
Q Consensus 67 ~~~~~~~---~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 143 (473)
+..+... ....++||||++++|.+++.... .+++.+++.|+.||+.||+|||++||+||||||+||||+.+ ..+.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~~ 191 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPDQ 191 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-STTS
T ss_pred ecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-CCCc
Confidence 4443332 67899999999999999987443 79999999999999999999999999999999999999622 2238
Q ss_pred EEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHH-H
Q 011988 144 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-Q 222 (473)
Q Consensus 144 vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~-~ 222 (473)
+||+|||+++.+..................||..|+|||++.+..++.++|||||||+||||++|..||.+....... .
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999999877543322111111224568999999999999999999999999999999999999999653222111 1
Q ss_pred HHHHHhhccccccHHHHhc--CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 223 KYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 223 ~~~~i~~~~~~~~~~~l~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
................... .+|+++.++|..||..||++||++.+|++.|+++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1111111122222222222 7899999999999999999999999999988764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=361.57 Aligned_cols=259 Identities=17% Similarity=0.257 Sum_probs=214.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++.++|++ |..+..++......++||
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRN-ILHLHESFESMEELVMIF 80 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTT-BCCEEEEEEETTEEEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCC-CCeEeEEEecCCEEEEEE
Confidence 46789999999999999999999999999999999865433 334789999999998555 555555667788999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ |++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+++.+.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECCTTCE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECCCCCc
Confidence 999 779999997555679999999999999999999999999999999999999521 268999999999987654322
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+........ ....
T Consensus 160 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~-~~~~ 227 (321)
T 1tki_A 160 --------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTFD-EEAF 227 (321)
T ss_dssp --------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCC-HHHH
T ss_pred --------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHHHcCCCCCC-hhhh
Confidence 123578999999999999889999999999999999999999998743 3444555554444333 3345
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
..+++++.++|..||..||.+||++.++ |++.|.+.
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~---l~hp~~~~ 263 (321)
T 1tki_A 228 KEISIEAMDFVDRLLVKERKSRMTASEA---LQHPWLKQ 263 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHH---hcChhhcc
Confidence 6789999999999999999999998877 55666554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=361.58 Aligned_cols=244 Identities=25% Similarity=0.328 Sum_probs=202.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
..++|++++.||+|+||.||+|.+..+|+.||||++.+.. ...+.+|+++++.++|+ +|..+..+.......++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP-NIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCT-TBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCC-CEeeEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999864432 23477899999999855 45555566677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSS
T ss_pred EEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCCC
Confidence 99999 88999998754 569999999999999999999999999999999999999 47889999999999866543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s-~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
.. ....+||+.|+|||++.+..+. .++|||||||+||||++|+.||.+.. ..+....+.......
T Consensus 168 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~--- 233 (328)
T 3fe3_A 168 GK--------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRERVLRGKYRI--- 233 (328)
T ss_dssp CG--------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCC---
T ss_pred Cc--------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCC---
Confidence 21 2356899999999999988875 89999999999999999999998743 334444444433321
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...+++++.++|..||..||.+|||+++++
T Consensus 234 --p~~~s~~~~~li~~~L~~dP~~R~t~~eil 263 (328)
T 3fe3_A 234 --PFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263 (328)
T ss_dssp --CTTSCHHHHHHHHHHCCSSTTTSCCHHHHT
T ss_pred --CCCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 235789999999999999999999987773
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=357.72 Aligned_cols=265 Identities=20% Similarity=0.248 Sum_probs=205.5
Q ss_pred CCCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHH--hcCCCCCCeeEEeeEe---CC
Q 011988 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKI--LQGGTGIPNLRWFGVE---GD 75 (473)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~--L~~~~~i~~~~~~~~~---~~ 75 (473)
|...+.++|++.+.||+|+||.||+|.+ +++.||||++.......+..|.+++.. ++|++++..+..+... ..
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 5678899999999999999999999986 789999999877666777888888888 5666555555443332 34
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCcccCCCCCcEEEeeCCCCCcEEE
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------SKSFLHRDIKPDNFLMGLGRRANQVYI 146 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH--------~~gIvHrDIKP~NILl~~~~~~~~vkL 146 (473)
..++||||+ +++|.++++ ...+++..++.|+.||+.||.||| ++||+||||||+|||++ .++.+||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~---~~~~~kl 154 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK---KNGQCCI 154 (301)
T ss_dssp EEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC---TTSCEEE
T ss_pred eeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc---CCCCEEE
Confidence 579999999 779999996 457999999999999999999999 99999999999999994 7789999
Q ss_pred EecCCcccccCCCCccccccccCCCcccCccccccccccCC------CCCchhhHHHHHHHHHHHHcC----------CC
Q 011988 147 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRG----------SL 210 (473)
Q Consensus 147 ~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~------~~s~ksDVwSlGviL~elltG----------~~ 210 (473)
+|||+|+.......... .......||+.|+|||++.+. .++.++|||||||++|||++| ..
T Consensus 155 ~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLD---VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp CCCTTCEEEETTTTEEE---CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred eeCCCeeeccccccccc---ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 99999987655433211 112345899999999999887 455799999999999999999 88
Q ss_pred CCCCCCCCC-HHHHHHHHh-hccccc--cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 211 PWQGLKAGT-KKQKYEKIS-EKKVST--SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 211 Pf~~~~~~~-~~~~~~~i~-~~~~~~--~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
||....... ....+.... ...... ........+++++.++|..||+.||++||++.+|++.|+++
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 987654322 222222221 111111 11112233568899999999999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=374.72 Aligned_cols=255 Identities=20% Similarity=0.250 Sum_probs=208.7
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ...+.+|+.+++.|+|++ |..+..+..+....
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~ 85 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN-IVRLHDSISEEGHH 85 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTT-BCCEEEEEECSSEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcC-CCeEEEEEEECCEE
Confidence 345678999999999999999999999999999999865543 234789999999998555 55555666788889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ |++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+...+.+||+|||+++...
T Consensus 86 ~lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999 7899999874 4579999999999999999999999999999999999999755467889999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
.... ......||+.|+|||++.+..++.++|||||||+||+|++|..||.+.. ....+..+.........
T Consensus 165 ~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 165 GEQQ-------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYDFPS 234 (444)
T ss_dssp TTCC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCCCCCT
T ss_pred CCCc-------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhCCCCCCc
Confidence 4322 1235689999999999999999999999999999999999999997743 34444555444332221
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.....+++++.+||..||..||++||++.++++
T Consensus 235 -~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 -PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 123568999999999999999999999887743
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=366.36 Aligned_cols=261 Identities=22% Similarity=0.250 Sum_probs=215.2
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.+... ....|+.++..+..|++|..+..++.+....++||||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 356789999999999999999999999999999999765443 3567999999997777888888888889999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC-CCCCcEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+... +..+.+||+|||+++.+......
T Consensus 98 ~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 176 (342)
T 2qr7_A 98 MKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176 (342)
T ss_dssp CCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc
Confidence 9 7899999874 4579999999999999999999999999999999999998532 12246999999999876543321
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
....+||+.|+|||++.+..++.++|||||||+||||++|..||.+.......+.+..+........ ...+.
T Consensus 177 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~~~ 248 (342)
T 2qr7_A 177 -------LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS-GGYWN 248 (342)
T ss_dssp -------BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC-STTTT
T ss_pred -------eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC-ccccc
Confidence 1345889999999999988899999999999999999999999987655555666666655443321 12235
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
.+++++.+||..||..||++||++.++ |++.|.
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~i---l~hp~~ 281 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALV---LRHPWI 281 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHH---TTSHHH
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHH---hcCCee
Confidence 689999999999999999999998766 555554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=365.71 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=206.4
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.|+|+ +|..+..+..+....++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP-NIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCT-TBCCEEEEEECSSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCC-CCCeEEEEEEeCCEEEE
Confidence 4568999999999999999999999999999999965433 23578899999999855 55556666677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||+++.....
T Consensus 106 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 99999 7799998873 456999999999999999999999999999999999999975445567999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+......... .
T Consensus 185 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~-~ 252 (362)
T 2bdw_A 185 EA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPS-P 252 (362)
T ss_dssp CS--------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT-T
T ss_pred cc--------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCc-c
Confidence 21 134689999999999999999999999999999999999999998743 33444444443322211 2
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
....+++++.+||..||..||++||++.+++
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 283 (362)
T 2bdw_A 253 EWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283 (362)
T ss_dssp GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 2356789999999999999999999988774
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=361.89 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=204.5
Q ss_pred CCCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
|...+.++|++++.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|+ +|..+..++.....
T Consensus 1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~ 79 (323)
T 3tki_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-NVVKFYGHRREGNI 79 (323)
T ss_dssp -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCT-TBCCEEEEEECSSE
T ss_pred CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCC-CCCeEEEEEecCCe
Confidence 66778899999999999999999999999999999999854332 34588999999999855 45556666778888
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
.++||||+ +++|.+++. ....+++.+++.|+.||+.||+|||++||+||||||+|||++ ..+.+||+|||+++.+
T Consensus 80 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVF 155 (323)
T ss_dssp EEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe---CCCCEEEEEeecccee
Confidence 99999999 779999886 344699999999999999999999999999999999999994 7789999999999876
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
...... .......||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+....... +..........
T Consensus 156 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~~ 228 (323)
T 3tki_A 156 RYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTYL 228 (323)
T ss_dssp EETTEE-----CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--HHHHHTTCTTS
T ss_pred ccCCcc-----cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHHhcccccC
Confidence 433221 11235689999999999998775 78999999999999999999999875543222 22222221111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.....+++++.+||..||..||++||++.+++
T Consensus 229 ---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil 260 (323)
T 3tki_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIK 260 (323)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred ---CccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11356789999999999999999999987763
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=355.77 Aligned_cols=244 Identities=18% Similarity=0.219 Sum_probs=199.6
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc-----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~-----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.++|++.++||+|+||+||+|.+..+++.||||++..... .....|+..+..+..+++|..+..++......++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 3689999999999999999999999999999998544321 23455666666665677777787788889999999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 81 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 81 ~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|||++++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---GGGCEEECCCTTCEECC----
T ss_pred EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEccceeeeecccCCC
Confidence 99999999999987777899999999999999999999999999999999999994 678999999999987654322
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
.....||+.|+|||++.+ .++.++|||||||+||||++|..||.+. .....+..... ...+.
T Consensus 213 --------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~~~~~~~~~~---~~~~~ 274 (311)
T 3p1a_A 213 --------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EGWQQLRQGYL---PPEFT 274 (311)
T ss_dssp ----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HHHHHHTTTCC---CHHHH
T ss_pred --------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHhccCC---Ccccc
Confidence 134579999999999987 7999999999999999999997766442 12233333222 23455
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..+++++.++|..||..||++||++.+|++
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 678999999999999999999999888753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=353.55 Aligned_cols=250 Identities=21% Similarity=0.250 Sum_probs=201.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
++|+++++||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|+ +|..+..+.......++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK-NIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCT-TBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCC-CEeeEEeEEEeCCEEEEEE
Confidence 68999999999999999999999999999999854332 24577899999999855 5555666667888999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
||++++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECCSCCS-
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccceecCCccc-
Confidence 9999999999887778899999999999999999999999999999999999994 778999999999987643322
Q ss_pred cccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc-------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------- 233 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 233 (473)
......||..|+|||++.+.. ++.++|||||||++|||++|..||.... .....+..+......
T Consensus 157 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp ------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCT
T ss_pred ------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhh
Confidence 224568899999999998876 7999999999999999999888864322 223333333221100
Q ss_pred -----------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 234 -----------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 234 -----------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.....+...+++++.+||..||+.||++|||+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 001112235789999999999999999999988774
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=362.60 Aligned_cols=259 Identities=17% Similarity=0.248 Sum_probs=208.5
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCc---EEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
...++|++.+.||+|+||.||+|.+..+++ .||||++.... ...+.+|+.+++.|+|+ +|..+..++.....
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP-NIIRLEGVVTRGRL 124 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCT-TBCCEEEEECGGGC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCC-CCCcEEEEEEeCCc
Confidence 345789999999999999999999986554 59999965432 23578899999999854 55555556677778
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
.++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEEC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCccccc
Confidence 89999999 789999998666789999999999999999999999999999999999999 47789999999999876
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
....... .......+|..|+|||++.+..++.++|||||||+||||++ |..||.+... ......+.......
T Consensus 202 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~~~~ 274 (325)
T 3kul_A 202 EDDPDAA----YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVEEGYRLP 274 (325)
T ss_dssp C----CC----EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCCC
T ss_pred ccCccce----eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCCCC
Confidence 5432211 11233456889999999999899999999999999999999 9999987543 33333333322111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
....+++++.++|..||..||++||++.+|++.|+.++.
T Consensus 275 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 275 ----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 234689999999999999999999999999999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=363.77 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=215.4
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
..++|++.+.||+|+||.||+|++..+++.||||++.+ .....+..|..++..+..|++|..+..++......+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 45789999999999999999999999999999998543 334557889999998866777778877888888999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+||||+ |++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+....
T Consensus 95 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC---CCCCEEEeEChhhhhccc
Confidence 999999 88999999853 4699999999999999999999999999999999999994 778999999999986433
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+......
T Consensus 171 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~---- 236 (345)
T 1xjd_A 171 GDA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNPF---- 236 (345)
T ss_dssp TTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC----
T ss_pred CCC-------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCCC----
Confidence 221 1245689999999999999999999999999999999999999998743 34444444443322
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHhCCCCCCccccccccccc
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYA-YLKRLFRDLFIREGFQFDYVFDWTILKYQQ 296 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~-~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~ 296 (473)
+...+++++.++|..||..||.+||++. +| +++ .+-..++|+.+...+
T Consensus 237 -~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i---~~h-------p~f~~~~w~~l~~~~ 285 (345)
T 1xjd_A 237 -YPRWLEKEAKDLLVKLFVREPEKRLGVRGDI---RQH-------PLFREINWEELERKE 285 (345)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG---GGS-------GGGTTCCHHHHHTTC
T ss_pred -CCcccCHHHHHHHHHHhcCCHhHcCCChHHH---HcC-------ccccCCCHHHHhhCC
Confidence 2346789999999999999999999975 33 332 233457888775443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=364.57 Aligned_cols=256 Identities=21% Similarity=0.291 Sum_probs=204.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhc----CCCCCCeeEEeeEeCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQ----GGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~----~~~~i~~~~~~~~~~~~~ 77 (473)
.+.++|+++++||+|+||.||+|++..+++.||||++.... ...+..|+.+++.+. .|++|..+..++...+..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 56789999999999999999999999999999999965432 345678999999997 356677777777888899
Q ss_pred EEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC------------------
Q 011988 78 VLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG------------------ 138 (473)
Q Consensus 78 ~lv~e~~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~------------------ 138 (473)
++||||++++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+..
T Consensus 112 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 112 CLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 9999999999999998544 359999999999999999999999999999999999999521
Q ss_pred ----CCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 011988 139 ----RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214 (473)
Q Consensus 139 ----~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~ 214 (473)
...+.+||+|||+|+...... ....||+.|+|||++.+..++.++|||||||+||||++|+.||.+
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDYH----------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSCC----------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccCCCCEEEEeccCceecCCCC----------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 126789999999998644322 346899999999999999999999999999999999999999987
Q ss_pred CCCCCHHHHHHHHhhccccccH--------------------------------------HHHhcCCcHHHHHHHHHHhc
Q 011988 215 LKAGTKKQKYEKISEKKVSTSI--------------------------------------EALCRGYPTEFASYFHYCRS 256 (473)
Q Consensus 215 ~~~~~~~~~~~~i~~~~~~~~~--------------------------------------~~l~~~~p~~l~~li~~cl~ 256 (473)
.........+..+......... ..+....++.+.+||..||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 5433222222222111100000 00111224788899999999
Q ss_pred CCCCCCCCHHHHH
Q 011988 257 LRFDDKPDYAYLK 269 (473)
Q Consensus 257 ~dp~~RPt~~~l~ 269 (473)
.||++||++.+++
T Consensus 342 ~dP~~Rpta~elL 354 (360)
T 3llt_A 342 IDPTLRPSPAELL 354 (360)
T ss_dssp SSGGGSCCHHHHT
T ss_pred CChhhCCCHHHHh
Confidence 9999999988874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=355.23 Aligned_cols=267 Identities=22% Similarity=0.261 Sum_probs=205.2
Q ss_pred CCccCCceEEE-eeEeecCceEEEEEEEcCCCcEEEEEEcccC---CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 2 EPRVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 2 ~~~i~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
..++.++|++. +.||+|+||.||+|.+..+++.||||++... ....+.+|+.++..+..|++|..+..+.......
T Consensus 7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45678899996 7899999999999999999999999996443 2456889999999977677777777778888999
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++....+||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999 78999999754 469999999999999999999999999999999999999643334459999999998664
Q ss_pred CCCCccccccccCCCcccCccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC------------
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------ 219 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~------------ 219 (473)
.................||..|+|||++.+ ..++.++|||||||++|||++|..||.+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 322211111112234569999999999975 457899999999999999999999998754322
Q ss_pred HHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 220 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 220 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
....+..+.......+ ......+++++.+||..||..||++||++.++++
T Consensus 246 ~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFP-DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHCCCCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccCcccC-chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1223334443333222 2234578999999999999999999999887743
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=362.58 Aligned_cols=254 Identities=22% Similarity=0.268 Sum_probs=192.9
Q ss_pred CCceEEE---eeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 6 GNKFRLG---RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 6 ~~~y~i~---~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.++|.+. +.||+|+||.||+|.+..+++.||||++.+.....+.+|+.+++.+.+|++|..+..++.+....++|||
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 86 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence 4678886 7899999999999999999999999998777677889999999999977888888888888899999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+|||++.++....+||+|||+++........
T Consensus 87 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 87 LLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 99 7799999985 457999999999999999999999999999999999999974444458999999999865443221
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----CCHHHHHHHHhhccccccHH
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA----GTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~----~~~~~~~~~i~~~~~~~~~~ 237 (473)
.....||..|+|||++.+..++.++|||||||++|||++|..||.+... ....+.+..+........ .
T Consensus 166 -------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~-~ 237 (325)
T 3kn6_A 166 -------LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE-G 237 (325)
T ss_dssp -------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC-S
T ss_pred -------ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC-c
Confidence 2345789999999999999999999999999999999999999976432 223344444444333222 2
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
.....+++++.+||..||..||.+||++.+|
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el 268 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTS
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHH
Confidence 2345789999999999999999999998776
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=371.82 Aligned_cols=260 Identities=22% Similarity=0.254 Sum_probs=192.5
Q ss_pred CCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEe--C
Q 011988 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVE--G 74 (473)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~--~ 74 (473)
+..+.++|+++++||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.+.+|++|..+..+... .
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 4567789999999999999999999999999999999854322 23467899999999855666555555443 3
Q ss_pred CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 75 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
...++||||++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+.
T Consensus 84 ~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 84 RDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRS 158 (388)
T ss_dssp SCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred CEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCccccc
Confidence 46899999999999999974 479999999999999999999999999999999999999 4778999999999987
Q ss_pred ccCCCCcc-c-------------cccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 011988 155 YRDTATHQ-H-------------IPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 219 (473)
Q Consensus 155 ~~~~~~~~-~-------------~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~ 219 (473)
+....... . .........+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~- 237 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM- 237 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 64321100 0 00112245689999999999987 56899999999999999999999999875432
Q ss_pred HHHHHHHHhhccccccHHHH------------------------------------------hcCCcHHHHHHHHHHhcC
Q 011988 220 KKQKYEKISEKKVSTSIEAL------------------------------------------CRGYPTEFASYFHYCRSL 257 (473)
Q Consensus 220 ~~~~~~~i~~~~~~~~~~~l------------------------------------------~~~~p~~l~~li~~cl~~ 257 (473)
..+..+......+..+.+ ...+++++.+||.+||..
T Consensus 238 --~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 238 --NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp --HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred --HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 223322211110000000 126789999999999999
Q ss_pred CCCCCCCHHHHH
Q 011988 258 RFDDKPDYAYLK 269 (473)
Q Consensus 258 dp~~RPt~~~l~ 269 (473)
||++|||+++++
T Consensus 316 dP~~R~t~~e~l 327 (388)
T 3oz6_A 316 NPNKRISANDAL 327 (388)
T ss_dssp SGGGSCCHHHHT
T ss_pred CcccCCCHHHHh
Confidence 999999987763
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=366.69 Aligned_cols=261 Identities=18% Similarity=0.274 Sum_probs=208.4
Q ss_pred ccCCceEEEeeEeecCceEEEEEE-----EcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~-----~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
...++|+++++||+|+||.||+|+ +..+++.||||++.... ...+.+|+.+++.++|++++ .+..++...
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~ 146 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV-RCIGVSLQS 146 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBC-CEEEEECSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCC-eEEEEEecC
Confidence 445789999999999999999999 44577899999965432 23477899999999855544 555556667
Q ss_pred CeEEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEE
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 147 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~ 147 (473)
...++||||+ +++|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||+||||+.++....+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 7789999999 789999998653 359999999999999999999999999999999999999644455679999
Q ss_pred ecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHH
Q 011988 148 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK 226 (473)
Q Consensus 148 DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~ 226 (473)
|||+|+.+..... ........||+.|+|||++.+..++.++|||||||+||||++ |..||.+.. ..+.+..
T Consensus 227 DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHH
T ss_pred CCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH
Confidence 9999986543221 112234578999999999999999999999999999999998 999998743 3333343
Q ss_pred HhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 227 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 227 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
+....... ....++.++.+||..||+.||++||++.+|++.|+.+..
T Consensus 299 i~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 299 VTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCC----CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 33322211 235688999999999999999999999999999988764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=362.72 Aligned_cols=261 Identities=20% Similarity=0.280 Sum_probs=208.7
Q ss_pred cCCceEEEeeEeecCceEEEEEE-----EcCCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeE-eC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGV-EG 74 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~-----~~~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~-~~ 74 (473)
..++|++.+.||+|+||.||+|+ +..+++.||||++..... ..+.+|+.++..+.+|++|..+..++. .+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 35789999999999999999998 445678999999655432 348899999999976666666655544 45
Q ss_pred CeEEEEEecC-CCCHHHHHHHcCC--------------------------------------------------------
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCSR-------------------------------------------------------- 97 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~~-------------------------------------------------------- 97 (473)
...++||||+ +++|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 5689999999 7799999975432
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccccccc
Q 011988 98 ---------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 168 (473)
Q Consensus 98 ---------~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~ 168 (473)
.+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.+...... ..
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~-----~~ 251 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDY-----VR 251 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCGGGSCTTSCTTC-----EE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCcEEEEeccceeeecccccc-----hh
Confidence 189999999999999999999999999999999999994 6789999999999866443221 12
Q ss_pred CCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHH
Q 011988 169 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 247 (473)
Q Consensus 169 ~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 247 (473)
.....||..|+|||++.+..++.++|||||||++|||++ |..||.+...... ....+...... .....+++++
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~l 325 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEGTRM----RAPDYTTPEM 325 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHHHTCCC----CCCTTCCHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHHcCCCC----CCCCCCCHHH
Confidence 245678999999999999999999999999999999998 9999987654322 12222221111 1234678999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 248 ASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 248 ~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.++|..||..||.+||++.+|++.|+.++...
T Consensus 326 ~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 326 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=355.66 Aligned_cols=252 Identities=20% Similarity=0.255 Sum_probs=206.5
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---------chhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.|+|+ +|..+..++...
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~ 86 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP-NVITLHEVYENK 86 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCT-TBCCEEEEEECS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCC-CCCcEEEEEEeC
Confidence 45678999999999999999999999999999999854432 34588999999999855 455556666778
Q ss_pred CeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCC-CCCcEEEEecCCc
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA 152 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~DFGla 152 (473)
...++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+. ....+||+|||++
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 8899999999 8899999973 45799999999999999999999999999999999999995221 1237999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
+.+..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+.....
T Consensus 166 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~~ 234 (326)
T 2y0a_A 166 HKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSAVNY 234 (326)
T ss_dssp EECCTTSC--------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHTCC
T ss_pred eECCCCCc--------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHHhcCC
Confidence 87653321 134579999999999999999999999999999999999999997743 3334444433332
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.. .......++.++.+||..||..||++||++.+++
T Consensus 235 ~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 270 (326)
T 2y0a_A 235 EF-EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270 (326)
T ss_dssp CC-CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred Cc-CccccccCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 22 2344567899999999999999999999988774
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=357.95 Aligned_cols=254 Identities=21% Similarity=0.302 Sum_probs=198.3
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
..++|++.++||+|+||.||+|++ +++.||||++.... ...+.+|+.+++.++|++ |..+..++......++
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN-IVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTT-BCCEEEEECSTTCCEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCC-EeeEEEEEEECCceEE
Confidence 357899999999999999999986 68899999965433 234778999999998554 5555556667777899
Q ss_pred EEecC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 80 VIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~--~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
||||+ +++|.+++..... .+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC---TTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe---CCCcEEECCCCCCcc
Confidence 99999 7799999974321 3999999999999999999999999 99999999999994 778999999999975
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+....+.......
T Consensus 189 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~~~~~~ 258 (309)
T 3p86_A 189 KASTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKCKRL 258 (309)
T ss_dssp --------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHHSCCCC
T ss_pred cccccc-------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCC
Confidence 443221 12356899999999999999999999999999999999999999987543 33333332211111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
.+...+++++.++|..||..||++||++.+|.+.|+.++.
T Consensus 259 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 259 ---EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 2345789999999999999999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=355.63 Aligned_cols=264 Identities=19% Similarity=0.216 Sum_probs=204.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEE----EcCCCcEEEEEEcccCCc---hhHHHHHHHHHHhcCCCCCCeeEEeeE-eCC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLNVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGV-EGD 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~----~~~~~~~vAiK~~~~~~~---~~l~~E~~il~~L~~~~~i~~~~~~~~-~~~ 75 (473)
...++|+++++||+|+||.||+|+ +..+++.||||++..... ..+.+|+.+++.++|++++..+..+.. ...
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 456889999999999999999998 567899999999655443 357899999999997666665554432 345
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKV 163 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCSCC-
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccCccccc
Confidence 679999999 8899999987666799999999999999999999999999999999999995 678999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC---------CHH----
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---------TKK---- 221 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~---------~~~---- 221 (473)
+....... .......++..|+|||++.+..++.++|||||||++|||++|..||...... ...
T Consensus 164 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 164 LPQDKEFF----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp ----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccCCccee----eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 65432211 1123446788899999999999999999999999999999999998642110 000
Q ss_pred HHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 222 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 222 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
.....+..... ......+|+++.++|..||..||++||++.+|.+.|+++..+
T Consensus 240 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 240 HLIELLKNNGR----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHTTCC----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhccCc----CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00111111100 112346889999999999999999999999999999998653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=362.60 Aligned_cols=264 Identities=20% Similarity=0.292 Sum_probs=215.5
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCC-------CcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVE 73 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~ 73 (473)
..++|.+.++||+|+||.||+|++..+ +..||||++..... ..+.+|+++++.+..|++|..+..++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 357899999999999999999997643 35799999655432 4478999999999556677777777777
Q ss_pred CCeEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEee
Q 011988 74 GDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 137 (473)
Q Consensus 74 ~~~~~lv~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~ 137 (473)
....++||||+ +++|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||+||||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~- 225 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT- 225 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc-
Confidence 88889999999 779999998653 3599999999999999999999999999999999999994
Q ss_pred CCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 011988 138 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 216 (473)
Q Consensus 138 ~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~ 216 (473)
.++.+||+|||+++........ .......||..|+|||++.+..++.++|||||||+||||++ |..||.+..
T Consensus 226 --~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 226 --EDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp --TTCCEEECSCSCCCCSSCCCTT-----CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred --CCCcEEEcccCccccccccccc-----ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 7789999999999876543221 12234567899999999999999999999999999999999 999998754
Q ss_pred CCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCC
Q 011988 217 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQF 283 (473)
Q Consensus 217 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~ 283 (473)
. .+....+....... ....+++++.++|..||..||++||++.+|++.|+.++.....+.
T Consensus 299 ~---~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 299 V---EELFKLLKEGHRMD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp H---HHHHHHHHTTCCCC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred H---HHHHHHHHcCCCCC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 2 33333333322111 235688999999999999999999999999999999987765443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=352.10 Aligned_cols=251 Identities=23% Similarity=0.307 Sum_probs=197.7
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
++|++++.||+|+||.||+|++ .+++.||||++.... ...+.+|+.+++.++|++ |..+..+.......++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN-IVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTT-BCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCC-EeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 678999999854322 356789999999998554 555555666778899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHHHCC----
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEeECccccccCcccc-
Confidence 9999999999987767899999999999999999999999999999999999994 778999999999986643221
Q ss_pred cccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc--------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 232 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 232 (473)
......||..|+|||++.+. .++.++|||||||++|||++|..||.+.........+........
T Consensus 156 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 11345789999999999864 589999999999999999999999987543222222222111100
Q ss_pred -------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 -------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
......+...+++++.+||..||..||++||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 279 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0011223356889999999999999999999988774
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=370.90 Aligned_cols=261 Identities=16% Similarity=0.179 Sum_probs=198.3
Q ss_pred cCCceEEE-eeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEe----CCeEEE
Q 011988 5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVE----GDYNVL 79 (473)
Q Consensus 5 i~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~----~~~~~l 79 (473)
+.++|.+. +.||.|+||.||+|.+..+++.||||++.. ...+.+|+.++..+.+|++|..+..++.. ....+|
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 44667776 789999999999999999999999999753 35678899998777666666666554433 567899
Q ss_pred EEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 80 VIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
||||+ |++|.+++.... ..+++.+++.|+.||+.||.|||++|||||||||+||||+..+.++.+||+|||+++....
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 99999 779999997432 3599999999999999999999999999999999999996433478999999999986543
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCH-HHHHHHHhhccccccH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSI 236 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~ 236 (473)
... ....+||+.|+|||++.+..++.++|||||||+||||++|..||.+...... ......+.........
T Consensus 217 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 217 HNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp ------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred CCc--------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 221 2356889999999999999999999999999999999999999987543221 0111222222221111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.....+++++.+||..||..||++||++.+| |++.|...
T Consensus 289 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ei---l~hp~~~~ 327 (400)
T 1nxk_A 289 -PEWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPWIMQ 327 (400)
T ss_dssp -TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHHT
T ss_pred -cccccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCccccC
Confidence 1234688999999999999999999998776 55666543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=362.01 Aligned_cols=265 Identities=21% Similarity=0.302 Sum_probs=214.8
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
+..++|++++.||+|+||.||+|.+..+++.||||++.+ .....+.+|+.+++.++| ++|..+..++......
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH-PFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCEE
Confidence 345789999999999999999999999999999998533 334567899999999975 4555556666777889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ |++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||| +..+.+||+|||+|+.+.
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeecc
Confidence 9999999 8899999973 5579999999999999999999999999999999999999 478899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
.... ....+||+.|+|||++.+ ..++.++|||||||+||||++|..||...........+..+......
T Consensus 167 ~~~~--------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T 4fr4_A 167 RETQ--------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT 238 (384)
T ss_dssp TTCC--------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC
T ss_pred CCCc--------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC
Confidence 4321 245689999999999974 45899999999999999999999999876655555555544433322
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC-HHHHHHHHHHHHHHhCCCCCCccccccccccc
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRLFRDLFIREGFQFDYVFDWTILKYQQ 296 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt-~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~ 296 (473)
+...+++++.+||..||..||.+||+ +++|. . ..+-..++|......+
T Consensus 239 -----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~---~-------hp~f~~~~w~~~~~~~ 287 (384)
T 4fr4_A 239 -----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ---N-------FPYMNDINWDAVFQKR 287 (384)
T ss_dssp -----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH---T-------SGGGTTCCHHHHHTTC
T ss_pred -----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH---c-------ChhhhcCCHHHHHhCC
Confidence 23467899999999999999999998 44442 2 2344567888765443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=348.97 Aligned_cols=258 Identities=20% Similarity=0.298 Sum_probs=199.1
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCC---CcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
...++|++.+.||+|+||.||+|.+..+ +..||||+..... ...+.+|+.+++.++|++++..+..+ ....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~ 89 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI--TENP 89 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE--ccCc
Confidence 3467899999999999999999998654 4579999855433 23477899999999866666555443 3456
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
.++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYM 166 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECcccccccc
Confidence 78999999 6799999987666799999999999999999999999999999999999995 5689999999999876
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+...... +..+......
T Consensus 167 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~~~~~~- 236 (281)
T 1mp8_A 167 EDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGERL- 236 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTTCCC-
T ss_pred Cccccc------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHHcCCCC-
Confidence 543221 1233467889999999999899999999999999999997 9999987654332 2333222211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.+...+|+++.++|..||..||++||++.+|.+.|++++.++
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 237 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 123578999999999999999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=354.84 Aligned_cols=257 Identities=21% Similarity=0.283 Sum_probs=211.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++++.||+|+||.||+|++..+|+.||||++.+ .....+..|..+++.+.|+ +|..+..+..+....++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP-FIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBT-TBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCC-CCceEeEEEEeCCEEEE
Confidence 4789999999999999999999999999999998543 2345577899999988754 55556666677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCCc
Confidence 99999 7899999984 4579999999999999999999999999999999999999 47889999999999865432
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
. ...+||+.|+|||++.+..++.++|||||||++|||++|..||.+. .....+..+......
T Consensus 160 ~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~----- 221 (318)
T 1fot_A 160 T----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELR----- 221 (318)
T ss_dssp B----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCC-----
T ss_pred c----------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCC-----
Confidence 1 3468999999999999999999999999999999999999999774 334445555444332
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
+...+++++.++|..||..||.+|| ++++| +++.| -..++|..+...
T Consensus 222 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i---~~hp~-------f~~~~~~~~~~~ 273 (318)
T 1fot_A 222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV---KNHPW-------FKEVVWEKLLSR 273 (318)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHH---HTSGG-------GSSCCHHHHHTT
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHH---hcCcc-------ccCCCHHHHHhC
Confidence 2346789999999999999999999 65555 33333 345788876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=359.02 Aligned_cols=259 Identities=19% Similarity=0.286 Sum_probs=214.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
...++|++++.||+|+||.||+|++..+++.||||++.+ .....+.+|+.+++.+.| ++|..+..+.......
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcCCEE
Confidence 345789999999999999999999999999999998533 234567889999999974 5555666667778889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ |++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++...
T Consensus 117 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceecc
Confidence 9999999 88999999854 469999999999999999999999999999999999999 478899999999998764
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
... ...+||+.|+|||++.+..++.++|||||||+||||++|..||.+. ...+.+..+......
T Consensus 193 ~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~--- 256 (350)
T 1rdq_E 193 GRT----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVR--- 256 (350)
T ss_dssp SCB----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC---
T ss_pred CCc----------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHHHHHHHcCCCC---
Confidence 321 3468999999999999999999999999999999999999999874 344555555544332
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
+...+++++.++|..||..||.+||+ +++| +++. +-...||..+...
T Consensus 257 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei---~~h~-------~f~~~~w~~~~~~ 308 (350)
T 1rdq_E 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI---KNHK-------WFATTDWIAIYQR 308 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHH---HTSG-------GGTTCCHHHHHTT
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHH---HhCc-------CcCCCCHHHHhhc
Confidence 23568999999999999999999998 5555 3333 3345789876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=372.78 Aligned_cols=265 Identities=21% Similarity=0.275 Sum_probs=213.8
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|+++++||+|+||.||+|++..+++.||||++.+ .....+..|..++..+. |++|..+..++.+....++
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCEEEE
Confidence 4789999999999999999999999999999998543 23344889999999986 5566666667778889999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ |++|.+++......+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.+...
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcccC
Confidence 99999 899999998656789999999999999999999999999999999999999 47889999999999876543
Q ss_pred CCccccccccCCCcccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
... .....+||+.|+|||++. +..++.++|||||||+||||++|+.||.+. +..+.+.++......
T Consensus 229 ~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 229 GTV------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHKER 299 (437)
T ss_dssp SCE------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHHH
T ss_pred CCc------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC---ChhHHHHhhhhcccc
Confidence 321 123468999999999997 456899999999999999999999999874 344445555432211
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHhCCCCCCcccccccc
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 293 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 293 (473)
...+.....+++++.+||..||..+|++ ||+++++ +++.| -..+||+.+.
T Consensus 300 ~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~ei---l~Hpf-------f~~i~w~~l~ 351 (437)
T 4aw2_A 300 FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDF---KKHPF-------FSGIDWDNIR 351 (437)
T ss_dssp CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHH---HTSGG-------GTTCCTTTGG
T ss_pred ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHH---hCCCc-------cCCCCHHHHh
Confidence 1112223457899999999999988887 8997766 44433 3457898874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=370.88 Aligned_cols=265 Identities=22% Similarity=0.300 Sum_probs=211.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
..++|++++.||+|+||.||+|++..+++.||||++.+. ....+..|..++..+. |++|..+..++.+....+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEEE
Confidence 357899999999999999999999999999999986432 2334788999999887 556666667777888999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+||||+ |++|.+++...+..+++..++.++.||+.||+|||++|||||||||+|||| +..+.+||+|||+|+.+..
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheeccC
Confidence 999999 899999998766689999999999999999999999999999999999999 4788999999999987654
Q ss_pred CCCccccccccCCCcccCcccccccccc-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHL-------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 230 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-------~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 230 (473)
.... .....+||+.|+|||++. +..++.++|||||||+||||++|+.||.+.. ..+.+.++...
T Consensus 215 ~~~~------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~ 285 (412)
T 2vd5_A 215 DGTV------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS---TAETYGKIVHY 285 (412)
T ss_dssp TSCE------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTH
T ss_pred CCcc------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhc
Confidence 3321 123468999999999998 3568999999999999999999999998743 34445555432
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCC---CHHHHHHHHHHHHHHhCCCCCCcccccccc
Q 011988 231 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYLKRLFRDLFIREGFQFDYVFDWTILK 293 (473)
Q Consensus 231 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP---t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 293 (473)
......+.+...+++++.+||.+||. +|.+|+ ++++| +++.| -..+||+.+.
T Consensus 286 ~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei---~~Hpf-------f~~i~w~~l~ 340 (412)
T 2vd5_A 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF---RTHPF-------FFGLDWDGLR 340 (412)
T ss_dssp HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH---HTSGG-------GTTCCSTTST
T ss_pred ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH---hcCCC-------cCCCCHHHHh
Confidence 21112222345789999999999999 999984 66655 44433 3456888764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=362.02 Aligned_cols=254 Identities=24% Similarity=0.284 Sum_probs=207.1
Q ss_pred CCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
..+..++|++.+.||+|+||.||+|.+..+++.||||++.+ .....+.+|+.+++.++|+ +|..+..+.....
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~ 82 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP-HIIKLYDVITTPT 82 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCT-TBCCEEEEEECSS
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCC-CCCeEEEEEEeCC
Confidence 45667899999999999999999999999999999998532 2345688999999999855 4555556667778
Q ss_pred eEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 76 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 76 ~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
..++||||++++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 83 ~~~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---DNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC---TTCCEEECCSSCTBTT
T ss_pred EEEEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc---CCCCEEEEEeccceec
Confidence 89999999999999998753 5699999999999999999999999999999999999994 7789999999999866
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
..... ....+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+....... ..+..
T Consensus 159 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---~~i~~----- 222 (336)
T 3h4j_B 159 TDGNF--------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---KKVNS----- 222 (336)
T ss_dssp TTSBT--------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---CCCCS-----
T ss_pred cCCcc--------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---HHHHc-----
Confidence 54321 235689999999999998876 78999999999999999999999764432111 11111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
....+...+++++.++|..||..||.+|||+++| +++.|.+.
T Consensus 223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~ei---l~hp~~~~ 264 (336)
T 3h4j_B 223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEI---RRDPWFNV 264 (336)
T ss_dssp SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHH---TTCHHHHT
T ss_pred CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHH---HhChhhcc
Confidence 1111234578999999999999999999998777 55666554
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=368.47 Aligned_cols=257 Identities=21% Similarity=0.297 Sum_probs=209.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ..+.+|+++++.++|++ |..+..++......++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN-IVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTT-BCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCC-EEEEEEEEecCCCcEEEE
Confidence 4689999999999999999999998999999999654432 34778999999998555 455555566677889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~---~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc---CCCcEEECcCCCceecCCCce
Confidence 999 7899999987666799999999999999999999999999999999999994 778999999999986543211
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. .......++..|+|||++.+..++.++|||||||+||||++ |..||.+... .+....+...... ..
T Consensus 269 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~ 336 (377)
T 3cbl_A 269 A-----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTREFVEKGGRL----PC 336 (377)
T ss_dssp E-----CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHHHHHTTCCC----CC
T ss_pred e-----ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CC
Confidence 0 01122346788999999998899999999999999999998 9999987543 2222222222111 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
...+|+++.++|..||+.||++||++.+|.+.|+++..+
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 346899999999999999999999999999999998765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=348.49 Aligned_cols=254 Identities=17% Similarity=0.262 Sum_probs=201.8
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc----------hhHHHHHHHHHHhcCCCCCCeeEEeeEe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH----------PQLQYEAKLYKILQGGTGIPNLRWFGVE 73 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~----------~~l~~E~~il~~L~~~~~i~~~~~~~~~ 73 (473)
...++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+|+.+++.++|++++..+.. ...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL-MHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE-ETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee-ecC
Confidence 457899999999999999999999999999999998543221 568899999999986555555443 333
Q ss_pred CCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEEeeCC--CCCcEEEEe
Q 011988 74 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGR--RANQVYIID 148 (473)
Q Consensus 74 ~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~--~~~~vkL~D 148 (473)
. .++||||+ +++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++ ....+||+|
T Consensus 95 ~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 P--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp T--TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred C--CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 3 37999999 68999998766668999999999999999999999999 99999999999995321 112399999
Q ss_pred cCCcccccCCCCccccccccCCCcccCcccccccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 011988 149 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 226 (473)
Q Consensus 149 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~--~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~ 226 (473)
||+++..... .....||..|+|||++. +..++.++|||||||++|||++|..||....... ......
T Consensus 173 fg~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~ 241 (287)
T 4f0f_A 173 FGLSQQSVHS----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-IKFINM 241 (287)
T ss_dssp CTTCBCCSSC----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-HHHHHH
T ss_pred CCcccccccc----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-HHHHHH
Confidence 9999754332 13457999999999984 4557899999999999999999999998765432 222233
Q ss_pred HhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 227 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 227 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
+....... .+...+|+++.++|..||+.||++||++.+|++.|++
T Consensus 242 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 242 IREEGLRP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HhccCCCC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 32222222 2345789999999999999999999999999998875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=349.64 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=212.9
Q ss_pred CCceEEEeeEeecCceEEEEEEE-----cCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
.++|++.+.||+|+||.||+|.+ ..+++.||||++.... ...+.+|+.+++.|..|++|..+..++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 57899999999999999999985 3567899999965443 24578999999999556677777777777788
Q ss_pred EEEEEecC-CCCHHHHHHHcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSR-----------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 138 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~ 138 (473)
.++||||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-- 179 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-- 179 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE--
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc--
Confidence 89999999 7799999986543 489999999999999999999999999999999999995
Q ss_pred CCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 011988 139 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 217 (473)
Q Consensus 139 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~ 217 (473)
.++.+||+|||+++........ .......||..|+|||++.+..++.++|||||||+||||++ |..||.+...
T Consensus 180 -~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 180 -HGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp -TTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred -CCCCEEEccccccccccccccc-----eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 6789999999999876554321 11234567889999999999999999999999999999999 9999987654
Q ss_pred CCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 218 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 218 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
..... ..+.. ..... ....+|.++.++|..||..||.+||++.+|++.|++++.+..
T Consensus 254 ~~~~~--~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 254 DSKFY--KMIKE-GFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp SHHHH--HHHHH-TCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred hhHHH--HHhcc-CCCCC---CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 32221 11111 11111 124678999999999999999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=351.49 Aligned_cols=248 Identities=21% Similarity=0.295 Sum_probs=196.6
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----------------------------chhHHHHHHH
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------------------------HPQLQYEAKL 54 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----------------------------~~~l~~E~~i 54 (473)
...++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34578999999999999999999999999999999854432 2457899999
Q ss_pred HHHhcCCCCCCeeEEeeE-eCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 011988 55 YKILQGGTGIPNLRWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 132 (473)
Q Consensus 55 l~~L~~~~~i~~~~~~~~-~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~N 132 (473)
++.|+|++++..+..+.. .....++||||+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999986666655554443 367889999999 678877654 4579999999999999999999999999999999999
Q ss_pred EEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCC---CCchhhHHHHHHHHHHHHcCC
Q 011988 133 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGS 209 (473)
Q Consensus 133 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~---~s~ksDVwSlGviL~elltG~ 209 (473)
||++ .++.+||+|||+++.+...... .....||+.|+|||++.+.. ++.++|||||||++|||++|.
T Consensus 168 il~~---~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 237 (298)
T 2zv2_A 168 LLVG---EDGHIKIADFGVSNEFKGSDAL-------LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237 (298)
T ss_dssp EEEC---TTSCEEECCCTTCEECSSSSCE-------ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred EEEC---CCCCEEEecCCCcccccccccc-------ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 9994 7789999999999876543221 13457999999999998765 378999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 210 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 210 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.||.+.. .......+........ ....+++++.++|..||..||++||++.+|+
T Consensus 238 ~pf~~~~---~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l 291 (298)
T 2zv2_A 238 CPFMDER---IMCLHSKIKSQALEFP---DQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291 (298)
T ss_dssp CSSCCSS---HHHHHHHHHHCCCCCC---SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCCCcc---HHHHHHHHhcccCCCC---CccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 9997643 2233333333222111 1246789999999999999999999988774
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=355.84 Aligned_cols=264 Identities=19% Similarity=0.221 Sum_probs=204.7
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEe-CCeEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYNV 78 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~-~~~~~ 78 (473)
.+.++|++.++||+|+||.||+|.+..+++.||||++.. .....+.+|+.+++.++|++++..+..+... ....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 567899999999999999999999999999999999543 2345578999999999966655555444332 33779
Q ss_pred EEEecC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC-CCCCcEEEEecCCccc
Q 011988 79 LVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKR 154 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~--~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGla~~ 154 (473)
+||||+ +++|.+++..... .+++.+++.|+.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||+++.
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 999999 7899999985432 39999999999999999999999999999999999998432 3556799999999987
Q ss_pred ccCCCCccccccccCCCcccCcccccccccc--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-CHHHHHH
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHL--------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYE 225 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~--------~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~-~~~~~~~ 225 (473)
+..... .....||..|+|||++. +..++.++|||||||+||||++|..||...... ...+.+.
T Consensus 166 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 166 LEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp CCTTCC--------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred cCCCCc--------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 654332 13457999999999987 567899999999999999999999999764432 2233333
Q ss_pred HHhhccccc--------------------cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 226 KISEKKVST--------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 226 ~i~~~~~~~--------------------~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
.+....... ....+...++..+.++|..||..||++||+++++++...+-
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 333222110 00011223467899999999999999999999887666544
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=359.24 Aligned_cols=257 Identities=19% Similarity=0.286 Sum_probs=201.4
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc-----hhHHHHHHHHHHhcCC-CCCCeeEEeeEeCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH-----PQLQYEAKLYKILQGG-TGIPNLRWFGVEGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~-----~~l~~E~~il~~L~~~-~~i~~~~~~~~~~~~~ 77 (473)
..+++|++++.||+|+||.||+|.+ .+++.||||++..... ..+.+|+.+++.|+|+ ++|..+..++......
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3477899999999999999999997 5688999998544322 4578899999999864 7788888888889999
Q ss_pred EEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 78 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 78 ~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
++|||+.+++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+..
T Consensus 85 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC--
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccCc
Confidence 99999889999999985 45799999999999999999999999999999999999994 57899999999987654
Q ss_pred CCCccccccccCCCcccCccccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 226 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-----------~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~ 226 (473)
..... ......||+.|+|||++.+ ..++.++|||||||+||||++|..||.+... ....+..
T Consensus 160 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~ 232 (343)
T 3dbq_A 160 DTTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHA 232 (343)
T ss_dssp ---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHH
T ss_pred ccccc-----cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHHHHH
Confidence 32211 1234579999999999975 6789999999999999999999999976432 2222333
Q ss_pred HhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 227 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 227 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
+....... .+...++.++.+||..||..||.+||++.++ |++.|.+.
T Consensus 233 ~~~~~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~---l~hp~~~~ 279 (343)
T 3dbq_A 233 IIDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQI 279 (343)
T ss_dssp HHCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHHS
T ss_pred HhcCCccc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHH---HhCccccc
Confidence 22211111 1234457899999999999999999998777 55666543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=360.36 Aligned_cols=253 Identities=20% Similarity=0.224 Sum_probs=192.2
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.+.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.|.|++ |..+..++......++|||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPN-IIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTT-BCCEEEEEECSSEEEEEEC
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCC-CcceeeeEecCCeEEEEEE
Confidence 3567799999999999999999999999999999996543 3455788999999998555 5555566677788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||+++.......
T Consensus 129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 206 (349)
T 2w4o_A 129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL- 206 (349)
T ss_dssp CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc-
Confidence 99 7899999873 45699999999999999999999999999999999999996444578999999999986543221
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
.....||+.|+|||++.+..++.++|||||||+||||++|..||.+... ....+..+....... ......
T Consensus 207 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~i~~~~~~~-~~~~~~ 276 (349)
T 2w4o_A 207 -------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFMFRRILNCEYYF-ISPWWD 276 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHHHHHHHTTCCCC-CTTTTT
T ss_pred -------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHHHHHHHhCCCcc-CCchhh
Confidence 1345799999999999999999999999999999999999999976432 222334443332211 122345
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.++.++.+||..||..||++||++.+++
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l 304 (349)
T 2w4o_A 277 EVSLNAKDLVRKLIVLDPKKRLTTFQAL 304 (349)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred hCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 7899999999999999999999987763
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=343.40 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=209.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.++|++.+.||+|+||.||+|.+. +++.||||++... ....+.+|+.+++.++|+ +|..+..++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP-KLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCT-TBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCC-CEeeEEEEEecCCceEEEEEe
Confidence 468999999999999999999986 5778999996543 345688999999999855 555555566677788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~-- 161 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQY-- 161 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---GGGCEEECCTTGGGGBCCHHH--
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc---CCCCEEecccccccccccccc--
Confidence 9 7899999986666799999999999999999999999999999999999994 678899999999986543221
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
.......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+... .+....+...... ....
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~ 230 (269)
T 4hcu_A 162 ----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRL----YKPR 230 (269)
T ss_dssp ----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC----CCCT
T ss_pred ----ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhcCccC----CCCC
Confidence 11234567889999999999999999999999999999999 9999987433 3333333332111 1124
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
.+++++.+++..||..||++||++.++++.|+++..
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 568999999999999999999999999999998864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=357.31 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=208.9
Q ss_pred cCCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
..++|++.+.||+|+||.||+|++. .+++.||||++.... ...+.+|+.+++.++|+ +|..+..++....
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~~ 123 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP-NIVKLLGVCAVGK 123 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCT-TBCCEEEEECSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCC-CEEEEEEEEccCC
Confidence 3578999999999999999999987 355899999965543 23578899999999755 5555555666777
Q ss_pred eEEEEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 131 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~-----------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~ 131 (473)
..++||||+ +++|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 889999999 779999998642 56999999999999999999999999999999999
Q ss_pred cEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCC
Q 011988 132 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSL 210 (473)
Q Consensus 132 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~ 210 (473)
|||++ .++.+||+|||+++.+..... +.......||..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 204 NIl~~---~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 204 NCLVG---ENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp GEEEC---GGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eEEEC---CCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 99994 678999999999986643321 112234578999999999999899999999999999999999 999
Q ss_pred CCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 211 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 211 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
||.+.. ..+....+...... .+...+|+++.++|..||..||++||++.+|.+.|+++..+
T Consensus 276 p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 276 PYYGMA---HEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTTTSC---HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred cCCCCC---hHHHHHHHhCCCcC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 998743 23333344333221 12357899999999999999999999999999999988643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=366.42 Aligned_cols=253 Identities=20% Similarity=0.248 Sum_probs=202.2
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCC-----CCCCeeEEeeEeCCe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGG-----TGIPNLRWFGVEGDY 76 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~-----~~i~~~~~~~~~~~~ 76 (473)
.+.++|+++++||+|+||.||+|.+..+++.||||++.... ..++..|+.+++.+.+. ++|..+..++.....
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 45678999999999999999999999999999999965543 34577899999998643 356666667777889
Q ss_pred EEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCc--EEEEecCCcc
Q 011988 77 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAK 153 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGla~ 153 (473)
.++||||++++|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+ ..+. +||+|||+|+
T Consensus 174 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcceEEeecccce
Confidence 99999999999999998654 3599999999999999999999999999999999999995 4444 9999999997
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
...... ....||+.|+|||++.+..++.++|||||||+||||++|..||.+.........+.........
T Consensus 251 ~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 251 YEHQRV----------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp ETTCCC----------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ecCCcc----------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 543321 3468999999999999999999999999999999999999999875433222222211110000
Q ss_pred ---------------------------------------------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCC
Q 011988 234 ---------------------------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDK 262 (473)
Q Consensus 234 ---------------------------------------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~R 262 (473)
.....+....++++.+||..||.+||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 00111222347889999999999999999
Q ss_pred CCHHHHH
Q 011988 263 PDYAYLK 269 (473)
Q Consensus 263 Pt~~~l~ 269 (473)
||+++++
T Consensus 401 pta~e~L 407 (429)
T 3kvw_A 401 MTPGQAL 407 (429)
T ss_dssp CCHHHHH
T ss_pred CCHHHHh
Confidence 9988773
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=343.34 Aligned_cols=260 Identities=21% Similarity=0.277 Sum_probs=210.6
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++.++| ++|..+..+.......
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCC-CCcCeEEEEEEcCCEE
Confidence 357899999999999999999999999999999999854332 2457789999999985 5555566666788888
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+++|||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||++....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999 77998888743 569999999999999999999999999999999999999754455669999999997665
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. .......+.........
T Consensus 160 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 160 DSEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPS 228 (284)
T ss_dssp SSCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT
T ss_pred cCcc--------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHHHhccccCCc
Confidence 4322 134679999999999999999999999999999999999999997743 33334444333322221
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.....+++++.++|..||..||++||++.++ |++.|.+.
T Consensus 229 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~---l~h~~~~~ 267 (284)
T 3kk8_A 229 -PEWDTVTPEAKSLIDSMLTVNPKKRITADQA---LKVPWICN 267 (284)
T ss_dssp -TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHH---TTSHHHHS
T ss_pred -hhhcccCHHHHHHHHHHcccChhhCCCHHHH---hcCccccC
Confidence 1234678999999999999999999998877 55555544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=364.05 Aligned_cols=254 Identities=19% Similarity=0.292 Sum_probs=201.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcC-CCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQG-GTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~-~~~i~~~~~~~~~~~~~~l 79 (473)
+.+|++++.||+|+||.||+|.+.. ++.||||++.... ...+.+|+.+++.|.+ +++|..+..++......++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 4569999999999999999999754 8999999864432 2457899999999986 6788888888888899999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 80 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 80 v~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+.+++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+....
T Consensus 134 v~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC----
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCccccccCCC
Confidence 999889999999985 45799999999999999999999999999999999999993 4789999999998765432
Q ss_pred CccccccccCCCcccCccccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 228 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~-----------~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 228 (473)
... ......||+.|+|||++.+ ..++.++||||||||||||++|..||.+... ....+..+.
T Consensus 209 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~~~ 281 (390)
T 2zmd_A 209 TSV-----VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAII 281 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHH
T ss_pred ccc-----cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHHHh
Confidence 211 1235679999999999976 3689999999999999999999999976432 223333333
Q ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 229 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 229 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
...... .+...++.++.+||..||..||++||++.+| |++.|.+
T Consensus 282 ~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~el---l~hp~~~ 325 (390)
T 2zmd_A 282 DPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQ 325 (390)
T ss_dssp CTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred CccccC---CCCccchHHHHHHHHHHcccChhhCCCHHHH---hhCcCcc
Confidence 222111 1223457899999999999999999998777 5555554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=347.94 Aligned_cols=256 Identities=18% Similarity=0.275 Sum_probs=207.9
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.++|++++.||+|+||.||+|.+. ++..||||++... ....+.+|+++++.++|+ +|..+..++......++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHE-KLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCT-TBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCC-CEeeEEEEEecCCCeEEEEec
Confidence 468999999999999999999875 6778999996544 345688999999999855 455555566677788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~~~~~~-- 175 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEY-- 175 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTSCEEECSTTGGGGBCCHHH--
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc---CCCCEEEcccccccccccccc--
Confidence 9 8899999986566799999999999999999999999999999999999994 778999999999986644221
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
.......+|..|+|||++.+..++.++|||||||++|||++ |..||..... ......+....... ...
T Consensus 176 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~~----~~~ 244 (283)
T 3gen_A 176 ----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRLY----RPH 244 (283)
T ss_dssp ----HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCCC----CCT
T ss_pred ----ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---hHHHHHHhcccCCC----CCC
Confidence 11234567889999999999899999999999999999998 9999987543 33333333322111 124
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.+++++.++|..||+.||++||++.+|++.|++++.++
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 56899999999999999999999999999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=366.32 Aligned_cols=248 Identities=22% Similarity=0.295 Sum_probs=203.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|+++++||+|+||.||+|++..+++.||||++.+ .....+..|+.+++.++| ++|..+..++.+....++
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEE
Confidence 4789999999999999999999999999999998543 334558899999999975 555566666778889999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ |++|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||| +..+.+||+|||+|+.....
T Consensus 147 V~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccC
Confidence 99999 8899999974 469999999999999999999999999999999999999 47889999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~----~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
.. ......+||+.|+|||++.+.. ++.++|||||||+||||++|..||.+. +....+.++.......
T Consensus 222 ~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 222 GM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKIMNHKNSL 292 (410)
T ss_dssp SE------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHHHC
T ss_pred Cc------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC---ChhhHHHHHHhccccc
Confidence 21 1124568999999999998765 789999999999999999999999874 3344455554322111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLK 269 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~ 269 (473)
..+ ....+++++.+||..||..+|.+ ||++++|+
T Consensus 293 ~~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~ 328 (410)
T 3v8s_A 293 TFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIK 328 (410)
T ss_dssp CCC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHH
T ss_pred cCC-CcccccHHHHHHHHHHccChhhhCCCCCHHHHh
Confidence 111 12367899999999999988888 99987763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=360.95 Aligned_cols=261 Identities=16% Similarity=0.192 Sum_probs=200.5
Q ss_pred cCCceEEEeeEeec--CceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 5 VGNKFRLGRKIGSG--SFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 5 i~~~y~i~~~LG~G--~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
-+++|+++++||+| +||.||+|++..+++.||||++.... ...+.+|+.+++.++|++ |..+..++......
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPN-IVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTT-BCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCC-CCcEeEEEEECCEE
Confidence 35789999999999 99999999999999999999854332 234778999999998655 44555666778889
Q ss_pred EEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 78 VLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence 9999999 78999999754 3569999999999999999999999999999999999999 47889999999998765
Q ss_pred cCCCCccccccccCCCcccCccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc---
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 230 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 230 (473)
..................||..|+|||++.+ ..++.++|||||||+||||++|+.||.+................
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 4432222111122344589999999999988 57899999999999999999999999875543322111000000
Q ss_pred -----------------------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 -----------------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 -----------------------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
............+++++.+||..||..||++||++.+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 000001123356789999999999999999999988774
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=370.51 Aligned_cols=267 Identities=18% Similarity=0.229 Sum_probs=187.7
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeE----eC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGV----EG 74 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~----~~ 74 (473)
.+.++|+++++||+|+||.||+|++..+++.||||++.... ...+.+|+.+|+.|+|++++..+..+.. ..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 46789999999999999999999999999999999864432 2357789999999987666666555532 22
Q ss_pred CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 75 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
...|+||||++++|.+++. ....+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.
T Consensus 130 ~~~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 130 DELYVVLEIADSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLART 205 (458)
T ss_dssp CCEEEEECCCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBC
T ss_pred ceEEEEEeccccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccchh
Confidence 5689999999999999997 34579999999999999999999999999999999999999 4778999999999987
Q ss_pred ccCCCCcccc--------------------ccccCCCcccCcccccccccc-CCCCCchhhHHHHHHHHHHHHc------
Q 011988 155 YRDTATHQHI--------------------PYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLR------ 207 (473)
Q Consensus 155 ~~~~~~~~~~--------------------p~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSlGviL~ellt------ 207 (473)
.......... ........+||+.|+|||++. +..++.++||||||||||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 6533211000 001234568899999999874 5569999999999999999998
Q ss_pred -----CCCCCCCCCCCC-----------------HHHHHHHHhhc--------------------------cccccHHHH
Q 011988 208 -----GSLPWQGLKAGT-----------------KKQKYEKISEK--------------------------KVSTSIEAL 239 (473)
Q Consensus 208 -----G~~Pf~~~~~~~-----------------~~~~~~~i~~~--------------------------~~~~~~~~l 239 (473)
|+.+|.+..... ....+..+... .........
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 677776533100 01111111110 001111222
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
...+++++.+||.+||..||++|||++++ |++.|.
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~---L~Hp~f 400 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINEC---LAHPFF 400 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHH---HHSGGG
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHH---hcCHhh
Confidence 34568999999999999999999998776 555543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=363.47 Aligned_cols=265 Identities=20% Similarity=0.273 Sum_probs=207.3
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHH-HHhcCCCCCCeeEEeeEeCCeE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLY-KILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il-~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
..++|++++.||+|+||.||+|++..+++.||||++.+.. ...+..|..++ +.++ |++|..+..++......
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCCEE
Confidence 3468999999999999999999999999999999864432 22345555553 3444 56666777777888899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++...
T Consensus 115 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGB
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccc
Confidence 9999999 7899999875 3469999999999999999999999999999999999999 478899999999998644
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. ...+.+..+......
T Consensus 191 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~--- 257 (373)
T 2r5t_A 191 EHNS-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNILNKPLQ--- 257 (373)
T ss_dssp CCCC-------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS---BHHHHHHHHHHSCCC---
T ss_pred cCCC-------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhcccC---
Confidence 3221 124578999999999999999999999999999999999999999774 344555555544332
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHH-HHHHHHHHHHHhCCCCCCccccccccccc
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAY-LKRLFRDLFIREGFQFDYVFDWTILKYQQ 296 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~-l~~~L~~l~~~~~~~~~~~~dw~~~~~~~ 296 (473)
+...++.++.+||..||..||.+||++.+ +.+++++. +...++|+.+...+
T Consensus 258 --~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~-------~f~~~~w~~l~~~~ 309 (373)
T 2r5t_A 258 --LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV-------FFSLINWDDLINKK 309 (373)
T ss_dssp --CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSG-------GGTTCCHHHHHTTC
T ss_pred --CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCc-------cccCCCHHHHHhCC
Confidence 23568899999999999999999999753 33334333 34457898875443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=355.18 Aligned_cols=253 Identities=22% Similarity=0.269 Sum_probs=186.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.++|+++++||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.++|+ +|..+..+.......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHE-NIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBT-TBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCC-CcceEEEEEEECCeEEEEE
Confidence 47899999999999999999999999999999985432 235688999999999855 4555555666778899999
Q ss_pred ecCCCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 82 DLLGPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 82 e~~g~sL~~~l~~~~-----~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
||+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+.
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCSSCEETT
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc---CCCCEEECcCccceecC
Confidence 999999999987442 3599999999999999999999999999999999999994 77899999999998764
Q ss_pred CCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc---
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--- 232 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--- 232 (473)
.... ......||..|+|||++.+. .++.++|||||||++|||++|..||.+.........+........
T Consensus 160 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IPVN-------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCCC-------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred CCcc-------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 3321 12345789999999999874 589999999999999999999999987543222222222111000
Q ss_pred ------------------cccHHH-----HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 ------------------STSIEA-----LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 ------------------~~~~~~-----l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...... ....++.++.+||..||..||++||++.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 000001 1135789999999999999999999987763
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=354.50 Aligned_cols=257 Identities=20% Similarity=0.261 Sum_probs=199.2
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEE----EEEEccc----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEV----AIKLNVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~v----AiK~~~~----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
...++|++.++||+|+||.||+|++..+++.| |+|.+.. .....+.+|+.+++.++|++++. +..++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~ 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR-LLGICLTST 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCC-EEEEEESSS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeE-EEEEEecCC
Confidence 34678999999999999999999998887754 7776432 23456889999999998655554 444555555
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
. +++++++ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 91 ~-~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 V-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL 166 (327)
T ss_dssp E-EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTHHHH
T ss_pred e-EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCcceeE
Confidence 4 5556655 8999999987777899999999999999999999999999999999999995 678899999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
+....... ......||..|+|||++.+..++.++|||||||++|||++ |..||.+.........+. .....
T Consensus 167 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~~~ 238 (327)
T 3poz_A 167 LGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGERL 238 (327)
T ss_dssp HTTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCCC
T ss_pred ccCCcccc-----cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH---cCCCC
Confidence 65443211 1234467889999999999999999999999999999999 999998765433322222 11111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
. ....++.++.+++..||..||++||++.+|++.|+.+..
T Consensus 239 ~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 239 P----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp C----CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred C----CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1 134578999999999999999999999999999988763
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=351.65 Aligned_cols=253 Identities=21% Similarity=0.327 Sum_probs=194.9
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc------hhHHHHHHHHHHhcCCCCCCeeEEeeEeCC--
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH------PQLQYEAKLYKILQGGTGIPNLRWFGVEGD-- 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~------~~l~~E~~il~~L~~~~~i~~~~~~~~~~~-- 75 (473)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+|+.+++.++|++++..+..+.....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 567899999999999999999999999999999999654321 246788888888987666665555443322
Q ss_pred -eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 76 -YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 76 -~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
..++||||+ +++|.+++... ..+++.+++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEECCCSCC-
T ss_pred cccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEeeccCcc
Confidence 459999999 78999999754 4799999999999999999999999999999999999995 67889999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
.+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ........... .
T Consensus 165 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~-~ 236 (311)
T 3ork_A 165 AIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVRED-P 236 (311)
T ss_dssp ---------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCC-C
T ss_pred ccccccccc----ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCC-C
Confidence 765432211 122346799999999999999999999999999999999999999987432 22222222222 2
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
.........+++++.++|..||+.||++||+..++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~ 271 (311)
T 3ork_A 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271 (311)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHH
Confidence 23344556799999999999999999999975543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=358.85 Aligned_cols=252 Identities=19% Similarity=0.253 Sum_probs=196.8
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
++|+++++||+|+||.||+|.+..+++.||||++..... ..+.+|+.+++.++|+ +|..+..++......++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA-NIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCT-TBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCC-CCCeeeeEEeeCCEEEEEec
Confidence 689999999999999999999999999999998543322 2345799999999854 55556666677788899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 83 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 83 ~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
|++++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a~~~~~~~~-- 155 (324)
T 3mtl_A 81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIPTK-- 155 (324)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC---TTCCEEECSSSEEECC-------
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC---CCCCEEEccCcccccccCCcc--
Confidence 999999999987777899999999999999999999999999999999999994 778999999999986543321
Q ss_pred ccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc---------
Q 011988 163 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 232 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 232 (473)
......||..|+|||++.+ ..++.++|||||||++|||++|..||.+.........+..+.....
T Consensus 156 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 -----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 1234578999999999987 5689999999999999999999999987544332222222211110
Q ss_pred -------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 -------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..........+++++.+||..||..||++||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 1112233456789999999999999999999987774
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=356.64 Aligned_cols=261 Identities=19% Similarity=0.226 Sum_probs=207.5
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeC----Ce
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG----DY 76 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~----~~ 76 (473)
++++|++++.||+|+||.||+|.+..+++.||||++..... ..+.+|+++++.++|++++..+..+.... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 46899999999999999999999999999999999654332 34778999999999777666655554332 46
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 77 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
.++|||+++++|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++...
T Consensus 105 ~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEECC
T ss_pred EEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC---CCCCEEEEeCcceEecC
Confidence 899999999999999974 4699999999999999999999999999999999999994 77899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc----
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---- 231 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~---- 231 (473)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.......
T Consensus 180 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 180 PDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp GGGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred CCCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 432211 112456899999999987654 48999999999999999999999998866544443333221111
Q ss_pred -------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 232 -------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 232 -------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
.......+...+++++.+||..||..||++||++.++ |++.|.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~---l~hp~~ 317 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA---LAHPYL 317 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSGGG
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHH---hcCcch
Confidence 1122344456788999999999999999999997776 455443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=349.19 Aligned_cols=258 Identities=22% Similarity=0.375 Sum_probs=197.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
+..++|++.++||+|+||.||+|.+. ..||||++.... ...+.+|+.+++.++|++++..+. +. .....+
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~-~~~~~~ 95 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YS-TAPQLA 95 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEE-EE-CSSSCE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEe-ec-cCCccE
Confidence 45788999999999999999999853 359999854332 234788999999999766665544 43 445578
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC-------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceecccccc
Confidence 999999 7899999976667799999999999999999999999999999999999995 678999999999986543
Q ss_pred CCCccccccccCCCcccCcccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
..... ......||..|+|||++. +..++.++|||||||++|||++|..||.+... .......+.......
T Consensus 173 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 173 WSGSH-----QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSP 245 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHHTSCCC
T ss_pred ccccc-----cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhcccccCc
Confidence 22111 123457999999999987 56689999999999999999999999987543 233344444444444
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
....+...+|+++.++|..||..||++||++.+|++.|+++.
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 444455678999999999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=356.58 Aligned_cols=262 Identities=18% Similarity=0.197 Sum_probs=201.7
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc--hhHHHHHHHHHHhcCCCCCCeeEEeeEeC---CeEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH--PQLQYEAKLYKILQGGTGIPNLRWFGVEG---DYNVLV 80 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~--~~l~~E~~il~~L~~~~~i~~~~~~~~~~---~~~~lv 80 (473)
.++|++.++||+|+||.||+|++. ++.||||++..... .....|+.+++.++|++++..+..+.... ...++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999864 89999999654433 23556788888898777666666555443 347999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCcccCCCCCcEEEeeCCCCCcEEEEec
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK----------SFLHRDIKPDNFLMGLGRRANQVYIIDF 149 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~----------gIvHrDIKP~NILl~~~~~~~~vkL~DF 149 (473)
|||+ +++|.+++.. ..+++..++.|+.||+.||.|||++ ||+||||||+|||++ ..+.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~---~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC---TTCCEEECCC
T ss_pred EecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC---CCCeEEEccC
Confidence 9999 7799999974 4599999999999999999999999 999999999999994 7789999999
Q ss_pred CCcccccCCCCccccccccCCCcccCccccccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC-----
Q 011988 150 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT----- 219 (473)
Q Consensus 150 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-----~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~----- 219 (473)
|+++.+...... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.....
T Consensus 176 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 176 GLALKFEAGKSA-----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp TTCEEECTTSCC-----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred CcccccccccCc-----cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 999876543321 122346899999999999873 45678899999999999999999997643321
Q ss_pred --------HHHHHHHHhhccccccHHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 220 --------KKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 220 --------~~~~~~~i~~~~~~~~~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.......+............. ..+++++.+||..||+.||++||++.+|++.|+++....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111111222222111111111 123467999999999999999999999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=349.56 Aligned_cols=258 Identities=17% Similarity=0.281 Sum_probs=209.1
Q ss_pred cCCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
..++|.+.+.||+|+||.||+|.+. .+++.||||++..... ..+.+|+.+++.++|+ +|..+..++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP-HVIKLYGACSQDG 99 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCT-TBCCEEEEECSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCC-ceeeEEEEEecCC
Confidence 3578999999999999999999984 4558999999654432 4577899999999755 4555555666777
Q ss_pred eEEEEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCC
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 131 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~-----------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~ 131 (473)
..++||||+ +++|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 179 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence 889999999 789999998543 23899999999999999999999999999999999
Q ss_pred cEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCC
Q 011988 132 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSL 210 (473)
Q Consensus 132 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~ 210 (473)
|||++ .++.+||+|||+++........ .......+|..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 180 NIli~---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 180 NILVA---EGRKMKISDFGLSRDVYEEDSY-----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp GEEEE---TTTEEEECCCTTCEECTTTSCE-----ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred eEEEc---CCCCEEEccccccccccccccc-----eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 99995 6789999999999876543321 11234567899999999999899999999999999999999 999
Q ss_pred CCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 211 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 211 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
||.+....... ..+...... .....+++++.++|..||..||++||++.+|.+.|++++.+
T Consensus 252 p~~~~~~~~~~---~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 252 PYPGIPPERLF---NLLKTGHRM----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp SSTTCCGGGHH---HHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCHHHHH---HHhhcCCcC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99876543322 222222111 12356899999999999999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=367.18 Aligned_cols=250 Identities=20% Similarity=0.292 Sum_probs=206.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
.++|++.++||+|+||.||+|.+ .++.||||++... ....+.+|+.+++.|+|++++..+..+.......++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 46799999999999999999986 4789999996543 45668999999999997776666655555555789999999
Q ss_pred -CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 85 -GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 85 -g~sL~~~l~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC---CCCCEEEeeCCCcccccccc---
Confidence 7899999986554 379999999999999999999999999999999999994 77899999999998543221
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
....++..|+|||++.+..++.++|||||||+||||++ |..||.+.........+ ...... ....
T Consensus 344 -------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~~~~~~----~~p~ 409 (450)
T 1k9a_A 344 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---EKGYKM----DAPD 409 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH---HTTCCC----CCCT
T ss_pred -------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCCCC----CCCC
Confidence 22367889999999999999999999999999999998 99999887654433332 221111 1235
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
.+|+++.++|..||..||++||++.+|.+.|+++..
T Consensus 410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 789999999999999999999999999999998864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=354.07 Aligned_cols=259 Identities=20% Similarity=0.272 Sum_probs=208.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
.++|++.+.||+|+||.||+|.+. .++..||||++... ....+.+|+.+++.|..|++|..+..++.....
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 468999999999999999999973 35678999995432 345688999999999556677777777777888
Q ss_pred EEEEEecC-CCCHHHHHHHcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcE
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSR----------------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 133 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~----------------------~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NI 133 (473)
.++||||+ +++|.+++..... .+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 99999999 7899999975432 379999999999999999999999999999999999
Q ss_pred EEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 011988 134 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPW 212 (473)
Q Consensus 134 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf 212 (473)
||+ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||+||||++ |..||
T Consensus 204 ll~---~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 204 LVT---HGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp EEE---TTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred EEc---CCCcEEeCCCccCcccccCccce-----eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 995 67899999999998765433211 1234567889999999999999999999999999999998 99999
Q ss_pred CCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 213 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 213 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
.+...... +..+....... .....+++++.++|..||..||.+||++.+|.+.|+.++..
T Consensus 276 ~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 276 PGIPVDAN---FYKLIQNGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTCCCSHH---HHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCcHHH---HHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 87654322 22222221111 12345789999999999999999999999999999988754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=349.37 Aligned_cols=248 Identities=19% Similarity=0.300 Sum_probs=200.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEe--CCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVE--GDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~--~~~~~lv~e~ 83 (473)
.++|+++++||+|+||.||+|.+..+++.||||++.......+.+|+.+++.|.+|++|..+..+... ....+++|||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 57899999999999999999999999999999998877788899999999999977777777666665 6678999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+ +++|.+++. .+++..++.|+.||+.||.|||++||+||||||+||||+ .+...+||+|||+++.+.....
T Consensus 115 ~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~-- 186 (330)
T 3nsz_A 115 VNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE-- 186 (330)
T ss_dssp CCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCC--
T ss_pred cCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCc--
Confidence 9 789988875 489999999999999999999999999999999999996 3344899999999987654322
Q ss_pred ccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc------
Q 011988 163 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS------ 235 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~------ 235 (473)
.....||..|+|||++.+ ..++.++|||||||+||||++|..||..... ....+..+........
T Consensus 187 ------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 187 ------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp ------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHHHH
T ss_pred ------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCCchhhhHHH
Confidence 234578999999999987 5689999999999999999999999954322 2222222111100000
Q ss_pred ---------HHH-----------------HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 236 ---------IEA-----------------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 236 ---------~~~-----------------l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
... ....+++++.+||..||..||++|||+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l 318 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 000 0122689999999999999999999988774
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=369.93 Aligned_cols=247 Identities=20% Similarity=0.262 Sum_probs=191.9
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeC-----
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----- 74 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~----- 74 (473)
+.++|+++++||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.++|++++..+..+....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 457899999999999999999999999999999996442 2345778999999998777776666554332
Q ss_pred CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 75 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
...++||||++++|.+.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+|||+|+.
T Consensus 140 ~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~---~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe---CCCCEEEEEEEeeee
Confidence 4679999999888888775 3599999999999999999999999999999999999994 778999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
...... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+... ...+..+.......
T Consensus 214 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 214 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTP 282 (464)
T ss_dssp ---CCC--------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSC
T ss_pred cCCCcc--------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence 654321 2356899999999999999999999999999999999999999987543 22233322211100
Q ss_pred -------------------------cHHHHhcC------------CcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 235 -------------------------SIEALCRG------------YPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 235 -------------------------~~~~l~~~------------~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
....+... .++++.+||.+||..||++|||++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 353 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 01111110 15679999999999999999998776
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=363.80 Aligned_cols=266 Identities=17% Similarity=0.245 Sum_probs=197.7
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC----
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG---- 74 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~---- 74 (473)
.+.++|++++.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.|+|++++..+..+....
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 47899999999999999999999999999999999865432 235789999999999766666555554332
Q ss_pred CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 75 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
...|+||||++++|.+++. ....+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+|+.
T Consensus 103 ~~~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 103 DELYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLART 178 (432)
T ss_dssp CCEEEEEECCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred CeEEEEEecCCcCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCccc
Confidence 5689999999999999997 34569999999999999999999999999999999999999 4778999999999987
Q ss_pred ccCCCCcccc---------------ccccCCCcccCcccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCC------
Q 011988 155 YRDTATHQHI---------------PYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPW------ 212 (473)
Q Consensus 155 ~~~~~~~~~~---------------p~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSlGviL~elltG~~Pf------ 212 (473)
.......... ........+||+.|+|||++. +..++.++||||||||||||++|..||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 6543221000 001125678999999999864 556999999999999999999855444
Q ss_pred -----CCCCCC--------------CHHHHHHHHhh--------------------------ccccccHHHHhcCCcHHH
Q 011988 213 -----QGLKAG--------------TKKQKYEKISE--------------------------KKVSTSIEALCRGYPTEF 247 (473)
Q Consensus 213 -----~~~~~~--------------~~~~~~~~i~~--------------------------~~~~~~~~~l~~~~p~~l 247 (473)
.+.... .....+..+.. .............+++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 332110 00111111111 111122333446789999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 248 ASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 248 ~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
.+||..||..||++|||++++ |++.|
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~---L~Hp~ 364 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQA---LDHPY 364 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHH---HTCGG
T ss_pred HHHHHHHhcCCcccCCCHHHH---hcChh
Confidence 999999999999999998776 44444
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=363.12 Aligned_cols=251 Identities=21% Similarity=0.218 Sum_probs=205.3
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++.|+|++ |..+..++......++||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK-LINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTT-BCCEEEEEECSSEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcC-CCeEEEEEEeCCEEEEEE
Confidence 4578999999999999999999999999999999965543 335788999999998554 555556667788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|.+++......+++.+++.++.||+.||+|||++||+||||||+|||++. +..+.+||+|||+++.+.....
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccceecCCCcc
Confidence 999 78999998755557999999999999999999999999999999999999952 2356899999999987654322
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
. ....||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ....+..+....... .....
T Consensus 207 ~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~~~-~~~~~ 274 (387)
T 1kob_A 207 V--------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEF-DEDAF 274 (387)
T ss_dssp E--------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCC-CSSTT
T ss_pred e--------eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCC-Ccccc
Confidence 1 23479999999999999999999999999999999999999998743 333344443322211 11223
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..+++++.+||..||..||++||++.+++
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell 303 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDAL 303 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 56899999999999999999999988774
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=339.83 Aligned_cols=251 Identities=22% Similarity=0.257 Sum_probs=207.7
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc---CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~---~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.+.++|++.++||+|+||.||+|.+..++..||+|++.. .....+.+|+.+++.++| ++|..+..++......++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH-PNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCeEEEE
Confidence 356789999999999999999999999999999998543 345678899999999975 4555566667788889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+..++..+.+||+|||++..+....
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 85 MELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred EeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999 7799998874 4569999999999999999999999999999999999999655577899999999998765432
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. .....||+.|+|||++.+. ++.++|||||||++|||++|..||.... ..+....+........ ...
T Consensus 164 ~--------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~-~~~ 230 (277)
T 3f3z_A 164 M--------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIREGTFTFP-EKD 230 (277)
T ss_dssp C--------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC-HHH
T ss_pred c--------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCC-chh
Confidence 2 2345799999999998765 8999999999999999999999998743 3444444444443332 233
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...+++++.++|..||+.||++||++.+++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l 260 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQAL 260 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 457899999999999999999999988774
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=354.90 Aligned_cols=255 Identities=18% Similarity=0.217 Sum_probs=201.7
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcE----EEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~----vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
-.++|++++.||+|+||.||+|.+..+++. ||+|++... ....+..|+.+++.++|++++..+. ++. ...
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~-~~~ 88 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG-LCP-GSS 88 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEE-EEC-BSS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEE-EEc-CCc
Confidence 357899999999999999999999888876 677764322 2345778999999998666555554 443 445
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
.++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ ..+.+||+|||+++.+
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES---SSSCEEECSCSGGGGS
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC---CCCeEEECCCCccccc
Confidence 77888888 7899999986556799999999999999999999999999999999999994 7789999999999877
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
....... ......||..|+|||++.+..++.++|||||||++|||++ |..||.+......... +.......
T Consensus 166 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~~~~ 237 (325)
T 3kex_A 166 PPDDKQL-----LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL---LEKGERLA 237 (325)
T ss_dssp CCCTTCC-----C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH---HHTTCBCC
T ss_pred Ccccccc-----cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH---HHcCCCCC
Confidence 5443211 1234578889999999999999999999999999999999 9999988654332222 22211111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
....++.++.++|..||..||.+||++.+|.+.|+.+.
T Consensus 238 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 238 ----QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ----CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ----CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12346789999999999999999999999999998874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=343.16 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=198.8
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
..+.++|.+.++||+|+||.||+|.+..+++.||+|++... ....+.+|+++++.++|++ |..+..++......+
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN-IIKIFEVFEDYHNMY 96 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTT-BCCEEEEEECSSEEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCch-HHhHHHheecCCeEE
Confidence 34678899999999999999999999999999999984332 2356889999999998654 555555667788899
Q ss_pred EEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 79 LVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
+||||+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.++..+.+||+|||+++.
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999 77999988532 46799999999999999999999999999999999999996545568899999999986
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
+..... .....||..|+|||++. ..++.++|||||||++|||++|..||.+... ......+.......
T Consensus 177 ~~~~~~--------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~ 244 (285)
T 3is5_A 177 FKSDEH--------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQKATYKEPNY 244 (285)
T ss_dssp ------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCC
T ss_pred cCCccc--------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhhhccCCccc
Confidence 654322 13457999999999986 4689999999999999999999999987542 22222222222111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
. ..+..+++++.++|..||..||++||++.+|+
T Consensus 245 ~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 277 (285)
T 3is5_A 245 A--VECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277 (285)
T ss_dssp C--C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHH
T ss_pred c--cccCcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1 12345789999999999999999999988874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=348.39 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=206.6
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---------chhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.+.|++ |..+..++...
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~ 87 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN-VITLHDVYENR 87 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTT-BCCEEEEEECS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCC-cceEEEEEecC
Confidence 34568999999999999999999999999999999854432 345889999999998655 55555666778
Q ss_pred CeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCC----cEEEEec
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIIDF 149 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~----~vkL~DF 149 (473)
...++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ..+ .+||+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLIDF 163 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEEccC
Confidence 8899999999 8899999974 45799999999999999999999999999999999999995 334 7999999
Q ss_pred CCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011988 150 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 229 (473)
Q Consensus 150 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 229 (473)
|+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+..
T Consensus 164 g~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~ 232 (321)
T 2a2a_A 164 GLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITS 232 (321)
T ss_dssp TTCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHT
T ss_pred ccceecCcccc--------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHh
Confidence 99987654322 134579999999999999999999999999999999999999997743 3344444443
Q ss_pred ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 230 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 230 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.... ....+...+++++.++|..||..||++||++.++++
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 233 VSYD-FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TCCC-CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cccc-cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 3322 223455678999999999999999999999887743
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=344.35 Aligned_cols=260 Identities=17% Similarity=0.250 Sum_probs=206.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCC---cEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
..+|++.++||+|+||.||+|.+..++ ..||+|....... ..+.+|+.+++.++|++++..+..+.......+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 357999999999999999999976443 3589998554332 457889999999997777777766666777889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
++|||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccccccc
Confidence 999999 669999998666779999999999999999999999999999999999999 4778999999999987654
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
..... ........||..|+|||.+.+..++.++|||||||++|||++ |.+||.+.......... .......
T Consensus 181 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~-- 252 (298)
T 3f66_A 181 KEYYS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQGRRLL-- 252 (298)
T ss_dssp GGGCB---C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH---HTTCCCC--
T ss_pred cchhc---cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH---hcCCCCC--
Confidence 32211 122345578899999999999999999999999999999999 66777665443332222 2211111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
....+|+++.++|..||..||++||++.+|++.|+.++..
T Consensus 253 --~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 253 --QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1245789999999999999999999999999999998864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=352.07 Aligned_cols=254 Identities=24% Similarity=0.239 Sum_probs=195.4
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
...++|+++++||+|+||.||+|++..+++.||||++.... ...+.+|+.+++.++| ++|..+..+.......+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH-RNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCC-TTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCC-CCcceEEEEEecCCEEE
Confidence 45678999999999999999999999999999999964433 2346789999999975 55555666677888999
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC--CCCCcEEEEecCCccccc
Q 011988 79 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 79 lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~--~~~~~vkL~DFGla~~~~ 156 (473)
+||||+.++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+ +..+.+||+|||+++.+.
T Consensus 110 lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999999999999985 4469999999999999999999999999999999999999632 245569999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc---
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--- 232 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--- 232 (473)
.... ......||..|+|||++.+.. ++.++|||||||++|||++|..||.+... ...+..+.....
T Consensus 189 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 189 IPIR-------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---IDQLFKIFEVLGLPD 258 (329)
T ss_dssp ------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred Cccc-------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HHHHHHHHHHhCCCc
Confidence 3322 123457899999999998754 89999999999999999999999987543 222222221100
Q ss_pred ----------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 ----------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 ----------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
......+...+++++.+||..||..||++||++.+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 0111222334789999999999999999999987773
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=358.29 Aligned_cols=248 Identities=20% Similarity=0.303 Sum_probs=194.9
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC----
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG---- 74 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~---- 74 (473)
.+.++|++++.||+|+||.||+|.+..+|+.||||++.... ...+.+|+.+++.++|++++..+..+....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 35688999999999999999999999999999999864432 234678999999999776666665554332
Q ss_pred -CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 75 -DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 75 -~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
...++||||++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 102 FTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLAR 176 (367)
T ss_dssp CCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCE
T ss_pred CceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc---CCCCEEEEeeeccc
Confidence 34699999999999999984 5699999999999999999999999999999999999994 77899999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||.+... ...+..+.....
T Consensus 177 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g 243 (367)
T 1cm8_A 177 QADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTG 243 (367)
T ss_dssp ECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHC
T ss_pred ccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcC
Confidence 75432 134688999999999988 6799999999999999999999999987543 222222221110
Q ss_pred c--------------------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 S--------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 ~--------------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
. .....+...+++++.+||.+||..||++|||+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l 306 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 306 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHh
Confidence 0 111223346789999999999999999999988764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=385.60 Aligned_cols=268 Identities=19% Similarity=0.245 Sum_probs=222.4
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
-.++|++++.||+|+||.||+|++..+++.||||++.+ .....+..|..++..+.++++|..+..+....+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 35789999999999999999999999999999998543 334557889999998888999999988888889999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
|||||+ |++|.+++... ..+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+....
T Consensus 419 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeecccc
Confidence 999999 88999999854 469999999999999999999999999999999999999 4788999999999986443
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
... ....++||+.|+|||++.+..|+.++|||||||+||||++|..||.+. +..+.+..+......
T Consensus 495 ~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~---- 560 (674)
T 3pfq_A 495 DGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVA---- 560 (674)
T ss_dssp TTC-------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHSSCCC----
T ss_pred CCc-------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCC----
Confidence 222 124578999999999999999999999999999999999999999874 445556666554432
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDY--AYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 298 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~--~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 298 (473)
+...+++++.+||..||..||++||++ ....+++++. +-..+||+.+...+.+
T Consensus 561 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~-------ff~~i~w~~l~~~~~~ 615 (674)
T 3pfq_A 561 -YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA-------FFRYIDWEKLERKEIQ 615 (674)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG-------GGSSCCHHHHTTTCSC
T ss_pred -CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc-------cccCCCHHHHHhCCCC
Confidence 235689999999999999999999997 2223334333 3445789987655433
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=345.29 Aligned_cols=259 Identities=19% Similarity=0.329 Sum_probs=213.6
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|++ |..+..++......++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN-LVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTT-BCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCC-EeeEEEEEccCCCEEEEEE
Confidence 4578999999999999999999999999999999965443 356889999999998555 4455556667777899999
Q ss_pred cC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC---GGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc---CCCCEEEccCccceeccCCcc
Confidence 99 689999998643 4599999999999999999999999999999999999994 678899999999987654332
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. ......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+......... +...... ..
T Consensus 167 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~---~~~~~~~----~~ 233 (288)
T 3kfa_A 167 T------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDYRM----ER 233 (288)
T ss_dssp E------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HHTTCCC----CC
T ss_pred c------cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HhccCCC----CC
Confidence 1 1234567889999999999999999999999999999999 9999987654332222 2221111 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
...+|+++.++|..||..||.+||++.+|.+.|+.++.+..
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 35688999999999999999999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=354.78 Aligned_cols=259 Identities=20% Similarity=0.231 Sum_probs=196.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.++|+++++||+|+||.||+|++..+++.||||++... ....+.+|+.+++.++|+ +|..+..++......++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCT-TBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCC-CCCcEEEEEeeCCEEEEEEEe
Confidence 57899999999999999999999999999999986443 346688999999999855 455566666778889999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+ +++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+. +..+.+||+|||+++.......
T Consensus 98 ~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~~-- 173 (361)
T 3uc3_A 98 ASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQ-- 173 (361)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC----------
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCccccccccCC--
Confidence 9 88999998743 46999999999999999999999999999999999999951 1233599999999974432211
Q ss_pred ccccccCCCcccCccccccccccCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCCC-HHHHHHHHhhccccccHHHHh
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~k-sDVwSlGviL~elltG~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~~~l~ 240 (473)
.....||+.|+|||++.+..++.+ +|||||||+||+|++|+.||.+..... ....+..+.......+ ..
T Consensus 174 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~ 244 (361)
T 3uc3_A 174 ------PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP---DD 244 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC---TT
T ss_pred ------CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC---Cc
Confidence 234579999999999998887655 899999999999999999998754432 2233333333222111 11
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCC
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 281 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 281 (473)
..+++++.+||..||..||.+||++.+| |++.|.....
T Consensus 245 ~~~s~~~~~li~~~L~~dP~~Rps~~el---l~hp~f~~~~ 282 (361)
T 3uc3_A 245 IRISPECCHLISRIFVADPATRISIPEI---KTHSWFLKNL 282 (361)
T ss_dssp SCCCHHHHHHHHHHSCSCTTTSCCHHHH---HTSHHHHTTC
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHH---HhCcchhcCC
Confidence 2578999999999999999999998776 6666665543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=348.95 Aligned_cols=264 Identities=20% Similarity=0.278 Sum_probs=202.6
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEc---CCCcEEEEEEcccC-------CchhHHHHHHHHHHhcCCCCCCeeEEeeEe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLNVKT-------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE 73 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~~~~~-------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~ 73 (473)
...++|++.+.||+|+||.||+|++. .+++.||||++.+. ....+..|+.+++.++|++ |..+..++..
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~ 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF-IVDLIYAFQT 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTT-BCCEEEEEEC
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCC-ccceeEEEEc
Confidence 44678999999999999999999985 68999999986543 2334678999999998555 5555556677
Q ss_pred CCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 74 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 74 ~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
....++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLTDFGLC 168 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTSCEEECCCSCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC---CCCcEEEEeCCcc
Confidence 78889999999 78999999753 4699999999999999999999999999999999999994 7789999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
+....... ......||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ....+..+.....
T Consensus 169 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~ 238 (327)
T 3a62_A 169 KESIHDGT-------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKILKCKL 238 (327)
T ss_dssp -----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCC
T ss_pred cccccCCc-------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCC
Confidence 86443221 1234689999999999999999999999999999999999999998743 3344444444332
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHhCCCCCCccccccccc
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKY 294 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 294 (473)
. +...+++++.++|..||..||.+||++. .+.+++++.|. ..++|.....
T Consensus 239 ~-----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f-------~~~~~~~~~~ 290 (327)
T 3a62_A 239 N-----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF-------RHINWEELLA 290 (327)
T ss_dssp C-----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG-------SSCCHHHHHT
T ss_pred C-----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc-------cCCCHHHHhh
Confidence 2 2346789999999999999999999443 34444655543 3457776543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.32 Aligned_cols=254 Identities=17% Similarity=0.219 Sum_probs=208.0
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
..++|++.+.||+|+||.||+|.+. ++..||||++... ....+.+|+.+++.++|+ +|..+..++......++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHP-KLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCT-TBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCC-CEeeEEEEEccCCceEEEEE
Confidence 4578999999999999999999874 6778999996543 345688999999999854 55555556677778899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC---TTCCEEECCTTCEEECCTTCEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC---CCCCEEEccCccceecchhhhh
Confidence 99 7899999987666799999999999999999999999999999999999994 7789999999999876543321
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
......+|..|+|||++.+..++.++|||||||++|||++ |..||..... ......+....... ..
T Consensus 161 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~----~~ 227 (268)
T 3sxs_A 161 ------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEVVLKVSQGHRLY----RP 227 (268)
T ss_dssp ------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCCC----CC
T ss_pred ------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---HHHHHHHHcCCCCC----CC
Confidence 1234567888999999999899999999999999999999 9999977443 33333333222111 12
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
..+++++.++|..||..||++||++.+|++.|+.+.
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 346899999999999999999999999999988764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=349.43 Aligned_cols=257 Identities=18% Similarity=0.213 Sum_probs=202.2
Q ss_pred CccCCceEEEeeEeecCceEEEEEEE-cCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCC-----CCCeeEEeeEeC
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTN-IQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGT-----GIPNLRWFGVEG 74 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~-~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~-----~i~~~~~~~~~~ 74 (473)
.++.++|++.+.||+|+||.||+|.+ ..+++.||||++.... ...+.+|+.+++.+.+.+ ++..+..+....
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 45778999999999999999999998 5688999999965432 345788999999998654 355666677788
Q ss_pred CeEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC-------------
Q 011988 75 DYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR------------- 140 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~------------- 140 (473)
...++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++..+.
T Consensus 90 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 90 GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 8999999999999999998544 36899999999999999999999999999999999999953211
Q ss_pred ---CCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 011988 141 ---ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 217 (473)
Q Consensus 141 ---~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~ 217 (473)
.+.+||+|||+++...... ....||..|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEHH----------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EESCCCEEECCCSSCEETTSCC----------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccCCCceEeeCcccccCcccc----------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 5679999999998643321 345899999999999999999999999999999999999999987543
Q ss_pred CCHHHHHHHHhhccccccH--------------------------HHH----------hcCCcHHHHHHHHHHhcCCCCC
Q 011988 218 GTKKQKYEKISEKKVSTSI--------------------------EAL----------CRGYPTEFASYFHYCRSLRFDD 261 (473)
Q Consensus 218 ~~~~~~~~~i~~~~~~~~~--------------------------~~l----------~~~~p~~l~~li~~cl~~dp~~ 261 (473)
......+..+......... ... ...+++++.+||..||..||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 3222222222211000000 000 0123578999999999999999
Q ss_pred CCCHHHHH
Q 011988 262 KPDYAYLK 269 (473)
Q Consensus 262 RPt~~~l~ 269 (473)
||++.+++
T Consensus 320 Rpt~~ell 327 (339)
T 1z57_A 320 RITLREAL 327 (339)
T ss_dssp SCCHHHHT
T ss_pred ccCHHHHh
Confidence 99988774
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=344.05 Aligned_cols=253 Identities=21% Similarity=0.260 Sum_probs=194.0
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc-----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~-----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
+.++|+++++||+|+||.||+|.+..+++.||||++..... ..+.+|+.+++.++|++ |..+..+.......++
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN-LVNLLEVFRRKRRLHL 79 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTT-BCCEEEEEEETTEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCC-ccchhheeecCCeEEE
Confidence 35789999999999999999999999999999998544332 34678999999998554 5555556677888999
Q ss_pred EEecCC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLLG-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~g-~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+. ++|.+++. ....+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 80 v~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 80 VFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp EEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECC--
T ss_pred EEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc---CCCCEEEeeCCCchhccCc
Confidence 999994 56666665 456799999999999999999999999999999999999994 7789999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc------
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------ 231 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~------ 231 (473)
... .....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......
T Consensus 156 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 156 SDY-------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp -----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccc-------cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 221 134578999999999987 568999999999999999999999998754432222222211110
Q ss_pred -----------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 -----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 -----------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...........++.++.+||..||..||++|||+++|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 283 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence 01112233357889999999999999999999988774
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=353.73 Aligned_cols=258 Identities=20% Similarity=0.225 Sum_probs=200.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEe-------
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVE------- 73 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~------- 73 (473)
.++|+++++||+|+||.||+|++..+++.||||++.... ...+.+|+.+++.++|++++..+..+...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 478999999999999999999999999999999853322 33578999999999976666665554432
Q ss_pred CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 74 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 74 ~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
....++||||++++|.+.+......+++.+++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCCEEEccchhcc
Confidence 456899999999999999886667899999999999999999999999999999999999994 77899999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
.+........ .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+........
T Consensus 173 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 173 AFSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp ECCCCSSSSC---CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccccc---cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 7654322111 122456789999999999874 589999999999999999999999987543322222222211111
Q ss_pred cccHH-----------------------HH-hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 STSIE-----------------------AL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 ~~~~~-----------------------~l-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..... .+ ....++++.+||..||..||++||++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 310 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHh
Confidence 10000 00 001367899999999999999999987763
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=364.37 Aligned_cols=250 Identities=21% Similarity=0.226 Sum_probs=197.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEe-----CCeEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVE-----GDYNVLV 80 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~-----~~~~~lv 80 (473)
..+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+++++.|+|++++..+..+... ..+.++|
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 347999999999999999999999999999999864432 3345799999999977777766555432 2246799
Q ss_pred EecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 81 IDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 81 ~e~~g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
|||+.++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+||||+ .+.+.+||+|||+++.+..
T Consensus 132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCT
T ss_pred hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhccc
Confidence 99999888887653 356799999999999999999999999999999999999995 3456789999999987644
Q ss_pred CCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc---
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS--- 233 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~--- 233 (473)
... .....||..|+|||++.+. .++.++|||||||+||||++|+.||.+.... ..+.++......
T Consensus 210 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 210 GEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTR 278 (420)
T ss_dssp TCC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCH
T ss_pred CCC--------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence 322 2346889999999999875 6999999999999999999999999875432 222222211000
Q ss_pred ---------------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 234 ---------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 234 ---------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.....+...+++++.+||.+||..||++||++.+++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 011112345689999999999999999999987763
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=348.52 Aligned_cols=260 Identities=20% Similarity=0.244 Sum_probs=204.5
Q ss_pred CCceEEEeeEeecCceEEEEEE----EcCCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEe-CCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~----~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~-~~~ 76 (473)
.++|+++++||+|+||.||+|+ +..+++.||||++... ....+.+|+.+++.++|++++..+..+... ...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4569999999999999999998 5678999999985433 235688999999999866655555444332 266
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
.++||||+ +++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECcccccccc
Confidence 89999999 7799999977777899999999999999999999999999999999999995 6689999999999876
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----------CCCHHHH-
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK-----------AGTKKQK- 223 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~-----------~~~~~~~- 223 (473)
....... .......||..|+|||++.+..++.++|||||||++|||++|..||.... .......
T Consensus 177 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 177 ETDKEYY----TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CTTCCEE----ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cCCCcce----eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 5543211 12245578999999999999999999999999999999999999874311 0001111
Q ss_pred HHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 224 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 224 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
...+..... ......+++++.++|..||..||.+||++.+|++.|++++
T Consensus 253 ~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGKR----LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTCC----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCC----CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111110 1123467899999999999999999999999999999876
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=356.60 Aligned_cols=257 Identities=16% Similarity=0.209 Sum_probs=204.9
Q ss_pred CCceEEEeeEeecCceEEEEE-----EEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcC--CCCCCeeEEeeEeCCeEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLG-----TNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a-----~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~--~~~i~~~~~~~~~~~~~~ 78 (473)
.++|.+.++||+|+||.||+| .+..+++.||||++.......+..|+.+++.|.+ ++++..+..++...+..+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~ 143 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence 567999999999999999999 4667899999999888888889999999999873 344555666667778889
Q ss_pred EEEecC-CCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEee--------CCCCCcEE
Q 011988 79 LVIDLL-GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL--------GRRANQVY 145 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~----~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~--------~~~~~~vk 145 (473)
+||||+ +++|.+++.. ....+++..++.|+.||+.||+|||++|||||||||+||||+. ++..+.+|
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~k 223 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEE
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEE
Confidence 999999 7999999975 2456999999999999999999999999999999999999953 11278999
Q ss_pred EEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 011988 146 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 225 (473)
Q Consensus 146 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~ 225 (473)
|+|||+|+.+....... .....+||..|+|||++.+..++.++|||||||+||||++|+.||........
T Consensus 224 l~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----- 293 (365)
T 3e7e_A 224 LIDLGQSIDMKLFPKGT-----IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----- 293 (365)
T ss_dssp ECCCTTCEEGGGSCTTE-----EECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred EeeCchhhhhhccCCCc-----eeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence 99999997654322211 12456899999999999999999999999999999999999999964322100
Q ss_pred HHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCC-CCHHHHHHHHHHHHHHh
Q 011988 226 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK-PDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 226 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~R-Pt~~~l~~~L~~l~~~~ 279 (473)
........ ...++.+.+++..||+.+|.+| |++.+|.+.|++++.+.
T Consensus 294 -----~~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 -----KPEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -----EECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----eechhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00000000 1235788999999999999998 68899999999988765
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=352.90 Aligned_cols=242 Identities=21% Similarity=0.303 Sum_probs=200.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
+.|.+++.||+|+||.||+|++..+++.||||++.... ...+.+|+.+++.++|++ |..+..++......++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN-TIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTT-BCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCC-EeeEEEEEEECCeEEEE
Confidence 46999999999999999999999999999999864432 235789999999998555 55555666778899999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 81 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 81 ~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|||+.++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 133 ~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSSB--
T ss_pred EecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEeeccCceecCCC--
Confidence 99999999999977777899999999999999999999999999999999999995 6789999999999765432
Q ss_pred ccccccccCCCcccCcccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
....||+.|+|||++. +..++.++|||||||+||||++|..||.+... ...+..+........
T Consensus 208 ---------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~-- 273 (348)
T 1u5q_A 208 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPAL-- 273 (348)
T ss_dssp ---------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCC--
T ss_pred ---------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCC--
Confidence 3457999999999985 45689999999999999999999999977532 223333333222111
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
....+++++.+||..||..||++||++++|+
T Consensus 274 -~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll 304 (348)
T 1u5q_A 274 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 304 (348)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred -CCCCCCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 1246789999999999999999999988774
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=347.95 Aligned_cols=244 Identities=18% Similarity=0.265 Sum_probs=200.1
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
.|...++||+|+||.||+|++..+|+.||||++... ....+.+|+.+++.++|++++ .+..+.......++||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVV-EMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBC-CEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEECCEEEEEEecC
Confidence 488999999999999999999989999999985433 234578999999999865544 5555666778899999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 -g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++........
T Consensus 125 ~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~~~~-- 197 (321)
T 2c30_A 125 QGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVPK-- 197 (321)
T ss_dssp CSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCSSSCC--
T ss_pred CCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCcEEEeeeeeeeecccCccc--
Confidence 889999986 45699999999999999999999999999999999999994 6789999999999876543221
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+........ .....+
T Consensus 198 -----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~--~~~~~~ 267 (321)
T 2c30_A 198 -----RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMKRLRDSPPPKL--KNSHKV 267 (321)
T ss_dssp -----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSSCCCC--TTGGGS
T ss_pred -----cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCCCCc--CccccC
Confidence 235689999999999999999999999999999999999999997643 2333333333221111 112457
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 244 PTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
++++.++|..||..||++||++.+|+
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell 293 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELL 293 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHh
Confidence 89999999999999999999988774
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=351.85 Aligned_cols=257 Identities=19% Similarity=0.262 Sum_probs=198.1
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEE----EEEEccc----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEV----AIKLNVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~v----AiK~~~~----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
...++|+++++||+|+||.||+|.+..+++.| |+|.+.. .....+.+|+.+++.++|++++..+. ++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~-~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCE-EEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEE-EEecCC
Confidence 44688999999999999999999998888765 5555322 23456889999999998665555544 444444
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
.+++++++ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ ..+.+||+|||+++.
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCcceeE
Confidence 45566665 8999999987777899999999999999999999999999999999999995 678899999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
+....... ......||..|+|||++.+..++.++|||||||+||||++ |..||.+.........+ ......
T Consensus 167 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---~~~~~~ 238 (327)
T 3lzb_A 167 LGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGERL 238 (327)
T ss_dssp ------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HTTCCC
T ss_pred ccCccccc-----cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCCCC
Confidence 65433211 1234467889999999999999999999999999999999 99999886554332222 221111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
. ....++.++.++|..||..||.+||++.+|++.|+.+..
T Consensus 239 ~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 239 P----QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp C----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred C----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 134578999999999999999999999999999998863
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=351.44 Aligned_cols=268 Identities=21% Similarity=0.326 Sum_probs=203.6
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhc-CCCCCCeeEEeeEeC----CeEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQ-GGTGIPNLRWFGVEG----DYNV 78 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~-~~~~i~~~~~~~~~~----~~~~ 78 (473)
.+.++|++.++||+|+||.||+|++ +++.||||++..........|.+++..+. .|++|..+..+.... ...+
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 4567899999999999999999986 48999999976666666677777776652 355555555555554 6889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccCCCCCcEEEeeCCCCCcEEEEec
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIIDF 149 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~--------gIvHrDIKP~NILl~~~~~~~~vkL~DF 149 (473)
+||||+ +++|.+++.. ..+++..++.|+.||+.||.|||++ ||+||||||+|||++ .++.+||+||
T Consensus 112 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~---~~~~~kl~Df 186 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK---KNGTCCIADL 186 (337)
T ss_dssp EEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC---TTSCEEECCC
T ss_pred EEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC---CCCCEEEEeC
Confidence 999999 7799999974 4699999999999999999999998 999999999999994 7789999999
Q ss_pred CCcccccCCCCccccccccCCCcccCccccccccccCCCCCch------hhHHHHHHHHHHHHcC----------CCCCC
Q 011988 150 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRR------DDLESLGYVLMYFLRG----------SLPWQ 213 (473)
Q Consensus 150 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~k------sDVwSlGviL~elltG----------~~Pf~ 213 (473)
|+++.+......... ......||..|+|||++.+..++.. +|||||||++|||++| ..||.
T Consensus 187 g~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 187 GLAVKFISDTNEVDI---PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp TTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCceeeccccccccC---CCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 999876544322111 1235689999999999988776654 9999999999999999 77886
Q ss_pred CCCCCCH-HHHHHH-HhhccccccHH--HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCC
Q 011988 214 GLKAGTK-KQKYEK-ISEKKVSTSIE--ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 281 (473)
Q Consensus 214 ~~~~~~~-~~~~~~-i~~~~~~~~~~--~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 281 (473)
....... ...... +.......... .....+++++.++|..||+.||++||++.+|++.|+.+......
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence 6443221 122222 21111111111 11124678899999999999999999999999999999876544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=350.22 Aligned_cols=260 Identities=20% Similarity=0.298 Sum_probs=210.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCc-----EEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-----~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
.++|++.+.||+|+||.||+|.+..+++ .||||++.... ...+.+|+.+++.|..|++|..+..++.....
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 5789999999999999999999877664 79999865543 24578999999999556667677677777788
Q ss_pred EEEEEecC-CCCHHHHHHHc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCC
Q 011988 77 NVLVIDLL-GPSLEDLFNFC-------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 142 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~-------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~ 142 (473)
.++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE---GGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC---CCC
Confidence 89999999 67999998743 34589999999999999999999999999999999999995 678
Q ss_pred cEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHH
Q 011988 143 QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 221 (473)
Q Consensus 143 ~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~ 221 (473)
.+||+|||+++........ .......||..|+|||++.+..++.++|||||||++|||++ |..||.+.......
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNY-----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTS-----EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred eEEECccccccccccccce-----eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 9999999999876543321 11234567889999999999999999999999999999998 99999876543222
Q ss_pred HHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 222 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 222 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
..+....... .....+|+++.++|..||+.||.+||++.+|.+.|+++..+.
T Consensus 277 ---~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 277 ---YKLVKDGYQM---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp ---HHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HHHHhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 1222111111 112457899999999999999999999999999999987654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=359.57 Aligned_cols=257 Identities=20% Similarity=0.255 Sum_probs=197.0
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcC-------CCCCCeeEEeeE-
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQG-------GTGIPNLRWFGV- 72 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~-------~~~i~~~~~~~~- 72 (473)
..+.++|++.++||+|+||.||+|++..+++.||||++.... ...+.+|+.+++.+.+ +++|..+..+..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 346789999999999999999999999999999999965433 3457899999999974 233444433333
Q ss_pred ---eCCeEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCcEEEeeCC--------
Q 011988 73 ---EGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGR-------- 139 (473)
Q Consensus 73 ---~~~~~~lv~e~~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~-------- 139 (473)
.....++||||++++|.+++.... ..+++..++.|+.||+.||.|||++ ||+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 455789999999999988876543 5699999999999999999999998 999999999999995221
Q ss_pred --------------------------------------CCCcEEEEecCCcccccCCCCccccccccCCCcccCcccccc
Q 011988 140 --------------------------------------RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 181 (473)
Q Consensus 140 --------------------------------------~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~AP 181 (473)
....+||+|||+++...... ....||..|+||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----------~~~~gt~~y~aP 262 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----------TEDIQTRQYRSL 262 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----------CSCCSCGGGCCH
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----------ccCCCCCcccCC
Confidence 11379999999998764321 345799999999
Q ss_pred ccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC---HHHHHHHHhhccccccH----------------------
Q 011988 182 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKYEKISEKKVSTSI---------------------- 236 (473)
Q Consensus 182 E~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~---~~~~~~~i~~~~~~~~~---------------------- 236 (473)
|++.+..++.++|||||||+||||++|..||....... ....+..+.......+.
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 99999999999999999999999999999998654332 11112221111000000
Q ss_pred ---------HHH------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 237 ---------EAL------CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 237 ---------~~l------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..+ ...++.++.+||..||..||++||++.+|+
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 390 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHH
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 000 112346789999999999999999988874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=339.60 Aligned_cols=257 Identities=19% Similarity=0.229 Sum_probs=204.4
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCC---CcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
..++|++.+.||+|+||.||+|.+... +..||||+..... ...+.+|+.+++.++|++++..+..+ . ....
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~-~~~~ 87 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-E-EEPT 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE-C-SSSC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEE-c-CCCC
Confidence 457899999999999999999987543 4469999965542 34578899999999866666555443 3 3445
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+++|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGGGCC-
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCCcccc
Confidence 8999999 7899999987777799999999999999999999999999999999999995 56899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
..... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||...........+. ......
T Consensus 165 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---~~~~~~- 234 (281)
T 3cc6_A 165 DEDYY------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---KGDRLP- 234 (281)
T ss_dssp --------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH---HTCCCC-
T ss_pred ccccc------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh---cCCCCC-
Confidence 43221 1234467889999999999899999999999999999998 999998755443332222 211111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
....+++.+.++|..||..||++||++.+|++.|++++..+
T Consensus 235 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 235 ---KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 13457899999999999999999999999999999987643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=349.21 Aligned_cols=260 Identities=17% Similarity=0.311 Sum_probs=210.7
Q ss_pred CCceEEEeeEeecCceEEEEEEEc-------CCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
.++|++.+.||+|+||.||+|.+. .+++.||||++..... ..+.+|+.+++.+..|++|..+..++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 578999999999999999999976 3567899999655432 34788999999996567777777777778
Q ss_pred CeEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 138 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~ 138 (473)
...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-- 191 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-- 191 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc--
Confidence 8899999999 779999997543 2489999999999999999999999999999999999994
Q ss_pred CCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 011988 139 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 217 (473)
Q Consensus 139 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~ 217 (473)
.++.+||+|||+++........ .......+|..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 192 -~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 192 -ENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp -TTCCEEECCCTTCEECTTTSSE-----ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred -CCCCEEEccccccccccccccc-----cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 7789999999999876543221 11234567889999999999889999999999999999999 9999987532
Q ss_pred CCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 218 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 218 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
.+....+...... .....++.++.++|..||..||.+||++.+|++.|+.++....
T Consensus 266 ---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 266 ---EELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp ---HHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---HHHHHHHhcCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 2333333222211 1235688999999999999999999999999999999987653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=350.80 Aligned_cols=259 Identities=17% Similarity=0.273 Sum_probs=191.1
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCc---EEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
..++|++.+.||+|+||.||+|.+..++. .||||++... ....+.+|+.+++.++|++++..+..+ .....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 99 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS-LRSRA 99 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE-ECC--
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee-ecccc
Confidence 46789999999999999999999877765 8999986443 234578999999999866555555444 33333
Q ss_pred ------EEEEEecC-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcE
Q 011988 77 ------NVLVIDLL-GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 144 (473)
Q Consensus 77 ------~~lv~e~~-g~sL~~~l~~~~-----~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~v 144 (473)
.+++|||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~---~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc---CCCCE
Confidence 38999999 779999986432 2599999999999999999999999999999999999994 67899
Q ss_pred EEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHH
Q 011988 145 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 223 (473)
Q Consensus 145 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~ 223 (473)
||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+......
T Consensus 177 kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--- 248 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYY-----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--- 248 (323)
T ss_dssp EECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---
T ss_pred EEeeccccccccccccc-----cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---
Confidence 99999999876543221 11234467889999999999999999999999999999999 9999987654332
Q ss_pred HHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 224 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 224 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
+..+...... .....+++++.++|..||..||++||++.+|.+.|++++...
T Consensus 249 ~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 249 YNYLIGGNRL----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHhcCCCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 2222222211 123467899999999999999999999999999999998643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=347.09 Aligned_cols=262 Identities=19% Similarity=0.285 Sum_probs=209.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEee-EeC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFG-VEG 74 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~-~~~ 74 (473)
..++|++.+.||+|+||.||+|.+. .+++.||||++..... ..+.+|+.+++.+.+|++|..+..++ ..+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 4578999999999999999999853 5678999999655432 34789999999997666666665554 445
Q ss_pred CeEEEEEecC-CCCHHHHHHHcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCSRK---------------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 138 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~~~---------------ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~ 138 (473)
...+++|||+ +++|.+++...... +++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~-- 182 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-- 182 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC--
Confidence 5689999999 67999999854322 89999999999999999999999999999999999994
Q ss_pred CCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 011988 139 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 217 (473)
Q Consensus 139 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~ 217 (473)
..+.+||+|||+++.+....... ......||..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 183 -~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 183 -EKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp -GGGCEEECCCGGGSCTTTCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred -CCCCEEECCCccccccccCccce-----eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 67889999999998765432211 1234578899999999999999999999999999999998 9999987653
Q ss_pred CCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 218 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 218 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
.. .....+...... .....+++++.++|..||..||.+||++.+|.+.|+.++....
T Consensus 257 ~~--~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 257 DE--EFCRRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp SH--HHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hH--HHHHHhccCccC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 32 222222221111 1234578999999999999999999999999999999987654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=359.46 Aligned_cols=255 Identities=21% Similarity=0.296 Sum_probs=199.8
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeE-----------
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV----------- 72 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~----------- 72 (473)
...++|++++.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++|++++..+..+..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 34678999999999999999999999999999999854432 334589999999997777776665533
Q ss_pred --------------------------eCCeEEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 011988 73 --------------------------EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSF 123 (473)
Q Consensus 73 --------------------------~~~~~~lv~e~~g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gI 123 (473)
...+.++||||+.++|.+++.. ....+++..++.|+.||+.||.|||++||
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi 162 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI 162 (383)
T ss_dssp ---------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence 3345889999999998888763 35679999999999999999999999999
Q ss_pred cccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHH
Q 011988 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVL 202 (473)
Q Consensus 124 vHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL 202 (473)
+||||||+|||++ ...+.+||+|||+|+.+..... .....||..|+|||++.+.. ++.++|||||||++
T Consensus 163 ~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 163 CHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEP--------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp ECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSC--------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred ccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCC--------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9999999999995 3578999999999987654332 23457899999999998755 89999999999999
Q ss_pred HHHHcCCCCCCCCCCCCHHHHHHHHhhcc---------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCC
Q 011988 203 MYFLRGSLPWQGLKAGTKKQKYEKISEKK---------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDD 261 (473)
Q Consensus 203 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~ 261 (473)
|||++|+.||.+....+....+.+..... .......+...+|+++.+||..||..||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999998754322222222111110 011112233457899999999999999999
Q ss_pred CCCHHHHH
Q 011988 262 KPDYAYLK 269 (473)
Q Consensus 262 RPt~~~l~ 269 (473)
|||+.+++
T Consensus 313 R~t~~e~l 320 (383)
T 3eb0_A 313 RINPYEAM 320 (383)
T ss_dssp SCCHHHHH
T ss_pred CCCHHHHh
Confidence 99988874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=351.05 Aligned_cols=257 Identities=17% Similarity=0.229 Sum_probs=201.8
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCC-cEEEEEEcccCC--chhHHHHHHHHHHhcCCCC-----CCeeEEeeEeC
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLNVKTK--HPQLQYEAKLYKILQGGTG-----IPNLRWFGVEG 74 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~-----i~~~~~~~~~~ 74 (473)
..+.++|++.+.||+|+||.||+|.+..++ +.||||++.... ...+..|+.+++.+.+.+. +..+..+....
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 457899999999999999999999998777 789999965432 3457789999999986553 55556667778
Q ss_pred CeEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC---------------
Q 011988 75 DYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--------------- 138 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~--------------- 138 (473)
...++||||++++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||...
T Consensus 95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 8999999999999998887544 469999999999999999999999999999999999999422
Q ss_pred -CCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 011988 139 -RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 217 (473)
Q Consensus 139 -~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~ 217 (473)
+..+.+||+|||+++...... ....||..|+|||++.+..++.++|||||||+||||++|..||.+...
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEHH----------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp EESCCCEEECCCTTCEETTSCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccCCCcEEEeecCccccccccc----------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 256889999999998644321 345899999999999999999999999999999999999999987544
Q ss_pred CCHHHHHHHHhhcccccc--------------------------HHHHh----------cCCcHHHHHHHHHHhcCCCCC
Q 011988 218 GTKKQKYEKISEKKVSTS--------------------------IEALC----------RGYPTEFASYFHYCRSLRFDD 261 (473)
Q Consensus 218 ~~~~~~~~~i~~~~~~~~--------------------------~~~l~----------~~~p~~l~~li~~cl~~dp~~ 261 (473)
......+.++........ ....+ ...+.++.+||..||..||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 322222222221110000 00000 011458999999999999999
Q ss_pred CCCHHHHH
Q 011988 262 KPDYAYLK 269 (473)
Q Consensus 262 RPt~~~l~ 269 (473)
||++.+++
T Consensus 325 Rpt~~e~l 332 (355)
T 2eu9_A 325 RITLAEAL 332 (355)
T ss_dssp SCCHHHHT
T ss_pred CcCHHHHh
Confidence 99987773
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=338.22 Aligned_cols=251 Identities=22% Similarity=0.368 Sum_probs=194.0
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
-.++|++.+.||+|+||.||+|.+ +++.||||+..... ...+.+|+.+++.++|+ +|..+..++......
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP-NIIALRGVCLKEPNL 81 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCT-TBCCEEEEECCC--C
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCC-CEeeEEEEEecCCce
Confidence 357899999999999999999996 48899999854321 24578899999999855 455555566677788
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcccCCCCCcEEEeeCC-----CCCcEEEEe
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGR-----RANQVYIID 148 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~-----~~~~vkL~D 148 (473)
++||||+ +++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++... ..+.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999 889999986 567999999999999999999999999 89999999999996321 267899999
Q ss_pred cCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011988 149 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 228 (473)
Q Consensus 149 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 228 (473)
||+++.+..... ....||..|+|||++.+..++.++|||||||++|+|++|+.||.+... ......+.
T Consensus 160 fg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~ 227 (271)
T 3dtc_A 160 FGLAREWHRTTK---------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYGVA 227 (271)
T ss_dssp CCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHH
T ss_pred CCcccccccccc---------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHhhh
Confidence 999986654322 245799999999999999999999999999999999999999987532 22223332
Q ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 229 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 229 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
....... +...+++++.++|..||..||++||++.++++.|+++
T Consensus 228 ~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 228 MNKLALP---IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cCCCCCC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 2222211 2356889999999999999999999999999988753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=340.88 Aligned_cols=259 Identities=16% Similarity=0.247 Sum_probs=206.1
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCc---EEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.|.+.++||+|+||.||+|.+..+++ .||+|+...... ..+.+|+.+++.++|++++..+..+.......+++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 47778999999999999999765554 799998654332 35778999999998777776666665556666899
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.+....
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCcEEeCcCCCcccccCCc
Confidence 9988 8999999986667899999999999999999999999999999999999994 77899999999998664432
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. .........+|..|+|||.+.+..++.++|||||||++|+|++|..| |....... ....+.......
T Consensus 179 ~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~---- 248 (298)
T 3pls_A 179 YY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFLAQGRRLP---- 248 (298)
T ss_dssp GG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHHHTTCCCC----
T ss_pred cc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHhhcCCCCC----
Confidence 11 11223456789999999999999999999999999999999995555 54433222 222222221111
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
....+++++.++|..||..||.+||++.+|++.|++++...
T Consensus 249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 13467899999999999999999999999999999998764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=364.48 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=195.4
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----------chhHHHHHHHHHHhcCCCCCCeeEEeeEe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------HPQLQYEAKLYKILQGGTGIPNLRWFGVE 73 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----------~~~l~~E~~il~~L~~~~~i~~~~~~~~~ 73 (473)
+.++|.+.++||+|+||.||+|.+..+++.||||++.+.. ...+.+|+.+++.|+|++++..+.. . .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~-~-~ 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-F-D 210 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE-E-E
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE-E-e
Confidence 4578999999999999999999999999999999854321 2247899999999987666665544 3 3
Q ss_pred CCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 74 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 74 ~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
....++||||+ +++|.+++. ....+++.+++.|+.||+.||.|||++||+||||||+||||+.++....+||+|||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred cCceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 45578999999 789988876 3457999999999999999999999999999999999999975445667999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 229 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 229 (473)
+....... .....||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+....... ...+..
T Consensus 290 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~i~~ 359 (419)
T 3i6u_A 290 KILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQITS 359 (419)
T ss_dssp TSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHHHHT
T ss_pred eecCCCcc--------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHHHhc
Confidence 87654321 234689999999999864 56889999999999999999999999875433221 122222
Q ss_pred ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 230 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 230 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
... .........+++++.+||..||..||++||++++++
T Consensus 360 ~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 398 (419)
T 3i6u_A 360 GKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398 (419)
T ss_dssp TCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 222 223445567899999999999999999999988774
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=353.60 Aligned_cols=203 Identities=26% Similarity=0.357 Sum_probs=174.7
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCC-----CCeeEEeeEeCCe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTG-----IPNLRWFGVEGDY 76 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~-----i~~~~~~~~~~~~ 76 (473)
.+.++|++.++||+|+||.||+|.+..+++.||||++.... ..++..|+.+++.+.++++ +..+..++.....
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 35689999999999999999999999999999999965432 3456789999999986664 5666677778889
Q ss_pred EEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 77 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH--~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
.++||||++++|.+++.... ..+++..++.|+.||+.||.||| +.|||||||||+||||+. +..+.+||+|||+|+
T Consensus 131 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 131 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCE
T ss_pred eEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCce
Confidence 99999999999999998654 46999999999999999999999 579999999999999952 246789999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 217 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~ 217 (473)
...... ....||+.|+|||++.+..++.++|||||||+||||++|+.||.+...
T Consensus 210 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 210 QLGQRI----------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp ETTCCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eccccc----------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 764321 346899999999999999999999999999999999999999987543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=365.92 Aligned_cols=260 Identities=20% Similarity=0.268 Sum_probs=202.4
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
..++|+++++||+|+||.||+|.+..+++.||||++.+ .....+..|+.+++.++|+ +|..+..++......+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTALKYSFQTHDRLC 224 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCT-TSCCEEEEEEETTEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCC-eEeeEEEEEeeCCEEE
Confidence 34789999999999999999999999999999998543 2234567888888888854 5556666677888899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+||||+ +++|.+++.. ...+++..++.|+.||+.||+|||+ +|||||||||+||||+ .++.+||+|||+|+...
T Consensus 225 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~---~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC---SSSCEEECCCCCCCTTC
T ss_pred EEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC---CCCCEEEccCCCceecc
Confidence 999999 7799999875 3579999999999999999999998 9999999999999994 77899999999998644
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ....+..+......
T Consensus 301 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~--- 367 (446)
T 4ejn_A 301 KDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIR--- 367 (446)
T ss_dssp C------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC---
T ss_pred CCCc-------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCC---
Confidence 3222 1245689999999999999999999999999999999999999997743 33444444433322
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCccccccccc
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKY 294 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 294 (473)
+...+++++.+||..||..||.+|| ++++| |++.| -..++|.....
T Consensus 368 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~el---l~hp~-------f~~~~~~~~~~ 418 (446)
T 4ejn_A 368 --FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEI---MQHRF-------FAGIVWQHVYE 418 (446)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH---HTSGG-------GTTCCHHHHHT
T ss_pred --CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHH---HhCcc-------ccCCCHHHHhh
Confidence 2356789999999999999999999 87766 44443 23457876543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=352.50 Aligned_cols=255 Identities=22% Similarity=0.241 Sum_probs=195.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC-----
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG----- 74 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~----- 74 (473)
++.++|++++.||+|+||.||+|++..+++.||||++.... ...+.+|+.+++.|+|++++..+..+....
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 34578999999999999999999999999999999864322 345889999999998777666665543322
Q ss_pred ---------------------------------------------------CeEEEEEecC-CCCHHHHHHHcCC--CCC
Q 011988 75 ---------------------------------------------------DYNVLVIDLL-GPSLEDLFNFCSR--KLS 100 (473)
Q Consensus 75 ---------------------------------------------------~~~~lv~e~~-g~sL~~~l~~~~~--~ls 100 (473)
.+.+++|||+ +++|.+++..... ..+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 2479999999 7799999984332 356
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc-----ccccCCCcccC
Q 011988 101 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI-----PYRENKNLTGT 175 (473)
Q Consensus 101 ~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~-----p~~~~~~~~Gt 175 (473)
+..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++........... .+.......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe---CCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 677999999999999999999999999999999994 7789999999999877654321110 01223456899
Q ss_pred ccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHh
Q 011988 176 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR 255 (473)
Q Consensus 176 ~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl 255 (473)
+.|+|||++.+..++.++|||||||++|||++|..|+.. .......+...... .....+++++.++|..||
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l 310 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFP----LLFTQKYPQEHMMVQDML 310 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCC----HHHHHHCHHHHHHHHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCC----cccccCChhHHHHHHHHc
Confidence 999999999999999999999999999999998777532 12222222222222 222345688899999999
Q ss_pred cCCCCCCCCHHHHHH
Q 011988 256 SLRFDDKPDYAYLKR 270 (473)
Q Consensus 256 ~~dp~~RPt~~~l~~ 270 (473)
+.||++||++.++++
T Consensus 311 ~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 311 SPSPTERPEATDIIE 325 (332)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCCCCcCCCHHHHhh
Confidence 999999999887753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=343.48 Aligned_cols=248 Identities=19% Similarity=0.186 Sum_probs=201.8
Q ss_pred CCCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
|..++.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.++..+..|++|..+..+.....
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 55677889999999999999999999999999999999865432 3357788999999856777777777778889
Q ss_pred eEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCC------------
Q 011988 76 YNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR------------ 139 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~------------ 139 (473)
..++||||+ +++|.+++... ...+++.+++.|+.||+.||.|||++||+||||||+|||++.+.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999 77999999753 25699999999999999999999999999999999999996332
Q ss_pred ----CCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 011988 140 ----RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQG 214 (473)
Q Consensus 140 ----~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~ 214 (473)
....+||+|||++...... ....||..|+|||++.+. .++.++|||||||++|+|++|..|+..
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP-----------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS-----------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred cccCCceEEEEcccccccccCCc-----------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 4457999999999876442 234699999999999876 567899999999999999999887744
Q ss_pred CCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 215 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 215 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
. .....+...... .+...+++++.++|..||..||++||++.+++
T Consensus 234 ~------~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 234 G------DQWHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp S------HHHHHHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred h------hHHHHHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 2 122333332221 23457889999999999999999999988774
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=366.69 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=209.5
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcc-----cCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~-----~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
+.++|+++++||+|+||.||+|.+..+++.||||++. ......+.+|+.+++.|+|+ +|..+..+.......++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP-NIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCT-TBCCEEEEEECSSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCC-CcCeEEEEEEcCCEEEE
Confidence 5678999999999999999999999999999999853 23455688999999999855 55555566677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ +++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++..+..+.+||+|||+++.+...
T Consensus 99 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999 78999988743 57999999999999999999999999999999999999965556678999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+.........+
T Consensus 178 ~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~- 244 (486)
T 3mwu_A 178 TK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLP- 244 (486)
T ss_dssp ------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCSCSG-
T ss_pred Cc--------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCc-
Confidence 21 234579999999999987 59999999999999999999999998743 344445554443332222
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
....+++++.+||..||..||.+||++.++ |++.|.+.
T Consensus 245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~---l~hp~~~~ 282 (486)
T 3mwu_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQC---LEHPWIQK 282 (486)
T ss_dssp GGGGSCHHHHHHHHHHTCSSTTTSCCHHHH---HHCHHHHH
T ss_pred ccCCCCHHHHHHHHHHcCCChhhCcCHHHH---hcCHhhcc
Confidence 235678999999999999999999998777 55555544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=349.58 Aligned_cols=264 Identities=19% Similarity=0.232 Sum_probs=190.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEee--------EeC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFG--------VEG 74 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~--------~~~ 74 (473)
..+|++.++||+|+||.||+|++..+++.||||++.... ...+.+|+.+++.+..|++|..+..+. ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 458999999999999999999999999999999864433 345788999999997555555554444 234
Q ss_pred CeEEEEEecCCCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEEeeCCCCCcEEEEecC
Q 011988 75 DYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFG 150 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~--~~~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFG 150 (473)
...+++|||++++|.+++.. ....+++.+++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC---TTSCEEBCCCT
T ss_pred ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC---CCCCEEEecCc
Confidence 45799999999999999874 3456999999999999999999999999 99999999999994 77899999999
Q ss_pred CcccccCCCCcccc-----ccccCCCcccCccccccccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHH
Q 011988 151 LAKRYRDTATHQHI-----PYRENKNLTGTARYASMNTH---LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 222 (473)
Q Consensus 151 la~~~~~~~~~~~~-----p~~~~~~~~Gt~~Y~APE~~---~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~ 222 (473)
+++.+......... .........||+.|+|||++ .+..++.++|||||||++|||++|..||.+.... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~ 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---R 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---H
Confidence 99876543221100 00112245699999999998 5667899999999999999999999999763321 1
Q ss_pred HHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCC
Q 011988 223 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 282 (473)
Q Consensus 223 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~ 282 (473)
+........ ....++..+.+||..||+.||++||++.++++.|+.+.......
T Consensus 261 ----~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 261 ----IVNGKYSIP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp ---------CCCC---TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred ----hhcCcccCC---cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 111111111 12456788999999999999999999999999999998766543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=357.82 Aligned_cols=257 Identities=16% Similarity=0.253 Sum_probs=196.6
Q ss_pred CCceEEEeeEeecCceEEEEEEEc---CCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
.++|.+.+.||+|+||.||+|++. .++..||||++.... ...+.+|+.+++.++|+ +|..+..++......+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP-NIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCT-TBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCC-CCCeEEEEEeeCCceE
Confidence 457999999999999999999876 467789999965432 23578899999999855 5555556666777889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC--------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCcccccccc
Confidence 999999 889999998666679999999999999999999999999999999999999 4778999999999987654
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
..... .......+|..|+|||++.+..++.++|||||||+||||++ |..||.+... ......+.......
T Consensus 200 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~~~~-- 270 (373)
T 2qol_A 200 DPEAA----YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGYRLP-- 270 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTEECC--
T ss_pred CCccc----eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC--
Confidence 32211 01122346788999999999999999999999999999998 9999987543 33333333222111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
....+|.++.++|..||+.||.+||++.+|++.|+.++.
T Consensus 271 --~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 271 --PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp --CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 124678999999999999999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.37 Aligned_cols=253 Identities=18% Similarity=0.266 Sum_probs=205.8
Q ss_pred cCCceEEE-eeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
+.++|.+. +.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+.++++|..+..++......+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 45778888 8999999999999999999999999985432 23568899999999998888888888888899999
Q ss_pred EEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 79 LVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+||||+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.....+.+||+|||+++...
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999 77999887532 3569999999999999999999999999999999999999643346899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
.... .....||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ....+..+....... .
T Consensus 186 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~-~ 253 (327)
T 3lm5_A 186 HACE--------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETYLNISQVNVDY-S 253 (327)
T ss_dssp ----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCC-C
T ss_pred Cccc--------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHhccccc-C
Confidence 4322 134579999999999999999999999999999999999999997743 333333333332222 2
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
......+++++.++|..||..||++||++++|+
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll 286 (327)
T 3lm5_A 254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286 (327)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred chhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 223456889999999999999999999987773
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=351.52 Aligned_cols=251 Identities=20% Similarity=0.188 Sum_probs=198.5
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ...+.+|+.+++.++|++++ .+..++.....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII-GLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBC-CEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCC-eEEEEEeeCCc
Confidence 3578999999999999999999999999999999854321 24578999999999855544 55555566778
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 77 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 77 ~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
.++||||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+.
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCGGGSTTT
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc---CCCCEEEEecccceecc
Confidence 899999998899999986666799999999999999999999999999999999999994 77899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc---
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--- 232 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--- 232 (473)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ...+..+.....
T Consensus 164 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 164 SPNR-------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPT 233 (346)
T ss_dssp SCCC-------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred CCcc-------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCC
Confidence 4322 12345789999999999765 489999999999999999999999987543 333333322110
Q ss_pred --------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 --------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 --------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
......+...+++++.+||..||..||++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 290 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 1123344567789999999999999999999987763
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=342.82 Aligned_cols=257 Identities=19% Similarity=0.325 Sum_probs=205.0
Q ss_pred CCceEEEe-eEeecCceEEEEEEE--cCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 6 GNKFRLGR-KIGSGSFGEIYLGTN--IQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 6 ~~~y~i~~-~LG~G~fG~Vy~a~~--~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
.++|.+.+ .||+|+||.||+|.+ ..+++.||||++.... ...+.+|+.+++.++|++++..+..+ .....
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC--EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE--ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--CCCCc
Confidence 45799998 999999999999954 4667899999964432 34588999999999866655555444 55667
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 93 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCcceeec
Confidence 8999999 6899999985 45699999999999999999999999999999999999996 56899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
...... .......+|..|+|||++.+..++.++|||||||++|||++ |..||.+... .+....+......
T Consensus 169 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~-- 239 (291)
T 1xbb_A 169 ADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM-- 239 (291)
T ss_dssp TTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC--
T ss_pred cCCCcc----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCC--
Confidence 433211 11223456789999999999889999999999999999999 9999987543 2333333222211
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.+...+|+++.++|..||..||++||++.+|.+.|++++...
T Consensus 240 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 240 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 123568999999999999999999999999999999998654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=343.34 Aligned_cols=257 Identities=21% Similarity=0.273 Sum_probs=207.9
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+.++|.+.+.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.++|++ |..+..+.......+++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN-IVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTT-BCCEEEEEECSSEEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCC-eeehhhhcccCCEEEEEE
Confidence 567899999999999999999999999999999986543 2345889999999998554 555666667788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~- 163 (304)
T 2jam_A 86 QLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI- 163 (304)
T ss_dssp CCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-
T ss_pred EcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-
Confidence 999 78999998743 469999999999999999999999999999999999999544567899999999997543321
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
.....||..|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+....... .....
T Consensus 164 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~-~~~~~ 231 (304)
T 2jam_A 164 --------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFEKIKEGYYEF-ESPFW 231 (304)
T ss_dssp --------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHCCCCC-CTTTT
T ss_pred --------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCC-Ccccc
Confidence 123468999999999999999999999999999999999999997743 333444444333221 11234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
..+++++.++|..||..||++||++.++ |++.|...
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~---l~h~~~~~ 267 (304)
T 2jam_A 232 DDISESAKDFICHLLEKDPNERYTCEKA---LSHPWIDG 267 (304)
T ss_dssp TTSCHHHHHHHHHHHCSSTTTSCCHHHH---HTSHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHH---hcCccccC
Confidence 5789999999999999999999998776 55555544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=350.95 Aligned_cols=258 Identities=20% Similarity=0.298 Sum_probs=207.7
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
+..++|++.+.||+|+||.||+|.+. .+++.||||++..... ..+.+|+.+++.+.|++ |..+..+....
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~ 100 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VVRLLGVVSQG 100 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTT-BCCEEEEECSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCC-EeeeEEEEccC
Confidence 34678999999999999999999876 3578899999654432 24778999999998655 55555566667
Q ss_pred CeEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcE
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 144 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~---------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~v 144 (473)
...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc---CCCeE
Confidence 7889999999 779999987432 4579999999999999999999999999999999999994 77899
Q ss_pred EEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHH
Q 011988 145 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 223 (473)
Q Consensus 145 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~ 223 (473)
||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.. ..+.
T Consensus 178 kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~ 249 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQV 249 (322)
T ss_dssp EECCTTCCCGGGGGGCE-----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHH
T ss_pred EECcCcccccccccccc-----ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC---HHHH
Confidence 99999999866443221 11234567899999999999899999999999999999999 899998753 2333
Q ss_pred HHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 224 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 224 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
...+....... ....+|+++.++|..||..||.+||++.++.+.|++++.
T Consensus 250 ~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 LRFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 33333332211 235688999999999999999999999999999887653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=340.58 Aligned_cols=260 Identities=19% Similarity=0.291 Sum_probs=209.3
Q ss_pred CCceEEEe-eEeecCceEEEEEEEc--CCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 6 GNKFRLGR-KIGSGSFGEIYLGTNI--QTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 6 ~~~y~i~~-~LG~G~fG~Vy~a~~~--~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
.++|.+.+ .||+|+||.||+|.+. .++..||||++.... ...+.+|+.+++.++|++++..+..+ ..+..+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~ 85 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC--QAEALM 85 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--ESSSEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe--cCCCcE
Confidence 45687877 9999999999999864 467889999965533 34578999999999866655555544 455689
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+|||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceeeecc
Confidence 999999 6799999976666799999999999999999999999999999999999995 678999999999987654
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
..... .......||..|+|||++.+..++.++|||||||++|||++ |..||.+... .+....+......
T Consensus 163 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i~~~~~~--- 232 (287)
T 1u59_A 163 DDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRM--- 232 (287)
T ss_dssp CSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCC---
T ss_pred Cccee----eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHhcCCcC---
Confidence 32211 11234467899999999998889999999999999999998 9999987543 2233333332211
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCC
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 281 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 281 (473)
.+...+|+++.++|..||..||++||++.+|.+.|++++...+.
T Consensus 233 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 233 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred -CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 12357899999999999999999999999999999999877653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=365.36 Aligned_cols=259 Identities=22% Similarity=0.325 Sum_probs=210.1
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----------------CchhHHHHHHHHHHhcCCCCCCe
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----------------KHPQLQYEAKLYKILQGGTGIPN 66 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----------------~~~~l~~E~~il~~L~~~~~i~~ 66 (473)
..+.++|+++++||+|+||.||+|.+..+++.||||++.+. ....+.+|+.+++.|+| ++|..
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~ 110 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH-PNIIK 110 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC-TTBCC
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC-CCCCe
Confidence 35678999999999999999999999999999999985432 23458899999999985 55556
Q ss_pred eEEeeEeCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEE
Q 011988 67 LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 145 (473)
Q Consensus 67 ~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vk 145 (473)
+..++......++||||| +++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++....+|
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 666677888999999999 78999988743 5699999999999999999999999999999999999996433344799
Q ss_pred EEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 011988 146 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 225 (473)
Q Consensus 146 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~ 225 (473)
|+|||+++.+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+.
T Consensus 190 l~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~ 257 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK--------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDIIK 257 (504)
T ss_dssp ECCCTTCEECCTTSC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH
T ss_pred EEECCCCEEcCCCCc--------cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHH
Confidence 999999987654322 234579999999999875 68999999999999999999999998743 344555
Q ss_pred HHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 226 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 226 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.+.......... ....+++++.+||..||..||.+||++.++ |++.|.+.
T Consensus 258 ~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~e~---l~h~~~~~ 307 (504)
T 3q5i_A 258 KVEKGKYYFDFN-DWKNISDEAKELIKLMLTYDYNKRCTAEEA---LNSRWIKK 307 (504)
T ss_dssp HHHHCCCCCCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHHH
T ss_pred HHHcCCCCCCcc-ccCCCCHHHHHHHHHHcCCChhHCCCHHHH---hcCHhhhh
Confidence 555544433333 346789999999999999999999998877 55666554
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=357.67 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=184.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEe-----C
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVE-----G 74 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~-----~ 74 (473)
+.++|++++.||+|+||.||+|.+..+|+.||||++.... ...+.+|+.+++.++|++++..+..+... .
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 5689999999999999999999999999999999965432 23567899999999977766666555432 2
Q ss_pred CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 75 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
...+++||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARH 181 (367)
T ss_dssp CCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECC------
T ss_pred CeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC---CCCCEEEeecccccc
Confidence 55799999999999999873 5799999999999999999999999999999999999994 778999999999986
Q ss_pred ccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc---
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 230 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 230 (473)
.... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.+....
T Consensus 182 ~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 182 TADE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred cccc----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 5432 134589999999999987 67899999999999999999999999875432222222211110
Q ss_pred --------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 --------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
........+...+++++.+||.+||..||++||++.+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L 310 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh
Confidence 011223444567789999999999999999999987763
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=352.70 Aligned_cols=265 Identities=19% Similarity=0.281 Sum_probs=210.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEc---CCCcEEEEEEccc-------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLNVK-------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~~~~-------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
.++|++.++||+|+||.||+|++. .+++.||||++.+ .....+..|+.+++.+.++++|..+..++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 378999999999999999999985 4889999998543 233457789999999987888888888888889
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCcEEEeeCCCCee
Confidence 999999999 77999999753 4699999999999999999999999999999999999994 778999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHH-HHHHHhhcc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-KYEKISEKK 231 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~-~~~~i~~~~ 231 (473)
+...... ......||+.|+|||++.+. .++.++|||||||+||||++|..||.......... ....+....
T Consensus 209 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 209 FVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282 (355)
T ss_dssp CCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred cccCCCC------cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC
Confidence 6443221 12346799999999999863 47899999999999999999999997654333222 222222211
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 232 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 232 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
. .+...++..+.+||..||..||.+|| ++++| +++.|. ..++|..+..+
T Consensus 283 ~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~el---l~h~~f-------~~~~~~~l~~~ 336 (355)
T 1vzo_A 283 P-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI---KEHLFF-------QKINWDDLAAK 336 (355)
T ss_dssp C-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH---HTSGGG-------TTCCHHHHHTT
T ss_pred C-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHH---HcCcch-------hcCChhHhhhc
Confidence 1 12356789999999999999999999 76655 444442 23577766543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=355.92 Aligned_cols=259 Identities=17% Similarity=0.252 Sum_probs=198.6
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCC---cEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.|.+.+.||+|+||.||+|.+..++ ..||||.+.... ...+.+|+.+++.++|++++..+..+.......++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 5889999999999999999976443 468999854432 245788999999998777666666555566778999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+....
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC---CCCCEEEeeccccccccccc
Confidence 9999 7799999986666799999999999999999999999999999999999994 77899999999998764432
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
... ........+|..|+|||++.+..++.++|||||||+||||++ |..||.+.........+ .......
T Consensus 247 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---~~~~~~~---- 316 (373)
T 3c1x_A 247 FDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQGRRLL---- 316 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH---HTTCCCC----
T ss_pred ccc---ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH---HcCCCCC----
Confidence 111 111234567889999999999999999999999999999999 78888876554433322 2211111
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
....+|+++.++|..||..||++||++.+|++.|+.++...
T Consensus 317 ~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 13468899999999999999999999999999999998643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=341.43 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=199.3
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|+ +|..+..++......
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP-NVIKYYASFIEDNEL 107 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCT-TBCCEEEEEEETTEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCC-CEeeEEEEEEcCCcE
Confidence 34578999999999999999999999999999999854321 23477899999999855 455555666778889
Q ss_pred EEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 78 VLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
+++|||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~---~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc---CCCCEEEEecccee
Confidence 9999999 6699999864 345699999999999999999999999999999999999994 77899999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+... ........+......
T Consensus 185 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~ 256 (310)
T 2wqm_A 185 FFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYP 256 (310)
T ss_dssp ---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTTCSC
T ss_pred eecCCCc-------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhcccCC
Confidence 6644322 11345789999999999999999999999999999999999999976432 222333333322221
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
.. ....+++++.++|..||..||++||++.+|.+.|+++.....
T Consensus 257 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 257 PL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11 124678999999999999999999999999999999876543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=344.21 Aligned_cols=260 Identities=16% Similarity=0.219 Sum_probs=202.2
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCC----cEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
+..++|.+.+.||+|+||.||+|.+..++ ..||||++.... ...+.+|+.+++.++|++ |..+..+.....
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~ 119 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN-IIRLEGVISKYK 119 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTT-BCCEEEEECSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCC-CCcEEEEEecCC
Confidence 34678999999999999999999986553 459999965433 234778999999998554 555555666777
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC---CCCcEEECCCCcchh
Confidence 889999999 6699999987667899999999999999999999999999999999999994 778999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
........ .......+|..|+|||++.+..++.++|||||||+||||++ |..||.+... .+....+......
T Consensus 197 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~~ 269 (333)
T 1mqb_A 197 LEDDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFRL 269 (333)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC
T ss_pred hccccccc----cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHCCCcC
Confidence 65432211 01123456889999999999999999999999999999999 9999977533 3333333332211
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
. ....+++++.++|..||..||++||++.+|.+.|++++..
T Consensus 270 ~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 270 P----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp C----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1 1346889999999999999999999999999999998854
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=337.81 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=203.9
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
+.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.++| ++|..+..++....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH-PNIITLHDIFENKT 81 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCC-CCeeehhheecCCC
Confidence 567899999999999999999999999999999985433 23568899999999985 55555666667788
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCC-CCCcEEEEecCCcc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLAK 153 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~DFGla~ 153 (473)
..++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 899999999 7899999974 45799999999999999999999999999999999999995321 12389999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
....... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+......
T Consensus 161 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~ 229 (283)
T 3bhy_A 161 KIEAGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETLTNISAVNYD 229 (283)
T ss_dssp ECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCC
T ss_pred eccCCCc--------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHHHHhHhcccC
Confidence 7654321 134579999999999999999999999999999999999999998743 33334444333322
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
. .......+++++.++|..||..||++||++.++++
T Consensus 230 ~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 F-DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C-CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 2 23445678999999999999999999999888754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=347.84 Aligned_cols=249 Identities=20% Similarity=0.234 Sum_probs=206.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----------chhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
.++|.+.+.||.|+||.||+|.+..+|+.||||++.... ...+.+|+.+++.+..+++|..+..++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 357999999999999999999998899999999854433 234678999999996677777777777888
Q ss_pred CeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
...++||||+ |++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~---~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD---DNMQIRLSDFGFSC 248 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEEecCccc
Confidence 9999999999 7799999974 35699999999999999999999999999999999999994 77899999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 227 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~------~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i 227 (473)
.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|..||.+.. ....+..+
T Consensus 249 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i 317 (365)
T 2y7j_A 249 HLEPGEK--------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRMI 317 (365)
T ss_dssp ECCTTCC--------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH
T ss_pred ccCCCcc--------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHHH
Confidence 7654322 2346899999999998743 57899999999999999999999997643 33444444
Q ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 228 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 228 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.........+ ....++.++.++|..||..||++||++.++++
T Consensus 318 ~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 MEGQYQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHTCCCCCHH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhCCCCCCCc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 4444333332 34578899999999999999999999888753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=343.30 Aligned_cols=261 Identities=19% Similarity=0.273 Sum_probs=200.4
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEee---------
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFG--------- 71 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~--------- 71 (473)
.++++|++++.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|++++..+..+.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 46899999999999999999999999999999999865443 245778999999998777666665542
Q ss_pred ----EeCCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEE
Q 011988 72 ----VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 147 (473)
Q Consensus 72 ----~~~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~ 147 (473)
......++||||++++|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++ ..++.+||+
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~ 163 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIG 163 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEEC
T ss_pred cccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEEc
Confidence 3446789999999999999986 45799999999999999999999999999999999999995 346789999
Q ss_pred ecCCcccccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 011988 148 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 226 (473)
Q Consensus 148 DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~ 226 (473)
|||+++......... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+... ...+..
T Consensus 164 Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~ 236 (320)
T 2i6l_A 164 DFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQMQL 236 (320)
T ss_dssp CCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH
T ss_pred cCccccccCCCcccc----cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHH
Confidence 999998764322111 11234567999999999876 6789999999999999999999999987543 222222
Q ss_pred Hhhcc-------------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 227 ISEKK-------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 227 i~~~~-------------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
+.... .......+...++.++.++|..||..||++||++.++ |++.|.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~~~ 310 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA---LSHPYMS 310 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH---HTSHHHH
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH---hCCcccc
Confidence 22111 1122344556789999999999999999999998777 4555543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.34 Aligned_cols=254 Identities=20% Similarity=0.278 Sum_probs=208.6
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.++|++.+.||+|+||.||+|.+. +++.||||++... ....+.+|+.+++.++|+ +|..+..++......+++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP-KLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCT-TBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCC-CEeeEEEEEccCCCeEEEEeC
Confidence 468999999999999999999985 6788999996544 345688999999999854 555555566667788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~~~~~-- 159 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQY-- 159 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---GGGCEEECCTTGGGGBCCHHH--
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC---CCCCEEEcccccccccccccc--
Confidence 9 7899999987667799999999999999999999999999999999999994 678899999999986543211
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
.......|+..|+|||++.+..++.++|||||||++|||++ |..||.+.. ..+....+...... ....
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~i~~~~~~----~~~~ 228 (267)
T 3t9t_A 160 ----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFRL----YKPR 228 (267)
T ss_dssp ----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCCC----CCCT
T ss_pred ----cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---HHHHHHHHhcCCcC----CCCc
Confidence 11234567889999999998899999999999999999999 999998743 23333333332111 1124
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
.++.++.+++..||..||++||++.++.+.|+++..
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 578999999999999999999999999999998864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=348.66 Aligned_cols=261 Identities=19% Similarity=0.208 Sum_probs=201.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEe----CC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVE----GD 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~----~~ 75 (473)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++..... ..+.+|+.+++.++|++++..+..+... ..
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 567899999999999999999999999999999999654332 3467899999999866665555443322 26
Q ss_pred eEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 76 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 76 ~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
..+++|||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+
T Consensus 88 ~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN---SNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---CCCcEEEEeccccccc
Confidence 7899999999999999874 4699999999999999999999999999999999999994 7789999999999876
Q ss_pred cCCCCccccc---cccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh--
Q 011988 156 RDTATHQHIP---YRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-- 229 (473)
Q Consensus 156 ~~~~~~~~~p---~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~-- 229 (473)
.........+ ........||..|+|||++.+ ..++.++|||||||++|||++|..||.+.........+..+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 5432211100 011234679999999998875 6789999999999999999999999987543211111111110
Q ss_pred ----------------------ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 230 ----------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 230 ----------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.........+...+++++.+||..||..||++||++.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 0111233445567899999999999999999999988763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=337.87 Aligned_cols=251 Identities=21% Similarity=0.279 Sum_probs=206.4
Q ss_pred CCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeE---------
Q 011988 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV--------- 72 (473)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~--------- 72 (473)
+.+++++|++.+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++|++++..+..+..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC-SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 456778999999999999999999999989999999986544 3568899999999997766666554432
Q ss_pred ------eCCeEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcE
Q 011988 73 ------EGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 144 (473)
Q Consensus 73 ------~~~~~~lv~e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~v 144 (473)
.....++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc---CCCCE
Confidence 244579999999 56999999754 35799999999999999999999999999999999999995 67899
Q ss_pred EEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 011988 145 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 224 (473)
Q Consensus 145 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~ 224 (473)
||+|||++........ .....||..|+|||++.+..++.++|||||||++|||++|..||... ....
T Consensus 162 kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~ 228 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK--------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFF 228 (284)
T ss_dssp EECCCTTCEESSCCSC--------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHH
T ss_pred EECcchhheecccccc--------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHH
Confidence 9999999987654322 13457999999999999999999999999999999999999988431 1222
Q ss_pred HHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 225 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 225 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
..+.... +...++.++.++|..||..||.+||++.++++.|..+.
T Consensus 229 ~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 229 TDLRDGI-------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHTTC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHhhccc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 2222211 12457899999999999999999999999988887653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=347.11 Aligned_cols=263 Identities=18% Similarity=0.263 Sum_probs=205.5
Q ss_pred CccCCceEEEeeEeecCceEEEEEE-----EcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEe
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE 73 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~-----~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~ 73 (473)
....++|++.+.||+|+||.||+|+ +..+++.||||++.... ...+.+|+.+++.+.|+ +|..+..++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ-NIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCT-TBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCC-CCCeEEEEEcC
Confidence 3567899999999999999999999 55678899999965432 23578899999999754 55555566666
Q ss_pred CCeEEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEE
Q 011988 74 GDYNVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 146 (473)
Q Consensus 74 ~~~~~lv~e~~-g~sL~~~l~~~~------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL 146 (473)
....++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 77789999999 889999998653 34899999999999999999999999999999999999965445667999
Q ss_pred EecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHH
Q 011988 147 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYE 225 (473)
Q Consensus 147 ~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~ 225 (473)
+|||+++........ .......||..|+|||++.+..++.++|||||||+||||++ |..||.... ......
T Consensus 185 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~ 256 (327)
T 2yfx_A 185 GDFGMARDIYRASYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLE 256 (327)
T ss_dssp CCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHH
T ss_pred Ccccccccccccccc-----ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC---HHHHHH
Confidence 999999865433221 11234578999999999999899999999999999999998 999997643 233333
Q ss_pred HHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 226 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 226 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
.+....... ....+++++.++|..||..||.+||++.+|++.|+.+...
T Consensus 257 ~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 257 FVTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhcCCCCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 333322211 2356889999999999999999999999999999877643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=363.29 Aligned_cols=267 Identities=19% Similarity=0.225 Sum_probs=208.6
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEe-CCeEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYNV 78 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~-~~~~~ 78 (473)
.++++|++.++||+|+||.||+|.+..+++.||||++.. .....+.+|+.+++.++|++++..+..+... ....+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 467899999999999999999999999999999999543 2345578999999999966665555444332 33779
Q ss_pred EEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC-CCCCcEEEEecCCccc
Q 011988 79 LVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKR 154 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~--~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGla~~ 154 (473)
+||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||+++.
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 999999 789999987432 239999999999999999999999999999999999998432 3456799999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-CCHHHHHH
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-GTKKQKYE 225 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~--------~~~s~ksDVwSlGviL~elltG~~Pf~~~~~-~~~~~~~~ 225 (473)
...... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+.+.
T Consensus 166 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 166 LEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp CCCGGG--------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred ccCCCc--------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 654321 234579999999999875 4678899999999999999999999976443 22333344
Q ss_pred HHhhcccccc--------------------HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 226 KISEKKVSTS--------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 226 ~i~~~~~~~~--------------------~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
++........ ...+...++..+.++|..||..||++||++.++.+.+++++.+
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 4433221110 0011123467899999999999999999999999999888754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=345.26 Aligned_cols=254 Identities=18% Similarity=0.233 Sum_probs=200.2
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCC-------cEEEEEEcccC---CchhHHHHHHHHHHhcCCCCCCeeEEeeE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTN-------EEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGV 72 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~-------~~vAiK~~~~~---~~~~l~~E~~il~~L~~~~~i~~~~~~~~ 72 (473)
.+..++|++.+.||+|+||.||+|.+..++ ..||+|++... ....+.+|+.+++.++|++ |..+..++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH-LVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTT-BCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCC-EeEEEEEEE
Confidence 345689999999999999999999998877 47999985433 2355889999999998554 555555666
Q ss_pred eCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCC-----CCcEEE
Q 011988 73 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-----ANQVYI 146 (473)
Q Consensus 73 ~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~-----~~~vkL 146 (473)
.....++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++.+.. .+.+||
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 677889999999 68999999876656999999999999999999999999999999999999963321 112999
Q ss_pred EecCCcccccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCCHHHHH
Q 011988 147 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQKY 224 (473)
Q Consensus 147 ~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~-~Pf~~~~~~~~~~~~ 224 (473)
+|||++...... ....||..|+|||++.+ ..++.++|||||||++|||++|. .||..... ....
T Consensus 163 ~Dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~ 228 (289)
T 4fvq_A 163 SDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---QRKL 228 (289)
T ss_dssp CCCCSCTTTSCH-----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHH
T ss_pred ccCcccccccCc-----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch---HHHH
Confidence 999999755332 22468899999999998 67999999999999999999954 55544321 2222
Q ss_pred HHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 225 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 225 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
..... .. .+...+++++.++|..||+.||++||++.+|++.|++++.
T Consensus 229 ~~~~~-~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 229 QFYED-RH-----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHT-TC-----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHhhc-cC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111 11 1224567889999999999999999999999999987764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=337.10 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=203.3
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
...++|++.+.||+|+||.||+|.+..+++.||||++.. .....+.+|+.+++.++| ++|..+..++......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATRV 84 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCC-CCCcchhheEecCCEE
Confidence 345789999999999999999999999999999998533 234558889999999985 5555666667778889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC---TTSCEEECSCCEESCC-
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc---CCCCEEEEeccccccCC
Confidence 9999999 67999998754 4699999999999999999999999999999999999994 78899999999986543
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
... .....||..|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+......
T Consensus 161 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~--- 225 (279)
T 3fdn_A 161 SSR---------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVEFT--- 225 (279)
T ss_dssp ----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCC---
T ss_pred ccc---------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHHHHHHhCCCC---
Confidence 322 134578999999999999999999999999999999999999998643 33333333332221
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
+...+++++.+||..||..||++||++.+| |++.|.+.
T Consensus 226 --~~~~~~~~~~~li~~~l~~~p~~Rps~~e~---l~h~~~~~ 263 (279)
T 3fdn_A 226 --FPDFVTEGARDLISRLLKHNPSQRPMLREV---LEHPWITA 263 (279)
T ss_dssp --CCTTSCHHHHHHHHHHCCSSGGGSCCHHHH---HHCHHHHH
T ss_pred --CCCcCCHHHHHHHHHHhccChhhCCCHHHH---hhCccccC
Confidence 234578999999999999999999998777 55555443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=348.48 Aligned_cols=263 Identities=20% Similarity=0.221 Sum_probs=206.2
Q ss_pred CCceEEEeeEeecCceEEEEEE----EcCCCcEEEEEEcccCCc---hhHHHHHHHHHHhcCCCCCCeeEEee-EeCCeE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLNVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFG-VEGDYN 77 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~----~~~~~~~vAiK~~~~~~~---~~l~~E~~il~~L~~~~~i~~~~~~~-~~~~~~ 77 (473)
.++|++.+.||+|+||.||+|+ +..+++.||||++..... ..+.+|+.+++.++|++++..+..+. ......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4689999999999999999999 467899999999655443 34789999999997665555544433 356678
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcccccceecc
Confidence 9999999 8899999987666799999999999999999999999999999999999995 67899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-----------CH-HHHH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----------TK-KQKY 224 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~-----------~~-~~~~ 224 (473)
...... .......||..|+|||++.+..++.++|||||||++|+|++|..||...... .. ....
T Consensus 179 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 179 LDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp TTCSEE----ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred cCCccc----eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 433211 1223457889999999999989999999999999999999999999642210 00 0111
Q ss_pred HHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 225 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 225 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
..+..... ......+++++.++|..||..||++||++.+|++.|+.++...
T Consensus 255 ~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 255 ELLEEGQR----LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHhhcccC----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11111110 1123467899999999999999999999999999999886543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=370.72 Aligned_cols=254 Identities=19% Similarity=0.332 Sum_probs=209.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.++|++.++||+|+||.||+|.+..++..||||++... ....+.+|+.+++.|+|+++ ..+..++......+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-VQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTB-CCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCE-eeEEEEEecCCcEEEEEEc
Confidence 35799999999999999999999988999999996543 34668899999999986554 4555556667788999999
Q ss_pred C-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+ +++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGGCEEECCTTCEECCTTCCE-
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC---CCCcEEEeecccceeccCCce-
Confidence 9 789999998643 4699999999999999999999999999999999999994 678999999999987654321
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
.......++..|+|||++.+..++.++|||||||+||||++ |..||.+.......+ .+.... .. ...
T Consensus 374 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~---~~~~~~-~~---~~~ 441 (495)
T 1opk_A 374 -----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE---LLEKDY-RM---ERP 441 (495)
T ss_dssp -----ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---HHHTTC-CC---CCC
T ss_pred -----eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCC-CC---CCC
Confidence 12234467889999999999899999999999999999999 999998865433222 222211 11 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
..+|+++.+||..||..||++||++.+|++.|+.++
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 568999999999999999999999999999998775
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=356.34 Aligned_cols=251 Identities=21% Similarity=0.228 Sum_probs=199.6
Q ss_pred CCceEE--EeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 6 GNKFRL--GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 6 ~~~y~i--~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.+.|.+ .+.||+|+||.||+|.+..+|+.||||++.... ...+.+|+.+++.|+|+ +|..+..++......++|
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA-NLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCT-TBCCEEEEEECSSEEEEE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCC-CCCeEEEEEEECCEEEEE
Confidence 345665 678999999999999999999999999965543 34588999999999855 455555666777889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+.. +..+.+||+|||+++.+....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCcc
Confidence 9999 78999988765567999999999999999999999999999999999999953 246789999999998765432
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. .....||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ....+..+........ ...
T Consensus 244 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~-~~~ 311 (373)
T 2x4f_A 244 K--------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETLNNILACRWDLE-DEE 311 (373)
T ss_dssp B--------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCSC-SGG
T ss_pred c--------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCC-hhh
Confidence 2 134579999999999999999999999999999999999999998753 3344444444332221 123
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
...+++++.+||..||..||.+||++.++++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 4578999999999999999999999888744
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=368.07 Aligned_cols=253 Identities=20% Similarity=0.351 Sum_probs=205.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.++|++.++||+|+||.||+|.+. .+..||||++... ....+.+|+.+++.|+|++++..+.. .. ....++||||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~-~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV-VT-KEPIYIITEF 263 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEE-EC-SSSCEEEECC
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEE-Ee-CCccEEEEee
Confidence 467999999999999999999974 5778999986543 34568899999999987666655544 33 5667999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DFG~a~~~~~~~~- 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNEY- 339 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTCCEEECSTTGGGGBCCHHH-
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC---CCCcEEEeeCCCceEcCCCce-
Confidence 9 78999999733 23689999999999999999999999999999999999994 778999999999987643211
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
.......+|..|+|||++.+..++.++|||||||+||||++ |+.||.+... .+.+..+....... ..
T Consensus 340 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~----~~ 407 (454)
T 1qcf_A 340 -----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALERGYRMP----RP 407 (454)
T ss_dssp -----HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCCCC----CC
T ss_pred -----eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC----CC
Confidence 11234457889999999998899999999999999999999 9999987543 33333333221111 13
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
..+|+++.+||..||..||++||++.+|.+.|++++.
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 5689999999999999999999999999999988764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=343.68 Aligned_cols=258 Identities=22% Similarity=0.308 Sum_probs=198.4
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|+ +|..+..++......
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp-~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP-HVVPIHDFGEIDGQL 109 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCT-TBCCEEEEEEETTEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCC-CeeEEEEEEeeCCeE
Confidence 34678999999999999999999999999999999964432 24578899999999854 555566666778899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+++|||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 110 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~---~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSCCC-----
T ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc---CCCCEEEecCccCcccc
Confidence 9999999 67999999853 4699999999999999999999999999999999999994 67899999999998665
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
.... .......||..|+|||++.+..++.++|||||||++|||++|..||.+... ..+........ ...
T Consensus 186 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~-~~~ 254 (309)
T 2h34_A 186 DEKL------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL----SVMGAHINQAI-PRP 254 (309)
T ss_dssp -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----HHHHHHHHSCC-CCG
T ss_pred cccc------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----HHHHHHhccCC-CCc
Confidence 4321 112345799999999999999999999999999999999999999986432 12222222211 122
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFI 277 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~l~~ 277 (473)
..+...+|+++.++|..||..||++|| +++++.+.|+.++.
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 234567899999999999999999999 99999999887754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=340.05 Aligned_cols=252 Identities=20% Similarity=0.289 Sum_probs=199.3
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
..++|++.+.||+|+||.||+|.+ +++.||||++... ....+.+|+.+++.++|++++..+..+.......++||||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 347899999999999999999986 5889999996544 3456889999999999777666666555555678999999
Q ss_pred C-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe---CCCcEEEeeccccccccccc--
Confidence 9 5699999975432 389999999999999999999999999999999999994 77899999999997654322
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
....++..|+|||++.+..++.++|||||||++|||++ |..||....... ....+..... ....
T Consensus 172 --------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~~~----~~~~ 236 (278)
T 1byg_A 172 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYK----MDAP 236 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTTCC----CCCC
T ss_pred --------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCCC----CCCc
Confidence 23367889999999999899999999999999999998 999998754322 2222322211 1123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
..+|+++.++|..||..||++||++.+|.+.|+++...
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 57899999999999999999999999999999998654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=374.63 Aligned_cols=267 Identities=19% Similarity=0.278 Sum_probs=208.5
Q ss_pred CceEEEe-eEeecCceEEEEEEEc--CCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 7 NKFRLGR-KIGSGSFGEIYLGTNI--QTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 7 ~~y~i~~-~LG~G~fG~Vy~a~~~--~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
++|.+.+ +||+|+||.||+|.+. .++..||||++... ....+.+|+++++.|+|++++..+.. +.. +..++
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~-~~~-~~~~l 412 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV-CQA-EALML 412 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEE-EES-SSEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEE-ecc-CCeEE
Confidence 4566666 8999999999999876 35667999996543 34568899999999986666555544 443 55899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ +++|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+++.+...
T Consensus 413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCSTTTTCC--
T ss_pred EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccCcccccCC
Confidence 99999 7899999976666799999999999999999999999999999999999995 6789999999999876443
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
... +.......+|..|+|||++.+..++.++|||||||+||||++ |..||.+.... +.+..+......
T Consensus 490 ~~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~~~~~~---- 558 (613)
T 2ozo_A 490 DSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKRM---- 558 (613)
T ss_dssp ----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHHTTCCC----
T ss_pred Cce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCC----
Confidence 211 111123356789999999999999999999999999999998 99999886543 333333332211
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccc
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDW 289 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw 289 (473)
.....+|+++.+||..||..||++||++.+|.+.|++++...+.+.+...++
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s~l 610 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSAL 610 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSSSC
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCccce
Confidence 1235689999999999999999999999999999999998877665544333
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=345.04 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=209.3
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
+...++|.+.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+.|. +|..+..++.....
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~ 115 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFHGFFEDNDF 115 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCT-TBCCEEEEEECSSE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCC-CCCeEEEEEecCCe
Confidence 45678999999999999999999999999999999985433 134578899999999755 45556666677888
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
.+++|||+ +++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 116 ~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLATKV 191 (335)
T ss_dssp EEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc---CCCCEEEeeccCceec
Confidence 99999999 6899999875 35799999999999999999999999999999999999994 7789999999999876
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
...... .....||..|+|||++.+..++.++|||||||+||||++|..||.... ..+.+..+......
T Consensus 192 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~-- 259 (335)
T 2owb_A 192 EYDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEYS-- 259 (335)
T ss_dssp CSTTCC-------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCC--
T ss_pred ccCccc-------ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHhcCCCC--
Confidence 533221 234679999999999999999999999999999999999999997643 23333333332221
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCC
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 281 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 281 (473)
+...+++++.++|..||..||++||++.+| |++.|...++
T Consensus 260 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~el---l~~~~~~~~~ 299 (335)
T 2owb_A 260 ---IPKHINPVAASLIQKMLQTDPTARPTINEL---LNDEFFTSGY 299 (335)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGG---GGSHHHHTSC
T ss_pred ---CCccCCHHHHHHHHHHccCChhHCcCHHHH---hcCccccCCC
Confidence 234678999999999999999999998777 5566655543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=348.22 Aligned_cols=267 Identities=19% Similarity=0.213 Sum_probs=204.3
Q ss_pred ccCCce-EEEeeEeecCceEEEEEEE----cCCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEe-
Q 011988 4 RVGNKF-RLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVE- 73 (473)
Q Consensus 4 ~i~~~y-~i~~~LG~G~fG~Vy~a~~----~~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~- 73 (473)
.+.++| +++++||+|+||.||++.. ..+++.||||++..... ..+.+|+.+++.++|++++..+..+...
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 456666 9999999999999988764 35788999999665442 3478999999999966655555544443
Q ss_pred CCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 74 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 74 ~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
....++||||+ +++|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLA 181 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCGGGC
T ss_pred CceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc---CCCCEEECCcccc
Confidence 46789999999 7799999973 3599999999999999999999999999999999999994 7789999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--------CHHHHH
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--------TKKQKY 224 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--------~~~~~~ 224 (473)
+.+....... .......||..|+|||++.+..++.++|||||||++|||++|..||...... ......
T Consensus 182 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 257 (318)
T 3lxp_A 182 KAVPEGHEYY----RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257 (318)
T ss_dssp EECCTTCSEE----EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHH
T ss_pred cccccccccc----ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhH
Confidence 8775433211 1223457889999999999989999999999999999999999999652110 000000
Q ss_pred HHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 225 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 225 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
..+...............+++++.+||..||..||++||++.+|++.|+.+..+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 0000000000001123468899999999999999999999999999999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=348.55 Aligned_cols=257 Identities=20% Similarity=0.272 Sum_probs=209.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEE--EEEEccc----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEV--AIKLNVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~v--AiK~~~~----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++.+.||+|+||.||+|++..++..+ |||.+.. .....+.+|+.+++.+.+|++|..+..++......++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 378999999999999999999998888865 8887543 2345688999999999667777777777888899999
Q ss_pred EEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCc
Q 011988 80 VIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 143 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 143 (473)
||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc---CCCe
Confidence 99999 789999997432 3699999999999999999999999999999999999994 6789
Q ss_pred EEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHH
Q 011988 144 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 222 (473)
Q Consensus 144 vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~ 222 (473)
+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.. ...
T Consensus 181 ~kL~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~ 249 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAE 249 (327)
T ss_dssp EEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHH
T ss_pred EEEcccCcCccccccc--------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc---HHH
Confidence 9999999997433211 1133467889999999999889999999999999999998 999998753 233
Q ss_pred HHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 223 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 223 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
.+..+...... .....+++++.++|..||..||++||++.++++.|+.++.+..
T Consensus 250 ~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 250 LYEKLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HHHHGGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHhhcCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 33433332111 1234678999999999999999999999999999999987654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=350.78 Aligned_cols=261 Identities=16% Similarity=0.223 Sum_probs=175.5
Q ss_pred ccCCceEEEe-eEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEe----CCeEE
Q 011988 4 RVGNKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVE----GDYNV 78 (473)
Q Consensus 4 ~i~~~y~i~~-~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~----~~~~~ 78 (473)
.+.++|.+.+ .||+|+||.||+|.+..+++.||||++... .....|+..+..+..+++|..+..+... ....+
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4678999965 599999999999999999999999996543 3344455544444344555444444332 45579
Q ss_pred EEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 79 LVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+||||+ +++|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||+|||++.++..+.+||+|||+++...
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 999999 679999998543 369999999999999999999999999999999999999755556779999999998654
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH-HHHhhcccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVSTS 235 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~~ 235 (473)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|..||............ ..+.......
T Consensus 183 ~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 252 (336)
T 3fhr_A 183 QNAL---------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF- 252 (336)
T ss_dssp ------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC-
T ss_pred cccc---------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc-
Confidence 3221 3457899999999999888999999999999999999999999765432211111 1111111110
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.......+++++.+||..||..||.+||++.++ |++.|.+.
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~~~~ 293 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF---MNHPWINQ 293 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH---HHSHHHHT
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCccccc
Confidence 111224679999999999999999999998877 55555543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=366.81 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=210.2
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
.+.++|++.++||+|+||.||+|.+..+++.||||++.+. ....+.+|+.+++.|+|+ +|..+..++......
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP-NIMKLYEFFEDKGYF 101 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCT-TBCCEEEEEECSSEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCC-CCCcEEEEEEeCCEE
Confidence 3567899999999999999999999999999999985432 345688999999999854 555556666778889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+...+..+.+||+|||+++.+.
T Consensus 102 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999 8899998873 4579999999999999999999999999999999999999654567899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+.........
T Consensus 181 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~ 248 (484)
T 3nyv_A 181 ASKK--------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEKGKYTFEL 248 (484)
T ss_dssp CCCS--------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCS
T ss_pred cccc--------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCCC
Confidence 4322 123479999999999987 69999999999999999999999998743 34445555444433222
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
+ ....+++++.+||..||..||.+||++.++ |++.|.+
T Consensus 249 ~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~---l~h~~~~ 286 (484)
T 3nyv_A 249 P-QWKKVSESAKDLIRKMLTYVPSMRISARDA---LDHEWIQ 286 (484)
T ss_dssp G-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHH---HTSHHHH
T ss_pred c-ccccCCHHHHHHHHHHCCCChhHCcCHHHH---hhChhhc
Confidence 2 235688999999999999999999998777 4555544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=337.88 Aligned_cols=256 Identities=21% Similarity=0.367 Sum_probs=207.1
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
..++|++.+.||+|+||.||+|.+. ++..||||++... ....+.+|+.+++.++|++++..+.. .. .+..+++||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~-~~~~~~v~e 87 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV-VT-QEPIYIITE 87 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEE-EC-SSSCEEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEE-Ec-CCCcEEEEe
Confidence 3578999999999999999999964 6778999985443 34568899999999986666555543 33 445789999
Q ss_pred cC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 83 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
|+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc---CCCCEEECCCcccccccCccc
Confidence 99 889999986322 2699999999999999999999999999999999999994 778999999999987654321
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+... .+.+..+...... ..
T Consensus 165 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~ 231 (279)
T 1qpc_A 165 ------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRM----VR 231 (279)
T ss_dssp ------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CC
T ss_pred ------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHhcccCC----CC
Confidence 11234567889999999998889999999999999999999 9999987543 3333333222111 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
...+++++.+++..||..||++||++.+|.+.|++++...
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 3568899999999999999999999999999999998654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=340.88 Aligned_cols=257 Identities=19% Similarity=0.292 Sum_probs=201.9
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc-CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK-TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~-~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
...++|++.+.||+|+||.||+|.+..+|+.||||++.. .....+.+|+.+++.+.|++ |..+..+.......++|||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPH-VVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTT-BCCEEEEEEETTEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCC-CccEEEEEEeCCEEEEEee
Confidence 456789999999999999999999999999999998543 34567899999999997554 5555556667888899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC---CCCCEEEeecccchhhhhhcc-
Confidence 99 6699999986677899999999999999999999999999999999999994 678999999999987654322
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
......||..|+|||++.+..++.++|||||||++|+|++|..||..... ......+....... .....
T Consensus 181 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~--~~~~~ 249 (314)
T 3com_A 181 ------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAIFMIPTNPPPT--FRKPE 249 (314)
T ss_dssp ------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC--CSSGG
T ss_pred ------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCcc--cCCcc
Confidence 12345799999999999999999999999999999999999999976432 22222222211111 01134
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.++.++.++|..||..||.+||++.+| |++.|.+.
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~l---l~~~~~~~ 284 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQL---LQHPFVRS 284 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHH---TTSHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHH---HhCHHHhc
Confidence 578999999999999999999998877 55555544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=341.93 Aligned_cols=251 Identities=20% Similarity=0.335 Sum_probs=195.3
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc--CCchhHHHHHHHHHHhcCCCCCCeeEEeeEe------CC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK--TKHPQLQYEAKLYKILQGGTGIPNLRWFGVE------GD 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~--~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~------~~ 75 (473)
...++|++.+.||+|+||.||+|.+..+++.||||++.. .....+.+|+.+++.+.+|++|..+..+... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 356889999999999999999999999999999998543 3456789999999999656666666555544 56
Q ss_pred eEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
..++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~---~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc---CCCCEEEeeCcCce
Confidence 789999999 569999998543 4699999999999999999999999999999999999994 77899999999998
Q ss_pred cccCCCCccccccccCCCcccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 228 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 228 (473)
.+..... ......||..|+|||++. +..++.++|||||||++|+|++|..||.+... ...+..+.
T Consensus 178 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~ 247 (326)
T 2x7f_A 178 QLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIP 247 (326)
T ss_dssp --------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH
T ss_pred ecCcCcc-------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhh
Confidence 6643221 123457999999999997 55689999999999999999999999976432 22222222
Q ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 229 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 229 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
...... .....++.++.++|..||..||.+||++.+|++
T Consensus 248 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 222111 113467899999999999999999999887743
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=369.39 Aligned_cols=269 Identities=20% Similarity=0.216 Sum_probs=213.2
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
+...++|++.+.||+|+||.||+|++..+|+.||||++.+ .....+..|+.+++.++|+ +|..+..++.....
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVSLAYAYETKDA 258 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCT-TBCCEEEEEECSSE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCC-CEeeEEEEEeeCCE
Confidence 3456789999999999999999999999999999998533 2334578899999999855 55555666677889
Q ss_pred EEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
.++||||+ |++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEeccccee
Confidence 99999999 889999987443 349999999999999999999999999999999999999 4788999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHH-HHHHHhhcccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-KYEKISEKKVS 233 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~-~~~~i~~~~~~ 233 (473)
+..... ....+||+.|+|||++.+..++.++|||||||+||||++|..||.+........ ....+.....
T Consensus 336 ~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~- 406 (576)
T 2acx_A 336 VPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE- 406 (576)
T ss_dssp CCTTCC--------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-
T ss_pred cccCcc--------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc-
Confidence 654322 124589999999999999899999999999999999999999998765433222 2233322221
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
.+...+++++.+||..||..||.+||++. .+.+++++.| -..++|..+...
T Consensus 407 ----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf-------F~~i~w~~l~~~ 459 (576)
T 2acx_A 407 ----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL-------FKKLNFKRLGAG 459 (576)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG-------GTTCCHHHHHTT
T ss_pred ----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh-------hccCCHHHHhcC
Confidence 12356889999999999999999999431 2333355443 334688876543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=340.77 Aligned_cols=252 Identities=19% Similarity=0.251 Sum_probs=200.3
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEc-CCCcEEEEEEccc-----CCchhHHHHHHHHHHhc--CCCCCCeeEEeeE---
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLNVK-----TKHPQLQYEAKLYKILQ--GGTGIPNLRWFGV--- 72 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAiK~~~~-----~~~~~l~~E~~il~~L~--~~~~i~~~~~~~~--- 72 (473)
+..++|++.+.||+|+||.||+|.+. .+++.||||++.. .....+.+|+.+++.+. .|++|..+..++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45688999999999999999999995 6789999998432 22345788999998884 3455555544433
Q ss_pred --eCCeEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEec
Q 011988 73 --EGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 149 (473)
Q Consensus 73 --~~~~~~lv~e~~g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 149 (473)
.....++||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~---~~~~~kl~Df 164 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADF 164 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECSC
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc---CCCCEEEecC
Confidence 456789999999999999998654 3499999999999999999999999999999999999994 7789999999
Q ss_pred CCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011988 150 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 229 (473)
Q Consensus 150 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 229 (473)
|+++...... ......||..|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+..
T Consensus 165 g~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~ 233 (326)
T 1blx_A 165 GLARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILD 233 (326)
T ss_dssp CSCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH
T ss_pred cccccccCCC--------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHH
Confidence 9998654321 12346789999999999999999999999999999999999999987543 222333221
Q ss_pred cc----------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 230 KK----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 230 ~~----------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.. .......+...++.++.+||..||..||++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 10 01122334467899999999999999999999987774
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=349.20 Aligned_cols=263 Identities=23% Similarity=0.338 Sum_probs=202.5
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc--------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK--------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~--------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
+.++|++.+.||+|+||.||+|.+..+++.||||++.+ .....+.+|+.+++.++| ++|..+..++.....
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~ 102 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH-PNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCC-CCcceeehhhccCCe
Confidence 45789999999999999999999999999999998532 223568899999999985 555556666678889
Q ss_pred EEEEEecC-CCCHHHHHHHc---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 011988 77 NVLVIDLL-GPSLEDLFNFC---------------------------------------SRKLSLKTVLMLADQMINRVE 116 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~---------------------------------------~~~ls~~~~~~i~~qi~~aL~ 116 (473)
.++||||+ +++|.+++... ...+++..++.|+.||+.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999 89999988411 112467889999999999999
Q ss_pred HHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccC--CCCCchhh
Q 011988 117 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDD 194 (473)
Q Consensus 117 yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksD 194 (473)
|||++||+||||||+|||++. +....+||+|||+++.+....... ........||+.|+|||++.+ ..++.++|
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccc---cccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999999999999999952 123389999999998765432211 112245679999999999976 57899999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 195 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 195 VwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
||||||+||||++|+.||.+... .+.+..+......... .....+++++.+||..||..||.+||++.++ |++
T Consensus 259 iwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~---l~h 331 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVND---ADTISQVLNKKLCFEN-PNYNVLSPLARDLLSNLLNRNVDERFDAMRA---LQH 331 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCTTS-GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH---HHS
T ss_pred HHHHHHHHHHHHHCCCCCCCCCh---HHHHHHHHhcccccCC-cccccCCHHHHHHHHHHcCCChhHCCCHHHH---hcC
Confidence 99999999999999999987543 3344444433322211 1234578999999999999999999998776 556
Q ss_pred HHHHh
Q 011988 275 LFIRE 279 (473)
Q Consensus 275 l~~~~ 279 (473)
.|.+.
T Consensus 332 p~~~~ 336 (345)
T 3hko_A 332 PWISQ 336 (345)
T ss_dssp HHHHT
T ss_pred hhhcc
Confidence 66543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=348.24 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=199.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----------chhHHHHHHHHHHhcCCCCCCeeEEeeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------HPQLQYEAKLYKILQGGTGIPNLRWFGV 72 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----------~~~l~~E~~il~~L~~~~~i~~~~~~~~ 72 (473)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|++++..+. +..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~-~~~ 85 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN-FFD 85 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEE-EEE
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEee-EEc
Confidence 35678999999999999999999999999999999854322 234789999999998666555544 444
Q ss_pred eCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCC
Q 011988 73 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 151 (473)
Q Consensus 73 ~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 151 (473)
... .++||||+ +++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred CCc-eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 444 79999999 679999886 345799999999999999999999999999999999999996444455699999999
Q ss_pred cccccCCCCccccccccCCCcccCcccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011988 152 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 228 (473)
Q Consensus 152 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 228 (473)
++....... .....||..|+|||++. +..++.++|||||||++|+|++|..||......... ...+.
T Consensus 164 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~ 233 (322)
T 2ycf_A 164 SKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQIT 233 (322)
T ss_dssp CEECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHH
T ss_pred ceecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHH
Confidence 987643211 12346899999999974 456899999999999999999999999875443221 12222
Q ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 229 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 229 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.... .........+++++.++|..||..||++||++.+++
T Consensus 234 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 234 SGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp HTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hCcc-ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 2222 223445577899999999999999999999988874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=348.61 Aligned_cols=254 Identities=20% Similarity=0.274 Sum_probs=192.2
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC-----
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG----- 74 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~----- 74 (473)
+.++|++++.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|++++..+..+....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4578999999999999999999999999999999865432 234778999999998766666655554332
Q ss_pred CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 75 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
...++||||+.++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCCCC---
T ss_pred cceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEEEeecccc
Confidence 3789999999999999886 3599999999999999999999999999999999999994 778999999999986
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
...... .....||..|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+.......
T Consensus 177 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 177 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTP 245 (371)
T ss_dssp ---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCCC
T ss_pred cccccc--------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCC
Confidence 543221 1345899999999999999999999999999999999999999987532 23333332211100
Q ss_pred c-------------------------HHHHh------------cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 235 S-------------------------IEALC------------RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 235 ~-------------------------~~~l~------------~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
. ...+. ...+.++.+||..||..||++|||++++ |++.|.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~---l~hp~~ 322 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA---LQHPYI 322 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH---HHSHHH
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH---hCCcch
Confidence 0 00000 1125789999999999999999998776 666665
Q ss_pred H
Q 011988 278 R 278 (473)
Q Consensus 278 ~ 278 (473)
+
T Consensus 323 ~ 323 (371)
T 2xrw_A 323 N 323 (371)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=364.34 Aligned_cols=268 Identities=19% Similarity=0.230 Sum_probs=214.4
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
...++|.+.+.||+|+||.||+|++..+|+.||||++.+ .....+..|+.+++.++| ++|..+..+.......
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS-RFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCC-CCEeeEEEEEeeCCEE
Confidence 445789999999999999999999999999999998543 233457889999999975 5555566666778889
Q ss_pred EEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 78 VLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
++||||+ |++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAV 337 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceee
Confidence 9999999 78999998744 2369999999999999999999999999999999999999 478899999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-CHHHHHHHHhhccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKV 232 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~ 232 (473)
.+...... ....+||+.|+|||++.+..++.++|||||||+||||++|..||.+.... ........+.....
T Consensus 338 ~~~~~~~~-------~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~ 410 (543)
T 3c4z_A 338 ELKAGQTK-------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410 (543)
T ss_dssp ECCTTCCC-------BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred eccCCCcc-------cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence 76543221 23468999999999999999999999999999999999999999875432 23333444433322
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHhCCCCCCccccccccc
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY--LKRLFRDLFIREGFQFDYVFDWTILKY 294 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~--l~~~L~~l~~~~~~~~~~~~dw~~~~~ 294 (473)
. +...+++++.+||..||..||.+||++.+ +.+++++.| -..++|..+..
T Consensus 411 ~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpf-------f~~i~w~~l~~ 462 (543)
T 3c4z_A 411 T-----YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL-------FRDISWRQLEA 462 (543)
T ss_dssp C-----CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGG-------GTTCCHHHHHT
T ss_pred C-----CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcc-------ccCCCHHHHHc
Confidence 2 23568899999999999999999998632 233344433 33567887654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=344.83 Aligned_cols=254 Identities=22% Similarity=0.262 Sum_probs=194.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc-----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~-----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
..++|++++.||+|+||.||+|++..+++.||||++..... ..+.+|+.+++.++| ++|..+..++......++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH-ENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCC-CCEeeEEEEeecCCEEEE
Confidence 45789999999999999999999999999999998544332 236789999999985 455556666778889999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 80 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 80 v~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||||+.+.+.+.+......+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.+....
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCTTC-------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc---CCCcEEEEeCCCceeecCCc
Confidence 999995544444433556799999999999999999999999999999999999994 77899999999998665432
Q ss_pred CccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc--------
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-------- 230 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~-------- 230 (473)
. ......||..|+|||++.+. .++.++|||||||++|+|++|..||.+.........+......
T Consensus 179 ~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 179 E-------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c-------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 2 11345789999999999876 6899999999999999999999999875432222111111100
Q ss_pred ---------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 ---------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 ---------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
............+++++.+||..||..||++||++.+|+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 305 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHh
Confidence 011223334457899999999999999999999988774
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=338.07 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=209.0
Q ss_pred CCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
++...++|.+.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+.|+ +|..+..++...+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~ 88 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFHGFFEDND 88 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCT-TBCCEEEEEECSS
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCC-CEeeeeeeeccCC
Confidence 356788999999999999999999999999999999985432 134577899999999755 5555666667788
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..+++|||+ +++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEE
T ss_pred EEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc---CCCCEEEEeccCcee
Confidence 899999999 6899998874 34799999999999999999999999999999999999994 778999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
....... .....||..|+|||++.+..++.++|||||||++|+|++|..||.... ..+.+..+......
T Consensus 165 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~- 233 (294)
T 2rku_A 165 VEYDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEYS- 233 (294)
T ss_dssp CCSTTCC-------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCC-
T ss_pred cccCccc-------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhhccCC-
Confidence 6533221 234579999999999999889999999999999999999999997743 23333333332221
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhC
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 280 (473)
+...+++++.++|..||..||++||+++++ |++.+...+
T Consensus 234 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l---l~~~~~~~~ 272 (294)
T 2rku_A 234 ----IPKHINPVAASLIQKMLQTDPTARPTINEL---LNDEFFTSG 272 (294)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGG---GGSHHHHTS
T ss_pred ----CccccCHHHHHHHHHHcccChhhCcCHHHH---hhChheecC
Confidence 234678999999999999999999998777 555555543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=335.12 Aligned_cols=250 Identities=18% Similarity=0.193 Sum_probs=205.5
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------------chhHHHHHHHHHHhcCCCCCCeeEEee
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------------HPQLQYEAKLYKILQGGTGIPNLRWFG 71 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------------~~~l~~E~~il~~L~~~~~i~~~~~~~ 71 (473)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.+.+|++|..+..++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 35689999999999999999999999999999999965432 234678999999998677777777778
Q ss_pred EeCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecC
Q 011988 72 VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 150 (473)
Q Consensus 72 ~~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 150 (473)
......++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFG 169 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc---CCCcEEEeccc
Confidence 8889999999999 6899999975 35799999999999999999999999999999999999994 77899999999
Q ss_pred CcccccCCCCccccccccCCCcccCcccccccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 011988 151 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 224 (473)
Q Consensus 151 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~------~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~ 224 (473)
++........ .....||..|+|||++. ...++.++|||||||++|+|++|..||.... .....
T Consensus 170 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~ 238 (298)
T 1phk_A 170 FSCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML 238 (298)
T ss_dssp TCEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH
T ss_pred chhhcCCCcc--------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHH
Confidence 9987654321 13457899999999986 4568899999999999999999999997643 23333
Q ss_pred HHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 225 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 225 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..+......... .....++.++.++|..||..||++||++.+++
T Consensus 239 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 282 (298)
T 1phk_A 239 RMIMSGNYQFGS-PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 282 (298)
T ss_dssp HHHHHTCCCCCT-TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHhcCCcccCc-ccccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 333333322211 12346789999999999999999999988774
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=364.15 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=202.2
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
+.++|+++++||+|+||.||+|++..+++.||||++.+. ....+.+|+.+++.++|++ |..+..++......++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN-IMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTT-BCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCC-CCeEEEEEEeCCEEEE
Confidence 345799999999999999999999999999999985432 3456889999999998555 5555566677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ +++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++..+..+.+||+|||+++.+...
T Consensus 114 v~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999 78999988743 56999999999999999999999999999999999999975445677999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+......... .
T Consensus 193 ~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~-~ 259 (494)
T 3lij_A 193 KK--------MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEILRKVEKGKYTFDS-P 259 (494)
T ss_dssp BC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCS-G
T ss_pred cc--------ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCc-h
Confidence 22 234679999999999864 69999999999999999999999998743 34444444443332221 2
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
....+++++.+||..||..||.+||++.+++
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l 290 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQAL 290 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHHh
Confidence 2457899999999999999999999988875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=348.03 Aligned_cols=259 Identities=17% Similarity=0.188 Sum_probs=196.2
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--------------chhHHHHHHHHHHhcCCCCCCeeEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--------------HPQLQYEAKLYKILQGGTGIPNLRW 69 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--------------~~~l~~E~~il~~L~~~~~i~~~~~ 69 (473)
.+.++|++.+.||+|+||.||+|.+. +++.||||++.... ...+.+|+.+++.++|++++..+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 35789999999999999999999975 48999999843321 1568899999999997777666665
Q ss_pred eeEe----CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEE
Q 011988 70 FGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 145 (473)
Q Consensus 70 ~~~~----~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vk 145 (473)
+... ....++||||++++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ ..+.+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~~~~~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA---DNNDIT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEE
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc---CCCCEE
Confidence 5432 336899999999999999986666799999999999999999999999999999999999994 778999
Q ss_pred EEecCCcccccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 011988 146 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 224 (473)
Q Consensus 146 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~ 224 (473)
|+|||+++....... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+
T Consensus 175 l~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 246 (362)
T 3pg1_A 175 ICDFNLAREDTADAN--------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246 (362)
T ss_dssp ECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred EEecCcccccccccc--------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999975443322 234578999999999987 66899999999999999999999999875432222222
Q ss_pred HHHhhc------------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 225 EKISEK------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 225 ~~i~~~------------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
...... ........+...+++.+.+||..||..||.+||++.++ |++.|.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~f 320 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA---LRHPYF 320 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH---HTSGGG
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH---HcCchh
Confidence 111110 01112233445678999999999999999999998776 445443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=349.52 Aligned_cols=249 Identities=21% Similarity=0.294 Sum_probs=195.3
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCC----
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD---- 75 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~---- 75 (473)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ...+.+|+.+++.++|++++..+..+.....
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 5689999999999999999999999999999999865432 2457789999999997766666655543332
Q ss_pred -eEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 -YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 -~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..++||||++++|.+++. ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 120 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECSTTCC--
T ss_pred eeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC---CCCCEEEEecCcccc
Confidence 239999999999888774 4599999999999999999999999999999999999994 778999999999986
Q ss_pred ccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh----
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---- 229 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~---- 229 (473)
..... ....||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.........+.....
T Consensus 194 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 194 ADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 263 (371)
T ss_dssp ----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred cccCc----------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence 54322 34578999999999987 6789999999999999999999999987543222222111110
Q ss_pred -------------------ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 230 -------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 230 -------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.........+...+++++.+||..||..||++||++.+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 322 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 322 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence 0111222334456789999999999999999999987763
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=339.87 Aligned_cols=258 Identities=19% Similarity=0.296 Sum_probs=197.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEcC---CCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC---
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG--- 74 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~--- 74 (473)
.++|.+.+.||+|+||.||+|.+.. +++.||||++.... ...+.+|+.+++.++|++++..+..+....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4689999999999999999998765 45689999965432 234788999999999766666665544332
Q ss_pred -CeEEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEE
Q 011988 75 -DYNVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 147 (473)
Q Consensus 75 -~~~~lv~e~~-g~sL~~~l~~~-----~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~ 147 (473)
...+++|||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC---TTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCcEEEe
Confidence 2458999999 77999998532 35699999999999999999999999999999999999994 67899999
Q ss_pred ecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHH
Q 011988 148 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK 226 (473)
Q Consensus 148 DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~ 226 (473)
|||+++.+..... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+...... ...
T Consensus 190 Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~ 261 (313)
T 3brb_A 190 DFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YDY 261 (313)
T ss_dssp SCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHH
T ss_pred ecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHH
Confidence 9999987654321 111234567889999999999999999999999999999999 9999987654332 222
Q ss_pred HhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 227 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 227 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
+...... .....+++++.++|..||..||++||++.+|++.|+.++.+
T Consensus 262 ~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 262 LLHGHRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHTTCCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 2222111 12356889999999999999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=339.13 Aligned_cols=249 Identities=19% Similarity=0.268 Sum_probs=194.6
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
.++|++.+.||+|+||.||+|.+ .++.||||++.... ...+.+|+.+++.++|++++..+. +.. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~-~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYG-ACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEE-BCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEE-EEc--CCcEEEEEcC
Confidence 46899999999999999999986 47899999965433 456889999999998666555543 322 4478999999
Q ss_pred -CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCCcccCCCCCcEEEeeCCCCC-cEEEEecCCcccccC
Q 011988 85 -GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRD 157 (473)
Q Consensus 85 -g~sL~~~l~~~~~--~ls~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~ 157 (473)
+++|.+++..... .++...++.++.||+.||.|||+ +||+||||||+|||++ .++ .+||+|||++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEccccccccccc
Confidence 7899999974332 47899999999999999999999 8999999999999996 444 489999999976543
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
.. ....||..|+|||++.+..++.++|||||||++|||++|+.||...... .......+..... .
T Consensus 159 ~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~----~ 223 (307)
T 2eva_A 159 HM----------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-AFRIMWAVHNGTR----P 223 (307)
T ss_dssp ----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-HHHHHHHHHTTCC----C
T ss_pred cc----------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-HHHHHHHHhcCCC----C
Confidence 21 2346999999999999999999999999999999999999999865432 2222222222211 1
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
.+...+|+++.++|..||..||++||++.+|++.|+.+..
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 2345789999999999999999999999999999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=336.06 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=202.7
Q ss_pred CCCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
|...+.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|+ +|..+..+......
T Consensus 1 M~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-NVVKFYGHRREGNI 79 (276)
T ss_dssp -CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCT-TBCCEEEEEEETTE
T ss_pred CCCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCC-CceeeeeEEEcCCE
Confidence 44456689999999999999999999999999999999854322 34578999999999854 55556666778888
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
.++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVF 155 (276)
T ss_dssp EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc---cCCCEEEeeCCCcccc
Confidence 99999999 6699998863 44699999999999999999999999999999999999994 6789999999999866
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
...... .......||..|+|||++.+..+ +.++|||||||++|||++|..||........ .+..+.......
T Consensus 156 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~ 228 (276)
T 2yex_A 156 RYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTYL 228 (276)
T ss_dssp EETTEE-----CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHHTTCTTS
T ss_pred CCCcch-----hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhhccccc
Confidence 433211 11235679999999999988775 7899999999999999999999987554322 222222221111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.....+++++.++|..||..||++||++.+|+
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (276)
T 2yex_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIK 260 (276)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred ---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHh
Confidence 11346789999999999999999999988774
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=360.98 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=207.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
...++|.+.+.||+|+||.||+|++..+|+.||||++.+. ....+.+|+.+++.++|++ |..+..+.......
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~~~ 91 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH-IIKLYQVISTPSDI 91 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTT-BCCEEEEEECSSEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCC-CCcEEEEEEECCEE
Confidence 4567899999999999999999999999999999985432 2346889999999998655 55555566777889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 92 ~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~---~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC---TTCCEEECCCSSCEECC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe---cCCCeEEEeccchhhcc
Confidence 9999999 8899999873 45799999999999999999999999999999999999994 77899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
.... ....+||+.|+|||++.+..+ +.++|||||||+||||++|..||.+... ...+.++......
T Consensus 168 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~-- 234 (476)
T 2y94_A 168 DGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKKICDGIFY-- 234 (476)
T ss_dssp TTCC--------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHHHHHTTCCC--
T ss_pred cccc--------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHHHHhcCCcC--
Confidence 4321 234689999999999998775 7899999999999999999999987443 3334444433322
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
....+++++.+||..||..||.+||++.+| +++.|.+.
T Consensus 235 ---~p~~~s~~~~~Li~~~L~~dP~~Rpt~~ei---l~hp~~~~ 272 (476)
T 2y94_A 235 ---TPQYLNPSVISLLKHMLQVDPMKRATIKDI---REHEWFKQ 272 (476)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHH---HTCHHHHT
T ss_pred ---CCccCCHHHHHHHHHHcCCCchhCcCHHHH---HhCHHhhh
Confidence 124578999999999999999999998877 45555443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=350.68 Aligned_cols=257 Identities=19% Similarity=0.250 Sum_probs=204.7
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----------CchhHHHHHHHHHHhcCCCCCCeeEEeeEe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE 73 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~ 73 (473)
+.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.++| ++|..+..++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH-ANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCC-TTBCCEEEEEEC
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEee
Confidence 457899999999999999999999999999999985543 23357789999999975 455555566677
Q ss_pred CCeEEEEEecC-CC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCC
Q 011988 74 GDYNVLVIDLL-GP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 151 (473)
Q Consensus 74 ~~~~~lv~e~~-g~-sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 151 (473)
....++||||+ ++ +|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~ 176 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGS 176 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTT
T ss_pred CCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc---CCCcEEEeeccc
Confidence 88899999988 33 99999873 45799999999999999999999999999999999999994 678999999999
Q ss_pred cccccCCCCccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011988 152 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 230 (473)
Q Consensus 152 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 230 (473)
++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|..||..... ....
T Consensus 177 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~ 239 (335)
T 3dls_A 177 AAYLERGKL--------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TVEA 239 (335)
T ss_dssp CEECCTTCC--------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------GTTT
T ss_pred ceECCCCCc--------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------HHhh
Confidence 987654322 134579999999999998876 8899999999999999999999976321 1111
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 011988 231 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 292 (473)
Q Consensus 231 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 292 (473)
... ....+++++.+||..||..||++||++.+| |++.|.+.... ...++|+..
T Consensus 240 ~~~-----~~~~~~~~l~~li~~~L~~dP~~Rps~~el---l~hp~~~~~~~-~~~~~~~~~ 292 (335)
T 3dls_A 240 AIH-----PPYLVSKELMSLVSGLLQPVPERRTTLEKL---VTDPWVTQPVN-LADYTWEEV 292 (335)
T ss_dssp CCC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHH---HHCTTTTCCCC-GGGCCHHHH
T ss_pred ccC-----CCcccCHHHHHHHHHHccCChhhCcCHHHH---hcCccccCCcc-ccccCHHHH
Confidence 111 123578999999999999999999997776 55555433211 123455544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=333.35 Aligned_cols=243 Identities=19% Similarity=0.294 Sum_probs=201.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
..++|++.+.||+|+||.||+|.+..+++.||||++.. .....+.+|+.+++.++|+ +|..+..+.......+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP-NILRMYNYFHDRKRIY 90 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCT-TBCCEEEEEECSSEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCC-CEeeEEEEEEcCCEEE
Confidence 45789999999999999999999999999999998532 2345688999999999855 4555556667788899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
++|||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECSS
T ss_pred EEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc---CCCCEEEecccccccCcc
Confidence 999999 67999999754 4699999999999999999999999999999999999994 778999999999976543
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
.. .....||..|+|||++.+..++.++|||||||++|+|++|..||.... .......+......
T Consensus 167 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~---- 230 (284)
T 2vgo_A 167 LR---------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS---HTETHRRIVNVDLK---- 230 (284)
T ss_dssp SC---------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCC----
T ss_pred cc---------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC---HhHHHHHHhccccC----
Confidence 21 134579999999999999999999999999999999999999997643 23333333332221
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
+...++.++.++|..||..||.+||++.+|+
T Consensus 231 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 261 (284)
T 2vgo_A 231 -FPPFLSDGSKDLISKLLRYHPPQRLPLKGVM 261 (284)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred -CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHh
Confidence 2346789999999999999999999988774
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.96 Aligned_cols=245 Identities=24% Similarity=0.322 Sum_probs=180.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.++|+ +|..+..+.......++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP-SILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCT-TBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCC-CeEeEEEEEccCCeEEE
Confidence 46799999999999999999999999999999985332 235688999999999855 45555566677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
+|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC---TTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEEeecceeeccCC
Confidence 99999 7799999986667799999999999999999999999999999999999994 7789999999999876433
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. ......||..|+|||++.+..++.++|||||||++|||++|..||....... .+..+..... .
T Consensus 166 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~-----~ 230 (278)
T 3cok_A 166 HE-------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLNKVVLADY-----E 230 (278)
T ss_dssp ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCC-----C
T ss_pred CC-------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHHHHhhccc-----C
Confidence 21 1134578999999999999899999999999999999999999998754322 1222221111 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
+...++.++.++|..||..||++||++++++
T Consensus 231 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 261 (278)
T 3cok_A 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVL 261 (278)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CccccCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 2345789999999999999999999988774
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=345.02 Aligned_cols=254 Identities=18% Similarity=0.213 Sum_probs=186.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCC------eE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD------YN 77 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~------~~ 77 (473)
.++|++.+.||+|+||.||+|++..+++.||||++... .......|++.+..++|++++..+..+..... +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 46899999999999999999999999999999985332 34456778888888887777766666544332 47
Q ss_pred EEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 78 VLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 78 ~lv~e~~g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH--~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
++||||+.++|.+.+.. ....+++..++.++.||+.||.||| ++||+||||||+||||+ ..++.+||+|||++
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTC
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCc
Confidence 89999998888776653 3456899999999999999999999 99999999999999996 33789999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 231 (473)
+.+..... .....||..|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+.......
T Consensus 180 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 180 KKLSPSEP--------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp BCCCTTSC--------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eecCCCCC--------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 87654332 23457899999999997755 8999999999999999999999998754322222222111111
Q ss_pred ccc--------------------cHHHHh----cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 VST--------------------SIEALC----RGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 ~~~--------------------~~~~l~----~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
... ....+. ..+++++.+||..||+.||.+||++.+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 313 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence 000 011111 12578999999999999999999987773
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=347.97 Aligned_cols=267 Identities=16% Similarity=0.211 Sum_probs=195.2
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHH--HhcCCCCCCeeEEeeE----eCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYK--ILQGGTGIPNLRWFGV----EGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~--~L~~~~~i~~~~~~~~----~~~~~ 77 (473)
.-.++|++.+.||+|+||.||+|++ +++.||||++.......+..|..++. .+.|.+++..+..+.. .....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 3457899999999999999999975 78999999977666666666666654 3666666655543322 23357
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCcccCCCCCcEEEeeCCCCCcEEEE
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---------SFLHRDIKPDNFLMGLGRRANQVYII 147 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~---------gIvHrDIKP~NILl~~~~~~~~vkL~ 147 (473)
++||||+ +++|.+++.. ..+++..++.|+.||+.||.|||++ ||+||||||+||||+ .++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~---~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK---NDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC---TTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc---CCCcEEEe
Confidence 8999999 8899999974 3468999999999999999999999 999999999999994 67899999
Q ss_pred ecCCcccccCCCCccc-cccccCCCcccCccccccccccC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 011988 148 DFGLAKRYRDTATHQH-IPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 219 (473)
Q Consensus 148 DFGla~~~~~~~~~~~-~p~~~~~~~~Gt~~Y~APE~~~~-------~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~ 219 (473)
|||+++.+........ ..........||..|+|||++.+ ..++.++|||||||+||||++|..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987654322110 01112235579999999999987 356789999999999999999977764322111
Q ss_pred H--------------HHHHHH-HhhccccccHHHHhc---CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 220 K--------------KQKYEK-ISEKKVSTSIEALCR---GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 220 ~--------------~~~~~~-i~~~~~~~~~~~l~~---~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
. ...+.. +........+...+. .+++++.+||..||..||++||++.+|++.|++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 0 000111 111111111111111 134589999999999999999999999999999984
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.58 Aligned_cols=253 Identities=22% Similarity=0.360 Sum_probs=200.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.++|++.++||+|+||.||+|.+.. +..||||++... ....+.+|+.+++.|+|++++..+..+ .. ...++||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~-~~~~iv~e~ 259 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SE-EPIYIVTEY 259 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CS-SSCEEEECC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEE-cC-CceEEEehh
Confidence 4679999999999999999999854 567999996543 345689999999999976666655443 33 567899999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~~~~~- 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEY- 335 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC---CCCCEEECCCccceecCCCce-
Confidence 9 78999999743 34699999999999999999999999999999999999994 678999999999987654321
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
.......++..|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+...... ...
T Consensus 336 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~~ 403 (452)
T 1fmk_A 336 -----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PCP 403 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CCC
T ss_pred -----ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 11233467889999999999899999999999999999999 9999987543 3333333322111 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
..+|+++.++|..||..||++||++++|.+.|++++.
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 4689999999999999999999999999999998763
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=335.28 Aligned_cols=250 Identities=18% Similarity=0.282 Sum_probs=185.5
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCch----hHHHHHHH-HHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP----QLQYEAKL-YKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~----~l~~E~~i-l~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
+..++|++.+.||+|+||.||+|.+..+++.||||++...... ....|... ++.+. |++|..+..+.......+
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD-CPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCC-CCeEEEEeeeeeccCCEE
Confidence 3457899999999999999999999999999999986544322 22333333 44444 566666666777788899
Q ss_pred EEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 79 LVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 79 lv~e~~g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
+||||++++|.+++.. ....+++..++.|+.||+.||.|||++ ||+||||||+|||++ ..+.+||+|||+++.
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC---TTCCEEBCCC-----
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeecCCccc
Confidence 9999999999888764 356799999999999999999999998 999999999999994 678999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 230 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~----~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 230 (473)
...... .....||+.|+|||++ .+..++.++|||||||++|||++|..||..... ....+......
T Consensus 160 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~ 229 (290)
T 3fme_A 160 LVDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQVVEE 229 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHHHHHS
T ss_pred cccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHHHhcc
Confidence 654322 1234799999999996 556789999999999999999999999976432 22333333222
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 231 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 231 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..... ....+++++.++|..||..||++||++.++++
T Consensus 230 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 PSPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 22111 12467899999999999999999999888854
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=346.23 Aligned_cols=266 Identities=23% Similarity=0.300 Sum_probs=207.0
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHH--hcCCCCCCeeEEeeEeCC----eEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKI--LQGGTGIPNLRWFGVEGD----YNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~--L~~~~~i~~~~~~~~~~~----~~~ 78 (473)
+.++|++.+.||+|+||.||+|.+ +++.||||++.......+..|.+++.. ++|++ |..+..+..... ..+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~n-i~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHEN-ILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTT-BCCEEEEEECCCSSCCCEE
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCc-EEEEEeeecccCCccceeE
Confidence 457899999999999999999996 589999999877666778899999988 55544 444444444443 789
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCcccCCCCCcEEEeeCCCCCcEEEEec
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------SKSFLHRDIKPDNFLMGLGRRANQVYIIDF 149 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH--------~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 149 (473)
+||||+ +++|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+||||+ .++.+||+||
T Consensus 117 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~---~~~~~kL~Df 191 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADL 191 (342)
T ss_dssp EEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC---TTSCEEECCC
T ss_pred EEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC---CCCCEEEEEC
Confidence 999999 6699999974 46999999999999999999999 89999999999999994 7789999999
Q ss_pred CCcccccCCCCccccccccCCCcccCccccccccccCCC------CCchhhHHHHHHHHHHHHcC----------CCCCC
Q 011988 150 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRG----------SLPWQ 213 (473)
Q Consensus 150 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~------~s~ksDVwSlGviL~elltG----------~~Pf~ 213 (473)
|+++.......... .......||..|+|||++.+.. ++.++|||||||+||||++| ..||.
T Consensus 192 g~~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 192 GLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp TTCEEEETTTTEEE---ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCceeccccccccc---cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 99987655432111 0124567999999999998763 34789999999999999999 88997
Q ss_pred CCCCCC--HHHHHHHHhhccccccHHHH--hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCC
Q 011988 214 GLKAGT--KKQKYEKISEKKVSTSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 281 (473)
Q Consensus 214 ~~~~~~--~~~~~~~i~~~~~~~~~~~l--~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 281 (473)
...... .......+........+... ...++..+.++|..||..||++||++.+|++.|+++..+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence 754322 22223333332222211111 123457899999999999999999999999999999877654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=358.11 Aligned_cols=249 Identities=14% Similarity=0.126 Sum_probs=185.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhc--CCCCCCeeE-------Eee
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQ--GGTGIPNLR-------WFG 71 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~--~~~~i~~~~-------~~~ 71 (473)
.+|++.++||+|+||.||+|++..+++.||||++.... ...+..|+.+++.|. |++++..+. .+.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 35999999999999999999999999999999965543 234677877777776 555443232 222
Q ss_pred EeC----------------CeEEEEEecCCCCHHHHHHHcCCCCCHHHH------HHHHHHHHHHHHHHHhCCCcccCCC
Q 011988 72 VEG----------------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTV------LMLADQMINRVEFVHSKSFLHRDIK 129 (473)
Q Consensus 72 ~~~----------------~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~------~~i~~qi~~aL~yLH~~gIvHrDIK 129 (473)
..+ ...++||||+.++|.+++...+..+....+ +.|+.||+.||+|||++||||||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 111 347999999999999999865555665566 7888999999999999999999999
Q ss_pred CCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccC--CCCCchhhHHHHHHHHHHHHc
Q 011988 130 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLR 207 (473)
Q Consensus 130 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~ellt 207 (473)
|+||||+ .++.+||+|||+|+...... ....||+.|+|||++.+ ..++.++|||||||+||||++
T Consensus 222 p~NIll~---~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 222 PDNLFIM---PDGRLMLGDVSALWKVGTRG----------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp GGGEEEC---TTSCEEECCGGGEEETTCEE----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEEC---CCCCEEEEecceeeecCCCc----------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999994 77899999999998654321 13467799999999987 679999999999999999999
Q ss_pred CCCCCCCCCCCCHHHHHHHH--hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 208 GSLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 208 G~~Pf~~~~~~~~~~~~~~i--~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
|+.||.+....... .+... ............+..+++++.+||..||..||++||++.+++
T Consensus 289 g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 289 LFLPFGLVTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp SSCSTTBCCTTCTT-CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred CCCCCCCcCccccc-chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99999875332110 00000 000000111112357899999999999999999999988874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=332.12 Aligned_cols=248 Identities=10% Similarity=0.164 Sum_probs=199.5
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeC--CeE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG--DYN 77 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~--~~~ 77 (473)
-.++|++.+.||+|+||.||+|++ .++.||||++.... ...+.+|+.+++.++|++++..+. +.... ...
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~~~~ 84 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG-ACQSPPAPHP 84 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEE-EECTTTSSSC
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEE-EEccCCCCCe
Confidence 357899999999999999999997 48899999965433 235788999999998655555544 44443 678
Q ss_pred EEEEecC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
+++|||+ +++|.+++..... .+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~---~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKF 161 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC---TTSCEEEEGGGSCC
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc---CCcceeEEecccee
Confidence 9999999 6799999985433 4899999999999999999999999 99999999999994 77889999999876
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCc---hhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSR---RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 230 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~---ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 230 (473)
.... ....||+.|+|||++.+..++. ++|||||||++|||++|..||.+... ......+...
T Consensus 162 ~~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~ 226 (271)
T 3kmu_A 162 SFQS------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEIGMKVALE 226 (271)
T ss_dssp TTSC------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHHHHHHHHS
T ss_pred eecc------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHHHHHHHhc
Confidence 4322 2347899999999999876544 89999999999999999999987543 2222333222
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 231 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 231 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
.... .+...+++++.++|..||+.||++||++.++++.|+++.
T Consensus 227 ~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 227 GLRP---TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 2221 234568999999999999999999999999999998874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=333.18 Aligned_cols=246 Identities=21% Similarity=0.312 Sum_probs=199.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEe---CCeE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVE---GDYN 77 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~---~~~~ 77 (473)
+..|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+|+.+++.++|++++..+..+... ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 556999999999999999999999999999999854322 23478899999999877666666555432 4668
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
++||||+ +++|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+|||++ ...+.+||+|||++..
T Consensus 105 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGG
T ss_pred EEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCccc
Confidence 9999999 77999999753 56999999999999999999999999 99999999999994 3678999999999975
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
...... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ....+..+......
T Consensus 182 ~~~~~~---------~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~- 248 (290)
T 1t4h_A 182 KRASFA---------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKP- 248 (290)
T ss_dssp CCTTSB---------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCC-
T ss_pred cccccc---------ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccCCc-
Confidence 443221 23579999999998875 589999999999999999999999977432 33333333332221
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..+...+++++.++|..||..||.+||++.+|+
T Consensus 249 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 281 (290)
T 1t4h_A 249 --ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp --GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred --cccCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 123456789999999999999999999988774
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=336.51 Aligned_cols=246 Identities=22% Similarity=0.329 Sum_probs=203.1
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
..+.|++++.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+.| ++|..+..++......++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEEE
Confidence 346799999999999999999999999999999985433 23568899999999975 4555555666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+....
T Consensus 99 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECBTTB
T ss_pred EEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC---CCCCEEEeecccceecCccc
Confidence 9999 679999986 45799999999999999999999999999999999999994 77899999999998765432
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. ......||..|+|||++.+..++.++|||||||++|+|++|..||..... ......+..... ..+
T Consensus 174 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~ 239 (303)
T 3a7i_A 174 I-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIPKNNP----PTL 239 (303)
T ss_dssp C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCC----CCC
T ss_pred c-------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHhhcCCC----CCC
Confidence 2 12346799999999999999999999999999999999999999976432 222222222221 123
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
...++.++.++|..||..||++||++.+|++
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 4578999999999999999999999888754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=349.11 Aligned_cols=264 Identities=18% Similarity=0.227 Sum_probs=205.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
..++|++.+.||+|+||.||+|.+ .+++.||||+..... ...+.+|+.+++.++|++ |..+..++......++||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH-LVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTT-BCCEEEECCCTTCCEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCC-EeeEEEEEcCCCeEEEEE
Confidence 468899999999999999999995 578999999854433 345788999999998554 555555666777889999
Q ss_pred ecC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 82 DLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~---~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccccccccc
Confidence 999 789999886432 258999999999999999999999999999999999999 4788999999999986543
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH----hhcccc
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----SEKKVS 233 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i----~~~~~~ 233 (473)
.... .......||..|+|||++.+..++.++|||||||++|||++|+.||.+............. ......
T Consensus 192 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 192 LDQT-----HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp SSCC-----CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccc-----ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 2211 1123456899999999999999999999999999999999999999765443221111111 000000
Q ss_pred -----ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 234 -----TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 234 -----~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
.....+...++.++.+++..||..||++||++.+|++.|+.++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 000111223467899999999999999999999999999988753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=348.61 Aligned_cols=257 Identities=18% Similarity=0.272 Sum_probs=201.5
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
....++|++.++||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++.++| ++|..+..++......+
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCC-CCEEEEeEEEEECCEEE
Confidence 345688999999999999999999999999999999965443 2357889999999975 55555556667788899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+||||+ +++|.+++... ..+++..++.|+.||+.||.|||++ ||+||||||+||||+ .++.+||+|||++....
T Consensus 108 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCHHHH
T ss_pred EEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC---CCCCEEEEECCCCcccc
Confidence 999999 77999999754 4699999999999999999999996 999999999999994 77899999999997654
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH------------
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY------------ 224 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~------------ 224 (473)
... .....||..|+|||++.+..++.++|||||||++|||++|..||...........+
T Consensus 184 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3eqc_A 184 DSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254 (360)
T ss_dssp HHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred ccc---------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence 322 13458999999999999999999999999999999999999999764321111000
Q ss_pred ---------------------------HHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 225 ---------------------------EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 225 ---------------------------~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
..+....... .....++.++.+||..||..||++|||++++ |++.|.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~~ 328 (360)
T 3eqc_A 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKNPAERADLKQL---MVHAFI 328 (360)
T ss_dssp -------------------CCCHHHHHHHHHHSCCCC---CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHH---HTSHHH
T ss_pred CCcccCCCcccccccCCCCcccchhhhhHHhccCCCC---CCcccccHHHHHHHHHHhhcChhhCCCHHHH---hhChHh
Confidence 0000000000 0012368899999999999999999998877 455554
Q ss_pred Hh
Q 011988 278 RE 279 (473)
Q Consensus 278 ~~ 279 (473)
+.
T Consensus 329 ~~ 330 (360)
T 3eqc_A 329 KR 330 (360)
T ss_dssp HH
T ss_pred hc
Confidence 43
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=343.39 Aligned_cols=264 Identities=18% Similarity=0.213 Sum_probs=205.5
Q ss_pred cCCceEEEeeEeecCceEEEEEEE----cCCCcEEEEEEcccCCc---hhHHHHHHHHHHhcCCCCCCeeEEeeE-eCCe
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLNVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGV-EGDY 76 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~----~~~~~~vAiK~~~~~~~---~~l~~E~~il~~L~~~~~i~~~~~~~~-~~~~ 76 (473)
..++|++++.||+|+||.||+|.+ ..+++.||||++..... ..+.+|+.+++.++|++++..+..+.. ....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 456799999999999999999984 56899999999655433 357899999999986666655554433 2346
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
.++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVL 195 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEecCcchhhc
Confidence 79999999 7799999987767799999999999999999999999999999999999995 6789999999999876
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CCHHH---H
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA---------GTKKQ---K 223 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~---------~~~~~---~ 223 (473)
....... .......++..|+|||++.+..++.++|||||||++|||++|..||..... ..... .
T Consensus 196 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 196 PQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CSSCSEE----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccccc----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 5433211 112344678889999999998899999999999999999999999864210 00000 0
Q ss_pred HHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 224 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 224 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
+......... ......+|+++.++|..||..||++||++.+|.+.|+++..+
T Consensus 272 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 272 LIELLKNNGR---LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHTTCC---CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCC---CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0011110000 012356889999999999999999999999999999988654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=360.76 Aligned_cols=238 Identities=14% Similarity=0.100 Sum_probs=183.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhc---CCCCCCeeE------Ee
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQ---GGTGIPNLR------WF 70 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~---~~~~i~~~~------~~ 70 (473)
.++|++.+.||+|+||.||+|++..+|+.||||++... ....+.+|+.+++.|. |++++..+. .+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 57899999999999999999999899999999996432 1245788996666554 444433321 22
Q ss_pred eEeCC-----------------eEEEEEecCCCCHHHHHHHcCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCccc
Q 011988 71 GVEGD-----------------YNVLVIDLLGPSLEDLFNFCSRKLS-------LKTVLMLADQMINRVEFVHSKSFLHR 126 (473)
Q Consensus 71 ~~~~~-----------------~~~lv~e~~g~sL~~~l~~~~~~ls-------~~~~~~i~~qi~~aL~yLH~~gIvHr 126 (473)
..... ..+++|||++++|.+++.... .++ +..++.|+.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 22221 378999999999999998542 243 48888999999999999999999999
Q ss_pred CCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCC-----------CCCchhhH
Q 011988 127 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----------EQSRRDDL 195 (473)
Q Consensus 127 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-----------~~s~ksDV 195 (473)
||||+||||+ .++.+||+|||+|+..... .....| ..|+|||++.+. .++.++||
T Consensus 231 Dikp~NIll~---~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 231 YLRPVDIVLD---QRGGVFLTGFEHLVRDGAR----------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp CCCGGGEEEC---TTCCEEECCGGGCEETTCE----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred CCCHHHEEEc---CCCCEEEEechhheecCCc----------ccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 9999999994 6789999999999853321 124567 999999999987 89999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 196 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 196 wSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
|||||+||||++|+.||.+....... . .+...+..+|+++.+||..||..||++||++.++++
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~~---~---------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGGS---E---------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CCS---G---------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHHHHCCCCCcccccccch---h---------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999999999764322111 0 111123578999999999999999999999998864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=346.02 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=194.1
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcC-----------CCCCCeeEE
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQG-----------GTGIPNLRW 69 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~-----------~~~i~~~~~ 69 (473)
+...++|++.+.||+|+||.||+|++..+++.||||++.... ...+..|+.+++.+.+ .+++..+..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 345679999999999999999999999999999999965432 3457889999999873 344444444
Q ss_pred eeEeC---CeEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCcEEEeeC---CCC
Q 011988 70 FGVEG---DYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLG---RRA 141 (473)
Q Consensus 70 ~~~~~---~~~~lv~e~~g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~---~~~ 141 (473)
+...+ ...+++||+++++|.+++... ...+++..++.|+.||+.||.|||++ ||+||||||+||||+.+ +..
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 43322 278999999999999999864 34599999999999999999999998 99999999999999643 234
Q ss_pred CcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC--
Q 011988 142 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-- 219 (473)
Q Consensus 142 ~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~-- 219 (473)
+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||+||||++|..||.+.....
T Consensus 175 ~~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp EEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ceEEEcccccccccCCCC----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 479999999998764422 24578999999999999999999999999999999999999998654211
Q ss_pred -HHHHHHHHhhcccccc------------------------------HHH-------HhcCCcHHHHHHHHHHhcCCCCC
Q 011988 220 -KKQKYEKISEKKVSTS------------------------------IEA-------LCRGYPTEFASYFHYCRSLRFDD 261 (473)
Q Consensus 220 -~~~~~~~i~~~~~~~~------------------------------~~~-------l~~~~p~~l~~li~~cl~~dp~~ 261 (473)
....+..+.......+ ... +...+++++.+||..||..||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 1112222111000000 000 01234578999999999999999
Q ss_pred CCCHHHH
Q 011988 262 KPDYAYL 268 (473)
Q Consensus 262 RPt~~~l 268 (473)
||++.+|
T Consensus 325 Rpt~~el 331 (373)
T 1q8y_A 325 RADAGGL 331 (373)
T ss_dssp CBCHHHH
T ss_pred cCCHHHH
Confidence 9998777
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=334.77 Aligned_cols=250 Identities=21% Similarity=0.249 Sum_probs=200.2
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEee-EeCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFG-VEGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~-~~~~~~ 77 (473)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|++++..+..+. ......
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 34578999999999999999999999999999999865432 234788999999998766665555443 346788
Q ss_pred EEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CcccCCCCCcEEEeeCCCCCcEEEEe
Q 011988 78 VLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIID 148 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~g-----IvHrDIKP~NILl~~~~~~~~vkL~D 148 (473)
++||||+ +++|.+++... ...+++..++.|+.||+.||+|||++| |+||||||+|||++ .++.+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~---~~~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC---SSSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc---CCCCEEEec
Confidence 9999999 67999998743 335999999999999999999999999 99999999999994 778999999
Q ss_pred cCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011988 149 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 228 (473)
Q Consensus 149 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 228 (473)
||+++........ .....||..|+|||++.+..++.++|||||||++|+|++|..||.... .......+.
T Consensus 160 fg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~ 229 (279)
T 2w5a_A 160 FGLARILNHDTSF-------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIR 229 (279)
T ss_dssp CCHHHHC---CHH-------HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH
T ss_pred Cchheeecccccc-------ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHHHHHh
Confidence 9999876443211 123478999999999999999999999999999999999999998753 233333333
Q ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 229 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 229 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
..... .+...+++++.++|..||..||++||++.+|++
T Consensus 230 ~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 230 EGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp HTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 33221 223468899999999999999999999888754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=337.98 Aligned_cols=255 Identities=20% Similarity=0.289 Sum_probs=198.6
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcC-CCCCCeeEEeeEeCCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQG-GTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~-~~~i~~~~~~~~~~~~~~ 78 (473)
.+++|++++.||+|+||.||+|.+. +++.||||++.... ...+.+|+.+++.+.+ +++|..+..++......+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 4678999999999999999999974 58899999864332 2457899999999986 677878888888888999
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 79 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 79 lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
++||+.+++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+...
T Consensus 105 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 105 MVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC----
T ss_pred EEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccccccccCc
Confidence 9999889999999985 45799999999999999999999999999999999999994 478999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 227 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-----------~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i 227 (473)
.... ......||..|+|||++.+ ..++.++|||||||++|||++|..||..... ....+..+
T Consensus 180 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~ 252 (313)
T 3cek_A 180 TTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAI 252 (313)
T ss_dssp ---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHH
T ss_pred cccc-----cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--HHHHHHHH
Confidence 2211 1134579999999999976 4688999999999999999999999976432 22222222
Q ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 228 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 228 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
....... .+...++.++.++|..||..||++||++.+| |++.|.+
T Consensus 253 ~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el---l~h~~~~ 297 (313)
T 3cek_A 253 IDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQ 297 (313)
T ss_dssp HCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred Hhccccc---CCcccchHHHHHHHHHHccCCcccCcCHHHH---hcCcccc
Confidence 2211111 1234567899999999999999999998777 5555544
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=349.65 Aligned_cols=253 Identities=18% Similarity=0.252 Sum_probs=194.4
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeC-----CeEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG-----DYNVL 79 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~-----~~~~l 79 (473)
...+|++.+.||+|+||.||+|++..+++ ||+|.+.... ....+|+.+++.++|++++..+..+...+ .+.++
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc-chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 45679999999999999999999877666 7777643322 22347999999999777776666554433 24789
Q ss_pred EEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 80 VIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 80 v~e~~g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
||||+.++|.+.+.. ....+++..++.|+.||+.||.|||++||+||||||+||||+ ...+.+||+|||+|+.+.
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCccccc
Confidence 999998887766542 356799999999999999999999999999999999999995 367899999999998764
Q ss_pred CCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc---
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--- 232 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--- 232 (473)
.... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.........+.+......
T Consensus 194 ~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 194 AGEP--------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp TTCC--------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCC--------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 4322 2346789999999999875 489999999999999999999999988543222222222111000
Q ss_pred -----------------cccH-HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 -----------------STSI-EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 -----------------~~~~-~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.... ..+...+++++.+||.+||..||.+||++.+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 0111 122235789999999999999999999987763
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=332.65 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=204.1
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc-----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~-----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.. .....+.+|+.+++.++|+ +|..+..+.......+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP-NIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCT-TBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCC-CccEEEEEEeCCCeEE
Confidence 356789999999999999999999999999999998533 2345688999999999754 5555556667788899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
++||++ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 999999 78999988643 4699999999999999999999999999999999999996544456899999999986644
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
... .....||..|+|||++.+ .++.++|||||||++|+|++|..||.+.. .......+..........
T Consensus 177 ~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~ 244 (287)
T 2wei_A 177 NTK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLP 244 (287)
T ss_dssp CSS--------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCSG
T ss_pred CCc--------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCch
Confidence 321 123468999999999886 48999999999999999999999998743 333344444333322211
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
....+++++.++|..||..||++||++.++++
T Consensus 245 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 -QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 23568899999999999999999999888754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=341.66 Aligned_cols=240 Identities=25% Similarity=0.369 Sum_probs=200.7
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---------CchhHHHHHHHHHHhcC-CCCCCeeEEeeEe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---------KHPQLQYEAKLYKILQG-GTGIPNLRWFGVE 73 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---------~~~~l~~E~~il~~L~~-~~~i~~~~~~~~~ 73 (473)
.+.++|++.+.||+|+||.||+|.+..+++.||||++... ....+..|+.+++.+.+ ++++..+..+...
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 5678999999999999999999999999999999985432 22457789999999985 6777777777788
Q ss_pred CCeEEEEEecCC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCC
Q 011988 74 GDYNVLVIDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 151 (473)
Q Consensus 74 ~~~~~lv~e~~g--~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 151 (473)
....+++||++. ++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++ .+.+.+||+|||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGS 196 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTT
T ss_pred CCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEeeCcc
Confidence 888999999984 799999975 45799999999999999999999999999999999999995 3568999999999
Q ss_pred cccccCCCCccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011988 152 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 230 (473)
Q Consensus 152 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 230 (473)
++....... ....||..|+|||++.+..+ +.++|||||||+||||++|..||.... .+...
T Consensus 197 ~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~~~~~ 258 (320)
T 3a99_A 197 GALLKDTVY---------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRG 258 (320)
T ss_dssp CEECCSSCB---------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHHC
T ss_pred ccccccccc---------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------hhhcc
Confidence 987654321 34579999999999987765 788999999999999999999996521 11111
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.. .+...+++++.++|..||..||++||++++|+
T Consensus 259 ~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 292 (320)
T 3a99_A 259 QV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 292 (320)
T ss_dssp CC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11 12356899999999999999999999988774
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=337.47 Aligned_cols=250 Identities=20% Similarity=0.298 Sum_probs=197.4
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
...++|++++.||+|+||.||+|.+..+++.||+|++... ....+..|+.+++.+.|++ |..+..++......++|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY-IVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTT-BCCEEEEEECC-CEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCC-EeeeeeeeeeCCeEEEE
Confidence 4567899999999999999999999999999999985432 3456888999999998555 55555555667788999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTSCEEECCCHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC---CCCCEEEEECCCCccccccc
Confidence 9999 7799999887677899999999999999999999999999999999999994 67899999999986432211
Q ss_pred CccccccccCCCcccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
. ......||..|+|||++. +..++.++|||||||++|+|++|..||..... ...+..+.......
T Consensus 172 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~ 241 (302)
T 2j7t_A 172 Q-------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSDPPT 241 (302)
T ss_dssp H-------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC
T ss_pred c-------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHhccCCcc
Confidence 1 113457999999999984 66789999999999999999999999987543 22333332222111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
. .....++.++.++|..||..||++||++.+|+
T Consensus 242 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 274 (302)
T 2j7t_A 242 L--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLL 274 (302)
T ss_dssp C--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHT
T ss_pred c--CCccccCHHHHHHHHHHcccChhhCCCHHHHh
Confidence 1 11245789999999999999999999988774
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=342.07 Aligned_cols=263 Identities=17% Similarity=0.212 Sum_probs=199.1
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEe---CCeEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVE---GDYNV 78 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~---~~~~~ 78 (473)
-.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|++++..+..+... ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 3578999999999999999999999999999999854433 34578999999999877766666555432 34678
Q ss_pred EEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 79 LVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
+||||+ +++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc---CCCCEEEEecCcchh
Confidence 999999 6699999875 256799999999999999999999999999999999999994 778999999999876
Q ss_pred ccCCCCccc--cccccCCCcccCccccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011988 155 YRDTATHQH--IPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 229 (473)
Q Consensus 155 ~~~~~~~~~--~p~~~~~~~~Gt~~Y~APE~~~~~~---~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 229 (473)
......... ..........||..|+|||++.+.. ++.++|||||||++|||++|..||.......... ...+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~ 262 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV-ALAVQN 262 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH-HHHHHC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh-hHHhhc
Confidence 532211000 0000012245799999999998664 6899999999999999999999995421110000 111111
Q ss_pred ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 230 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 230 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
.... .....+++++.++|..||..||.+||++.+|++.|+.+
T Consensus 263 -~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 263 -QLSI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp -C--C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -cCCC---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 1110 11246789999999999999999999999999888765
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=333.96 Aligned_cols=256 Identities=17% Similarity=0.274 Sum_probs=201.6
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-------CchhHHHHHHHHHHhcCCCCCCeeEEee-EeCC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-------KHPQLQYEAKLYKILQGGTGIPNLRWFG-VEGD 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-------~~~~l~~E~~il~~L~~~~~i~~~~~~~-~~~~ 75 (473)
++.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.++|++++..+..+. ....
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 4678999999999999999999999999999999985432 2356889999999998666665555443 4456
Q ss_pred eEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..++||||+.++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~---~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALGVAEA 158 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---CCCcEEeeccccccc
Confidence 78999999988888888754 45699999999999999999999999999999999999994 778999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
........ ......||..|+|||++.+.. ++.++|||||||++|||++|..||.+.. ....+..+.....
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~~~~ 230 (305)
T 2wtk_C 159 LHPFAADD-----TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFENIGKGSY 230 (305)
T ss_dssp CCTTCSSC-----EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCC
T ss_pred cCcccccc-----ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHHhcCCC
Confidence 65322211 113457999999999998754 3789999999999999999999998743 3333444433322
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
. +...+++++.++|..||..||++||++.+| +++.|.+
T Consensus 231 ~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l---l~~~~~~ 268 (305)
T 2wtk_C 231 A-----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQI---RQHSWFR 268 (305)
T ss_dssp C-----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHH---HHSHHHH
T ss_pred C-----CCCccCHHHHHHHHHHccCChhhCCCHHHH---hcCcccc
Confidence 1 235688999999999999999999998877 4555544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=326.96 Aligned_cols=252 Identities=20% Similarity=0.279 Sum_probs=197.1
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
...++|++.+.||+|+||.||+|.+..+++.||||++.. .....+.+|+.+++.++|+ +|..+..+.......
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP-HIIKLYQVISTPTDF 86 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCT-TBCCEEEEEECSSEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCC-CEeEEEEEEecCCeE
Confidence 446889999999999999999999999999999998533 2334688999999999855 455555666778889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC---TTSCEEECCCCGGGCCC
T ss_pred EEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC---CCCCEEEeecccccccC
Confidence 9999999 78999999754 4699999999999999999999999999999999999994 77899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
.... .....||..|+|||++.+..+ +.++|||||||++|+|++|..||.... ....+..+......
T Consensus 163 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~-- 229 (276)
T 2h6d_A 163 DGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIRGGVFY-- 229 (276)
T ss_dssp C---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC--
T ss_pred CCcc--------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCccc--
Confidence 4321 124578999999999998765 689999999999999999999997643 23333333332211
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
+...++.++.++|..||+.||++||++.+| +++.+.+.
T Consensus 230 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~---l~h~~~~~ 267 (276)
T 2h6d_A 230 ---IPEYLNRSVATLLMHMLQVDPLKRATIKDI---REHEWFKQ 267 (276)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH---HHSHHHHT
T ss_pred ---CchhcCHHHHHHHHHHccCChhhCCCHHHH---HhChhhcc
Confidence 234578999999999999999999998877 44555443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=370.83 Aligned_cols=253 Identities=20% Similarity=0.348 Sum_probs=198.5
Q ss_pred eEE-EeeEeecCceEEEEEEE--cCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 9 FRL-GRKIGSGSFGEIYLGTN--IQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 9 y~i-~~~LG~G~fG~Vy~a~~--~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
+.+ .++||+|+||.||+|.+ ..+++.||||++.... ...+.+|+.+++.|+|++++..+. ++. .+..++|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~-~~~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG-ICE-AESWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEE-EEE-SSSEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEE-EEe-cCCEEEE
Confidence 444 34899999999999965 3567899999854422 356889999999999666665554 444 4457899
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+....
T Consensus 448 ~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC--
T ss_pred EEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCccccccCc
Confidence 9999 7899999974 55799999999999999999999999999999999999996 67899999999998765433
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. +.......||..|+|||++.+..++.++|||||||+||||++ |..||.+... .+....+...... .
T Consensus 524 ~~----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~----~ 592 (635)
T 4fl3_A 524 NY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM----G 592 (635)
T ss_dssp ---------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----C
T ss_pred cc----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----C
Confidence 21 111233467889999999999999999999999999999998 9999987543 2333333322211 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
....+|+++.+||..||..||++||++.+|++.|++++..
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 2357899999999999999999999999999999998864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=368.41 Aligned_cols=253 Identities=22% Similarity=0.372 Sum_probs=205.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.++|++.++||+|+||.||+|.+.. +..||||++... ....+.+|+.+|+.|+|.+++..+..+ .. ...+|||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~-~~~~lv~e~ 342 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SE-EPIYIVTEY 342 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CS-SSCEEEECC
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEE-ee-ccceEeeeh
Confidence 4679999999999999999999854 567999996543 345689999999999976666655443 33 567999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+ +++|.+++... ...+++.+++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+++.+....
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~~~~~-- 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE-- 417 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCTTSTTTCCCHH--
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc---CCCcEEEcccccceecCCCc--
Confidence 9 77999999743 34699999999999999999999999999999999999994 67899999999998764321
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
+.......++..|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+...... ...
T Consensus 418 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~~ 486 (535)
T 2h8h_A 418 ----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PCP 486 (535)
T ss_dssp ----HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHHTTCCC----CCC
T ss_pred ----eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 111234467889999999999899999999999999999999 9999987543 3333333322111 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
..+|+++.+||..||..||++||++++|.+.|++++.
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 5689999999999999999999999999999988763
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=335.15 Aligned_cols=257 Identities=22% Similarity=0.267 Sum_probs=196.0
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcC-CCc--EEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-TNE--EVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~--~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
..++|++.+.||+|+||.||+|.+.. +++ .||||++.... ...+.+|+.+++.++|++++..+.. .....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~ 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGV-VLTPP 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEE-ECSSS
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEE-EccCC
Confidence 35689999999999999999998643 333 68999854321 3457899999999986655555544 44433
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
.+++||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRA 170 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEE
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEcccccccc
Confidence 78999998 7899999986666799999999999999999999999999999999999995 668999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
+....... .......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+... .+.+..+......
T Consensus 171 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~ 243 (291)
T 1u46_A 171 LPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEGER 243 (291)
T ss_dssp CCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTSCCC
T ss_pred ccccccch----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHHHccCCC
Confidence 65433211 11234567889999999999889999999999999999999 9999987542 3333443332221
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
.. ....+|.++.++|..||..||++||++.+|.+.|+++.
T Consensus 244 ~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 244 LP---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC---CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 11 23568999999999999999999999999999988774
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=354.08 Aligned_cols=266 Identities=19% Similarity=0.257 Sum_probs=187.0
Q ss_pred ccCCceEE-EeeEeecCceEEEEEEEc--CCCcEEEEEEcccCC-chhHHHHHHHHHHhcCCCCCCeeEEeeE-eCCeEE
Q 011988 4 RVGNKFRL-GRKIGSGSFGEIYLGTNI--QTNEEVAIKLNVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNV 78 (473)
Q Consensus 4 ~i~~~y~i-~~~LG~G~fG~Vy~a~~~--~~~~~vAiK~~~~~~-~~~l~~E~~il~~L~~~~~i~~~~~~~~-~~~~~~ 78 (473)
++.+.|.+ .++||+|+||.||+|++. .+++.||||++.... ...+.+|+.+++.|+|++++..+..+.. .....+
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 45567888 458999999999999976 568899999965443 4568899999999997766666655543 467889
Q ss_pred EEEecCCCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC-CCCCcEEEEec
Q 011988 79 LVIDLLGPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDF 149 (473)
Q Consensus 79 lv~e~~g~sL~~~l~~~~--------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~DF 149 (473)
+||||++++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||... +..+.+||+||
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 999999999999886321 249999999999999999999999999999999999999543 35689999999
Q ss_pred CCcccccCCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC------HHH
Q 011988 150 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQ 222 (473)
Q Consensus 150 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~------~~~ 222 (473)
|+|+.+..... +........||+.|+|||++.+. .++.++|||||||+||||++|..||.+..... ...
T Consensus 177 g~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 177 GFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp TCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred CCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99987654321 11122456899999999999885 48999999999999999999999997643310 111
Q ss_pred HHHHHhhcc---ccc--------------------------c----HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 223 KYEKISEKK---VST--------------------------S----IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 223 ~~~~i~~~~---~~~--------------------------~----~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.+..+.... ... . ........++++.+||..||..||.+|||++++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~- 331 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA- 331 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH-
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH-
Confidence 122211100 000 0 000011226789999999999999999998776
Q ss_pred HHHHHHH
Q 011988 270 RLFRDLF 276 (473)
Q Consensus 270 ~~L~~l~ 276 (473)
|++.|
T Consensus 332 --L~hp~ 336 (405)
T 3rgf_A 332 --MQDPY 336 (405)
T ss_dssp --HTSGG
T ss_pred --hcChh
Confidence 44544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=342.85 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=193.5
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCC----
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD---- 75 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~---- 75 (473)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ...+.+|+.+++.++|++++..+..+.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 4678999999999999999999999999999999965432 2346789999999997666666655544332
Q ss_pred -eEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 -YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 -~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..+++|||++++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 102 YDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILDFGLARH 175 (353)
T ss_dssp CCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTCCEEECSTTCTTC
T ss_pred eeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC---CCCcEEEeecccccC
Confidence 359999999988887764 4599999999999999999999999999999999999994 778999999999986
Q ss_pred ccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc-
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV- 232 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~- 232 (473)
..... ....||..|+|||++.+ ..++.++|||||||++|||++|..||.+... ...+..+.....
T Consensus 176 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~ 242 (353)
T 3coi_A 176 ADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGV 242 (353)
T ss_dssp ------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHCB
T ss_pred CCCCc----------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCC
Confidence 54321 34578999999999987 6789999999999999999999999987543 222222211100
Q ss_pred -------------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 -------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 -------------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
......+...+++++.+||..||..||++||++.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 304 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0111122346789999999999999999999987763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=343.08 Aligned_cols=259 Identities=18% Similarity=0.226 Sum_probs=198.4
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
..++|++.+.||+|+||.||+|.+ .+++.||||++.... ...+.+|+.+++.+.|+++ ..+..++......++|
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLV 105 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTB-CCCCEEECCSSCCEEE
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCc-cceEEEEecCCceEEE
Confidence 568899999999999999999984 578999999854432 3368899999999985554 4555555667778999
Q ss_pred EecC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 81 IDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~---~~ls~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
|||+ +++|.+++.... ..+++..++.|+.||+.||.|||++ ||+||||||+|||++ .++.+||+|||+++
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAK 182 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC---TTCCEEECCCSSCE
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC---CCCCEEeccCcccc
Confidence 9999 779999997432 2499999999999999999999999 999999999999994 77899999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-----CCCCHHHHHHHHh
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL-----KAGTKKQKYEKIS 228 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~-----~~~~~~~~~~~i~ 228 (473)
......... .....||+.|+|||++.+..++.++|||||||++|||++|..||... .............
T Consensus 183 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 183 LMDYKDTHV------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp ECCSSSSCE------ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred ccCcccccc------cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 765433211 23456999999999999889999999999999999999999999521 1111111111100
Q ss_pred hcc-cccc-----HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 229 EKK-VSTS-----IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 229 ~~~-~~~~-----~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
... .... ........+.++.+++..||+.||.+||++.+|++.|+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 000 0000 000111234789999999999999999999999888875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=331.41 Aligned_cols=255 Identities=25% Similarity=0.329 Sum_probs=197.7
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
|...++||+|+||.||+|.+ +++.||||++.... ...+.+|+.+++.++|+ +|..+..++......+++|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE-NLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT-TBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC-CeEEEEEEEecCCceEEEE
Confidence 33458999999999999984 68899999854321 34588999999999855 5555555666777889999
Q ss_pred ecC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 82 DLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 82 e~~-g~sL~~~l~~~--~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD---EAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc---CCCcEEEeecccccccccc
Confidence 999 88999998743 34699999999999999999999999999999999999994 7789999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.... ......||..|+|||++.+ .++.++|||||||++|+|++|..||.+.........+........ ..+..
T Consensus 187 ~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 259 (307)
T 2nru_A 187 AQTV-----MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE-KTIED 259 (307)
T ss_dssp SSCE-----ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTS-CCHHH
T ss_pred cccc-----cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhh-hhhhh
Confidence 2211 1234579999999999876 589999999999999999999999987654332222211111111 11111
Q ss_pred H--------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 239 L--------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 239 l--------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
. ...++..+.+++..||..||.+||++.+|.+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 260 YIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1 1123578999999999999999999999999998863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=332.08 Aligned_cols=258 Identities=19% Similarity=0.222 Sum_probs=192.5
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeE---------
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGV--------- 72 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~--------- 72 (473)
++.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.++|++++..+..+..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4567899999999999999999999999999999986432 23457889999999987666666554433
Q ss_pred ---eCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEe
Q 011988 73 ---EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 148 (473)
Q Consensus 73 ---~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 148 (473)
.....++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~---~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc---CCCCEEEee
Confidence 245679999999 7799999987666789999999999999999999999999999999999994 778999999
Q ss_pred cCCcccccCCCCccc-----c--ccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCH
Q 011988 149 FGLAKRYRDTATHQH-----I--PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 220 (473)
Q Consensus 149 FGla~~~~~~~~~~~-----~--p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~ 220 (473)
||+++.......... . .........||..|+|||++.+. .++.++|||||||++|||++ ||.... ..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~ 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ER 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hH
Confidence 999987653211000 0 01112345799999999999875 68999999999999999998 564311 11
Q ss_pred HHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 221 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 221 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
......+..... .....+...++..+.++|..||..||++||++.+|++
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKKLRSVSI-EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHSTTC-CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcccccc-ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 222222222111 1112234566788999999999999999999887743
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=336.09 Aligned_cols=258 Identities=21% Similarity=0.264 Sum_probs=182.4
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
..++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.++|+ +|..+..++......++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHP-NIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCT-TBCCEEEEEESSSCEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCC-CEeeEEEEEeecCCcEEE
Confidence 467899999999999999999998889999999985432 234577888888888755 455555666777788999
Q ss_pred EecC-CCCHHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 81 IDLL-GPSLEDLFNF-------CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~-------~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
|||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc---CCCCEEEEeccch
Confidence 9999 8899999874 244599999999999999999999999999999999999994 7789999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 231 (473)
........... ........||..|+|||++.+ ..++.++|||||||++|||++|..||......... ...+....
T Consensus 169 ~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~ 244 (303)
T 2vwi_A 169 AFLATGGDITR--NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--MLTLQNDP 244 (303)
T ss_dssp HHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHHHTSSC
T ss_pred heeccCCCccc--hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--HHHhccCC
Confidence 76644321110 111234579999999999876 46899999999999999999999999875443221 11111111
Q ss_pred c--cc--cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 232 V--ST--SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 232 ~--~~--~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
. .. ....+...++.++.++|..||..||.+||++.+|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 00 111223567899999999999999999999888753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=331.59 Aligned_cols=249 Identities=19% Similarity=0.302 Sum_probs=182.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCch----hHHHHH-HHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP----QLQYEA-KLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~----~l~~E~-~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.++|++++.||+|+||.||+|.+..+++.||||++...... .+..|. .+++.+. |++|..+..++......++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD-CPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEE
Confidence 46899999999999999999999999999999996554322 233333 3444454 56666676777788899999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+++.+..+.......+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||++..+....
T Consensus 103 ~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC---TTSCEEECCCTTC-------
T ss_pred EeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC---CCCCEEEEECCCchhccCCc
Confidence 99998888888876677899999999999999999999995 999999999999994 77899999999997665432
Q ss_pred CccccccccCCCcccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 234 (473)
. .....||..|+|||++. +..++.++|||||||++|||++|..||..... ....+..+.......
T Consensus 180 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 180 A--------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEPPL 249 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSCCCC
T ss_pred c--------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccCCCC
Confidence 2 12457999999999995 45689999999999999999999999976432 233333333322111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 235 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 235 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
. .....+++++.++|..||..||.+||++.+|++
T Consensus 250 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 L--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 012357899999999999999999999988854
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=336.41 Aligned_cols=253 Identities=16% Similarity=0.276 Sum_probs=176.9
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .++..|+..+.....|++|..+..+.......++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 35789999999999999999999999999999998655432 23445555333333466666776777778889999
Q ss_pred EecCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 81 IDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 81 ~e~~g~sL~~~l~~----~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
|||+.++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||+++.+
T Consensus 100 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE---TTTEEEECCCSSSCC-
T ss_pred EeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc---CCCCEEEccCCCceec
Confidence 99999999988864 256799999999999999999999998 999999999999995 7789999999999876
Q ss_pred cCCCCccccccccCCCcccCccccccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~----~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 231 (473)
..... .....||..|+|||++ .+..++.++|||||||++|||++|..||.+.... ...+..+....
T Consensus 177 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~ 246 (327)
T 3aln_A 177 VDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKGD 246 (327)
T ss_dssp -------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSC
T ss_pred ccccc--------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcCC
Confidence 54322 1234799999999998 4566899999999999999999999999764321 11111111111
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 232 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 232 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
...........+++++.+||..||..||++||++.+|++
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111112457899999999999999999999888854
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=364.46 Aligned_cols=257 Identities=20% Similarity=0.302 Sum_probs=206.3
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCC---CcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
..++|++.+.||+|+||.||+|.+..+ +..||||+...... ..+.+|+.+++.++|++++..+..+ .....
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~--~~~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI--TENPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--ecCce
Confidence 346799999999999999999998653 46799998554332 4578899999999876666655443 34557
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecCCCeecC
Confidence 8999999 7899999987666799999999999999999999999999999999999995 67899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
..... ......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+.......
T Consensus 543 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~~- 612 (656)
T 2j0j_A 543 DSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERLP- 612 (656)
T ss_dssp C----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHHTCCCC-
T ss_pred CCcce------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCCCC-
Confidence 43221 1233467889999999999899999999999999999997 9999987543 33333333322211
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
+...+|+++.++|..||..||++||++.+|.+.|++++.++
T Consensus 613 ---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 613 ---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 23578999999999999999999999999999999998765
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=339.77 Aligned_cols=270 Identities=18% Similarity=0.244 Sum_probs=196.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
..++|++.+.||+|+||.||+|.+.. .||||++... ....+.+|+.+++.++|++++ .+..+.......++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV-LFMGACMSPPHLAI 106 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBC-CCCEEEECSSCEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEe-EEEEEEecCCceEE
Confidence 45789999999999999999998743 4899985432 234577899999999865554 45555666777899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
+|||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC-----
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCccccccc
Confidence 99999 7899999986556799999999999999999999999999999999999994 578999999998765322
Q ss_pred CCccccccccCCCcccCccccccccccC---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLG---------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 229 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~---------~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 229 (473)
.... .........||..|+|||++.+ ..++.++|||||||++|||++|..||..... ......+..
T Consensus 183 ~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~ 257 (319)
T 2y4i_B 183 QAGR--REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQMGT 257 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHHHHHT
T ss_pred cccc--cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhcc
Confidence 1111 0112234569999999999875 3578999999999999999999999977432 233333322
Q ss_pred ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccc
Q 011988 230 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWT 290 (473)
Q Consensus 230 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~ 290 (473)
...... ....++.++.++|..||..||++||++.+|.+.|+++..+.....+....|.
T Consensus 258 ~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~ 315 (319)
T 2y4i_B 258 GMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK 315 (319)
T ss_dssp TCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred CCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence 221111 1235789999999999999999999999999999998877655444444454
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=354.97 Aligned_cols=238 Identities=15% Similarity=0.131 Sum_probs=185.8
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhcCCCCC----------CeeEEe
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQGGTGI----------PNLRWF 70 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~~~~~i----------~~~~~~ 70 (473)
..|++.+.||+|+||.||+|++..+|+.||||++... ....+.+|+.+++.|.|..++ ..+...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3488999999999999999999999999999985522 245688999999888763321 111110
Q ss_pred -----------eE-----eCCeEEEEEecCCCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCC
Q 011988 71 -----------GV-----EGDYNVLVIDLLGPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 128 (473)
Q Consensus 71 -----------~~-----~~~~~~lv~e~~g~sL~~~l~~~------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDI 128 (473)
.. .....+++|++++++|.+++... ...+++..++.|+.||+.||+|||++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11 12346889999999999999633 345788899999999999999999999999999
Q ss_pred CCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccc----------cCCCCCchhhHHHH
Q 011988 129 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH----------LGIEQSRRDDLESL 198 (473)
Q Consensus 129 KP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~----------~~~~~s~ksDVwSl 198 (473)
||+||||+ .++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||
T Consensus 238 Kp~NILl~---~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 238 RPVDIVLD---QRGGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CGGGEEEC---TTCCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred ccceEEEe---cCCeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 99999994 7788999999999865432 134577 999999999 55568899999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 199 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 199 GviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
||+||||++|+.||.+....... . .+...+..+|+++.+||..||..||++||++.++++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~~---~---------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGGS---E---------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSCS---G---------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCcchhhhH---H---------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999999775432111 0 111123478999999999999999999999877743
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=330.90 Aligned_cols=240 Identities=22% Similarity=0.333 Sum_probs=188.8
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---------chhHHHHHHHHHHhc---CCCCCCeeEEee
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---------HPQLQYEAKLYKILQ---GGTGIPNLRWFG 71 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---------~~~l~~E~~il~~L~---~~~~i~~~~~~~ 71 (473)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+|+.++..+. .|++|..+..++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 45788999999999999999999999999999999964432 233567999999994 355566666666
Q ss_pred EeCCeEEEEEec-C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEec
Q 011988 72 VEGDYNVLVIDL-L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 149 (473)
Q Consensus 72 ~~~~~~~lv~e~-~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 149 (473)
...+..+++||+ + +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~df 184 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLIDF 184 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEECCC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEEEc
Confidence 667778899997 3 7899999985 34699999999999999999999999999999999999995 36789999999
Q ss_pred CCcccccCCCCccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011988 150 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 228 (473)
Q Consensus 150 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 228 (473)
|+++....... ....||..|+|||++.+..+ +.++|||||||++|||++|+.||.... .+.
T Consensus 185 g~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~ 246 (312)
T 2iwi_A 185 GSGALLHDEPY---------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------EIL 246 (312)
T ss_dssp SSCEECCSSCB---------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHH
T ss_pred chhhhcccCcc---------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------HHh
Confidence 99987654321 34579999999999987665 458999999999999999999996521 111
Q ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 229 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 229 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..... +...++.++.++|..||..||++||++.+++
T Consensus 247 ~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 282 (312)
T 2iwi_A 247 EAELH-----FPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282 (312)
T ss_dssp HTCCC-----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhccC-----CcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11111 2356789999999999999999999988774
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=326.40 Aligned_cols=243 Identities=22% Similarity=0.290 Sum_probs=191.2
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCC
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 87 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~s 87 (473)
...||+|+||.||+|.+..+++.||||++.... ...+.+|+.+++.++|++++ .+..+.......++||||+ +++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~ 105 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV-QYLGSFSENGFIKIFMEQVPGGS 105 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBC-CEEEEEEETTEEEEEEECCSEEE
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEe-eEeeEEEeCCcEEEEEEeCCCCC
Confidence 348999999999999999999999999854432 45588999999999865544 5555667788899999999 789
Q ss_pred HHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccccc
Q 011988 88 LEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 165 (473)
Q Consensus 88 L~~~l~~~~~--~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 165 (473)
|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ ...+.+||+|||+++.......
T Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~----- 178 (295)
T 2clq_A 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINP----- 178 (295)
T ss_dssp HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC--------
T ss_pred HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCC-----
Confidence 9999986533 467899999999999999999999999999999999996 3378999999999987644221
Q ss_pred cccCCCcccCccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011988 166 YRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 166 ~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
......||..|+|||++.+.. ++.++|||||||++|+|++|..||...... ............. ..+...+
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~---~~~~~~~ 251 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKVGMFKVH---PEIPESM 251 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--HHHHHHHHHHCCC---CCCCTTS
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--hHHHHhhcccccc---ccccccC
Confidence 113457999999999998654 899999999999999999999999764321 1111111111111 1234568
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 244 PTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
++++.++|..||..||++||++.+++
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll 277 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLL 277 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHh
Confidence 89999999999999999999988773
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=347.91 Aligned_cols=259 Identities=20% Similarity=0.227 Sum_probs=191.4
Q ss_pred CCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++.......+.+|+.+++.+..|++|..+..+.......++||
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 34567888999999999999998754 46899999999766556678899999998866777777777788889999999
Q ss_pred ecCCCCHHHHHHHcCCC------CCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC----------CCCCcEE
Q 011988 82 DLLGPSLEDLFNFCSRK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----------RRANQVY 145 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~------ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~----------~~~~~vk 145 (473)
||++++|.+++...... .++..++.|+.||+.||+|||++|||||||||+||||+.+ +....+|
T Consensus 89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 99999999999743211 1233467899999999999999999999999999999632 2356899
Q ss_pred EEecCCcccccCCCCccccccccCCCcccCccccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 011988 146 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 217 (473)
Q Consensus 146 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-------~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~ 217 (473)
|+|||+++.+........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+...
T Consensus 169 L~DFG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFR---TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp ECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EcccccceecCCCCccce---eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 999999987754322110 01234579999999999976 568999999999999999999 9999976432
Q ss_pred CCHHHHHHHHhhccccc-cHHHH-hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 218 GTKKQKYEKISEKKVST-SIEAL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 218 ~~~~~~~~~i~~~~~~~-~~~~l-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
. .. .+....... ....+ ...+++++.++|..||..||.+||++.+|+
T Consensus 246 ~--~~---~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 246 R--ES---NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp H--HH---HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred h--HH---HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 1 11 111111110 00000 112458899999999999999999988875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=347.65 Aligned_cols=253 Identities=17% Similarity=0.197 Sum_probs=190.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecCCC
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGP 86 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~g~ 86 (473)
.+|.+.+.||+|+||+||.. ...+++.||||++.......+.+|+.+++.+..|++|..+..+.......+|||||+++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g 102 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA 102 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC
Confidence 35999999999999997643 34789999999977766667889999999996667777777778888999999999999
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCC--CCCcEEEEecCCcccccCCCCcccc
Q 011988 87 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 87 sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~--~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
+|.+++......+.+..++.|+.||+.||.|||++||+||||||+||||+.++ ....+||+|||+|+.+......
T Consensus 103 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~--- 179 (432)
T 3p23_A 103 TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS--- 179 (432)
T ss_dssp EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---------
T ss_pred CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc---
Confidence 99999986655667777889999999999999999999999999999996332 2346889999999876543211
Q ss_pred ccccCCCcccCcccccccccc---CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 165 PYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~---~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
+.......||+.|+|||++. +..++.++|||||||+||||++ |..||..... .+ ...+........ ....
T Consensus 180 -~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---~~-~~~~~~~~~~~~-~~~~ 253 (432)
T 3p23_A 180 -FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---RQ-ANILLGACSLDC-LHPE 253 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---HH-HHHHTTCCCCTT-SCTT
T ss_pred -eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---HH-HHHHhccCCccc-cCcc
Confidence 11224567999999999998 4567889999999999999999 9999965322 11 111111111000 0001
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...+..+.+||..||..||.+||++.+|+
T Consensus 254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 254 KHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp CHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 12346689999999999999999988875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.48 Aligned_cols=250 Identities=17% Similarity=0.228 Sum_probs=198.2
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----c----------------hhHHHHHHHHHHhcCCCC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----H----------------PQLQYEAKLYKILQGGTG 63 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~----------------~~l~~E~~il~~L~~~~~ 63 (473)
...++|++.+.||+|+||.||+|.+ +++.||||++.... . ..+.+|+.+++.|+|+ +
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~ 104 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE-Y 104 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT-T
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC-C
Confidence 3457999999999999999999998 89999999843211 0 6789999999999855 4
Q ss_pred CCeeEEeeEeCCeEEEEEecC-CCCHHHH------HHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEE
Q 011988 64 IPNLRWFGVEGDYNVLVIDLL-GPSLEDL------FNFC-SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFL 134 (473)
Q Consensus 64 i~~~~~~~~~~~~~~lv~e~~-g~sL~~~------l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NIL 134 (473)
|..+..+....+..++||||+ +++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 555555667778899999999 6699988 5422 4579999999999999999999999 99999999999999
Q ss_pred EeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCC-CCCc-hhhHHHHHHHHHHHHcCCCCC
Q 011988 135 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSR-RDDLESLGYVLMYFLRGSLPW 212 (473)
Q Consensus 135 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~-ksDVwSlGviL~elltG~~Pf 212 (473)
++ .++.+||+|||++....... .....||..|+|||++.+. .++. ++|||||||++|||++|..||
T Consensus 185 ~~---~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 185 MD---KNGRVKLSDFGESEYMVDKK---------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp EC---TTSCEEECCCTTCEECBTTE---------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred Ec---CCCcEEEecccccccccccc---------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 94 77899999999998764431 1345799999999999987 5666 999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhhcccccc--------------HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 213 QGLKAGTKKQKYEKISEKKVSTS--------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 213 ~~~~~~~~~~~~~~i~~~~~~~~--------------~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
...... ......+.......+ .......++.++.+||..||..||.+||++.++++
T Consensus 253 ~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 253 SLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 875431 333344433222111 01112568899999999999999999999887743
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=321.04 Aligned_cols=240 Identities=18% Similarity=0.215 Sum_probs=183.3
Q ss_pred ccCCceEEE-eeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEe----CCeEE
Q 011988 4 RVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVE----GDYNV 78 (473)
Q Consensus 4 ~i~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~----~~~~~ 78 (473)
.+.++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++..+..|++|..+..++.. ....+
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 355678887 789999999999999999999999999653 45678899998666556666666555544 66789
Q ss_pred EEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 79 LVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++..+..+.+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 999999 679999998653 369999999999999999999999999999999999999643337899999999986432
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH-HHHhhcccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVSTS 235 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~~ 235 (473)
+..++.++|||||||+||||++|..||.+.......... ..+..... ..
T Consensus 172 -----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 221 (299)
T 3m2w_A 172 -----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EF 221 (299)
T ss_dssp -----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC-SS
T ss_pred -----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc-cC
Confidence 134678999999999999999999999764321100000 00111111 11
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
.......+++++.++|..||..||.+||++.++ |++.|..
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~---l~hp~~~ 261 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPWIM 261 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHH---hcChhhc
Confidence 122335789999999999999999999998877 5555544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=317.38 Aligned_cols=230 Identities=11% Similarity=0.064 Sum_probs=185.7
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc------hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH------PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~------~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
.++++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+|+.++..+.|+ +|..+..++...+..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp-~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP-GVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCT-TBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCC-CcceeeEEEEECCcE
Confidence 567899999999999999999999999999999999654432 4588999999999755 555666677788899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
|+||||+ |++|.+++.. .....+++.|+.||+.||+|||++||+||||||+||||+ .++.+||+++|.
T Consensus 107 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~~----- 175 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPAT----- 175 (286)
T ss_dssp EEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCCC-----
T ss_pred EEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEeccc-----
Confidence 9999999 7899999852 246678899999999999999999999999999999995 678888875442
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
++ .++.++|||||||+||||++|+.||.+...........+... ......
T Consensus 176 ----------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~ 225 (286)
T 3uqc_A 176 ----------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA-GQPIEP 225 (286)
T ss_dssp ----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT-SCBCCH
T ss_pred ----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc-cCCCCh
Confidence 22 368899999999999999999999987554221100000011 112334
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
..+...+|+++.++|.+||+.||++| ++.++++.|+++.
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 45667899999999999999999999 9999999998875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.32 Aligned_cols=241 Identities=15% Similarity=0.200 Sum_probs=190.0
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcC-CCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCC---
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD--- 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~--- 75 (473)
++.++|++.+.||+|+||.||+|.+.. +++.||||++..... ..+..|+.+++.++|++++..+..+.....
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 467899999999999999999999976 789999998654332 346789999999987666666555544433
Q ss_pred -eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 76 -YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 76 -~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
..||||||+ |++|.+++. ..+++.+++.|+.||+.||.|||++|||||||||+||||+ .+.+||+|||+++
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~----~~~~kl~DFG~a~ 229 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVS 229 (681)
T ss_dssp EEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----SSCEEECCCTTCE
T ss_pred ceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe----CCcEEEEecccch
Confidence 269999999 789988775 2799999999999999999999999999999999999995 2489999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
..... ....||+.|+|||++.+.. +.++|||||||+||+|++|..||.+....... ..
T Consensus 230 ~~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------~~ 287 (681)
T 2pzi_A 230 RINSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------ED 287 (681)
T ss_dssp ETTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------TT
T ss_pred hcccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc----------cc
Confidence 66432 2457999999999998754 89999999999999999999998753221100 00
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHH
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFI 277 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~l~~ 277 (473)
... ..+++.+.++|.+||..||++|| +++++.+.|..++.
T Consensus 288 ~~~----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 288 DPV----LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp CHH----HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ccc----cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 001 12357899999999999999999 46777777776653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=348.42 Aligned_cols=265 Identities=17% Similarity=0.231 Sum_probs=194.3
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeE-----eC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV-----EG 74 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~-----~~ 74 (473)
...++|++.++||.|+||.||+|.+..+|+.||||++.... ...+.+|+.+++.++|++++..+..+.. ..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 34588999999999999999999999999999999865432 2347789999999986655554443221 26
Q ss_pred CeEEEEEecC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCC
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 151 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~~--~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 151 (473)
...++||||+ |++|.+++..... .+++..++.|+.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 6779999999 8899999985432 589999999999999999999999999999999999997544455699999999
Q ss_pred cccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCH------HHHHH
Q 011988 152 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYE 225 (473)
Q Consensus 152 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~------~~~~~ 225 (473)
++....... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+...... .....
T Consensus 171 a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQGEL--------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp CCBTTSCCC--------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred ccccccccc--------cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 987654322 1346899999999999999999999999999999999999999965311000 00000
Q ss_pred HHh-hc---------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHH-----HHHHHHHHH
Q 011988 226 KIS-EK---------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY-----LKRLFRDLF 276 (473)
Q Consensus 226 ~i~-~~---------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~-----l~~~L~~l~ 276 (473)
.+. .. ........+...+++++.++|..||..||++||++.+ ..+.+++++
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 000 00 0000011123346789999999999999999999877 344555554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=316.90 Aligned_cols=240 Identities=19% Similarity=0.170 Sum_probs=177.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----------chhHHHHHHHHHHhc--------CCCCCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------HPQLQYEAKLYKILQ--------GGTGIPN 66 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----------~~~l~~E~~il~~L~--------~~~~i~~ 66 (473)
.++|++.++||+|+||+||+|++ +|+.||||++.... ...+.+|+.+++.|+ .|+++..
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 36799999999999999999997 78999999965432 156889999999997 2444443
Q ss_pred e-EEeeE-----------------------------eCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHH
Q 011988 67 L-RWFGV-----------------------------EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115 (473)
Q Consensus 67 ~-~~~~~-----------------------------~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL 115 (473)
+ ..+.. .....+|||||+ ++++.+.+. ...+++..++.|+.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHH
Confidence 3 33221 267889999998 664444443 35689999999999999999
Q ss_pred HHHH-hCCCcccCCCCCcEEEeeCC-----------------CCCcEEEEecCCcccccCCCCccccccccCCCcccCcc
Q 011988 116 EFVH-SKSFLHRDIKPDNFLMGLGR-----------------RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 177 (473)
Q Consensus 116 ~yLH-~~gIvHrDIKP~NILl~~~~-----------------~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~ 177 (473)
+||| ++|||||||||+||||+.++ ....+||+|||+|+..... ...||+.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------~~~gt~~ 242 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------IVVFCDV 242 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------EEECCCC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------cEEEeec
Confidence 9999 99999999999999997432 1128999999999876532 3479999
Q ss_pred ccccccccCCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCCCCHHHHHHHHhhc-c-ccccHHHHhcCCcHHHHHHHHHH
Q 011988 178 YASMNTHLGIEQSRRDDLESLGYV-LMYFLRGSLPWQGLKAGTKKQKYEKISEK-K-VSTSIEALCRGYPTEFASYFHYC 254 (473)
Q Consensus 178 Y~APE~~~~~~~s~ksDVwSlGvi-L~elltG~~Pf~~~~~~~~~~~~~~i~~~-~-~~~~~~~l~~~~p~~l~~li~~c 254 (473)
|+|||++.+.. +.++||||||++ .++++.|..||.+... .......+... . .......+...+++++.+||..|
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence 99999999876 999999998887 6778889999843100 01111122211 0 01111223345689999999999
Q ss_pred hcCCCCCCCCHHHHH
Q 011988 255 RSLRFDDKPDYAYLK 269 (473)
Q Consensus 255 l~~dp~~RPt~~~l~ 269 (473)
|..| |+++++
T Consensus 320 L~~d-----sa~e~l 329 (336)
T 2vuw_A 320 LNFS-----SATDLL 329 (336)
T ss_dssp GGSS-----SHHHHH
T ss_pred hccC-----CHHHHH
Confidence 9976 766664
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=285.73 Aligned_cols=184 Identities=15% Similarity=0.140 Sum_probs=130.8
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEcccCC-------------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-------------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-------------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
..++.|++|.+..++....|+.|+||++.+.. ..++.+|+++|+++.++++|+.+..++.+....||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 34567888888887877889999999864431 23588999999999889999999999999999999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ |++|.+++.. ..++++. .|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~---~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD---ARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC---TTSCEEECCCTTEESCC--
T ss_pred EEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC---CCCCEEEeecccCeeCCCC
Confidence 99999 8899999984 4567765 4789999999999999999999999999994 7889999999999876554
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 211 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~P 211 (473)
... ..+.+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 393 ~~~-------~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSW-------PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CC-------SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Ccc-------ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 321 245689999999999987 467789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-27 Score=253.38 Aligned_cols=187 Identities=20% Similarity=0.167 Sum_probs=139.1
Q ss_pred EEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
...+.||+|+||.||+|. ..++.+++|...... ...+.+|+++++.++|++++ .+..++...+..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv-~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIP-APYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCC-CCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcC-ceEEEEEeCCccE
Confidence 345689999999999995 567889999733322 12368999999999866555 3344445667779
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
|||||+ |++|.+++.. ++.|+.||+.||+|||++||+||||||+|||++ . .+||+|||+|+....
T Consensus 416 lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCC
T ss_pred EEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCC
Confidence 999999 7999999873 678999999999999999999999999999994 3 999999999997754
Q ss_pred CCCccccccccCCCcccCccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQ 213 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~--~~~s~ksDVwSlGviL~elltG~~Pf~ 213 (473)
........+.....+.||+.|||||++.+ ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32211000011235689999999999987 557888999999999999888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-24 Score=210.43 Aligned_cols=141 Identities=16% Similarity=0.237 Sum_probs=111.6
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---------------------chhHHHHHHHHHHhcCCCCCCe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---------------------HPQLQYEAKLYKILQGGTGIPN 66 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---------------------~~~l~~E~~il~~L~~~~~i~~ 66 (473)
.|.+.+.||+|+||.||+|.+ .+|+.||||+..... ...+.+|+.+++.+.+ +..
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 455669999999999999999 889999999864321 2347899999999982 444
Q ss_pred eEEeeEeCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEE
Q 011988 67 LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 145 (473)
Q Consensus 67 ~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vk 145 (473)
+..+.. ...++||||+ |++|.+ +. ......++.||+.||.|||++||+||||||+|||++ ++.+|
T Consensus 167 ~~~~~~--~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~vk 232 (282)
T 1zar_A 167 PKVYAW--EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIW 232 (282)
T ss_dssp CCEEEE--ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEE
T ss_pred CeEEec--cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcEE
Confidence 443333 3458999999 679987 32 134567999999999999999999999999999994 78999
Q ss_pred EEecCCcccccCCCCccccccccCCCcccCccccccccccC
Q 011988 146 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG 186 (473)
Q Consensus 146 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~ 186 (473)
|+|||+|+. +..|+|||.+..
T Consensus 233 l~DFG~a~~--------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 233 IIDFPQSVE--------------------VGEEGWREILER 253 (282)
T ss_dssp ECCCTTCEE--------------------TTSTTHHHHHHH
T ss_pred EEECCCCeE--------------------CCCCCHHHHHHH
Confidence 999999952 345788998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=188.87 Aligned_cols=135 Identities=19% Similarity=0.246 Sum_probs=106.2
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcE--EEEEEcccCCc---------------------------hhHHHHHHHHHHh
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLNVKTKH---------------------------PQLQYEAKLYKIL 58 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~--vAiK~~~~~~~---------------------------~~l~~E~~il~~L 58 (473)
-|.+.+.||+|+||.||+|.+..+|+. ||||+...... ..+.+|+.++..|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998778999 99998432210 1478899999999
Q ss_pred cCCCC-CCeeEEeeEeCCeEEEEEecCCC------CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccCCCC
Q 011988 59 QGGTG-IPNLRWFGVEGDYNVLVIDLLGP------SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKP 130 (473)
Q Consensus 59 ~~~~~-i~~~~~~~~~~~~~~lv~e~~g~------sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH-~~gIvHrDIKP 130 (473)
.+... ++.+.. . ...+|||||+++ +|.++... +++..+..++.||+.||.||| ++|||||||||
T Consensus 128 ~~~~i~~p~~~~--~--~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYT--Y--MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEE--E--ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEE--c--CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 86532 333332 2 245899999953 77776431 335577899999999999999 99999999999
Q ss_pred CcEEEeeCCCCCcEEEEecCCcccc
Q 011988 131 DNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 131 ~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
+|||++ . .++|+|||+|...
T Consensus 200 ~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEES---S--SEEECCCTTCEET
T ss_pred HHEEEc---C--cEEEEECcccccC
Confidence 999994 3 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-17 Score=167.71 Aligned_cols=135 Identities=18% Similarity=0.256 Sum_probs=97.6
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----------------chh--------HHHHHHHHHHhcCCCC
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----------------HPQ--------LQYEAKLYKILQGGTG 63 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----------------~~~--------l~~E~~il~~L~~~~~ 63 (473)
|.|.++||.|+||.||+|.+ .+|+.||||+..... ... ..+|...|..|. ..+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HTT
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hcC
Confidence 89999999999999999997 579999999843210 000 235777888885 344
Q ss_pred CCeeEEeeEeCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCC-
Q 011988 64 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA- 141 (473)
Q Consensus 64 i~~~~~~~~~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~- 141 (473)
+.....+.... .+|||||+ |..|.++. .......++.||+.+|.|||++|||||||||.|||++.+++.
T Consensus 175 v~vp~p~~~~~--~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 175 FPVPEPIAQSR--HTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CSCCCEEEEET--TEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCCeeeeccC--ceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 44433333333 37999999 55654432 223456788999999999999999999999999999743211
Q ss_pred ------CcEEEEecCCccc
Q 011988 142 ------NQVYIIDFGLAKR 154 (473)
Q Consensus 142 ------~~vkL~DFGla~~ 154 (473)
..+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 1489999998864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=2.3e-12 Score=123.37 Aligned_cols=136 Identities=17% Similarity=0.262 Sum_probs=108.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc---CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~---~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
+.|++...++.|+++.||++.. .+..+++|+... .....+..|+.+++.|..+..++.+..++......+++||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 5699999999999999999973 468899999543 34456999999999997666677787788888889999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS------------------------------------------ 120 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~------------------------------------------ 120 (473)
+ |.+|.+.+. +......++.+++.+|..||+
T Consensus 92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 9 667776521 122345788999999999998
Q ss_pred -----------------CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 121 -----------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 121 -----------------~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
..++|+|++|.|||++ +...+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhcc
Confidence 4589999999999994 34455799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.5e-11 Score=116.79 Aligned_cols=134 Identities=16% Similarity=0.091 Sum_probs=98.6
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCC-CCeeEEeeEeCCeEEEEEecC-
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTG-IPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~-i~~~~~~~~~~~~~~lv~e~~- 84 (473)
..|.+....+.|..+.||++.. .+|..++||+........+..|+.+++.|.++.. ++.+..++......+++||++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 4577765555667799999963 5677899999655444668999999999987644 666767777777789999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 011988 85 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS------------------------------------------ 122 (473)
Q Consensus 85 g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g------------------------------------------ 122 (473)
|.+|. .. ..+ ...++.+++..|..||+..
T Consensus 99 G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 99 GQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp SEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred CcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 55663 11 122 2356777778888888643
Q ss_pred ----------------CcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 123 ----------------FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 123 ----------------IvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
++|+|++|.|||++ +...+.|+|||.+.
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhcc
Confidence 99999999999994 34456799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=4.6e-10 Score=112.62 Aligned_cols=139 Identities=14% Similarity=0.221 Sum_probs=99.6
Q ss_pred EEEeeEeecCceEEEEEEEcCCCcEEEEEEcc--cCC----chhHHHHHHHHHHhcCCCC-CCeeEEeeEeC---CeEEE
Q 011988 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNV--KTK----HPQLQYEAKLYKILQGGTG-IPNLRWFGVEG---DYNVL 79 (473)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~--~~~----~~~l~~E~~il~~L~~~~~-i~~~~~~~~~~---~~~~l 79 (473)
..++.|+.|.++.||++.. .+..+++|+.. ... ...+.+|..+++.|..... ++.+..++.+. ...++
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 3467889999999999874 34678899854 221 3468899999999986332 55565555544 34789
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-------------------------------------- 120 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-------------------------------------- 120 (473)
|||++ |..+.+. .-..++..+...++.+++..|..||.
T Consensus 119 vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999 4444321 12347788889999999999999997
Q ss_pred --------------------CCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 121 --------------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 121 --------------------~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
.++||+|++|.|||++.+ ....+.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~-~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPT-EPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSS-SSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCC-CCcEEEEECcccccc
Confidence 358999999999999521 113468999999863
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.02 E-value=1.7e-10 Score=113.01 Aligned_cols=189 Identities=15% Similarity=0.182 Sum_probs=118.3
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccC-CchhHHHHHHHHHHhcCCCCC--CeeEEeeEeCC---eEEEEEecC-
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-KHPQLQYEAKLYKILQGGTGI--PNLRWFGVEGD---YNVLVIDLL- 84 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~~~~i--~~~~~~~~~~~---~~~lv~e~~- 84 (473)
++.++.|.+..||++. ..+++|+.... ....+..|..+++.|.....+ +.+..++.... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999863 46889984332 235688999999998654433 44444433333 347889999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 011988 85 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-------------------------------------------- 120 (473)
Q Consensus 85 g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-------------------------------------------- 120 (473)
|..|.+... ..++..+...++.|++..|..||+
T Consensus 100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 556654322 247788888889999999998886
Q ss_pred --------------CCCcccCCCCCcEEEeeCCC-CCcEEEEecCCcccccCCCCcccccccc-------CCCcccCccc
Q 011988 121 --------------KSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKRYRDTATHQHIPYRE-------NKNLTGTARY 178 (473)
Q Consensus 121 --------------~gIvHrDIKP~NILl~~~~~-~~~vkL~DFGla~~~~~~~~~~~~p~~~-------~~~~~Gt~~Y 178 (473)
..++|+|++|.|||++ ++ ...+.|+||+.+................ ...+.....+
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~--~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFD--TEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEE--TTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEe--CCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1369999999999996 22 4567899999986532211000000000 0000000001
Q ss_pred cc-cccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 011988 179 AS-MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 212 (473)
Q Consensus 179 ~A-PE~~~~~~~s~ksDVwSlGviL~elltG~~Pf 212 (473)
.. |+.... .....+.|++|.++|.+.+|..+|
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 221111 122358999999999999998877
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=2.6e-07 Score=88.33 Aligned_cols=132 Identities=17% Similarity=0.167 Sum_probs=95.0
Q ss_pred eEeecCce-EEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CCCHHHH
Q 011988 14 KIGSGSFG-EIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDL 91 (473)
Q Consensus 14 ~LG~G~fG-~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~sL~~~ 91 (473)
.+..|..| .||+......+..+++|+........+..|..+|+.|...--++.+..++.+.+..+++|+++ |.++.+.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 34445554 699988766778899998655555678899999999986555777888888888999999999 5566665
Q ss_pred HHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------------
Q 011988 92 FNFCSRKLSLKTVLMLADQMINRVEFVHSK-------------------------------------------------- 121 (473)
Q Consensus 92 l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-------------------------------------------------- 121 (473)
.... ......+..+++..|..||..
T Consensus 111 ~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 185 (272)
T 4gkh_A 111 LEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK 185 (272)
T ss_dssp HHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred ccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence 4421 122334555666666666631
Q ss_pred --------CCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 122 --------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 122 --------gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
.++|+|+.+.|||++ ..+.+-|+||+.+.
T Consensus 186 ~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 186 LLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred cccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECcccc
Confidence 168999999999995 44556799999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=5.5e-07 Score=88.19 Aligned_cols=135 Identities=24% Similarity=0.265 Sum_probs=90.1
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccC-CchhHHHHHHHHHHhcCCCC--CCeeEEeeE-eCCeEEEEEecC-CC
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-KHPQLQYEAKLYKILQGGTG--IPNLRWFGV-EGDYNVLVIDLL-GP 86 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~~~~--i~~~~~~~~-~~~~~~lv~e~~-g~ 86 (473)
++.++.|....||+. +..+++|+.... ....+..|..+|+.|.++.. ++.+..++. .....+++|+++ |.
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456788999999987 567889984221 23468899999999986432 455555553 345678999999 55
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 011988 87 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------------------------------------------- 121 (473)
Q Consensus 87 sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~--------------------------------------------- 121 (473)
.|.+..- ..++..+...++.++...|..||+.
T Consensus 99 ~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 6554221 1345555555666666666655542
Q ss_pred ---------------CCcccCCCCCcEEEeeCCCCCc-EEEEecCCccc
Q 011988 122 ---------------SFLHRDIKPDNFLMGLGRRANQ-VYIIDFGLAKR 154 (473)
Q Consensus 122 ---------------gIvHrDIKP~NILl~~~~~~~~-vkL~DFGla~~ 154 (473)
.++|+|++|.|||++.++..+. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999952111344 58999998853
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.4e-06 Score=86.62 Aligned_cols=74 Identities=15% Similarity=0.190 Sum_probs=49.9
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEEcccC----------CchhHHHHHHHHHHhcCC--CCCCeeEEeeEeCCeEE
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT----------KHPQLQYEAKLYKILQGG--TGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~----------~~~~l~~E~~il~~L~~~--~~i~~~~~~~~~~~~~~ 78 (473)
-.+.||.|.++.||++.....++.|+||..... ....+..|.++++.+... ..++.+..+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 356899999999999976556788999973221 123467899999998653 345555444 344568
Q ss_pred EEEecCCC
Q 011988 79 LVIDLLGP 86 (473)
Q Consensus 79 lv~e~~g~ 86 (473)
+|||++.+
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999954
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1.8e-06 Score=86.01 Aligned_cols=77 Identities=13% Similarity=0.297 Sum_probs=52.3
Q ss_pred eEEEeeE-eecCceEEEEEEEc--C----CCcEEEEEEcccCC------chhHHHHHHHHHHhcCC--CCCCeeEEeeEe
Q 011988 9 FRLGRKI-GSGSFGEIYLGTNI--Q----TNEEVAIKLNVKTK------HPQLQYEAKLYKILQGG--TGIPNLRWFGVE 73 (473)
Q Consensus 9 y~i~~~L-G~G~fG~Vy~a~~~--~----~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~--~~i~~~~~~~~~ 73 (473)
....+.| +.|....+|+.... . ++..+++|+..... ...+..|..+++.|... -.++.+..++..
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456778 88889999988643 1 26689999843321 24688999999999754 235555555544
Q ss_pred C---CeEEEEEecCC
Q 011988 74 G---DYNVLVIDLLG 85 (473)
Q Consensus 74 ~---~~~~lv~e~~g 85 (473)
. ...+++||++.
T Consensus 102 ~~~~g~~~~v~e~l~ 116 (357)
T 3ats_A 102 GDVLGTPFFLMDYVE 116 (357)
T ss_dssp STTTSSCEEEEECCC
T ss_pred CCccCCceEEEEecC
Confidence 3 24578999983
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.04 E-value=3.1e-05 Score=76.01 Aligned_cols=72 Identities=11% Similarity=0.143 Sum_probs=42.6
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCC-CCCeeEE------eeEeCCeEEEEEecC
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGT-GIPNLRW------FGVEGDYNVLVIDLL 84 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~-~i~~~~~------~~~~~~~~~lv~e~~ 84 (473)
++.|+.|..+.||++.. .+..+++|+... ....+..|..+++.|.... .++.+.. +.......+++|+++
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 44566677899999874 234589998654 3345667788888776321 2233221 223466778999999
Q ss_pred CC
Q 011988 85 GP 86 (473)
Q Consensus 85 g~ 86 (473)
.|
T Consensus 114 ~G 115 (346)
T 2q83_A 114 EG 115 (346)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00011 Score=71.28 Aligned_cols=67 Identities=12% Similarity=0.096 Sum_probs=46.7
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-CC
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GP 86 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~-g~ 86 (473)
++.|+.|....+|++ ..+++|+.... ..-....|..+++.+......+.+..+ +.+..+++++|+ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 678899999999998 56889985432 122356899999998866555565543 344457889998 44
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00013 Score=74.44 Aligned_cols=72 Identities=14% Similarity=0.331 Sum_probs=44.9
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEEcc-------cC---CchhHHHHHHHHHHhc--CCCCCCeeEEeeEeCCeEE
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNV-------KT---KHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~-------~~---~~~~l~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~ 78 (473)
-.+.||.|..+.||++. .++..++||... .. .......|.+++..+. .+..++.+..++ ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 35678999999999996 356789999411 11 0123344555554442 233455555554 56678
Q ss_pred EEEecC-CC
Q 011988 79 LVIDLL-GP 86 (473)
Q Consensus 79 lv~e~~-g~ 86 (473)
+|||++ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 65
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00022 Score=69.92 Aligned_cols=73 Identities=22% Similarity=0.319 Sum_probs=57.2
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCC--CCCCeeEEeeEeCCeEEEEEecCC
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGG--TGIPNLRWFGVEGDYNVLVIDLLG 85 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~--~~i~~~~~~~~~~~~~~lv~e~~g 85 (473)
-.+.|+.|.+..+|+... .+..++||+........+..|...|+.|... ..++.+..++......+++||++.
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 457789999999999873 5678899986554456688999999999743 456667777777778999999993
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.63 E-value=0.0012 Score=60.65 Aligned_cols=123 Identities=13% Similarity=0.108 Sum_probs=79.7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 86 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 86 ~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yL-H~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
-+|.+++...+.+++++++|.++.|.+.+|.-+ +.+.-..+=+-|..|+|. .+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-cccc-----------
Confidence 489999998899999999999999999998776 222212333446788884 667666553 1110
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCc
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 244 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 244 (473)
.....+.+||... ...+.+.=|||||++||..+-=.+|=. ....++
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~-------------------------eE~eLS 143 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN-------------------------EERELS 143 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT-------------------------EEECCC
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc-------------------------cchhhC
Confidence 1123466787763 245678899999999999887333311 124567
Q ss_pred HHHHHHHHHHhcC
Q 011988 245 TEFASYFHYCRSL 257 (473)
Q Consensus 245 ~~l~~li~~cl~~ 257 (473)
++|.+||..|..-
T Consensus 144 ~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 144 PPLEQLIDHMANT 156 (229)
T ss_dssp HHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhc
Confidence 8888899888755
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.0012 Score=63.42 Aligned_cols=77 Identities=14% Similarity=0.093 Sum_probs=56.2
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.+.+..-++.+|.|..+.||+.+. .+|+.|++|+..... ...+..|...|+.|.....++....+..... +++|
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~--~lv~ 89 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDDR--TLAM 89 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEETT--EEEE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccCc--eEEE
Confidence 456677889999999999999984 678999999843322 3457899999999975544444444444443 6788
Q ss_pred ecC
Q 011988 82 DLL 84 (473)
Q Consensus 82 e~~ 84 (473)
|++
T Consensus 90 e~l 92 (288)
T 3f7w_A 90 EWV 92 (288)
T ss_dssp ECC
T ss_pred Eee
Confidence 887
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00021 Score=70.23 Aligned_cols=140 Identities=19% Similarity=0.154 Sum_probs=72.7
Q ss_pred EeeEeecCceE-EEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCC-CCeeEEeeEeCCeEEEEEecCCC-CH
Q 011988 12 GRKIGSGSFGE-IYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTG-IPNLRWFGVEGDYNVLVIDLLGP-SL 88 (473)
Q Consensus 12 ~~~LG~G~fG~-Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~-i~~~~~~~~~~~~~~lv~e~~g~-sL 88 (473)
.+.|+.|.... +|+... .++..+++|.........+..|+.+++.|..... ++.+..+.... .+++||.+++ .+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l 99 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALF 99 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBH
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcch
Confidence 34565554444 667652 2367788887444332456788999998875432 45554443322 3688998853 55
Q ss_pred HHHHHHc-------------------C------CCCCHHHHH-------H-HH------------HHHHHHHHHH-----
Q 011988 89 EDLFNFC-------------------S------RKLSLKTVL-------M-LA------------DQMINRVEFV----- 118 (473)
Q Consensus 89 ~~~l~~~-------------------~------~~ls~~~~~-------~-i~------------~qi~~aL~yL----- 118 (473)
.+.+... . ..++..... . +. ..+...+..|
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 4333210 0 012221110 0 00 0111222233
Q ss_pred -HhCCCcccCCCCCcEEEeeCCC-CCcEEEEecCCccc
Q 011988 119 -HSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKR 154 (473)
Q Consensus 119 -H~~gIvHrDIKP~NILl~~~~~-~~~vkL~DFGla~~ 154 (473)
+...++|+|+.+.|||++.+.. .+.+.|+||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1346999999999999952100 25789999999864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0011 Score=64.46 Aligned_cols=139 Identities=17% Similarity=0.190 Sum_probs=78.2
Q ss_pred EEEeeEeecCceEEEEEEEcCCCcEEEEEEccc-CCchhHHHHHHHHHHhcCCCC-CCeeEEe------eEeCCeEEEEE
Q 011988 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK-TKHPQLQYEAKLYKILQGGTG-IPNLRWF------GVEGDYNVLVI 81 (473)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~-~~~~~l~~E~~il~~L~~~~~-i~~~~~~------~~~~~~~~lv~ 81 (473)
.-++.|+.|....+|++.. ..+ .+++|+... .....+..|..+++.|..... ++.+... .......+++|
T Consensus 25 ~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 3456778888899999874 333 688998655 345568889999998874432 3333211 12345668899
Q ss_pred ecCCC-CH-----HH------H---HHHcCCCC--------CHHHHHH---------------HHHHHHHHHHHHHh---
Q 011988 82 DLLGP-SL-----ED------L---FNFCSRKL--------SLKTVLM---------------LADQMINRVEFVHS--- 120 (473)
Q Consensus 82 e~~g~-sL-----~~------~---l~~~~~~l--------s~~~~~~---------------i~~qi~~aL~yLH~--- 120 (473)
+++.| .+ .. . +......+ ....... +...+...+++|..
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 99843 21 11 1 11111111 1110000 00123445555653
Q ss_pred ----CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 121 ----KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 121 ----~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
.++||+|+.+.|||++ ....+.|+||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence 4699999999999995 33445799999874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0027 Score=64.86 Aligned_cols=71 Identities=13% Similarity=0.128 Sum_probs=50.2
Q ss_pred EEeeEeecCceEEEEEEEcC-------CCcEEEEEEcccCCc-hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 11 LGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLNVKTKH-PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~~~~~~~-~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
-++.|+.|-...||++.... .+..|++|+...... ..+..|..+++.|......+.+.++. .+ .++|+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~--g~v~e 152 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG--GRLEE 152 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT--EEEEC
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC--CEEEE
Confidence 45678888899999998642 257899999643233 56778999999998666666664433 22 37888
Q ss_pred cCC
Q 011988 83 LLG 85 (473)
Q Consensus 83 ~~g 85 (473)
|+.
T Consensus 153 ~l~ 155 (429)
T 1nw1_A 153 YIP 155 (429)
T ss_dssp CCC
T ss_pred EeC
Confidence 883
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.004 Score=60.67 Aligned_cols=72 Identities=11% Similarity=0.065 Sum_probs=46.2
Q ss_pred eeEeecCceEEEEEEEcCCCcEEEEEEccc--CCchhHHHHHHHHHHhcCCCC-CCeeEEe-----eEeCCeEEEEEecC
Q 011988 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLNVK--TKHPQLQYEAKLYKILQGGTG-IPNLRWF-----GVEGDYNVLVIDLL 84 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~--~~~~~l~~E~~il~~L~~~~~-i~~~~~~-----~~~~~~~~lv~e~~ 84 (473)
..|+ |....||++.. .+|+.+++|+... .....+..|..+++.|..... ++.+... .......+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3456 78889998763 4566799999643 234567889999998874322 2322221 12345668899998
Q ss_pred CC
Q 011988 85 GP 86 (473)
Q Consensus 85 g~ 86 (473)
+|
T Consensus 110 ~G 111 (328)
T 1zyl_A 110 GG 111 (328)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0025 Score=64.00 Aligned_cols=138 Identities=17% Similarity=0.174 Sum_probs=80.1
Q ss_pred EeeEeecCceEEEEEEEcC-------CCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 12 GRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
++.|..|-...+|++.... .++.|++|+.... ....+.+|..+++.|......+.+.+++. + .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEE
Confidence 3567678888899998532 3578999984321 23456789999999987666666654433 3 38899
Q ss_pred cCCC-CH--------------HHHHHH-cC------CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 011988 83 LLGP-SL--------------EDLFNF-CS------RKLS--LKTVLMLADQMIN-------------------RVEFVH 119 (473)
Q Consensus 83 ~~g~-sL--------------~~~l~~-~~------~~ls--~~~~~~i~~qi~~-------------------aL~yLH 119 (473)
|+.| .| .+.+.. +. +... +..+..+..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 8832 21 111111 11 1122 3455555544422 233333
Q ss_pred ----h----CCCcccCCCCCcEEEeeC-CCCCcEEEEecCCcc
Q 011988 120 ----S----KSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAK 153 (473)
Q Consensus 120 ----~----~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGla~ 153 (473)
. ..++|+|+.+.|||+..+ +..+.+.|+||..|.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 258999999999999622 113689999999885
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0018 Score=64.60 Aligned_cols=72 Identities=15% Similarity=0.016 Sum_probs=44.0
Q ss_pred EEeeEeecCceEEEEEEEcC--------CCcEEEEEEcccCCc--hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 11 LGRKIGSGSFGEIYLGTNIQ--------TNEEVAIKLNVKTKH--PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~--------~~~~vAiK~~~~~~~--~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
-.+.|+.|....+|++.... .+..+++|+...... .....|..+++.|.....++.+.... . .+++
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 35677888888999998543 136899998543211 13478999999997655555554332 2 3688
Q ss_pred EecCCC
Q 011988 81 IDLLGP 86 (473)
Q Consensus 81 ~e~~g~ 86 (473)
|+++.+
T Consensus 113 ~e~i~G 118 (369)
T 3c5i_A 113 EEWLYG 118 (369)
T ss_dssp EECCCS
T ss_pred EEEecC
Confidence 998843
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0097 Score=61.31 Aligned_cols=70 Identities=13% Similarity=0.032 Sum_probs=47.0
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
-++.|+.|-...+|++.....+..|++|+..... .-....|..+++.|......+.+..++ .. .++|+|+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEee
Confidence 3567888889999999865445789999853322 112368999999998766666665554 22 3589988
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.62 E-value=0.039 Score=56.15 Aligned_cols=72 Identities=13% Similarity=0.131 Sum_probs=48.8
Q ss_pred EEeeEeecCceEEEEEEEcCC-------CcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 11 LGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~-------~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
-++.|..|-...+|++..... +..|++|+.... ..-...+|..+++.|......+.+.. ... .++||
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~--~~~--~~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIA--DFP--EGRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEE--EET--TEEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEE--EcC--CCEEE
Confidence 356677788889999986421 578999984332 12235789999999986666666653 223 26889
Q ss_pred ecCCC
Q 011988 82 DLLGP 86 (473)
Q Consensus 82 e~~g~ 86 (473)
+|+.+
T Consensus 150 efI~G 154 (424)
T 3mes_A 150 EFIDG 154 (424)
T ss_dssp ECCCS
T ss_pred EEeCC
Confidence 99833
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.45 E-value=0.13 Score=50.42 Aligned_cols=31 Identities=32% Similarity=0.555 Sum_probs=25.9
Q ss_pred CCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 121 ~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..++|+|+.+.|||++ .++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~---~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVG---NEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEEC---GGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEe---CCCeEEEEECCCCee
Confidence 4689999999999994 456799999988753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.23 E-value=0.18 Score=50.70 Aligned_cols=31 Identities=29% Similarity=0.538 Sum_probs=25.5
Q ss_pred CcccCCCCCcEEEeeC---CCCCcEEEEecCCcc
Q 011988 123 FLHRDIKPDNFLMGLG---RRANQVYIIDFGLAK 153 (473)
Q Consensus 123 IvHrDIKP~NILl~~~---~~~~~vkL~DFGla~ 153 (473)
++|+|+.+.|||+..+ ++...++|+||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999531 346789999999885
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 473 | ||||
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-96 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-93 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-31 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-31 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-30 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-30 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-30 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-30 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-28 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-27 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-27 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-26 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-26 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-26 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-26 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-25 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-25 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-24 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-24 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-24 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-24 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-24 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-24 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-24 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-23 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-23 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-23 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-23 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-23 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-23 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-23 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-22 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-22 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-21 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-21 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-21 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-20 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-19 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-18 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-18 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-18 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-17 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 290 bits (742), Expect = 4e-96
Identities = 229/299 (76%), Positives = 270/299 (90%), Gaps = 1/299 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQ 59
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIK VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASR 299
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 282 bits (722), Expect = 3e-93
Identities = 174/291 (59%), Positives = 214/291 (73%), Gaps = 3/291 (1%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQGGTG 63
VG +++GR+IG GSFG I+ GTN+ N++VAIK ++ PQL+ E + YK+L G TG
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 64 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 123
IPN+ +FG EG +NVLVIDLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H KS
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 124 LHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 181
++RDIKPDNFL+G + AN +Y++DFG+ K YRD T QHIPYRE KNL+GTARY S+
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 182 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241
NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKYE+I EKK ST + LC
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 292
G+P EF Y HY R+L FD PDY YL+ LF + R D FDW +L
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 8e-31
Identities = 56/233 (24%), Positives = 93/233 (39%), Gaps = 22/233 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKLYKILQG 60
F +GR +G G FG +YL Q+ +A+K L QL+ E ++ L+
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 64
Query: 61 GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
I L + + L+++ K + ++ N + + HS
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 180
K +HRDIKP+N L+G A ++ I DFG + + GT Y
Sbjct: 125 KRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLP 172
Query: 181 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233
G + DL SLG + FL G P++ T ++ Y++IS + +
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFT 222
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 8e-31
Identities = 63/284 (22%), Positives = 119/284 (41%), Gaps = 32/284 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ----LQYEAKLYKILQGG 61
+ +G++IGSGSFG +Y G + + +VA+K LNV PQ + E + + +
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 63
Query: 62 TGIPNL-RWFGVEGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 118
N+ + G + +V G SL + K + ++ +A Q ++++
Sbjct: 64 ---VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 178
H+KS +HRD+K +N + V I DFGLA + + L+G+ +
Sbjct: 121 HAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQF-----EQLSGSILW 172
Query: 179 ASMNTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235
+ ++ S + D+ + G VL + G LP+ + + Q + +S
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPD 230
Query: 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDY----AYLKRLFRDL 275
+ + P C + D++P + A ++ L R L
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-30
Identities = 48/233 (20%), Positives = 89/233 (38%), Gaps = 20/233 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKLYKILQGG 61
F+ G+ +G GSF + L + T+ E AIK + + K P + E + L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-H 67
Query: 62 TGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
L + + + + L ++++ +E++H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG 126
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 180
K +HRD+KP+N L+ + I DFG AK + + GTA+Y S
Sbjct: 127 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQYVS 178
Query: 181 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233
+ DL +LG ++ + G P++ G + ++KI + +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYD 228
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 119 bits (299), Expect = 1e-30
Identities = 44/212 (20%), Positives = 92/212 (43%), Gaps = 14/212 (6%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQLQYEAKLYKILQGGTG 63
+ + + ++G+G+FG ++ T T A K ++ ++ E + +L+
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPT 84
Query: 64 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 122
+ NL + + V++ + + G L + K+S + Q+ + +H +
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 182
++H D+KP+N + +R+N++ +IDFGL + + TGTA +A+
Sbjct: 145 YVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVT--------TGTAEFAAPE 195
Query: 183 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
G D+ S+G + L G P+ G
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-30
Identities = 47/271 (17%), Positives = 100/271 (36%), Gaps = 28/271 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP----QLQYEAKLYKILQGGT 62
+ F ++G+G+ G ++ ++ + +A KL P Q+ E ++
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SP 64
Query: 63 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
I + ++ + G SL+ + + ++ + + ++ +I + ++ K
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 122 -SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 180
+HRD+KP N L+ ++ + DFG++ + D+ + + GT Y S
Sbjct: 124 HKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYMS 171
Query: 181 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240
G S + D+ S+G L+ G P A + + +E
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ--------VEGDA 223
Query: 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 271
P + S D +P A + L
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELL 254
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-30
Identities = 45/229 (19%), Positives = 95/229 (41%), Gaps = 16/229 (6%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--NVKTKHPQLQYEAKLYKILQGGTGIP 65
K+ + +G G FG ++ + + K T ++ E + I + I
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNIL 64
Query: 66 NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 124
+L + V++ + + G + + N + +L+ + ++ Q+ ++F+HS +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 125 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 184
H DI+P+N + RR++ + II+FG A++ + + + Y + H
Sbjct: 125 HFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPEVH 175
Query: 185 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233
S D+ SLG ++ L G P+ T +Q E I + +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEYT 221
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (294), Expect = 7e-30
Identities = 51/234 (21%), Positives = 92/234 (39%), Gaps = 19/234 (8%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP----QLQYEAKLYKILQG 60
V + + + ++GSG+FG ++ T K + T +P ++ E + L
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLDKYTVKNEISIMNQLH- 84
Query: 61 GTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
+ NL + VL+++ L G L D K+S V+ Q ++ +H
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
S +H DIKP+N + ++A+ V IIDFGLA + + T TA +A
Sbjct: 145 EHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT--------TATAEFA 195
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233
+ D+ ++G + L G P+ G + + +
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCDWE 246
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-29
Identities = 41/232 (17%), Positives = 90/232 (38%), Gaps = 23/232 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKH--PQLQYEAKLYKILQGGTGIP 65
+ + ++G G+FG++Y N +T+ A K ++ K++ E + I
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIV 72
Query: 66 NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 124
L + ++I+ G +++ + R L+ + ++ Q ++ + ++H +
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 132
Query: 125 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 184
HRD+K N L + + DFG++ + T + + GT + +
Sbjct: 133 HRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRD-------SFIGTPYWMAPEVV 182
Query: 185 LGIEQSRRD-----DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231
+ R D+ SLG L+ P L + KI++ +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAKSE 231
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 3e-29
Identities = 59/248 (23%), Positives = 103/248 (41%), Gaps = 28/248 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---------LNVKTKHPQLQYEAKLYKI 57
+++++G +GSG FG +Y G + N VAIK ++ E L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 58 LQGG-TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINR 114
+ G +G+ L + D VL+++ P DLF+F + + L + Q++
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEA 122
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 174
V H+ LHRDIK +N L + ++ +IDFG +DT G
Sbjct: 123 VRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYTDFD---------G 171
Query: 175 TARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233
T Y+ R + SLG +L + G +P++ + + + ++VS
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEIIRGQVFFRQRVS 228
Query: 234 TSIEALCR 241
+ + L R
Sbjct: 229 SECQHLIR 236
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (282), Expect = 1e-28
Identities = 51/286 (17%), Positives = 110/286 (38%), Gaps = 22/286 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPN 66
+ ++L RK+G G + E++ NI NE+V +K+ K +++ E K+ + L+GG I
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 67 LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 126
L + + + D + L+ + +++ +++ HS +HR
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCHSMGIMHR 153
Query: 127 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG 186
D+KP N + + ++ +ID+GLA+ Y + + + +
Sbjct: 154 DVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPELLVD 203
Query: 187 IEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 245
+ D+ SLG +L + P+ + +I++ + + Y
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 246 EFASYFH-------YCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 284
E F+ R RF + + D + + ++D
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF-LDKLLRYD 306
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-28
Identities = 46/235 (19%), Positives = 93/235 (39%), Gaps = 26/235 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKLYKILQG 60
N F + +G G+FG++ L T A+K + K + E+++ + +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 61 GTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEF 117
P L ++ L + + +LF SR+ + + ++++ +E+
Sbjct: 65 ----PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 118 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 177
+HS+ ++RDIK +N ++ + + I DFGL K GT
Sbjct: 121 LHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMK-------TFCGTPE 170
Query: 178 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232
Y + + R D LG V+ + G LP+ ++ +E I +++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEI 222
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 110 bits (275), Expect = 6e-28
Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 26/225 (11%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKLYKI 57
+ +++ LG +G G E++L +++ + +VA+K + + + + EA+
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 58 LQGGTGIPNL-RWFGV------EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 109
L P + + G +V++ + G +L D+ + ++ K + +
Sbjct: 64 LNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIA 118
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 169
+ F H +HRD+KP N ++ N V ++DFG+A+ D+ +
Sbjct: 119 DACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVT----QT 171
Query: 170 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
+ GTA+Y S G R D+ SLG VL L G P+ G
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 6e-28
Identities = 56/247 (22%), Positives = 94/247 (38%), Gaps = 20/247 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----NVKTKHPQLQYEAKLYKILQGGT 62
+ L + +G G++GE+ L N T E VA+K+ ++ E + K+L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 63
Query: 63 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 122
+ EG+ L ++ + Q++ V ++H
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 182
HRDIKP+N L+ + + I DFGLA +R + + + GT Y +
Sbjct: 124 ITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLL-----NKMCGTLPYVAPE 175
Query: 183 THLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKVSTS 235
E + D+ S G VL L G LPW + K++K KK+ ++
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235
Query: 236 IEALCRG 242
AL
Sbjct: 236 PLALLHK 242
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 8e-28
Identities = 41/210 (19%), Positives = 82/210 (39%), Gaps = 16/210 (7%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNL--- 67
+ +G G G++ N +T E+ A+K + P+ + E +L+ I +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 68 -RWFGVEGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 124
++V++ L G L + + + + + + + ++++HS +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 133
Query: 125 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 184
HRD+KP+N L R + + DFG AK + Y T Y +
Sbjct: 134 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--------TPYYVAPEVL 185
Query: 185 LGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
+ + D+ SLG ++ L G P+
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (272), Expect = 2e-27
Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 23/245 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LNVKTKHPQLQYEAKLYKILQGGTG 63
K+ KIG G+ G +Y ++ T +EVAI+ L + K + E + + +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPN 78
Query: 64 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 122
I N + GD +V++ L G SL D+ + + + + + +EF+HS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 182
+HRDIK DN L+ V + DFG + + + + GT + +
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRS-------TMVGTPYWMAPE 186
Query: 183 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKVSTSI 236
+ D+ SLG + + + G P+ L E + +K+S
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 237 EALCR 241
Sbjct: 247 RDFLN 251
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (271), Expect = 4e-27
Identities = 48/248 (19%), Positives = 87/248 (35%), Gaps = 29/248 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKLYKILQGG 61
F R+IG GSFG +Y +++ +E VAIK K + E + + L+
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 74
Query: 62 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
R + LV++ S DL + L + + + + ++HS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 181
+ +HRD+K N L+ V + DFG A + GT + +
Sbjct: 135 NMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF-----------VGTPYWMAP 180
Query: 182 NTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGT-----KKQKYEKISEKKVS 233
L +++ + D D+ SLG + P + A + + + + S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
Query: 234 TSIEALCR 241
Sbjct: 241 EYFRNFVD 248
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 7e-27
Identities = 62/293 (21%), Positives = 103/293 (35%), Gaps = 25/293 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP-----QLQYEAKLYKILQG- 60
+K+ KIG G+FGE++ + +T ++VA+K + E K+ ++L+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 61 ------GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 114
+ LV D L L + K +L + + ++N
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 174
+ ++H LHRD+K N L+ R + + DFGLA+ + Q Y N
Sbjct: 130 LYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY---TNRVV 183
Query: 175 TARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233
T Y LG DL G ++ S QG T++ + IS+ S
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGS 240
Query: 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR--LFRDLFIREGFQFD 284
+ E E + + K R DL I + D
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL-IDKLLVLD 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 8e-27
Identities = 53/214 (24%), Positives = 85/214 (39%), Gaps = 16/214 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---NVKTKHPQLQYEAKLYKILQGGTG 63
F L + +G GSFG+++L +TN+ AIK +V ++ ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 64 IPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHS 120
P L F L + + DL K L A ++I ++F+HS
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 180
K ++RD+K DN L+ + + I DFG+ K + GT Y +
Sbjct: 122 KGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTN-------TFCGTPDYIA 171
Query: 181 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
LG + + D S G +L L G P+ G
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 106 bits (265), Expect = 1e-26
Identities = 41/238 (17%), Positives = 80/238 (33%), Gaps = 22/238 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------NVKTKHPQLQYEAKLY 55
+ +G G + + T +E A+K+ V+ E +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 56 KILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 114
+ + G I L+ + LV DL+ L D LS K + ++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEV 122
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 174
+ +H + +HRD+KP+N L+ + + DFG + + + + +
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 175 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232
+ + H G + D+ S G ++ L GS P+ + I
Sbjct: 180 IIECSMNDNHPGY--GKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMSGNY 232
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (267), Expect = 1e-26
Identities = 50/235 (21%), Positives = 99/235 (42%), Gaps = 20/235 (8%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----NVKTKHPQLQYEAKLYKILQG 60
+ + + +G+G+F E+ L + +T + VAIK ++ K ++ E + ++
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK- 65
Query: 61 GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFV 118
I L G + L++ L+ S +LF+ K + + L Q+++ V+++
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLV--SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 178
H +HRD+KP+N L +++ I DFGL+K + GT Y
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--------CGTPGY 175
Query: 179 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233
+ S+ D S+G + L G P+ + +E+I + +
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYE 227
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 4e-26
Identities = 59/277 (21%), Positives = 114/277 (41%), Gaps = 28/277 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ-LQYEAKLYKILQGGTGI 64
+L ++G+G FGE+++G + +VA+K L + P EA L K LQ
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH---- 67
Query: 65 PNL-RWFGVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
L R + V + ++ + + G ++ L KL++ +L +A Q+ + F+
Sbjct: 68 QRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 180
++++HRD++ N L+ I DFGLA+ D + ++ +
Sbjct: 128 RNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTA 178
Query: 181 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239
+ + D+ S G +L + G +P+ G+ T + + + +
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGYRMVRPD-- 233
Query: 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276
P E C R +D+P + YL+ + D F
Sbjct: 234 --NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 106 bits (265), Expect = 6e-26
Identities = 54/235 (22%), Positives = 87/235 (37%), Gaps = 21/235 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LNVKTKHPQLQYEAKLYKILQG 60
N F + R IG G FGE+Y T + A+K + +K E + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 61 GT--GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 118
G I + + D ++DL+ S + A ++I +E +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 178
H++ ++RD+KP N L+ V I D GLA + H + GT Y
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGY 171
Query: 179 ASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232
+ G+ D SLG +L LRG P++ K K + V
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 1e-25
Identities = 57/277 (20%), Positives = 92/277 (33%), Gaps = 24/277 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTN---EEVAIK------LNVKTKHPQLQYEAKLYKILQ 59
RL K+G GSFG + G + VA+K L+ E L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
+ L + ++ SL D L T+ A Q+ + ++
Sbjct: 70 H-RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SK F+HRD+ N L+ + V I DFGL + H Y ++ +
Sbjct: 129 SKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDH----YVMQEHRKVPFAWC 181
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238
+ + S D G L G PW GL Q KI ++
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDKEGERLPRPE 238
Query: 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275
C P + + C + + +D+P + L+ +
Sbjct: 239 DC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (258), Expect = 2e-25
Identities = 49/233 (21%), Positives = 91/233 (39%), Gaps = 23/233 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQY------EAKLYKILQG 60
F++ R +G+GSFG ++L + A+K+ K +L+ E + I+
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT- 62
Query: 61 GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
I + + +++D + S++ A ++ +E++HS
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 180
K ++RD+KP+N L+ + + I DFG AK D L GT Y +
Sbjct: 123 KDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------TLCGTPDYIA 169
Query: 181 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233
++ D S G ++ L G P+ + YEKI ++
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELR 219
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 6e-25
Identities = 48/245 (19%), Positives = 95/245 (38%), Gaps = 24/245 (9%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----NVKTKHPQLQYEAKLYKILQG 60
G + +IG GSF +Y G + +T EVA K++ + + EA++ K LQ
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH 67
Query: 61 GTGIPNLRWF---GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 117
+ + VLV +L+ + + + +K + Q++ ++F
Sbjct: 68 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127
Query: 118 VHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 175
+H+++ +HRD+K DN + V I D GLA R + K + GT
Sbjct: 128 LHTRTPPIIHRDLKCDNIF--ITGPTGSVKIGDLGLATLKRASFA---------KAVIGT 176
Query: 176 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235
+ + + + D+ + G ++ P+ Q Y +++ S
Sbjct: 177 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGVKPAS 233
Query: 236 IEALC 240
+ +
Sbjct: 234 FDKVA 238
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 7e-25
Identities = 57/294 (19%), Positives = 100/294 (34%), Gaps = 31/294 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP----QLQYEAKLYKILQG 60
VG ++ IG G++G + + VAIK +H + E K+ +
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 61 GTGIPNL-RWFGV-------EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 112
N+ + + LV L+G L L ++ LS + Q++
Sbjct: 66 ----ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQIL 119
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 172
++++HS + LHRD+KP N L+ + I DFGLA+ H
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTE----Y 172
Query: 173 TGTARYASMN-THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231
T Y + ++ D+ S+G +L L + G + I
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHYLDQLNHILGIL 229
Query: 232 VSTSIEALCRGYPTEFASY-FHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 284
S S E L + +Y + + DL + + F+
Sbjct: 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL-LDKMLTFN 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-24
Identities = 61/289 (21%), Positives = 102/289 (35%), Gaps = 33/289 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLR 68
+ + IG+GSFG +Y + E VAIK V E ++ + L I LR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQIMRKLD-HCNIVRLR 79
Query: 69 WFGVEGD------YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVH 119
+F Y LV+D + ++ + SR L + V + Q+ + ++H
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT----ATHQHIPYRENKNLTGT 175
S HRDIKP N L + + DFG AK+ + YR + + G
Sbjct: 140 SFGICHRDIKPQNL--LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 176 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235
Y + D+ S G VL L G + G + + +I + + +
Sbjct: 198 TDY-----------TSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEIIKVLGTPT 243
Query: 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 284
E + P F ++ + K L ++
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPW-TKVFRPRTPPEAIAL-CSRLLEYT 290
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-24
Identities = 48/240 (20%), Positives = 88/240 (36%), Gaps = 28/240 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----NVKTKHPQLQYEAKLYKILQGGT 62
+ + IG+GS+G + + K + + L E L + L+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 63 GIPNLRWFGVEGDYNV-LVIDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEF 117
+ + + +V++ G L + +++ L + VL + Q+ ++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 118 VHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 172
H +S LHRD+KP N + V + DFGLA+ + K
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFA-------KAF 174
Query: 173 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232
GT Y S + + + D+ SLG +L P+ ++K+ KI E K
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGKF 231
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-24
Identities = 59/274 (21%), Positives = 109/274 (39%), Gaps = 22/274 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQ-LQYEAKLYKILQGGTGI 64
RL K+G G FGE+++GT T VAIK L T P+ EA++ K L+ +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 74
Query: 65 PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKSF 123
L E ++ + SL D + K L ++ +A Q+ + + +V ++
Sbjct: 75 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 183
+HRD++ N L+G + DFGLA+ D + ++ +
Sbjct: 135 VHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTAR------QGAKFPIKWTAPEA 185
Query: 184 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242
L + + D+ S G +L +G +P+ G+ ++ +++
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRMPCPP----E 238
Query: 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276
P C +++P + YL+ D F
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 2e-24
Identities = 45/227 (19%), Positives = 86/227 (37%), Gaps = 18/227 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP--------QLQYEAKLYKILQG 60
F+ + +GSG+FG +Y G I E+V I + +K ++ EA + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69
Query: 61 GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 120
+ L + ++ + L D + + +L Q+ + ++
Sbjct: 70 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 121 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 180
+ +HRD+ N L+ V I DFGLAK H + ++ +
Sbjct: 130 RRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMA 181
Query: 181 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEK 226
+ + L + + D+ S G + + GS P+ G+ A EK
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-24
Identities = 54/275 (19%), Positives = 109/275 (39%), Gaps = 28/275 (10%)
Query: 13 RKIGSGSFGEIYLGTNIQTNE--EVAIKL----NVKTKHPQLQYEAKLYKILQGGTGIPN 66
++G G+FG + G + +VAIK+ K ++ EA++ L P
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN----PY 70
Query: 67 L-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 123
+ R GV + + +LV+++ G L ++ + V L Q+ ++++ K+F
Sbjct: 71 IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 183
+HRD+ N L+ + I DFGL+K ++ ++ +
Sbjct: 131 VHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAPEC 183
Query: 184 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242
+ S R D+ S G + L G P++ + + I + K
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQGK----RMECPPE 236
Query: 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277
P E + C +++D+PD+ +++ R +
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 99.6 bits (247), Expect = 4e-24
Identities = 54/218 (24%), Positives = 86/218 (39%), Gaps = 26/218 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----NVKTKHPQLQYEAKLYKILQGG 61
K+ KIG G++G +Y N E A+K + E + K L+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59
Query: 62 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
+ I L VLV + L L+ L + C L T Q++N + + H +
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH-----QHIPYRENKNLTGTA 176
LHRD+KP N L+ R ++ I DFGLA+ + + YR L G+
Sbjct: 120 RVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 177 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
+Y S D+ S+G + + G+ + G
Sbjct: 177 KY-----------STTIDIWSVGCIFAEMVNGTPLFPG 203
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 5e-24
Identities = 52/295 (17%), Positives = 105/295 (35%), Gaps = 32/295 (10%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIK-----LNVKTKHPQLQYEAKLYKI 57
R ++ +IG G++G+++ +++ VA+K + E + +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 58 LQGGTGIPNLRWFGV--------EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD 109
L+ +R F V E ++ + L + +T+ +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 110 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 169
Q++ ++F+HS +HRD+KP N L+ + Q+ + DFGLA+ Y +
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV----- 175
Query: 170 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 229
T Y + L + DL S+G + R ++G + + KI +
Sbjct: 176 ---VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG---SSDVDQLGKILD 229
Query: 230 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 284
E R ++ D + L +DL + + F+
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD---IDELGKDL-LLKCLTFN 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.6 bits (247), Expect = 5e-24
Identities = 58/283 (20%), Positives = 97/283 (34%), Gaps = 21/283 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LNVKTKHPQLQYEAKLYKILQGGT 62
F+ KIG G++G +Y N T E VA+K + E L K L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HP 61
Query: 63 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSK 121
I L + LV + L L+ + + L + Q++ + F HS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 181
LHRD+KP N L+ + + DFGLA+ + + A
Sbjct: 122 RVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPE 172
Query: 182 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241
S D+ SLG + + + G ++ + +I + + T E +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRI-FRTLGTPDEVVWP 228
Query: 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 284
G + + + R D L R L + + +D
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL-LSQMLHYD 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 5e-24
Identities = 52/277 (18%), Positives = 95/277 (34%), Gaps = 25/277 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLNVKTKHP----QLQYEAKLYKILQ 59
+ LGR IG G FG+++ G + VAIK + EA +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 119
I L E +++ L L L ++++ A Q+ + ++
Sbjct: 67 H-PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
SK F+HRDI N L+ + V + DFGL++ D+ ++ ++
Sbjct: 126 SKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKA------SKGKLPIKWM 176
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238
+ + + D+ G + L G P+QG+ +I +
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRIENGE----RLP 229
Query: 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275
+ P S C + +P + LK +
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.5 bits (247), Expect = 1e-23
Identities = 45/213 (21%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLY---KILQGGTG 63
++F + +G+GSFG + L + ++ A+K+ K K +L+ +ILQ
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 64 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK 121
++ D + L + + + ++F+ R + S A Q++ E++HS
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 181
++RD+KP+N L+ + + + DFG AKR + GT +
Sbjct: 161 DLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWTLC----------GTPEALAP 207
Query: 182 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 214
L ++ D +LG ++ G P+
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 2e-23
Identities = 50/267 (18%), Positives = 89/267 (33%), Gaps = 44/267 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLNVKTKHP----QLQYEAKLYKI 57
G+ +GSG+FG++ T ++ +VA+K+ + L E K+
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 58 LQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK------------------ 98
L I NL L+ + L + K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 99 ----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154
L+ + +L A Q+ +EF+ KS +HRD+ N L+ V I DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARD 213
Query: 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQ 213
+ Y N ++ + + + + D+ S G +L G P+
Sbjct: 214 IMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 214 GLKAGTKKQKYEKISEKKVSTSIEALC 240
G+ + K+ +
Sbjct: 269 GI---PVDANFYKLIQNGFKMDQPFYA 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 2e-23
Identities = 49/243 (20%), Positives = 91/243 (37%), Gaps = 22/243 (9%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP---------QLQYEAKLY 55
V + + G ++GSG F + T + A K K + ++ E +
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 56 KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 115
K +Q + L +L+++L+ F L+ + Q++N V
Sbjct: 68 KEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 116 EFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 174
++HS H D+KP+N ++ ++ IIDFGLA + ++I G
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--------FG 178
Query: 175 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 234
T + + D+ S+G + L G+ P+ G TK++ +S
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYEF 235
Query: 235 SIE 237
E
Sbjct: 236 EDE 238
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 2e-23
Identities = 55/281 (19%), Positives = 120/281 (42%), Gaps = 31/281 (11%)
Query: 13 RKIGSGSFGEIYLGT--NIQTNEEVAIK-LNVKTKHP----QLQYEAKLYKILQGGTGIP 65
+++GSG+FG + G + + VA+K L + P +L EA + + L P
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN----P 68
Query: 66 NL-RWFGV-EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 123
+ R G+ E + +LV+++ + + +R + K ++ L Q+ ++++ +F
Sbjct: 69 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 183
+HRD+ N L+ + I DFGL+K R + Y+ + ++ +
Sbjct: 129 VHRDLAARNVLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPEC 181
Query: 184 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242
+ S + D+ S G ++ G P++G+ + + + + G
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGERMGCPA----G 234
Query: 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF---IREG 280
P E + C + +++P +A ++ R+ + + EG
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.7 bits (240), Expect = 3e-23
Identities = 41/229 (17%), Positives = 87/229 (37%), Gaps = 18/229 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--NVKTKHPQLQYEAKLYKILQGGTGI 64
+++G+G FG + G + +VAIK+ + EAK+ L +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKL 61
Query: 65 PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 123
L + ++ + + L + + + +L + + +E++ SK F
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 183
LHRD+ N L+ V + DFGL++ D + R++
Sbjct: 122 LHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWSPPEV 172
Query: 184 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 231
+ + S + D+ + G ++ G +P++ T + E I++
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGL 218
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.8 bits (240), Expect = 4e-23
Identities = 56/307 (18%), Positives = 102/307 (33%), Gaps = 52/307 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLNVKTKHPQLQY----EAK 53
PR N R IG G+FG ++ + VA+K+ + +Q EA
Sbjct: 11 PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68
Query: 54 LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDL--------------------- 91
L + L G L+ + + L +
Sbjct: 69 LMAEFDNPNIVKLL-GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 92 --FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 149
+ LS L +A Q+ + ++ + F+HRD+ N L+G V I DF
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADF 184
Query: 150 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RG 208
GL++ Y+ + N R+ + + D+ + G VL G
Sbjct: 185 GLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 209 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268
P+ G+ ++ + + + E P E + C S D+P + +
Sbjct: 240 LQPYYGM---AHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSI 292
Query: 269 KRLFRDL 275
R+ + +
Sbjct: 293 HRILQRM 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.3 bits (239), Expect = 5e-23
Identities = 55/275 (20%), Positives = 111/275 (40%), Gaps = 22/275 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--NVKTKHPQLQYEAKLYKILQGGTGI 64
+ K+G G +GE+Y G + + VA+K + + EA + K ++ +
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNL 75
Query: 65 PNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 122
L ++ + + G L+ L +++S +L +A Q+ + +E++ K+
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 123 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 182
F+HRD+ N L+G + V + DFGL++ H + ++ +
Sbjct: 136 FIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTAPE 186
Query: 183 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241
+ + S + D+ + G +L G P+ G+ Q YE + + E
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEKDYRMERPE---- 239
Query: 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276
G P + C D+P +A + + F +F
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.5 bits (237), Expect = 7e-23
Identities = 54/277 (19%), Positives = 99/277 (35%), Gaps = 34/277 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQGGTGIP 65
+ +L + IG G FG++ LG +VA+K + EA + L+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 60
Query: 66 NL-RWFGV---EGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 119
NL + GV E +V + + SL D L + L +L + + +E++
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 120 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 179
+F+HRD+ N L+ N + DFGL K T ++
Sbjct: 121 GNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGK----------LPVKWT 167
Query: 180 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238
+ + S + D+ S G +L G +P+ + K ++ + + +
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPD- 223
Query: 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275
G P C L +P + L+ +
Sbjct: 224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 9e-23
Identities = 59/292 (20%), Positives = 111/292 (38%), Gaps = 31/292 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LNVKTKHPQLQYEAKLYKILQ 59
V +++ +GSG++G + + +T VA+K + E +L K ++
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 60 GGTGIPNLRWF-----GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 114
I L F E + LV L+G L ++ +KL+ V L Q++
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRG 133
Query: 115 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 174
++++HS +HRD+KP N + ++ I+DFGLA+ D T
Sbjct: 134 LKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGYVA---------- 180
Query: 175 TARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233
T Y + L ++ D+ S+G ++ L G + G + + I +
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILRLVGT 237
Query: 234 TSIEALCRGYPTEFASYFHYCRSL-RFDDKPDYAYLKRLFRDLFIREGFQFD 284
E L + +Y + + + + L DL + + D
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL-LEKMLVLD 288
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 95.2 bits (236), Expect = 2e-22
Identities = 36/234 (15%), Positives = 85/234 (36%), Gaps = 18/234 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLNVKTKHPQ----LQYEAKLYKILQ 59
+ ++ + IG+G FGE+ G + VAIK + EA +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85
Query: 60 GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 118
+ +L + +++ + + SL+ + ++ ++ + + ++++
Sbjct: 86 H-PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 178
+++HRD+ N L+ + DFGL++ D + Y R+
Sbjct: 145 ADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRW 199
Query: 179 ASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 231
+ + + D+ S G V+ + G P+ + T + I +
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDY 250
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (237), Expect = 2e-22
Identities = 53/253 (20%), Positives = 102/253 (40%), Gaps = 29/253 (11%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LNVKTKHPQLQYEAKLYKIL 58
V +++ + IGSG+ G + + + VAIK +T + E L K +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 59 QGGTGIPNLRWFGV------EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 112
I +L E LV++L+ +L + +L + + L QM+
Sbjct: 74 N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQML 129
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 172
++ +HS +HRD+KP N ++ + + I+DFGLA+ +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPY-------- 178
Query: 173 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232
T Y + LG+ D+ S+G ++ +R + + G ++ K+ E+
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQLG 235
Query: 233 STSIEALCRGYPT 245
+ E + + PT
Sbjct: 236 TPCPEFMKKLQPT 248
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 5e-22
Identities = 55/293 (18%), Positives = 110/293 (37%), Gaps = 33/293 (11%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LNVKTKHPQLQYEAKLYKILQ 59
V +R + +GSG++G + + +T +VAIK + + E +L K ++
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 60 GGTGIPNLRWFGVEGDYN------VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 113
+ L + LV+ +G L L KL + L QM+
Sbjct: 76 -HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLK 132
Query: 114 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ--HIPYRENKN 171
+ ++H+ +HRD+KP N + ++ I+DFGLA++ T YR +
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSEMTGYVVTRWYRAPEV 189
Query: 172 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231
+ RY ++ D+ S+G ++ + G ++G + ++ K++
Sbjct: 190 ILNWMRY-----------TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238
Query: 232 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 284
+ ++ L + F A L +L + + D
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA--SPLAVNL-LEKMLVLD 288
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.1 bits (235), Expect = 5e-22
Identities = 53/288 (18%), Positives = 106/288 (36%), Gaps = 32/288 (11%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--NVKTKHPQLQYEAKLYKILQ 59
EP ++ L RK+G G F ++L ++ N VA+K+ K + E KL + +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 60 ----------GGTGIPNLRWFGVEGDYNVLVIDLLG-----PSLEDLFNFCSRKLSLKTV 104
G I L N + + ++ L + + R + L V
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 105 LMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163
++ Q++ ++++H + +H DIKP+N L + + +I +A +H
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVL--MEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 223
T Y S LG D+ S ++ + G ++ + + +
Sbjct: 186 YTNS-----IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 224 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 271
+ I++ I L P+ Y R+ F+ + + +L
Sbjct: 241 DDHIAQ------IIELLGELPSYLLRNGKYTRTF-FNSRGLLRNISKL 281
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.5 bits (231), Expect = 6e-22
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 17/212 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----NVKTKHPQLQYEAKLYKILQGG 61
K+ KIG G++G ++ N +T+E VA+K + + E L K L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-H 60
Query: 62 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 121
I L LV + L+ F+ C+ L + V Q++ + F HS+
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 122 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 181
+ LHRD+KP N L+ R ++ + +FGLA+ + IP R T Y
Sbjct: 121 NVLHRDLKPQNLLIN---RNGELKLANFGLARAF-------GIPVRCYSAEVVTLWYRPP 170
Query: 182 NTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPW 212
+ G + S D+ S G + P
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.3 bits (231), Expect = 8e-22
Identities = 43/233 (18%), Positives = 80/233 (34%), Gaps = 35/233 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLNVKTKHP----QLQYEAKLYKI 57
N+ G+ +G+G+FG++ T VA+K+ + H L E K+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 58 LQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDL-----------------FNFCSRKL 99
L I NL G +++ + L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 100 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159
L+ +L + Q+ + F+ SK+ +HRD+ N L+ I DFGLA+ ++ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDS 199
Query: 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 212
+ N ++ + + + D+ S G L
Sbjct: 200 NYVV-----KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.3 bits (231), Expect = 1e-21
Identities = 51/246 (20%), Positives = 87/246 (35%), Gaps = 37/246 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE--EVAIK----LNVKTKHPQLQYEAKLYKILQG 60
N + IG G+FG++ + + AIK K H E ++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 61 GTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDL---------------FNFCSRKLSLKTV 104
I NL Y L I+ +L D N + LS + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 105 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164
L A + ++++ K F+HRD+ N L+G I DFGL++
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQK 223
R+ ++ + + D+ S G +L + G P+ G+ T +
Sbjct: 187 --------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAEL 235
Query: 224 YEKISE 229
YEK+ +
Sbjct: 236 YEKLPQ 241
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 1e-21
Identities = 61/283 (21%), Positives = 96/283 (33%), Gaps = 30/283 (10%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK--------LNVKTKHPQLQYEAKLYKILQGGTGI 64
+G G F +Y + TN+ VAIK + E KL + L I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNI 62
Query: 65 PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 124
L LV D + LE + S L+ + + +E++H L
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 125 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 184
HRD+KP+N L+ + + DFGLAK + P R + T Y +
Sbjct: 123 HRDLKPNNLLL---DENGVLKLADFGLAKSFGS-------PNRAYTHQVVTRWYRAPELL 172
Query: 185 LGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243
G D+ ++G +L L G + + +I E + + E
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQW---- 225
Query: 244 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL--FIREGFQFD 284
+ S Y F P + DL I+ F F+
Sbjct: 226 -PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 1e-21
Identities = 51/273 (18%), Positives = 101/273 (36%), Gaps = 22/273 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--NVKTKHPQLQYEAKLYKILQGGTGI 64
++ ++IGSG FG ++LG + ++VAIK EA++ L +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKL 62
Query: 65 PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 123
L +E LV + + L D + +T+L + + + ++
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122
Query: 124 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 183
+HRD+ N L+ + + DFG+ + D + ++AS
Sbjct: 123 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWASPEV 173
Query: 184 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242
S + D+ S G ++ G +P++ + + E IS R
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFR----LYKPRL 226
Query: 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275
T ++C R +D+P ++ L R ++
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 2e-21
Identities = 45/224 (20%), Positives = 93/224 (41%), Gaps = 22/224 (9%)
Query: 4 RVG-NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLNVKTKHPQ-------LQYEA 52
+VG F L + +G+G++G+++L I T + A+K+ K Q + E
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 53 KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 112
++ + ++ + L + L++D + + + V + +++
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 172
+E +H ++RDIK +N L+ V + DFGL+K + T + +
Sbjct: 140 LALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFC----- 191
Query: 173 TGTARYASMNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLPWQG 214
GT Y + + G + + D SLG ++ L G+ P+
Sbjct: 192 -GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 7e-20
Identities = 31/233 (13%), Positives = 79/233 (33%), Gaps = 17/233 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP--------QLQYEAKLYKIL 58
+ + IG+G FGE+Y G ++ + + + +KT EA +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 59 QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 118
I ++ + +L+ + S+ ++ + + ++++
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 178
+ +++HRD+ N L+ + DFGL++ D + R+
Sbjct: 127 ANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPIRW 179
Query: 179 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231
+ + + D+ S G V+ + + + + I++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGF 230
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.5 bits (213), Expect = 2e-19
Identities = 47/253 (18%), Positives = 99/253 (39%), Gaps = 39/253 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE-------VAIKL----NVKTKHPQLQYEAKLY 55
++ LG+ +G G+FG++ L I +++ VA+K+ + L E ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 56 KILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---------------SRKL 99
K++ I NL + ++++ +L + +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 100 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159
S K ++ A Q+ +E++ SK +HRD+ N L+ N + I DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 189
Query: 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAG 218
++ N ++ + + + D+ S G +L G P+ G+
Sbjct: 190 YYKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--- 241
Query: 219 TKKQKYEKISEKK 231
++ ++ + E
Sbjct: 242 PVEELFKLLKEGH 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 1e-18
Identities = 48/245 (19%), Positives = 89/245 (36%), Gaps = 30/245 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLNVKTKHPQ----LQYEAKLYKI 57
K + R++G GSFG +Y G + VAIK + + EA + K
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 58 LQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR---------KLSLKTVLMLA 108
+ L V++ + L+ SL ++ +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 109 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 168
++ + + ++++ F+HRD+ N ++ V I DFG+ + +T YR+
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY-----YRK 191
Query: 169 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKI 227
R+ S + + D+ S G VL P+QGL + +Q +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFV 248
Query: 228 SEKKV 232
E +
Sbjct: 249 MEGGL 253
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (204), Expect = 3e-18
Identities = 41/218 (18%), Positives = 84/218 (38%), Gaps = 17/218 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLNVKTKHP----QLQYEAKLYKILQG 60
IG G FG +Y GT + + A+K + Q E + K
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 61 GTGIPNLRWFGVEGDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 118
+ +L + + + LV+ + L + + ++K ++ Q+ ++F+
Sbjct: 88 -PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 146
Query: 119 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 178
SK F+HRD+ N ++ V + DFGLA+ D ++
Sbjct: 147 ASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKW 200
Query: 179 ASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGL 215
++ + + + + D+ S G +L + RG+ P+ +
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.2 bits (197), Expect = 4e-18
Identities = 22/161 (13%), Positives = 54/161 (33%), Gaps = 32/161 (19%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------NVKTKHPQLQYEAKL--- 54
+G+ +G G ++ + + E +K A
Sbjct: 4 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 55 --YKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 112
++ LQ G+ + + EG+ ++ E + ++ ++ + D ++
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLM---------ELIDAKELYRVRVENPDEVLDMIL 113
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153
V + + +H D+ N L+ ++IIDF +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSV 150
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.5 bits (200), Expect = 9e-18
Identities = 42/232 (18%), Positives = 83/232 (35%), Gaps = 34/232 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIK-LNVKTKHPQLQYEAKLYKILQG 60
++ +LG+ +G G+FG++ T VA+K L H + + KIL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 61 GTGIPNLR----WFGVEGDYNVLVIDLL-GPSLEDL---------------FNFCSRKLS 100
N+ G +++++ +L + L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 101 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160
L+ ++ + Q+ +EF+ S+ +HRD+ N L+ N V I DFGLA+
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 189
Query: 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 212
+ + ++ + T + + D+ S G +L
Sbjct: 190 YVR-----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 1e-17
Identities = 58/273 (21%), Positives = 95/273 (34%), Gaps = 27/273 (9%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGG-TG 63
+ L IG G FGE++ G EEVA+K+ + EA++Y+ +
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHEN 58
Query: 64 IPNLRWFGVEGDYNVLVIDLLGPSLE--DLFNFCSR---------KLSLKTVLMLADQMI 112
I + + + L+ E LF++ +R KL+L T LA +
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 113 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 172
V + HRD+K N L+ + I D GLA R+ I +
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAP---NHR 172
Query: 173 TGTARY------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 226
GT RY E +R D+ ++G V R +
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232
Query: 227 ISEKKVSTSIEALC-RGYPTEFASYFHYCRSLR 258
S+ V + +C + + + C +LR
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 265
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 473 | |||
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.47 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.0 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.96 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.95 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.6 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-61 Score=472.18 Aligned_cols=295 Identities=77% Similarity=1.352 Sum_probs=264.6
Q ss_pred CCCccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcc-cCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNV-KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~-~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
||-+++++|+++++||+|+||.||+|++..+|+.||||++. .....++..|+++++.++|+++|..+..++......++
T Consensus 1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 89999999999999999999999999999999999999843 34456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 80 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 80 v~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||||++++|.+.+....+.+++.+++.++.||+.||+|||++|||||||||+|||++..+....+||+|||+|+.+.+..
T Consensus 81 vme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 81 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99999999999988778889999999999999999999999999999999999999766667789999999999988776
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
.....+++......||+.|||||++.+..++.++|||||||++|||++|+.||...........+..........+.+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 66666666677889999999999999999999999999999999999999999987766666666666666666777888
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
+.++|+++.++|..||+.||++||++++|.++|++++.+.++..+..|||+.++..
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~~~ 296 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFG 296 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGGGT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhcCC
Confidence 89999999999999999999999999999999999999999999999999998754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-58 Score=455.12 Aligned_cols=289 Identities=60% Similarity=1.019 Sum_probs=264.4
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcc-cCCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNV-KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~-~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
+++++|+++++||+|+||+||+|++..+|+.||||++. ......+..|+++++.|+++++++.+..++..+...++|||
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 57899999999999999999999999999999999853 34456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCC--CCCcEEEEecCCcccccCCCC
Q 011988 83 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 83 ~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~--~~~~vkL~DFGla~~~~~~~~ 160 (473)
|++++|.+++......++..+++.|+.|++.||+|||++|||||||||+||||+... ..+.+||+|||+|+.+.+...
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 999999999987778899999999999999999999999999999999999996422 357899999999999887666
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
....+.+....+.||+.|||||++.+..++.++|||||||++|||++|+.||.+.........+..+...+.......++
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHT
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhc
Confidence 66666666778899999999999999999999999999999999999999999888877888888887777777888899
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccc
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 292 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 292 (473)
..+|+++.+++..||..+|++||+++.|.++|++++.+.++..++.|||+.+
T Consensus 242 ~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~~ 293 (293)
T d1csna_ 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293 (293)
T ss_dssp TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCcC
Confidence 9999999999999999999999999999999999999999999999999863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=405.60 Aligned_cols=242 Identities=24% Similarity=0.338 Sum_probs=205.6
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++++.||+|+||+||+|+++.+++.||||++.+ .....+.+|+.+++.++|++ |..+..++.+....++
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN-ILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTT-BCCEEEEEECSSEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCC-CCeEEEEEEECCEEEE
Confidence 3689999999999999999999999999999998532 33456889999999998655 5556666778888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||| +++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.....
T Consensus 84 vmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCSCSCCCCC
T ss_pred EEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec---CCCCEeecccceeeecCCC
Confidence 99999 7899999975 34699999999999999999999999999999999999994 7789999999999866543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. ....||+.|||||++.+..++.++|||||||+||||++|+.||.+. +..+.+..+......
T Consensus 160 ~~---------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~----- 222 (263)
T d2j4za1 160 RR---------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRVEFT----- 222 (263)
T ss_dssp CC---------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTTCCC-----
T ss_pred cc---------cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCC-----
Confidence 22 3458999999999999999999999999999999999999999774 344455555544332
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
+...+++++.+||..||+.||++|||+++++
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil 253 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVL 253 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 2356899999999999999999999988774
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-53 Score=409.20 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=202.4
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
+.++|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+|+.+++.|+|++ |..+..+..+.+..+||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN-VVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTT-BCCEEEEEEETTEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCC-EeeEeeeeccCceeEEE
Confidence 3578999999999999999999999999999999854432 345889999999998655 55556666788899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||| +++|.+++. ....+++.+++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+....
T Consensus 82 mEy~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~---~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEECEETT
T ss_pred EeccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC---CCCCEEEccchhheeeccCC
Confidence 9999 779999986 345799999999999999999999999999999999999994 67899999999998765432
Q ss_pred CccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. ......+||+.|||||++.+..+ +.++|||||||+||||++|+.||......... +..+....... .
T Consensus 158 ~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~~~~~~~~~~---~ 227 (271)
T d1nvra_ 158 RE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTYL---N 227 (271)
T ss_dssp EE-----CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HHHHHTTCTTS---T
T ss_pred cc-----ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HHHHhcCCCCC---C
Confidence 21 11245689999999999998876 67899999999999999999999775443322 22222222111 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
....+++++.+||..||+.||++|||++++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~ei 257 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDI 257 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 235678999999999999999999998877
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=410.42 Aligned_cols=245 Identities=21% Similarity=0.309 Sum_probs=203.1
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc---CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~---~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.++|+++++||+|+||+||+|++..+|+.||||++.. .....+.+|+.+++.++|+++ ..+..++...+..+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI-VNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTB-CCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCE-eeEeEEEEECCEEEEEEE
Confidence 3589999999999999999999999999999998533 334568899999999986554 455556677888999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 83 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 83 ~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
|| |++|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+......
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCSTTCC
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC---CCCcEeeccchhheeecccccc
Confidence 99 8899998863 4699999999999999999999999999999999999994 6789999999999877543321
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
....+||+.|+|||++.+..++.++|||||||+||||++|..||.+... ...+..+........ ....
T Consensus 173 -------~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~~~~~~~~--~~~~ 240 (293)
T d1yhwa1 173 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPEL--QNPE 240 (293)
T ss_dssp -------BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCCC--SSGG
T ss_pred -------ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHHHHhCCCCCC--CCcc
Confidence 2456899999999999999999999999999999999999999977432 333333332221111 1235
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYL 268 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l 268 (473)
.+++++.+||..||..||++||+++++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~ei 267 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 688999999999999999999998877
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=408.17 Aligned_cols=267 Identities=19% Similarity=0.305 Sum_probs=214.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++++.||+|+||+||+|+++.+++.||||++.+ .....+.+|+++++.|+|++ |..+..++.+.+..++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF-FVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTT-BCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCC-eeEEEEEEEECCEEEE
Confidence 3679999999999999999999999999999998532 33456889999999998655 4455566677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+...
T Consensus 86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC--
T ss_pred EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccC
Confidence 99999 7899999874 4579999999999999999999999999999999999999 47789999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+. +..+.+.++......
T Consensus 162 ~~~~-----~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~----- 228 (288)
T d1uu3a_ 162 SKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKIIKLEYD----- 228 (288)
T ss_dssp -------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCCC-----
T ss_pred Cccc-----ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHHHcCCCC-----
Confidence 2211 124568999999999999999999999999999999999999999874 344555555544432
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCCCCCccccccccc
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 294 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 294 (473)
+...+++++.+||..||+.||++|||++++.+. .+... .++-..+||..+..
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~---~~i~~-Hpff~~i~w~~l~~ 280 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY---GPLKA-HPFFESVTWENLHQ 280 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH---HHHHT-SGGGTTCCCTTGGG
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC---HHHHc-CCccCCCCHHHhhc
Confidence 235689999999999999999999999887442 22222 23444578987653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=406.25 Aligned_cols=257 Identities=21% Similarity=0.336 Sum_probs=204.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
.++|++.++||+|+||+||+|+. +..||||++... ....+.+|+.+++.++|+++|. +..+... ...++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~-~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL-FMGYSTA-PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCC-EEEEECS-SSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEee-eeEEEec-cEEEEE
Confidence 47899999999999999999974 346999985432 2345789999999998666654 4445443 456899
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~---~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTSSEEECCCCCSCC-----
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc---CCCCEEEccccceeeccccC
Confidence 9999 6899999986667899999999999999999999999999999999999995 77899999999998765432
Q ss_pred CccccccccCCCcccCccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~---~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
... ......||+.|||||++.+. .|+.++|||||||+||||++|+.||.+... .......+......+..
T Consensus 159 ~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--~~~~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 159 GSH-----QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPDL 231 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHHTSCCCCG
T ss_pred Ccc-----cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCCCcc
Confidence 211 12456899999999999754 489999999999999999999999987643 22333334443344444
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
..+...+|+++.+||..||+.||++|||+.+|++.|+.+..
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 55667899999999999999999999999999999987753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-52 Score=407.17 Aligned_cols=247 Identities=18% Similarity=0.275 Sum_probs=203.2
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
+.|+++++||+|+||.||+|++..+++.||||++.... ...+.+|+++++.|+|++ |..+..++.+.+..+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN-IVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTT-BCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCC-CCeEEEEEeeCCeEEEEEec
Confidence 56999999999999999999999999999999964432 346889999999998655 55555666778889999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
| +++|.+++....+.+++.++..|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.......
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~---~~~~~Kl~DFG~a~~~~~~~~-- 165 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQ-- 165 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECHHHHH--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC---CCCCEEEEechhhhccCCCcc--
Confidence 9 8899999876677899999999999999999999999999999999999994 778999999999976543211
Q ss_pred ccccccCCCcccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 163 HIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
......||+.|+|||++. +..|+.++|||||||+||||++|+.||.+..... .+.++....... .
T Consensus 166 -----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~~i~~~~~~~--~ 235 (288)
T d2jfla1 166 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLLKIAKSEPPT--L 235 (288)
T ss_dssp -----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHHSCCCC--C
T ss_pred -----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHHHHHcCCCCC--C
Confidence 123568999999999985 4458999999999999999999999998865433 333333322111 1
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.....+++++.+||..||+.||++|||+++|+
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell 267 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 12346889999999999999999999988773
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=405.23 Aligned_cols=247 Identities=21% Similarity=0.250 Sum_probs=194.2
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc-----hhHHHHHHHHHHhcCCCCCCeeEEee-EeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFG-VEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~-----~~l~~E~~il~~L~~~~~i~~~~~~~-~~~~~~~l 79 (473)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ..+.+|+++++.|+|++++..+..+. ......+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 3689999999999999999999999999999998654432 34788999999999777666665544 34566799
Q ss_pred EEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CcccCCCCCcEEEeeCCCCCcEEEEecC
Q 011988 80 VIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFG 150 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~g-----IvHrDIKP~NILl~~~~~~~~vkL~DFG 150 (473)
||||| +++|.+++.. .+..+++..++.|+.||+.||+|||++| ||||||||+||||+ .++.+||+|||
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~---~~~~vkl~DFG 159 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFG 159 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC---TTSCEEECCHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC---CCCcEEEeecc
Confidence 99999 7899999863 3567999999999999999999999976 99999999999994 77899999999
Q ss_pred CcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011988 151 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 230 (473)
Q Consensus 151 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 230 (473)
+|+.+...... .....||+.|||||++.+..|+.++|||||||+||||++|+.||.+.. ..+.+..+...
T Consensus 160 ~a~~~~~~~~~-------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i~~~ 229 (269)
T d2java1 160 LARILNHDTSF-------AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREG 229 (269)
T ss_dssp HHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHT
T ss_pred ceeecccCCCc-------cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHHHcC
Confidence 99877543221 245689999999999999999999999999999999999999998743 34445555444
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.... +...+++++.+||.+||+.||++||++++|+
T Consensus 230 ~~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 230 KFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 3322 3457899999999999999999999988874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-52 Score=410.98 Aligned_cols=251 Identities=20% Similarity=0.250 Sum_probs=195.8
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
+.+.|++.+.||+|+||+||+|+++.+++.||||++.+.. ...+.+|+.+++.|+|++ |..+..++.++...+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN-IVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTT-BCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCC-CCcEEEEEEECCEEEEE
Confidence 5678999999999999999999999999999999864432 344778999999998654 55556666788889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||| |++|.+++.. ...+++.++..|+.||+.||+|||++|||||||||+|||+...++++.+||+|||+|+......
T Consensus 86 mE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp ECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999 7899999974 5579999999999999999999999999999999999999755567899999999998664432
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. ....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.. ..+.+..+........ ...
T Consensus 165 ~--------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~~~~-~~~ 232 (307)
T d1a06a_ 165 V--------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLFEQILKAEYEFD-SPY 232 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHTTCCCCC-TTT
T ss_pred e--------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHhccCCCCC-Ccc
Confidence 2 235689999999999999999999999999999999999999998743 3444455544433222 123
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...+|+++.+||..||..||++|||+++++
T Consensus 233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil 262 (307)
T d1a06a_ 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262 (307)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ccCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 457899999999999999999999988773
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=397.57 Aligned_cols=247 Identities=21% Similarity=0.319 Sum_probs=201.0
Q ss_pred CCce-EEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEe---CCe
Q 011988 6 GNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVE---GDY 76 (473)
Q Consensus 6 ~~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~---~~~ 76 (473)
.++| ++.++||+|+||+||+|++..+++.||||++.... ...+.+|+++++.|+|+++|..+..+... ...
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 4555 78889999999999999999999999999854322 23578999999999977777666655432 456
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
.++||||+ +++|.+++... ..+++.+++.|+.||+.||+|||+++ ||||||||+||||+ ++++.+||+|||+|+
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred EEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcce
Confidence 79999999 88999999753 57999999999999999999999998 99999999999995 356789999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 233 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 233 (473)
....... ...+||+.|||||++.+ .++.++|||||||+||||++|+.||.+.. ...+.+..+......
T Consensus 164 ~~~~~~~---------~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~~i~~~~~~ 231 (270)
T d1t4ha_ 164 LKRASFA---------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVKP 231 (270)
T ss_dssp GCCTTSB---------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCCC
T ss_pred eccCCcc---------CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--cHHHHHHHHHcCCCC
Confidence 6443221 34689999999999876 59999999999999999999999997643 333444444443322
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 234 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 234 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
. .+...+++++.+||..||+.||++|||+++|++
T Consensus 232 ~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 A---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 2 234567899999999999999999999888743
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-51 Score=411.82 Aligned_cols=251 Identities=19% Similarity=0.287 Sum_probs=208.7
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc---hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~---~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+.++|++++.||+|+||.||+|++..+|+.||||++..... ..+.+|+.+|+.|+|++ |..+..++.+.+..+|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT-LVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTT-BCCEEEEEEETTEEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCC-CCcEEEEEEECCEEEEEE
Confidence 34689999999999999999999999999999999655432 34788999999998555 555555667888999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||| |++|.+++......+++.+++.|+.||+.||+|||++|||||||||+||||+. +.++.+||+|||+|+.+.....
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSC
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheecccccc
Confidence 999 88999999655667999999999999999999999999999999999999952 2357899999999987654332
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
.....||+.|||||++.+..++.++|||||||+||||++|+.||.+. +..+.+..+........ ....
T Consensus 182 --------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~ 249 (350)
T d1koaa2 182 --------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMD-DSAF 249 (350)
T ss_dssp --------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCSC-CGGG
T ss_pred --------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCC-cccc
Confidence 13468999999999999999999999999999999999999999874 33444555544433221 2234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..+++++.+||.+||..||++|||+++|+
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil 278 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQAL 278 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 57899999999999999999999987773
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-51 Score=400.89 Aligned_cols=259 Identities=15% Similarity=0.240 Sum_probs=198.6
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCc---EEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
.++|++.++||+|+||+||+|++..+++ .||||.+..... ..+.+|+.+|+.|+|+++| .+..++......+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI-HLEGVVTKSTPVM 103 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBC-CEEEEECSSSSCE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCc-cEEEEEeeCCEEE
Confidence 4679999999999999999999887664 588888544332 3588999999999855555 5555667778889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccC
Q 011988 79 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 157 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 157 (473)
+||||| +++|.+++......+++.+++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+..
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC--------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEccC
Confidence 999999 889999988666789999999999999999999999999999999999999 4788999999999987654
Q ss_pred CCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 158 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 158 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
...... ........||+.|||||++.+..++.++|||||||+||||++ |..||.+... .+.+..+.......
T Consensus 181 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~~-- 253 (299)
T d1jpaa_ 181 DTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIEQDYRLP-- 253 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCC--
T ss_pred CCCcce--eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC--
Confidence 332111 111233568999999999999999999999999999999998 8999987543 33444443332211
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
....+|+++.+||..||+.||++||++.+|++.|+++++
T Consensus 254 --~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 254 --PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 235689999999999999999999999999999998875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.7e-52 Score=404.17 Aligned_cols=255 Identities=20% Similarity=0.304 Sum_probs=208.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
++|++.++||+|+||+||+|++..+++.||||++... ...++.+|+.+++.|+|+++| .+..++.+++..+|+|||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv-~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV-QLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBC-CEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEe-cCCccEeeCCeeEEEeecc
Confidence 4799999999999999999999999999999996443 345689999999999865555 5555556777889999999
Q ss_pred -CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 85 -GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 85 -g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.........
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCCTTTCCSSSSEE
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC---CCCcEEEccccceeecCCCCcee
Confidence 78999998753 45799999999999999999999999999999999999994 67899999999998765543211
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
.....||..|+|||++.+..|+.++|||||||+||||++|..||.... +..+.+..+... ... .+...
T Consensus 173 ------~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~~~~~i~~~-~~~---~~~~~ 240 (287)
T d1opja_ 173 ------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKD-YRM---ERPEG 240 (287)
T ss_dssp ------ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTT-CCC---CCCTT
T ss_pred ------eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHHHHHHHhcC-CCC---CCCcc
Confidence 234568999999999999999999999999999999999777664422 223333333222 211 23457
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
+|+++.+||..||+.||++|||+++|.+.|+.+++
T Consensus 241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 89999999999999999999999999998887754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-52 Score=410.90 Aligned_cols=252 Identities=17% Similarity=0.257 Sum_probs=197.9
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
..++|+++++||+|+||+||+|++..+|+.||||++.... ...+.+|+.+|+.|+|++ |..+..++.+....+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-IVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTT-BCCEEEEEECSSEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCC-CCcEEEEEEECCEEEEE
Confidence 4678999999999999999999999999999999964432 345789999999998655 55555566777889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
|||+ |++|.+++... ..+++..+..++.||+.||.|||+ +|||||||||+||||+ .++.+||+|||+|+.+.+.
T Consensus 83 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCHHHHHH
T ss_pred EEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC---CCCCEEEeeCCCccccCCC
Confidence 9999 78999999754 469999999999999999999997 5999999999999994 7889999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc--------
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-------- 230 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~-------- 230 (473)
. ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+................
T Consensus 159 ~---------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 159 M---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp T---------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred c---------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence 2 24568999999999999999999999999999999999999999774432111000000000
Q ss_pred ---------------cccc----cHHHHh---------cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 231 ---------------KVST----SIEALC---------RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 231 ---------------~~~~----~~~~l~---------~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
.... ....+. ..++.++.+||.+||..||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000 000000 125689999999999999999999888743
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-51 Score=392.30 Aligned_cols=253 Identities=20% Similarity=0.278 Sum_probs=198.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
++|+++++||+|+||.||+|.+. +++.||||++... ...++.+|+++++.++|++ |..+..++......++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK-LVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTT-BCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCC-cccccceeccCCceEEEEEec
Confidence 68999999999999999999975 6778999996543 3466899999999998555 555555666677789999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 -g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++......+++..++.|+.||+.||+|||+++|+||||||+||||+ .++.+||+|||+|+........
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~~~~~~-- 157 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYT-- 157 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC---GGGCEEECSCC-------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec---CCCCeEecccchheeccCCCce--
Confidence 8899999886667799999999999999999999999999999999999994 7789999999999876543321
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
......||..|+|||++.+..++.++|||||||+||||+++ .+||... ...+.+..+....... ....
T Consensus 158 ----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~---~~~~~~~~i~~~~~~~----~p~~ 226 (263)
T d1sm2a_ 158 ----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFRLY----KPRL 226 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC---CHHHHHHHHHHTCCCC----CCTT
T ss_pred ----eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC---CHHHHHHHHHhcCCCC----Cccc
Confidence 12345789999999999999999999999999999999995 5555543 3334444443322211 2346
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
+++++.+||..||+.||++||++++|++.|+++.+
T Consensus 227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 78999999999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=397.02 Aligned_cols=252 Identities=20% Similarity=0.258 Sum_probs=209.4
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---------chhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
-+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ...+.+|+.+|+.|+|++ |..+..+..+.
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~~~~~~~~~ 85 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN-VITLHEVYENK 85 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTT-BCCEEEEEECS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCC-CCcEEEEEEEC
Confidence 35678999999999999999999999999999999854321 345889999999998655 55566667788
Q ss_pred CeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCC-CCCcEEEEecCCc
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA 152 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~DFGla 152 (473)
...+|||||| |++|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||++.++ ....+||+|||+|
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 8999999999 78999999754 4799999999999999999999999999999999999996322 2236999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
+....... .....||+.|+|||++.+..++.++|||||||+||||++|+.||.+. +..+.+..+.....
T Consensus 165 ~~~~~~~~--------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 165 HKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNY 233 (293)
T ss_dssp EECTTSCB--------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCC
T ss_pred hhcCCCcc--------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC---CHHHHHHHHHhcCC
Confidence 87654322 23568999999999999999999999999999999999999999874 34445555555443
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
... ......+++++.+||..||..||++||++++++
T Consensus 234 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 234 EFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp CCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 322 344567899999999999999999999988774
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=398.42 Aligned_cols=257 Identities=19% Similarity=0.289 Sum_probs=208.8
Q ss_pred CceEEEee-EeecCceEEEEEEEcC--CCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 7 NKFRLGRK-IGSGSFGEIYLGTNIQ--TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 7 ~~y~i~~~-LG~G~fG~Vy~a~~~~--~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
++|.+.+. ||+|+||+||+|.+.. ++..||||++.... ...+.+|+++++.|+|+++|..+. ++. .+..+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g-~~~-~~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQ-AEALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEE-EEE-SSSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEee-eec-cCeEEE
Confidence 56888884 9999999999998764 45579999865433 235889999999998666665554 444 345789
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ +++|.+++...+..+++.+++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhccccc
Confidence 99999 7899999876667899999999999999999999999999999999999995 6789999999999877543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
.... .......||+.|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+......
T Consensus 163 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~~~~~~---- 231 (285)
T d1u59a_ 163 DSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRM---- 231 (285)
T ss_dssp SCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCC----
T ss_pred cccc----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----
Confidence 3211 12245578999999999999999999999999999999998 9999988653 2333444332221
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.+...+|+++.+||..||+.||++||++.+|.+.|++++...
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 234578999999999999999999999999999999988654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=408.28 Aligned_cols=261 Identities=16% Similarity=0.183 Sum_probs=203.7
Q ss_pred ccCCceEEEe-eEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeEe----CCeEE
Q 011988 4 RVGNKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVE----GDYNV 78 (473)
Q Consensus 4 ~i~~~y~i~~-~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~----~~~~~ 78 (473)
.+.++|.+++ .||+|+||.||+|++..+++.||||++.+ ...+.+|+.++.++.+|++|..+..++.+ ....|
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 3567899875 59999999999999999999999999753 45688999998777555555555444332 46689
Q ss_pred EEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 79 LVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 79 lv~e~~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
|||||| |++|.+++... ...|++.+++.|+.||+.||+|||++||+||||||+|||++..+..+.+||+|||+|+...
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence 999999 78999999754 3469999999999999999999999999999999999999755567789999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH-HHHhhcccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVSTS 235 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~~ 235 (473)
.... .....||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.........+ ..+.......+
T Consensus 166 ~~~~--------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~ 237 (335)
T d2ozaa1 166 SHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237 (335)
T ss_dssp CCCC--------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred CCCc--------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 5332 23568999999999999999999999999999999999999999775443222221 12221111111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
......+++++.+||..||..||++||++.++ |++.|..
T Consensus 238 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei---l~hp~~~ 276 (335)
T d2ozaa1 238 -NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPWIM 276 (335)
T ss_dssp -TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHH---HHSHHHH
T ss_pred -CcccccCCHHHHHHHHHHccCChhHCcCHHHH---HcCHHhh
Confidence 11234578999999999999999999998876 5555443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-50 Score=392.02 Aligned_cols=261 Identities=20% Similarity=0.317 Sum_probs=205.7
Q ss_pred CccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeC--
Q 011988 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG-- 74 (473)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~-- 74 (473)
..+.++|++.+.||+|+||+||+|++..+|+.||||++.+.. ...+.+|+++++.++|++++..+..+....
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 357889999999999999999999999999999999965432 224788999999999887777776665544
Q ss_pred -CeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 75 -DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 75 -~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
...||||||+ |++|.+++.. .+.+++.+++.|+.||+.||+|||++|||||||||+||||+ ..+.++|+|||++
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIA 158 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEECCCTTC
T ss_pred CceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceeehhhhh
Confidence 3578999999 7899998874 45799999999999999999999999999999999999995 7889999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
+......... .......||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ..+.+..+.....
T Consensus 159 ~~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~~~~~~~ 231 (277)
T d1o6ya_ 159 RAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVAYQHVREDP 231 (277)
T ss_dssp EECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCC
T ss_pred hhhccccccc----cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC---HHHHHHHHHhcCC
Confidence 7664433211 12345689999999999999999999999999999999999999998743 3333333333322
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHH
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDL 275 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~l 275 (473)
. ........+|+++.++|.+||+.||++|| ++++|++.|..+
T Consensus 232 ~-~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 232 I-PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp C-CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred C-CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 2 22234467899999999999999999999 889887777665
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.1e-51 Score=408.93 Aligned_cols=251 Identities=21% Similarity=0.218 Sum_probs=208.2
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
+.++|++++.||+|+||.||+|++..+|+.||||++.... ...+.+|+.+|+.|+|++ |..+..++.+....+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK-LINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTT-BCCEEEEEECSSEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCC-CCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999999999999999865543 235778999999998655 455556667888899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||| |++|.+++.....++++.+++.|+.||+.||+|||++|||||||||+||||+. ...+.+||+|||+|+.+.....
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCCCCc
Confidence 999 88999988755667999999999999999999999999999999999999942 2467899999999988765332
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
.....||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ..+.+..+....... .....
T Consensus 185 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~-~~~~~ 252 (352)
T d1koba_ 185 --------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEF-DEDAF 252 (352)
T ss_dssp --------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCC-CSSTT
T ss_pred --------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCC-Ccccc
Confidence 134579999999999999999999999999999999999999998743 344445554433321 12234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..+++++.+||..||..||++|||+++++
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil 281 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDAL 281 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 57899999999999999999999988773
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-50 Score=399.07 Aligned_cols=240 Identities=21% Similarity=0.319 Sum_probs=197.3
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc------hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH------PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~------~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.|+++++||+|+||+||+|++..+++.||||++..... ..+.+|+.+++.|+|+++| .+..+..+....++||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI-QYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBC-CEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEe-eEEEEEEECCEEEEEE
Confidence 49999999999999999999999999999998654332 3478899999999865554 5555667788999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||| +++|..++ .....+++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp ECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSSB--
T ss_pred EecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---CCCCEEEeecccccccCCC--
Confidence 999 45554444 3567899999999999999999999999999999999999995 7789999999999865432
Q ss_pred ccccccccCCCcccCccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~---~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
....||+.|||||++.+. .|+.++|||||||+||||++|..||.+.. ..+.+..+.........
T Consensus 169 ---------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~~~~~~~i~~~~~~~~~- 235 (309)
T d1u5ra_ 169 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNESPALQ- 235 (309)
T ss_dssp ---------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCCS-
T ss_pred ---------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCC-
Confidence 345899999999999753 48999999999999999999999998743 33444444443332211
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...+++++.+||..||..||++|||+++|+
T Consensus 236 --~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 265 (309)
T d1u5ra_ 236 --SGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265 (309)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred --CCCCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 246789999999999999999999988874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=400.11 Aligned_cols=260 Identities=20% Similarity=0.287 Sum_probs=214.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|++++.||+|+||.||+|+++.+|+.||||++.+ .....+.+|+.+|+.++| ++|..+..+..+.+..++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCC-CCEEEEEeeecccccccc
Confidence 4689999999999999999999999999999998543 334568899999999984 556666667778889999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 83 v~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCT
T ss_pred ceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccC
Confidence 99999 8899999885 4579999999999999999999999999999999999999 47789999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
.. .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+ ..+.+..+......
T Consensus 159 ~~-------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~i~~~~~~----- 223 (337)
T d1o6la_ 159 GA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIR----- 223 (337)
T ss_dssp TC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC-----
T ss_pred Cc-------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHHHHHhcCCCC-----
Confidence 22 1245789999999999999999999999999999999999999998743 34445555444332
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
++..+++++.+||..||+.||.+|++ +++| +++.|- ..++|..+...
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~ei---l~Hp~f-------~~i~~~~l~~~ 275 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV---MEHRFF-------LSINWQDVVQK 275 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH---HTSGGG-------TTCCHHHHHTT
T ss_pred CCccCCHHHHHHHHhhccCCchhhcccccccHHHH---HcCccc-------ccCCHHHHHhC
Confidence 24578999999999999999999995 4444 444432 33578766443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-51 Score=394.39 Aligned_cols=255 Identities=20% Similarity=0.312 Sum_probs=205.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
.++|++.++||+|+||.||+|.+. +++.||||++... ....+.+|+.+++.++|+++|..+. +..+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g-~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEE-EECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEe-eecc-CCeEEEEEe
Confidence 368999999999999999999974 6788999986443 3456899999999998766666554 4443 456899999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 84 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 84 ~-g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+ +++|.+++... ..++++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+|+.......
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~- 164 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEY- 164 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCcc-
Confidence 9 88999876532 2369999999999999999999999999999999999999 4788999999999987754322
Q ss_pred cccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 241 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 241 (473)
.......||+.|+|||++.+..++.++|||||||+||||++|..||... ....+.+..+....... ...
T Consensus 165 -----~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~--~~~~~~~~~i~~~~~~~----~p~ 233 (272)
T d1qpca_ 165 -----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVIQNLERGYRMV----RPD 233 (272)
T ss_dssp -----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCCC----CCT
T ss_pred -----ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCCC----Ccc
Confidence 1124567999999999999989999999999999999999965554332 23334444443322211 235
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011988 242 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 278 (473)
Q Consensus 242 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 278 (473)
.+|+++.+||..||+.||++|||+++|++.|+++|..
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 7899999999999999999999999999999998853
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=400.76 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=206.3
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCc-----EEEEEEccc----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLNVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~-----~vAiK~~~~----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
++|++.++||+|+||+||+|++..+++ .||||++.. .....+.+|+.++..+.+|++|..+..++...+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 689999999999999999999876554 689998533 23446889999999996677777777777788889
Q ss_pred EEEEecC-CCCHHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEE
Q 011988 78 VLVIDLL-GPSLEDLFNFCS----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 134 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~----------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NIL 134 (473)
++||||| +++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 9999999 889999997432 24889999999999999999999999999999999999
Q ss_pred EeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 011988 135 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ 213 (473)
Q Consensus 135 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~ 213 (473)
++ .++.+||+|||+|+......... ......||+.|||||++.+..++.++|||||||+||||++ |..||.
T Consensus 197 l~---~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 197 VT---HGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp EE---TTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cc---cCCeEEEeeccccccccCCCcee-----eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 95 77899999999998765543321 1234578999999999999999999999999999999997 899998
Q ss_pred CCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011988 214 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 273 (473)
Q Consensus 214 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 273 (473)
+..... .+.++........ ....+|+++.+||..||+.||++|||+++|++.|.
T Consensus 269 ~~~~~~---~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDA---NFYKLIQNGFKMD---QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSH---HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHH---HHHHHHhcCCCCC---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 765432 2233333222221 23568999999999999999999999999988875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=391.26 Aligned_cols=248 Identities=19% Similarity=0.334 Sum_probs=198.8
Q ss_pred eeEeecCceEEEEEEEc--CCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 13 RKIGSGSFGEIYLGTNI--QTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~--~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
++||+|+||+||+|.+. .+++.||||++.... ...+.+|+++++.|+|++++..+. ++.. +..+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g-~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG-ICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEE-EEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEE-Eecc-CCEEEEEEcCC
Confidence 47999999999999864 356789999864322 245889999999998766665554 4443 4568999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcccc
Q 011988 85 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 164 (473)
Q Consensus 85 g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 164 (473)
+++|.+++.. ...+++.+++.|+.||+.||+|||++|||||||||+||||+ ..+.+||+|||+|+.+.......
T Consensus 91 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~---~~~~~kl~DFGla~~~~~~~~~~-- 164 (277)
T d1xbba_ 91 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYY-- 164 (277)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEE--
T ss_pred CCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc---ccCcccccchhhhhhcccccccc--
Confidence 7899999874 55799999999999999999999999999999999999995 67899999999998765433221
Q ss_pred ccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011988 165 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 243 (473)
Q Consensus 165 p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 243 (473)
.......||+.|||||++.+..++.++|||||||++|||++ |+.||.+... .+....+...... .+...+
T Consensus 165 --~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~----~~p~~~ 235 (277)
T d1xbba_ 165 --KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM----GCPAGC 235 (277)
T ss_dssp --EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CCCTTC
T ss_pred --ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCccc
Confidence 12234579999999999999999999999999999999998 9999987543 3334444332221 123578
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 244 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 244 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
|+++.+||..||+.||++||++++|.+.|++.+.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999999999999999999998874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-50 Score=396.38 Aligned_cols=259 Identities=18% Similarity=0.267 Sum_probs=214.7
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCch--hHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHP--QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~--~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
.+-++|++++.||+|+||+||+|.+..+++.||||++...... .+.+|+++|+.++|++ |..+..++.+....||||
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRN-ILHLHESFESMEELVMIF 80 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTT-BCCEEEEEEETTEEEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCC-CCeEEEEEEECCEEEEEE
Confidence 4678999999999999999999999999999999997655433 4779999999999655 555555667788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||| |++|.+++...+..+++.+++.|+.||+.||+|||++||+||||||+|||++. +....+||+|||+++.......
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccccCCc
Confidence 999 78999999865567999999999999999999999999999999999999952 2456899999999987654321
Q ss_pred ccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 240 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 240 (473)
.....||+.|+|||.+.+..++.++|||||||+||+|++|..||.+. ...+.+..+........ ....
T Consensus 160 --------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~ 227 (321)
T d1tkia_ 160 --------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMNAEYTFD-EEAF 227 (321)
T ss_dssp --------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHTCCCCC-HHHH
T ss_pred --------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCC-hhhc
Confidence 12457899999999999999999999999999999999999999874 34455555655444332 3345
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 241 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 241 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
..+++++.+||..||..||++||+++++ |++-|.++
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~R~s~~ei---l~hp~~~~ 263 (321)
T d1tkia_ 228 KEISIEAMDFVDRLLVKERKSRMTASEA---LQHPWLKQ 263 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHH---hcCHhhcc
Confidence 6789999999999999999999998877 55555443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-49 Score=400.11 Aligned_cols=257 Identities=20% Similarity=0.296 Sum_probs=211.7
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
.++|+++++||+|+||.||+|+++.+|+.||||++.+ .....+.+|+++|+.++|++ |..+..+.......++
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF-LVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTT-BCCEEEEEECSSEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCc-Eeeccccccccccccc
Confidence 3789999999999999999999999999999998542 23445789999999998555 4555556677788899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ +++|.+++... +.+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 119 v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~---~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECSSC
T ss_pred ccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC---CCCCEEeeeceeeeecccc
Confidence 99998 88999998754 4799999999999999999999999999999999999994 7789999999999876542
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 238 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 238 (473)
. ....||+.|||||++.+..++.++|||||||+||||++|..||.+. +....+..+.......
T Consensus 195 ~----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~~---- 257 (350)
T d1rdqe_ 195 T----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVRF---- 257 (350)
T ss_dssp B----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCC----
T ss_pred c----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHHhcCCCCC----
Confidence 2 3568999999999999999999999999999999999999999874 3445555555544322
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 239 LCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 239 l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
...+++++.+||..||..||.+|+ ++++|+ ++- |-...+|..+..+
T Consensus 258 -p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell---~Hp-------~f~~~~~~~~~~~ 308 (350)
T d1rdqe_ 258 -PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK---NHK-------WFATTDWIAIYQR 308 (350)
T ss_dssp -CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH---TSG-------GGTTCCHHHHHTT
T ss_pred -CccCCHHHHHHHHHHhhhCHHhccccccccHHHHH---cCc-------cccCCCHHHHHhc
Confidence 356899999999999999999994 766663 332 3334678876543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=386.52 Aligned_cols=258 Identities=15% Similarity=0.178 Sum_probs=199.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCC----cEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
.+.|++.+.||+|+||.||+|.+..++ ..||||++..... ..+.+|+.+++.|+|++ |..+..++......
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~n-Iv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN-IIRLEGVISKYKPM 84 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTT-BCCEEEEECSSSSE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCC-EeeeeEEEecCCce
Confidence 457999999999999999999987654 4799998644332 34789999999998655 44555566677778
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
+++|||+ +++|.+++......+++.+++.|+.||+.||+|||+++||||||||+|||| +.++.+||+|||+|+.+.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-----
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhccc
Confidence 9999999 778888887777789999999999999999999999999999999999999 478899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 236 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 236 (473)
....... ......||+.|||||++.+..++.++|||||||+||||++|..||.... ...+.+..+.......
T Consensus 162 ~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~~-- 233 (283)
T d1mqba_ 162 DDPEATY----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGFRLP-- 233 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCC--
T ss_pred CCCccce----EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHHHhccCCCC--
Confidence 4332111 1234578999999999999999999999999999999999666654322 2334444444332221
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 237 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 237 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
....+|.++.+||..||+.||++||++.+|.+.|+.++.
T Consensus 234 --~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 234 --TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp --CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 235689999999999999999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=390.22 Aligned_cols=260 Identities=20% Similarity=0.279 Sum_probs=201.0
Q ss_pred CCceEEEeeEeecCceEEEEEEEcC-----CCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeE-eCC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGD 75 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~-~~~ 75 (473)
.++|+++++||+|+||.||+|++.. +++.||||++.... ...+..|..++..+.+|++|..+..+.. .+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 3689999999999999999999754 34689999865433 2347788888999988877776655544 456
Q ss_pred eEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCC
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 139 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~ 139 (473)
..+++|||| +++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~--- 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS--- 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC---
Confidence 789999999 899999997432 3489999999999999999999999999999999999994
Q ss_pred CCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCC
Q 011988 140 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAG 218 (473)
Q Consensus 140 ~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG-~~Pf~~~~~~ 218 (473)
.++.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||++| ..||.+....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GGGCEEECC------CCSCTTSC-----CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CCCcEEEccCcchhhcccccccc-----ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 77899999999998765433211 22456899999999999999999999999999999999986 5678765433
Q ss_pred CHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 219 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 219 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
. .....+..... . .+...+++++.++|..||+.||++|||+++|++.|+++++.+
T Consensus 244 ~--~~~~~~~~~~~-~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 244 E--EFCRRLKEGTR-M---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp H--HHHHHHHHTCC-C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H--HHHHHHhcCCC-C---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 2 22222222211 1 123568899999999999999999999999999999998654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-49 Score=385.80 Aligned_cols=249 Identities=18% Similarity=0.191 Sum_probs=208.3
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc------------hhHHHHHHHHHHhcCCCCCCeeEEeeE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH------------PQLQYEAKLYKILQGGTGIPNLRWFGV 72 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~------------~~l~~E~~il~~L~~~~~i~~~~~~~~ 72 (473)
+.++|++.+.||+|+||+||+|++..+|+.||||++.+... ..+.+|+.+++.|..|++|..+..++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 46899999999999999999999999999999998654321 247789999999997777777777888
Q ss_pred eCCeEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCC
Q 011988 73 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 151 (473)
Q Consensus 73 ~~~~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 151 (473)
+++..||||||+ +++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~ 156 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 156 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred cCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchh
Confidence 999999999999 7899999975 4579999999999999999999999999999999999999 4788999999999
Q ss_pred cccccCCCCccccccccCCCcccCccccccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 011988 152 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 225 (473)
Q Consensus 152 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~------~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~ 225 (473)
|+.+..... .....||..|+|||.+.+ ..++.++|||||||+||||++|+.||.+.. ....+.
T Consensus 157 a~~~~~~~~--------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~ 225 (277)
T d1phka_ 157 SCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLR 225 (277)
T ss_dssp CEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH
T ss_pred eeEccCCCc--------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHHH
Confidence 987654322 134689999999999863 346889999999999999999999998753 344444
Q ss_pred HHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 226 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 226 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.+......... .....+++++.+||.+||+.||++||++++|+
T Consensus 226 ~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 226 MIMSGNYQFGS-PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp HHHHTCCCCCT-TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHhCCCCCCC-cccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 45544332222 12357899999999999999999999988773
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=385.66 Aligned_cols=250 Identities=18% Similarity=0.282 Sum_probs=208.1
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
++|++.++||+|+||+||+|++ .+++.||||++.+. ...++.+|+.+++.++|++++ .+..++.+....++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv-~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV-QLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBC-CEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCcee-eEEEEEeeCCceEEEEEcc
Confidence 6899999999999999999997 47889999985543 346789999999999865554 5555556677889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 -g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.+......
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~---~~~~~kl~DfG~a~~~~~~~~~-- 156 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYT-- 156 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC---TTCCEEECCCSSCCBCSSSSCC--
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc---CCCcEEECcchhheeccCCCce--
Confidence 7899999876667899999999999999999999999999999999999994 7889999999999876554321
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
......||..|+|||.+.+..++.++|||||||++|||++ |+.||.+... .+....+....... .+..
T Consensus 157 ----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~~----~p~~ 225 (258)
T d1k2pa_ 157 ----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRLY----RPHL 225 (258)
T ss_dssp ----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCCC----CCTT
T ss_pred ----eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHHhCCCCC----Cccc
Confidence 2234679999999999999999999999999999999998 8999987643 34444444432211 2356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 274 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 274 (473)
+|+++.+||..||+.||++|||+++|++.|.+
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 78999999999999999999999999887653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-49 Score=393.06 Aligned_cols=255 Identities=21% Similarity=0.291 Sum_probs=211.1
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++++.||+|+||+||+|+++.+|+.||||++.+ .....+.+|+.+++.++|+ +|..+..++.+....++|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp-nIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP-FIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBT-TBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCc-ChhheeeeEeeCCeeeeE
Confidence 679999999999999999999999999999998532 3345688999999999855 555666667788899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ |++|..++. ....+++..++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+...+..
T Consensus 83 mE~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~---~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp ECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSCEECSSCB
T ss_pred eeecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc---CCCCEEEecCccceEecccc
Confidence 9999 788888887 456789999999999999999999999999999999999994 78899999999998765432
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
...+||+.|||||++.+..|+.++|||||||+||||++|+.||.+. +..+.+.++...... +
T Consensus 159 ----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~-----~ 220 (316)
T d1fota_ 159 ----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELR-----F 220 (316)
T ss_dssp ----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCC-----C
T ss_pred ----------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHHHHHcCCCC-----C
Confidence 3568999999999999999999999999999999999999999874 344455555544332 2
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHhCCCCCCccccccccc
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKY 294 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 294 (473)
...+++++.++|..||..||.+|+ ++++| |++.| -..++|..+..
T Consensus 221 p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~i---l~Hp~-------f~~i~~~~l~~ 270 (316)
T d1fota_ 221 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV---KNHPW-------FKEVVWEKLLS 270 (316)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHH---HTSGG-------GSSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHH---HcCcc-------cccCCHHHHHh
Confidence 356889999999999999999996 66665 44433 23467876543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-50 Score=387.14 Aligned_cols=255 Identities=20% Similarity=0.308 Sum_probs=198.7
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCC---cEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 79 (473)
++|++.+.||+|+||.||+|++..++ ..||||.+..... ..+.+|+.+++.++|++++..+..+ . ....++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~-~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T-ENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C-SSSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-e-cCeEEE
Confidence 68999999999999999999987553 4688888544332 3478999999999876666655544 3 456789
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
||||+ +++|.+++......+++..++.++.||+.||.|||++|||||||||+|||++ ..+.+||+|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchhheeccCC
Confidence 99999 7899998877777899999999999999999999999999999999999995 6789999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
... ......||+.|+|||++.+..++.++|||||||+||||++ |..||.+..... .+..+......
T Consensus 162 ~~~------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~~~~~---- 228 (273)
T d1mp8a_ 162 TYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGERL---- 228 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTCCC----
T ss_pred cce------eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCCC----
Confidence 221 1234578999999999999999999999999999999998 899998865433 33333333222
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
.+..++|+++.+||..||+.||++|||+.+|++.|+.++.++
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 134678999999999999999999999999999999988654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.8e-49 Score=399.12 Aligned_cols=262 Identities=23% Similarity=0.290 Sum_probs=209.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC------CchhHHHHHHHHHHhc--CCCCCCeeEEeeEeCCeE
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT------KHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~------~~~~l~~E~~il~~L~--~~~~i~~~~~~~~~~~~~ 77 (473)
.++|++++.||+|+||.||+|++..+|+.||||++.+. ....+.+|..+++.+. +|++|..+..++...+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 36899999999999999999999999999999985432 2334566666666654 356666677777888899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
|+||||+ |++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||| +..+.+||+|||+|+.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecC
Confidence 9999999 7999999975 4579999999999999999999999999999999999999 477899999999998765
Q ss_pred CCCCccccccccCCCcccCccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
.... ....||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+............+.....
T Consensus 159 ~~~~---------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~--- 226 (364)
T d1omwa3 159 KKKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--- 226 (364)
T ss_dssp SSCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC---
T ss_pred CCcc---------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC---
Confidence 4322 34689999999999975 5689999999999999999999999988665544443333322221
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHhCCCCCCcccccccccc
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 295 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 295 (473)
.+...+++++.+||..||..||++||+ +++| +++.| -..++|..+..+
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~ei---l~Hp~-------f~~i~~~~~~~~ 279 (364)
T d1omwa3 227 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV---KESPF-------FRSLDWQMVFLQ 279 (364)
T ss_dssp --CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHH---HTSGG-------GTTCCHHHHHTT
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHH---HcCcc-------ccCCCHHHHhcC
Confidence 123578999999999999999999999 4544 44443 334688876543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=387.60 Aligned_cols=239 Identities=26% Similarity=0.376 Sum_probs=198.7
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC---------CchhHHHHHHHHHHhcC-CCCCCeeEEeeEeC
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT---------KHPQLQYEAKLYKILQG-GTGIPNLRWFGVEG 74 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~---------~~~~l~~E~~il~~L~~-~~~i~~~~~~~~~~ 74 (473)
+.++|++.+.||+|+||+||+|++..+|+.||||++.+. ....+.+|+.+++.+++ |++|..+..++...
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 568999999999999999999999999999999985432 12346789999999984 56677777788888
Q ss_pred CeEEEEEecCC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCc
Q 011988 75 DYNVLVIDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 152 (473)
Q Consensus 75 ~~~~lv~e~~g--~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 152 (473)
+..++||||+. +++.+++.. ...+++.+++.|+.||+.||+|||++|||||||||+|||++ .+.+.+||+|||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccc
Confidence 89999999983 578888764 45799999999999999999999999999999999999996 34578999999999
Q ss_pred ccccCCCCccccccccCCCcccCccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011988 153 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 231 (473)
Q Consensus 153 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 231 (473)
+...... .....||+.|+|||++.+..+ +.++|||||||+||||++|+.||.+. ..+....
T Consensus 159 ~~~~~~~---------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---------~~i~~~~ 220 (273)
T d1xwsa_ 159 ALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------EEIIRGQ 220 (273)
T ss_dssp EECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HHHHHCC
T ss_pred eeccccc---------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---------hHHhhcc
Confidence 8654432 245689999999999987765 67899999999999999999999752 1122222
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
. .+...+|+++.+||.+||..||++|||+++++
T Consensus 221 ~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 221 V-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp C-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred c-----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 1 12356899999999999999999999988874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=392.20 Aligned_cols=243 Identities=22% Similarity=0.295 Sum_probs=203.7
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++++.||+|+||+||+|+++.+++.||||++.+ .....+..|..++...-+|++|..+..+..+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 679999999999999999999999999999998642 33345677888776544466677777778888999999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 81 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
|||+ +++|.+++.. ...+++.+++.++.||+.||+|||++|||||||||+|||+ +..+.+||+|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence 9999 8899999974 4579999999999999999999999999999999999999 478899999999998655432
Q ss_pred CccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 239 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 239 (473)
. ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ..+.+.++...... +
T Consensus 158 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~-----~ 222 (320)
T d1xjda_ 158 A-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNPF-----Y 222 (320)
T ss_dssp C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC-----C
T ss_pred c-------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCC-----C
Confidence 2 1245689999999999999999999999999999999999999998743 34445555443322 2
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHH-HH
Q 011988 240 CRGYPTEFASYFHYCRSLRFDDKPDYA-YL 268 (473)
Q Consensus 240 ~~~~p~~l~~li~~cl~~dp~~RPt~~-~l 268 (473)
.+.+++++.+||.+||..||++||++. +|
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l 252 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred CccCCHHHHHHHHHhcccCCCCCcCHHHHH
Confidence 356899999999999999999999974 55
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=390.55 Aligned_cols=254 Identities=19% Similarity=0.255 Sum_probs=199.9
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCc----EEEEEEcccC----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLNVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 78 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~~~~~----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 78 (473)
.+|+++++||+|+||+||+|.+..+|+ +||||.+... ....+.+|+.+++.|+|++++. +..++.++...+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~-l~g~~~~~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR-LLGICLTSTVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCC-EEEEEESSSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEee-EEEEEecCCeeE
Confidence 569999999999999999999988876 5788864332 2456899999999998655554 455556666655
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCC
Q 011988 79 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 158 (473)
Q Consensus 79 lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 158 (473)
+++++++++|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~---~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---CCCCeEeeccccceecccc
Confidence 5555669999999887778899999999999999999999999999999999999995 6789999999999876543
Q ss_pred CCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011988 159 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 237 (473)
Q Consensus 159 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 237 (473)
.... ......||..|+|||++.+..++.++|||||||+||||+| |..||.+......... +......
T Consensus 165 ~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~---i~~~~~~---- 232 (317)
T d1xkka_ 165 EKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERL---- 232 (317)
T ss_dssp CC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH---HHHTCCC----
T ss_pred cccc-----cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH---HHcCCCC----
Confidence 3211 1234578999999999999999999999999999999998 8999988654433322 2222211
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 238 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 238 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
.....+|+++.+||..||+.||++||++.+|++.|..+.
T Consensus 233 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 123467899999999999999999999999998887765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=381.58 Aligned_cols=252 Identities=21% Similarity=0.228 Sum_probs=201.7
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
++|+++++||+|+||+||+|++..+|+.||||++... ....+.+|+++++.++|++ |..+..+..+....++||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~-Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-IVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTT-BCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCc-EEEeccccccccceeEEE
Confidence 6899999999999999999999999999999985332 2456889999999998555 555566667888999999
Q ss_pred ecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCC
Q 011988 82 DLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 160 (473)
Q Consensus 82 e~~g~sL~~~l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 160 (473)
||+++++.+++... ...+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.......
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSB
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCcc
Confidence 99988887777543 4569999999999999999999999999999999999999 4778999999999987654332
Q ss_pred ccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh----------
Q 011988 161 HQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---------- 229 (473)
Q Consensus 161 ~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~---------- 229 (473)
......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 158 -------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 158 -------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp -------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred -------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 124568999999999988766 58999999999999999999999987543221111111100
Q ss_pred -----------ccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 230 -----------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 230 -----------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.............+++++.+||.+||..||++|||+++|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell 281 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0112223344556789999999999999999999988874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-49 Score=385.00 Aligned_cols=248 Identities=19% Similarity=0.155 Sum_probs=196.0
Q ss_pred EEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.+++||+|+||+||+|++..+|+.||||++.... ...+.+|+.+++.++|+++|. +..+....+..+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~-~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG-LLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCC-EEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeE-EEeeeccCCceeehhh
Confidence 4689999999999999999999999999854322 235789999999999665555 4555566777899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 83 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 83 ~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
|+.+.+...+...+..+++.++..|+.||+.||+|||++||+||||||+|||+ +..+.+||+|||+|+.......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCC--
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcc--
Confidence 99776666665556779999999999999999999999999999999999999 4789999999999987655332
Q ss_pred ccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-----------
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------- 230 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 230 (473)
.....+||+.|+|||++.+. .|+.++|||||||+||||++|..||.+....+....+.+....
T Consensus 156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 -----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp -----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred -----cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence 12356899999999998755 5799999999999999999999999875433222222221110
Q ss_pred ---------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 ---------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 ---------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
........+...+++++.+||..||..||++|||+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 011223445567789999999999999999999988773
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-48 Score=382.97 Aligned_cols=255 Identities=21% Similarity=0.326 Sum_probs=206.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
.++|+++++||+|+||+||+|++. .+++.||||++.... ...+.+|+.+++.++|++++..+. ++.....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~-~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG-VCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE-EECSSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCccccee-eeccCCc
Confidence 367999999999999999999975 356789999965543 235889999999998666555554 4556677
Q ss_pred EEEEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCc
Q 011988 77 NVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 132 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~-----------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~N 132 (473)
.+++|||+ +++|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 89999999 889999986432 248899999999999999999999999999999999
Q ss_pred EEEeeCCCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCC-CC
Q 011988 133 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS-LP 211 (473)
Q Consensus 133 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~-~P 211 (473)
|||+ .++.+||+|||+|+........ .......||+.|+|||.+.+..++.++|||||||+||||++|. .|
T Consensus 171 ILld---~~~~~Kl~DFGls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 171 CLVG---ENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp EEEC---GGGCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eEEC---CCCcEEEccchhheeccCCccc-----cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 9994 6789999999999866543221 1223567899999999999999999999999999999999985 57
Q ss_pred CCCCCCCCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 212 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 212 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
|.+. ...+.+..+...... .+...+|+++.+||..||+.||++|||+.+|.+.|+++.
T Consensus 243 ~~~~---~~~e~~~~v~~~~~~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGM---AHEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTS---CHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCC---CHHHHHHHHHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 7764 334455555544432 234578999999999999999999999999999998763
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=380.90 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=196.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCC-C--cEEEEEEcccCC------chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQT-N--EEVAIKLNVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~--~~vAiK~~~~~~------~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
++|++++.||+|+||+||+|++... + ..||||++.+.. ...+.+|+.+++.|+|++++..+.++ .+ ...
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~-~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV-LT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-ee-cch
Confidence 5699999999999999999986533 3 468999854321 24588999999999866655555444 44 356
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccccc
Q 011988 78 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 156 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 156 (473)
++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.+.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~---~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc---cccceeeccchhhhhcc
Confidence 7899999 8899998876677899999999999999999999999999999999999996 56799999999999875
Q ss_pred CCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011988 157 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 235 (473)
Q Consensus 157 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 235 (473)
....... ......|+..|+|||++.+..++.++|||||||++|||++ |..||.+.+ ..+.+..+........
T Consensus 163 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---~~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 163 QNDDHYV----MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGERLP 235 (273)
T ss_dssp C-CCEEE----C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTSCCCCC
T ss_pred cCCCcce----ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC---HHHHHHHHHhCCCCCC
Confidence 5433221 1234568899999999999999999999999999999998 899998753 3444455544333222
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011988 236 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 275 (473)
Q Consensus 236 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 275 (473)
....+|+++.+||..||..||++|||+.+|.+.|.++
T Consensus 236 ---~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 ---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2357899999999999999999999999999888764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=381.48 Aligned_cols=254 Identities=18% Similarity=0.240 Sum_probs=196.5
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCC-CcEEEEEEccc-----CCchhHHHHHHHHHHhc---CCCCCCeeEEeeE---
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLNVK-----TKHPQLQYEAKLYKILQ---GGTGIPNLRWFGV--- 72 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~vAiK~~~~-----~~~~~l~~E~~il~~L~---~~~~i~~~~~~~~--- 72 (473)
..++|+++++||+|+||+||+|++..+ ++.||||++.. .....+.+|+.+++.|. |++++..+..+..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 457899999999999999999999765 67799998432 22345778999998884 5555555544432
Q ss_pred -eCCeEEEEEecCCCCHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecC
Q 011988 73 -EGDYNVLVIDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 150 (473)
Q Consensus 73 -~~~~~~lv~e~~g~sL~~~l~-~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 150 (473)
.....+++||++.+.+..+.. .....+++..++.|+.||+.||+|||++|||||||||+|||+ +..+.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence 234679999999766655443 345569999999999999999999999999999999999999 477899999999
Q ss_pred CcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011988 151 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 230 (473)
Q Consensus 151 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 230 (473)
+++....... .....||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.......+......
T Consensus 162 ~~~~~~~~~~--------~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 162 LARIYSFQMA--------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp SCCCCCGGGG--------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhhhhccccc--------CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 9986543321 24568999999999999999999999999999999999999999875432222222221110
Q ss_pred -------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 -------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 -------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
........+...+++++.+||.+||..||++|||+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L 291 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 111122334456789999999999999999999988763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=378.93 Aligned_cols=257 Identities=20% Similarity=0.315 Sum_probs=207.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCC-------cEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-------EEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG 74 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~-------~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~ 74 (473)
.++|++++.||+|+||.||+|++..++ ..||||++.+... .++..|..++..+.+|++|..+..++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 478999999999999999999976554 4799998655442 45778999999997677777777777788
Q ss_pred CeEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC
Q 011988 75 DYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 138 (473)
Q Consensus 75 ~~~~lv~e~~-g~sL~~~l~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~ 138 (473)
...++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||++|||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl--- 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--- 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee---
Confidence 8899999999 899999997442 358999999999999999999999999999999999999
Q ss_pred CCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 011988 139 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 217 (473)
Q Consensus 139 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~ 217 (473)
+.++.+||+|||+++......... ......||+.|+|||.+.+..|+.++|||||||+||||++ |..||.+...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTC-----CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCCeEeccchhhcccccccccc-----ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 477899999999998776543321 2245679999999999999999999999999999999998 7899977543
Q ss_pred CCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 218 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 218 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
.+.+..+...... .....+++++.+||..||+.||.+|||+.+|++.|+.++.
T Consensus 244 ---~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 ---EELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---HHHHHHHHTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHcCCCC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 3333444332221 1245789999999999999999999999999999998864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=381.93 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=197.4
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (473)
++|++.++||+|+||+||+|++..+ +.||||++.... ...+.+|+.+++.++|++++..+.. ..+ +..++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~-~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEE-ECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEE-Eec-CCeEEEEEec
Confidence 6899999999999999999998644 679999965443 3569999999999998776666554 443 4468999999
Q ss_pred -CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 85 -GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 85 -g~sL~~~l~~-~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+++|.+++.. ....+++.+++.|+.||+.||+|||++||+||||||+||||+ .++.+||+|||+|+.+......
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~---~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC---CCCcEEEcccchhhhccCCCce-
Confidence 7888888753 345699999999999999999999999999999999999994 6789999999999876543321
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
......||+.|+|||++.+..++.++|||||||+||||++|..||... ....+.+..+....... ....
T Consensus 170 -----~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~--~~~~~~~~~i~~~~~~~----~~~~ 238 (285)
T d1fmka3 170 -----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVERGYRMP----CPPE 238 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCCC----CCTT
T ss_pred -----eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCCC----CCcc
Confidence 123457899999999999999999999999999999999966555432 23344444444332211 2457
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
+|+++.+||.+||+.||++||++++|.+.|++.+
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 8999999999999999999999999998888755
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=375.21 Aligned_cols=249 Identities=20% Similarity=0.294 Sum_probs=197.9
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEecC-
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 84 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~~- 84 (473)
++|+++++||+|+||.||+|.+ .|..||||++.+.. ...+.+|+++++.++|++++..+..+.......++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 5799999999999999999997 57899999965543 4568999999999986655555544444455679999999
Q ss_pred CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCccc
Q 011988 85 GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 163 (473)
Q Consensus 85 g~sL~~~l~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 163 (473)
+++|.+++.... ..+++..++.|+.||+.||.|||+++||||||||+|||+ +.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~~---- 157 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ---- 157 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCCCC----
Confidence 889999986432 358999999999999999999999999999999999999 478899999999998654322
Q ss_pred cccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 164 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 164 ~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
....+|..|+|||++.+..++.++|||||||++|||++ |+.||...... +.+..+....... +...
T Consensus 158 ------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~~~~~~~----~~~~ 224 (262)
T d1byga_ 158 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYKMD----APDG 224 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTTTCCCC----CCTT
T ss_pred ------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCCC----CCcc
Confidence 23478899999999999999999999999999999998 78898775443 3344444332222 3456
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
+++++.+||..||..||++||++.+|.+.|+++-.
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 88999999999999999999999999999988743
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=384.61 Aligned_cols=257 Identities=20% Similarity=0.226 Sum_probs=200.8
Q ss_pred ccCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEe----CC
Q 011988 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVE----GD 75 (473)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~----~~ 75 (473)
.++++|+++++||+|+||+||+|++..+|+.||||++.+... ..+.+|+.+|+.|+|++++..+..+... ..
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 367899999999999999999999999999999999765443 2567899999999987777666655432 23
Q ss_pred eEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 76 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 76 ~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
..+++|++++++|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+ ..+.+||+|||+|+..
T Consensus 85 ~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~---~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVA 159 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred eEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC---CCCCEEEcccCceeec
Confidence 5688888889999999974 4699999999999999999999999999999999999994 7789999999999876
Q ss_pred cCCCCccccccccCCCcccCcccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh------
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS------ 228 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~------ 228 (473)
....... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||.+....+.......+.
T Consensus 160 ~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 160 DPDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CGGGCBC----CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cCCCccc----eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 5433221 1224568999999999985 4567999999999999999999999997754322221111111
Q ss_pred -----------------hccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 229 -----------------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 229 -----------------~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..........+...+++++.+||..||..||++||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L 293 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 01111223445567788999999999999999999988874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=376.56 Aligned_cols=260 Identities=21% Similarity=0.317 Sum_probs=212.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEc-----CCCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 76 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~ 76 (473)
.++|++.++||+|+||.||+|++. .+++.||||++..... ..+.+|+.+++.+.+|++|..+..++.....
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 378999999999999999999863 4567899999655432 3477899999999778888888888888888
Q ss_pred EEEEEecC-CCCHHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeC
Q 011988 77 NVLVIDLL-GPSLEDLFNFCS-----------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 138 (473)
Q Consensus 77 ~~lv~e~~-g~sL~~~l~~~~-----------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~ 138 (473)
.+++|||| +++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~-- 179 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-- 179 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE--
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc--
Confidence 99999999 889999987432 2589999999999999999999999999999999999995
Q ss_pred CCCCcEEEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 011988 139 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 217 (473)
Q Consensus 139 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~ 217 (473)
..+.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++ |.+||.+...
T Consensus 180 -~~~~~ki~DfG~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 180 -HGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp -TTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred -ccCcccccccchheeccCCCcc-----eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 7789999999999876554331 12345689999999999999999999999999999999998 6666666543
Q ss_pred CCHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 218 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 218 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
... +.++........ ....+|+++.+||..||+.||++||++++|++.|+..+.+.
T Consensus 254 ~~~---~~~~i~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 254 DSK---FYKMIKEGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp SHH---HHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHH---HHHHHhcCCCCC---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 322 222222222221 12467899999999999999999999999999999887653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=380.46 Aligned_cols=255 Identities=20% Similarity=0.267 Sum_probs=208.5
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcE--EEEEEccc----CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLNVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 80 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--vAiK~~~~----~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv 80 (473)
++|++.++||+|+||+||+|++..++.. ||||.+.. .....+.+|+++|..+.+|++|..+..++......++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 5899999999999999999999888875 66676432 23456899999999996677777777778888999999
Q ss_pred EecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcE
Q 011988 81 IDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 144 (473)
Q Consensus 81 ~e~~-g~sL~~~l~~~---------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~v 144 (473)
|||+ +++|.+++... ...+++..++.++.||+.||.|||+++||||||||+|||++ ..+.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~---~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc---CCCce
Confidence 9999 89999998632 35699999999999999999999999999999999999994 77899
Q ss_pred EEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCCHHHH
Q 011988 145 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQK 223 (473)
Q Consensus 145 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~-~Pf~~~~~~~~~~~ 223 (473)
||+|||+|+....... .....||..|+|||.+.+..++.++|||||||++|||++|. .||.+. +..+.
T Consensus 167 kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~ 235 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAEL 235 (309)
T ss_dssp EECCTTCEESSCEECC--------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHH
T ss_pred EEcccccccccccccc--------ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHH
Confidence 9999999986544322 13457899999999999999999999999999999999965 567664 34455
Q ss_pred HHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHh
Q 011988 224 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 279 (473)
Q Consensus 224 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 279 (473)
+..+...... .....+|+++.+||..||+.||++||++.+|++.|+.++.+.
T Consensus 236 ~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 236 YEKLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHGGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHhcCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 5555443222 123568999999999999999999999999999999987543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=383.01 Aligned_cols=251 Identities=20% Similarity=0.290 Sum_probs=195.9
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc-----hhHHHHHHHHHHhcCCCCCCeeEEeeEeC-----
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEG----- 74 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~-----~~l~~E~~il~~L~~~~~i~~~~~~~~~~----- 74 (473)
+.++|+++++||+|+||+||+|.+..+|+.||||++.+... ..+.+|+++|+.|+|+++|..+..|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 67899999999999999999999999999999999654332 34778999999999777776666554332
Q ss_pred CeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 75 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 75 ~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
...++||||++.+|..+++. ..+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 96 ~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccceec
Confidence 25699999999999998873 469999999999999999999999999999999999999 4789999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc---
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 230 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 230 (473)
..... ....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.........+......
T Consensus 171 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 171 ADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp CCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCCcc----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 65432 356899999999999875 4689999999999999999999999875432222222111110
Q ss_pred --------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011988 231 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 270 (473)
Q Consensus 231 --------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 270 (473)
........+...+++++.+||..||..||++|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0111112233466889999999999999999999887743
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.5e-47 Score=372.21 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=196.8
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
++|+++++||+|+||+||+|++. +|+.||||++... ....+.+|+.+|+.++|++++ .+..+.......+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV-KLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBC-CEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEE-eeeeecccCCceeEEE
Confidence 68999999999999999999985 7899999985433 245688999999999865555 5556666777889999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+++++.+...+....+.+++..+..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|.........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCccc
Confidence 999888877777667789999999999999999999999999999999999999 47789999999999876543321
Q ss_pred cccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc---------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 231 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 231 (473)
.....|++.|+|||.+.+.. ++.++|||||||++|||++|+.||.+....+....+.......
T Consensus 157 -------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 157 -------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 23457899999999998654 6999999999999999999999998754322222222111100
Q ss_pred ------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 232 ------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 232 ------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...........+++++.+||..||..||++|||+.+|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00111223456789999999999999999999988774
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=380.38 Aligned_cols=251 Identities=21% Similarity=0.231 Sum_probs=195.2
Q ss_pred ceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeE-----eCCeEEEEEe
Q 011988 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-----EGDYNVLVID 82 (473)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~-----~~~~~~lv~e 82 (473)
+|..+++||+|+||+||+|++..+|+.||||++.... ....+|+.+|+.|+|++++..+..|.. ...+.+||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 6999999999999999999999999999999965543 334689999999997777776665533 2346789999
Q ss_pred cCCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCC
Q 011988 83 LLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 159 (473)
Q Consensus 83 ~~g~sL~~~l~---~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 159 (473)
||++++.+.+. .....+++.+++.|+.||+.||+|||++|||||||||+||||+ .+...+||+|||+|+.+....
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECCTTS
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecccchhhccCCc
Confidence 99887766653 2355799999999999999999999999999999999999995 234589999999998765432
Q ss_pred CccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc---
Q 011988 160 THQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS--- 235 (473)
Q Consensus 160 ~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~--- 235 (473)
. .....||..|+|||.+.+. .++.++|||||||++|||++|+.||...........+.+.........
T Consensus 178 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 178 P--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp C--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred c--------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 2 2356899999999998764 689999999999999999999999987543222222211111100000
Q ss_pred ------------------HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 236 ------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 236 ------------------~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.......+++++.+||.+||.+||++|||+.+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 301 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0111234688999999999999999999988763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=373.74 Aligned_cols=262 Identities=20% Similarity=0.228 Sum_probs=200.4
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccC-----CchhHHHHHHHHHHhcCCCCCCeeEEeeE-------e
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGV-------E 73 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~-----~~~~l~~E~~il~~L~~~~~i~~~~~~~~-------~ 73 (473)
.++|+++++||+|+||+||+|++..+|+.||||++... ...++.+|+.+|+.|+|++++..+..+.. .
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999999999999999985332 23458899999999998777777665533 2
Q ss_pred CCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcc
Q 011988 74 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 153 (473)
Q Consensus 74 ~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 153 (473)
....+++||++++.+...+......+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~---~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec---CCCcEEeeecceee
Confidence 346799999998888877776677899999999999999999999999999999999999994 78899999999998
Q ss_pred cccCCCCccccccccCCCcccCccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 154 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 154 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
.+....... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+..+.....
T Consensus 166 ~~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 166 AFSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp ECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ecccccccc---cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 765433211 1223456899999999999876 589999999999999999999999987544333333322221110
Q ss_pred cc----------------------cHHH-H-hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 233 ST----------------------SIEA-L-CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 233 ~~----------------------~~~~-l-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
.. .... + ....++++.+||.+||..||++|||++++ |++-|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el---L~Hpf 307 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA---LNHDF 307 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH---HHSGG
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH---HcChh
Confidence 00 0000 0 01235778899999999999999998876 55544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=370.51 Aligned_cols=255 Identities=17% Similarity=0.229 Sum_probs=202.6
Q ss_pred EEeeEeecCceEEEEEEEcCCC---cEEEEEEcccCC----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 11 LGRKIGSGSFGEIYLGTNIQTN---EEVAIKLNVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~---~~vAiK~~~~~~----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
+.++||+|+||+||+|++..++ ..||||.+.+.. ...+.+|++++++|+|+++|..+..+.......++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 3678999999999999987643 368999865432 245889999999999766666666555556788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
| +++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||| +.++.+||+|||+++.........
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCCC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccccccc
Confidence 9 889999988666678899999999999999999999999999999999999 478899999999998765543322
Q ss_pred ccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 242 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 242 (473)
........||..|+|||.+.+..++.++|||||||+||||++|..||..... ..+....+....... ....
T Consensus 188 ---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~g~~~~----~p~~ 258 (311)
T d1r0pa_ 188 ---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRLL----QPEY 258 (311)
T ss_dssp ---TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCCC----CCTT
T ss_pred ---ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCCC----Cccc
Confidence 1223456799999999999999999999999999999999998888765322 122223333222211 2356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 243 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 243 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
+|+++.+||..||..||++||++.+|++.|+.++.
T Consensus 259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 78999999999999999999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.3e-47 Score=375.33 Aligned_cols=248 Identities=19% Similarity=0.283 Sum_probs=197.8
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCCCCeeEEeeE--eCCeEEEEEec
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV--EGDYNVLVIDL 83 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~i~~~~~~~~--~~~~~~lv~e~ 83 (473)
.++|+++++||+|+||+||+|++..+|+.||||++.......+.+|+.+|+.+.+|++|..+..++. .....++||||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 4679999999999999999999999999999999888788889999999999986777777665554 34568999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCcc
Q 011988 84 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 162 (473)
Q Consensus 84 ~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 162 (473)
+ +++|..+ .+.+++.+++.++.||+.||+|||++|||||||||+||||+ .+.+.+||+|||+|+.......
T Consensus 114 ~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~-- 185 (328)
T d3bqca1 114 VNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE-- 185 (328)
T ss_dssp CCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCC--
T ss_pred cCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCc--
Confidence 9 5677654 34699999999999999999999999999999999999996 3455799999999987654322
Q ss_pred ccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc---------
Q 011988 163 HIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 232 (473)
Q Consensus 163 ~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 232 (473)
.....||..|+|||.+.+.. ++.++|||||||++|||++|..||...... ......+.....
T Consensus 186 ------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~--~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 186 ------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp ------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHH
T ss_pred ------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh--HHHHHHHHHHHCCchhhhhhh
Confidence 24568999999999988765 799999999999999999999999764321 111111110000
Q ss_pred ------cc-----------------cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 ------ST-----------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 ------~~-----------------~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
.. ........+++++.+||.+||..||.+|||+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L 317 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00 00001134678999999999999999999988874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=371.66 Aligned_cols=268 Identities=21% Similarity=0.251 Sum_probs=201.9
Q ss_pred cCCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHH--HHhcCCCCCCeeEEeeEeC---CeEEE
Q 011988 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLY--KILQGGTGIPNLRWFGVEG---DYNVL 79 (473)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il--~~L~~~~~i~~~~~~~~~~---~~~~l 79 (473)
|..+|.+.++||+|+||.||+|++ +|+.||||++..........|.+++ ..++|+++|..+..+.... ...++
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 457899999999999999999985 6899999997665555555565554 4566666666555444433 25799
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCcccCCCCCcEEEeeCCCCCcEEEEecC
Q 011988 80 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------KSFLHRDIKPDNFLMGLGRRANQVYIIDFG 150 (473)
Q Consensus 80 v~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~--------~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 150 (473)
||||+ +++|.++++. .++++..++.++.|++.||.|||+ +|||||||||+|||| +.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEecC
Confidence 99999 8899999984 469999999999999999999996 699999999999999 478899999999
Q ss_pred CcccccCCCCccccccccCCCcccCccccccccccCCC------CCchhhHHHHHHHHHHHHcCCCCCCCCCC-------
Q 011988 151 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSLPWQGLKA------- 217 (473)
Q Consensus 151 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~------~s~ksDVwSlGviL~elltG~~Pf~~~~~------- 217 (473)
+++.+........ .......||+.|+|||++.+.. ++.++|||||||+||||++|..||.....
T Consensus 154 l~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 154 LAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp TCEEEETTTTEEC---C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ccccccCCCccee---ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 9998765433221 1224568999999999988653 57789999999999999999888743221
Q ss_pred -----CCHHHHHHHHhhccccccHHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHhCCC
Q 011988 218 -----GTKKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 282 (473)
Q Consensus 218 -----~~~~~~~~~i~~~~~~~~~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~ 282 (473)
.........+......+.+.... ...+.++.+|+..||..||++|||+.+|.+.|+++..+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence 11122222222222222211111 123467999999999999999999999999999999988765
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=372.02 Aligned_cols=271 Identities=18% Similarity=0.272 Sum_probs=214.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEc---CCCcEEEEEEccc-------CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLNVK-------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 75 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~~~~-------~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~ 75 (473)
.++|+++++||+|+||+||+|++. .+|+.||||++.+ .....+.+|+++++.++|+++|..+..+..+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 378999999999999999999974 4689999998533 223457899999999999999999988999999
Q ss_pred eEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCccc
Q 011988 76 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 154 (473)
Q Consensus 76 ~~~lv~e~~-g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 154 (473)
..+++|||+ +++|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec---CCCCEEEeeccchhh
Confidence 999999999 88999998754 4688999999999999999999999999999999999994 678999999999987
Q ss_pred ccCCCCccccccccCCCcccCccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011988 155 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 232 (473)
Q Consensus 155 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~--~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 232 (473)
+...... ......|++.|+|||.+.+.. ++.++|||||||+||||++|+.||.+.........+........
T Consensus 179 ~~~~~~~------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 179 FVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252 (322)
T ss_dssp CCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred hcccccc------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC
Confidence 6543321 123468999999999998654 68899999999999999999999988766554444433322211
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHhCCCCCCcccccccccccc
Q 011988 233 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQS 297 (473)
Q Consensus 233 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~ 297 (473)
. .+...+++++.+||.+||..||++||+.. .+.++|++.|. ..++|..+..+..
T Consensus 253 ~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff-------~~i~~~~l~~~~~ 308 (322)
T d1vzoa_ 253 P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF-------QKINWDDLAAKKV 308 (322)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG-------TTCCHHHHHTTCS
T ss_pred C----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh-------cCCCHHHHHhCCC
Confidence 1 12346899999999999999999999531 13333555443 2356766544433
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=369.37 Aligned_cols=254 Identities=19% Similarity=0.283 Sum_probs=205.8
Q ss_pred CceEEEeeEeecCceEEEEEEEcC-----CCcEEEEEEcccCCc----hhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLNVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 77 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~~~~~~~----~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 77 (473)
++|++.++||+|+||.||+|.+.. +++.||||++..... ..+.+|+.+++.++|++++.. ..++......
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~-~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL-LGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE-EEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeee-eeEEecCCce
Confidence 789999999999999999998753 357899998654332 237899999999986655554 4455667778
Q ss_pred EEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEE
Q 011988 78 VLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 147 (473)
Q Consensus 78 ~lv~e~~-g~sL~~~l~~~~---------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~ 147 (473)
++||||+ +++|.+++.... ..+++..+..|+.||+.||.|||+++||||||||+|||| +.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceEEEe
Confidence 9999999 889999886331 247899999999999999999999999999999999999 478899999
Q ss_pred ecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCCHHHHHHH
Q 011988 148 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEK 226 (473)
Q Consensus 148 DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG-~~Pf~~~~~~~~~~~~~~ 226 (473)
|||+|+.+....... ......||+.|+|||.+.+..++.++|||||||+||||++| ..||.+. ...+.+..
T Consensus 176 DFGla~~~~~~~~~~-----~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~~~~ 247 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRF 247 (308)
T ss_dssp CTTCCCGGGGGGCEE-----GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHHHHH
T ss_pred ecccceeccCCccee-----eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---CHHHHHHH
Confidence 999998765543211 12345789999999999999999999999999999999998 5788764 34445555
Q ss_pred HhhccccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011988 227 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 276 (473)
Q Consensus 227 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 276 (473)
+....... ....+|+++.++|..||+.||++||++.+|++.|++.+
T Consensus 248 i~~~~~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 248 VMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHhCCCCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 54433322 23578899999999999999999999999988887653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=373.85 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=196.3
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCCc-----hhHHHHHHHHHHhcCCCCCCeeEEeeE-----eCC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGV-----EGD 75 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~~-----~~l~~E~~il~~L~~~~~i~~~~~~~~-----~~~ 75 (473)
.++|+++++||+|+||+||+|++..+|+.||||++.+... ..+.+|+.+|+.|+|++++..+..+.. +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5789999999999999999999999999999999655432 346789999999998777776665542 234
Q ss_pred eEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 76 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 76 ~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
..+++|+++|++|.+++. .+++++.+++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|...
T Consensus 97 ~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhccc
Confidence 567778878999999986 4579999999999999999999999999999999999999 47889999999999765
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc----
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---- 230 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~---- 230 (473)
.... ....||..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+......
T Consensus 172 ~~~~----------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 172 DDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp TGGG----------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred Cccc----------ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 4322 3568999999999988765 689999999999999999999999875432222222111110
Q ss_pred -------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 231 -------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 231 -------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
...........++++++.+||..||..||.+|||+.+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL 299 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHh
Confidence 011222334457889999999999999999999988773
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=357.47 Aligned_cols=250 Identities=21% Similarity=0.247 Sum_probs=197.1
Q ss_pred CceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEE
Q 011988 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 81 (473)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~ 81 (473)
++|+++++||+|+||+||+|++..+++.||||++.... ..++.+|+.+++.++|++++ .+..+.......+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv-~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV-RLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBC-CEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEE-eeccccccccceeEEe
Confidence 68999999999999999999999999999999854332 34578999999999866554 5566677788889999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccccCCCCc
Q 011988 82 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 161 (473)
Q Consensus 82 e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 161 (473)
+++.+.+...+....+.+++..+..++.|++.||+|||++|||||||||+|||+. ..+.+||+|||.|+........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~---~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCSCCSC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc---cCCceeeeecchhhcccCCCcc
Confidence 9995544444444677899999999999999999999999999999999999994 6789999999999877554321
Q ss_pred cccccccCCCcccCccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc--------
Q 011988 162 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 232 (473)
Q Consensus 162 ~~~p~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 232 (473)
.....++..|+|||.+.+.. ++.++|||||||++|||++|..||.... +..+.+.++.....
T Consensus 158 -------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 158 -------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp -------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCT
T ss_pred -------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhhh
Confidence 23456788999999988765 6999999999999999999999975432 22333333221110
Q ss_pred ----------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011988 233 ----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 269 (473)
Q Consensus 233 ----------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 269 (473)
..........+++++.+||..||..||.+|||+++|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0111223345678999999999999999999988773
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=368.99 Aligned_cols=255 Identities=19% Similarity=0.220 Sum_probs=188.8
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC-----chhHHHHHHHHHHhcCCCCCCeeEEeeE-----eCC
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGV-----EGD 75 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~-----~~~l~~E~~il~~L~~~~~i~~~~~~~~-----~~~ 75 (473)
.++|+++++||+|+||+||+|++..+|+.||||++.+.. ...+.+|+.+++.++|++++..+..|.. ...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 478999999999999999999999999999999965432 2247799999999987666666666543 346
Q ss_pred eEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEEecCCcccc
Q 011988 76 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 155 (473)
Q Consensus 76 ~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 155 (473)
..|+||||+.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 96 ~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~---~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC----
T ss_pred eeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc---cccceeeechhhhhcc
Confidence 889999999888877664 5699999999999999999999999999999999999994 7788999999998866
Q ss_pred cCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc----
Q 011988 156 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---- 231 (473)
Q Consensus 156 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~---- 231 (473)
..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+.......
T Consensus 170 ~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 170 GTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp -------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccc--------cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence 54322 245679999999999999999999999999999999999999998754322221111111000
Q ss_pred ---ccc---------------cHH------------HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011988 232 ---VST---------------SIE------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 277 (473)
Q Consensus 232 ---~~~---------------~~~------------~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 277 (473)
... ... ......++++.+||.+||..||++|||+++| |++-|.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el---L~Hpw~ 314 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA---LQHPYI 314 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH---HTSTTT
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH---hcCccc
Confidence 000 000 0111235788999999999999999998887 555443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-40 Score=333.15 Aligned_cols=253 Identities=23% Similarity=0.299 Sum_probs=182.5
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHhcCCC----------CCC-eeEEee-
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK--HPQLQYEAKLYKILQGGT----------GIP-NLRWFG- 71 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~--~~~l~~E~~il~~L~~~~----------~i~-~~~~~~- 71 (473)
.++|+++++||+|+||+||+|++..+|+.||||++.+.. ...+.+|+++++.+.+.+ +|. .+..+.
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 357999999999999999999999999999999976543 345788999999987533 333 333332
Q ss_pred EeCCeEEEEEecC--CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccCCCCCcEEEeeCCCC---CcE
Q 011988 72 VEGDYNVLVIDLL--GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRA---NQV 144 (473)
Q Consensus 72 ~~~~~~~lv~e~~--g~sL~~~l~~-~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~---~~v 144 (473)
......+++|+++ +.+....... ....+++..++.++.||+.||+|||+ .||+||||||+||||+.++.. ..+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 3445566666655 4444444432 34579999999999999999999998 899999999999999643222 258
Q ss_pred EEEecCCcccccCCCCccccccccCCCcccCccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC---HH
Q 011988 145 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KK 221 (473)
Q Consensus 145 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~---~~ 221 (473)
+|+|||.|....... ....||+.|+|||++.+..++.++|||||||++++|++|+.||....... ..
T Consensus 172 kl~dfg~s~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 172 KIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp EECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred eEeeccccccccccc----------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 999999998654322 34689999999999999999999999999999999999999997543211 11
Q ss_pred HHHHHHhhccc------------------------------cccHHH-------HhcCCcHHHHHHHHHHhcCCCCCCCC
Q 011988 222 QKYEKISEKKV------------------------------STSIEA-------LCRGYPTEFASYFHYCRSLRFDDKPD 264 (473)
Q Consensus 222 ~~~~~i~~~~~------------------------------~~~~~~-------l~~~~p~~l~~li~~cl~~dp~~RPt 264 (473)
..+........ ...... +....++++.+||..||.+||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 11111100000 000000 01123578999999999999999999
Q ss_pred HHHH
Q 011988 265 YAYL 268 (473)
Q Consensus 265 ~~~l 268 (473)
++++
T Consensus 322 a~e~ 325 (362)
T d1q8ya_ 322 AGGL 325 (362)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.3e-24 Score=197.99 Aligned_cols=163 Identities=16% Similarity=0.212 Sum_probs=114.2
Q ss_pred eEEEeeEeecCceEEEEEEEcCCCcEEEEEEcccCC---------------------chhHHHHHHHHHHhcCCCCCCee
Q 011988 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVKTK---------------------HPQLQYEAKLYKILQGGTGIPNL 67 (473)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~~~---------------------~~~l~~E~~il~~L~~~~~i~~~ 67 (473)
+.+.++||+|+||+||+|++ .+|+.||||+..... ......|..++..+.+.+.+..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 56899999999999999997 478999999743210 01134577778888755433322
Q ss_pred EEeeEeCCeEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcccCCCCCcEEEeeCCCCCcEEEE
Q 011988 68 RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 147 (473)
Q Consensus 68 ~~~~~~~~~~~lv~e~~g~sL~~~l~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~ 147 (473)
.... .+++|||+++... ..++...+..++.||+.+|.|||++||+||||||+|||++ ...++|+
T Consensus 81 ---~~~~--~~lvme~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~li 144 (191)
T d1zara2 81 ---AWEG--NAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWII 144 (191)
T ss_dssp ---EEET--TEEEEECCCCEEG-------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEEC
T ss_pred ---EecC--CEEEEEeeccccc-------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEEEE
Confidence 2222 3799999965321 1255566788999999999999999999999999999995 3569999
Q ss_pred ecCCcccccCCCCccccccccCCCcccCcccccc--c---cccCCCCCchhhHHHHHHHHH
Q 011988 148 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASM--N---THLGIEQSRRDDLESLGYVLM 203 (473)
Q Consensus 148 DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~AP--E---~~~~~~~s~ksDVwSlGviL~ 203 (473)
|||+|+....... ..|... + .+....|+.++||||+.--+.
T Consensus 145 DFG~a~~~~~~~~---------------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGW---------------REILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTH---------------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCc---------------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 9999976543221 111111 0 122356788999999865543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.47 E-value=6.9e-07 Score=82.56 Aligned_cols=83 Identities=17% Similarity=0.230 Sum_probs=60.9
Q ss_pred CCceEEEeeEeecCceEEEEEEEcCCCcEEEEEEccc---CCchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEe
Q 011988 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 82 (473)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~---~~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e 82 (473)
.+.|++.+..+.++.+.||+.. ..+..++||+... .....+..|..++..|...--++.+..++..+...++||+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 3568888876666678999886 4566778888432 2234578999999999766557777777888888999999
Q ss_pred cC-CCCHHH
Q 011988 83 LL-GPSLED 90 (473)
Q Consensus 83 ~~-g~sL~~ 90 (473)
++ |..+.+
T Consensus 91 ~l~G~~~~~ 99 (263)
T d1j7la_ 91 EADGVLCSE 99 (263)
T ss_dssp CCSSEEHHH
T ss_pred ecccccccc
Confidence 99 445543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.10 E-value=5.2e-06 Score=76.01 Aligned_cols=69 Identities=14% Similarity=0.045 Sum_probs=52.3
Q ss_pred EeecC-ceEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHhcCCCC-CCeeEEeeEeCCeEEEEEecC
Q 011988 15 IGSGS-FGEIYLGTNIQTNEEVAIKLNVKTKHPQLQYEAKLYKILQGGTG-IPNLRWFGVEGDYNVLVIDLL 84 (473)
Q Consensus 15 LG~G~-fG~Vy~a~~~~~~~~vAiK~~~~~~~~~l~~E~~il~~L~~~~~-i~~~~~~~~~~~~~~lv~e~~ 84 (473)
+..|. .+.||+... ..+..+++|.........+..|..+++.|..... ++.+..+..++...+++|+++
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 88 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence 34444 468999874 5677789999666666678999999999876544 566677777778889999998
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.00 E-value=1e-05 Score=79.68 Aligned_cols=73 Identities=15% Similarity=0.215 Sum_probs=48.1
Q ss_pred EeeEeecCceEEEEEEEcCCCcEEEEEEccc------C----CchhHHHHHHHHHHhcCC--CCCCeeEEeeEeCCeEEE
Q 011988 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK------T----KHPQLQYEAKLYKILQGG--TGIPNLRWFGVEGDYNVL 79 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~------~----~~~~l~~E~~il~~L~~~--~~i~~~~~~~~~~~~~~l 79 (473)
.+.||.|....||++.+..+++.|+||.... . .......|..+|+.+... ..++.+.. .+....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence 5578999999999998777788999996211 1 123456799999888643 33455543 45556689
Q ss_pred EEecCCC
Q 011988 80 VIDLLGP 86 (473)
Q Consensus 80 v~e~~g~ 86 (473)
+||++++
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999843
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.96 E-value=0.0024 Score=60.19 Aligned_cols=64 Identities=13% Similarity=0.138 Sum_probs=43.2
Q ss_pred ceEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHhcCCCCCCee-------EEeeEeCCeEEEEEecCC
Q 011988 20 FGEIYLGTNIQTNEEVAIKLNVKT--KHPQLQYEAKLYKILQGGTGIPNL-------RWFGVEGDYNVLVIDLLG 85 (473)
Q Consensus 20 fG~Vy~a~~~~~~~~vAiK~~~~~--~~~~l~~E~~il~~L~~~~~i~~~-------~~~~~~~~~~~lv~e~~g 85 (473)
--.||++.. .+|+.|++|+.... ...++..|..++..|.... ++.. ..........+.++++++
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~g-ipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDE-VPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTT-CSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcC-CCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 347999984 67889999996543 3567889999999987432 2211 112245667788888774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.95 E-value=0.0017 Score=63.09 Aligned_cols=70 Identities=13% Similarity=0.132 Sum_probs=50.0
Q ss_pred EeeEeecCceEEEEEEEcC-------CCcEEEEEEcccC-CchhHHHHHHHHHHhcCCCCCCeeEEeeEeCCeEEEEEec
Q 011988 12 GRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLNVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 83 (473)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~~~~~-~~~~l~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (473)
++.|+.|-.-.+|++.... ..+.|++++.... ..-...+|..+++.+......+.+.+++. + .+||+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEEEE
Confidence 4678888889999998643 2456888885432 22346789999999987777777766653 2 678888
Q ss_pred CC
Q 011988 84 LG 85 (473)
Q Consensus 84 ~g 85 (473)
+.
T Consensus 123 i~ 124 (395)
T d1nw1a_ 123 IP 124 (395)
T ss_dssp CC
T ss_pred ec
Confidence 73
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.60 E-value=0.002 Score=60.22 Aligned_cols=50 Identities=16% Similarity=0.167 Sum_probs=31.7
Q ss_pred EEEeeEeecCceEEEEEEEcCCCcEEEEEEccc-CCchhHHHHHHHHHHhcCC
Q 011988 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLNVK-TKHPQLQYEAKLYKILQGG 61 (473)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~~~~-~~~~~l~~E~~il~~L~~~ 61 (473)
.-.+.|..|---+.|+... ..| .+++|+... .....+..|..++..|...
T Consensus 21 ~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~ 71 (316)
T d2ppqa1 21 TSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAK 71 (316)
T ss_dssp EEEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHT
T ss_pred eEeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCCCHHHHHHHHHHHHhhhhc
Confidence 3345566777778899874 334 589999644 3556788899999988743
|